name: CRDC-H notes: - Derived from [CDM_Dictionary_v1 (Active)](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4) id: https://example.org/crdch version: v1.1-77-gfb63fbee imports: - linkml:types license: https://creativecommons.org/publicdomain/zero/1.0/ prefixes: linkml: https://w3id.org/linkml/ crdch: https://example.org/crdch/ NCIT: http://purl.obolibrary.org/obo/NCIT_ GDC: http://example.org/gdc/ PDC: http://example.org/pdc/ ICDC: http://example.org/icdc/ HTAN: http://example.org/htan/ default_prefix: crdch types: crdch_string: name: crdch_string description: A sequence of Unicode characters. There are no limits on the number of characters in the string. notes: - Derived from [crdch_string in sheet Primitives](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=497370447) typeof: string crdch_integer: name: crdch_integer description: An integer number. This data type is based on the decimal type, but the fractional component is not allowed. There are no restrictions on the size of the integer. notes: - Derived from [crdch_integer in sheet Primitives](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=497370447) typeof: integer crdch_decimal: name: crdch_decimal description: A rational number that has a decimal representation. This data type does not restrict the size or precision of the number. notes: - Derived from [crdch_decimal in sheet Primitives](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=497370447) typeof: decimal crdch_boolean: name: crdch_boolean description: "Value representing either \u201Ctrue\u201D or \u201Cfalse\u201D\ . Permissible values (case-sensitive) = \u201Ctrue\u201D, \u201Cfalse\u201D\ , \u201C1\u201D, \u201C0\u201D." notes: - Derived from [crdch_boolean in sheet Primitives](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=497370447) typeof: boolean crdch_dateTime: name: crdch_dateTime description: A date and time string specified using a specialized concatenation of the date and time data types, in the general format YYYY-MM-DDThh:mm:ss+zz:zz. notes: - Derived from [crdch_dateTime in sheet Primitives](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=497370447) typeof: datetime crdch_curie: name: crdch_curie description: "A compact URI (CURIE), which is a bipartite identifier of the form\ \ prefix:reference, in which the prefix is a convenient abbreviation of a URI.\ \ It is expressed in the format \u201Cprefix:reference\u201D. When a mapping\ \ of prefix to base URI is provided (external to this data type), a CURIE may\ \ be mapped to a URI." notes: - Derived from [crdch_curie in sheet Primitives](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=497370447) typeof: uriorcurie crdch_code: name: crdch_code description: '' notes: - Derived from [crdch_code in sheet Primitives](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=497370447) typeof: string enums: enum_CRDCH_AlcoholExposureObservation_category: name: enum_CRDCH_AlcoholExposureObservation_category description: Autogenerated Enumeration for CRDC-H AlcoholExposureObservation category comments: - 'Name according to TCCM: "CRDC-H.AlcoholExposureObservation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.AlcoholExposureObservation.category code_set_version: '2021-12-16T18:03:46.901555+00:00' enum_CRDCH_AlcoholExposureObservation_observation_type: name: enum_CRDCH_AlcoholExposureObservation_observation_type description: Types of observations about a Subject's exposure to alcohol. notes: - Derived from [AlcoholExposureObservation.observation_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: alcohol_days_per_week: text: alcohol_days_per_week description: Numeric value used to describe the average number of days each week that a person consumes an alcoholic beverage. alcohol_drinks_per_day: text: alcohol_drinks_per_day description: Numeric value used to describe the average number of alcoholic beverages a person consumes per day. alcohol_history: text: alcohol_history description: A response to a question that asks whether the participant has consumed at least 12 drinks of any kind of alcoholic beverage in their lifetime. alcohol_intensity: text: alcohol_intensity description: Category to describe the patient's current level of alcohol use as self-reported by the patient. enum_CRDCH_AlcoholExposureObservation_method_type: name: enum_CRDCH_AlcoholExposureObservation_method_type description: Autogenerated Enumeration for CRDC-H AlcoholExposureObservation method_type comments: - 'Name according to TCCM: "CRDC-H.AlcoholExposureObservation.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.AlcoholExposureObservation.method_type code_set_version: '2021-12-16T18:03:47.431359+00:00' enum_CRDCH_AlcoholExposureObservation_value_codeable_concept: name: enum_CRDCH_AlcoholExposureObservation_value_codeable_concept description: Autogenerated Enumeration for CRDC-H AlcoholExposureObservation value_codeable_concept comments: - 'Name according to TCCM: "CRDC-H.AlcoholExposureObservation.value_codeable_concept"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.AlcoholExposureObservation.value_codeable_concept code_set_version: '2021-12-16T18:03:47.581332+00:00' permissible_values: Non-Drinker: text: Non-Drinker Lifelong Non-Drinker: text: Lifelong Non-Drinker Drinker: text: Drinker Unknown: text: Unknown Heavy Drinker: text: Heavy Drinker Not Reported: text: Not Reported Occasional Drinker: text: Occasional Drinker description: Occasional Drinker 'No': text: 'No' description: 'No' 'Yes': text: 'Yes' description: 'Yes' enum_CRDCH_BodySite_site: name: enum_CRDCH_BodySite_site description: Autogenerated Enumeration for CRDC-H BodySite site comments: - 'Name according to TCCM: "CRDC-H.BodySite.site"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.BodySite.site code_set_version: '2021-12-16T18:03:47.749381+00:00' permissible_values: Nasopharynx: text: Nasopharynx description: Nasopharynx Retina: text: Retina description: Retina Brain Stem: text: Brain Stem description: Brain Stem Lymph Node(s) Pelvic: text: Lymph Node(s) Pelvic description: Pelvic Lymph Node Ocular Orbits: text: Ocular Orbits description: Orbit Mantle: text: Mantle Breast: text: Breast description: Breast Sinus: text: Sinus description: Sinus Abdomen, total: text: Abdomen, total Clavicle: text: Clavicle description: Clavicle Kidney: text: Kidney description: Kidney Brain: text: Brain description: Brain Tonsil: text: Tonsil description: Tonsil Axilla: text: Axilla description: Axilla Arm: text: Arm description: Arm Anus: text: Anus description: Anus Bronchiole: text: Bronchiole description: Bronchiole Femoral Vein: text: Femoral Vein description: Femoral Vein Bone, non-spine: text: Bone, non-spine Groin: text: Groin description: Inguinal Region Hilar: text: Hilar Pouch: text: Pouch description: Pouch Head - Face Or Neck, Nos: text: Head - Face Or Neck, Nos Neck: text: Neck description: Neck Shoulder: text: Shoulder description: Shoulder Joint Gum: text: Gum description: Gingiva Ankle: text: Ankle description: Ankle Lip: text: Lip description: Lip Wrist: text: Wrist description: Wrist Ischium: text: Ischium description: Ischium Skull: text: Skull description: Skull Pericardium: text: Pericardium description: Pericardium Fundus of Stomach: text: Fundus of Stomach Ovary: text: Ovary description: Ovary Vertebra: text: Vertebra description: Vertebra Bone: text: Bone description: Bone Amniotic Fluid: text: Amniotic Fluid description: Amniotic Fluid Ileum: text: Ileum description: Ileum Nasal Soft Tissue: text: Nasal Soft Tissue description: Nasal Soft Tissue Lymph Node(s) Paraaortic: text: Lymph Node(s) Paraaortic Hypopharynx: text: Hypopharynx description: Hypopharynx Palate: text: Palate description: Palate Back: text: Back description: Back Thumb: text: Thumb description: Hand Digit 1 Heart: text: Heart description: Heart Lymph Node: text: Lymph Node description: Lymph node Vein: text: Vein description: Vein Lymph Node(s) Cervical: text: Lymph Node(s) Cervical description: Cervical Lymph Node Lymph Node(s) Regional: text: Lymph Node(s) Regional Rib: text: Rib description: Rib Buccal Mucosa: text: Buccal Mucosa description: Buccal Mucosa Placenta: text: Placenta description: Placenta Fluid: text: Fluid description: Body Fluid or Substance Stomach: text: Stomach description: Stomach Peritoneum: text: Peritoneum description: Peritoneum Ear: text: Ear description: Ear Sacrum: text: Sacrum description: Sacrum Vagina: text: Vagina description: Vagina Finger: text: Finger description: Fingers (Phalanges) Skin, upper extremity, local: text: Skin, upper extremity, local Foreskin: text: Foreskin description: Male Prepuce Adenoid: text: Adenoid description: Tonsillar Tissue Joint: text: Joint description: Joint Hepatic Duct: text: Hepatic Duct description: Hepatic Duct Nasal Cavity: text: Nasal Cavity description: Nasal Cavity Index Finger: text: Index Finger Fallopian Tube: text: Fallopian Tube description: Fallopian tube Ascites: text: Ascites Splenic Flexure: text: Splenic Flexure description: Splenic Flexure Parametrium: text: Parametrium Peritoneal Cavity: text: Peritoneal Cavity description: Peritoneal Cavity Blood Vessel: text: Blood Vessel Blood: text: Blood description: Blood Lymph Node(s) Scalene: text: Lymph Node(s) Scalene Floor of Mouth: text: Floor of Mouth description: Floor of Mouth Antrum: text: Antrum description: Antrum Pylori Distant Site: text: Distant Site Broad Ligament: text: Broad Ligament description: Broad Ligament Parotid Gland: text: Parotid Gland description: Parotid Gland Spinal Cord: text: Spinal Cord description: Spinal Cord Aorta: text: Aorta description: Aorta Soft Tissue: text: Soft Tissue description: Soft tissue Thorax: text: Thorax description: Thorax Scapula: text: Scapula description: Scapula Tongue: text: Tongue description: Tongue Hand: text: Hand description: Hand Capillary: text: Capillary description: Capillary Humerus: text: Humerus description: Humerus Primary tumor site: text: Primary tumor site Buttock: text: Buttock description: Buttock Buccal Cavity: text: Buccal Cavity description: Buccal Cavity Larynx: text: Larynx description: Larynx Aqueous Fluid: text: Aqueous Fluid description: Aqueous Fluid Periorbital Soft Tissue: text: Periorbital Soft Tissue description: Periorbital Soft Tissue Carina: text: Carina description: Carina Leptomeninges: text: Leptomeninges description: Leptomeninges Conjunctiva: text: Conjunctiva description: Conjunctiva Lymph Node(s) Hilar: text: Lymph Node(s) Hilar description: Hilar Lymph Node Cerebral Cortex: text: Cerebral Cortex description: Cerebral Cortex Lymph Node(s) Internal Mammary: text: Lymph Node(s) Internal Mammary description: Internal Mammary Lymph Node Regional Site: text: Regional Site Esophagogastric Junction: text: Esophagogastric Junction Small Bowel - Mucosa Only: text: Small Bowel - Mucosa Only description: Small Bowel Mucosa White Blood Cells: text: White Blood Cells description: Leukocyte Penis: text: Penis description: Penis Lymph Node(s) Iliac-External: text: Lymph Node(s) Iliac-External Autonomic Nervous System: text: Autonomic Nervous System description: Autonomic Nervous System Skin, lower extremity, local: text: Skin, lower extremity, local Sinus(es), Maxillary: text: Sinus(es), Maxillary description: Maxillary Sinus Vas Deferens: text: Vas Deferens description: Vas Deferens Forehead: text: Forehead description: Forehead Skin, trunk, local: text: Skin, trunk, local Skin, total: text: Skin, total Ear, Pinna (External): text: Ear, Pinna (External) description: External Ear Anorectum: text: Anorectum description: Anorectum Epidural Space: text: Epidural Space description: Epidural Spinal Canal Space Lymph Node(s) Mediastinal: text: Lymph Node(s) Mediastinal Laryngopharynx: text: Laryngopharynx description: Hypopharynx (Laryngopharynx) Carotid Body: text: Carotid Body description: Carotid Body Parathyroid: text: Parathyroid description: Parathyroid Gland Antecubital Fossa: text: Antecubital Fossa description: Antecubital Fossa Thymus: text: Thymus description: Thymus Lymph Node(s) Axilla: text: Lymph Node(s) Axilla description: Axillary Lymph Node Chest: text: Chest description: Chest Calf: text: Calf description: Calf Nails: text: Nails description: Nail Mediastinal Soft Tissue: text: Mediastinal Soft Tissue description: Mediastinal Soft Tissue Lymph Node(s) Supraclavicular: text: Lymph Node(s) Supraclavicular description: Supraclavicular Lymph Node Gallbladder: text: Gallbladder description: Gallbladder Ring Finger: text: Ring Finger Bile Duct: text: Bile Duct description: Bile Duct Frontal Lobe: text: Frontal Lobe description: Frontal Lobe Hepatic: text: Hepatic description: Hepatic Cartilage: text: Cartilage description: Cartilage Pancreas: text: Pancreas description: Pancreas Elbow: text: Elbow description: Elbow Joint Ligament: text: Ligament description: Ligament Mesentery: text: Mesentery description: Mesentery Maxilla: text: Maxilla description: Maxilla Frontal Cortex: text: Frontal Cortex description: Frontal Lobe Head and Neck: text: Head and Neck Venous: text: Venous description: Venous Cerebrum: text: Cerebrum description: Cerebral Hemisphere Prostate: text: Prostate description: Prostate Ampulla of Vater: text: Ampulla of Vater description: Ampulla of Vater Connective Tissue: text: Connective Tissue description: Connective Tissue Clitoris: text: Clitoris description: Clitoris Ureter: text: Ureter description: Ureter Hippocampus: text: Hippocampus description: Hippocampus Thoracic Spine: text: Thoracic Spine description: Thoracic Spine Oral Cavity: text: Oral Cavity description: Oral Cavity Middle Finger: text: Middle Finger Body, total: text: Body, total Chest Wall: text: Chest Wall description: Chest Wall Eye: text: Eye description: Eye Forearm: text: Forearm description: Forearm Central Nervous System: text: Central Nervous System description: Central Nervous System Lymph Node(s) Retroperitoneal: text: Lymph Node(s) Retroperitoneal description: Retroperitoneal Lymph Node Testis: text: Testis description: Testis Femur: text: Femur description: Femur Liver: text: Liver description: Liver Scalp: text: Scalp description: Scalp Tonsil (Pharyngeal): text: Tonsil (Pharyngeal) description: Pharynx Tonsil Gastrointestinal, Intestine: text: Gastrointestinal, Intestine Anal Sphincter: text: Anal Sphincter description: Anal Sphincter Pelvis: text: Pelvis description: Pelvis Spleen: text: Spleen description: Spleen Occipital Cortex: text: Occipital Cortex description: Occipital Lobe Rectum: text: Rectum description: Rectum Lymph Node(s) Mammary: text: Lymph Node(s) Mammary description: Mammary Lymph Node Ileocecal Valve: text: Ileocecal Valve description: Ileocecal Valve Skeletal Muscle: text: Skeletal Muscle description: Skeletal Muscle Tissue Thyroid: text: Thyroid description: Thyroid Gland Paraspinal Ganglion: text: Paraspinal Ganglion description: Spinal Ganglion Ear Canal: text: Ear Canal description: Ear Canal Round Ligament: text: Round Ligament description: Round Ligament Lung: text: Lung description: Lung Oropharynx: text: Oropharynx description: Oropharynx Epitrochlear: text: Epitrochlear Lymph Node(s) Inguinal: text: Lymph Node(s) Inguinal description: Inguinal Lymph Node Auditory Canal: text: Auditory Canal description: Auditory Canal Uterus: text: Uterus description: Uterus Cervical Spine: text: Cervical Spine description: Cervical Spine Scrotum: text: Scrotum description: Scrotum Stomach - Mucosa Only: text: Stomach - Mucosa Only description: Stomach Mucosa Urethra: text: Urethra description: Urethra Uvula: text: Uvula description: Uvula Acetabulum: text: Acetabulum description: Acetabulum Trunk: text: Trunk description: Trunk Ganglia: text: Ganglia description: Ganglion Popliteal Fossa: text: Popliteal Fossa Colon - Mucosa Only: text: Colon - Mucosa Only description: Colon Mucosa Esophagus - Mucosa Only: text: Esophagus - Mucosa Only description: Esophagus Mucosa Retro-Orbital Region: text: Retro-Orbital Region description: Retro-Orbital Region Trachea / Major Bronchi: text: Trachea / Major Bronchi description: Trachea / Major Bronchi Bowel: text: Bowel description: Bowel Prostate, Seminal Vesicles and Lymph Nodes: text: Prostate, Seminal Vesicles and Lymph Nodes Nerve: text: Nerve description: nerve Cerebrospinal Fluid: text: Cerebrospinal Fluid description: Cerebrospinal Fluid Tibia: text: Tibia description: Tibia Artery: text: Artery description: Artery Epididymis: text: Epididymis description: Epididymis Aortic Body: text: Aortic Body description: Aortic Body Cecum: text: Cecum description: Cecum Muscle: text: Muscle description: Muscle Lymph Node(s) Femoral: text: Lymph Node(s) Femoral description: Femoral Lymph Node Hard Palate: text: Hard Palate description: Hard Palate Other: text: Other description: Other Oral Cavity - Mucosa Only: text: Oral Cavity - Mucosa Only description: Oral Cavity Mucosa Pylorus: text: Pylorus description: Pylorus Colon: text: Colon description: Colon Common Duct: text: Common Duct description: Common Bile Duct Umbilical Cord: text: Umbilical Cord description: Umbilical Cord Abdominal Wall: text: Abdominal Wall description: Abdominal Wall Islet Cells: text: Islet Cells description: Islet Cell Skin: text: Skin description: Skin Vulva: text: Vulva description: Vulva Cerebellum: text: Cerebellum description: Cerebellum Genitourinary, NOS: text: Genitourinary, NOS Salivary Gland: text: Salivary Gland description: Salivary Gland Spine: text: Spine Lymph Node(s) Occipital: text: Lymph Node(s) Occipital description: Occipital Lymph Node Lymph Node(s) Parotid: text: Lymph Node(s) Parotid description: Parotid Gland Lymph Node Leg: text: Leg description: Leg Lymph Node(s) Splenic: text: Lymph Node(s) Splenic description: Splenic Lymph Node Rectosigmoid Junction: text: Rectosigmoid Junction description: Rectosigmoid Region Cervix: text: Cervix description: Cervix Foot: text: Foot description: Foot Brow: text: Brow description: Eyebrow Hip: text: Hip description: Hip Bronchus: text: Bronchus description: Bronchus Jejunum: text: Jejunum description: Jejunum Jaw: text: Jaw description: Jaw Lymph Node(s) Submandibular: text: Lymph Node(s) Submandibular description: Submandibular Lymph Node Tendon: text: Tendon description: Tendon Cell-Line: text: Cell-Line description: Cell Line Mandible: text: Mandible description: Mandible Ascending Colon: text: Ascending Colon description: Ascending Colon Pineal: text: Pineal description: Pineal Seminal Vesicle: text: Seminal Vesicle description: Seminal Vesicle Temporal Cortex: text: Temporal Cortex description: Temporal Lobe Omentum: text: Omentum description: Omentum Patella: text: Patella description: Patella Adipose: text: Adipose description: Adipose Tissue Pituitary Gland: text: Pituitary Gland description: Pituitary Gland Duodenum: text: Duodenum description: Duodenum Bone Marrow: text: Bone Marrow description: Bone Marrow Lymph Node(s) Iliac-Common: text: Lymph Node(s) Iliac-Common Endocrine Gland: text: Endocrine Gland description: Endocrine Gland Subcutaneous Tissue: text: Subcutaneous Tissue description: Subcutis Descending Colon: text: Descending Colon description: Descending Colon Mitochondria: text: Mitochondria description: Mitochondrion Mediastinum: text: Mediastinum description: Mediastinum Ilium: text: Ilium description: Ilium Sciatic Nerve: text: Sciatic Nerve description: Sciatic Nerve Knee: text: Knee description: Knee Joint Spinal Column: text: Spinal Column description: Vertebral Column Diaphragm: text: Diaphragm description: Diaphragm Urinary Tract: text: Urinary Tract description: Urinary System Esophagus: text: Esophagus description: Esophagus Lymph Node(s) Mesenteric: text: Lymph Node(s) Mesenteric description: Mesenteric Lymph Node Alveolar Ridge: text: Alveolar Ridge description: Alveolar Ridge Prostate Bed: text: Prostate Bed Appendix: text: Appendix description: Appendix Pineal Gland: text: Pineal Gland description: Pineal Gland Lacrimal Gland: text: Lacrimal Gland description: Lacrimal Gland Lymph Node(s) Distant: text: Lymph Node(s) Distant Sternum: text: Sternum description: Sternum Thigh: text: Thigh description: Thigh Pleura: text: Pleura description: Pleura Transverse Colon: text: Transverse Colon description: Transverse Colon Femoral Artery: text: Femoral Artery description: Femoral Artery Nerve(s) Cranial: text: Nerve(s) Cranial description: Cranial Nerve Cardia: text: Cardia description: Gastric Cardia Carotid Artery: text: Carotid Artery description: Carotid Artery Dermal: text: Dermal description: Dermal Hepatic Vein: text: Hepatic Vein description: Hepatic Vein Small Bowel: text: Small Bowel description: Small Intestine Ascending Colon Hepatic Flexure: text: Ascending Colon Hepatic Flexure description: Ascending Colon Hepatic Flexure Throat: text: Throat description: Throat Fibroblasts: text: Fibroblasts description: Fibroblast Fibula: text: Fibula description: Fibula Primary Tumor Field: text: Primary Tumor Field Gastrointestinal Tract: text: Gastrointestinal Tract description: Gastrointestinal Tract Chin: text: Chin description: Mentum Small Finger: text: Small Finger Gastroesophageal Junction: text: Gastroesophageal Junction description: Gastroesophageal Junction Bladder: text: Bladder description: Bladder Retroperitoneum: text: Retroperitoneum description: Retroperitoneum Large Bowel: text: Large Bowel description: Large Intestine Lymph Node(s) Epitrochlear: text: Lymph Node(s) Epitrochlear description: Epitrochlear Lymph Node Sigmoid Colon: text: Sigmoid Colon description: Sigmoid Colon Lymph Node(s) Subclavicular: text: Lymph Node(s) Subclavicular description: Infraclavicular Lymph Node Pharynx: text: Pharynx description: Pharynx Mesothelium: text: Mesothelium description: Mesothelium Lymph Node(s) Popliteal: text: Lymph Node(s) Popliteal description: Popliteal Lymph Node Synovium: text: Synovium description: Synovial Membrane Lumbar Spine: text: Lumbar Spine description: Lumbar Spine Adrenal: text: Adrenal description: Adrenal Gland Abdomen: text: Abdomen description: Abdominal Cavity Unknown: text: Unknown description: Unknown Not Allowed To Collect: text: Not Allowed To Collect Esophageal; Proximal: text: Esophageal; Proximal description: Proximal Esophageal Lymph Nodes(s) Mediastinal: text: Lymph Nodes(s) Mediastinal Esophageal; Distal: text: Esophageal; Distal description: Distal Esophageal Ampulla Of Vater: text: Ampulla Of Vater Fundus Of Stomach: text: Fundus Of Stomach Effusion: text: Effusion description: Effusion Esophageal; Mid: text: Esophageal; Mid description: Middle Esophageal Floor Of Mouth: text: Floor Of Mouth Hepatic Flexure: text: Hepatic Flexure description: Hepatic Flexure Head & Neck: text: Head & Neck Other endocrine glands and related structures: text: Other endocrine glands and related structures description: Other endocrine glands and related structures Meninges: text: Meninges description: Meninges Not Reported: text: Not Reported description: Not Reported Parotid gland: text: Parotid gland description: Parotid Gland Peripheral nerves and autonomic nervous system: text: Peripheral nerves and autonomic nervous system description: Peripheral Nerve and Autonomic Nervous System Eye and adnexa: text: Eye and adnexa description: Adnexa And Eye Corpus uteri: text: Corpus uteri description: Corpus Uteri Other and unspecified male genital organs: text: Other and unspecified male genital organs description: Other and unspecified male genital organs Base of tongue: text: Base of tongue description: Base of the Tongue Retroperitoneum and peritoneum: text: Retroperitoneum and peritoneum description: Retroperitoneum and Peritoneum Uterus, NOS: text: Uterus, NOS description: Not Otherwise Specified Uterus Lymph nodes: text: Lymph nodes description: Lymph Node Other and ill-defined sites within respiratory system and intrathoracic organs: text: Other and ill-defined sites within respiratory system and intrathoracic organs description: Other and ill-defined sites within respiratory system and intrathoracic organs Other and unspecified parts of tongue: text: Other and unspecified parts of tongue description: Other and unspecified parts of tongue Small intestine: text: Small intestine description: Small Intestine Other and ill-defined sites: text: Other and ill-defined sites description: Other and ill-defined sites Floor of mouth: text: Floor of mouth Liver and intrahepatic bile ducts: text: Liver and intrahepatic bile ducts description: Liver and Intrahepatic Bile Duct Other and ill-defined sites in lip, oral cavity and pharynx: text: Other and ill-defined sites in lip, oral cavity and pharynx description: Other and ill-defined sites in lip, oral cavity and pharynx Rectosigmoid junction: text: Rectosigmoid junction description: Rectosigmoid Region Other and ill-defined digestive organs: text: Other and ill-defined digestive organs description: Other and ill-defined digestive organs Other and unspecified parts of biliary tract: text: Other and unspecified parts of biliary tract description: Other and unspecified parts of biliary tract Bronchus and lung: text: Bronchus and lung description: Bronchus and Lung Cervix uteri: text: Cervix uteri description: Cervix Uteri Thyroid gland: text: Thyroid gland description: Thyroid Gland Other and unspecified parts of mouth: text: Other and unspecified parts of mouth description: Other and unspecified parts of mouth Spinal cord, cranial nerves, and other parts of central nervous system: text: Spinal cord, cranial nerves, and other parts of central nervous system description: Spinal Cord Cranial Nerve and Other Central Nervous System Other and unspecified major salivary glands: text: Other and unspecified major salivary glands description: Other and unspecified major salivary glands Pyriform sinus: text: Pyriform sinus description: Pyriform Sinus Hematopoietic and reticuloendothelial systems: text: Hematopoietic and reticuloendothelial systems description: Hematopoietic and Reticuloendothelial System Other and unspecified female genital organs: text: Other and unspecified female genital organs description: Other and unspecified female genital organs Adrenal gland: text: Adrenal gland description: Adrenal Gland Anus and anal canal: text: Anus and anal canal description: Anus and Anal Canal Connective, subcutaneous and other soft tissues: text: Connective, subcutaneous and other soft tissues description: Connective, Subcutaneous and Other Soft Tissue Prostate gland: text: Prostate gland description: Prostate Gland Renal pelvis: text: Renal pelvis description: Renal Pelvis Bones, joints and articular cartilage of other and unspecified sites: text: Bones, joints and articular cartilage of other and unspecified sites description: Bone, Joint ,Articular Cartilage of Other and Unspecified Anatomic Site Bones, joints and articular cartilage of limbs: text: Bones, joints and articular cartilage of limbs description: Bone, Joint, Articular Cartilage of Limb Heart, mediastinum, and pleura: text: Heart, mediastinum, and pleura description: Heart, Mediastinum and Pleura Accessory sinuses: text: Accessory sinuses description: Paranasal Sinus Nasal cavity and middle ear: text: Nasal cavity and middle ear description: Nasal Cavity and Middle Ear Trachea: text: Trachea description: Trachea Other and unspecified urinary organs: text: Other and unspecified urinary organs description: Other and unspecified urinary organs Lymph nodes of inguinal region or leg: text: Lymph nodes of inguinal region or leg Overlapping lesion of skin: text: Overlapping lesion of skin Fundus uteri: text: Fundus uteri Hard palate: text: Hard palate Ill-defined sites within respiratory system: text: Ill-defined sites within respiratory system Axillary tail of breast: text: Axillary tail of breast Overlapping lesion of respiratory system and intrathoracic organs: text: Overlapping lesion of respiratory system and intrathoracic organs Middle third of esophagus: text: Middle third of esophagus Bladder, NOS: text: Bladder, NOS Lower-outer quadrant of breast: text: Lower-outer quadrant of breast Craniopharyngeal duct: text: Craniopharyngeal duct Rectum, NOS: text: Rectum, NOS Overlapping lesion of larynx: text: Overlapping lesion of larynx Kidney, NOS: text: Kidney, NOS Paraurethral gland: text: Paraurethral gland Head, face or neck, NOS: text: Head, face or neck, NOS Other specified parts of pancreas: text: Other specified parts of pancreas Unknown primary site: text: Unknown primary site Tonsillar fossa: text: Tonsillar fossa Maxillary sinus: text: Maxillary sinus Waldeyer ring: text: Waldeyer ring Upper lobe, lung: text: Upper lobe, lung Labium majus: text: Labium majus Skin of lip, NOS: text: Skin of lip, NOS Upper-inner quadrant of breast: text: Upper-inner quadrant of breast Ciliary body: text: Ciliary body Head of pancreas: text: Head of pancreas Floor of mouth, NOS: text: Floor of mouth, NOS Transverse colon: text: Transverse colon Branchial cleft: text: Branchial cleft Pelvic bones, sacrum, coccyx and associated joints: text: Pelvic bones, sacrum, coccyx and associated joints Lacrimal gland: text: Lacrimal gland Nasopharynx, NOS: text: Nasopharynx, NOS Overlapping lesion of bones, joints and articular cartilage: text: Overlapping lesion of bones, joints and articular cartilage Retromolar area: text: Retromolar area Lung, NOS: text: Lung, NOS Skin of lower limb and hip: text: Skin of lower limb and hip Lymph nodes of axilla or arm: text: Lymph nodes of axilla or arm Upper respiratory tract, NOS: text: Upper respiratory tract, NOS Overlapping lesion of bones, joints and articular cartilage of limbs: text: Overlapping lesion of bones, joints and articular cartilage of limbs Spinal cord: text: Spinal cord Endocrine gland, NOS: text: Endocrine gland, NOS Penis, NOS: text: Penis, NOS Long bones of upper limb, scapula and associated joints: text: Long bones of upper limb, scapula and associated joints Overlapping lesion of breast: text: Overlapping lesion of breast Pleura, NOS: text: Pleura, NOS Skin of other and unspecified parts of face: text: Skin of other and unspecified parts of face Splenic flexure of colon: text: Splenic flexure of colon Cheek mucosa: text: Cheek mucosa Bone, NOS: text: Bone, NOS Cerebellum, NOS: text: Cerebellum, NOS Overlapping lesion of cervix uteri: text: Overlapping lesion of cervix uteri Sphenoid sinus: text: Sphenoid sinus Olfactory nerve: text: Olfactory nerve Eyelid: text: Eyelid Connective, subcutaneous and other soft tissues, NOS: text: Connective, subcutaneous and other soft tissues, NOS Overlapping lesion of major salivary glands: text: Overlapping lesion of major salivary glands Connective, subcutaneous and other soft tissues of head, face, and neck: text: Connective, subcutaneous and other soft tissues of head, face, and neck Mouth, NOS: text: Mouth, NOS Overlapping lesion of small intestine: text: Overlapping lesion of small intestine Overlapping lesion of connective, subcutaneous and other soft tissues: text: Overlapping lesion of connective, subcutaneous and other soft tissues Ureteric orifice: text: Ureteric orifice Intrathoracic lymph nodes: text: Intrathoracic lymph nodes Biliary tract, NOS: text: Biliary tract, NOS Postcricoid region: text: Postcricoid region Connective, subcutaneous and other soft tissues of thorax: text: Connective, subcutaneous and other soft tissues of thorax Lymph nodes of multiple regions: text: Lymph nodes of multiple regions Parietal lobe: text: Parietal lobe Anterior wall of bladder: text: Anterior wall of bladder Urachus: text: Urachus Overlapping lesion of lip, oral cavity and pharynx: text: Overlapping lesion of lip, oral cavity and pharynx Other specified parts of female genital organs: text: Other specified parts of female genital organs Lower lobe, lung: text: Lower lobe, lung Mucosa of lower lip: text: Mucosa of lower lip Accessory sinus, NOS: text: Accessory sinus, NOS Ventral surface of tongue, NOS: text: Ventral surface of tongue, NOS Soft palate, NOS: text: Soft palate, NOS Tonsil, NOS: text: Tonsil, NOS Peripheral nerves and autonomic nervous system of head, face, and neck: text: Peripheral nerves and autonomic nervous system of head, face, and neck Upper limb, NOS: text: Upper limb, NOS Small intestine, NOS: text: Small intestine, NOS Overlapping lesion of accessory sinuses: text: Overlapping lesion of accessory sinuses Palate, NOS: text: Palate, NOS Cervical esophagus: text: Cervical esophagus Body of stomach: text: Body of stomach Overlapping lesion of rectum, anus and anal canal: text: Overlapping lesion of rectum, anus and anal canal Cornea, NOS: text: Cornea, NOS Tongue, NOS: text: Tongue, NOS Pelvic lymph nodes: text: Pelvic lymph nodes Greater curvature of stomach, NOS: text: Greater curvature of stomach, NOS Cortex of adrenal gland: text: Cortex of adrenal gland Reticuloendothelial system, NOS: text: Reticuloendothelial system, NOS Hepatic flexure of colon: text: Hepatic flexure of colon Peripheral nerves and autonomic nervous system of pelvis: text: Peripheral nerves and autonomic nervous system of pelvis Pancreatic neck: text: Pancreatic neck Choroid: text: Choroid Lateral wall of bladder: text: Lateral wall of bladder Vertebral column: text: Vertebral column Anterior 2/3 of tongue, NOS: text: Anterior 2/3 of tongue, NOS Peripheral nerves and autonomic nervous system of lower limb and hip: text: Peripheral nerves and autonomic nervous system of lower limb and hip Cauda equina: text: Cauda equina Endometrium: text: Endometrium Middle lobe, lung: text: Middle lobe, lung Overlapping lesion of endocrine glands and related structures: text: Overlapping lesion of endocrine glands and related structures Upper third of esophagus: text: Upper third of esophagus Other specified parts of male genital organs: text: Other specified parts of male genital organs Glans penis: text: Glans penis Body of pancreas: text: Body of pancreas Prepuce: text: Prepuce Bone marrow: text: Bone marrow Abdomen, NOS: text: Abdomen, NOS Esophagus, NOS: text: Esophagus, NOS Upper gum: text: Upper gum Peripheral nerves and autonomic nervous system of trunk, NOS: text: Peripheral nerves and autonomic nervous system of trunk, NOS Breast, NOS: text: Breast, NOS Overlapping lesion of floor of mouth: text: Overlapping lesion of floor of mouth Anterior surface of epiglottis: text: Anterior surface of epiglottis Peripheral nerves and autonomic nervous system of upper limb and shoulder: text: Peripheral nerves and autonomic nervous system of upper limb and shoulder Vallecula: text: Vallecula Posterior wall of bladder: text: Posterior wall of bladder Cloacogenic zone: text: Cloacogenic zone Overlapping lesion of corpus uteri: text: Overlapping lesion of corpus uteri Other ill-defined sites: text: Other ill-defined sites Bladder neck: text: Bladder neck Posterior mediastinum: text: Posterior mediastinum External upper lip: text: External upper lip Pancreas, NOS: text: Pancreas, NOS Overlapping lesion of female genital organs: text: Overlapping lesion of female genital organs Overlapping lesion of pancreas: text: Overlapping lesion of pancreas Mucosa of lip, NOS: text: Mucosa of lip, NOS Optic nerve: text: Optic nerve Myometrium: text: Myometrium Overlapping lesion of tonsil: text: Overlapping lesion of tonsil Carotid body: text: Carotid body Body of penis: text: Body of penis Skin of upper limb and shoulder: text: Skin of upper limb and shoulder Tail of pancreas: text: Tail of pancreas Oropharynx, NOS: text: Oropharynx, NOS Male genital organs, NOS: text: Male genital organs, NOS Anterior mediastinum: text: Anterior mediastinum Submandibular gland: text: Submandibular gland Ethmoid sinus: text: Ethmoid sinus Anterior floor of mouth: text: Anterior floor of mouth Thoracic esophagus: text: Thoracic esophagus Anal canal: text: Anal canal External ear: text: External ear Mediastinum, NOS: text: Mediastinum, NOS Fundus of stomach: text: Fundus of stomach Trigone of bladder: text: Trigone of bladder Hematopoietic system, NOS: text: Hematopoietic system, NOS Connective, subcutaneous and other soft tissues of trunk, NOS: text: Connective, subcutaneous and other soft tissues of trunk, NOS Peripheral nerves and autonomic nervous system of thorax: text: Peripheral nerves and autonomic nervous system of thorax Hypopharynx, NOS: text: Hypopharynx, NOS Posterior wall of nasopharynx: text: Posterior wall of nasopharynx Brain stem: text: Brain stem Main bronchus: text: Main bronchus Border of tongue: text: Border of tongue Lower third of esophagus: text: Lower third of esophagus Overlapping lesion of brain: text: Overlapping lesion of brain Lateral floor of mouth: text: Lateral floor of mouth Thorax, NOS: text: Thorax, NOS Lip, NOS: text: Lip, NOS Pelvis, NOS: text: Pelvis, NOS Sublingual gland: text: Sublingual gland Overlapping lesion of hypopharynx: text: Overlapping lesion of hypopharynx Brain, NOS: text: Brain, NOS Nervous system, NOS: text: Nervous system, NOS Islets of Langerhans: text: Islets of Langerhans Extrahepatic bile duct: text: Extrahepatic bile duct Dome of bladder: text: Dome of bladder Bone of limb, NOS: text: Bone of limb, NOS Overlapping lesion of lip: text: Overlapping lesion of lip Pancreatic duct: text: Pancreatic duct Intestinal tract, NOS: text: Intestinal tract, NOS Overlapping lesion of bladder: text: Overlapping lesion of bladder Overlapping lesion of peripheral nerves and autonomic nervous system: text: Overlapping lesion of peripheral nerves and autonomic nervous system Uterine adnexa: text: Uterine adnexa Larynx, NOS: text: Larynx, NOS Cerebral meninges: text: Cerebral meninges Lower-inner quadrant of breast: text: Lower-inner quadrant of breast Meninges, NOS: text: Meninges, NOS Descended testis: text: Descended testis Upper-outer quadrant of breast: text: Upper-outer quadrant of breast Overlapping lesions of oropharynx: text: Overlapping lesions of oropharynx Gastrointestinal tract, NOS: text: Gastrointestinal tract, NOS Lateral wall of oropharynx: text: Lateral wall of oropharynx Intrahepatic bile duct: text: Intrahepatic bile duct Intra-abdominal lymph nodes: text: Intra-abdominal lymph nodes Gum, NOS: text: Gum, NOS Overlapping lesion of brain and central nervous system: text: Overlapping lesion of brain and central nervous system Overlapping lesion of biliary tract: text: Overlapping lesion of biliary tract Specified parts of peritoneum: text: Specified parts of peritoneum Fallopian tube: text: Fallopian tube Endocervix: text: Endocervix Ascending colon: text: Ascending colon Cardia, NOS: text: Cardia, NOS Overlapping lesion of eye and adnexa: text: Overlapping lesion of eye and adnexa Connective, subcutaneous and other soft tissues of pelvis: text: Connective, subcutaneous and other soft tissues of pelvis Central portion of breast: text: Central portion of breast Abdominal esophagus: text: Abdominal esophagus Overlapping lesion of urinary organs: text: Overlapping lesion of urinary organs Commissure of lip: text: Commissure of lip Spinal meninges: text: Spinal meninges Short bones of upper limb and associated joints: text: Short bones of upper limb and associated joints Female genital tract, NOS: text: Female genital tract, NOS Urinary system, NOS: text: Urinary system, NOS Bones of skull and face and associated joints: text: Bones of skull and face and associated joints Peritoneum, NOS: text: Peritoneum, NOS Aortic body and other paraganglia: text: Aortic body and other paraganglia Round ligament: text: Round ligament Lower gum: text: Lower gum Overlapping lesion of male genital organs: text: Overlapping lesion of male genital organs Cranial nerve, NOS: text: Cranial nerve, NOS Major salivary gland, NOS: text: Major salivary gland, NOS Autonomic nervous system, NOS: text: Autonomic nervous system, NOS Pituitary gland: text: Pituitary gland Superior wall of nasopharynx: text: Superior wall of nasopharynx Posterior wall of oropharynx: text: Posterior wall of oropharynx Overlapping lesion of nasopharynx: text: Overlapping lesion of nasopharynx External lip, NOS: text: External lip, NOS Short bones of lower limb and associated joints: text: Short bones of lower limb and associated joints Anterior wall of nasopharynx: text: Anterior wall of nasopharynx Sigmoid colon: text: Sigmoid colon Descending colon: text: Descending colon Anus, NOS: text: Anus, NOS Rib, sternum, clavicle and associated joints: text: Rib, sternum, clavicle and associated joints Lingual tonsil: text: Lingual tonsil Adrenal gland, NOS: text: Adrenal gland, NOS Temporal lobe: text: Temporal lobe Spermatic cord: text: Spermatic cord Vagina, NOS: text: Vagina, NOS Stomach, NOS: text: Stomach, NOS Overlapping lesion of retroperitoneum and peritoneum: text: Overlapping lesion of retroperitoneum and peritoneum Acoustic nerve: text: Acoustic nerve Hypopharyngeal aspect of aryepiglottic fold: text: Hypopharyngeal aspect of aryepiglottic fold Parathyroid gland: text: Parathyroid gland Connective, subcutaneous and other soft tissues of abdomen: text: Connective, subcutaneous and other soft tissues of abdomen Base of tongue, NOS: text: Base of tongue, NOS Overlapping lesion of penis: text: Overlapping lesion of penis Gastric antrum: text: Gastric antrum Lateral wall of nasopharynx: text: Lateral wall of nasopharynx Posterior wall of hypopharynx: text: Posterior wall of hypopharynx Broad ligament: text: Broad ligament Lower limb, NOS: text: Lower limb, NOS Skin of scalp and neck: text: Skin of scalp and neck Overlapping lesion of palate: text: Overlapping lesion of palate Laryngeal cartilage: text: Laryngeal cartilage Frontal lobe: text: Frontal lobe Pharynx, NOS: text: Pharynx, NOS Scrotum, NOS: text: Scrotum, NOS Lymph node, NOS: text: Lymph node, NOS Nasal cavity: text: Nasal cavity Connective, subcutaneous and other soft tissues of upper limb and shoulder: text: Connective, subcutaneous and other soft tissues of upper limb and shoulder Overlapping lesion of lung: text: Overlapping lesion of lung Middle ear: text: Middle ear Ventricle, NOS: text: Ventricle, NOS Connective, subcutaneous and other soft tissues of lower limb and hip: text: Connective, subcutaneous and other soft tissues of lower limb and hip Skin of trunk: text: Skin of trunk Overlapping lesion of stomach: text: Overlapping lesion of stomach Undescended testis: text: Undescended testis Skin, NOS: text: Skin, NOS Vulva, NOS: text: Vulva, NOS Dorsal surface of tongue, NOS: text: Dorsal surface of tongue, NOS Overlapping lesion of other and unspecified parts of mouth: text: Overlapping lesion of other and unspecified parts of mouth External lower lip: text: External lower lip Occipital lobe: text: Occipital lobe Overlapping lesion of digestive system: text: Overlapping lesion of digestive system Overlapping lesion of tongue: text: Overlapping lesion of tongue Frontal sinus: text: Frontal sinus Colon, NOS: text: Colon, NOS Lymph nodes of head, face and neck: text: Lymph nodes of head, face and neck Orbit, NOS: text: Orbit, NOS Lesser curvature of stomach, NOS: text: Lesser curvature of stomach, NOS Mucosa of upper lip: text: Mucosa of upper lip Long bones of lower limb and associated joints: text: Long bones of lower limb and associated joints Eye, NOS: text: Eye, NOS Meckel diverticulum: text: Meckel diverticulum Pineal gland: text: Pineal gland Overlapping lesion of heart, mediastinum and pleura: text: Overlapping lesion of heart, mediastinum and pleura Labium minus: text: Labium minus Overlapping lesion of vulva: text: Overlapping lesion of vulva Isthmus uteri: text: Isthmus uteri Overlapping lesion of colon: text: Overlapping lesion of colon Testis, NOS: text: Testis, NOS Medulla of adrenal gland: text: Medulla of adrenal gland Nipple: text: Nipple Exocervix: text: Exocervix Tonsillar pillar: text: Tonsillar pillar Peripheral nerves and autonomic nervous system of abdomen: text: Peripheral nerves and autonomic nervous system of abdomen Overlapping lesion of ill-defined sites: text: Overlapping lesion of ill-defined sites Vestibule of mouth: text: Vestibule of mouth Overlapping lesion of esophagus: text: Overlapping lesion of esophagus Nervous System: text: Nervous System Not Applicable: text: Not Applicable Colorectal: text: Colorectal Adrenal Gland: text: Adrenal Gland Lymph Nodes: text: Lymph Nodes Paranasal Sinuses: text: Paranasal Sinuses Sublingual Gland: text: Sublingual Gland Subglottis: text: Subglottis description: Subglottis Glottis: text: Glottis description: Glottis Submandibular Gland: text: Submandibular Gland Supraglottis: text: Supraglottis description: Supraglottis enum_CRDCH_BodySite_qualifier: name: enum_CRDCH_BodySite_qualifier description: Autogenerated Enumeration for CRDC-H BodySite qualifier comments: - 'Name according to TCCM: "CRDC-H.BodySite.qualifier"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.BodySite.qualifier code_set_version: '2021-12-16T18:03:50.851596+00:00' permissible_values: Left: text: Left description: Left Not Reported: text: Not Reported Bilateral: text: Bilateral description: Bilateral Unknown: text: Unknown Right: text: Right description: Right enum_CRDCH_BiologicProduct_product_type: name: enum_CRDCH_BiologicProduct_product_type description: Autogenerated Enumeration for CRDC-H BiologicProduct product_type comments: - 'Name according to TCCM: "CRDC-H.BiologicProduct.product_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.BiologicProduct.product_type code_set_version: '2021-12-16T18:03:50.998844+00:00' enum_CRDCH_CancerGradeObservation_category: name: enum_CRDCH_CancerGradeObservation_category description: Autogenerated Enumeration for CRDC-H CancerGradeObservation category comments: - 'Name according to TCCM: "CRDC-H.CancerGradeObservation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.CancerGradeObservation.category code_set_version: '2021-12-16T18:03:51.135762+00:00' enum_CRDCH_CancerGradeObservation_observation_type: name: enum_CRDCH_CancerGradeObservation_observation_type description: '' notes: - Derived from [CancerGradeObservation.observation_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: enneking_msts_grade: text: enneking_msts_grade description: The text term used to describe the surgical grade of the musculoskeletal sarcoma, using the Enneking staging system approved by the Musculoskeletal Tumor Society (MSTS). esophageal_columnar_dysplasia_degree: text: esophageal_columnar_dysplasia_degree description: Text term to describe the amount of dysplasia found within the benign esophageal columnar mucosa. inpc_grade: text: inpc_grade description: Text term used to describe the classification of neuroblastic differentiation within neuroblastoma tumors, as defined by the International Neuroblastoma Pathology Classification (INPC). gleason_grade_group: text: gleason_grade_group description: The text term used to describe the overall grouping of grades defined by the Gleason grading classification, which is used to determine the aggressiveness of prostate cancer. Note that this grade describes the entire prostatectomy specimen and is not specific to the sample used for sequencing. primary_gleason_grade: text: primary_gleason_grade description: The text term used to describe the primary Gleason score, which describes the pattern of cells making up the largest area of the tumor. The primary and secondary Gleason pattern grades are combined to determine the patient's Gleason grade group, which is used to determine the aggressiveness of prostate cancer. Note that this grade describes the entire prostatectomy specimen and is not specific to the sample used for sequencing. secondary_gleason_grade: text: secondary_gleason_grade description: The text term used to describe the secondary Gleason score, which describes the pattern of cells making up the second largest area of the tumor. The primary and secondary Gleason pattern grades are combined to determine the patient's Gleason grade group, which is used to determine the aggressiveness of prostate cancer. Note that this grade describes the entire prostatectomy specimen and is not specific to the sample used for sequencing. tumor_grade: text: tumor_grade description: Text value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness. enum_CRDCH_CancerGradeObservation_method_type: name: enum_CRDCH_CancerGradeObservation_method_type description: Autogenerated Enumeration for CRDC-H CancerGradeObservation method_type comments: - 'Name according to TCCM: "CRDC-H.CancerGradeObservation.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.CancerGradeObservation.method_type code_set_version: '2021-12-16T18:03:51.400069+00:00' enum_CRDCH_CancerGradeObservation_value_codeable_concept: name: enum_CRDCH_CancerGradeObservation_value_codeable_concept description: Autogenerated Enumeration for CRDC-H CancerGradeObservation value_codeable_concept comments: - 'Name according to TCCM: "CRDC-H.CancerGradeObservation.value_codeable_concept"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.CancerGradeObservation.value_codeable_concept code_set_version: '2021-12-16T18:03:51.528534+00:00' permissible_values: Group 2: text: Group 2 Group 4: text: Group 4 Group 1: text: Group 1 Group 5: text: Group 5 Group 3: text: Group 3 Poorly Differentiated: text: Poorly Differentiated description: Poorly Differentiated Neuroblastoma Unknown: text: Unknown description: Unknown Differentiating: text: Differentiating description: Differentiating Neuroblastoma Undifferentiated: text: Undifferentiated description: Undifferentiated Neuroblastoma G4: text: G4 description: Undifferentiated Histology not reported: text: not reported G1: text: G1 description: Well Differentiated GX: text: GX description: Grade Cannot be Assessed GB: text: GB description: Borderline Histologic Grade Low Grade: text: Low Grade description: Low Grade G3: text: G3 description: Poorly Differentiated G2: text: G2 description: Moderately Differentiated High Grade: text: High Grade description: High Grade High Grade Dysplasia: text: High Grade Dysplasia Negative/ No Dysplasia: text: Negative/ No Dysplasia Not Reported: text: Not Reported description: Not Reported Indefinite for Dysplasia: text: Indefinite for Dysplasia Low Grade Dysplasia: text: Low Grade Dysplasia Pattern 2: text: Pattern 2 Pattern 3: text: Pattern 3 Pattern 1: text: Pattern 1 Pattern 5: text: Pattern 5 Pattern 4: text: Pattern 4 High Grade (G2): text: High Grade (G2) description: Enneking High Surgical Grade Low Grade (G1): text: Low Grade (G1) description: Enneking Low Surgical Grade Intermediate Grade: text: Intermediate Grade description: Intermediate Grade enum_CRDCH_CancerGradeObservationSet_category: name: enum_CRDCH_CancerGradeObservationSet_category description: Autogenerated Enumeration for CRDC-H CancerGradeObservationSet category comments: - 'Name according to TCCM: "CRDC-H.CancerGradeObservationSet.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.CancerGradeObservationSet.category code_set_version: '2021-12-16T18:03:51.780008+00:00' enum_CRDCH_CancerGradeObservationSet_method_type: name: enum_CRDCH_CancerGradeObservationSet_method_type description: A morphologic classification system of malignant tumors, usually relating to disease progression and clinical outcome. It is based upon the presence or absence of several morphologic parameters, including tumor cell necrosis, cytologic atypia, nuclear pleomorphism and mitotic figures, the architectural infiltrating patterns, and the degree of tumor cell differentiation. Malignant tumors usually are graded I-III notes: - Derived from [CancerGradeObservationSet.method_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: Gleason: text: Gleason description: A grading system for prostatic carcinoma based on the microscopic glandular architectural patterns of the malignant epithelial cells. Nuclear atypia is not evaluated. It defines five patterns or grades which reflect decreasing differentiation. INPC: text: INPC description: '' Unspecified grading system: text: Unspecified grading system description: '' enum_CRDCH_CancerStageObservation_category: name: enum_CRDCH_CancerStageObservation_category description: Autogenerated Enumeration for CRDC-H CancerStageObservation category comments: - 'Name according to TCCM: "CRDC-H.CancerStageObservation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.CancerStageObservation.category code_set_version: '2021-12-16T18:03:52.072037+00:00' enum_CRDCH_CancerStageObservation_observation_type: name: enum_CRDCH_CancerStageObservation_observation_type description: Types of observations or components of a cancer staging assessment. notes: - Derived from [CancerStageObservation.observation_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: Overall: text: Overall description: The overall stage of the disease Tumor (T): text: Tumor (T) description: T classifies the size or direct extent of the primary tumor Node (N): text: Node (N) description: N classifies the degree of spread to regional lymph nodes Metastasis (M): text: Metastasis (M) description: M classifies the presence of distant metastasis Clinical Overall: text: Clinical Overall description: The overall stage of the disease; clinical stage is determined from evidence acquired before treatment (including clinical examination, imaging, endoscopy, biopsy, surgical exploration) Clinical Tumor (T): text: Clinical Tumor (T) description: T classifies the size or direct extent of the primary tumor; clinical stage is determined from evidence acquired before treatment (including clinical examination, imaging, endoscopy, biopsy, surgical exploration) Clinical Node (N): text: Clinical Node (N) description: N classifies the degree of spread to regional lymph nodes; clinical stage is determined from evidence acquired before treatment (including clinical examination, imaging, endoscopy, biopsy, surgical exploration) Clinical Metastasis (M): text: Clinical Metastasis (M) description: M classifies the presence of distant metastasis; clinical stage is determined from evidence acquired before treatment (including clinical examination, imaging, endoscopy, biopsy, surgical exploration) Pathological Overall: text: Pathological Overall description: The overall stage of the disease; stage given by histopathologic examination of a surgical specimen Pathological Tumor (T): text: Pathological Tumor (T) description: T classifies the size or direct extent of the primary tumor; stage given by histopathologic examination of a surgical specimen Pathological Node (N): text: Pathological Node (N) description: N classifies the degree of spread to regional lymph nodes; stage given by histopathologic examination of a surgical specimen Pathological Metastasis (M): text: Pathological Metastasis (M) description: M classifies the presence of distant metastasis; stage given by histopathologic examination of a surgical specimen Ann Arbor Substage Modifier: text: Ann Arbor Substage Modifier description: The substage classification modifiers amend each stage based on distinct features. enum_CRDCH_CancerStageObservation_method_type: name: enum_CRDCH_CancerStageObservation_method_type description: Autogenerated Enumeration for CRDC-H CancerStageObservation method_type comments: - 'Name according to TCCM: "CRDC-H.CancerStageObservation.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.CancerStageObservation.method_type code_set_version: '2021-12-16T18:03:52.365338+00:00' enum_CRDCH_CancerStageObservation_value_codeable_concept: name: enum_CRDCH_CancerStageObservation_value_codeable_concept description: Autogenerated Enumeration for CRDC-H CancerStageObservation value_codeable_concept comments: - 'Name according to TCCM: "CRDC-H.CancerStageObservation.value_codeable_concept"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.CancerStageObservation.value_codeable_concept code_set_version: '2021-12-16T18:03:52.512125+00:00' permissible_values: No Metastasis (M0): text: No Metastasis (M0) Unknown: text: Unknown description: Unknown Regional or Distant Metastasis (M1): text: Regional or Distant Metastasis (M1) Not Reported: text: Not Reported description: Not Reported Stage IA: text: Stage IA description: Stage IA Stage III: text: Stage III description: SIOP/COG/NWTSG Stage III Stage IIA: text: Stage IIA description: Stage IIA Stage IIB: text: Stage IIB description: Stage IIB Stage IB: text: Stage IB description: Stage IB 'Yes': text: 'Yes' description: 'Yes' 'No': text: 'No' description: 'No' Not Allowed To Collect: text: Not Allowed To Collect Stage 1: text: Stage 1 description: INSS Stage 1 Stage 4S: text: Stage 4S description: INSS Stage 4S Stage 3: text: Stage 3 description: INSS Stage 3 Stage 2B: text: Stage 2B description: INSS Stage 2B Stage 4: text: Stage 4 description: INSS Stage 4 Stage 2A: text: Stage 2A description: INSS Stage 2A Intermediate Prognosis: text: Intermediate Prognosis Poor Prognosis: text: Poor Prognosis Good Prognosis: text: Good Prognosis Stage IIIC: text: Stage IIIC description: Stage IIIC Stage IIIA: text: Stage IIIA description: Stage IIIA Stage IIA2: text: Stage IIA2 description: Stage IIA2 Stage IV: text: Stage IV description: SIOP/COG/NWTSG Stage IV Stage IIIC1: text: Stage IIIC1 description: FIGO Stage IIIC1 Stage IIIC2: text: Stage IIIC2 description: FIGO Stage IIIC2 Stage IIA1: text: Stage IIA1 description: Stage IIA1 Stage IIIB: text: Stage IIIB description: Stage IIIB Stage IVA: text: Stage IVA description: Stage IVA Stage 0: text: Stage 0 description: Stage 0 Stage I: text: Stage I description: SIOP/COG/NWTSG Stage I Stage IVB: text: Stage IVB description: Stage IVB Stage IA1: text: Stage IA1 description: Stage IA1 Stage IA2: text: Stage IA2 description: Stage IA2 Stage IB1: text: Stage IB1 description: Stage IB1 Stage IB2: text: Stage IB2 description: Stage IB2 Stage II: text: Stage II description: SIOP/COG/NWTSG Stage II Stage IC: text: Stage IC description: Stage IC '2': text: '2' description: Unfavorable site, <= 5 cm, no regional node involvement '1': text: '1' description: Favorable Site '3': text: '3' description: Unfavorable site, >5cm, and/or regional node involvement '4': text: '4' description: Metastatic disease M1a: text: M1a description: M1a Stage Finding M1: text: M1 description: M1 Stage Finding M1c: text: M1c description: M1c Stage Finding MX: text: MX description: MX Stage Finding M0: text: M0 description: M0 Stage Finding cM0 (i+): text: cM0 (i+) description: cM0 (i+) Stage Finding M1b: text: M1b description: M1b Stage Finding TX: text: TX description: TX Stage Finding T3d: text: T3d description: T3d Stage Finding T1a1: text: T1a1 description: Stage T1a1 Finding Ta: text: Ta description: Ta Stage Finding T2a1: text: T2a1 description: Stage T2a1 Finding T1b: text: T1b description: T1b Stage Finding T1c: text: T1c description: T1c Stage Finding T1b2: text: T1b2 description: T1b2 Stage Finding T2d: text: T2d description: T2d Stage Finding T2c: text: T2c description: T2c Stage Finding T2a: text: T2a description: T2a Stage Finding Tis (Paget's): text: Tis (Paget's) description: Tis Stage Finding Paget Disease of the Breast without Invasive Carcinoma T1b1: text: T1b1 description: T1b1 Stage Finding T3: text: T3 description: T3 Stage Finding T1: text: T1 description: T1 Stage Finding Tis (DCIS): text: Tis (DCIS) description: Tis Stage Finding Ductal Breast Carcinoma In Situ T4a: text: T4a description: T4a Stage Finding T2a2: text: T2a2 description: Stage T2a2 Finding T0: text: T0 description: T0 Stage Finding Tis: text: Tis description: Tis Stage Finding T1mi: text: T1mi description: T1mi Stage Finding T3a: text: T3a description: T3a Stage Finding Tis (LCIS): text: Tis (LCIS) description: Tis Stage Finding Lobular Breast Carcinoma In Situ T4e: text: T4e description: T4e Stage Finding T3b: text: T3b description: T3b Stage Finding T1a2: text: T1a2 description: Stage T1a2 Finding T4d: text: T4d description: T4d Stage Finding T4c: text: T4c description: T4c Stage Finding T2b: text: T2b description: T2b Stage Finding T1a: text: T1a description: T1a Stage Finding T4: text: T4 description: T4 Stage Finding T4b: text: T4b description: T4b Stage Finding T3c: text: T3c description: T3c Stage Finding T2: text: T2 description: T2 Stage Finding M1d: text: M1d M2: text: M2 description: M2 Stage Finding Stage Tis: text: Stage Tis description: Tis Stage Finding Stage X: text: Stage X description: Stage X Stage IVC: text: Stage IVC description: Stage IVC Stage 0a: text: Stage 0a description: Stage 0a Stage IIC1: text: Stage IIC1 Stage IS: text: Stage IS description: Stage Is Stage 0is: text: Stage 0is description: Stage 0is Stage IIC: text: Stage IIC description: Stage IIC N1bIII: text: N1bIII description: N1bIII Stage Finding N2c: text: N2c description: N2c Stage Finding N0 (mol+): text: N0 (mol+) description: N0 (mol+) Stage Finding N0: text: N0 description: N0 Stage Finding N4: text: N4 description: N4 Stage Finding N0 (mol-): text: N0 (mol-) description: N0 (mol-) Stage Finding N1bIV: text: N1bIV description: N1bIV Stage Finding N1b: text: N1b description: N1b Stage Finding N2b: text: N2b description: N2b Stage Finding N3a: text: N3a description: N3a Stage Finding N1bII: text: N1bII description: N1bII Stage Finding N0 (i+): text: N0 (i+) description: N0 (i+) Stage Finding N1: text: N1 description: N1 Stage Finding N3: text: N3 description: N3 Stage Finding N2a: text: N2a description: N2a Stage Finding N1c: text: N1c description: N1c Stage Finding N0 (i-): text: N0 (i-) description: N0 (i-) Stage Finding N3c: text: N3c description: N3c Stage Finding N3b: text: N3b description: N3b Stage Finding N1bI: text: N1bI description: N1bI Stage Finding N1mi: text: N1mi description: N1mi Stage Finding N1a: text: N1a description: N1a Stage Finding N2: text: N2 description: N2 Stage Finding NX: text: NX description: NX Stage Finding Stage IIID: text: Stage IIID Stage IIb: text: Stage IIb Stage IIa: text: Stage IIa Stage IVb: text: Stage IVb Stage IVa: text: Stage IVa Intracompartmental (T1): text: Intracompartmental (T1) description: Intracompartmental Tumor Extracompartmental (T2): text: Extracompartmental (T2) description: Extracompartmental Tumor II: text: II description: II III: text: III description: III I: text: I description: I Ms: text: Ms description: INRG Stage MS L2: text: L2 description: INRG Stage L2 L1: text: L1 description: INRG Stage L1 M: text: M description: INRG Stage M Stage IA3: text: Stage IA3 description: Stage IA3 Stage IB Cervix: text: Stage IB Cervix description: Stage IB Cervix Stage IIA Cervix: text: Stage IIA Cervix description: Stage IIA Cervix Stage II Cervix: text: Stage II Cervix description: Stage II Cervix Stage IIIAii: text: Stage IIIAii Stage IIIAi: text: Stage IIIAi Stage IC3: text: Stage IC3 Stage IC2: text: Stage IC2 Stage IIIA2: text: Stage IIIA2 Stage IIIA1: text: Stage IIIA1 Stage IC1: text: Stage IC1 3rd: text: 3rd description: Third Edition (published 1988) 7th: text: 7th description: Seventh Edition 1st: text: 1st description: First Edition 4th: text: 4th description: Fourth Edition (published 1992) 2nd: text: 2nd description: Second Edition (published 1983) 5th: text: 5th description: Fifth Edition (published 1997) 8th: text: 8th description: Eighth Edition 6th: text: 6th description: Sixth Edition (published 2002) enum_CRDCH_CancerStageObservationSet_category: name: enum_CRDCH_CancerStageObservationSet_category description: Autogenerated Enumeration for CRDC-H CancerStageObservationSet category comments: - 'Name according to TCCM: "CRDC-H.CancerStageObservationSet.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.CancerStageObservationSet.category code_set_version: '2021-12-16T18:03:53.169837+00:00' enum_CRDCH_CancerStageObservationSet_method_type: name: enum_CRDCH_CancerStageObservationSet_method_type description: Classification systems used for defining the point in the natural history of a malignant disease a patient is when a diagnosis is made notes: - Derived from [CancerStageObservationSet.method_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: AJCC staging system 1st edition: text: AJCC staging system 1st edition description: The 1st edition of the criteria developed by the American Joint Committee on Cancer (AJCC) used for the classification and staging of neoplastic diseases. AJCC staging system 2nd edition: text: AJCC staging system 2nd edition description: The 2nd edition of the criteria developed by the American Joint Committee on Cancer (AJCC) used for the classification and staging of neoplastic diseases. AJCC staging system 3rd edition: text: AJCC staging system 3rd edition description: The 3rd edition of the criteria developed by the American Joint Committee on Cancer (AJCC) used for the classification and staging of neoplastic diseases. AJCC staging system 4th edition: text: AJCC staging system 4th edition description: The 4th edition of the criteria developed by the American Joint Committee on Cancer (AJCC) used for the classification and staging of neoplastic diseases. AJCC staging system 5th edition: text: AJCC staging system 5th edition description: The 5th edition of the criteria developed by the American Joint Committee on Cancer (AJCC) used for the classification and staging of neoplastic diseases. AJCC staging system 6th edition: text: AJCC staging system 6th edition description: The 6th edition of the criteria developed by the American Joint Committee on Cancer (AJCC) used for the classification and staging of neoplastic diseases. AJCC staging system 7th edition: text: AJCC staging system 7th edition description: The 7th edition of the criteria developed by the American Joint Committee on Cancer (AJCC) in 2010, used for the classification and staging of neoplastic diseases. AJCC staging system 8th edition: text: AJCC staging system 8th edition description: The 8th edition of the criteria developed by the American Joint Committee on Cancer (AJCC), implemented in 2018, used for the classification and staging of neoplastic diseases Ann Arbor staging system: text: Ann Arbor staging system description: The Ann Arbor Staging guidelines used in the staging of lymphomas COG Liver staging system: text: COG Liver staging system description: A staging system developed by Children's Oncology Group (COG) that categorizes liver tumors based on the size and extent of the tumor. COG Renal staging system: text: COG Renal staging system description: A staging system developed by Children's Oncology Group (COG) that categorizes renal tumors, often Wilms tumor, based on the size and extent of the tumor. Enneking MSTS staging system: text: Enneking MSTS staging system description: A staging system for malignant mesenchymal tumors that takes into account the surgical grade, local extent, and presence or absence of metastasis. FIGO staging system: text: FIGO staging system description: A set of staging terms for carcinoma developed by the International Federation of Gynecology and Obstetrics (FIGO). IGCCCG staging system: text: IGCCCG staging system description: '' INRG staging system: text: INRG staging system description: A clinical staging system for neuroblastoma based on preoperative imaging and determined prior to any treatment, including surgery. It includes two stages of localized disease (L1 and L2) and two stages of metastatic disease (M and MS). INSS staging system: text: INSS staging system description: A surgicopathological staging system for neuroblastoma, based on the Evans staging system. IRS staging system: text: IRS staging system description: A system developed by the Intergroup Rhabdomyosarcoma Studies (IRS) group for staging rhabdomyosarcomas based on a modified TNM staging system. ISS staging system: text: ISS staging system description: A plasma cell myeloma stage defined according to the international staging system. Masaoka staging system: text: Masaoka staging system description: A thymoma stage defined according to the Masaoka-Koga staging criteria. Unspecified staging system: text: Unspecified staging system description: For use when a data contributor has a cancer staging value, but no clearly specified staging system under which that value falls. enum_CRDCH_Diagnosis_condition: name: enum_CRDCH_Diagnosis_condition description: Autogenerated Enumeration for CRDC-H Diagnosis condition comments: - 'Name according to TCCM: "CRDC-H.Diagnosis.condition"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Diagnosis.condition code_set_version: '2021-12-16T18:03:53.462956+00:00' permissible_values: M6A: text: M6A Myeloid neoplasms with PDGFRB rearrangement: text: Myeloid neoplasms with PDGFRB rearrangement PEComa, malignant: text: PEComa, malignant Acute erythroid leukaemia: text: Acute erythroid leukaemia Transitional papilloma: text: Transitional papilloma Enchondroma: text: Enchondroma Pre-B ALL: text: Pre-B ALL Acute panmyelosis with myelofibrosis: text: Acute panmyelosis with myelofibrosis Mixed mesenchymal sarcoma: text: Mixed mesenchymal sarcoma Stromal tumor with minor sex cord elements: text: Stromal tumor with minor sex cord elements Myoma: text: Myoma Adrenal cortical adenoma, glomerulosa cell: text: Adrenal cortical adenoma, glomerulosa cell Glomangiomyoma: text: Glomangiomyoma Non-invasive encapsulated follicular variant of papillary thyroid carcinoma (non-invasive EFVPTC): text: Non-invasive encapsulated follicular variant of papillary thyroid carcinoma (non-invasive EFVPTC) Epithelioid mesothelioma, malignant: text: Epithelioid mesothelioma, malignant Sertoli cell carcinoma: text: Sertoli cell carcinoma Odontogenic tumor, NOS: text: Odontogenic tumor, NOS Neurinomatosis: text: Neurinomatosis Intraductal papilloma: text: Intraductal papilloma Nonencapsulated sclerosing adenocarcinoma: text: Nonencapsulated sclerosing adenocarcinoma Precursor B-cell lymphoblastic leukemia: text: Precursor B-cell lymphoblastic leukemia Stromal sarcoma, NOS: text: Stromal sarcoma, NOS Gliofibroma: text: Gliofibroma Papillary cystadenoma lymphomatosum: text: Papillary cystadenoma lymphomatosum SALT lymphoma: text: SALT lymphoma Fibroxanthoma, malignant: text: Fibroxanthoma, malignant Endometrioid adenoma, borderline malignancy: text: Endometrioid adenoma, borderline malignancy Hand-Schuller-Christian disease: text: Hand-Schuller-Christian disease Ancient schwannoma: text: Ancient schwannoma Primary serous papillary carcinoma of peritoneum: text: Primary serous papillary carcinoma of peritoneum Compound odontoma: text: Compound odontoma Endocervical adenocarcinoma usual type: text: Endocervical adenocarcinoma usual type DCIS, NOS: text: DCIS, NOS Sclerosing sweat duct carcinoma: text: Sclerosing sweat duct carcinoma Complex odontoma: text: Complex odontoma Tubular androblastoma, NOS: text: Tubular androblastoma, NOS Ceruminous carcinoma: text: Ceruminous carcinoma Folliculome lipidique: text: Folliculome lipidique Perineurioma, malignant: text: Perineurioma, malignant Transitional cell carcinoma, spindle cell: text: Transitional cell carcinoma, spindle cell Embryonal teratoma: text: Embryonal teratoma Acute non-lymphocytic leukemia: text: Acute non-lymphocytic leukemia Lymphomatoid papulosis: text: Lymphomatoid papulosis Giant pigmented nevus, NOS: text: Giant pigmented nevus, NOS Fibrous histiocytoma of tendon sheath: text: Fibrous histiocytoma of tendon sheath Lipoma-like liposarcoma: text: Lipoma-like liposarcoma Diktyoma, benign: text: Diktyoma, benign Intraductal micropapillary carcinoma: text: Intraductal micropapillary carcinoma Large cell calcifying Sertoli cell tumor: text: Large cell calcifying Sertoli cell tumor Odontogenic myxoma: text: Odontogenic myxoma Hemangiopericytoma, NOS: text: Hemangiopericytoma, NOS Langerhans cell histiocytosis, multifocal: text: Langerhans cell histiocytosis, multifocal Chloroma: text: Chloroma Primary cutaneous CD30+ large T-cell lymphoma: text: Primary cutaneous CD30+ large T-cell lymphoma Thymoma, malignant, NOS: text: Thymoma, malignant, NOS Solitary myeloma: text: Solitary myeloma Rhabdomyosarcoma with ganglionic differentiation: text: Rhabdomyosarcoma with ganglionic differentiation Fibrous papule of nose: text: Fibrous papule of nose Neurocytoma: text: Neurocytoma Malignant lymphoma, centroblastic, diffuse: text: Malignant lymphoma, centroblastic, diffuse VAIN III: text: VAIN III Spongioneuroblastoma: text: Spongioneuroblastoma Sarcoma, NOS: text: Sarcoma, NOS Congenital peribronchial myofibroblastic tumor: text: Congenital peribronchial myofibroblastic tumor Angiomyolipoma: text: Angiomyolipoma Conventional central osteosarcoma: text: Conventional central osteosarcoma Plasmacytoma, NOS: text: Plasmacytoma, NOS NK-cell large granular lymphocytic leukemia: text: NK-cell large granular lymphocytic leukemia Water-clear cell carcinoma: text: Water-clear cell carcinoma Malignant lymphoma, mixed cell type, follicular: text: Malignant lymphoma, mixed cell type, follicular Papillary squamous cell carcinoma: text: Papillary squamous cell carcinoma Tumor embolus: text: Tumor embolus Anaplastic astrocytoma, IDH-wildtype: text: Anaplastic astrocytoma, IDH-wildtype Teratoid medulloepithelioma, benign: text: Teratoid medulloepithelioma, benign Fascial fibrosarcoma: text: Fascial fibrosarcoma Chondroid chordoma: text: Chondroid chordoma Intramuscular hemangioma: text: Intramuscular hemangioma Giant cell sarcoma: text: Giant cell sarcoma Hepatoma, malignant: text: Hepatoma, malignant Langerhans cell histiocytosis, poly-ostotic: text: Langerhans cell histiocytosis, poly-ostotic Atypical proliferative mucinous tumor: text: Atypical proliferative mucinous tumor Noninvasive pancreatobiliary papillary neoplasm with high grade intraepithelial neoplasia: text: Noninvasive pancreatobiliary papillary neoplasm with high grade intraepithelial neoplasia Chronic myelomonocytic leukemia, NOS: text: Chronic myelomonocytic leukemia, NOS Pituicytoma: text: Pituicytoma Sclerosing stromal tumor: text: Sclerosing stromal tumor VIN III: text: VIN III Ependymoma, anaplastic: text: Ependymoma, anaplastic Glycogen-rich carcinoma: text: Glycogen-rich carcinoma Renal carcinoma, collecting duct type: text: Renal carcinoma, collecting duct type Diffuse astrocytoma, low grade: text: Diffuse astrocytoma, low grade Squamous cell carcinoma, acantholytic: text: Squamous cell carcinoma, acantholytic Sarcomatoid mesothelioma: text: Sarcomatoid mesothelioma description: Sarcomatoid Mesothelioma Intraductal papillary-mucinous neoplasm with moderate dysplasia: text: Intraductal papillary-mucinous neoplasm with moderate dysplasia Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS: text: Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS Papillary adenoma, NOS: text: Papillary adenoma, NOS Sebaceous adenoma: text: Sebaceous adenoma Invasive mole, NOS: text: Invasive mole, NOS Oligodendroglioma, anaplastic: text: Oligodendroglioma, anaplastic Transitional cell papilloma, inverted, NOS: text: Transitional cell papilloma, inverted, NOS Hypereosinophilic syndrome: text: Hypereosinophilic syndrome Condylomatous carcinoma: text: Condylomatous carcinoma Malignant peripheral nerve sheath tumor: text: Malignant peripheral nerve sheath tumor Acute myeloid leukemia, AML1(CBF-alpha)/ETO: text: Acute myeloid leukemia, AML1(CBF-alpha)/ETO Neurilemoma, malignant: text: Neurilemoma, malignant Malignant mastocytoma: text: Malignant mastocytoma Periosteal chondroma: text: Periosteal chondroma Hodgkin paragranuloma, nodular: text: Hodgkin paragranuloma, nodular Thymoma, type B2, malignant: text: Thymoma, type B2, malignant Small cell carcinoma, fusiform cell: text: Small cell carcinoma, fusiform cell Somatostatin cell tumor, malignant: text: Somatostatin cell tumor, malignant Choroid plexus papilloma, anaplastic: text: Choroid plexus papilloma, anaplastic Clear cell cystic tumor of borderline malignancy: text: Clear cell cystic tumor of borderline malignancy Malignant lymphoma, diffuse, NOS: text: Malignant lymphoma, diffuse, NOS Esophageal squamous intraepithelial neoplasia (dysplasia), high grade: text: Esophageal squamous intraepithelial neoplasia (dysplasia), high grade Mixed liposarcoma: text: Mixed liposarcoma Mixed endocrine and exocrine adenocarcinoma: text: Mixed endocrine and exocrine adenocarcinoma Mixed adenocarcinoma and epidermoid carcinoma: text: Mixed adenocarcinoma and epidermoid carcinoma NK/T-cell lymphoma, nasal and nasal-type: text: NK/T-cell lymphoma, nasal and nasal-type Well differentiated liposarcoma of superficial soft tissue: text: Well differentiated liposarcoma of superficial soft tissue Aleukemic myelogenous leukemia: text: Aleukemic myelogenous leukemia Scirrhous carcinoma: text: Scirrhous carcinoma Not Reported: text: Not Reported Hodgkin disease, nodular sclerosis, mixed cellularity: text: Hodgkin disease, nodular sclerosis, mixed cellularity Papillary serous tumor of low malignant potential: text: Papillary serous tumor of low malignant potential Acinar cell cystadenocarcinoma: text: Acinar cell cystadenocarcinoma description: Pancreatic Acinar Cell Cystadenocarcinoma Refractory anemia with ringed sideroblasts: text: Refractory anemia with ringed sideroblasts Struma ovarii, NOS: text: Struma ovarii, NOS Ependymoblastoma: text: Ependymoblastoma Aggressive osteoblastoma: text: Aggressive osteoblastoma Thymoma, mixed type, NOS: text: Thymoma, mixed type, NOS Unknown: text: Unknown description: Unknown Eosinophil adenoma: text: Eosinophil adenoma Angiomyosarcoma: text: Angiomyosarcoma Nodular hidradenoma, malignant: text: Nodular hidradenoma, malignant Hurthle cell carcinoma: text: Hurthle cell carcinoma Chronic myelocytic leukemia, NOS: text: Chronic myelocytic leukemia, NOS Hilar cell tumor: text: Hilar cell tumor Lymphosarcoma, NOS: text: Lymphosarcoma, NOS Adamantinoma of long bones: text: Adamantinoma of long bones Grawitz tumor: text: Grawitz tumor Juvenile hemangioma: text: Juvenile hemangioma Serous cystadenoma, NOS: text: Serous cystadenoma, NOS Familial polyposis coli: text: Familial polyposis coli Intraductal papillary neoplasm with low grade intraepithelial neoplasia: text: Intraductal papillary neoplasm with low grade intraepithelial neoplasia Mixed acinar-endocrine carcinoma: text: Mixed acinar-endocrine carcinoma Multiple adenomatous polyps: text: Multiple adenomatous polyps Combined/mixed carcinoid and adenocarcinoma: text: Combined/mixed carcinoid and adenocarcinoma Clear cell ependymoma: text: Clear cell ependymoma Essential thrombocythemia: text: Essential thrombocythemia Clear cell (glycogen-rich) urothelial carcinoma: text: Clear cell (glycogen-rich) urothelial carcinoma Desmoplastic melanoma, malignant: text: Desmoplastic melanoma, malignant Papillary pseudomucinous cystadenoma, borderline malignancy: text: Papillary pseudomucinous cystadenoma, borderline malignancy Chronic idiopathic myelofibrosis: text: Chronic idiopathic myelofibrosis Hemangioendothelial sarcoma: text: Hemangioendothelial sarcoma Basaloid carcinoma: text: Basaloid carcinoma Malignant giant cell tumor of soft parts: text: Malignant giant cell tumor of soft parts Pagetoid reticulosis: text: Pagetoid reticulosis Hepatocellular carcinoma, pleomorphic type: text: Hepatocellular carcinoma, pleomorphic type Cholangioma: text: Cholangioma Hairy cell leukemia variant: text: Hairy cell leukemia variant Ductal carcinoma in situ, papillary: text: Ductal carcinoma in situ, papillary Mucinous cystic neoplasm with intermediate-grade intraepithelial neoplasia: text: Mucinous cystic neoplasm with intermediate-grade intraepithelial neoplasia Myelosclerosis with myeloid metaplasia: text: Myelosclerosis with myeloid metaplasia Follicular thyroid carcinoma (FTC), encapsulated angioinvasive: text: Follicular thyroid carcinoma (FTC), encapsulated angioinvasive Psammomatous schwannoma: text: Psammomatous schwannoma Malignant lymphoma, centrocytic: text: Malignant lymphoma, centrocytic Soft tissue sarcoma: text: Soft tissue sarcoma Krukenberg tumor: text: Krukenberg tumor Neuroendocrine carcinoma, poorly differentiated: text: Neuroendocrine carcinoma, poorly differentiated Genital rhabdomyoma: text: Genital rhabdomyoma G cell tumor, NOS: text: G cell tumor, NOS Histiocytosis X, NOS: text: Histiocytosis X, NOS Brenner tumor, proliferating: text: Brenner tumor, proliferating Myelodysplastic/myeloproliferative neoplasm, unclassifiable: text: Myelodysplastic/myeloproliferative neoplasm, unclassifiable Waldenstrom macroglobulinemia: text: Waldenstrom macroglobulinemia Precursor cell lymphoblastic lymphoma, NOS: text: Precursor cell lymphoblastic lymphoma, NOS Medulloblastoma, classic: text: Medulloblastoma, classic Well differentiated papillary mesothelioma, benign: text: Well differentiated papillary mesothelioma, benign Arrhenoblastoma, NOS: text: Arrhenoblastoma, NOS Phyllodes tumor, benign: text: Phyllodes tumor, benign Rhabdosarcoma: text: Rhabdosarcoma Malignant lymphoma, large B-cell, NOS: text: Malignant lymphoma, large B-cell, NOS Hemangioma, NOS: text: Hemangioma, NOS Serous surface papillary tumor of borderline malignancy: text: Serous surface papillary tumor of borderline malignancy Granulosa cell tumor, malignant: text: Granulosa cell tumor, malignant Gangliocytic paraganglioma: text: Gangliocytic paraganglioma Malignant schwannoma, NOS: text: Malignant schwannoma, NOS Osteochondromatosis, NOS: text: Osteochondromatosis, NOS Urothelial carcinoma with squamous differentiation: text: Urothelial carcinoma with squamous differentiation Large cell (Ki-1+) lymphoma: text: Large cell (Ki-1+) lymphoma Acute myelocytic leukemia: text: Acute myelocytic leukemia Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1: text: Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1 Ductal papilloma: text: Ductal papilloma Classical Hodgkin lymphoma, nodular sclerosis, grade 1: text: Classical Hodgkin lymphoma, nodular sclerosis, grade 1 Malignant lymphoma, lymphocytic, diffuse, NOS: text: Malignant lymphoma, lymphocytic, diffuse, NOS Bile duct adenoma: text: Bile duct adenoma Juvenile chronic myelomonocytic leukemia: text: Juvenile chronic myelomonocytic leukemia Sertoli cell adenoma: text: Sertoli cell adenoma Serous cystadenocarcinofibroma: text: Serous cystadenocarcinofibroma Thymoma, cortical, malignant: text: Thymoma, cortical, malignant Papillary serous cystadenoma, borderline malignancy: text: Papillary serous cystadenoma, borderline malignancy Papillary mucinous cystadenocarcinoma: text: Papillary mucinous cystadenocarcinoma Hepatocholangiocarcinoma: text: Hepatocholangiocarcinoma Cellular leiomyoma: text: Cellular leiomyoma Malignant serous adenofibroma: text: Malignant serous adenofibroma Balloon cell melanoma: text: Balloon cell melanoma Therapy-related myelodysplastic syndrome, NOS: text: Therapy-related myelodysplastic syndrome, NOS Fibrous mesothelioma, benign: text: Fibrous mesothelioma, benign Cribriform carcinoma in situ: text: Cribriform carcinoma in situ Malignant lymphoma, large cell, cleaved, diffuse: text: Malignant lymphoma, large cell, cleaved, diffuse Solid and cystic tumor: text: Solid and cystic tumor Cylindroma of skin: text: Cylindroma of skin Chondromatous giant cell tumor: text: Chondromatous giant cell tumor Embryonal rhabdomyosarcoma, NOS: text: Embryonal rhabdomyosarcoma, NOS Noninfiltrating intraductal papillary adenocarcinoma: text: Noninfiltrating intraductal papillary adenocarcinoma Liver cell adenoma: text: Liver cell adenoma Follicular adenocarcinoma, moderately differentiated: text: Follicular adenocarcinoma, moderately differentiated Seminoma with high mitotic index: text: Seminoma with high mitotic index Therapy related myeloid neoplasm: text: Therapy related myeloid neoplasm Subacute lymphatic leukemia: text: Subacute lymphatic leukemia Neuroendocrine tumor, well differentiated: text: Neuroendocrine tumor, well differentiated Pineocytoma: text: Pineocytoma Ganglioneuroma: text: Ganglioneuroma Non-invasive mammary carcinoma: text: Non-invasive mammary carcinoma MPNST with mesenchymal differentiation: text: MPNST with mesenchymal differentiation Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214: text: Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214 Jadassohn blue nevus: text: Jadassohn blue nevus Intraductal papillary adenocarcinoma with invasion: text: Intraductal papillary adenocarcinoma with invasion Atypical proliferating clear cell tumor: text: Atypical proliferating clear cell tumor Nerve sheath myxoma: text: Nerve sheath myxoma Transitional papilloma, inverted, benign: text: Transitional papilloma, inverted, benign Chronic myelomonocytic leukemia, Type 1: text: Chronic myelomonocytic leukemia, Type 1 Malignant melanoma in junctional nevus: text: Malignant melanoma in junctional nevus Hodgkin paragranuloma, NOS: text: Hodgkin paragranuloma, NOS Mesothelial papilloma: text: Mesothelial papilloma Pleuropulmonary blastoma: text: Pleuropulmonary blastoma Skin-associated lymphoid tissue lymphoma: text: Skin-associated lymphoid tissue lymphoma Papillotubular adenoma: text: Papillotubular adenoma Lymphangioendothelioma, malignant: text: Lymphangioendothelioma, malignant Ependymoma, RELA fusion-positive: text: Ependymoma, RELA fusion-positive Myxoma, NOS: text: Myxoma, NOS Fibrosarcomatous dermatofibrosarcoma protuberans: text: Fibrosarcomatous dermatofibrosarcoma protuberans Signet ring cell adenocarcinoma: text: Signet ring cell adenocarcinoma Monocytoid B-cell lymphoma: text: Monocytoid B-cell lymphoma Pleomorphic lobular carcinoma: text: Pleomorphic lobular carcinoma Malignant serous cystadenofibroma: text: Malignant serous cystadenofibroma Ameloblastic fibro-odontoma: text: Ameloblastic fibro-odontoma Myeloid and lymphoid neoplasms with PDGFRA rearrangement: text: Myeloid and lymphoid neoplasms with PDGFRA rearrangement Acute myeloid leukemia, PML/RAR-alpha: text: Acute myeloid leukemia, PML/RAR-alpha Neurofibromatosis, NOS: text: Neurofibromatosis, NOS Cementifying fibroma: text: Cementifying fibroma Monoclonal gammopathy, NOS: text: Monoclonal gammopathy, NOS Pituitary adenoma, NOS: text: Pituitary adenoma, NOS Indeterminate dendritic cell tumor: text: Indeterminate dendritic cell tumor Papillary carcinoma of thyroid: text: Papillary carcinoma of thyroid Fibroepithelioma of Pinkus type: text: Fibroepithelioma of Pinkus type Pancreatic endocrine tumor, NOS: text: Pancreatic endocrine tumor, NOS Lymphatic leukemic, NOS: text: Lymphatic leukemic, NOS T/NK-cell lymphoma: text: T/NK-cell lymphoma MiT family translocation renal cell carcinoma: text: MiT family translocation renal cell carcinoma description: MiT Family Translocation-Associated Renal Cell Carcinoma Fibroma, NOS: text: Fibroma, NOS Spongioblastoma multiforme: text: Spongioblastoma multiforme Liposarcoma, well differentiated: text: Liposarcoma, well differentiated Large cell carcinoma with rhabdoid phenotype: text: Large cell carcinoma with rhabdoid phenotype Fibroblastic reticular cell tumor: text: Fibroblastic reticular cell tumor Acute promyelocytic leukaemia, PML-RAR-alpha: text: Acute promyelocytic leukaemia, PML-RAR-alpha Clear cell cystadenocarcinofibroma: text: Clear cell cystadenocarcinofibroma Large granular lymphocytosis, NOS: text: Large granular lymphocytosis, NOS Renal cell carcinoma, spindle cell: text: Renal cell carcinoma, spindle cell T-zone lymphoma: text: T-zone lymphoma Hemangioma simplex: text: Hemangioma simplex Spindle cell carcinoma, NOS: text: Spindle cell carcinoma, NOS Invasive mammary carcinoma: text: Invasive mammary carcinoma Matrical carcinoma: text: Matrical carcinoma Black adenoma: text: Black adenoma Malignant lymphoma, small lymphocytic, NOS: text: Malignant lymphoma, small lymphocytic, NOS Malignant mucinous cystadenofibroma: text: Malignant mucinous cystadenofibroma Differentiated penile intraepithelial neoplasia: text: Differentiated penile intraepithelial neoplasia Mycosis fungoides: text: Mycosis fungoides Juvenile histiocytoma: text: Juvenile histiocytoma Transitional cell carcinoma in situ: text: Transitional cell carcinoma in situ Epithelioid leiomyosarcoma: text: Epithelioid leiomyosarcoma Prolymphocytic leukemia, B-cell type: text: Prolymphocytic leukemia, B-cell type Balloon cell nevus: text: Balloon cell nevus Papillary and follicular adenocarcinoma: text: Papillary and follicular adenocarcinoma Malignant tumor, clear cell type: text: Malignant tumor, clear cell type Plexiform neurofibroma: text: Plexiform neurofibroma Monocytic leukemia, NOS: text: Monocytic leukemia, NOS Unclassified tumor, benign: text: Unclassified tumor, benign Mammary carcinoma, in situ: text: Mammary carcinoma, in situ Microfollicular adenoma, NOS: text: Microfollicular adenoma, NOS Adenosquamous carcinoma: text: Adenosquamous carcinoma Adenocarcinoma in situ in tubular adenoma: text: Adenocarcinoma in situ in tubular adenoma Hairy nevus: text: Hairy nevus Traditional serrated adenoma: text: Traditional serrated adenoma Hydroa vacciniforme-like lymphoma: text: Hydroa vacciniforme-like lymphoma Craniopharyngioma, papillary: text: Craniopharyngioma, papillary Mucinous cystadenofibroma, NOS: text: Mucinous cystadenofibroma, NOS Cystosarcoma phyllodes, benign: text: Cystosarcoma phyllodes, benign Chordoid meningioma: text: Chordoid meningioma Common ALL: text: Common ALL Mesothelioma, biphasic, malignant: text: Mesothelioma, biphasic, malignant Dentinoma: text: Dentinoma Brooke tumor: text: Brooke tumor Glandular papilloma: text: Glandular papilloma Hilus cell tumor: text: Hilus cell tumor Luteinoma: text: Luteinoma Acinar carcinoma: text: Acinar carcinoma Bronchiolo-alveolar carcinoma, indeterminate type: text: Bronchiolo-alveolar carcinoma, indeterminate type Metatypical carcinoma: text: Metatypical carcinoma Gynandroblastoma: text: Gynandroblastoma Adenocarcinoma in multiple adenomatous polyps: text: Adenocarcinoma in multiple adenomatous polyps Osteoblastoma, malignant: text: Osteoblastoma, malignant Hodgkin disease, nodular sclerosis, NOS: text: Hodgkin disease, nodular sclerosis, NOS Merkel cell tumor: text: Merkel cell tumor c-ALL: text: c-ALL Lymphoepithelioma-like carcinoma: text: Lymphoepithelioma-like carcinoma Meningeal melanoma: text: Meningeal melanoma Adenocarcinoma, diffuse type: text: Adenocarcinoma, diffuse type Intraductal papillary mucinous neoplasm (IPMN) with an associated invasive carcinoma: text: Intraductal papillary mucinous neoplasm (IPMN) with an associated invasive carcinoma Sertoli-Leydig cell tumor of intermediate differentiation: text: Sertoli-Leydig cell tumor of intermediate differentiation Myxoliposarcoma: text: Myxoliposarcoma Degenerated schwannoma: text: Degenerated schwannoma Unclassified tumor, borderline malignancy: text: Unclassified tumor, borderline malignancy Malignant lymphoma, immunoblastic, NOS: text: Malignant lymphoma, immunoblastic, NOS Infantile fibrosarcoma: text: Infantile fibrosarcoma Tumor cells, NOS: text: Tumor cells, NOS Endometrioid adenofibroma, malignant: text: Endometrioid adenofibroma, malignant Cutaneous mastocytosis: text: Cutaneous mastocytosis Follicular lymphoma, grade 1: text: Follicular lymphoma, grade 1 Undifferentiated sarcoma: text: Undifferentiated sarcoma Hepatosplenic T-cell lymphoma: text: Hepatosplenic T-cell lymphoma Squamous cell carcinoma, HPV-negative: text: Squamous cell carcinoma, HPV-negative Endometrioid cystadenoma, NOS: text: Endometrioid cystadenoma, NOS Villous adenoma, NOS: text: Villous adenoma, NOS Leydig cell tumor, NOS: text: Leydig cell tumor, NOS Hepatocellular adenoma: text: Hepatocellular adenoma Acute lymphoblastic leukemia, mature B-cell type: text: Acute lymphoblastic leukemia, mature B-cell type Systemic mastocytosis with associated hematological clonal non-mast cell disorder: text: Systemic mastocytosis with associated hematological clonal non-mast cell disorder Tubulo-papillary adenoma: text: Tubulo-papillary adenoma Endodermal sinus tumor: text: Endodermal sinus tumor Gastrointestinal autonomic nerve tumor: text: Gastrointestinal autonomic nerve tumor Malignant lymphoma, histiocytic, nodular: text: Malignant lymphoma, histiocytic, nodular Malignant tumor, fusiform cell type: text: Malignant tumor, fusiform cell type Cementoma, NOS: text: Cementoma, NOS Mucinous cystadenocarcinoma, non-invasive: text: Mucinous cystadenocarcinoma, non-invasive Oncocytoma: text: Oncocytoma Malignant lymphoma, undifferentiated cell, non-Burkitt: text: Malignant lymphoma, undifferentiated cell, non-Burkitt MGUS: text: MGUS Mixed type rhabdomyosarcoma: text: Mixed type rhabdomyosarcoma Gastrointestinal stromal tumor, NOS: text: Gastrointestinal stromal tumor, NOS Chorioadenoma: text: Chorioadenoma Malignant lymphoma, lymphocytic, poorly differentiated, diffuse: text: Malignant lymphoma, lymphocytic, poorly differentiated, diffuse Mesonephroma, NOS: text: Mesonephroma, NOS Duct adenoma, NOS: text: Duct adenoma, NOS Langerhans cell histiocytosis, disseminated: text: Langerhans cell histiocytosis, disseminated Osteosarcoma in Paget disease of bone: text: Osteosarcoma in Paget disease of bone Ovarian stromal tumor: text: Ovarian stromal tumor Pick tubular adenoma: text: Pick tubular adenoma Lobular carcinoma in situ, NOS: text: Lobular carcinoma in situ, NOS Malignant lymphoma, lymphocytic, well differentiated, diffuse: text: Malignant lymphoma, lymphocytic, well differentiated, diffuse Mesenchymal tumor, malignant: text: Mesenchymal tumor, malignant Villoglandular adenoma: text: Villoglandular adenoma Thecoma, malignant: text: Thecoma, malignant Papilloma, NOS: text: Papilloma, NOS Glucagonoma, malignant: text: Glucagonoma, malignant Tumor cells, uncertain whether benign or malignant: text: Tumor cells, uncertain whether benign or malignant Myxoid liposarcoma: text: Myxoid liposarcoma Papillary pseudomucinous cystadenoma, NOS: text: Papillary pseudomucinous cystadenoma, NOS Low-grade intramedullary osteosarcoma: text: Low-grade intramedullary osteosarcoma Glioblastoma multiforme: text: Glioblastoma multiforme Mucoid carcinoma: text: Mucoid carcinoma Malignant lymphoma, small cell diffuse: text: Malignant lymphoma, small cell diffuse Primary cutaneous neuroendocrine carcinoma: text: Primary cutaneous neuroendocrine carcinoma Mucinous carcinoma, intestinal type: text: Mucinous carcinoma, intestinal type RARS: text: RARS Choroid plexus papilloma, malignant: text: Choroid plexus papilloma, malignant Odontogenic tumor, malignant: text: Odontogenic tumor, malignant Mucosal-associated lymphoid tissue lymphoma: text: Mucosal-associated lymphoid tissue lymphoma Pinkus tumor: text: Pinkus tumor Blast cell leukemia: text: Blast cell leukemia Lepidic adenocarcinoma: text: Lepidic adenocarcinoma Mucinous cystic neoplasm with an associated invasive carcinoma: text: Mucinous cystic neoplasm with an associated invasive carcinoma description: Bile Duct Cystadenocarcinoma Pseudomucinous cystadenoma, borderline malignancy: text: Pseudomucinous cystadenoma, borderline malignancy Lipoma, NOS: text: Lipoma, NOS Noninvasive pancreatobiliary papillary neoplasm with high grade dysplasia: text: Noninvasive pancreatobiliary papillary neoplasm with high grade dysplasia Unclassified tumor, malignant, uncertain whether primary or metastatic: text: Unclassified tumor, malignant, uncertain whether primary or metastatic Psammomatous meningioma: text: Psammomatous meningioma Sweat gland carcinoma: text: Sweat gland carcinoma Malignant myelosclerosis: text: Malignant myelosclerosis Canalicular adenoma: text: Canalicular adenoma T-cell rich large B-cell lymphoma: text: T-cell rich large B-cell lymphoma Teratoma, benign: text: Teratoma, benign Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related: text: Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related Subacute lymphoid leukemia: text: Subacute lymphoid leukemia Struma ovarii, malignant: text: Struma ovarii, malignant Sessile serrated polyp: text: Sessile serrated polyp Ameloblastic carcinoma: text: Ameloblastic carcinoma Osteosarcoma, NOS: text: Osteosarcoma, NOS Malignant lymphoma, large cell, NOS: text: Malignant lymphoma, large cell, NOS Combined small cell carcinoma: text: Combined small cell carcinoma Adenocarcinoma in situ, mucinous: text: Adenocarcinoma in situ, mucinous description: Mucinous Lung Adenocarcinoma In Situ Lymphomatoid granulomatosis: text: Lymphomatoid granulomatosis Oncocytic adenoma: text: Oncocytic adenoma Adult teratoma, NOS: text: Adult teratoma, NOS RAEB-T: text: RAEB-T Angiomyofibroblastoma: text: Angiomyofibroblastoma Enterochromaffin-like cell tumor, malignant: text: Enterochromaffin-like cell tumor, malignant Paget disease of breast: text: Paget disease of breast Spindle cell melanoma, type B: text: Spindle cell melanoma, type B Acute myeloid leukemia, MLL: text: Acute myeloid leukemia, MLL Neurilemosarcoma: text: Neurilemosarcoma Mucinous cystic tumor with moderate dysplasia: text: Mucinous cystic tumor with moderate dysplasia Carcinoid, NOS: text: Carcinoid, NOS Small cell carcinoma, hypercalcemic type: text: Small cell carcinoma, hypercalcemic type description: Ovarian Small Cell Carcinoma, Hypercalcemic Type Hepatoblastoma, epithelioid: text: Hepatoblastoma, epithelioid Adenocarcinoma, pancreatobiliary type: text: Adenocarcinoma, pancreatobiliary type Intraepidermal nevus: text: Intraepidermal nevus Mesenchymoma, NOS: text: Mesenchymoma, NOS Extra-abdominal desmoid: text: Extra-abdominal desmoid Mucinous cystic tumor with an associated invasive carcinoma: text: Mucinous cystic tumor with an associated invasive carcinoma Gastrinoma, malignant: text: Gastrinoma, malignant Lentigo maligna: text: Lentigo maligna AML M6: text: AML M6 Serous adenofibroma of borderline malignancy: text: Serous adenofibroma of borderline malignancy Tubular carcinoid: text: Tubular carcinoid Duct adenocarcinoma, NOS: text: Duct adenocarcinoma, NOS Glomoid sarcoma: text: Glomoid sarcoma Hurthle cell tumor: text: Hurthle cell tumor Marginal zone B-cell lymphoma, NOS: text: Marginal zone B-cell lymphoma, NOS Solid carcinoma with mucin formation: text: Solid carcinoma with mucin formation Juvenile angiofibroma: text: Juvenile angiofibroma Intraductal tubulopapillary neoplasm: text: Intraductal tubulopapillary neoplasm Fibroxanthoma, NOS: text: Fibroxanthoma, NOS Dedifferentiated chondrosarcoma: text: Dedifferentiated chondrosarcoma Transitional pineal tumor: text: Transitional pineal tumor Vipoma, NOS: text: Vipoma, NOS Transitional cell carcinoma, sarcomatoid: text: Transitional cell carcinoma, sarcomatoid Intraductal papillary neoplasm with associated invasive carcinoma: text: Intraductal papillary neoplasm with associated invasive carcinoma Kaposi sarcoma: text: Kaposi sarcoma Granular cell tumor, NOS: text: Granular cell tumor, NOS Adenocarcinoma, intestinal type: text: Adenocarcinoma, intestinal type description: Intestinal-Type Adenocarcinoma Carcinoma in adenomatous polyp: text: Carcinoma in adenomatous polyp Malignant lymphoma, convoluted cell: text: Malignant lymphoma, convoluted cell Teratocarcinoma: text: Teratocarcinoma Intimal sarcoma: text: Intimal sarcoma Langerhans cell sarcoma: text: Langerhans cell sarcoma Tanycytic ependymoma: text: Tanycytic ependymoma Schneiderian papilloma, inverted: text: Schneiderian papilloma, inverted Well differentiated thymic carcinoma: text: Well differentiated thymic carcinoma Malignant teratoma, trophoblastic: text: Malignant teratoma, trophoblastic Parafollicular cell carcinoma: text: Parafollicular cell carcinoma Mixed basal-squamous cell carcinoma: text: Mixed basal-squamous cell carcinoma Hidradenoma, NOS: text: Hidradenoma, NOS Pigmented spindle cell nevus of Reed: text: Pigmented spindle cell nevus of Reed Acute lymphoblastic leukemia, precursor cell type: text: Acute lymphoblastic leukemia, precursor cell type Encapsulated follicular variant of papillary thyroid carcinoma, NOS (EFVPTC, NOS): text: Encapsulated follicular variant of papillary thyroid carcinoma, NOS (EFVPTC, NOS) Sezary disease: text: Sezary disease Serous cystadenofibroma, NOS: text: Serous cystadenofibroma, NOS Primary intraosseous carcinoma: text: Primary intraosseous carcinoma Neuroendocrine carcinoma, NOS: text: Neuroendocrine carcinoma, NOS Retinoblastoma, diffuse: text: Retinoblastoma, diffuse Gastrointestinal pacemaker cell tumor: text: Gastrointestinal pacemaker cell tumor Adenocarcinoma in situ in tubulovillous adenoma: text: Adenocarcinoma in situ in tubulovillous adenoma Epithelioid hemangioendothelioma, NOS: text: Epithelioid hemangioendothelioma, NOS Embryonal carcinoma, polyembryonal type: text: Embryonal carcinoma, polyembryonal type Arrhenoblastoma, malignant: text: Arrhenoblastoma, malignant Spindle cell nevus, NOS: text: Spindle cell nevus, NOS Histiocytic sarcoma: text: Histiocytic sarcoma Malignant teratoma, anaplastic: text: Malignant teratoma, anaplastic Thymoma, lymphocyte-rich, malignant: text: Thymoma, lymphocyte-rich, malignant Intraductal papillary neoplasm with intermediate grade neoplasia: text: Intraductal papillary neoplasm with intermediate grade neoplasia Atypical polypoid adenomyoma: text: Atypical polypoid adenomyoma Mixed ductal-endocrine carcinoma: text: Mixed ductal-endocrine carcinoma Insular carcinoma: text: Insular carcinoma Arrhenoblastoma, benign: text: Arrhenoblastoma, benign Papillary carcinoma, follicular variant: text: Papillary carcinoma, follicular variant Astrocytoma, anaplastic: text: Astrocytoma, anaplastic Thymoma, type B1, NOS: text: Thymoma, type B1, NOS Solitary fibrous tumor/hemangiopericytoma Grade 1 (CNS): text: Solitary fibrous tumor/hemangiopericytoma Grade 1 (CNS) Eosinophil carcinoma: text: Eosinophil carcinoma Sessile serrated adenoma: text: Sessile serrated adenoma Micropapillary serous carcinoma: text: Micropapillary serous carcinoma Malignancy: text: Malignancy Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1: text: Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 Mixed pineocytoma-pineoblastoma: text: Mixed pineocytoma-pineoblastoma Esthesioneurocytoma: text: Esthesioneurocytoma Acoustic neuroma: text: Acoustic neuroma Gliosarcoma: text: Gliosarcoma Endometrioid carcinoma with squamous differentiation: text: Endometrioid carcinoma with squamous differentiation description: Endometrial Squamous Cell Carcinoma Granular cell tumor of the sellar region: text: Granular cell tumor of the sellar region Intraductal papillary neoplasm with high grade intraepithelial neoplasia: text: Intraductal papillary neoplasm with high grade intraepithelial neoplasia Embryonal carcinoma, NOS: text: Embryonal carcinoma, NOS Hodgkin lymphoma, nodular sclerosis, NOS: text: Hodgkin lymphoma, nodular sclerosis, NOS Complete hydatidiform mole: text: Complete hydatidiform mole Intraductal tubular-papillary neoplasm, high grade: text: Intraductal tubular-papillary neoplasm, high grade Anaplastic oligoastrocytoma: text: Anaplastic oligoastrocytoma Neoplasm, uncertain whether benign or malignant: text: Neoplasm, uncertain whether benign or malignant Symplastic leiomyoma: text: Symplastic leiomyoma Hemangioendothelioma, benign: text: Hemangioendothelioma, benign Small cell carcinoma, intermediate cell: text: Small cell carcinoma, intermediate cell Serous adenocarcinofibroma: text: Serous adenocarcinofibroma Juxtacortical chondrosarcoma: text: Juxtacortical chondrosarcoma Adenomyoepithelioma with carcinoma: text: Adenomyoepithelioma with carcinoma Malignant multilocular cystic nephroma: text: Malignant multilocular cystic nephroma Neuroastrocytoma: text: Neuroastrocytoma Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1: text: Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1 Sebaceous epithelioma: text: Sebaceous epithelioma Meningioma, anaplastic: text: Meningioma, anaplastic Sex cord-gonadal stromal tumor, NOS: text: Sex cord-gonadal stromal tumor, NOS Chronic granulocytic leukemia, t(9;22)(q34;q11): text: Chronic granulocytic leukemia, t(9;22)(q34;q11) Glycogenic rhabdomyoma: text: Glycogenic rhabdomyoma Therapy-related myelodysplastic syndrome, alkylating agent related: text: Therapy-related myelodysplastic syndrome, alkylating agent related Goblet cell carcinoid: text: Goblet cell carcinoid Non-invasive FTP: text: Non-invasive FTP Papillary squamous cell carcinoma, non-invasive: text: Papillary squamous cell carcinoma, non-invasive Basal cell epithelioma: text: Basal cell epithelioma Adenoameloblastoma: text: Adenoameloblastoma Thymoma, type A, NOS: text: Thymoma, type A, NOS Choroid plexus papilloma, NOS: text: Choroid plexus papilloma, NOS Multicentric basal cell carcinoma: text: Multicentric basal cell carcinoma Acute myeloid leukemia, NOS: text: Acute myeloid leukemia, NOS Adenomatoid tumor, NOS: text: Adenomatoid tumor, NOS FAB M6: text: FAB M6 Thymoma, predominantly cortical, NOS: text: Thymoma, predominantly cortical, NOS Adenoacanthoma: text: Adenoacanthoma Mixed adenomatous and hyperplastic polyp: text: Mixed adenomatous and hyperplastic polyp Hemangiopericytic meningioma: text: Hemangiopericytic meningioma Intraepidermal carcinoma, NOS: text: Intraepidermal carcinoma, NOS Germ cell tumor, NOS: text: Germ cell tumor, NOS Florid osseous dysplasia: text: Florid osseous dysplasia Embryonal adenoma: text: Embryonal adenoma Eccrine adenocarcinoma: text: Eccrine adenocarcinoma Abdominal fibromatosis: text: Abdominal fibromatosis Chondrosarcoma grade 2/3: text: Chondrosarcoma grade 2/3 Angioendothelioma: text: Angioendothelioma Atypical lipoma: text: Atypical lipoma Small cell sarcoma: text: Small cell sarcoma Metaplastic carcinoma, NOS: text: Metaplastic carcinoma, NOS Paget disease and intraductal carcinoma of breast: text: Paget disease and intraductal carcinoma of breast Malignant lymphoma, large cell, diffuse, NOS: text: Malignant lymphoma, large cell, diffuse, NOS Transitional cell carcinoma: text: Transitional cell carcinoma description: Ovarian Transitional Cell Carcinoma Tubular carcinoma: text: Tubular carcinoma Sweat gland tumor, benign: text: Sweat gland tumor, benign Carcinoid tumor, NOS: text: Carcinoid tumor, NOS Intraductal papillomatosis, NOS: text: Intraductal papillomatosis, NOS Infiltrating basal cell carcinoma, sclerosing: text: Infiltrating basal cell carcinoma, sclerosing Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease: text: Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease Desmoplastic medulloblastoma: text: Desmoplastic medulloblastoma Prostatic intraepithelial neoplasia, grade III: text: Prostatic intraepithelial neoplasia, grade III Askin tumor: text: Askin tumor Odontoma, NOS: text: Odontoma, NOS Gastrinoma, NOS: text: Gastrinoma, NOS Superficial spreading adenocarcinoma: text: Superficial spreading adenocarcinoma Malignant lymphoma, Hodgkin: text: Malignant lymphoma, Hodgkin Primary amyloidosis: text: Primary amyloidosis Reticulohistiocytoma: text: Reticulohistiocytoma B-ALL: text: B-ALL Pilomatrixoma, malignant: text: Pilomatrixoma, malignant Acute myeloid leukemia with mutated NPM1: text: Acute myeloid leukemia with mutated NPM1 Desmoplastic melanoma, amelanotic: text: Desmoplastic melanoma, amelanotic Proliferative dermal lesion in congenital nevus: text: Proliferative dermal lesion in congenital nevus Neurinoma: text: Neurinoma Sarcoma botryoides: text: Sarcoma botryoides Non-invasive low grade serous carcinoma: text: Non-invasive low grade serous carcinoma Merkel cell carcinoma: text: Merkel cell carcinoma Low grade cribriform cystadenocarcinoma (LGCCC): text: Low grade cribriform cystadenocarcinoma (LGCCC) Di Guglielmo disease: text: Di Guglielmo disease Desmoplastic nodular medulloblastoma: text: Desmoplastic nodular medulloblastoma Retinoblastoma, undifferentiated: text: Retinoblastoma, undifferentiated Cribriform carcinoma, NOS: text: Cribriform carcinoma, NOS Islet cell adenoma: text: Islet cell adenoma Malignant lymphoma, large B-cell, diffuse, NOS: text: Malignant lymphoma, large B-cell, diffuse, NOS Basal cell tumor: text: Basal cell tumor Somatostatinoma, NOS: text: Somatostatinoma, NOS Anaplastic large cell lymphoma, NOS: text: Anaplastic large cell lymphoma, NOS Undifferentiated high-grade pleomorphic sarcoma: text: Undifferentiated high-grade pleomorphic sarcoma Odontogenic fibrosarcoma: text: Odontogenic fibrosarcoma Papillary cystic tumor: text: Papillary cystic tumor Mixed medullary-papillary carcinoma: text: Mixed medullary-papillary carcinoma Mixed medullary-follicular carcinoma: text: Mixed medullary-follicular carcinoma Small cell carcinoma pulmonary type: text: Small cell carcinoma pulmonary type Basophil adenoma: text: Basophil adenoma Ductal carcinoma in situ, NOS: text: Ductal carcinoma in situ, NOS Ganglioglioma, NOS: text: Ganglioglioma, NOS Hodgkin disease, nodular sclerosis, syncytial variant: text: Hodgkin disease, nodular sclerosis, syncytial variant Elastofibroma: text: Elastofibroma Reninoma: text: Reninoma Acute lymphocytic leukemia: text: Acute lymphocytic leukemia Pseudomyxoma peritonei: text: Pseudomyxoma peritonei Squamotransitional cell carcinoma: text: Squamotransitional cell carcinoma Extranodal NK/T-cell lymphoma, nasal type: text: Extranodal NK/T-cell lymphoma, nasal type Adrenal cortical tumor, NOS: text: Adrenal cortical tumor, NOS FAB M2, t(8;21)(q22;q22): text: FAB M2, t(8;21)(q22;q22) Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor: text: Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor Basal cell carcinoma, desmoplastic type: text: Basal cell carcinoma, desmoplastic type Undifferentiated pleomorphic sarcoma: text: Undifferentiated pleomorphic sarcoma Osteogenic sarcoma, NOS: text: Osteogenic sarcoma, NOS MPNST with rhabdomyoblastic differentiation: text: MPNST with rhabdomyoblastic differentiation Malignant reticulosis, NOS: text: Malignant reticulosis, NOS Chronic granulocytic leukemia, BCR/ABL: text: Chronic granulocytic leukemia, BCR/ABL Rodent ulcer: text: Rodent ulcer Glioblastoma with sarcomatous component: text: Glioblastoma with sarcomatous component Nodal marginal zone lymphoma: text: Nodal marginal zone lymphoma Calcifying odontogenic cyst: text: Calcifying odontogenic cyst Endotheliomatous meningioma: text: Endotheliomatous meningioma Carcinoma in pleomorphic adenoma: text: Carcinoma in pleomorphic adenoma Thymic large B-cell lymphoma: text: Thymic large B-cell lymphoma Porocarcinoma: text: Porocarcinoma Lymphoplasmacyte-rich meningioma: text: Lymphoplasmacyte-rich meningioma Acute lymphatic leukemia: text: Acute lymphatic leukemia Squamous intraepithelial neoplasia, grade I: text: Squamous intraepithelial neoplasia, grade I Diffuse midline glioma, H3 K27M-mutant: text: Diffuse midline glioma, H3 K27M-mutant Intracystic papillary tumor with high grade intraepithelial neoplasia: text: Intracystic papillary tumor with high grade intraepithelial neoplasia Infiltrating and papillary adenocarcinoma: text: Infiltrating and papillary adenocarcinoma Desmoplastic small round cell tumor: text: Desmoplastic small round cell tumor Refractory thrombocytopenia: text: Refractory thrombocytopenia Strumal carcinoid: text: Strumal carcinoid Melanoameloblastoma: text: Melanoameloblastoma Alpha cell tumor, NOS: text: Alpha cell tumor, NOS Melanotic neuroectodermal tumor: text: Melanotic neuroectodermal tumor Pseudomyxoma peritonei with unknown primary site: text: Pseudomyxoma peritonei with unknown primary site Trichilemmocarcinoma: text: Trichilemmocarcinoma Hypernephroid tumor: text: Hypernephroid tumor Cutaneous lymphoma, NOS: text: Cutaneous lymphoma, NOS Fibromyxoma: text: Fibromyxoma Junctional nevus, NOS: text: Junctional nevus, NOS Squamous intraepithelial neoplasia, high grade: text: Squamous intraepithelial neoplasia, high grade Leptomeningeal sarcoma: text: Leptomeningeal sarcoma Deep histiocytoma: text: Deep histiocytoma Arteriovenous hemangioma: text: Arteriovenous hemangioma Polycythemia rubra vera: text: Polycythemia rubra vera Infantile myofibromatosis: text: Infantile myofibromatosis Epithelioid MPNST: text: Epithelioid MPNST Pre-T ALL: text: Pre-T ALL Encapsulated papillary carcinoma with invasion: text: Encapsulated papillary carcinoma with invasion Carcinoid tumor, argentaffin, NOS: text: Carcinoid tumor, argentaffin, NOS Endovascular papillary angioendothelioma: text: Endovascular papillary angioendothelioma Pituitary carcinoma, NOS: text: Pituitary carcinoma, NOS Renomedullary fibroma: text: Renomedullary fibroma Juxtaglomerular tumor: text: Juxtaglomerular tumor Serous tubal intraepithelial carcinoma: text: Serous tubal intraepithelial carcinoma Malignant lymphoma, centroblasticcentrocytic, follicular: text: Malignant lymphoma, centroblasticcentrocytic, follicular Follicular lymphoma, grade 2: text: Follicular lymphoma, grade 2 Eccrine poroma, malignant: text: Eccrine poroma, malignant Meningothelial meningioma: text: Meningothelial meningioma Endometrial stromal sarcoma, low grade: text: Endometrial stromal sarcoma, low grade Myelofibrosis as a result of myeloproliferative disease: text: Myelofibrosis as a result of myeloproliferative disease Medullary carcinoma, NOS: text: Medullary carcinoma, NOS Adenocystic carcinoma: text: Adenocystic carcinoma Intraductal papillary-mucinous tumor with moderate dysplasia: text: Intraductal papillary-mucinous tumor with moderate dysplasia Agnogenic myeloid metaplasia: text: Agnogenic myeloid metaplasia Mucinous adenocarcinofibroma: text: Mucinous adenocarcinofibroma T-cell large granular lymphocytic leukemia: text: T-cell large granular lymphocytic leukemia Neurofibroma, NOS: text: Neurofibroma, NOS Refractory anemia with excess blasts in transformation: text: Refractory anemia with excess blasts in transformation Trichilemmal carcinoma: text: Trichilemmal carcinoma Glandular intraepithelial neoplasia, high grade: text: Glandular intraepithelial neoplasia, high grade Neuroectodermal tumor, NOS: text: Neuroectodermal tumor, NOS Collecting duct carcinoma: text: Collecting duct carcinoma description: Carcinoma of the Collecting Ducts of Bellini Wilms tumor: text: Wilms tumor Acidophil adenocarcinoma: text: Acidophil adenocarcinoma Malignant lymphoma, large cell, noncleaved, diffuse: text: Malignant lymphoma, large cell, noncleaved, diffuse Thymoma, benign: text: Thymoma, benign Juvenile nevus: text: Juvenile nevus Low grade appendiceal mucinous neoplasm: text: Low grade appendiceal mucinous neoplasm Columnar cell papilloma: text: Columnar cell papilloma Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia: text: Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia Fibroblastic osteosarcoma: text: Fibroblastic osteosarcoma Chorionepithelioma: text: Chorionepithelioma Lennert lymphoma: text: Lennert lymphoma Megakaryocytic leukemia: text: Megakaryocytic leukemia Reticulum cell sarcoma, NOS: text: Reticulum cell sarcoma, NOS Ameloblastic sarcoma: text: Ameloblastic sarcoma Hepatocellular carcinoma, NOS: text: Hepatocellular carcinoma, NOS Infiltrating duct and lobular carcinoma: text: Infiltrating duct and lobular carcinoma Solitary fibrous tumor: text: Solitary fibrous tumor Pro-T ALL: text: Pro-T ALL Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged: text: Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged Pulmonary adenomatosis: text: Pulmonary adenomatosis ECL cell carcinoid, NOS: text: ECL cell carcinoid, NOS Adenomatoid odontogenic tumor: text: Adenomatoid odontogenic tumor Ecchondroma: text: Ecchondroma Anaplastic large cell lymphoma, ALK negative: text: Anaplastic large cell lymphoma, ALK negative Malignant teratoma, intermediate: text: Malignant teratoma, intermediate Serous cystadenofibroma of borderline malignancy: text: Serous cystadenofibroma of borderline malignancy Mixed cell adenoma: text: Mixed cell adenoma Osteoma, NOS: text: Osteoma, NOS Bronchiolo-alveolar adenocarcinoma, NOS: text: Bronchiolo-alveolar adenocarcinoma, NOS Nephroma, NOS: text: Nephroma, NOS Carcinoma, metastatic, NOS: text: Carcinoma, metastatic, NOS Chronic monocytic leukemia: text: Chronic monocytic leukemia Malignant lymphoma, lymphoplasmacytic: text: Malignant lymphoma, lymphoplasmacytic Synovioma, benign: text: Synovioma, benign Myxoid chondrosarcoma: text: Myxoid chondrosarcoma Intraductal papillary tumor with high grade dysplasia: text: Intraductal papillary tumor with high grade dysplasia Oxyphilic adenoma: text: Oxyphilic adenoma Mixed carcinoid-adenocarcinoma: text: Mixed carcinoid-adenocarcinoma Cystic hygroma: text: Cystic hygroma Heavy chain disease, NOS: text: Heavy chain disease, NOS Phyllodes tumor, borderline: text: Phyllodes tumor, borderline Papillary cystadenocarcinoma, NOS: text: Papillary cystadenocarcinoma, NOS Malignant lymphoma, lymphoplasmacytoid: text: Malignant lymphoma, lymphoplasmacytoid Malignant lymphoma, centroblastic, follicular: text: Malignant lymphoma, centroblastic, follicular Lymphoepithelioma: text: Lymphoepithelioma Mucinous cystic neoplasm with high-grade dysplasia: text: Mucinous cystic neoplasm with high-grade dysplasia Circumscribed arachnoidal cerebellar sarcoma: text: Circumscribed arachnoidal cerebellar sarcoma Papillary urothelial carcinoma: text: Papillary urothelial carcinoma Polymorphous low grade adenocarcinoma: text: Polymorphous low grade adenocarcinoma Periosteal osteosarcoma: text: Periosteal osteosarcoma Hodgkin disease, lymphocytic-histiocytic predominance: text: Hodgkin disease, lymphocytic-histiocytic predominance Hepatoma, NOS: text: Hepatoma, NOS Pigmented dermatofibrosarcoma protuberans: text: Pigmented dermatofibrosarcoma protuberans Calcifying epithelioma of Malherbe: text: Calcifying epithelioma of Malherbe Adenocarcinoma of anal glands: text: Adenocarcinoma of anal glands T-cell lymphoma, NOS: text: T-cell lymphoma, NOS Gastrointestinal stromal sarcoma: text: Gastrointestinal stromal sarcoma Eccrine dermal cylindroma: text: Eccrine dermal cylindroma RAEB II: text: RAEB II Halo nevus: text: Halo nevus Beta cell adenoma: text: Beta cell adenoma Dermoid cyst, NOS: text: Dermoid cyst, NOS Angiocentric immunoproliferative lesion: text: Angiocentric immunoproliferative lesion Fetal fat cell lipoma: text: Fetal fat cell lipoma Oncocytic Schneiderian papilloma: text: Oncocytic Schneiderian papilloma Chromaffinoma: text: Chromaffinoma Cystic lymphangioma: text: Cystic lymphangioma Chromaffin tumor: text: Chromaffin tumor Intracystic papillary neoplasm with intermediate grade intraepithelial neoplasia: text: Intracystic papillary neoplasm with intermediate grade intraepithelial neoplasia Carcinoma, undifferentiated, NOS: text: Carcinoma, undifferentiated, NOS Glandular intraepithelial neoplasia, grade II: text: Glandular intraepithelial neoplasia, grade II Cavernous lymphangioma: text: Cavernous lymphangioma Adenocarcinoid tumor: text: Adenocarcinoid tumor Mixed acinar-endocrine-ductal carcinoma: text: Mixed acinar-endocrine-ductal carcinoma Hairy cell leukemia: text: Hairy cell leukemia Polar spongioblastoma: text: Polar spongioblastoma Subependymoma: text: Subependymoma Clear cell adenocarcinoma, NOS: text: Clear cell adenocarcinoma, NOS Large cell carcinoma, NOS: text: Large cell carcinoma, NOS Adult cystic teratoma: text: Adult cystic teratoma Intracystic carcinoma, NOS: text: Intracystic carcinoma, NOS Enterochromaffin cell carcinoid: text: Enterochromaffin cell carcinoid Olfactory neuroblastoma: text: Olfactory neuroblastoma Odontoameloblastoma: text: Odontoameloblastoma Comedocarcinoma, noninfiltrating: text: Comedocarcinoma, noninfiltrating Adnexal tumor, benign: text: Adnexal tumor, benign B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH: text: B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH Bronchiolo-alveolar carcinoma, NOS: text: Bronchiolo-alveolar carcinoma, NOS Gastrointestinal stromal tumor, uncertain malignant potential: text: Gastrointestinal stromal tumor, uncertain malignant potential Mesothelioma, benign: text: Mesothelioma, benign FAB M3 (includes all variants): text: FAB M3 (includes all variants) Extra-adrenal paraganglioma, malignant: text: Extra-adrenal paraganglioma, malignant Fibrous histiocytoma, NOS: text: Fibrous histiocytoma, NOS Retinoblastoma, NOS: text: Retinoblastoma, NOS Infiltrating duct and tubular carcinoma: text: Infiltrating duct and tubular carcinoma Malignant mastocytosis: text: Malignant mastocytosis Papillary microcarcinoma: text: Papillary microcarcinoma Anaplastic medulloblastoma: text: Anaplastic medulloblastoma Giant osteoid osteoma: text: Giant osteoid osteoma Teratoma, malignant, NOS: text: Teratoma, malignant, NOS Undifferentiated uterine sarcoma: text: Undifferentiated uterine sarcoma Primary diffuse large B-cell lymphoma of the CNS: text: Primary diffuse large B-cell lymphoma of the CNS Neoplasm, malignant: text: Neoplasm, malignant Myelodysplastic syndrome, unclassifiable: text: Myelodysplastic syndrome, unclassifiable Malignant rhabdoid tumor: text: Malignant rhabdoid tumor Systemic tissue mast cell disease: text: Systemic tissue mast cell disease Transitional carcinoma: text: Transitional carcinoma Interdigitating cell sarcoma: text: Interdigitating cell sarcoma Paraganglioma, benign: text: Paraganglioma, benign Mucinous cystic tumor with high-grade dysplasia: text: Mucinous cystic tumor with high-grade dysplasia Desmoplastic fibroma: text: Desmoplastic fibroma Fibrillary astrocytoma: text: Fibrillary astrocytoma Infiltrating duct and mucinous carcinoma: text: Infiltrating duct and mucinous carcinoma Anaplastic large cell lymphoma, T cell and Null cell type: text: Anaplastic large cell lymphoma, T cell and Null cell type Mixed hepatocellular and bile duct carcinoma: text: Mixed hepatocellular and bile duct carcinoma Serous microcystic adenoma: text: Serous microcystic adenoma Spitz nevus: text: Spitz nevus Sex cord-gonadal stromal tumor, mixed forms: text: Sex cord-gonadal stromal tumor, mixed forms Medullary osteosarcoma: text: Medullary osteosarcoma Acute granulocytic leukemia: text: Acute granulocytic leukemia Embryonal carcinoma, infantile: text: Embryonal carcinoma, infantile Glomus jugulare tumor, NOS: text: Glomus jugulare tumor, NOS Central odontogenic fibroma: text: Central odontogenic fibroma Malignant lymphoma, small cell, NOS: text: Malignant lymphoma, small cell, NOS Mucoid cell adenocarcinoma: text: Mucoid cell adenocarcinoma Follicular lymphoma, grade 3A: text: Follicular lymphoma, grade 3A Adenoma of nipple: text: Adenoma of nipple Precursor cell lymphoblastic leukemia, NOS: text: Precursor cell lymphoblastic leukemia, NOS Chronic leukemia, NOS: text: Chronic leukemia, NOS Haemangiosarcoma: text: Haemangiosarcoma Invasive lobular carcinoma, solid type: text: Invasive lobular carcinoma, solid type Serrated adenocarcinoma: text: Serrated adenocarcinoma Carcinoma showing thymus-like element: text: Carcinoma showing thymus-like element Ductal carcinoma in situ, comedo type: text: Ductal carcinoma in situ, comedo type Glomangiosarcoma: text: Glomangiosarcoma Adult T-cell lymphoma/leukemia: text: Adult T-cell lymphoma/leukemia Interstitial cell tumor, malignant: text: Interstitial cell tumor, malignant Classical Hodgkin lymphoma, lymphocyte depletion, reticular: text: Classical Hodgkin lymphoma, lymphocyte depletion, reticular Thymoma, spindle cell, malignant: text: Thymoma, spindle cell, malignant Urothelial carcinoma in situ: text: Urothelial carcinoma in situ Apocrine adenoma: text: Apocrine adenoma Diffuse meningiomatosis: text: Diffuse meningiomatosis Odontogenic ghost cell tumor: text: Odontogenic ghost cell tumor Tubulopapillary adenocarcinoma: text: Tubulopapillary adenocarcinoma Mucin-secreting carcinoma: text: Mucin-secreting carcinoma Primitive polar spongioblastoma: text: Primitive polar spongioblastoma Burkitt lymphoma, NOS (Includes all variants): text: Burkitt lymphoma, NOS (Includes all variants) Recklinghausen disease: text: Recklinghausen disease Follicular carcinoma, encapsulated: text: Follicular carcinoma, encapsulated Immunoproliferative disease, NOS: text: Immunoproliferative disease, NOS Ewing tumor: text: Ewing tumor Superficial spreading melanoma: text: Superficial spreading melanoma description: Superficial Spreading Melanoma Epithelioid glioblastoma: text: Epithelioid glioblastoma Papillary urothelial carcinoma, non-invasive: text: Papillary urothelial carcinoma, non-invasive Follicular carcinoma, NOS: text: Follicular carcinoma, NOS Biliary intraepithelial neoplasia, high grade: text: Biliary intraepithelial neoplasia, high grade Follicular carcinoma, oxyphilic cell: text: Follicular carcinoma, oxyphilic cell Malignant lymphoma, small noncleaved, Burkitt type: text: Malignant lymphoma, small noncleaved, Burkitt type Dermoid, NOS: text: Dermoid, NOS Stromal tumor, benign: text: Stromal tumor, benign Clear cell adenocarcinoma, mesonephroid: text: Clear cell adenocarcinoma, mesonephroid Chorioepithelioma: text: Chorioepithelioma Spindle cell sarcoma: text: Spindle cell sarcoma Malignant fibrous histiocytoma (MFH) of bone: text: Malignant fibrous histiocytoma (MFH) of bone Infiltrating lobular carcinoma and ductal carcinoma in situ: text: Infiltrating lobular carcinoma and ductal carcinoma in situ Gliomatosis cerebri: text: Gliomatosis cerebri Urothelial carcinoma with trophoblastic differentiation: text: Urothelial carcinoma with trophoblastic differentiation Myelofibrosis with myeloid metaplasia: text: Myelofibrosis with myeloid metaplasia Verrucous carcinoma, NOS: text: Verrucous carcinoma, NOS Embryonal tumor with rhabdoid features: text: Embryonal tumor with rhabdoid features Acute myelomonocytic leukemia: text: Acute myelomonocytic leukemia Spermatocytic seminoma: text: Spermatocytic seminoma Meningeal melanomatosis: text: Meningeal melanomatosis Odontogenic myxofibroma: text: Odontogenic myxofibroma Parosteal osteosarcoma: text: Parosteal osteosarcoma Epithelioid leiomyoma: text: Epithelioid leiomyoma Cystadenofibroma, NOS: text: Cystadenofibroma, NOS Malignant lymphoma, centroblasticcentrocytic, NOS: text: Malignant lymphoma, centroblasticcentrocytic, NOS Trabecular carcinoma: text: Trabecular carcinoma Intracystic papillary tumor with high grade dysplasia: text: Intracystic papillary tumor with high grade dysplasia Acidophil adenoma: text: Acidophil adenoma Sweat gland adenoma: text: Sweat gland adenoma Squamous cell papilloma, NOS: text: Squamous cell papilloma, NOS B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: text: B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma Intradermal nevus: text: Intradermal nevus Proliferative polycythemia: text: Proliferative polycythemia Serous cystoma: text: Serous cystoma Meningioma, malignant: text: Meningioma, malignant Malignant lymphoma, noncleaved cell, follicular, NOS: text: Malignant lymphoma, noncleaved cell, follicular, NOS Granulosa cell-theca cell tumor: text: Granulosa cell-theca cell tumor Chronic lymphoid leukemia: text: Chronic lymphoid leukemia Pheochromoblastoma: text: Pheochromoblastoma Apocrine adenocarcinoma: text: Apocrine adenocarcinoma Medulloblastoma with extensive nodularity: text: Medulloblastoma with extensive nodularity Diffuse astrocytoma, IDH-wildtype: text: Diffuse astrocytoma, IDH-wildtype Androblastoma, NOS: text: Androblastoma, NOS Adenoid cystic carcinoma: text: Adenoid cystic carcinoma Ameloblastoma, malignant: text: Ameloblastoma, malignant Erythroleukemia: text: Erythroleukemia Granulosa cell tumor, juvenile: text: Granulosa cell tumor, juvenile Oncocytic carcinoma: text: Oncocytic carcinoma description: Oxyphilic Adenocarcinoma Meningeal sarcoma: text: Meningeal sarcoma Subacute lymphocytic leukemia: text: Subacute lymphocytic leukemia GANT: text: GANT Combined hepatocellular carcinoma and cholangiocarcinoma: text: Combined hepatocellular carcinoma and cholangiocarcinoma ? B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma : text: B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma Osteochondrosarcoma: text: Osteochondrosarcoma Juvenile myelomonocytic leukemia: text: Juvenile myelomonocytic leukemia Hemangioendothelioma, NOS: text: Hemangioendothelioma, NOS Metaplastic carcinoma with osseous differentiation: text: Metaplastic carcinoma with osseous differentiation Sertoli cell tumor, NOS: text: Sertoli cell tumor, NOS Common precursor B ALL: text: Common precursor B ALL Infantile hemangioma: text: Infantile hemangioma Acute monoblastic and monocytic leukemia: text: Acute monoblastic and monocytic leukemia Malignant lymphoma, small cleaved cell, follicular: text: Malignant lymphoma, small cleaved cell, follicular CPNET: text: CPNET Central primitive neuroectodermal tumor, NOS: text: Central primitive neuroectodermal tumor, NOS Monoblastic leukemia, NOS: text: Monoblastic leukemia, NOS Syncytial meningioma: text: Syncytial meningioma Ependymoma, NOS: text: Ependymoma, NOS Granulosa cell tumor, sarcomatoid: text: Granulosa cell tumor, sarcomatoid High-grade neuroendocrine carcinoma: text: High-grade neuroendocrine carcinoma Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): text: Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) Thecoma, luteinized: text: Thecoma, luteinized Stem cell leukemia: text: Stem cell leukemia Cystosarcoma phyllodes, malignant: text: Cystosarcoma phyllodes, malignant Thymoma, lymphocytic, malignant: text: Thymoma, lymphocytic, malignant Phosphaturic mesenchymal tumor, malignant: text: Phosphaturic mesenchymal tumor, malignant Plexiform leiomyoma: text: Plexiform leiomyoma Cartilaginous exostosis: text: Cartilaginous exostosis Thymoma, spindle cell, NOS: text: Thymoma, spindle cell, NOS Myxofibroma, NOS: text: Myxofibroma, NOS Gastrointestinal stromal tumor, benign: text: Gastrointestinal stromal tumor, benign Intravascular bronchial alveolar tumor: text: Intravascular bronchial alveolar tumor Metaplastic carcinoma with chondroid differentiation: text: Metaplastic carcinoma with chondroid differentiation Composite Hodgkin and non-Hodgkin lymphoma: text: Composite Hodgkin and non-Hodgkin lymphoma Teratoid medulloepithelioma: text: Teratoid medulloepithelioma Rhabdomyosarcoma, NOS: text: Rhabdomyosarcoma, NOS Giant cell tumor of soft parts, NOS: text: Giant cell tumor of soft parts, NOS Mucinous carcinoid: text: Mucinous carcinoid Atypical adenoma: text: Atypical adenoma Spindle epithelial tumor with thymus-like element: text: Spindle epithelial tumor with thymus-like element Intermediate and giant congenital nevus: text: Intermediate and giant congenital nevus Papillary glioneuronal tumor: text: Papillary glioneuronal tumor Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: text: Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue Nesidioblastoma: text: Nesidioblastoma Systemic light chain disease: text: Systemic light chain disease Infiltrating papillary adenocarcinoma: text: Infiltrating papillary adenocarcinoma Hidradenocarcinoma: text: Hidradenocarcinoma Adenomatous polyp, NOS: text: Adenomatous polyp, NOS Epithelial ependymoma: text: Epithelial ependymoma Pleomorphic rhabdomyosarcoma, adult type: text: Pleomorphic rhabdomyosarcoma, adult type Renal cell carcinoma, chromophobe type: text: Renal cell carcinoma, chromophobe type Acinar cell adenoma: text: Acinar cell adenoma Myoepithelial adenoma: text: Myoepithelial adenoma Carcinoma with osteoclast-like giant cells: text: Carcinoma with osteoclast-like giant cells Adenocarcinoma admixed with neuroendocrine carcinoma: text: Adenocarcinoma admixed with neuroendocrine carcinoma Adenocarcinoma with osseous metaplasia: text: Adenocarcinoma with osseous metaplasia Adult granulosa cell tumor: text: Adult granulosa cell tumor Hodgkin disease, NOS: text: Hodgkin disease, NOS Primary cutaneous gamma-delta T-cell lymphoma: text: Primary cutaneous gamma-delta T-cell lymphoma Angiosarcoma: text: Angiosarcoma Atypical fibrous histiocytoma: text: Atypical fibrous histiocytoma Neuroblastoma, NOS: text: Neuroblastoma, NOS Minimally invasive adenocarcinoma, non-mucinous: text: Minimally invasive adenocarcinoma, non-mucinous Bizarre leiomyoma: text: Bizarre leiomyoma Diffuse intraductal papillomatosis: text: Diffuse intraductal papillomatosis Biliary papillomatosis: text: Biliary papillomatosis Proliferating trichilemmal tumor: text: Proliferating trichilemmal tumor RAEB: text: RAEB NUT carcinoma: text: NUT carcinoma description: NUT Carcinoma Lobular carcinoma, NOS: text: Lobular carcinoma, NOS Vaginal intraepithelial neoplasia, grade III: text: Vaginal intraepithelial neoplasia, grade III Androblastoma, benign: text: Androblastoma, benign Bile duct cystadenoma: text: Bile duct cystadenoma Pancreatic endocrine tumor, benign: text: Pancreatic endocrine tumor, benign Acute myeloblastic leukemia: text: Acute myeloblastic leukemia Noninvasive pancreatobiliary papillary neoplasm with low grade intraepithelial neoplasia: text: Noninvasive pancreatobiliary papillary neoplasm with low grade intraepithelial neoplasia Follicular adenocarcinoma, NOS: text: Follicular adenocarcinoma, NOS Perineurioma, NOS: text: Perineurioma, NOS Keratotoc papilloma: text: Keratotoc papilloma Granular cell tumor, malignant: text: Granular cell tumor, malignant GIST, NOS: text: GIST, NOS Alveolar soft part sarcoma: text: Alveolar soft part sarcoma Oat cell carcinoma: text: Oat cell carcinoma Fibroepithelioma, NOS: text: Fibroepithelioma, NOS Plexiform hemangioma: text: Plexiform hemangioma Myofibroma: text: Myofibroma Skin appendage adenoma: text: Skin appendage adenoma Carcinoma simplex: text: Carcinoma simplex Carcinoma with other types mesenchymal differentiation: text: Carcinoma with other types mesenchymal differentiation Essential hemorrhagic thrombocythaemia: text: Essential hemorrhagic thrombocythaemia Medulloepithelioma, NOS: text: Medulloepithelioma, NOS Malignant lymphoma, large B-cell, diffuse, centroblastic, NOS: text: Malignant lymphoma, large B-cell, diffuse, centroblastic, NOS Neuroendocrine tumor, grade 2: text: Neuroendocrine tumor, grade 2 Papillary mucinous cystadenoma, NOS: text: Papillary mucinous cystadenoma, NOS Pheochromocytoma, malignant: text: Pheochromocytoma, malignant Mullerian mixed tumor: text: Mullerian mixed tumor EBV positive diffuse large B-cell lymphoma of the elderly: text: EBV positive diffuse large B-cell lymphoma of the elderly Verrucous epidermoid carcinoma: text: Verrucous epidermoid carcinoma Desmoplastic infantile ganglioglioma: text: Desmoplastic infantile ganglioglioma Intracortical osteosarcoma: text: Intracortical osteosarcoma Lymphosarcoma cell leukemia: text: Lymphosarcoma cell leukemia Mucinous adenocarcinoma: text: Mucinous adenocarcinoma Theca cell-granulosa cell tumor: text: Theca cell-granulosa cell tumor Glomus tumor, NOS: text: Glomus tumor, NOS Intravascular leiomyomatosis: text: Intravascular leiomyomatosis Endometrial stromal sarcoma, NOS: text: Endometrial stromal sarcoma, NOS Immunocytoma: text: Immunocytoma M6B: text: M6B Ameloblastic fibrodentinoma: text: Ameloblastic fibrodentinoma Mucinous cystoma: text: Mucinous cystoma Chronic myelogenous leukemia, BCR-ABL positive: text: Chronic myelogenous leukemia, BCR-ABL positive Malignant lymphoma, undifferentiated, Burkitt type: text: Malignant lymphoma, undifferentiated, Burkitt type Thecoma, NOS: text: Thecoma, NOS Pilomatrixoma, NOS: text: Pilomatrixoma, NOS Noninfiltrating intracystic carcinoma: text: Noninfiltrating intracystic carcinoma Cellular ependymoma: text: Cellular ependymoma Oligoastrocytoma: text: Oligoastrocytoma description: Oligoastrocytoma Epithelioid malignant peripheral nerve sheath tumor: text: Epithelioid malignant peripheral nerve sheath tumor Mixed tumor, malignant, NOS: text: Mixed tumor, malignant, NOS Gastrointestinal stromal tumor, malignant: text: Gastrointestinal stromal tumor, malignant Malignant lymphoma, large cell, noncleaved, follicular: text: Malignant lymphoma, large cell, noncleaved, follicular Esthesioneuroepithelioma: text: Esthesioneuroepithelioma Infiltrating duct and cribriform carcinoma: text: Infiltrating duct and cribriform carcinoma Langerhans cell histiocytosis, mono-ostotic: text: Langerhans cell histiocytosis, mono-ostotic Intravascular B-cell lymphoma: text: Intravascular B-cell lymphoma Angioimmunoblastic lymphadenopathy: text: Angioimmunoblastic lymphadenopathy Steroid cell tumor, malignant: text: Steroid cell tumor, malignant Alveolar rhabdomyosarcoma: text: Alveolar rhabdomyosarcoma Giant cell glioblastoma: text: Giant cell glioblastoma Epithelioma, malignant: text: Epithelioma, malignant Sertoli-Leydig cell tumor, NOS: text: Sertoli-Leydig cell tumor, NOS Intratubular germ cell neoplasia: text: Intratubular germ cell neoplasia Pleomorphic rhabdomyosarcoma, NOS: text: Pleomorphic rhabdomyosarcoma, NOS Intracystic papillary neoplasm with low grade intraepithelial neoplasia: text: Intracystic papillary neoplasm with low grade intraepithelial neoplasia Mucinous tubular and spindle cell carcinoma: text: Mucinous tubular and spindle cell carcinoma Invasive carcinoma of no special type: text: Invasive carcinoma of no special type Pindborg tumor: text: Pindborg tumor Lipoid cell tumor of ovary: text: Lipoid cell tumor of ovary Angiofibroma, NOS: text: Angiofibroma, NOS Hepatocellular carcinoma, scirrhous: text: Hepatocellular carcinoma, scirrhous Squamous cell carcinoma, large cell, nonkeratinizing, NOS: text: Squamous cell carcinoma, large cell, nonkeratinizing, NOS Pilomyxoid astrocytoma: text: Pilomyxoid astrocytoma Subependymal glioma: text: Subependymal glioma Atypical carcinoid tumor: text: Atypical carcinoid tumor Aggressive digital papillary adenoma: text: Aggressive digital papillary adenoma Adenocarcinoma in a polyp, NOS: text: Adenocarcinoma in a polyp, NOS Intraductal papillary tumor with high grade intraepithelial neoplasia: text: Intraductal papillary tumor with high grade intraepithelial neoplasia Mixed acinar-ductal carcinoma: text: Mixed acinar-ductal carcinoma description: Mixed Acinar-Ductal Carcinoma of the Pancreas Lymphoepithelioid lymphoma: text: Lymphoepithelioid lymphoma Blastoma, NOS: text: Blastoma, NOS Ameloblastic fibrodentinosarcoma: text: Ameloblastic fibrodentinosarcoma Adenocarcinoma of rete ovarii: text: Adenocarcinoma of rete ovarii Acute mixed lineage leukemia: text: Acute mixed lineage leukemia Intraductal carcinoma, noninfiltrating, NOS: text: Intraductal carcinoma, noninfiltrating, NOS Granulosa cell carcinoma: text: Granulosa cell carcinoma Squamous intraepithelial neoplasia, low grade: text: Squamous intraepithelial neoplasia, low grade Intramuscular lipoma: text: Intramuscular lipoma Noninvasive pancreatobiliary papillary neoplasm with low grade dysplasia: text: Noninvasive pancreatobiliary papillary neoplasm with low grade dysplasia Serous surface papilloma: text: Serous surface papilloma Polyvesicular vitelline tumor: text: Polyvesicular vitelline tumor Protoplasmic astrocytoma: text: Protoplasmic astrocytoma Combined small cell-adenocarcinoma: text: Combined small cell-adenocarcinoma Cutaneous histiocytoma, NOS: text: Cutaneous histiocytoma, NOS Parasympathetic paraganglioma: text: Parasympathetic paraganglioma Malignant lymphoma, small lymphocytic, diffuse: text: Malignant lymphoma, small lymphocytic, diffuse Serous adenocarcinoma, NOS: text: Serous adenocarcinoma, NOS Supratentorial PNET: text: Supratentorial PNET Mucinous cystadenoma, NOS: text: Mucinous cystadenoma, NOS Mucocarcinoid tumor: text: Mucocarcinoid tumor Acute basophilic leukaemia: text: Acute basophilic leukaemia Spindle cell lipoma: text: Spindle cell lipoma Retinoblastoma, spontaneously regressed: text: Retinoblastoma, spontaneously regressed Lipid-rich carcinoma: text: Lipid-rich carcinoma Blastic NK cell lymphoma: text: Blastic NK cell lymphoma Hereditary leiomyomatosis & RCC-associated renal cell carcinoma: text: Hereditary leiomyomatosis & RCC-associated renal cell carcinoma Hemangiopericytoma, malignant: text: Hemangiopericytoma, malignant Mast cell sarcoma: text: Mast cell sarcoma Giant cell tumor of bone, NOS: text: Giant cell tumor of bone, NOS Sertoli-Leydig cell tumor, poorly differentiated: text: Sertoli-Leydig cell tumor, poorly differentiated Dermoid cyst with malignant transformation: text: Dermoid cyst with malignant transformation Midline carcinoma of children and young adults with NUT rearrangement: text: Midline carcinoma of children and young adults with NUT rearrangement Haemangioblastoma: text: Haemangioblastoma Mucin-secreting adenocarcinoma: text: Mucin-secreting adenocarcinoma Neurolipocytoma: text: Neurolipocytoma Lentigo maligna melanoma: text: Lentigo maligna melanoma description: Lentigo Maligna Melanoma Neurosarcoma: text: Neurosarcoma Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements: text: Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements SETTLE: text: SETTLE Cystoma, NOS: text: Cystoma, NOS Malignant lymphoma, mixed small cleaved and large cell, follicular: text: Malignant lymphoma, mixed small cleaved and large cell, follicular Angiokeratoma: text: Angiokeratoma Liposarcoma, differentiated: text: Liposarcoma, differentiated Lobular adenocarcinoma: text: Lobular adenocarcinoma FAB M1: text: FAB M1 Papillary squamous cell carcinoma in situ: text: Papillary squamous cell carcinoma in situ Infiltrating angiolipoma: text: Infiltrating angiolipoma Fetal lipomatosis: text: Fetal lipomatosis Clear cell tumor, NOS: text: Clear cell tumor, NOS FAB M2, AML1(CBF-alpha)/ETO: text: FAB M2, AML1(CBF-alpha)/ETO Lobular carcinoma, noninfiltrating: text: Lobular carcinoma, noninfiltrating Intraductal carcinoma and lobular carcinoma in situ: text: Intraductal carcinoma and lobular carcinoma in situ Hepatocellular carcinoma, sarcomatoid: text: Hepatocellular carcinoma, sarcomatoid Flat intraepithelial glandular neoplasia, high grade: text: Flat intraepithelial glandular neoplasia, high grade Mucoid adenocarcinoma: text: Mucoid adenocarcinoma Apocrine cystadenoma: text: Apocrine cystadenoma CIN III with severe dysplasia: text: CIN III with severe dysplasia Mature T-cell lymphoma, NOS: text: Mature T-cell lymphoma, NOS Peripheral neuroectodermal tumor: text: Peripheral neuroectodermal tumor DIN 3: text: DIN 3 Metaplastic carcinoma with other types mesenchymal differentiation: text: Metaplastic carcinoma with other types mesenchymal differentiation Mixed pineal tumor: text: Mixed pineal tumor Solid pseudopapillary tumor: text: Solid pseudopapillary tumor Astroglioma: text: Astroglioma Bronchial adenoma, NOS: text: Bronchial adenoma, NOS Intraductal papillary-mucinous adenoma: text: Intraductal papillary-mucinous adenoma Bednar tumor: text: Bednar tumor Perineural MPNST: text: Perineural MPNST Monomorphic adenoma: text: Monomorphic adenoma Adenosarcoma: text: Adenosarcoma description: Adenosarcoma Lipid-rich Sertoli cell tumor: text: Lipid-rich Sertoli cell tumor Endometrioid carcinoma, NOS: text: Endometrioid carcinoma, NOS description: Endometrial Carcinoma Reserve cell carcinoma: text: Reserve cell carcinoma Pleomorphic adenoma: text: Pleomorphic adenoma Splenic B-cell lymphoma/leukemia, unclassifiable: text: Splenic B-cell lymphoma/leukemia, unclassifiable Angiotropic lymphoma: text: Angiotropic lymphoma Gonadal stromal tumor, NOS: text: Gonadal stromal tumor, NOS Sclerosing liposarcoma: text: Sclerosing liposarcoma Mast cell tumor, NOS: text: Mast cell tumor, NOS Islet cell tumor, NOS: text: Islet cell tumor, NOS High-grade serous carcinoma: text: High-grade serous carcinoma Cellular schwannoma: text: Cellular schwannoma Adrenal medullary paraganglioma: text: Adrenal medullary paraganglioma Desmoplastic mesothelioma: text: Desmoplastic mesothelioma description: Desmoplastic Mesothelioma Neurothekeoma: text: Neurothekeoma Neuroendocrine carcinoma, moderately differentiated: text: Neuroendocrine carcinoma, moderately differentiated Adenocarcinoma in tubular adenoma: text: Adenocarcinoma in tubular adenoma Spermatocytoma: text: Spermatocytoma Lymphosarcoma, diffuse: text: Lymphosarcoma, diffuse Choroid plexus carcinoma: text: Choroid plexus carcinoma Clear cell sarcoma, of tendons and aponeuroses: text: Clear cell sarcoma, of tendons and aponeuroses Hodgkin lymphoma, lymphocyte depletion, reticular: text: Hodgkin lymphoma, lymphocyte depletion, reticular Giant cell tumor of bone, malignant: text: Giant cell tumor of bone, malignant Mixed pancreatic endocrine and exocrine tumor, malignant: text: Mixed pancreatic endocrine and exocrine tumor, malignant Intraosseous well differentiated osteosarcoma: text: Intraosseous well differentiated osteosarcoma Malignant melanoma, regressing: text: Malignant melanoma, regressing Round cell osteosarcoma: text: Round cell osteosarcoma Adenolymphoma: text: Adenolymphoma Precursor cell lymphoblastic leukemia, not phenotyped: text: Precursor cell lymphoblastic leukemia, not phenotyped Hidrocystoma: text: Hidrocystoma Intraepidermal squamous cell carcinoma, Bowen type: text: Intraepidermal squamous cell carcinoma, Bowen type Hepatoid yolk sac tumor: text: Hepatoid yolk sac tumor Nonlipid reticuloendotheliosis: text: Nonlipid reticuloendotheliosis Malignant lymphoma, lymphocytic, intermediate differentiation, nodular: text: Malignant lymphoma, lymphocytic, intermediate differentiation, nodular Tumor, secondary: text: Tumor, secondary Pilomatrix carcinoma: text: Pilomatrix carcinoma Periapical cemental dysplasia: text: Periapical cemental dysplasia Islet cell adenomatosis: text: Islet cell adenomatosis Clear cell sarcoma of kidney: text: Clear cell sarcoma of kidney Sarcomatoid carcinoma: text: Sarcomatoid carcinoma Alveolar adenoma: text: Alveolar adenoma Chondroblastoma, NOS: text: Chondroblastoma, NOS Infiltrating lipoma: text: Infiltrating lipoma Mucinous cystadenoma, borderline malignancy: text: Mucinous cystadenoma, borderline malignancy Intraductal tubular-papillary neoplasm, low grade: text: Intraductal tubular-papillary neoplasm, low grade Medulloblastoma, group 3: text: Medulloblastoma, group 3 Intraductal carcinoma, solid type: text: Intraductal carcinoma, solid type FAB M5 (includes all variants): text: FAB M5 (includes all variants) Adult rhabdomyoma: text: Adult rhabdomyoma Malignant mucinous adenofibroma: text: Malignant mucinous adenofibroma Eccrine poroma: text: Eccrine poroma Sympathicoblastoma: text: Sympathicoblastoma Fibroameloblastic odontoma: text: Fibroameloblastic odontoma Immature teratoma, NOS: text: Immature teratoma, NOS Follicular lymphoma, small cleaved cell: text: Follicular lymphoma, small cleaved cell Interstitial cell tumor, NOS: text: Interstitial cell tumor, NOS Eccrine papillary adenocarcinoma: text: Eccrine papillary adenocarcinoma Lymphoepithelial carcinoma: text: Lymphoepithelial carcinoma description: Nasopharyngeal Type Undifferentiated Carcinoma Invasive lobular carcinoma: text: Invasive lobular carcinoma Carcinoma with osseous differentiation: text: Carcinoma with osseous differentiation Intraepidermal epithelioma of Jadassohn: text: Intraepidermal epithelioma of Jadassohn Neuroepithelioma, NOS: text: Neuroepithelioma, NOS Immunoproliferative small intestinal disease: text: Immunoproliferative small intestinal disease Carotid body paraganglioma: text: Carotid body paraganglioma Combined small cell-squamous cell carcinoma: text: Combined small cell-squamous cell carcinoma EC cell carcinoid: text: EC cell carcinoid MANEC: text: MANEC PIN III: text: PIN III Cystic astrocytoma: text: Cystic astrocytoma Neuroendocrine carcinoma, low grade: text: Neuroendocrine carcinoma, low grade Squamous cell carcinoma, sarcomatoid: text: Squamous cell carcinoma, sarcomatoid Carcinosarcoma, embryonal: text: Carcinosarcoma, embryonal Placental site trophoblastic tumor: text: Placental site trophoblastic tumor Mixed small cell carcinoma: text: Mixed small cell carcinoma Squamous cell carcinoma, metastatic, NOS: text: Squamous cell carcinoma, metastatic, NOS Phyllodes tumor, NOS: text: Phyllodes tumor, NOS Polymorphic post transplant lymphoproliferative disorder: text: Polymorphic post transplant lymphoproliferative disorder ALK positive large B-cell lymphoma: text: ALK positive large B-cell lymphoma Rathke pouch tumor: text: Rathke pouch tumor Medullary carcinoma with amyloid stroma: text: Medullary carcinoma with amyloid stroma Lymphangiosarcoma: text: Lymphangiosarcoma Esophageal squamous intraepithelial neoplasia (dysplasia), low grade: text: Esophageal squamous intraepithelial neoplasia (dysplasia), low grade Differentiated-type vulvar intraepithelial neoplasia: text: Differentiated-type vulvar intraepithelial neoplasia Metaplastic carcinoma of no special type: text: Metaplastic carcinoma of no special type Splenic marginal zone lymphoma, NOS: text: Splenic marginal zone lymphoma, NOS Mucinous carcinoma: text: Mucinous carcinoma Ossifying fibromyxoid tumor: text: Ossifying fibromyxoid tumor Renal cell adenocarcinoma: text: Renal cell adenocarcinoma Mesothelioma, malignant: text: Mesothelioma, malignant Clear cell adenofibroma of borderline malignancy: text: Clear cell adenofibroma of borderline malignancy Acute myeloid leukemia with maturation: text: Acute myeloid leukemia with maturation Fetal adenocarcinoma: text: Fetal adenocarcinoma Solitary mastocytoma of skin: text: Solitary mastocytoma of skin Metastatic signet ring cell carcinoma: text: Metastatic signet ring cell carcinoma Papillary cystadenoma, borderline malignancy: text: Papillary cystadenoma, borderline malignancy Mucoepidermoid tumor: text: Mucoepidermoid tumor Adrenal cortical adenoma, clear cell: text: Adrenal cortical adenoma, clear cell Leiomyomatosis, NOS: text: Leiomyomatosis, NOS Mast cell leukaemia: text: Mast cell leukaemia Smooth muscle tumor of uncertain malignant potential: text: Smooth muscle tumor of uncertain malignant potential Papillary carcinoma, NOS: text: Papillary carcinoma, NOS Verrucous papilloma: text: Verrucous papilloma Glioma, malignant: text: Glioma, malignant Classical Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis: text: Classical Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis Junction nevus: text: Junction nevus Lymphoblastoma: text: Lymphoblastoma Micropapillary carcinoma, NOS: text: Micropapillary carcinoma, NOS Acute myeloid leukemia with mutated CEBPA: text: Acute myeloid leukemia with mutated CEBPA Microcystic urothelial carcinoma: text: Microcystic urothelial carcinoma Carcinoma showing thymus-like differentiation: text: Carcinoma showing thymus-like differentiation Brown fat tumor: text: Brown fat tumor Sialoblastoma: text: Sialoblastoma Angiomyxoma: text: Angiomyxoma Clear cell odontogenic carcinoma: text: Clear cell odontogenic carcinoma Embryonal hepatoma: text: Embryonal hepatoma Endometrial sarcoma, NOS: text: Endometrial sarcoma, NOS Yolk sac tumor: text: Yolk sac tumor Undifferentiated spindle cell sarcoma: text: Undifferentiated spindle cell sarcoma Tubulolobular carcinoma: text: Tubulolobular carcinoma Odontogenic sarcoma: text: Odontogenic sarcoma Diffuse large B-cell lymphoma associated with chronic inflammation: text: Diffuse large B-cell lymphoma associated with chronic inflammation Spongioblastoma polare: text: Spongioblastoma polare Intraglandular papillary neoplasm with low grade intraepithelial neoplasia: text: Intraglandular papillary neoplasm with low grade intraepithelial neoplasia Enterochromaffin-like cell carcinoid, NOS: text: Enterochromaffin-like cell carcinoid, NOS Esophageal glandular dysplasia (intraepithelial neoplasia), low grade: text: Esophageal glandular dysplasia (intraepithelial neoplasia), low grade Leiomyofibroma: text: Leiomyofibroma Lymphocytic leukemia, NOS: text: Lymphocytic leukemia, NOS Mesonephric adenoma: text: Mesonephric adenoma Neuroendocrine carcinoma, well-differentiated: text: Neuroendocrine carcinoma, well-differentiated Giant cell sarcoma of bone: text: Giant cell sarcoma of bone Chondromatosis, NOS: text: Chondromatosis, NOS Basosquamous carcinoma: text: Basosquamous carcinoma Tenosynovial giant cell tumor: text: Tenosynovial giant cell tumor Adrenal cortical adenoma, mixed cell: text: Adrenal cortical adenoma, mixed cell Serous borderline tumor-micropapillary variant: text: Serous borderline tumor-micropapillary variant Myelocytic leukemia, NOS: text: Myelocytic leukemia, NOS Secretory meningioma: text: Secretory meningioma Leiomyosarcoma, NOS: text: Leiomyosarcoma, NOS Mucinous cystic tumor with intermediate dysplasia: text: Mucinous cystic tumor with intermediate dysplasia Von Recklinghausen disease: text: Von Recklinghausen disease Mucous carcinoma: text: Mucous carcinoma Villous papilloma: text: Villous papilloma Intraductal papillary-mucinous neoplasm with low grade dysplasia: text: Intraductal papillary-mucinous neoplasm with low grade dysplasia Endometrioid cystadenoma, borderline malignancy: text: Endometrioid cystadenoma, borderline malignancy Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma: text: Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma Cystic teratoma, NOS: text: Cystic teratoma, NOS Squamous cell carcinoma, clear cell type: text: Squamous cell carcinoma, clear cell type Verrucous squamous cell carcinoma: text: Verrucous squamous cell carcinoma Ameloblastic fibro-odontosarcoma: text: Ameloblastic fibro-odontosarcoma Ossifying fibroma: text: Ossifying fibroma Hodgkin lymphoma, lymphocyte depletion, NOS: text: Hodgkin lymphoma, lymphocyte depletion, NOS Invasive lobular carcinoma, tubulolobular variant: text: Invasive lobular carcinoma, tubulolobular variant Retinal anlage tumor: text: Retinal anlage tumor Chronic lymphatic leukemia: text: Chronic lymphatic leukemia Chronic myeloid leukemia, NOS: text: Chronic myeloid leukemia, NOS Myeloid leukemia associated with Down Syndrome: text: Myeloid leukemia associated with Down Syndrome Sebaceous adenocarcinoma: text: Sebaceous adenocarcinoma description: Head and Neck Sebaceous Carcinoma Adenocarcinoma in adenomatous polyposis coli: text: Adenocarcinoma in adenomatous polyposis coli Mucinous cystic neoplasm with low-grade intraepithelial neoplasia: text: Mucinous cystic neoplasm with low-grade intraepithelial neoplasia Synovial sarcoma, spindle cell: text: Synovial sarcoma, spindle cell Syringocystadenoma papilliferum: text: Syringocystadenoma papilliferum Adenoma, NOS: text: Adenoma, NOS Subacute myeloid leukemia: text: Subacute myeloid leukemia Rosette-forming glioneuronal tumor: text: Rosette-forming glioneuronal tumor Mucinous adenofibroma, NOS: text: Mucinous adenofibroma, NOS Infiltrating ductular carcinoma: text: Infiltrating ductular carcinoma Lipomatous medulloblastoma: text: Lipomatous medulloblastoma Acute leukemia, Burkitt type: text: Acute leukemia, Burkitt type Chondroma, NOS: text: Chondroma, NOS Malignant lymphoma, noncleaved, diffuse, NOS: text: Malignant lymphoma, noncleaved, diffuse, NOS Acinar adenocarcinoma, sarcomatoid: text: Acinar adenocarcinoma, sarcomatoid Serotonin producing carcinoid: text: Serotonin producing carcinoid Fibrosarcoma, NOS: text: Fibrosarcoma, NOS Acinar adenoma: text: Acinar adenoma Neoplasm, NOS: text: Neoplasm, NOS Spindle epithelial tumor with thymus-like differentiation: text: Spindle epithelial tumor with thymus-like differentiation Hurthle cell adenocarcinoma: text: Hurthle cell adenocarcinoma Giant cell carcinoma: text: Giant cell carcinoma Racemose hemangioma: text: Racemose hemangioma Spindle cell hemangioendothelioma: text: Spindle cell hemangioendothelioma LCIS, NOS: text: LCIS, NOS Therapy-related acute myeloid leukemia, alkylating agent related: text: Therapy-related acute myeloid leukemia, alkylating agent related Intraepithelial squamous cell carcinoma: text: Intraepithelial squamous cell carcinoma Anaplastic pleomorphic xanthroastrocytoma: text: Anaplastic pleomorphic xanthroastrocytoma Cystic tumor of atrio-ventricular node: text: Cystic tumor of atrio-ventricular node Endometrial stromal sarcoma, high grade: text: Endometrial stromal sarcoma, high grade Intraductal papillary mucinous neoplasm with high grade dysplasia: text: Intraductal papillary mucinous neoplasm with high grade dysplasia Hairy cell leukaemia variant: text: Hairy cell leukaemia variant Malignant melanoma, NOS: text: Malignant melanoma, NOS Basal cell adenocarcinoma: text: Basal cell adenocarcinoma description: Salivary Gland Basal Cell Adenocarcinoma Hepatoblastoma: text: Hepatoblastoma Malignant lymphoma, mixed small and large cell, diffuse: text: Malignant lymphoma, mixed small and large cell, diffuse Oligodendroblastoma: text: Oligodendroblastoma Prolactinoma: text: Prolactinoma Hepatocellular carcinoma, spindle cell variant: text: Hepatocellular carcinoma, spindle cell variant BALT lymphoma: text: BALT lymphoma Hepatoid adenocarcinoma: text: Hepatoid adenocarcinoma description: Hepatoid Adenocarcinoma Pigmented nevus, NOS: text: Pigmented nevus, NOS Calcifying epithelial odontogenic tumor: text: Calcifying epithelial odontogenic tumor Acute erythremic myelosis: text: Acute erythremic myelosis Pacinian tumor: text: Pacinian tumor Papillary renal cell carcinoma: text: Papillary renal cell carcinoma Polycythemia vera: text: Polycythemia vera Fibromatosis-like metaplastic carcinoma: text: Fibromatosis-like metaplastic carcinoma Myofibroblastic tumor, peribronchial: text: Myofibroblastic tumor, peribronchial Small cell carcinoma, NOS: text: Small cell carcinoma, NOS Diffuse leptomeningeal glioneuronal tumor: text: Diffuse leptomeningeal glioneuronal tumor Adrenal cortical tumor, malignant: text: Adrenal cortical tumor, malignant Squamous cell carcinoma, NOS: text: Squamous cell carcinoma, NOS Rhabdoid tumor, NOS: text: Rhabdoid tumor, NOS Acquired tufted hemangioma: text: Acquired tufted hemangioma Embryonal adenocarcinoma: text: Embryonal adenocarcinoma Hibernoma: text: Hibernoma Chondroblastic osteosarcoma: text: Chondroblastic osteosarcoma Acute myeloid leukaemia, t(8;21)(q22;q22): text: Acute myeloid leukaemia, t(8;21)(q22;q22) Glioma, NOS: text: Glioma, NOS Polyembryoma: text: Polyembryoma Glucagon-like peptide-producing tumor: text: Glucagon-like peptide-producing tumor Transitional meningioma: text: Transitional meningioma Therapy-related acute myeloid leukemia, epipodophyllotoxin-related: text: Therapy-related acute myeloid leukemia, epipodophyllotoxin-related Adenomyoma: text: Adenomyoma Vascular leiomyoma: text: Vascular leiomyoma Papillary and follicular carcinoma: text: Papillary and follicular carcinoma Infiltrating lobular carcinoma, NOS: text: Infiltrating lobular carcinoma, NOS Small congenital nevus: text: Small congenital nevus Enteroglucagonoma, NOS: text: Enteroglucagonoma, NOS Dedifferentiated chordoma: text: Dedifferentiated chordoma Chemodectoma: text: Chemodectoma Adenocarcinoma with apocrine metaplasia: text: Adenocarcinoma with apocrine metaplasia Immunoblastic sarcoma: text: Immunoblastic sarcoma Ghost cell odontogenic carcinoma: text: Ghost cell odontogenic carcinoma Anaplastic large cell lymphoma, ALK positive: text: Anaplastic large cell lymphoma, ALK positive Classical Hodgkin lymphoma, nodular sclerosis, cellular phase: text: Classical Hodgkin lymphoma, nodular sclerosis, cellular phase Mesonephric adenocarcinoma: text: Mesonephric adenocarcinoma Leiomyoma, NOS: text: Leiomyoma, NOS Malignant lymphoma, centroblasticcentrocytic, diffuse: text: Malignant lymphoma, centroblasticcentrocytic, diffuse Adrenal cortical adenocarcinoma: text: Adrenal cortical adenocarcinoma Esophageal intraepithelial neoplasia, high grade: text: Esophageal intraepithelial neoplasia, high grade Mesonephric tumor, NOS: text: Mesonephric tumor, NOS Xanthofibroma: text: Xanthofibroma Signet ring cell carcinoma: text: Signet ring cell carcinoma Adnexal carcinoma: text: Adnexal carcinoma Acute myeloid leukemia, CBF-beta/MYH11: text: Acute myeloid leukemia, CBF-beta/MYH11 Cementoblastoma, benign: text: Cementoblastoma, benign Wolffian duct tumor: text: Wolffian duct tumor Acute bilineal leukemia: text: Acute bilineal leukemia Tibial adamantinoma: text: Tibial adamantinoma Skin appendage tumor, benign: text: Skin appendage tumor, benign Granulosa cell tumor, NOS: text: Granulosa cell tumor, NOS Central osteosarcoma: text: Central osteosarcoma Mesothelioma, biphasic, NOS: text: Mesothelioma, biphasic, NOS Peripheral odontogenic fibroma: text: Peripheral odontogenic fibroma Carcinoma, diffuse type: text: Carcinoma, diffuse type Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma: text: Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma Glandular intraepithelial neoplasia, grade III: text: Glandular intraepithelial neoplasia, grade III Squamous odontogenic tumor: text: Squamous odontogenic tumor Myofibroblastoma: text: Myofibroblastoma Papillary meningioma: text: Papillary meningioma Epidermoid carcinoma, NOS: text: Epidermoid carcinoma, NOS Leukemic reticuloendotheliosis: text: Leukemic reticuloendotheliosis Glandular intraepithelial neoplasia, grade I: text: Glandular intraepithelial neoplasia, grade I Chronic lymphocytic leukemia, B-cell type (includes all variants of BCLL): text: Chronic lymphocytic leukemia, B-cell type (includes all variants of BCLL) Aggressive NK-cell leukaemia: text: Aggressive NK-cell leukaemia Solid teratoma: text: Solid teratoma Cystadenocarcinoma, NOS: text: Cystadenocarcinoma, NOS Infiltrating basal cell carcinoma, non-sclerosing: text: Infiltrating basal cell carcinoma, non-sclerosing Minimally invasive adenocarcinoma, NOS: text: Minimally invasive adenocarcinoma, NOS Intestinal-type adenocarcinoma: text: Intestinal-type adenocarcinoma Pseudomucinous cystadenocarcinoma, NOS: text: Pseudomucinous cystadenocarcinoma, NOS Trichodiscoma: text: Trichodiscoma Subacute myelogenous leukemia: text: Subacute myelogenous leukemia Chordoid glioma of third ventricle: text: Chordoid glioma of third ventricle Lymphangioleiomyomatosis: text: Lymphangioleiomyomatosis Salivary duct carcinoma: text: Salivary duct carcinoma description: Salivary Duct Carcinoma Mixed mesenchymal tumor: text: Mixed mesenchymal tumor Bronchiolo-alveolar carcinoma; type II pneumocyte: text: Bronchiolo-alveolar carcinoma; type II pneumocyte Acute biphenotypic leukemia: text: Acute biphenotypic leukemia Mixed acidophil-basophil adenoma: text: Mixed acidophil-basophil adenoma Capillary hemangioma: text: Capillary hemangioma Brenner tumor, malignant: text: Brenner tumor, malignant Chordoid glioma: text: Chordoid glioma Mixed teratoma and seminoma: text: Mixed teratoma and seminoma Embryonal tumor with multilayered rosettes C19MC-altered: text: Embryonal tumor with multilayered rosettes C19MC-altered Melanotic progonoma: text: Melanotic progonoma Thymoma, type B3, malignant: text: Thymoma, type B3, malignant Juxtacortical osteosarcoma: text: Juxtacortical osteosarcoma Reticulosarcoma, diffuse: text: Reticulosarcoma, diffuse Astrocytoma, low grade: text: Astrocytoma, low grade B-cell lymphocytic leukemia/small lymphocytic lymphoma: text: B-cell lymphocytic leukemia/small lymphocytic lymphoma Extraventricular neurocytoma: text: Extraventricular neurocytoma Glassy cell carcinoma: text: Glassy cell carcinoma ACTH-producing tumor: text: ACTH-producing tumor Malignant midline reticulosis: text: Malignant midline reticulosis Germ cell tumors with associated hematological malignancy: text: Germ cell tumors with associated hematological malignancy Choriocarcinoma combined with embryonal carcinoma: text: Choriocarcinoma combined with embryonal carcinoma Rhabdoid meningioma: text: Rhabdoid meningioma Mixed squamous cell and glandular papilloma: text: Mixed squamous cell and glandular papilloma Ganglioglioma, anaplastic: text: Ganglioglioma, anaplastic Bile duct carcinoma: text: Bile duct carcinoma Adenocarcinoma combined with other types of carcinoma: text: Adenocarcinoma combined with other types of carcinoma Biphenotypic sinonasal sarcoma: text: Biphenotypic sinonasal sarcoma description: Biphenotypic Sinonasal Sarcoma Adrenal medullary paraganglioma, malignant: text: Adrenal medullary paraganglioma, malignant Cutaneous T-cell lymphoma, NOS: text: Cutaneous T-cell lymphoma, NOS Adrenal cortical adenoma, pigmented: text: Adrenal cortical adenoma, pigmented PP/PYY producing tumor: text: PP/PYY producing tumor Malignant lymphoma, large cell, immunoblastic: text: Malignant lymphoma, large cell, immunoblastic Mucinous tumor, NOS, of low malignant potential: text: Mucinous tumor, NOS, of low malignant potential Burkitt tumor: text: Burkitt tumor Dedifferentiated liposarcoma: text: Dedifferentiated liposarcoma description: Dedifferentiated Liposarcoma Infiltrating duct and lobular carcinoma in situ: text: Infiltrating duct and lobular carcinoma in situ Ossifying fibromyxoid tumor, malignant: text: Ossifying fibromyxoid tumor, malignant Esophageal glandular dysplasia (intraepithelial neoplasia), high grade: text: Esophageal glandular dysplasia (intraepithelial neoplasia), high grade Flat adenoma: text: Flat adenoma Splenic lymphoma with villous lymphocytes: text: Splenic lymphoma with villous lymphocytes Mixed invasive mucinous and non-mucinous adenocarcinoma: text: Mixed invasive mucinous and non-mucinous adenocarcinoma Renomedullary interstitial cell tumor: text: Renomedullary interstitial cell tumor Malignant lymphoma, mixed cell type, diffuse: text: Malignant lymphoma, mixed cell type, diffuse Anaplastic large B-cell lymphoma: text: Anaplastic large B-cell lymphoma Chromophobe cell renal carcinoma: text: Chromophobe cell renal carcinoma Multiple neurofibromatosis: text: Multiple neurofibromatosis Epithelioid mesothelioma, benign: text: Epithelioid mesothelioma, benign Aleukemic lymphatic leukemia: text: Aleukemic lymphatic leukemia Adenocarcinoma of anal ducts: text: Adenocarcinoma of anal ducts Enteropathy type intestinal T-cell lymphoma: text: Enteropathy type intestinal T-cell lymphoma Retinoblastoma, differentiated: text: Retinoblastoma, differentiated Squamous cell carcinoma, adenoid: text: Squamous cell carcinoma, adenoid Cystic mesothelioma, NOS: text: Cystic mesothelioma, NOS Fascial fibroma: text: Fascial fibroma Perifollicular fibroma: text: Perifollicular fibroma Kaposiform hemangioendothelioma: text: Kaposiform hemangioendothelioma Basophil carcinoma: text: Basophil carcinoma Malignant lymphoma, non-Hodgkin, NOS: text: Malignant lymphoma, non-Hodgkin, NOS Pancreatobiliary-type carcinoma: text: Pancreatobiliary-type carcinoma Pheochromocytoma, NOS: text: Pheochromocytoma, NOS Epithelioma adenoides cysticum: text: Epithelioma adenoides cysticum Somatostatin cell tumor, NOS: text: Somatostatin cell tumor, NOS Plexiform fibromyxoma: text: Plexiform fibromyxoma Hepatocellular carcinoma, fibrolamellar: text: Hepatocellular carcinoma, fibrolamellar Leiomyoblastoma: text: Leiomyoblastoma Atypical teratoid/rhabdoid tumor: text: Atypical teratoid/rhabdoid tumor Serrated adenoma: text: Serrated adenoma Germ cell tumor, nonseminomatous: text: Germ cell tumor, nonseminomatous Immunoglobulin deposition disease: text: Immunoglobulin deposition disease Malignant teratoma, undifferentiated: text: Malignant teratoma, undifferentiated Oligodendroglioma, NOS: text: Oligodendroglioma, NOS Small cell osteosarcoma: text: Small cell osteosarcoma Cloacogenic carcinoma: text: Cloacogenic carcinoma Bronchio-alveolar carcinoma, mucinous: text: Bronchio-alveolar carcinoma, mucinous Adenomyoepithelioma: text: Adenomyoepithelioma Precursor T-cell lymphoblastic lymphoma: text: Precursor T-cell lymphoblastic lymphoma Alpha heavy chain disease: text: Alpha heavy chain disease Squamous cell carcinoma, HPV-positive: text: Squamous cell carcinoma, HPV-positive FAB Ll: text: FAB Ll Pro-B ALL: text: Pro-B ALL Schneiderian carcinoma: text: Schneiderian carcinoma Peripheral T-cell lymphoma, large cell: text: Peripheral T-cell lymphoma, large cell Primary effusion lymphoma: text: Primary effusion lymphoma Lipid cell tumor of ovary: text: Lipid cell tumor of ovary Thymoma, lymphocyte-rich, NOS: text: Thymoma, lymphocyte-rich, NOS Olfactory neurocytoma: text: Olfactory neurocytoma Mucoepidermoid carcinoma: text: Mucoepidermoid carcinoma description: Mucoepidermoid Carcinoma Malignant cystic nephroma: text: Malignant cystic nephroma Epithelial tumor, malignant: text: Epithelial tumor, malignant Medulloblastoma, NOS: text: Medulloblastoma, NOS Solid pseudopapillary carcinoma: text: Solid pseudopapillary carcinoma Cystic partially differentiated nephroblastoma: text: Cystic partially differentiated nephroblastoma Acute myeloid leukemia without prior myelodysplastic syndrome: text: Acute myeloid leukemia without prior myelodysplastic syndrome Mixed adenocarcinoma and squamous cell carcinoma: text: Mixed adenocarcinoma and squamous cell carcinoma Primary cutaneous CD30+ T-cell lymphoproliferative disorder: text: Primary cutaneous CD30+ T-cell lymphoproliferative disorder Epidermoid carcinoma, spindle cell: text: Epidermoid carcinoma, spindle cell Transitional papilloma, inverted, NOS: text: Transitional papilloma, inverted, NOS Papillary carcinoma in situ: text: Papillary carcinoma in situ B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1): text: B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) Bronchiolo-alveolar carcinoma, Clara cell: text: Bronchiolo-alveolar carcinoma, Clara cell Ectomesenchymoma: text: Ectomesenchymoma Central neuroblastoma: text: Central neuroblastoma Odontogenic carcinosarcoma: text: Odontogenic carcinosarcoma Endometrioid adenofibroma, borderline malignancy: text: Endometrioid adenofibroma, borderline malignancy Meningeal melanocytoma: text: Meningeal melanocytoma Eosinophilic leukemia: text: Eosinophilic leukemia Medullary carcinoma with lymphoid stroma: text: Medullary carcinoma with lymphoid stroma Serous surface papillary carcinoma: text: Serous surface papillary carcinoma B lymphoblastic leukemia/lymphoma with hyperdiploidy: text: B lymphoblastic leukemia/lymphoma with hyperdiploidy Thymoma, epithelial, NOS: text: Thymoma, epithelial, NOS Low-grade central osteosarcoma: text: Low-grade central osteosarcoma Osteofibrosarcoma: text: Osteofibrosarcoma Neoplasm, malignant, uncertain whether primary or metastatic: text: Neoplasm, malignant, uncertain whether primary or metastatic Glioblastoma, IDH wildtype: text: Glioblastoma, IDH wildtype Lipoadenoma: text: Lipoadenoma Myeloid sarcoma: text: Myeloid sarcoma Acute megakaryoblastic leukaemia: text: Acute megakaryoblastic leukaemia Cystic hypersecretory carcinoma: text: Cystic hypersecretory carcinoma Sclerosing hemangioma: text: Sclerosing hemangioma Chromaffin paraganglioma: text: Chromaffin paraganglioma Intratubular malignant germ cells: text: Intratubular malignant germ cells Acute myeloid leukemia, minimal differentiation: text: Acute myeloid leukemia, minimal differentiation Plasmacytic lymphoma: text: Plasmacytic lymphoma Clear cell adenocarcinofibroma: text: Clear cell adenocarcinofibroma Prolymphocytic leukemia, NOS: text: Prolymphocytic leukemia, NOS Post transplant lymphoproliferative disorder, NOS: text: Post transplant lymphoproliferative disorder, NOS Carcinoma with chondroid differentiation: text: Carcinoma with chondroid differentiation Odontogenic tumor, benign: text: Odontogenic tumor, benign Invasive fibroma: text: Invasive fibroma Argentaffinoma, NOS: text: Argentaffinoma, NOS Bronchiolar adenocarcinoma: text: Bronchiolar adenocarcinoma Langerhans cell granulomatosis, unifocal: text: Langerhans cell granulomatosis, unifocal Granulocytic leukemia, NOS: text: Granulocytic leukemia, NOS Refractory anemia with ring sideroblasts associated with marked thrombocytosis: text: Refractory anemia with ring sideroblasts associated with marked thrombocytosis Subependymal astrocytoma, NOS: text: Subependymal astrocytoma, NOS Medulloepithelioma, benign: text: Medulloepithelioma, benign Serous tumor, NOS, of low malignant potential: text: Serous tumor, NOS, of low malignant potential Endolymphatic stromal myosis: text: Endolymphatic stromal myosis Papillary serous cystadenoma, NOS: text: Papillary serous cystadenoma, NOS Medulloblastoma, SHH-activated and TP53-mutant: text: Medulloblastoma, SHH-activated and TP53-mutant Adenocarcinoma with cartilaginous metaplasia: text: Adenocarcinoma with cartilaginous metaplasia Refractory neutropenia: text: Refractory neutropenia Undifferentiated epithelioid sarcoma: text: Undifferentiated epithelioid sarcoma Acute erythremia: text: Acute erythremia Basal cell carcinoma, micronodular: text: Basal cell carcinoma, micronodular Water-clear cell adenoma: text: Water-clear cell adenoma Pericanalicular fibroadenoma: text: Pericanalicular fibroadenoma Malignant myoepithelioma: text: Malignant myoepithelioma Adenocarcinoma in polypoid adenoma: text: Adenocarcinoma in polypoid adenoma Tumor cells, malignant: text: Tumor cells, malignant Linitis plastica: text: Linitis plastica Pineoblastoma: text: Pineoblastoma Ductal carcinoma in situ, solid type: text: Ductal carcinoma in situ, solid type PNET, NOS: text: PNET, NOS Anaplastic large cell lymphoma, CD30+: text: Anaplastic large cell lymphoma, CD30+ Myloproliferative neoplasm, unclassifiable: text: Myloproliferative neoplasm, unclassifiable Polymorphic reticulosis: text: Polymorphic reticulosis Venous hemangioma: text: Venous hemangioma Adrenal cortical tumor, benign: text: Adrenal cortical tumor, benign Acinic cell adenoma: text: Acinic cell adenoma Hemangioendothelioma, malignant: text: Hemangioendothelioma, malignant Water-clear cell adenocarcinoma: text: Water-clear cell adenocarcinoma Tubulocystic renal cell carcinoma: text: Tubulocystic renal cell carcinoma description: Tubulocystic Renal Cell Carcinoma Extracutaneous mastocytoma: text: Extracutaneous mastocytoma Digital papillary adenocarcinoma: text: Digital papillary adenocarcinoma Hyalinizing trabecular adenoma: text: Hyalinizing trabecular adenoma Ductal carcinoma in situ, cribriform type: text: Ductal carcinoma in situ, cribriform type Giant cell tumor of tendon sheath, malignant: text: Giant cell tumor of tendon sheath, malignant Chondrosarcoma, NOS: text: Chondrosarcoma, NOS Fibromyxolipoma: text: Fibromyxolipoma Stromal tumor, NOS: text: Stromal tumor, NOS Plasmacytoma, extramedullary: text: Plasmacytoma, extramedullary Cystadenoma, NOS: text: Cystadenoma, NOS Diffuse astrocytoma, IDH-mutant: text: Diffuse astrocytoma, IDH-mutant Pleomorphic leiomyoma: text: Pleomorphic leiomyoma Serous carcinoma, NOS: text: Serous carcinoma, NOS Vulvar intraepithelial neoplasia, grade III: text: Vulvar intraepithelial neoplasia, grade III Diffuse cutaneous mastocytosis: text: Diffuse cutaneous mastocytosis Bronchiolar carcinoma: text: Bronchiolar carcinoma Embryonal sarcoma: text: Embryonal sarcoma Intracystic papillary neoplasm with high grade intraepithelial neoplasia: text: Intracystic papillary neoplasm with high grade intraepithelial neoplasia Extra-adrenal paraganglioma, NOS: text: Extra-adrenal paraganglioma, NOS Medullomyoblastoma: text: Medullomyoblastoma Clear cell cystadenofibroma of borderline malignancy: text: Clear cell cystadenofibroma of borderline malignancy Enteroglucagonoma, malignant: text: Enteroglucagonoma, malignant Skin appendage carcinoma: text: Skin appendage carcinoma Endometrial stromal nodule: text: Endometrial stromal nodule Peripheral T-cell lymphoma, pleomorphic medium and large cell: text: Peripheral T-cell lymphoma, pleomorphic medium and large cell Tubular adenocarcinoma: text: Tubular adenocarcinoma Pilocytic astrocytoma: text: Pilocytic astrocytoma Myeloproliferative neoplasm, NOS: text: Myeloproliferative neoplasm, NOS Malignant lymphoma, lymphocytic, poorly differentiated, nodular: text: Malignant lymphoma, lymphocytic, poorly differentiated, nodular Giant fibroadenoma: text: Giant fibroadenoma Fetal adenoma: text: Fetal adenoma Hydatid mole: text: Hydatid mole Mesoblastic nephroma: text: Mesoblastic nephroma Periosteal chondrosarcoma: text: Periosteal chondrosarcoma Mixed germ cell sex cord-stromal tumor, unclassified: text: Mixed germ cell sex cord-stromal tumor, unclassified Angioblastic meningioma: text: Angioblastic meningioma MPNST, NOS: text: MPNST, NOS Paraganglioma, malignant: text: Paraganglioma, malignant Epithelioid hemangioendothelioma, malignant: text: Epithelioid hemangioendothelioma, malignant Seminoma, NOS: text: Seminoma, NOS Microcystic adnexal carcinoma: text: Microcystic adnexal carcinoma Composite carcinoid: text: Composite carcinoid Teratoblastoma, malignant: text: Teratoblastoma, malignant Pleomorphic liposarcoma: text: Pleomorphic liposarcoma B lymphoblastic leukemia/lymphoma, NOS: text: B lymphoblastic leukemia/lymphoma, NOS Mantle zone lymphoma: text: Mantle zone lymphoma Infiltrating duct mixed with other types of carcinoma: text: Infiltrating duct mixed with other types of carcinoma Clear cell chondrosarcoma: text: Clear cell chondrosarcoma Ewing sarcoma: text: Ewing sarcoma Micropapillary adenocarcinoma: text: Micropapillary adenocarcinoma G cell tumor, malignant: text: G cell tumor, malignant Bile duct cystadenocarcinoma: text: Bile duct cystadenocarcinoma Glioblastoma, IDH-mutant: text: Glioblastoma, IDH-mutant Acute myeloid leukemia, inv(16)(p13;q22): text: Acute myeloid leukemia, inv(16)(p13;q22) Scirrhous adenocarcinoma: text: Scirrhous adenocarcinoma Secretory carcinoma of breast: text: Secretory carcinoma of breast Acute monocytic leukemia: text: Acute monocytic leukemia Myeloid leukemia, NOS: text: Myeloid leukemia, NOS Precancerous melanosis, NOS: text: Precancerous melanosis, NOS Subcutaneous panniculitis-like T-cell lymphoma: text: Subcutaneous panniculitis-like T-cell lymphoma Theca cell tumor: text: Theca cell tumor Involuting nevus: text: Involuting nevus Solid papillary carcinoma in situ: text: Solid papillary carcinoma in situ Mucin-producing adenocarcinoma: text: Mucin-producing adenocarcinoma Follicular adenoma: text: Follicular adenoma Acute myelogenous leukemia: text: Acute myelogenous leukemia Idiopathic hemorrhagic thrombocythaemia: text: Idiopathic hemorrhagic thrombocythaemia Anal intraepithelial neoplasia, low grade: text: Anal intraepithelial neoplasia, low grade Acute myeloid leukemia, M6 type: text: Acute myeloid leukemia, M6 type Myelolipoma: text: Myelolipoma Localized fibrous tumor: text: Localized fibrous tumor Kupffer cell sarcoma: text: Kupffer cell sarcoma Macrofollicular adenoma: text: Macrofollicular adenoma Malignant melanoma in giant pigmented nevus: text: Malignant melanoma in giant pigmented nevus Chromophobe adenocarcinoma: text: Chromophobe adenocarcinoma Mucinous cystic tumor with low grade dysplasia: text: Mucinous cystic tumor with low grade dysplasia Hodgkin lymphoma, nodular sclerosis, grade 2: text: Hodgkin lymphoma, nodular sclerosis, grade 2 Endometrioid cystadenofibroma, NOS: text: Endometrioid cystadenofibroma, NOS Inflammatory myofibroblastic tumor: text: Inflammatory myofibroblastic tumor description: Inflammatory Myofibroblastic Tumor Ectopic hamartomatous thymoma: text: Ectopic hamartomatous thymoma Invasive mucinous adenocarcinoma: text: Invasive mucinous adenocarcinoma Invasive micropapillary carcinoma: text: Invasive micropapillary carcinoma Pancreatoblastoma: text: Pancreatoblastoma description: Pancreatoblastoma Medulloblastoma, group 4: text: Medulloblastoma, group 4 Acinar cell carcinoma: text: Acinar cell carcinoma description: Acinar Cell Carcinoma Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted: text: Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted Luteoma, NOS: text: Luteoma, NOS Adenocarcinoma with neuroendocrine differentiation: text: Adenocarcinoma with neuroendocrine differentiation Precursor B-cell lymphoblastic lymphoma: text: Precursor B-cell lymphoblastic lymphoma Langerhans cell histiocytosis, unifocal: text: Langerhans cell histiocytosis, unifocal MPNST with glandular differentiation: text: MPNST with glandular differentiation Renal medullary carcinoma: text: Renal medullary carcinoma description: Kidney Medullary Carcinoma Round cell carcinoma: text: Round cell carcinoma Fibroepithelial basal cell carcinoma, Pinkus type: text: Fibroepithelial basal cell carcinoma, Pinkus type Granular cell myoblastoma, NOS: text: Granular cell myoblastoma, NOS Hygroma, NOS: text: Hygroma, NOS Gelatinous carcinoma: text: Gelatinous carcinoma Adenocarcinoma, endocervical type: text: Adenocarcinoma, endocervical type Cortical T ALL: text: Cortical T ALL Neuroma, NOS: text: Neuroma, NOS Sertoli-Leydig cell tumor, retiform, with heterologous elements: text: Sertoli-Leydig cell tumor, retiform, with heterologous elements Multifocal superficial basal cell carcinoma: text: Multifocal superficial basal cell carcinoma Glomus tumor, malignant: text: Glomus tumor, malignant Terminal duct adenocarcinoma: text: Terminal duct adenocarcinoma Urothelial papilloma, NOS: text: Urothelial papilloma, NOS Peripheral primitive neuroectodermal tumor, NOS: text: Peripheral primitive neuroectodermal tumor, NOS Squamous cell carcinoma, microinvasive: text: Squamous cell carcinoma, microinvasive Systemic EBV positive T-cell lymphoproliferative disease of childhood: text: Systemic EBV positive T-cell lymphoproliferative disease of childhood Pancreatic endocrine tumor, malignant: text: Pancreatic endocrine tumor, malignant Endocrine adenomatosis: text: Endocrine adenomatosis Blue nevus, NOS: text: Blue nevus, NOS Bellini duct carcinoma: text: Bellini duct carcinoma Carcinosarcoma, NOS: text: Carcinosarcoma, NOS Malignant lymphoma, small cleaved cell, NOS: text: Malignant lymphoma, small cleaved cell, NOS Sweat gland adenocarcinoma: text: Sweat gland adenocarcinoma Plasma cell tumor: text: Plasma cell tumor Follicular carcinoma, minimally invasive: text: Follicular carcinoma, minimally invasive Islet cell carcinoma: text: Islet cell carcinoma Chronic myeloproliferative disease, NOS: text: Chronic myeloproliferative disease, NOS Refractory anemia with sideroblasts: text: Refractory anemia with sideroblasts Apudoma: text: Apudoma Intraductal papillary neoplasm with high grade dysplasia: text: Intraductal papillary neoplasm with high grade dysplasia Aortic body tumor: text: Aortic body tumor Sertoli-Leydig cell tumor, retiform: text: Sertoli-Leydig cell tumor, retiform Gastrin cell tumor: text: Gastrin cell tumor Eccrine spiradenoma: text: Eccrine spiradenoma Meningiomatosis, NOS: text: Meningiomatosis, NOS Thymoma, predominantly cortical, malignant: text: Thymoma, predominantly cortical, malignant Epithelioid mesothelioma, NOS: text: Epithelioid mesothelioma, NOS Fibroadenoma, NOS: text: Fibroadenoma, NOS Endometrioid adenofibroma, NOS: text: Endometrioid adenofibroma, NOS Periapical cemento-osseous dysplasia: text: Periapical cemento-osseous dysplasia Adenolipoma: text: Adenolipoma Nevus, NOS: text: Nevus, NOS Chronic granulocytic leukemia, NOS: text: Chronic granulocytic leukemia, NOS Serous endometrial intraepithelial carcinoma: text: Serous endometrial intraepithelial carcinoma description: Serous Endometrial Intraepithelial Carcinoma Malignant lymphoma, lymphocytic, NOS: text: Malignant lymphoma, lymphocytic, NOS Cemento-ossifying fibroma: text: Cemento-ossifying fibroma Schmincke tumor: text: Schmincke tumor Hodgkin sarcoma: text: Hodgkin sarcoma Perivascular epithelioid cell tumor, malignant: text: Perivascular epithelioid cell tumor, malignant Classical Hodgkin lymphoma, mixed cellularity, NOS: text: Classical Hodgkin lymphoma, mixed cellularity, NOS Squamous cell carcinoma, pseudoglandular: text: Squamous cell carcinoma, pseudoglandular Hodgkin disease, nodular sclerosis, lymphocyte depletion: text: Hodgkin disease, nodular sclerosis, lymphocyte depletion Adenocarcinoma with spindle cell metaplasia: text: Adenocarcinoma with spindle cell metaplasia Metastasizing leiomyoma: text: Metastasizing leiomyoma Ossifying renal tumor: text: Ossifying renal tumor Infiltrating duct adenocarcinoma: text: Infiltrating duct adenocarcinoma Papillary adenofibroma: text: Papillary adenofibroma Bronchial adenoma, carcinoid: text: Bronchial adenoma, carcinoid Mixed embryonal carcinoma and teratoma: text: Mixed embryonal carcinoma and teratoma Chondroblastoma, malignant: text: Chondroblastoma, malignant Melanotic medulloblastoma: text: Melanotic medulloblastoma Mediastinal (thymic) large B-cell lymphoma: text: Mediastinal (thymic) large B-cell lymphoma Mucinous carcinoma, gastric type: text: Mucinous carcinoma, gastric type Fibrous mesothelioma, malignant: text: Fibrous mesothelioma, malignant Bronchiolo-alveolar carcinoma, goblet cell type: text: Bronchiolo-alveolar carcinoma, goblet cell type Cancer: text: Cancer Mucinous cystadenocarcinofibroma: text: Mucinous cystadenocarcinofibroma Synovial sarcoma, NOS: text: Synovial sarcoma, NOS Hepatoblastoma, mixed epithelial-mesenchymal: text: Hepatoblastoma, mixed epithelial-mesenchymal Aggressive fibromatosis: text: Aggressive fibromatosis Glandular intraepithelial neoplasia, low grade: text: Glandular intraepithelial neoplasia, low grade MALT lymphoma: text: MALT lymphoma Intraductal papilloma with ductal carcinoma in situ: text: Intraductal papilloma with ductal carcinoma in situ Myxoid leiomyosarcoma: text: Myxoid leiomyosarcoma Subareolar duct papillomatosis: text: Subareolar duct papillomatosis Lipoblastoma: text: Lipoblastoma Fibrofolliculoma: text: Fibrofolliculoma Liver cell carcinoma: text: Liver cell carcinoma Piloid astrocytoma: text: Piloid astrocytoma Chondroid lipoma: text: Chondroid lipoma Atypical hyperplasia/Endometrioid intraepithelial neoplasm: text: Atypical hyperplasia/Endometrioid intraepithelial neoplasm Mantle cell lymphoma (Includes all variants blastic, pleomorphic, small cell): text: Mantle cell lymphoma (Includes all variants blastic, pleomorphic, small cell) Thymoma, medullary, malignant: text: Thymoma, medullary, malignant T-cell large granular lymphocytosis: text: T-cell large granular lymphocytosis Follicular carcinoma, trabecular: text: Follicular carcinoma, trabecular Melanotic schwannoma: text: Melanotic schwannoma Pilar tumor: text: Pilar tumor Ecchondrosis: text: Ecchondrosis Glioneuroma: text: Glioneuroma Cylindrical cell carcinoma: text: Cylindrical cell carcinoma Craniopharyngioma, adamantinomatous: text: Craniopharyngioma, adamantinomatous Dermatofibroma, NOS: text: Dermatofibroma, NOS Chief cell adenoma: text: Chief cell adenoma Microcystic adenoma: text: Microcystic adenoma Granular cell carcinoma: text: Granular cell carcinoma Chronic myelomonocytic leukemia in transformation: text: Chronic myelomonocytic leukemia in transformation Carcinoid tumor, argentaffin, malignant: text: Carcinoid tumor, argentaffin, malignant Intraductal papilloma with lobular carcinoma in situ: text: Intraductal papilloma with lobular carcinoma in situ Jugular paraganglioma: text: Jugular paraganglioma Multiple hemorrhagic sarcoma: text: Multiple hemorrhagic sarcoma Papillary transitional cell carcinoma: text: Papillary transitional cell carcinoma Pigmented schwannoma: text: Pigmented schwannoma Mucin-producing carcinoma: text: Mucin-producing carcinoma Epidermoid carcinoma in situ with questionable stromal invasion: text: Epidermoid carcinoma in situ with questionable stromal invasion Lipoblastomatosis: text: Lipoblastomatosis Tumor, benign: text: Tumor, benign Mixed germ cell tumor: text: Mixed germ cell tumor Acute myloid leukemia, 11q23 abnormalities: text: Acute myloid leukemia, 11q23 abnormalities Adult T-cell lymphoma: text: Adult T-cell lymphoma Myelodysplastic syndrome with 5q deletion (5q-) syndrome: text: Myelodysplastic syndrome with 5q deletion (5q-) syndrome Triton tumor, malignant: text: Triton tumor, malignant Papillary mucinous cystadenoma, borderline malignancy: text: Papillary mucinous cystadenoma, borderline malignancy Mixed glioma: text: Mixed glioma Epithelioid and spindle cell nevus: text: Epithelioid and spindle cell nevus Germinoma: text: Germinoma Trichilemmoma: text: Trichilemmoma Papillary transitional cell neoplasm of low malignant potential: text: Papillary transitional cell neoplasm of low malignant potential Epidermoid carcinoma, keratinizing: text: Epidermoid carcinoma, keratinizing Endocrine tumor, functioning, NOS: text: Endocrine tumor, functioning, NOS Atypical proliferative endometrioid tumor: text: Atypical proliferative endometrioid tumor Cystosarcoma phyllodes, NOS: text: Cystosarcoma phyllodes, NOS Colloid adenoma: text: Colloid adenoma Lipoleiomyoma: text: Lipoleiomyoma Trichofolliculoma: text: Trichofolliculoma Fibroblastic liposarcoma: text: Fibroblastic liposarcoma Cerebellar sarcoma, NOS: text: Cerebellar sarcoma, NOS Spindled mesothelioma: text: Spindled mesothelioma Melanocytic nevus: text: Melanocytic nevus Vipoma, malignant: text: Vipoma, malignant Adenofibroma, NOS: text: Adenofibroma, NOS Mucinous cystic neoplasm with high-grade intraepithelial neoplasia: text: Mucinous cystic neoplasm with high-grade intraepithelial neoplasia Angiocentric T-cell lymphoma: text: Angiocentric T-cell lymphoma Gamma heavy chain disease: text: Gamma heavy chain disease Gemistocytic astrocytoma: text: Gemistocytic astrocytoma Mesenchymoma, benign: text: Mesenchymoma, benign Plexiform schwannoma: text: Plexiform schwannoma Minimally invasive adenocarcinoma, mucinous: text: Minimally invasive adenocarcinoma, mucinous description: Mucinous Bronchioloalveolar Carcinoma Bronchiolo-alveolar carcinoma, type II pneumocyte and goblet cell type: text: Bronchiolo-alveolar carcinoma, type II pneumocyte and goblet cell type Papillary adenocarcinoma, NOS: text: Papillary adenocarcinoma, NOS Splenic diffuse red pulp small B-cell lymphoma: text: Splenic diffuse red pulp small B-cell lymphoma Acquired cystic disease-associated renal cell carcinoma (RCC): text: Acquired cystic disease-associated renal cell carcinoma (RCC) Thymoma, type C: text: Thymoma, type C Anaplastic astrocytoma, IDH-mutant: text: Anaplastic astrocytoma, IDH-mutant Primary cutaneous anaplastic large cell lymphoma: text: Primary cutaneous anaplastic large cell lymphoma Non-small cell carcinoma: text: Non-small cell carcinoma Malignant histiocytosis: text: Malignant histiocytosis Neurotropic melanoma, malignant: text: Neurotropic melanoma, malignant Papillary carcinoma, oxyphilic cell: text: Papillary carcinoma, oxyphilic cell Epithelioid sarcoma: text: Epithelioid sarcoma Papillary serous adenocarcinoma: text: Papillary serous adenocarcinoma Superficial well differentiated liposarcoma: text: Superficial well differentiated liposarcoma Syringoma, NOS: text: Syringoma, NOS Thymoma, organoid, NOS: text: Thymoma, organoid, NOS Follicular adenocarcinoma, well differentiated: text: Follicular adenocarcinoma, well differentiated Angioleiomyoma: text: Angioleiomyoma Neoplasm, benign: text: Neoplasm, benign Myofibroblastic sarcoma: text: Myofibroblastic sarcoma Squamous papilloma: text: Squamous papilloma Hodgkin lymphoma, lymphocyte-rich: text: Hodgkin lymphoma, lymphocyte-rich Epithelioid cell melanoma: text: Epithelioid cell melanoma Urothelial carcinoma with divergent differentiation: text: Urothelial carcinoma with divergent differentiation Chordoma, NOS: text: Chordoma, NOS Acute progressive histiocytosis X: text: Acute progressive histiocytosis X Follicular fibroma: text: Follicular fibroma Papillary cystadenoma, NOS: text: Papillary cystadenoma, NOS Papillary carcinoma, encapsulated: text: Papillary carcinoma, encapsulated Glioblastoma: text: Glioblastoma Retinocytoma: text: Retinocytoma Idiopathic thrombocythemia: text: Idiopathic thrombocythemia Transitional cell papilloma, inverted, benign: text: Transitional cell papilloma, inverted, benign Hodgkin lymphoma, mixed cellularity, NOS: text: Hodgkin lymphoma, mixed cellularity, NOS Congenital fibrosarcoma: text: Congenital fibrosarcoma Burkitt cell leukemia: text: Burkitt cell leukemia Sezary syndrome: text: Sezary syndrome Endometrioid cystadenofibroma, borderline malignancy: text: Endometrioid cystadenofibroma, borderline malignancy Primary cutaneous CD4-positive small/medium T-cell lymphoma: text: Primary cutaneous CD4-positive small/medium T-cell lymphoma Sinonasal papilloma, fungiform: text: Sinonasal papilloma, fungiform Epithelioma, NOS: text: Epithelioma, NOS Myoepithelial tumor: text: Myoepithelial tumor Intraosseous low grade osteosarcoma: text: Intraosseous low grade osteosarcoma Epithelial tumor, benign: text: Epithelial tumor, benign True histiocytic lymphoma: text: True histiocytic lymphoma Schwannoma, NOS: text: Schwannoma, NOS Intracanalicular fibroadenoma: text: Intracanalicular fibroadenoma Malignant tumor, spindle cell type: text: Malignant tumor, spindle cell type Solid papillary carcinoma with invasion: text: Solid papillary carcinoma with invasion Malignant lymphoma, follicle center, NOS: text: Malignant lymphoma, follicle center, NOS Interstitial cell tumor, benign: text: Interstitial cell tumor, benign Lymphangioma, NOS: text: Lymphangioma, NOS Epidermoid carcinoma in situ, NOS: text: Epidermoid carcinoma in situ, NOS Chondroid syringoma: text: Chondroid syringoma Solitary plasmacytoma: text: Solitary plasmacytoma Ganglioneuromatosis: text: Ganglioneuromatosis Non-invasive EFVPTC: text: Non-invasive EFVPTC Enteropathy associated T-cell lymphoma: text: Enteropathy associated T-cell lymphoma Adenocarcinoma in situ in villous adenoma: text: Adenocarcinoma in situ in villous adenoma Histiocytoma, NOS: text: Histiocytoma, NOS Pancreatic endocrine tumor, nonfunctioning: text: Pancreatic endocrine tumor, nonfunctioning Lepidic predominant adenocarcinoma: text: Lepidic predominant adenocarcinoma description: Lepidic Predominant Adenocarcinoma Choriocarcinoma, NOS: text: Choriocarcinoma, NOS Inflammatory adenocarcinoma: text: Inflammatory adenocarcinoma Hodgkin lymphoma, nodular sclerosis, cellular phase: text: Hodgkin lymphoma, nodular sclerosis, cellular phase Myelomatosis: text: Myelomatosis Endometrial stromatosis: text: Endometrial stromatosis Synovial sarcoma, epithelioid cell: text: Synovial sarcoma, epithelioid cell Intraductal papillary mucinous neoplasm with an associated invasive carcinoma: text: Intraductal papillary mucinous neoplasm with an associated invasive carcinoma Aleukemic lymphocytic leukemia: text: Aleukemic lymphocytic leukemia Papilloma of bladder: text: Papilloma of bladder Myxoid fibroma: text: Myxoid fibroma Cellular blue nevus: text: Cellular blue nevus Mature teratoma: text: Mature teratoma Intracystic papilloma: text: Intracystic papilloma B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1: text: B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 Myelodysplastic syndrome, NOS: text: Myelodysplastic syndrome, NOS Colloid adenocarcinoma: text: Colloid adenocarcinoma description: Lung Mucinous Adenocarcinoma Fibrous mesothelioma, NOS: text: Fibrous mesothelioma, NOS Medullary adenocarcinoma: text: Medullary adenocarcinoma Dysgerminoma: text: Dysgerminoma description: Ovarian Dysgerminoma Ductal carcinoma, NOS: text: Ductal carcinoma, NOS Papillary epidermoid carcinoma: text: Papillary epidermoid carcinoma Acute lymphoblastic leukemia-lymphoma, NOS: text: Acute lymphoblastic leukemia-lymphoma, NOS Acute myeloid leukemia with prior myelodysplastic syndrome: text: Acute myeloid leukemia with prior myelodysplastic syndrome Dysplastic nevus: text: Dysplastic nevus Squamous cell carcinoma, small cell, nonkeratinizing: text: Squamous cell carcinoma, small cell, nonkeratinizing Atypical medullary carcinoma: text: Atypical medullary carcinoma Eccrine papillary adenoma: text: Eccrine papillary adenoma Mixed phenotype acute leukemia, B/myeloid, NOS: text: Mixed phenotype acute leukemia, B/myeloid, NOS Malignant eccrine spiradenoma: text: Malignant eccrine spiradenoma Refractory cytopenia with multilineage dysplasia: text: Refractory cytopenia with multilineage dysplasia Solid adenocarcinoma with mucin formation: text: Solid adenocarcinoma with mucin formation Juvenile melanoma: text: Juvenile melanoma Alpha cell tumor, malignant: text: Alpha cell tumor, malignant Spindle cell rhabdomyosarcoma: text: Spindle cell rhabdomyosarcoma Stromal endometriosis: text: Stromal endometriosis Malignant lymphoma, lymphocytic, nodular, NOS: text: Malignant lymphoma, lymphocytic, nodular, NOS Glomangioma: text: Glomangioma Medulloblastoma, WNT-activated: text: Medulloblastoma, WNT-activated Acute promyelocytic leukaemia, t(15;17)(q22;q11-12): text: Acute promyelocytic leukaemia, t(15;17)(q22;q11-12) Malignant lymphoma, mixed lymphocytic-histiocytic, diffuse: text: Malignant lymphoma, mixed lymphocytic-histiocytic, diffuse Chronic erythremia: text: Chronic erythremia Malignant melanoma in congenital melanocytic nevus: text: Malignant melanoma in congenital melanocytic nevus Lipid-rich urothelial carcinoma: text: Lipid-rich urothelial carcinoma Retroperitoneal fibromatosis: text: Retroperitoneal fibromatosis Klatskin tumor: text: Klatskin tumor Atypical proliferating serous tumor: text: Atypical proliferating serous tumor Squamous intraepithelial neoplasia, grade III: text: Squamous intraepithelial neoplasia, grade III Hutchinson melanotic freckle, NOS: text: Hutchinson melanotic freckle, NOS Combined carcinoid and adenocarcinoma: text: Combined carcinoid and adenocarcinoma Follicular lymphoma, grade 3: text: Follicular lymphoma, grade 3 Sex cord tumor, NOS: text: Sex cord tumor, NOS Sclerosing rhabdomyosarcoma: text: Sclerosing rhabdomyosarcoma Multiple endocrine adenomas: text: Multiple endocrine adenomas Fibromyoma: text: Fibromyoma Papillary tumor of the pineal region: text: Papillary tumor of the pineal region Intracystic papillary adenoma: text: Intracystic papillary adenoma High grade surface osteosarcoma: text: High grade surface osteosarcoma Adenocarcinoma in tubolovillous adenoma: text: Adenocarcinoma in tubolovillous adenoma Astroblastoma: text: Astroblastoma Basal cell carcinoma, morpheic: text: Basal cell carcinoma, morpheic Medulloblastoma, non-WNT/non-SHH: text: Medulloblastoma, non-WNT/non-SHH Periosteal fibrosarcoma: text: Periosteal fibrosarcoma Sex cord tumor with annular tubules: text: Sex cord tumor with annular tubules Primary myelofibrosis: text: Primary myelofibrosis Epithelioid cell sarcoma: text: Epithelioid cell sarcoma Angiocentric glioma: text: Angiocentric glioma Malignant lymphoma, large cleaved cell, NOS: text: Malignant lymphoma, large cleaved cell, NOS Papillary syringadenoma: text: Papillary syringadenoma Mucinous adenofibroma of borderline malignancy: text: Mucinous adenofibroma of borderline malignancy Esthesioneuroblastoma: text: Esthesioneuroblastoma Basophil adenocarcinoma: text: Basophil adenocarcinoma Aleukemic myeloid leukemia: text: Aleukemic myeloid leukemia Poorly cohesive carcinoma: text: Poorly cohesive carcinoma Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL: text: Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL CASTLE: text: CASTLE Reticulum cell sarcoma, diffuse: text: Reticulum cell sarcoma, diffuse Intracystic papillary adenocarcinoma: text: Intracystic papillary adenocarcinoma Malignant lymphoma, large cleaved cell, follicular: text: Malignant lymphoma, large cleaved cell, follicular Melanocytoma, NOS: text: Melanocytoma, NOS Plasmablastic lymphoma: text: Plasmablastic lymphoma Invasive carcinoma, NST: text: Invasive carcinoma, NST Serous cystadenocarcinoma, NOS: text: Serous cystadenocarcinoma, NOS Dermal and epidermal nevus: text: Dermal and epidermal nevus Gigantiform cementoma: text: Gigantiform cementoma Transitional cell carcinoma, micropapillary: text: Transitional cell carcinoma, micropapillary Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS): text: Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS) Squamous cell carcinoma, keratinizing, NOS: text: Squamous cell carcinoma, keratinizing, NOS Malignant lymphoma, lymphoblastic, NOS: text: Malignant lymphoma, lymphoblastic, NOS Adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants): text: Adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants) Pigmented adenoma: text: Pigmented adenoma Malignant chondroid syringoma: text: Malignant chondroid syringoma Thymoma, type B1, malignant: text: Thymoma, type B1, malignant Intraductal papillary-mucinous carcinoma, invasive: text: Intraductal papillary-mucinous carcinoma, invasive Malignant lymphoma, large cell, cleaved and noncleaved: text: Malignant lymphoma, large cell, cleaved and noncleaved Pleomorphic lipoma: text: Pleomorphic lipoma Diffuse large B-cell lymphoma, NOS: text: Diffuse large B-cell lymphoma, NOS Carcinoma in situ in adenomatous polyp: text: Carcinoma in situ in adenomatous polyp Adenocarcinoma, cribriform comedo-type: text: Adenocarcinoma, cribriform comedo-type Peripheral T-cell lymphoma, pleomorphic small cell: text: Peripheral T-cell lymphoma, pleomorphic small cell Acinar cell tumor: text: Acinar cell tumor Clear cell adenoma: text: Clear cell adenoma Adenocarcinoma in adenomatous polyp: text: Adenocarcinoma in adenomatous polyp Adenocarcinoma, NOS: text: Adenocarcinoma, NOS Chronic myeloproliferative disorder: text: Chronic myeloproliferative disorder Monstrocellular sarcoma: text: Monstrocellular sarcoma Leukemia, NOS: text: Leukemia, NOS Thymoma, type B2, NOS: text: Thymoma, type B2, NOS NUT midline carcinoma: text: NUT midline carcinoma Carcinoma, NOS: text: Carcinoma, NOS B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged: text: B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged Calcifying nested epithelial stromal tumor: text: Calcifying nested epithelial stromal tumor Myoepithelioma: text: Myoepithelioma Teratoma, NOS: text: Teratoma, NOS Neuroendocrine tumor, grade 1: text: Neuroendocrine tumor, grade 1 Polygonal cell carcinoma: text: Polygonal cell carcinoma Malignant tenosynovial giant cell tumor: text: Malignant tenosynovial giant cell tumor Tumor, NOS: text: Tumor, NOS Sympathetic paraganglioma: text: Sympathetic paraganglioma Basal cell carcinoma, fibroepithelial: text: Basal cell carcinoma, fibroepithelial Myxolipoma: text: Myxolipoma Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse: text: Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse Classical Hodgkin lymphoma, lymphocyte-rich: text: Classical Hodgkin lymphoma, lymphocyte-rich Osteoblastic sarcoma: text: Osteoblastic sarcoma Squamous cell carcinoma with horn formation: text: Squamous cell carcinoma with horn formation Histiocytic medullary reticulosis: text: Histiocytic medullary reticulosis Primitive neuroectodermal tumor, NOS: text: Primitive neuroectodermal tumor, NOS Classical Hodgkin lymphoma, lymphocyte depletion, NOS: text: Classical Hodgkin lymphoma, lymphocyte depletion, NOS Fibrochondrosarcoma: text: Fibrochondrosarcoma Trichoepithelioma: text: Trichoepithelioma Histiocytoid hemangioma: text: Histiocytoid hemangioma Mesonephroma, malignant: text: Mesonephroma, malignant Multiple meningiomas: text: Multiple meningiomas Mucinous cystadenofibroma of borderline malignancy: text: Mucinous cystadenofibroma of borderline malignancy Mu heavy chain disease: text: Mu heavy chain disease Chorioadenoma destruens: text: Chorioadenoma destruens Malignant lymphoma, nodular, NOS: text: Malignant lymphoma, nodular, NOS Duct cell carcinoma: text: Duct cell carcinoma Papillary carcinoma, tall cell: text: Papillary carcinoma, tall cell Thymoma, epithelial, malignant: text: Thymoma, epithelial, malignant Intraductal and lobular carcinoma: text: Intraductal and lobular carcinoma Urticaria pigmentosa: text: Urticaria pigmentosa Hodgkin granuloma: text: Hodgkin granuloma Thymic carcinoma, NOS: text: Thymic carcinoma, NOS T lymphoblastic leukemia/lymphoma: text: T lymphoblastic leukemia/lymphoma Basal cell carcinoma, nodular: text: Basal cell carcinoma, nodular Carcinoid tumor, NOS, of appendix: text: Carcinoid tumor, NOS, of appendix Squamous cell papilloma, inverted: text: Squamous cell papilloma, inverted Myoepithelial carcinoma: text: Myoepithelial carcinoma description: Malignant Myoepithelioma Adenocarcinoma, metastatic, NOS: text: Adenocarcinoma, metastatic, NOS Adenocarcinoma, cylindroid: text: Adenocarcinoma, cylindroid Osteocartilaginous exostosis: text: Osteocartilaginous exostosis Endometrioid adenoma, NOS: text: Endometrioid adenoma, NOS Bronchial-associated lymphoid tissue lymphoma: text: Bronchial-associated lymphoid tissue lymphoma Sertoli-Leydig cell tumor, sarcomatoid: text: Sertoli-Leydig cell tumor, sarcomatoid Follicular adenoma, oxyphilic cell: text: Follicular adenoma, oxyphilic cell Spindle cell angioendothelioma: text: Spindle cell angioendothelioma Carotid body tumor: text: Carotid body tumor Abdominal desmoid: text: Abdominal desmoid Mucinous cystic neoplasm with intermediate-grade dysplasia: text: Mucinous cystic neoplasm with intermediate-grade dysplasia Invasive hydatidiform mole: text: Invasive hydatidiform mole Blue nevus, malignant: text: Blue nevus, malignant Sclerosing hepatic carcinoma: text: Sclerosing hepatic carcinoma Myofibromatosis: text: Myofibromatosis Clear cell sarcoma, NOS: text: Clear cell sarcoma, NOS Gangliocytoma: text: Gangliocytoma Carcinomatosis: text: Carcinomatosis Hepatoma, benign: text: Hepatoma, benign Gemistocytoma: text: Gemistocytoma Adrenal cortical carcinoma: text: Adrenal cortical carcinoma Teratoma with malignant transformation: text: Teratoma with malignant transformation AIN III: text: AIN III Mixed tumor, salivary gland type, malignant: text: Mixed tumor, salivary gland type, malignant Proliferating trichilemmal cyst: text: Proliferating trichilemmal cyst Meningeal sarcomatosis: text: Meningeal sarcomatosis Sertoli-Leydig cell tumor, well differentiated: text: Sertoli-Leydig cell tumor, well differentiated Squamous cell carcinoma in situ, NOS: text: Squamous cell carcinoma in situ, NOS Unclassified tumor, uncertain whether benign or malignant: text: Unclassified tumor, uncertain whether benign or malignant L-cell tumor: text: L-cell tumor Giant cell tumor of tendon sheath: text: Giant cell tumor of tendon sheath Adenocarcinoma in situ in adenomatous polyp: text: Adenocarcinoma in situ in adenomatous polyp Papillary transitional cell carcinoma, non-invasive: text: Papillary transitional cell carcinoma, non-invasive Cin III, NOS: text: Cin III, NOS Langerhans cell histiocytosis, generalized: text: Langerhans cell histiocytosis, generalized Plasma cell myeloma: text: Plasma cell myeloma ECL cell carcinoid, malignant: text: ECL cell carcinoid, malignant Eosinophil adenocarcinoma: text: Eosinophil adenocarcinoma Malignant lymphoma, NOS: text: Malignant lymphoma, NOS Ductal intraepithelial neoplasia 3: text: Ductal intraepithelial neoplasia 3 Enteric adenocarcinoma: text: Enteric adenocarcinoma description: Lung Enteric Adenocarcinoma Squamous intraepithelial neoplasia, grade II: text: Squamous intraepithelial neoplasia, grade II Marginal zone lymphoma, NOS: text: Marginal zone lymphoma, NOS description: Marginal Zone Lymphoma Not Otherwise Specified Mixed meningioma: text: Mixed meningioma Carcinoid tumor of uncertain malignant potential: text: Carcinoid tumor of uncertain malignant potential Myxopapillary ependymoma: text: Myxopapillary ependymoma Acral lentiginous melanoma, malignant: text: Acral lentiginous melanoma, malignant Choriocarcinoma combined with teratorna: text: Choriocarcinoma combined with teratorna PTLD, NOS: text: PTLD, NOS Intraductal papillary adenocarcinoma, NOS: text: Intraductal papillary adenocarcinoma, NOS Fibrous meningioma: text: Fibrous meningioma Aorticopulmonary paraganglioma: text: Aorticopulmonary paraganglioma Dermal nevus: text: Dermal nevus Acinic cell tumor: text: Acinic cell tumor Embryonal tumor with multilayered rosettes, NOS: text: Embryonal tumor with multilayered rosettes, NOS Mediterranean lymphoma: text: Mediterranean lymphoma Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation: text: Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation Acute myeloid leukemia with abnormal marrow eosinophils (includes all variants): text: Acute myeloid leukemia with abnormal marrow eosinophils (includes all variants) Somatostatinoma, malignant: text: Somatostatinoma, malignant Alveolar adenocarcinoma: text: Alveolar adenocarcinoma Syringomatous carcinoma: text: Syringomatous carcinoma Synovial sarcoma, biphasic: text: Synovial sarcoma, biphasic Basal cell adenoma: text: Basal cell adenoma Renal cell carcinoma, unclassified: text: Renal cell carcinoma, unclassified description: Unclassified Renal Cell Carcinoma Nephrogenic adenofibroma: text: Nephrogenic adenofibroma Undifferentiated leukaemia: text: Undifferentiated leukaemia Syringadenoma, NOS: text: Syringadenoma, NOS Aggressive systemic mastocytosis: text: Aggressive systemic mastocytosis Cavernous hemangioma: text: Cavernous hemangioma Syringofibroadenoma: text: Syringofibroadenoma Mucosal lentiginous melanoma: text: Mucosal lentiginous melanoma Malignant lymphoma, small cell, noncleaved, diffuse: text: Malignant lymphoma, small cell, noncleaved, diffuse Neurofibrosarcoma: text: Neurofibrosarcoma Clear cell cystadenofibroma: text: Clear cell cystadenofibroma Pancreatic microadenoma: text: Pancreatic microadenoma Franklin disease: text: Franklin disease DCIS, papillary: text: DCIS, papillary Atypical follicular adenoma: text: Atypical follicular adenoma Preleukemia: text: Preleukemia Low grade adenosquamous carcinoma: text: Low grade adenosquamous carcinoma C cell carcinoma: text: C cell carcinoma Chronic eosinophilic leukemia, NOS: text: Chronic eosinophilic leukemia, NOS Hydatidiform mole, NOS: text: Hydatidiform mole, NOS Chronic neutrophilic leukemia: text: Chronic neutrophilic leukemia Acute lymphoblastic leukemia, NOS: text: Acute lymphoblastic leukemia, NOS Angioblastoma: text: Angioblastoma Lobular and ductal carcinoma: text: Lobular and ductal carcinoma Traditional sessile serrated adenoma: text: Traditional sessile serrated adenoma Choriocarcinoma combined with other germ cell elements: text: Choriocarcinoma combined with other germ cell elements Benign fibrous histiocytoma: text: Benign fibrous histiocytoma Hepatocellular carcinoma, clear cell type: text: Hepatocellular carcinoma, clear cell type Pre-pre-B ALL: text: Pre-pre-B ALL Carcinoma, intestinal type: text: Carcinoma, intestinal type Bronchio-alveolar carcinoma, mixed mucinous and non-mucinous: text: Bronchio-alveolar carcinoma, mixed mucinous and non-mucinous Hurthle cell adenoma: text: Hurthle cell adenoma RAEB I: text: RAEB I Parachordoma: text: Parachordoma Ameloblastoma, NOS: text: Ameloblastoma, NOS Invasive encapsulated follicular variant of papillary thyroid carcinoma (invasive EFVPTC): text: Invasive encapsulated follicular variant of papillary thyroid carcinoma (invasive EFVPTC) Eccrine cystadenoma: text: Eccrine cystadenoma Extraosseous plasmacytoma: text: Extraosseous plasmacytoma Granulocytic sarcoma: text: Granulocytic sarcoma Mixed cell adenocarcinoma: text: Mixed cell adenocarcinoma Fibromyxosarcoma: text: Fibromyxosarcoma Insulinoma, NOS: text: Insulinoma, NOS Adenocarcinoma with cartilaginous and osseous metaplasia: text: Adenocarcinoma with cartilaginous and osseous metaplasia Intraepithelial carcinoma, NOS: text: Intraepithelial carcinoma, NOS Hemolymphangioma: text: Hemolymphangioma Prolymphocytic leukemia, T-cell type: text: Prolymphocytic leukemia, T-cell type Cholangiocarcinoma: text: Cholangiocarcinoma description: Cholangiocarcinoma Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation: text: Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation Thymoma, organoid, malignant: text: Thymoma, organoid, malignant Sweat gland tumor, NOS: text: Sweat gland tumor, NOS Papillary pseudomucinous cystadenocarcinoma: text: Papillary pseudomucinous cystadenocarcinoma Microglioma: text: Microglioma Adenoid basal carcinoma: text: Adenoid basal carcinoma Teratoma, differentiated: text: Teratoma, differentiated Paraganglioma, NOS: text: Paraganglioma, NOS Squamous cell carcinoma, nonkeratinizing, NOS: text: Squamous cell carcinoma, nonkeratinizing, NOS Periosteal sarcoma, NOS: text: Periosteal sarcoma, NOS Hodgkin lymphoma, nodular lymphocyte predominance: text: Hodgkin lymphoma, nodular lymphocyte predominance Serous cystadenoma, borderline malignancy: text: Serous cystadenoma, borderline malignancy Glucagonoma, NOS: text: Glucagonoma, NOS Soft tissue perineurioma: text: Soft tissue perineurioma Mesenchymal chondrosarcoma: text: Mesenchymal chondrosarcoma Hodgkin disease, lymphocyte predominance, NOS: text: Hodgkin disease, lymphocyte predominance, NOS Olfactory neurogenic tumor: text: Olfactory neurogenic tumor Ganglioneuroblastoma: text: Ganglioneuroblastoma Villous adenocarcinoma: text: Villous adenocarcinoma Bronchiolo-alveolar carcinoma, non-mucinous: text: Bronchiolo-alveolar carcinoma, non-mucinous Atypical fibroxanthoma: text: Atypical fibroxanthoma Multiple myeloma: text: Multiple myeloma Biliary intraepithelial neoplasia, low grade: text: Biliary intraepithelial neoplasia, low grade Odontogenic carcinoma: text: Odontogenic carcinoma Amelanotic melanoma: text: Amelanotic melanoma Sclerosing epithelioid fibrosarcoma: text: Sclerosing epithelioid fibrosarcoma Myelodysplastic syndrome with isolated del (5q): text: Myelodysplastic syndrome with isolated del (5q) Monoclonal gammopathy of undetermined significance: text: Monoclonal gammopathy of undetermined significance Subacute granulocytic leukemia: text: Subacute granulocytic leukemia Myosarcoma: text: Myosarcoma Cerebellar liponeurocytoma: text: Cerebellar liponeurocytoma Testicular stromal tumor: text: Testicular stromal tumor Mesothelioma, NOS: text: Mesothelioma, NOS Pleomorphic cell sarcoma: text: Pleomorphic cell sarcoma Oxyphilic adenocarcinoma: text: Oxyphilic adenocarcinoma Malignant lymphoma, small B lymphocytic, NOS: text: Malignant lymphoma, small B lymphocytic, NOS Lymphangiomyomatosis: text: Lymphangiomyomatosis Histiocyte-rich large B-cell lymphoma: text: Histiocyte-rich large B-cell lymphoma Nonpigmented nevus: text: Nonpigmented nevus Pulmonary blastoma: text: Pulmonary blastoma Granular cell adenocarcinoma: text: Granular cell adenocarcinoma Pseudosarcomatous carcinoma: text: Pseudosarcomatous carcinoma Neuronevus: text: Neuronevus Lymphoid leukemia, NOS: text: Lymphoid leukemia, NOS Insulinoma, malignant: text: Insulinoma, malignant Granulosa cell tumor, adult type: text: Granulosa cell tumor, adult type description: Adult Type Ovarian Granulosa Cell Tumor Subependymal giant cell astrocytoma: text: Subependymal giant cell astrocytoma Meningioma, NOS: text: Meningioma, NOS Achromic nevus: text: Achromic nevus Argentaffinoma, malignant: text: Argentaffinoma, malignant Intraductal papillary neoplasm, NOS: text: Intraductal papillary neoplasm, NOS Alveolar carcinoma: text: Alveolar carcinoma Cylindrical cell papilloma: text: Cylindrical cell papilloma Papillotubular adenocarcinoma: text: Papillotubular adenocarcinoma Orchioblastoma: text: Orchioblastoma Neoplasm, metastatic: text: Neoplasm, metastatic Melanoma, NOS: text: Melanoma, NOS description: Not Otherwise Specified Melanoma Diktyoma, malignant: text: Diktyoma, malignant Pseudomucinous cystadenoma, NOS: text: Pseudomucinous cystadenoma, NOS Splenic marginal zone B-cell lymphoma: text: Splenic marginal zone B-cell lymphoma T-gamma lymphoproliferative disease: text: T-gamma lymphoproliferative disease Hepatoid carcinoma: text: Hepatoid carcinoma Neoplasm, secondary: text: Neoplasm, secondary Low-grade fibromyxoid sarcoma: text: Low-grade fibromyxoid sarcoma Telangiectatic osteosarcoma: text: Telangiectatic osteosarcoma Aortic body paraganglioma: text: Aortic body paraganglioma Malignant lymphoma, follicular, NOS: text: Malignant lymphoma, follicular, NOS Intravascular large B-cell lymphoma: text: Intravascular large B-cell lymphoma FAB L2: text: FAB L2 Comedocarcinoma, NOS: text: Comedocarcinoma, NOS Ceruminous adenoma: text: Ceruminous adenoma Clear cell hidradenoma: text: Clear cell hidradenoma Papillary carcinoma, diffuse sclerosing: text: Papillary carcinoma, diffuse sclerosing Osteofibroma: text: Osteofibroma Pseudomucinous adenocarcinoma: text: Pseudomucinous adenocarcinoma Mixed adenoneuroendocrine carcinoma: text: Mixed adenoneuroendocrine carcinoma description: Digestive System Mixed Adenoneuroendocrine Carcinoma Islet cell adenocarcinoma: text: Islet cell adenocarcinoma Plasmacytic leukemia: text: Plasmacytic leukemia Melanotic psammomatous MPNST: text: Melanotic psammomatous MPNST Neurilemoma, NOS: text: Neurilemoma, NOS Islet cell tumor, benign: text: Islet cell tumor, benign Jugulotympanic paraganglioma: text: Jugulotympanic paraganglioma Clear cell carcinoma: text: Clear cell carcinoma Pneumoblastoma: text: Pneumoblastoma Fibroliposarcoma: text: Fibroliposarcoma Bronchial adenoma, cylindroid: text: Bronchial adenoma, cylindroid Erythremic myelosis, NOS: text: Erythremic myelosis, NOS Papillomatosis, glandular: text: Papillomatosis, glandular Mixed islet cell and exocrine adenocarcinoma: text: Mixed islet cell and exocrine adenocarcinoma Hodgkin disease, lymphocyte predominance, diffuse: text: Hodgkin disease, lymphocyte predominance, diffuse Steroid cell tumor, NOS: text: Steroid cell tumor, NOS Acute leukemia, NOS: text: Acute leukemia, NOS Intracystic papillary neoplasm with associated invasive carcinoma: text: Intracystic papillary neoplasm with associated invasive carcinoma Cylindroma, NOS: text: Cylindroma, NOS Tumor, malignant, NOS: text: Tumor, malignant, NOS Non-Hodgkin lymphoma, NOS: text: Non-Hodgkin lymphoma, NOS Angiomatoid fibrous histiocytoma: text: Angiomatoid fibrous histiocytoma Squamous papillomatosis: text: Squamous papillomatosis GIST, benign: text: GIST, benign Adenocarcinoma in villous adenoma: text: Adenocarcinoma in villous adenoma Large cell neuroendocrine carcinoma: text: Large cell neuroendocrine carcinoma Acute myeloid leukemia with myelodysplasia-related changes: text: Acute myeloid leukemia with myelodysplasia-related changes Paget disease and infiltrating duct carcinoma of breast: text: Paget disease and infiltrating duct carcinoma of breast Aggressive angiomyxoma: text: Aggressive angiomyxoma Hemangiopericytoma, benign: text: Hemangiopericytoma, benign Mixed subependymoma-ependymoma: text: Mixed subependymoma-ependymoma Angioendotheliomatosis: text: Angioendotheliomatosis Follicular carcinoma, moderately differentiated: text: Follicular carcinoma, moderately differentiated B lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL): text: B lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL) Malignant lymphoma, histiocytic, diffuse: text: Malignant lymphoma, histiocytic, diffuse Fetal rhabdomyoma: text: Fetal rhabdomyoma Malignant lymphoma, centroblastic, NOS: text: Malignant lymphoma, centroblastic, NOS Osteoblastoma, NOS: text: Osteoblastoma, NOS Burkitt-like lymphoma: text: Burkitt-like lymphoma Tubulovillous adenoma, NOS: text: Tubulovillous adenoma, NOS Spiradenoma, NOS: text: Spiradenoma, NOS Malignant schwannoma with rhabdomyoblastic differentiation: text: Malignant schwannoma with rhabdomyoblastic differentiation Intraductal papillary-mucinous carcinoma, non-invasive: text: Intraductal papillary-mucinous carcinoma, non-invasive Alveolar cell carcinoma: text: Alveolar cell carcinoma Liposarcoma, NOS: text: Liposarcoma, NOS Adult T-cell leukemia: text: Adult T-cell leukemia Papillary urothelial neoplasm of low malignant potential: text: Papillary urothelial neoplasm of low malignant potential Pineal parenchymal tumor of intermediate differentiation: text: Pineal parenchymal tumor of intermediate differentiation Infiltrating duct and colloid carcinoma: text: Infiltrating duct and colloid carcinoma Multicystic mesothelioma, benign: text: Multicystic mesothelioma, benign Transitional cell papilloma, NOS: text: Transitional cell papilloma, NOS Adrenal cortical adenoma, NOS: text: Adrenal cortical adenoma, NOS Oncocytic adenocarcinoma: text: Oncocytic adenocarcinoma Medullocytoma: text: Medullocytoma Bronchiolo-alveolar carcinoma, Clara cell and goblet cell type: text: Bronchiolo-alveolar carcinoma, Clara cell and goblet cell type Mucinous cystadenocarcinoma, NOS: text: Mucinous cystadenocarcinoma, NOS Chromophobe adenoma: text: Chromophobe adenoma Hodgkin lymphoma, NOS: text: Hodgkin lymphoma, NOS Mixed tumor, salivary gland type, NOS: text: Mixed tumor, salivary gland type, NOS Mesodermal mixed tumor: text: Mesodermal mixed tumor Hepatocarcinoma: text: Hepatocarcinoma Cellular fibroma: text: Cellular fibroma Thymoma, atypical, malignant: text: Thymoma, atypical, malignant Angiomyoma: text: Angiomyoma Codman tumor: text: Codman tumor Adenocarcinoma in situ in polypoid adenoma: text: Adenocarcinoma in situ in polypoid adenoma Indolent systemic mastocytosis: text: Indolent systemic mastocytosis Struma ovarii and carcinoid: text: Struma ovarii and carcinoid Paget disease, mammary: text: Paget disease, mammary Myxoinflammatory fibroblastic sarcoma (MIFS): text: Myxoinflammatory fibroblastic sarcoma (MIFS) Gelatinous adenocarcinoma: text: Gelatinous adenocarcinoma Fibrolipoma: text: Fibrolipoma Refractory anemia without sideroblasts: text: Refractory anemia without sideroblasts Plasma cell leukemia: text: Plasma cell leukemia Epidermoid carcinoma, small cell, nonkeratinizing: text: Epidermoid carcinoma, small cell, nonkeratinizing Acute myeloid leukemia, t(15:17)(g22;q11-12): text: Acute myeloid leukemia, t(15:17)(g22;q11-12) Giant cell fibroblastoma: text: Giant cell fibroblastoma Seromucinous carcinoma: text: Seromucinous carcinoma description: Ovarian Seromucinous Carcinoma Carcinoma with apocrine metaplasia: text: Carcinoma with apocrine metaplasia Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos): text: Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) Epithelioid hemangioma: text: Epithelioid hemangioma Atypical choroid plexus papilloma: text: Atypical choroid plexus papilloma Pigmented basal cell carcinoma: text: Pigmented basal cell carcinoma Follicular adenocarcinoma, trabecular: text: Follicular adenocarcinoma, trabecular Follicular lymphoma, NOS: text: Follicular lymphoma, NOS Peripheral T-cell lymphoma, AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia): text: Peripheral T-cell lymphoma, AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia) Renal cell carcinoma, sarcomatoid: text: Renal cell carcinoma, sarcomatoid Juvenile carcinoma of breast: text: Juvenile carcinoma of breast Infiltrating duct carcinoma, NOS: text: Infiltrating duct carcinoma, NOS Acinar adenocarcinoma: text: Acinar adenocarcinoma Basal cell carcinoma, NOS: text: Basal cell carcinoma, NOS Thymoma, type B3, NOS: text: Thymoma, type B3, NOS Pinealoma: text: Pinealoma Central neurocytoma: text: Central neurocytoma Cervical intraepithelial neoplasia, grade III: text: Cervical intraepithelial neoplasia, grade III Pleomorphic carcinoma: text: Pleomorphic carcinoma Acute myelofibrosis: text: Acute myelofibrosis Hodgkin lymphoma, nodular sclerosis, grade 1: text: Hodgkin lymphoma, nodular sclerosis, grade 1 Nested urothelial carcinoma: text: Nested urothelial carcinoma Transient abnormal myelopoiesis: text: Transient abnormal myelopoiesis Synovioma, NOS: text: Synovioma, NOS Lymphoproliferative disease, NOS: text: Lymphoproliferative disease, NOS Chronic myelomonocytic leukemia, Type II: text: Chronic myelomonocytic leukemia, Type II Atypical proliferative papillary serous tumor: text: Atypical proliferative papillary serous tumor Squamous cell carcinoma in situ with questionable stromal invasion: text: Squamous cell carcinoma in situ with questionable stromal invasion Mucinous adenoma: text: Mucinous adenoma Ceruminous adenocarcinoma: text: Ceruminous adenocarcinoma Thymoma, cortical, NOS: text: Thymoma, cortical, NOS Acute promyelocytic leukemia, NOS: text: Acute promyelocytic leukemia, NOS Malignant tumor, giant cell type: text: Malignant tumor, giant cell type Malignant lymphoma, non-cleaved cell, NOS: text: Malignant lymphoma, non-cleaved cell, NOS Astrocytoma, NOS: text: Astrocytoma, NOS Dermatofibrosarcoma, NOS: text: Dermatofibrosarcoma, NOS Malignant hydatidiform mole: text: Malignant hydatidiform mole Aleukemic granulocytic leukemia: text: Aleukemic granulocytic leukemia Clear cell odontogenic tumor: text: Clear cell odontogenic tumor Mullerian adenosarcoma: text: Mullerian adenosarcoma Intraductal papillary-mucinous tumor with low grade dysplasia: text: Intraductal papillary-mucinous tumor with low grade dysplasia Colloid carcinoma: text: Colloid carcinoma Thymoma, mixed type, malignant: text: Thymoma, mixed type, malignant Nonencapsulated sclerosing carcinoma: text: Nonencapsulated sclerosing carcinoma Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements: text: Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements Round cell sarcoma: text: Round cell sarcoma Carcinoid, NOS, of appendix: text: Carcinoid, NOS, of appendix Hodgkin disease, nodular sclerosis, lymphocyte predominance: text: Hodgkin disease, nodular sclerosis, lymphocyte predominance Intraductal papillary carcinoma: text: Intraductal papillary carcinoma Papillary adenocarcinoma, follicular variant: text: Papillary adenocarcinoma, follicular variant Mixed acidophil-basophil carcinoma: text: Mixed acidophil-basophil carcinoma Carcinoma in situ in a polyp, NOS: text: Carcinoma in situ in a polyp, NOS Sinonasal papilloma, exophytic: text: Sinonasal papilloma, exophytic Nonchromaffin paraganglioma, malignant: text: Nonchromaffin paraganglioma, malignant Beta cell tumor, malignant: text: Beta cell tumor, malignant Microcystic meningioma: text: Microcystic meningioma Plasmacytoma of bone: text: Plasmacytoma of bone Malignant mast cell tumor: text: Malignant mast cell tumor Ameloblastic fibrosarcoma: text: Ameloblastic fibrosarcoma Tumor, metastatic: text: Tumor, metastatic Endometrioid adenocarcinoma, villoglandular: text: Endometrioid adenocarcinoma, villoglandular Giant cell and spindle cell carcinoma: text: Giant cell and spindle cell carcinoma Mesonephroma, benign: text: Mesonephroma, benign Refractory anemia with excess blasts: text: Refractory anemia with excess blasts Thymoma, type A, malignant: text: Thymoma, type A, malignant Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1: text: Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 Bile duct adenocarcinoma: text: Bile duct adenocarcinoma Mixed tumor, NOS: text: Mixed tumor, NOS Myeloma, NOS: text: Myeloma, NOS Papillary hidradenoma: text: Papillary hidradenoma Malignant lymphoma, histiocytic, NOS: text: Malignant lymphoma, histiocytic, NOS Epithelial-myoepithelial carcinoma: text: Epithelial-myoepithelial carcinoma description: Epithelial-Myoepithelial Carcinoma Queyrat erythroplasia: text: Queyrat erythroplasia Pancreatobiliary neoplasm, non-invasive: text: Pancreatobiliary neoplasm, non-invasive Acute lymphoblastic leukemia, L2 type, NOS: text: Acute lymphoblastic leukemia, L2 type, NOS Hodgkin lymphoma, lymphocyte predominance, nodular: text: Hodgkin lymphoma, lymphocyte predominance, nodular Malignant fibrous histiocytoma: text: Malignant fibrous histiocytoma Undifferentiated round cell sarcoma: text: Undifferentiated round cell sarcoma Malignant lymphoma, mixed lymphocytic-histiocytic, nodular: text: Malignant lymphoma, mixed lymphocytic-histiocytic, nodular Botryoid sarcoma: text: Botryoid sarcoma Letterer-Siwe disease: text: Letterer-Siwe disease Lymphoproliferative disorder, NOS: text: Lymphoproliferative disorder, NOS Seminoma, anaplastic: text: Seminoma, anaplastic Encapsulated papillary carcinoma: text: Encapsulated papillary carcinoma Transitional cell papilloma, benign: text: Transitional cell papilloma, benign Urothelial carcinoma, NOS: text: Urothelial carcinoma, NOS Metanephric adenoma: text: Metanephric adenoma Congenital generalized fibromatosis: text: Congenital generalized fibromatosis Primary cutaneous follicle centre lymphoma: text: Primary cutaneous follicle centre lymphoma Trabecular adenoma: text: Trabecular adenoma Chronic lymphoproliferative disorder of NK cells: text: Chronic lymphoproliferative disorder of NK cells Soft tissue tumor, benign: text: Soft tissue tumor, benign Melanocytoma, eyeball: text: Melanocytoma, eyeball Ductal carcinoma, cribriform type: text: Ductal carcinoma, cribriform type Dabska tumor: text: Dabska tumor FAB M4: text: FAB M4 Classical Hodgkin lymphoma, nodular sclerosis, NOS: text: Classical Hodgkin lymphoma, nodular sclerosis, NOS Myelomonocytic leukemia, NOS: text: Myelomonocytic leukemia, NOS Dendritic cell sarcoma, NOS: text: Dendritic cell sarcoma, NOS Carcinoma in a polyp, NOS: text: Carcinoma in a polyp, NOS Lymphangioendothelioma, NOS: text: Lymphangioendothelioma, NOS Parietal cell adenocarcinoma: text: Parietal cell adenocarcinoma Intraductal adenocarcinoma, noninfiltrating, NOS: text: Intraductal adenocarcinoma, noninfiltrating, NOS Malignant melanoma in Hutchinson melanotic freckle: text: Malignant melanoma in Hutchinson melanotic freckle Dermoid cyst with secondary tumor: text: Dermoid cyst with secondary tumor Peripheral T-cell lymphoma, NOS: text: Peripheral T-cell lymphoma, NOS T-cell rich/histiocyte-rich large B-cell lymphoma: text: T-cell rich/histiocyte-rich large B-cell lymphoma Nonchromaffin paraganglioma, NOS: text: Nonchromaffin paraganglioma, NOS Chondromyxoid fibroma: text: Chondromyxoid fibroma Diffuse astrocytoma: text: Diffuse astrocytoma Adenocarcinoma in situ in a polyp, NOS: text: Adenocarcinoma in situ in a polyp, NOS Stromal myosis, NOS: text: Stromal myosis, NOS Thymoma, type AB, malignant: text: Thymoma, type AB, malignant Pulmonary artery intimal sarcoma: text: Pulmonary artery intimal sarcoma Diffuse melanocytosis: text: Diffuse melanocytosis Serous papillary cystic tumor of borderline malignancy: text: Serous papillary cystic tumor of borderline malignancy Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis: text: Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis Bowen disease: text: Bowen disease Cystic mesothelioma, benign: text: Cystic mesothelioma, benign Chromophobe carcinoma: text: Chromophobe carcinoma Therapy-related acute myeloid leukemia, NOS: text: Therapy-related acute myeloid leukemia, NOS Wolffian duct carcinoma: text: Wolffian duct carcinoma PPNET: text: PPNET Anal intraepithelial neoplasia, grade III: text: Anal intraepithelial neoplasia, grade III Langerhans cell granulomatosis: text: Langerhans cell granulomatosis Epidermoid carcinoma, large cell, nonkeratinizing: text: Epidermoid carcinoma, large cell, nonkeratinizing Craniopharyngioma: text: Craniopharyngioma Paget disease, extramammary: text: Paget disease, extramammary Nephroblastoma, NOS: text: Nephroblastoma, NOS Thymic carcinoma with adenoid cystic carcinoma-like features: text: Thymic carcinoma with adenoid cystic carcinoma-like features Fibroblastic meningioma: text: Fibroblastic meningioma Tumorlet, NOS: text: Tumorlet, NOS Carcinoma with productive fibrosis: text: Carcinoma with productive fibrosis Chorioangioma: text: Chorioangioma Thymoma, medullary, NOS: text: Thymoma, medullary, NOS Intraductal carcinoma, NOS: text: Intraductal carcinoma, NOS FAB M2, NOS: text: FAB M2, NOS Duct carcinoma, NOS: text: Duct carcinoma, NOS Acute myeloid leukemia, t(16;16)(p 13;q 11): text: Acute myeloid leukemia, t(16;16)(p 13;q 11) Gonadoblastoma: text: Gonadoblastoma Dermatofibroma lenticulare: text: Dermatofibroma lenticulare Adrenal cortical adenoma, compact cell: text: Adrenal cortical adenoma, compact cell Primary cutaneous DLBCL, leg type: text: Primary cutaneous DLBCL, leg type Intraneural perineurioma: text: Intraneural perineurioma Malignant lymphoma, large cell, noncleaved, NOS: text: Malignant lymphoma, large cell, noncleaved, NOS Subacute monocytic leukemia: text: Subacute monocytic leukemia Eccrine acrospiroma: text: Eccrine acrospiroma Leydig cell tumor, malignant: text: Leydig cell tumor, malignant Astrocytic glioma: text: Astrocytic glioma Atypical leiomyoma: text: Atypical leiomyoma Warthin tumor: text: Warthin tumor Osteochondroma: text: Osteochondroma Meningothelial sarcoma: text: Meningothelial sarcoma Acute myelosclerosis, NOS: text: Acute myelosclerosis, NOS Fetal lipoma, NOS: text: Fetal lipoma, NOS Mucinous cystic tumor of borderline malignancy: text: Mucinous cystic tumor of borderline malignancy Adenomatosis, NOS: text: Adenomatosis, NOS Chronic myelogenous leukemia, Philadelphia chromosome (Ph 1) positive: text: Chronic myelogenous leukemia, Philadelphia chromosome (Ph 1) positive Langerhans cell histiocytosis, NOS: text: Langerhans cell histiocytosis, NOS Wolffian duct adenoma: text: Wolffian duct adenoma Thymoma, NOS: text: Thymoma, NOS Mucoid cell adenoma: text: Mucoid cell adenoma FAB M4Eo: text: FAB M4Eo Squamous cell carcinoma, large cell, keratinizing: text: Squamous cell carcinoma, large cell, keratinizing Papillomatosis, NOS: text: Papillomatosis, NOS Epithelioma, benign: text: Epithelioma, benign Trabecular adenocarcinoma: text: Trabecular adenocarcinoma Schneiderian papilloma, NOS: text: Schneiderian papilloma, NOS Ameloblastic fibroma: text: Ameloblastic fibroma Adenocarcinoma in situ, NOS: text: Adenocarcinoma in situ, NOS Leydig cell tumor, benign: text: Leydig cell tumor, benign Refractory anemia: text: Refractory anemia Brenner tumor, NOS: text: Brenner tumor, NOS Lymphoblastic leukemia, NOS: text: Lymphoblastic leukemia, NOS Spongioblastoma, NOS: text: Spongioblastoma, NOS Eosinophilic granuloma: text: Eosinophilic granuloma Spindle cell oncocytoma: text: Spindle cell oncocytoma Periosteal fibroma: text: Periosteal fibroma Rhabdoid sarcoma: text: Rhabdoid sarcoma Large cell medulloblastoma: text: Large cell medulloblastoma Aleukemic lymphoid leukemia: text: Aleukemic lymphoid leukemia Cyst-associated renal cell carcinoma: text: Cyst-associated renal cell carcinoma Malignant lymphomatous polyposis: text: Malignant lymphomatous polyposis Pilomatricoma, malignant: text: Pilomatricoma, malignant Medulloblastoma, SHH-activated and TP53-wildtype: text: Medulloblastoma, SHH-activated and TP53-wildtype Intracystic papillary tumor with high grade entraepithelial neoplasia: text: Intracystic papillary tumor with high grade entraepithelial neoplasia Hypernephroma: text: Hypernephroma Chronic lymphocytic leukemia: text: Chronic lymphocytic leukemia Fibrous astrocytoma: text: Fibrous astrocytoma Follicular dendritic cell sarcoma: text: Follicular dendritic cell sarcoma Carcinoma, anaplastic, NOS: text: Carcinoma, anaplastic, NOS Magnocellular nevus: text: Magnocellular nevus Non-lymphocytic leukemia, NOS: text: Non-lymphocytic leukemia, NOS Malignant lymphoma, large cell, cleaved, NOS: text: Malignant lymphoma, large cell, cleaved, NOS Flat intraepithelial neoplasia, high grade: text: Flat intraepithelial neoplasia, high grade Thymoma, type AB, NOS: text: Thymoma, type AB, NOS Thymoma, lymphocytic, NOS: text: Thymoma, lymphocytic, NOS Neurogenic sarcoma: text: Neurogenic sarcoma Aleukemic monocytic leukemia: text: Aleukemic monocytic leukemia GIST, malignant: text: GIST, malignant Carcinofibroma: text: Carcinofibroma Low-grade serous carcinoma: text: Low-grade serous carcinoma Polypoid adenoma: text: Polypoid adenoma Regressing nevus: text: Regressing nevus Sebaceous carcinoma: text: Sebaceous carcinoma Melanoma in situ: text: Melanoma in situ Melanotic neurofibroma: text: Melanotic neurofibroma Tubular androblastoma with lipid storage: text: Tubular androblastoma with lipid storage Squamous cell carcinoma, spindle cell: text: Squamous cell carcinoma, spindle cell Sarcomatosis, NOS: text: Sarcomatosis, NOS Adamantinoma, NOS: text: Adamantinoma, NOS Compound nevus: text: Compound nevus Clear cell adenofibroma: text: Clear cell adenofibroma Round cell liposarcoma: text: Round cell liposarcoma Sertoli cell tumor with lipid storage: text: Sertoli cell tumor with lipid storage Nodular hidradenoma: text: Nodular hidradenoma Carcinoma with neuroendocrine differentiation: text: Carcinoma with neuroendocrine differentiation Malignant tumor, small cell type: text: Malignant tumor, small cell type Pleomorphic lobular carcinoma in situ: text: Pleomorphic lobular carcinoma in situ Villoglandular carcinoma: text: Villoglandular carcinoma Acinic cell adenocarcinoma: text: Acinic cell adenocarcinoma Verrucous keratotic hemangioma: text: Verrucous keratotic hemangioma Spindle cell melanoma, NOS: text: Spindle cell melanoma, NOS Angioma, NOS: text: Angioma, NOS Unclassified tumor, malignant: text: Unclassified tumor, malignant Phyllodes tumor, malignant: text: Phyllodes tumor, malignant Gastrin cell tumor, malignant: text: Gastrin cell tumor, malignant Masculinovoblastoma: text: Masculinovoblastoma Intraductal papillary-mucinous tumor with intermediate dysplasia: text: Intraductal papillary-mucinous tumor with intermediate dysplasia Solid carcinoma, NOS: text: Solid carcinoma, NOS Squamous carcinoma: text: Squamous carcinoma Systemic mastocytosis with AHNMD: text: Systemic mastocytosis with AHNMD Synovioma, malignant: text: Synovioma, malignant Rhabdomyoma, NOS: text: Rhabdomyoma, NOS Epithelioid cell nevus: text: Epithelioid cell nevus Embryonal rhabdomyosarcoma, pleomorphic: text: Embryonal rhabdomyosarcoma, pleomorphic Mixed phenotype acute leukemia, T/myeloid, NOS: text: Mixed phenotype acute leukemia, T/myeloid, NOS Sweat gland tumor, malignant: text: Sweat gland tumor, malignant Parietal cell carcinoma: text: Parietal cell carcinoma Lymphangioendothelial sarcoma: text: Lymphangioendothelial sarcoma Inflammatory liposarcoma: text: Inflammatory liposarcoma Myofibroblastic tumor, NOS: text: Myofibroblastic tumor, NOS Endometrioid cystadenofibroma, malignant: text: Endometrioid cystadenofibroma, malignant Hemangioblastic meningioma: text: Hemangioblastic meningioma Adenomatous polyposis coli: text: Adenomatous polyposis coli Adenocarcinoma with squamous metaplasia: text: Adenocarcinoma with squamous metaplasia Renal cell carcinoma, NOS: text: Renal cell carcinoma, NOS Malignant lymphoma, undifferentiated cell type, NOS: text: Malignant lymphoma, undifferentiated cell type, NOS Lymphangiomyoma: text: Lymphangiomyoma Malignant lymphoma, cleaved cell, NOS: text: Malignant lymphoma, cleaved cell, NOS Papillary serous cystadenocarcinoma: text: Papillary serous cystadenocarcinoma FAB M7: text: FAB M7 Adenocarcinoma with mixed subtypes: text: Adenocarcinoma with mixed subtypes Myeloid and lymphoid neoplasms with FGFR1 abnormalities: text: Myeloid and lymphoid neoplasms with FGFR1 abnormalities Malignant lymphoma, noncleaved, NOS: text: Malignant lymphoma, noncleaved, NOS Subacute leukemia, NOS: text: Subacute leukemia, NOS Angiomatous meningioma: text: Angiomatous meningioma Preleukemic syndrome: text: Preleukemic syndrome Gonocytoma: text: Gonocytoma Giant cell angiofibroma: text: Giant cell angiofibroma Dysembryoplastic neuroepithelial tumor: text: Dysembryoplastic neuroepithelial tumor Interdigitating dendritic cell sarcoma: text: Interdigitating dendritic cell sarcoma Mucous adenocarcinoma: text: Mucous adenocarcinoma Melanotic MPNST: text: Melanotic MPNST Biliary intraepithelial neoplasia, grade 3: text: Biliary intraepithelial neoplasia, grade 3 Angioimmunoblastic T-cell lymphoma: text: Angioimmunoblastic T-cell lymphoma Lymphoma, NOS: text: Lymphoma, NOS Juvenile astrocytoma: text: Juvenile astrocytoma Atypical meningioma: text: Atypical meningioma Acute myeloid leukemia without maturation: text: Acute myeloid leukemia without maturation Urachal carcinoma: text: Urachal carcinoma Chronic myelogenous leukemia, t(9;22)(q34;q11): text: Chronic myelogenous leukemia, t(9;22)(q34;q11) Metaplastic meningioma: text: Metaplastic meningioma Papillocystic adenocarcinoma: text: Papillocystic adenocarcinoma Oligodendroglioma, IDH-mutant and 1p/19q-codeleted: text: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Malignant lymphoma, small cleaved cell, diffuse: text: Malignant lymphoma, small cleaved cell, diffuse Secondary carcinoma: text: Secondary carcinoma Papillary syringocystadenoma: text: Papillary syringocystadenoma Myeloproliferative disease, NOS: text: Myeloproliferative disease, NOS Malignant perivascular epithelial cell tumor: text: Malignant perivascular epithelial cell tumor Brenner tumor, borderline malignancy: text: Brenner tumor, borderline malignancy Synovial sarcoma, monophasic fibrous: text: Synovial sarcoma, monophasic fibrous Lactating adenoma: text: Lactating adenoma Papillary carcinoma, columnar cell: text: Papillary carcinoma, columnar cell Atypical chronic myeloid leukemia, Philadelphia chromosome (Ph1) negative: text: Atypical chronic myeloid leukemia, Philadelphia chromosome (Ph1) negative Small cell neuroendocrine carcinoma: text: Small cell neuroendocrine carcinoma description: Colorectal Small Cell Neuroendocrine Carcinoma FAB L3: text: FAB L3 Turban tumor: text: Turban tumor Chronic granulocytic leukemia, Philadelphia chromosome (Ph1) positive: text: Chronic granulocytic leukemia, Philadelphia chromosome (Ph1) positive Odontogenic fibroma, NOS: text: Odontogenic fibroma, NOS Tubular adenoma, NOS: text: Tubular adenoma, NOS Infiltrating lobular mixed with other types of carcinoma: text: Infiltrating lobular mixed with other types of carcinoma Noninfiltrating intraductal papillary carcinoma: text: Noninfiltrating intraductal papillary carcinoma Subepidermal nodular fibrosis: text: Subepidermal nodular fibrosis Thymoma, atypical, NOS: text: Thymoma, atypical, NOS DCIS, comedo type: text: DCIS, comedo type Serous adenofibroma, NOS: text: Serous adenofibroma, NOS FAB MO: text: FAB MO Papillary mucinous tumor of low malignant potential: text: Papillary mucinous tumor of low malignant potential Mesenchymoma, malignant: text: Mesenchymoma, malignant Adrenal rest tumor: text: Adrenal rest tumor Endometrioid cystadenocarcinoma: text: Endometrioid cystadenocarcinoma Sinonasal papilloma, NOS: text: Sinonasal papilloma, NOS Mucinous cystic neoplasm with low-grade dysplasia: text: Mucinous cystic neoplasm with low-grade dysplasia Follicular dendritic cell tumor: text: Follicular dendritic cell tumor B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1): text: B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) Cribriform comedo-type carcinoma: text: Cribriform comedo-type carcinoma Capillary lymphangioma: text: Capillary lymphangioma Desmoid, NOS: text: Desmoid, NOS Nodular melanoma: text: Nodular melanoma description: Nodular Melanoma Endometrioid adenocarcinoma, ciliated cell variant: text: Endometrioid adenocarcinoma, ciliated cell variant Acute monoblastic leukemia: text: Acute monoblastic leukemia Olfactory neuroepithelioma: text: Olfactory neuroepithelioma Angioimmunoblastic lymphoma: text: Angioimmunoblastic lymphoma Cervical intraepithelial neoplasia, low grade: text: Cervical intraepithelial neoplasia, low grade Mesenteric fibromatosis: text: Mesenteric fibromatosis Plexiform neuroma: text: Plexiform neuroma Reticulosarcoma, NOS: text: Reticulosarcoma, NOS Mastocytoma, NOS: text: Mastocytoma, NOS Melanoma, malignant, of soft parts: text: Melanoma, malignant, of soft parts Refractory cytopenia of childhood: text: Refractory cytopenia of childhood Malignant melanoma in precancerous melanosis: text: Malignant melanoma in precancerous melanosis Hidradenoma papilliferum: text: Hidradenoma papilliferum Infiltrating basal cell carcinoma, NOS: text: Infiltrating basal cell carcinoma, NOS Endometrioid adenocarcinoma, secretory variant: text: Endometrioid adenocarcinoma, secretory variant B cell lymphoma, NOS: text: B cell lymphoma, NOS Immature teratoma, malignant: text: Immature teratoma, malignant Tumorlet, benign: text: Tumorlet, benign Soft tissue tumor, malignant: text: Soft tissue tumor, malignant Adamantinoma, malignant: text: Adamantinoma, malignant Inflammatory carcinoma: text: Inflammatory carcinoma Precursor T-cell lymphoblastic leukemia: text: Precursor T-cell lymphoblastic leukemia Testicular adenoma: text: Testicular adenoma Basaloid squamous cell carcinoma: text: Basaloid squamous cell carcinoma description: Basaloid Squamous Cell Carcinoma Solitary fibrous tumor, malignant: text: Solitary fibrous tumor, malignant Carcinoma in situ, NOS: text: Carcinoma in situ, NOS Invasive lobular carcinoma, alveolar type: text: Invasive lobular carcinoma, alveolar type Warty carcinoma: text: Warty carcinoma Acidophil carcinoma: text: Acidophil carcinoma Low-grade myofibroblastic sarcoma: text: Low-grade myofibroblastic sarcoma Sex cord-gonadal stromal tumor, incompletely differentiated: text: Sex cord-gonadal stromal tumor, incompletely differentiated Fibro-osteoma: text: Fibro-osteoma Dermatofibrosarcoma protuberans, NOS: text: Dermatofibrosarcoma protuberans, NOS Ameloblastic odontosarcoma: text: Ameloblastic odontosarcoma Androblastoma, malignant: text: Androblastoma, malignant Acute myeloid leukemia with multilineage dysplasia: text: Acute myeloid leukemia with multilineage dysplasia Acute myelomonocytic leukemia with abnormal eosinophils: text: Acute myelomonocytic leukemia with abnormal eosinophils Intraductal carcinoma, clinging: text: Intraductal carcinoma, clinging Malignant lymphoma, lymphocytic, well differentiated, nodular: text: Malignant lymphoma, lymphocytic, well differentiated, nodular Partial hydatidiform mole: text: Partial hydatidiform mole Blastic plasmacytoid dendritic cell neoplasm: text: Blastic plasmacytoid dendritic cell neoplasm Follicular carcinoma, well differentiated: text: Follicular carcinoma, well differentiated Malignant lymphoma, plasmacytoid: text: Malignant lymphoma, plasmacytoid Acute panmyelosis, NOS: text: Acute panmyelosis, NOS Spindle cell melanoma, type A: text: Spindle cell melanoma, type A Clear cell meningioma: text: Clear cell meningioma Solitary fibrous tumor/hemangiopericytoma Grade 3 (CNS): text: Solitary fibrous tumor/hemangiopericytoma Grade 3 (CNS) Mature T ALL: text: Mature T ALL Trophoblastic tumor, epithelioid: text: Trophoblastic tumor, epithelioid Adenocarcinoma in situ, non-mucinous: text: Adenocarcinoma in situ, non-mucinous Classical Hodgkin lymphoma, nodular sclerosis, grade 2: text: Classical Hodgkin lymphoma, nodular sclerosis, grade 2 Duct carcinoma, desmoplastic type: text: Duct carcinoma, desmoplastic type Periductal stromal tumor, low grade: text: Periductal stromal tumor, low grade Myelogenous leukemia, NOS: text: Myelogenous leukemia, NOS Atypical chronic myeloid leukemia, BCR/ABL negative: text: Atypical chronic myeloid leukemia, BCR/ABL negative Fibroid uterus: text: Fibroid uterus Pleomorphic xanthoastrocytoma: text: Pleomorphic xanthoastrocytoma Endometrioid tumor of low malignant potential: text: Endometrioid tumor of low malignant potential Follicular lymphoma, grade 3B: text: Follicular lymphoma, grade 3B Acute lymphoid leukemia: text: Acute lymphoid leukemia Pilomatricoma, NOS: text: Pilomatricoma, NOS Juxtacortical chondroma: text: Juxtacortical chondroma Intestinal T-cell lymphoma: text: Intestinal T-cell lymphoma Combined large cell neuroendocrine carcinoma: text: Combined large cell neuroendocrine carcinoma Squamous cell epithelioma: text: Squamous cell epithelioma Angiolipoma, NOS: text: Angiolipoma, NOS Mucinous adenocarcinoma, endocervical type: text: Mucinous adenocarcinoma, endocervical type Osteoid osteoma, NOS: text: Osteoid osteoma, NOS Clear cell cystadenoma: text: Clear cell cystadenoma Hepatosplenic gamma-delta cell lymphoma: text: Hepatosplenic gamma-delta cell lymphoma CNS Embryonal tumor with rhabdoid features: text: CNS Embryonal tumor with rhabdoid features Malignant lymphoma, mixed cell type, nodular: text: Malignant lymphoma, mixed cell type, nodular Granular cell myoblastoma, malignant: text: Granular cell myoblastoma, malignant Cellular angiofibroma: text: Cellular angiofibroma Aleukemic leukemia, NOS: text: Aleukemic leukemia, NOS Typical carcinoid: text: Typical carcinoid Malignant lymphoma, large cell, follicular, NOS: text: Malignant lymphoma, large cell, follicular, NOS Combined small cell-large carcinoma: text: Combined small cell-large carcinoma Desmoplastic infantile astrocytoma: text: Desmoplastic infantile astrocytoma Malignant lymphoma, follicle center, follicular: text: Malignant lymphoma, follicle center, follicular Plexiform fibrohistiocytic tumor: text: Plexiform fibrohistiocytic tumor Endometrioid adenocarcinoma, NOS: text: Endometrioid adenocarcinoma, NOS Juvenile fibroadenoma: text: Juvenile fibroadenoma Mixed epithelioid and spindle cell melanoma: text: Mixed epithelioid and spindle cell melanoma Smooth muscle tumor, NOS: text: Smooth muscle tumor, NOS Megakaryocytic myelosclerosis: text: Megakaryocytic myelosclerosis Benign cystic nephroma: text: Benign cystic nephroma Tumor cells, benign: text: Tumor cells, benign Ductal carcinoma in situ, micropapillary: text: Ductal carcinoma in situ, micropapillary Solid and papillary epithelial neoplasm: text: Solid and papillary epithelial neoplasm Myxosarcoma: text: Myxosarcoma Papillary ependymoma: text: Papillary ependymoma Nonencapsulated sclerosing tumor: text: Nonencapsulated sclerosing tumor enum_CRDCH_Diagnosis_morphology: name: enum_CRDCH_Diagnosis_morphology description: Autogenerated Enumeration for CRDC-H Diagnosis morphology comments: - 'Name according to TCCM: "CRDC-H.Diagnosis.morphology"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Diagnosis.morphology code_set_version: '2021-12-16T18:04:16.147503+00:00' permissible_values: 8930/0: text: 8930/0 9282/0: text: 9282/0 9542/3: text: 9542/3 8575/3: text: 8575/3 9653/3: text: 9653/3 9432/1: text: 9432/1 9726/3: text: 9726/3 8120/2: text: 8120/2 8633/1: text: 8633/1 8831/0: text: 8831/0 8250/3: text: 8250/3 9510/0: text: 9510/0 9751/1: text: 9751/1 9808/3: text: 9808/3 8503/0: text: 8503/0 9705/3: text: 9705/3 9560/1: text: 9560/1 9700/3: text: 9700/3 8241/3: text: 8241/3 9910/3: text: 9910/3 8271/0: text: 8271/0 9535/0: text: 9535/0 9412/1: text: 9412/1 8890/0: text: 8890/0 8840/3: text: 8840/3 8380/3: text: 8380/3 8841/1: text: 8841/1 8070/3: text: 8070/3 9823/3: text: 9823/3 8211/0: text: 8211/0 8242/3: text: 8242/3 8003/3: text: 8003/3 8098/3: text: 8098/3 9015/1: text: 9015/1 8550/0: text: 8550/0 9260/3: text: 9260/3 9062/3: text: 9062/3 9740/3: text: 9740/3 8010/3: text: 8010/3 9523/3: text: 9523/3 9688/3: text: 9688/3 9478/3: text: 9478/3 8163/3: text: 8163/3 8593/1: text: 8593/1 8509/3: text: 8509/3 8966/0: text: 8966/0 8894/0: text: 8894/0 9983/3: text: 9983/3 8730/3: text: 8730/3 8380/1: text: 8380/1 8313/0: text: 8313/0 9801/3: text: 9801/3 8450/3: text: 8450/3 8959/0: text: 8959/0 8231/3: text: 8231/3 8712/0: text: 8712/0 8407/0: text: 8407/0 9102/3: text: 9102/3 8964/3: text: 8964/3 8040/0: text: 8040/0 9655/3: text: 9655/3 8858/3: text: 8858/3 9130/0: text: 9130/0 9383/1: text: 9383/1 8091/3: text: 8091/3 8576/3: text: 8576/3 9561/3: text: 9561/3 9837/3: text: 9837/3 9395/3: text: 9395/3 8720/3: text: 8720/3 9472/3: text: 9472/3 9000/0: text: 9000/0 8323/3: text: 8323/3 8243/3: text: 8243/3 8251/3: text: 8251/3 8501/2: text: 8501/2 8272/3: text: 8272/3 8300/3: text: 8300/3 8161/3: text: 8161/3 9967/3: text: 9967/3 8856/0: text: 8856/0 8891/3: text: 8891/3 9920/3: text: 9920/3 9053/3: text: 9053/3 Unknown: text: Unknown 8580/1: text: 8580/1 9813/3: text: 9813/3 8541/3: text: 8541/3 8325/0: text: 8325/0 8811/3: text: 8811/3 8582/1: text: 8582/1 8280/3: text: 8280/3 8521/1: text: 8521/1 8170/3: text: 8170/3 9964/3: text: 9964/3 8959/3: text: 8959/3 8941/3: text: 8941/3 8320/3: text: 8320/3 9712/3: text: 9712/3 9513/3: text: 9513/3 8551/3: text: 8551/3 8336/0: text: 8336/0 8683/0: text: 8683/0 9493/0: text: 9493/0 9016/0: text: 9016/0 9371/3: text: 9371/3 9562/0: text: 9562/0 9000/3: text: 9000/3 8339/3: text: 8339/3 8463/1: text: 8463/1 8250/2: text: 8250/2 9352/1: text: 9352/1 8898/1: text: 8898/1 8281/0: text: 8281/0 8246/3: text: 8246/3 8850/0: text: 8850/0 9440/3: text: 9440/3 9321/0: text: 9321/0 8905/0: text: 8905/0 8410/0: text: 8410/0 9540/0: text: 9540/0 8825/0: text: 8825/0 8214/3: text: 8214/3 8852/0: text: 8852/0 8330/3: text: 8330/3 9183/3: text: 9183/3 9758/3: text: 9758/3 8594/1: text: 8594/1 9539/1: text: 9539/1 9911/3: text: 9911/3 9732/3: text: 9732/3 9714/3: text: 9714/3 8440/0: text: 8440/0 8857/0: text: 8857/0 9650/3: text: 9650/3 8830/0: text: 8830/0 9431/1: text: 9431/1 8384/3: text: 8384/3 8210/2: text: 8210/2 8230/3: text: 8230/3 8521/3: text: 8521/3 8744/3: text: 8744/3 8202/0: text: 8202/0 8244/3: text: 8244/3 9755/3: text: 9755/3 8390/3: text: 8390/3 9270/3: text: 9270/3 8392/0: text: 8392/0 8510/3: text: 8510/3 9091/1: text: 9091/1 9290/0: text: 9290/0 9424/3: text: 9424/3 9131/0: text: 9131/0 9220/0: text: 9220/0 8053/0: text: 8053/0 8670/0: text: 8670/0 8630/1: text: 8630/1 8073/3: text: 8073/3 8391/0: text: 8391/0 8632/1: text: 8632/1 8750/0: text: 8750/0 8247/3: text: 8247/3 8461/3: text: 8461/3 8150/3: text: 8150/3 8983/3: text: 8983/3 8470/0: text: 8470/0 9865/3: text: 9865/3 8810/3: text: 8810/3 9860/3: text: 9860/3 9065/3: text: 9065/3 9050/0: text: 9050/0 8071/2: text: 8071/2 8070/6: text: 8070/6 8242/1: text: 8242/1 9473/3: text: 9473/3 9142/0: text: 9142/0 8589/3: text: 8589/3 8070/2: text: 8070/2 9474/3: text: 9474/3 8162/3: text: 8162/3 8070/33: text: 8070/33 8083/3: text: 8083/3 8311/3: text: 8311/3 9930/3: text: 9930/3 9137/3: text: 9137/3 9761/3: text: 9761/3 8420/0: text: 8420/0 8713/0: text: 8713/0 9505/1: text: 9505/1 9310/0: text: 9310/0 9261/3: text: 9261/3 8201/3: text: 8201/3 9709/3: text: 9709/3 8380/0: text: 8380/0 8620/1: text: 8620/1 8441/3: text: 8441/3 8462/1: text: 8462/1 9863/3: text: 9863/3 8102/0: text: 8102/0 9136/1: text: 9136/1 8723/0: text: 8723/0 9659/3: text: 9659/3 9184/3: text: 9184/3 9897/3: text: 9897/3 9442/3: text: 9442/3 8323/0: text: 8323/0 8149/0: text: 8149/0 9392/3: text: 9392/3 9242/3: text: 9242/3 9174/1: text: 9174/1 9273/0: text: 9273/0 9341/1: text: 9341/1 8522/3: text: 8522/3 8052/3: text: 8052/3 8140/2: text: 8140/2 8256/3: text: 8256/3 8812/3: text: 8812/3 8046/3: text: 8046/3 8762/1: text: 8762/1 8584/1: text: 8584/1 8322/0: text: 8322/0 8982/3: text: 8982/3 9082/3: text: 9082/3 8870/0: text: 8870/0 9809/3: text: 9809/3 8155/3: text: 8155/3 8520/3: text: 8520/3 9185/3: text: 9185/3 9341/3: text: 9341/3 8832/3: text: 8832/3 9200/1: text: 9200/1 8480/3: text: 8480/3 9735/3: text: 9735/3 8452/1: text: 8452/1 8084/3: text: 8084/3 8742/2: text: 8742/2 8692/1: text: 8692/1 9729/3: text: 9729/3 8574/3: text: 8574/3 9725/3: text: 9725/3 8728/1: text: 8728/1 9476/3: text: 9476/3 8630/3: text: 8630/3 8726/0: text: 8726/0 8810/1: text: 8810/1 9834/3: text: 9834/3 8571/3: text: 8571/3 8600/3: text: 8600/3 8480/0: text: 8480/0 8382/3: text: 8382/3 8691/1: text: 8691/1 9590/3: text: 9590/3 9541/0: text: 9541/0 9757/3: text: 9757/3 9963/3: text: 9963/3 8180/3: text: 8180/3 8031/3: text: 8031/3 8504/2: text: 8504/2 9861/3: text: 9861/3 8120/1: text: 8120/1 8897/1: text: 8897/1 8650/1: text: 8650/1 9501/3: text: 9501/3 9806/3: text: 9806/3 9230/3: text: 9230/3 8041/34: text: 8041/34 9133/1: text: 9133/1 8161/0: text: 8161/0 9501/0: text: 9501/0 8010/2: text: 8010/2 9580/0: text: 9580/0 9272/0: text: 9272/0 8760/0: text: 8760/0 8790/0: text: 8790/0 9187/3: text: 9187/3 8861/0: text: 8861/0 9290/3: text: 9290/3 8895/3: text: 8895/3 9310/3: text: 9310/3 8130/3: text: 8130/3 8480/1: text: 8480/1 8583/1: text: 8583/1 8263/2: text: 8263/2 8210/3: text: 8210/3 9510/3: text: 9510/3 9980/3: text: 9980/3 9597/3: text: 9597/3 9471/3: text: 9471/3 9742/3: text: 9742/3 9130/1: text: 9130/1 9413/0: text: 9413/0 8836/1: text: 8836/1 8825/3: text: 8825/3 8971/3: text: 8971/3 8912/3: text: 8912/3 8211/3: text: 8211/3 9100/0: text: 9100/0 8334/0: text: 8334/0 9125/0: text: 9125/0 8562/3: text: 8562/3 8143/3: text: 8143/3 8152/1: text: 8152/1 9661/3: text: 9661/3 9281/0: text: 9281/0 9815/3: text: 9815/3 8103/0: text: 8103/0 8693/3: text: 8693/3 9502/0: text: 9502/0 9521/3: text: 9521/3 8812/0: text: 8812/0 9769/1: text: 9769/1 9186/3: text: 9186/3 9719/3: text: 9719/3 9330/0: text: 9330/0 9274/0: text: 9274/0 9141/0: text: 9141/0 8959/1: text: 8959/1 9221/0: text: 9221/0 8723/3: text: 8723/3 8220/0: text: 8220/0 8318/3: text: 8318/3 8745/3: text: 8745/3 9382/3: text: 9382/3 8507/3: text: 8507/3 8892/0: text: 8892/0 8130/1: text: 8130/1 9090/0: text: 9090/0 8375/0: text: 8375/0 8590/1: text: 8590/1 8035/3: text: 8035/3 9070/3: text: 9070/3 8001/3: text: 8001/3 9560/0: text: 9560/0 9741/1: text: 9741/1 9241/0: text: 9241/0 8972/3: text: 8972/3 8700/0: text: 8700/0 8442/1: text: 8442/1 8932/0: text: 8932/0 9756/3: text: 9756/3 8260/0: text: 8260/0 9520/3: text: 9520/3 8390/0: text: 8390/0 8310/3: text: 8310/3 Not Reported: text: Not Reported 9020/0: text: 9020/0 8815/1: text: 8815/1 8902/3: text: 8902/3 9931/3: text: 9931/3 8586/3: text: 8586/3 8000/6: text: 8000/6 8602/0: text: 8602/0 8714/3: text: 8714/3 8740/3: text: 8740/3 9522/3: text: 9522/3 9891/3: text: 9891/3 8471/0: text: 8471/0 8005/0: text: 8005/0 8530/3: text: 8530/3 9945/3: text: 9945/3 8519/2: text: 8519/2 9423/3: text: 9423/3 9673/3: text: 9673/3 9741/3: text: 9741/3 9180/3: text: 9180/3 8827/1: text: 8827/1 9663/3: text: 9663/3 9243/3: text: 9243/3 8263/0: text: 8263/0 8212/0: text: 8212/0 8121/0: text: 8121/0 8854/0: text: 8854/0 8930/3: text: 8930/3 8780/0: text: 8780/0 8022/3: text: 8022/3 8373/0: text: 8373/0 9015/3: text: 9015/3 8001/1: text: 8001/1 9362/3: text: 9362/3 8904/0: text: 8904/0 8584/3: text: 8584/3 8406/0: text: 8406/0 9506/1: text: 9506/1 8015/3: text: 8015/3 9085/3: text: 9085/3 9975/3: text: 9975/3 8004/3: text: 8004/3 8215/3: text: 8215/3 9832/3: text: 9832/3 8319/3: text: 8319/3 9514/1: text: 9514/1 8040/1: text: 8040/1 8780/3: text: 8780/3 8313/3: text: 8313/3 8460/3: text: 8460/3 9664/3: text: 9664/3 9869/3: text: 9869/3 8513/3: text: 8513/3 9678/3: text: 9678/3 8963/3: text: 8963/3 9716/3: text: 9716/3 8990/0: text: 8990/0 8508/3: text: 8508/3 8850/3: text: 8850/3 8771/0: text: 8771/0 9192/3: text: 9192/3 8981/3: text: 8981/3 8080/2: text: 8080/2 9836/3: text: 9836/3 9250/3: text: 9250/3 9667/3: text: 9667/3 8012/3: text: 8012/3 8522/1: text: 8522/1 8842/0: text: 8842/0 8522/2: text: 8522/2 8381/3: text: 8381/3 8814/3: text: 8814/3 9582/0: text: 9582/0 8441/0: text: 8441/0 8940/3: text: 8940/3 9391/3: text: 9391/3 8403/0: text: 8403/0 8461/0: text: 8461/0 8980/3: text: 8980/3 8010/9: text: 8010/9 9011/0: text: 9011/0 8634/3: text: 8634/3 8523/3: text: 8523/3 8290/3: text: 8290/3 8854/3: text: 8854/3 8153/1: text: 8153/1 8504/0: text: 8504/0 8337/3: text: 8337/3 9051/3: text: 9051/3 8060/0: text: 8060/0 8260/3: text: 8260/3 9063/3: text: 9063/3 8825/1: text: 8825/1 8090/1: text: 8090/1 8076/3: text: 8076/3 8721/3: text: 8721/3 8896/3: text: 8896/3 8252/3: text: 8252/3 9537/0: text: 9537/0 8160/0: text: 8160/0 9530/1: text: 9530/1 8121/1: text: 8121/1 8400/3: text: 8400/3 9083/3: text: 9083/3 9500/3: text: 9500/3 8402/0: text: 8402/0 8771/3: text: 8771/3 8991/3: text: 8991/3 9504/3: text: 9504/3 9080/3: text: 9080/3 9702/3: text: 9702/3 9596/3: text: 9596/3 9538/1: text: 9538/1 8631/0: text: 8631/0 9982/3: text: 9982/3 8173/3: text: 8173/3 8261/3: text: 8261/3 8453/3: text: 8453/3 8372/0: text: 8372/0 8333/0: text: 8333/0 8512/3: text: 8512/3 8120/3: text: 8120/3 8344/3: text: 8344/3 9751/3: text: 9751/3 8023/3: text: 8023/3 8280/0: text: 8280/0 9064/2: text: 9064/2 9393/3: text: 9393/3 9895/3: text: 9895/3 9010/0: text: 9010/0 8200/0: text: 8200/0 9370/3: text: 9370/3 8321/0: text: 8321/0 9807/3: text: 9807/3 9966/3: text: 9966/3 9961/3: text: 9961/3 9948/3: text: 9948/3 8671/0: text: 8671/0 9121/0: text: 9121/0 8935/0: text: 8935/0 8973/3: text: 8973/3 8257/3: text: 8257/3 9960/3: text: 9960/3 8265/3: text: 8265/3 9300/0: text: 9300/0 8251/0: text: 8251/0 9394/1: text: 9394/1 8890/3: text: 8890/3 8124/3: text: 8124/3 8990/1: text: 8990/1 9480/3: text: 9480/3 9816/3: text: 9816/3 8622/1: text: 8622/1 8097/3: text: 8097/3 8322/3: text: 8322/3 8343/3: text: 8343/3 8021/3: text: 8021/3 8245/1: text: 8245/1 9050/3: text: 9050/3 8803/3: text: 8803/3 8471/3: text: 8471/3 8835/1: text: 8835/1 8441/2: text: 8441/2 9160/0: text: 9160/0 9200/0: text: 9200/0 8560/0: text: 8560/0 9512/3: text: 9512/3 9302/0: text: 9302/0 8454/0: text: 8454/0 8370/1: text: 8370/1 8936/1: text: 8936/1 9390/3: text: 9390/3 8920/3: text: 8920/3 8821/1: text: 8821/1 8561/0: text: 8561/0 8156/3: text: 8156/3 8891/0: text: 8891/0 8264/0: text: 8264/0 8158/1: text: 8158/1 8573/3: text: 8573/3 8834/1: text: 8834/1 9103/0: text: 9103/0 8405/0: text: 8405/0 8151/0: text: 8151/0 8700/3: text: 8700/3 8147/3: text: 8147/3 9560/3: text: 9560/3 8642/1: text: 8642/1 9441/3: text: 9441/3 8453/2: text: 8453/2 8051/0: text: 8051/0 8570/3: text: 8570/3 8110/3: text: 8110/3 9081/3: text: 9081/3 8403/3: text: 8403/3 9175/0: text: 9175/0 8862/0: text: 8862/0 8641/0: text: 8641/0 9170/0: text: 9170/0 9411/3: text: 9411/3 9946/3: text: 9946/3 9654/3: text: 9654/3 8810/0: text: 8810/0 8893/0: text: 8893/0 9090/3: text: 9090/3 9505/3: text: 9505/3 8071/3: text: 8071/3 9873/3: text: 9873/3 9105/3: text: 9105/3 9051/0: text: 9051/0 8983/0: text: 8983/0 8725/0: text: 8725/0 9084/3: text: 9084/3 8935/3: text: 8935/3 9814/3: text: 9814/3 8075/3: text: 8075/3 9687/3: text: 9687/3 8444/1: text: 8444/1 8000/0: text: 8000/0 9818/3: text: 9818/3 8370/0: text: 8370/0 8147/0: text: 8147/0 8141/3: text: 8141/3 9044/3: text: 9044/3 8347/3: text: 8347/3 8581/1: text: 8581/1 9734/3: text: 9734/3 8110/0: text: 8110/0 8552/3: text: 8552/3 8502/3: text: 8502/3 9591/3: text: 9591/3 9124/3: text: 9124/3 8900/3: text: 8900/3 9571/0: text: 9571/0 8460/2: text: 8460/2 8505/0: text: 8505/0 8501/3: text: 8501/3 8903/0: text: 8903/0 8591/1: text: 8591/1 8580/0: text: 8580/0 9231/3: text: 9231/3 8503/3: text: 8503/3 9840/3: text: 9840/3 8150/1: text: 8150/1 8830/3: text: 8830/3 9221/3: text: 9221/3 8670/3: text: 8670/3 8936/0: text: 8936/0 9041/3: text: 9041/3 8163/0: text: 8163/0 8401/3: text: 8401/3 8965/0: text: 8965/0 9252/3: text: 9252/3 8826/0: text: 8826/0 8213/3: text: 8213/3 8248/1: text: 8248/1 9055/1: text: 9055/1 9718/3: text: 9718/3 9800/3: text: 9800/3 8727/0: text: 8727/0 8811/0: text: 8811/0 9014/0: text: 9014/0 9340/0: text: 9340/0 8680/3: text: 8680/3 8081/2: text: 8081/2 9180/0: text: 9180/0 9240/3: text: 9240/3 8014/3: text: 8014/3 8044/3: text: 8044/3 8330/0: text: 8330/0 8900/0: text: 8900/0 8120/0: text: 8120/0 8921/3: text: 8921/3 8051/3: text: 8051/3 9320/0: text: 9320/0 8121/3: text: 8121/3 8720/2: text: 8720/2 9680/3: text: 9680/3 9511/3: text: 9511/3 8314/3: text: 8314/3 8034/3: text: 8034/3 8805/3: text: 8805/3 8078/3: text: 8078/3 9120/3: text: 9120/3 8380/2: text: 8380/2 8090/3: text: 8090/3 8300/0: text: 8300/0 9684/3: text: 9684/3 8860/0: text: 8860/0 9193/3: text: 9193/3 8472/1: text: 8472/1 8154/3: text: 8154/3 8200/3: text: 8200/3 9020/1: text: 9020/1 9728/3: text: 9728/3 8346/3: text: 8346/3 8270/0: text: 8270/0 9123/0: text: 9123/0 8142/3: text: 8142/3 9738/3: text: 9738/3 9970/1: text: 9970/1 8640/3: text: 8640/3 8430/3: text: 8430/3 9045/3: text: 9045/3 9490/3: text: 9490/3 8931/3: text: 8931/3 9174/0: text: 9174/0 8343/2: text: 8343/2 8077/0: text: 8077/0 8220/3: text: 8220/3 8250/1: text: 8250/1 8572/3: text: 8572/3 9534/0: text: 9534/0 9020/3: text: 9020/3 8600/0: text: 8600/0 8240/1: text: 8240/1 8281/3: text: 8281/3 9507/0: text: 9507/0 9055/0: text: 9055/0 8313/1: text: 8313/1 8800/0: text: 8800/0 9054/0: text: 9054/0 9322/0: text: 9322/0 8500/3: text: 8500/3 9750/3: text: 9750/3 9312/0: text: 9312/0 8660/0: text: 8660/0 9867/3: text: 9867/3 9384/1: text: 9384/1 9442/1: text: 9442/1 8802/3: text: 8802/3 8681/1: text: 8681/1 8145/3: text: 8145/3 8324/0: text: 8324/0 9301/0: text: 9301/0 8407/3: text: 8407/3 8360/1: text: 8360/1 8960/3: text: 8960/3 8623/1: text: 8623/1 9965/3: text: 9965/3 8420/3: text: 8420/3 9898/3: text: 9898/3 9992/3: text: 9992/3 9100/3: text: 9100/3 8451/1: text: 8451/1 9717/3: text: 9717/3 9400/3: text: 9400/3 8172/3: text: 8172/3 8155/1: text: 8155/1 8824/0: text: 8824/0 8221/0: text: 8221/0 9874/3: text: 9874/3 8261/2: text: 8261/2 8005/3: text: 8005/3 8504/3: text: 8504/3 8010/6: text: 8010/6 8710/3: text: 8710/3 8400/0: text: 8400/0 8514/3: text: 8514/3 8240/3: text: 8240/3 9101/3: text: 9101/3 8140/6: text: 8140/6 8940/0: text: 8940/0 9342/3: text: 9342/3 8020/3: text: 8020/3 8773/3: text: 8773/3 8160/3: text: 8160/3 8095/3: text: 8095/3 8470/2: text: 8470/2 9280/0: text: 9280/0 9708/3: text: 9708/3 8855/3: text: 8855/3 8761/0: text: 8761/0 9991/3: text: 9991/3 9110/0: text: 9110/0 9752/1: text: 9752/1 9150/1: text: 9150/1 8630/0: text: 8630/0 8330/1: text: 8330/1 9181/3: text: 9181/3 8813/0: text: 8813/0 8443/0: text: 8443/0 8832/0: text: 8832/0 8650/3: text: 8650/3 9040/3: text: 9040/3 9762/3: text: 9762/3 9460/3: text: 9460/3 8852/3: text: 8852/3 8361/0: text: 8361/0 9251/1: text: 9251/1 8317/3: text: 8317/3 8682/1: text: 8682/1 8833/3: text: 8833/3 8741/2: text: 8741/2 8967/0: text: 8967/0 8163/2: text: 8163/2 9698/3: text: 9698/3 8631/3: text: 8631/3 9104/1: text: 9104/1 9060/3: text: 9060/3 9451/3: text: 9451/3 8824/1: text: 8824/1 9811/3: text: 9811/3 9122/0: text: 9122/0 8123/3: text: 8123/3 9262/0: text: 9262/0 8772/0: text: 8772/0 8743/3: text: 8743/3 9014/1: text: 9014/1 8050/2: text: 8050/2 9898/1: text: 9898/1 8815/0: text: 8815/0 9872/3: text: 9872/3 8290/0: text: 8290/0 9665/3: text: 9665/3 8770/3: text: 8770/3 8000/3: text: 8000/3 8813/3: text: 8813/3 9764/3: text: 9764/3 9000/1: text: 9000/1 9570/0: text: 9570/0 9532/0: text: 9532/0 9475/3: text: 9475/3 8690/1: text: 8690/1 9110/3: text: 9110/3 8174/3: text: 8174/3 8490/3: text: 8490/3 8910/3: text: 8910/3 9690/3: text: 9690/3 9540/3: text: 9540/3 8811/1: text: 8811/1 9817/3: text: 9817/3 9390/1: text: 9390/1 9421/1: text: 9421/1 8254/3: text: 8254/3 9870/3: text: 9870/3 9550/0: text: 9550/0 9271/0: text: 9271/0 9330/3: text: 9330/3 9651/3: text: 9651/3 8582/3: text: 8582/3 9701/3: text: 9701/3 9876/3: text: 9876/3 8587/0: text: 8587/0 9984/3: text: 9984/3 8310/0: text: 8310/0 8011/3: text: 8011/3 9252/0: text: 9252/0 8000/9: text: 8000/9 8560/3: text: 8560/3 8610/0: text: 8610/0 8450/0: text: 8450/0 8934/3: text: 8934/3 9250/1: text: 9250/1 9052/3: text: 9052/3 9768/1: text: 9768/1 8340/3: text: 8340/3 9805/3: text: 9805/3 8255/3: text: 8255/3 8140/1: text: 8140/1 9826/3: text: 9826/3 8540/3: text: 8540/3 9971/3: text: 9971/3 8592/1: text: 8592/1 8975/1: text: 8975/1 9390/0: text: 9390/0 9675/3: text: 9675/3 8190/0: text: 8190/0 8581/3: text: 8581/3 8601/0: text: 8601/0 8761/1: text: 8761/1 8335/3: text: 8335/3 8409/3: text: 8409/3 9015/0: text: 9015/0 8383/3: text: 8383/3 8032/3: text: 8032/3 8152/3: text: 8152/3 9173/0: text: 9173/0 8312/3: text: 8312/3 8500/2: text: 8500/2 8650/0: text: 8650/0 8550/1: text: 8550/1 8262/3: text: 8262/3 9971/1: text: 9971/1 8741/3: text: 8741/3 8153/3: text: 8153/3 8880/0: text: 8880/0 8230/2: text: 8230/2 9477/3: text: 9477/3 8711/3: text: 8711/3 8550/3: text: 8550/3 8728/0: text: 8728/0 8950/3: text: 8950/3 8381/1: text: 8381/1 8045/3: text: 8045/3 8974/1: text: 8974/1 9072/3: text: 9072/3 8002/3: text: 8002/3 8146/0: text: 8146/0 8270/3: text: 8270/3 8452/3: text: 8452/3 9827/3: text: 9827/3 9385/3: text: 9385/3 9140/3: text: 9140/3 8851/3: text: 8851/3 9351/1: text: 9351/1 8482/3: text: 8482/3 9013/0: text: 9013/0 8331/3: text: 8331/3 8010/0: text: 8010/0 9100/1: text: 9100/1 8851/0: text: 8851/0 8151/3: text: 8151/3 8583/3: text: 8583/3 8342/3: text: 8342/3 8272/0: text: 8272/0 9270/0: text: 9270/0 8585/3: text: 8585/3 8190/3: text: 8190/3 8144/3: text: 8144/3 8640/1: text: 8640/1 9502/3: text: 9502/3 9987/3: text: 9987/3 8840/0: text: 8840/0 8585/1: text: 8585/1 9571/3: text: 9571/3 8074/3: text: 8074/3 8350/3: text: 8350/3 9445/3: text: 9445/3 8490/6: text: 8490/6 8430/1: text: 8430/1 9737/3: text: 9737/3 9989/3: text: 9989/3 8261/0: text: 8261/0 9350/1: text: 9350/1 8042/3: text: 8042/3 8815/3: text: 8815/3 9866/3: text: 9866/3 8509/2: text: 8509/2 8543/3: text: 8543/3 9425/3: text: 9425/3 9581/3: text: 9581/3 9161/1: text: 9161/1 8804/3: text: 8804/3 8631/1: text: 8631/1 8175/3: text: 8175/3 8316/3: text: 8316/3 8315/3: text: 8315/3 8823/0: text: 8823/0 9695/3: text: 9695/3 9509/1: text: 9509/1 8460/0: text: 8460/0 9061/3: text: 9061/3 8473/1: text: 8473/1 8970/3: text: 8970/3 8542/3: text: 8542/3 9503/3: text: 9503/3 9043/3: text: 9043/3 8374/0: text: 8374/0 9251/3: text: 9251/3 9835/3: text: 9835/3 8052/2: text: 8052/2 8094/3: text: 8094/3 9361/1: text: 9361/1 8774/3: text: 8774/3 9492/0: text: 9492/0 9538/3: text: 9538/3 9691/3: text: 9691/3 9727/3: text: 9727/3 9380/3: text: 9380/3 9373/0: text: 9373/0 8100/0: text: 8100/0 8332/3: text: 8332/3 8761/3: text: 8761/3 8520/2: text: 8520/2 8263/3: text: 8263/3 9365/3: text: 9365/3 8503/2: text: 8503/2 9833/3: text: 9833/3 8030/3: text: 8030/3 9831/3: text: 9831/3 8082/3: text: 8082/3 8404/0: text: 8404/0 8253/3: text: 8253/3 8050/3: text: 8050/3 8857/3: text: 8857/3 8213/0: text: 8213/0 8371/0: text: 8371/0 9430/3: text: 9430/3 8140/3: text: 8140/3 9539/3: text: 9539/3 8409/0: text: 8409/0 8131/3: text: 8131/3 8722/0: text: 8722/0 9064/3: text: 9064/3 9194/3: text: 9194/3 8580/3: text: 8580/3 8881/0: text: 8881/0 8101/0: text: 8101/0 9052/0: text: 9052/0 8620/3: text: 8620/3 8011/0: text: 8011/0 8830/1: text: 8830/1 8730/0: text: 8730/0 9820/3: text: 9820/3 8822/1: text: 8822/1 9040/0: text: 9040/0 8000/1: text: 8000/1 8148/2: text: 8148/2 8480/6: text: 8480/6 9671/3: text: 9671/3 8400/1: text: 8400/1 9760/3: text: 9760/3 8801/3: text: 8801/3 9689/3: text: 9689/3 9073/1: text: 9073/1 8720/0: text: 8720/0 9220/3: text: 9220/3 8413/3: text: 8413/3 8933/3: text: 8933/3 8935/1: text: 8935/1 8410/3: text: 8410/3 8711/0: text: 8711/0 9372/3: text: 9372/3 8043/3: text: 8043/3 9940/3: text: 9940/3 9410/3: text: 9410/3 8221/3: text: 8221/3 8901/3: text: 8901/3 8102/3: text: 8102/3 8092/3: text: 8092/3 9172/0: text: 9172/0 8800/3: text: 8800/3 9530/0: text: 9530/0 9679/3: text: 9679/3 8524/3: text: 8524/3 9171/0: text: 9171/0 9161/0: text: 9161/0 9450/3: text: 9450/3 9080/0: text: 9080/0 8728/3: text: 8728/3 8401/0: text: 8401/0 9210/1: text: 9210/1 8204/0: text: 8204/0 9150/0: text: 9150/0 9182/3: text: 9182/3 8770/0: text: 8770/0 9753/1: text: 9753/1 8982/0: text: 8982/0 9110/1: text: 9110/1 8370/3: text: 8370/3 8470/3: text: 8470/3 9733/3: text: 9733/3 8740/0: text: 8740/0 8408/1: text: 8408/1 8680/0: text: 8680/0 9120/0: text: 9120/0 8680/1: text: 8680/1 8806/3: text: 8806/3 8033/3: text: 8033/3 8093/3: text: 8093/3 9071/3: text: 9071/3 9724/3: text: 9724/3 8050/0: text: 8050/0 9754/3: text: 9754/3 8742/3: text: 8742/3 9962/3: text: 9962/3 8171/3: text: 8171/3 9531/0: text: 9531/0 8894/3: text: 8894/3 8072/3: text: 8072/3 9270/1: text: 9270/1 8333/3: text: 8333/3 8936/3: text: 8936/3 8052/0: text: 8052/0 8507/2: text: 8507/2 8122/3: text: 8122/3 8170/0: text: 8170/0 9530/3: text: 9530/3 8085/3: text: 8085/3 8693/1: text: 8693/1 9210/0: text: 9210/0 9364/3: text: 9364/3 8951/3: text: 8951/3 9986/3: text: 9986/3 9765/1: text: 9765/1 8140/33: text: 8140/33 9132/0: text: 9132/0 9670/3: text: 9670/3 9230/0: text: 9230/0 9875/3: text: 9875/3 8408/3: text: 8408/3 8408/0: text: 8408/0 8001/0: text: 8001/0 8245/3: text: 8245/3 8800/9: text: 8800/9 9812/3: text: 9812/3 8746/3: text: 8746/3 9401/3: text: 9401/3 8440/3: text: 8440/3 8474/1: text: 8474/1 9740/1: text: 9740/1 8191/0: text: 8191/0 8077/2: text: 8077/2 8634/1: text: 8634/1 8890/1: text: 8890/1 9491/0: text: 9491/0 9490/0: text: 9490/0 9275/0: text: 9275/0 9084/0: text: 9084/0 9191/0: text: 9191/0 8381/0: text: 8381/0 8990/3: text: 8990/3 9896/3: text: 9896/3 8341/3: text: 8341/3 8960/1: text: 8960/1 9871/3: text: 9871/3 8249/3: text: 8249/3 9580/3: text: 9580/3 8474/3: text: 8474/3 9767/1: text: 9767/1 8722/3: text: 8722/3 8013/3: text: 8013/3 9699/3: text: 9699/3 9662/3: text: 9662/3 8481/3: text: 8481/3 9012/0: text: 9012/0 9133/3: text: 9133/3 9420/3: text: 9420/3 8086/3: text: 8086/3 8076/2: text: 8076/2 9130/3: text: 9130/3 8140/0: text: 8140/0 9396/3: text: 9396/3 8402/3: text: 8402/3 8588/3: text: 8588/3 8621/1: text: 8621/1 9444/1: text: 9444/1 9080/1: text: 9080/1 9042/3: text: 9042/3 9195/3: text: 9195/3 9731/3: text: 9731/3 8210/0: text: 8210/0 8156/1: text: 8156/1 9360/1: text: 9360/1 8311/1: text: 8311/1 8820/0: text: 8820/0 8041/3: text: 8041/3 9170/3: text: 9170/3 9950/3: text: 9950/3 8150/0: text: 8150/0 9652/3: text: 9652/3 8772/3: text: 8772/3 8148/0: text: 8148/0 8853/3: text: 8853/3 8525/3: text: 8525/3 9311/0: text: 9311/0 9363/0: text: 9363/0 9508/3: text: 9508/3 9533/0: text: 9533/0 9766/1: text: 9766/1 9302/3: text: 9302/3 9470/3: text: 9470/3 9150/3: text: 9150/3 9540/1: text: 9540/1 9014/3: text: 9014/3 8850/1: text: 8850/1 8096/0: text: 8096/0 9135/1: text: 9135/1 8201/2: text: 8201/2 8345/3: text: 8345/3 9381/3: text: 9381/3 8506/0: text: 8506/0 8842/3: text: 8842/3 9220/1: text: 9220/1 9030/0: text: 9030/0 9086/3: text: 9086/3 9985/3: text: 9985/3 9759/3: text: 9759/3 8453/0: text: 8453/0 8895/0: text: 8895/0 8130/2: text: 8130/2 8720/6: text: 8720/6 8040/3: text: 8040/3 8800/6: text: 8800/6 8950/6: text: 8950/6 8482/6: text: 8482/6 8240/6: text: 8240/6 8804/6: text: 8804/6 8249/6: text: 8249/6 9180/6: text: 9180/6 8020/6: text: 8020/6 8311/6: text: 8311/6 8441/6: text: 8441/6 8500/6: text: 8500/6 9440/6: text: 9440/6 8046/6: text: 8046/6 8041/6: text: 8041/6 8471/1: text: 8471/1 8801/6: text: 8801/6 8310/6: text: 8310/6 8920/6: text: 8920/6 8806/6: text: 8806/6 enum_CRDCH_Diagnosis_disease_status: name: enum_CRDCH_Diagnosis_disease_status description: Autogenerated Enumeration for CRDC-H Diagnosis disease_status comments: - 'Name according to TCCM: "CRDC-H.Diagnosis.disease_status"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Diagnosis.disease_status code_set_version: '2021-12-16T18:04:21.392448+00:00' permissible_values: Initial Diagnosis: text: Initial Diagnosis Not Reported: text: Not Reported Progressive Disease: text: Progressive Disease Recurrent Disease: text: Recurrent Disease Residual Disease: text: Residual Disease Unknown: text: Unknown enum_CRDCH_Diagnosis_method_of_diagnosis: name: enum_CRDCH_Diagnosis_method_of_diagnosis description: Autogenerated Enumeration for CRDC-H Diagnosis method_of_diagnosis comments: - 'Name according to TCCM: "CRDC-H.Diagnosis.method_of_diagnosis"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Diagnosis.method_of_diagnosis code_set_version: '2021-12-16T18:04:21.594708+00:00' permissible_values: Laparoscopy: text: Laparoscopy description: Laparoscopy Core Biopsy: text: Core Biopsy description: Core Biopsy Pathologic Review: text: Pathologic Review description: Pathologic Examination Autopsy: text: Autopsy description: Autopsy Thoracentesis: text: Thoracentesis description: Thoracentesis Ultrasound Guided Biopsy: text: Ultrasound Guided Biopsy description: Ultrasound guided biopsy Incisional Biopsy: text: Incisional Biopsy description: Incisional Biopsy Laparotomy: text: Laparotomy description: Laparotomy Pap Smear: text: Pap Smear description: Papanicolaou Smear Procedure Cystoscopy: text: Cystoscopy description: Cystoscopy Diagnostic Imaging: text: Diagnostic Imaging description: Diagnostic Imaging Biopsy: text: Biopsy description: Biopsy Not Reported: text: Not Reported description: Not Reported Other: text: Other description: Other Surgical Resection: text: Surgical Resection description: Excision Debulking: text: Debulking description: Debulking Bone Marrow Aspirate: text: Bone Marrow Aspirate description: Bone Marrow Aspiration Blood Draw: text: Blood Draw description: Phlebotomy Fine Needle Aspiration: text: Fine Needle Aspiration description: Fine-Needle Aspiration Enucleation: text: Enucleation description: Enucleation Physical Exam: text: Physical Exam description: Physical Examination Unknown: text: Unknown description: Unknown Dilation and Curettage Procedure: text: Dilation and Curettage Procedure description: Dilation and Curettage Excisional Biopsy: text: Excisional Biopsy description: Excisional Biopsy Cytology: text: Cytology description: Cytology Imaging: text: Imaging description: Imaging Technique Not Allowed To Collect: text: Not Allowed To Collect enum_CRDCH_DimensionalObservation_category: name: enum_CRDCH_DimensionalObservation_category description: Autogenerated Enumeration for CRDC-H DimensionalObservation category comments: - 'Name according to TCCM: "CRDC-H.DimensionalObservation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.DimensionalObservation.category code_set_version: '2021-12-16T18:04:21.821225+00:00' enum_CRDCH_DimensionalObservation_observation_type: name: enum_CRDCH_DimensionalObservation_observation_type description: Types of measurements that describe the physical dimensions of an entity (e.g. a Specimen) notes: - Derived from [DimensionalObservation.observation_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: length: text: length description: The length of a three-dimensional specimen, as measured in a plane perpendicular to the planes in which the width and height of the specimen are measured. width: text: width description: The width of a three-dimensional specimen, as measured in a plane perpendicular to the planes in which the length and height of the specimen are measured. longest_dimension: text: longest_dimension description: The measured extent of the longest straight path across a specimen. shortest_dimension: text: shortest_dimension description: The measured extent of the shortest straight path across a specimen. intermediate_dimension: text: intermediate_dimension description: The measured extent of the intermediate straight path across a specimen. surface_area: text: surface_area description: The total surface area of the specimen enum_CRDCH_DimensionalObservation_method_type: name: enum_CRDCH_DimensionalObservation_method_type description: Autogenerated Enumeration for CRDC-H DimensionalObservation method_type comments: - 'Name according to TCCM: "CRDC-H.DimensionalObservation.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.DimensionalObservation.method_type code_set_version: '2021-12-16T18:04:22.114768+00:00' enum_CRDCH_DimensionalObservationSet_category: name: enum_CRDCH_DimensionalObservationSet_category description: Autogenerated Enumeration for CRDC-H DimensionalObservationSet category comments: - 'Name according to TCCM: "CRDC-H.DimensionalObservationSet.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.DimensionalObservationSet.category code_set_version: '2021-12-16T18:04:22.266296+00:00' enum_CRDCH_DimensionalObservationSet_method_type: name: enum_CRDCH_DimensionalObservationSet_method_type description: Autogenerated Enumeration for CRDC-H DimensionalObservationSet method_type comments: - 'Name according to TCCM: "CRDC-H.DimensionalObservationSet.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.DimensionalObservationSet.method_type code_set_version: '2021-12-16T18:04:22.411575+00:00' enum_CRDCH_Document_document_type: name: enum_CRDCH_Document_document_type description: The high-level type of the report (e.g. 'pathology report') notes: - Derived from [Document.document_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: pathology report: text: pathology report description: A pathology report describing the specimen protocol: text: protocol description: A protocol by which the sample was obtained or generated (e.g. a protocol listed in protocols.io) enum_CRDCH_EnvironmentalExposureObservation_category: name: enum_CRDCH_EnvironmentalExposureObservation_category description: Autogenerated Enumeration for CRDC-H EnvironmentalExposureObservation category comments: - 'Name according to TCCM: "CRDC-H.EnvironmentalExposureObservation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.EnvironmentalExposureObservation.category code_set_version: '2021-12-16T18:04:22.707614+00:00' enum_CRDCH_EnvironmentalExposureObservation_observation_type: name: enum_CRDCH_EnvironmentalExposureObservation_observation_type description: Types of observations about a Subject's environmental exposures. notes: - Derived from [EnvironmentalExposureObservation.observation_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: asbestos_exposure: text: asbestos_exposure description: The yes/no/unknown indicator used to describe whether the patient was exposed to asbestos. coal_dust_exposure: text: coal_dust_exposure description: The yes/no/unknown indicator used to describe whether a patient was exposed to fine powder derived by the crushing of coal. radon_exposure: text: radon_exposure description: The yes/no/unknown indicator used to describe whether the patient was exposed to radon. respirable_crystalline_silica_exposure: text: respirable_crystalline_silica_exposure description: The yes/no/unknown indicator used to describe whether a patient was exposed to respirable crystalline silica, a widespread, naturally occurring, crystalline metal oxide that consists of different forms including quartz, cristobalite, tridymite, tripoli, ganister, chert and novaculite. type_of_smoke_exposure: text: type_of_smoke_exposure description: The text term used to describe the patient's specific type of smoke exposure. enum_CRDCH_EnvironmentalExposureObservation_method_type: name: enum_CRDCH_EnvironmentalExposureObservation_method_type description: Autogenerated Enumeration for CRDC-H EnvironmentalExposureObservation method_type comments: - 'Name according to TCCM: "CRDC-H.EnvironmentalExposureObservation.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.EnvironmentalExposureObservation.method_type code_set_version: '2021-12-16T18:04:23.006233+00:00' enum_CRDCH_EnvironmentalExposureObservation_value_codeable_concept: name: enum_CRDCH_EnvironmentalExposureObservation_value_codeable_concept description: Autogenerated Enumeration for CRDC-H EnvironmentalExposureObservation value_codeable_concept comments: - 'Name according to TCCM: "CRDC-H.EnvironmentalExposureObservation.value_codeable_concept"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.EnvironmentalExposureObservation.value_codeable_concept code_set_version: '2021-12-16T18:04:23.144799+00:00' permissible_values: Accidental fire smoke, grass: text: Accidental fire smoke, grass Tobacco smoke, NOS: text: Tobacco smoke, NOS Work-related smoke, military: text: Work-related smoke, military Accidental forest fire smoke: text: Accidental forest fire smoke Wood burning smoke, NOS: text: Wood burning smoke, NOS Environmental tobacco smoke: text: Environmental tobacco smoke Tobacco smoke, pipe: text: Tobacco smoke, pipe Indoor stove or fireplace smoke, coal burning: text: Indoor stove or fireplace smoke, coal burning Wood burning smoke, factory: text: Wood burning smoke, factory Indoor stove or fireplace smoke, wood burning: text: Indoor stove or fireplace smoke, wood burning Aircraft smoke: text: Aircraft smoke Tobacco smoke, cigarettes: text: Tobacco smoke, cigarettes Cooking-related smoke, NOS: text: Cooking-related smoke, NOS Coal smoke, NOS: text: Coal smoke, NOS Work-related smoke, generators: text: Work-related smoke, generators Machine smoke: text: Machine smoke No Smoke Exposure: text: No Smoke Exposure Work-related smoke, NOS: text: Work-related smoke, NOS Waste burning smoke: text: Waste burning smoke Work-related smoke, fire fighting: text: Work-related smoke, fire fighting Marijuana smoke: text: Marijuana smoke Hashish smoke: text: Hashish smoke Work-related smoke, plastics factory: text: Work-related smoke, plastics factory Gas burning smoke, propane: text: Gas burning smoke, propane Smokehouse smoke: text: Smokehouse smoke Factory smokestack smoke: text: Factory smokestack smoke Work-related smoke, foundry: text: Work-related smoke, foundry Work-related smoke, artificial smoke machines: text: Work-related smoke, artificial smoke machines Burning tree smoke: text: Burning tree smoke Work-related smoke, paint baking: text: Work-related smoke, paint baking Smoke exposure, NOS: text: Smoke exposure, NOS Field burning smoke: text: Field burning smoke Grilling smoke: text: Grilling smoke Indoor stove or fireplace smoke, NOS: text: Indoor stove or fireplace smoke, NOS Tobacco smoke, cigar: text: Tobacco smoke, cigar Oil burning smoke, Kerosene: text: Oil burning smoke, Kerosene Accidental building fire smoke: text: Accidental building fire smoke Accidental vehicle fire smoke: text: Accidental vehicle fire smoke Oil burning smoke, NOS: text: Oil burning smoke, NOS Electronic cigarette smoke, NOS: text: Electronic cigarette smoke, NOS Recreational fire smoke: text: Recreational fire smoke Accidental fire smoke, NOS: text: Accidental fire smoke, NOS Work-related smoke, plumbing: text: Work-related smoke, plumbing Fire smoke, NOS: text: Fire smoke, NOS Furnace or boiler smoke: text: Furnace or boiler smoke Grease fire smoke: text: Grease fire smoke Electrical fire smoke: text: Electrical fire smoke Volcanic smoke: text: Volcanic smoke Work-related smoke, soldering/welding: text: Work-related smoke, soldering/welding Unknown: text: Unknown description: Unknown 'No': text: 'No' description: 'No' Not Reported: text: Not Reported 'Yes': text: 'Yes' description: 'Yes' enum_CRDCH_ExecutionConditionObservation_category: name: enum_CRDCH_ExecutionConditionObservation_category description: Autogenerated Enumeration for CRDC-H ExecutionConditionObservation category comments: - 'Name according to TCCM: "CRDC-H.ExecutionConditionObservation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.ExecutionConditionObservation.category code_set_version: '2021-12-16T18:04:23.401461+00:00' enum_CRDCH_ExecutionConditionObservation_observation_type: name: enum_CRDCH_ExecutionConditionObservation_observation_type description: Types of observations about the environmental conditions under which specific aspects of an activity were performed. notes: - Derived from [ExecutionConditionObservation.observation_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: ischemic_temperature: text: ischemic_temperature description: A term describing the temperature of a specimen when it experienced ischemia. enum_CRDCH_ExecutionConditionObservation_method_type: name: enum_CRDCH_ExecutionConditionObservation_method_type description: Autogenerated Enumeration for CRDC-H ExecutionConditionObservation method_type comments: - 'Name according to TCCM: "CRDC-H.ExecutionConditionObservation.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.ExecutionConditionObservation.method_type code_set_version: '2021-12-16T18:04:23.676105+00:00' enum_CRDCH_ExecutionConditionObservation_value_codeable_concept: name: enum_CRDCH_ExecutionConditionObservation_value_codeable_concept description: Autogenerated Enumeration for CRDC-H ExecutionConditionObservation value_codeable_concept comments: - 'Name according to TCCM: "CRDC-H.ExecutionConditionObservation.value_codeable_concept"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.ExecutionConditionObservation.value_codeable_concept code_set_version: '2021-12-16T18:04:23.810181+00:00' enum_CRDCH_ExecutionTimeObservation_category: name: enum_CRDCH_ExecutionTimeObservation_category description: Autogenerated Enumeration for CRDC-H ExecutionTimeObservation category comments: - 'Name according to TCCM: "CRDC-H.ExecutionTimeObservation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.ExecutionTimeObservation.category code_set_version: '2021-12-16T18:04:23.949157+00:00' enum_CRDCH_ExecutionTimeObservation_observation_type: name: enum_CRDCH_ExecutionTimeObservation_observation_type description: An observation about the duration of specific aspects / parts of an activity. notes: - Derived from [ExecutionTimeObservation.observation_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: time_between_excision_and_freezing: text: time_between_excision_and_freezing description: The elapsed time between the excision and freezing of the specimen from its subject/source. time_between_clamping_and_freezing: text: time_between_clamping_and_freezing description: The elapsed time between the clamping of blood supply and freezing of the specimen from its subject/source. ischemic_time: text: ischemic_time description: Duration of time, in seconds, between when the specimen stopped receiving oxygen and when it was preserved or processed. enum_CRDCH_ExecutionTimeObservation_method_type: name: enum_CRDCH_ExecutionTimeObservation_method_type description: Autogenerated Enumeration for CRDC-H ExecutionTimeObservation method_type comments: - 'Name according to TCCM: "CRDC-H.ExecutionTimeObservation.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.ExecutionTimeObservation.method_type code_set_version: '2021-12-16T18:04:24.231603+00:00' enum_CRDCH_HistologicalCompositionObservation_category: name: enum_CRDCH_HistologicalCompositionObservation_category description: Autogenerated Enumeration for CRDC-H HistologicalCompositionObservation category comments: - 'Name according to TCCM: "CRDC-H.HistologicalCompositionObservation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.HistologicalCompositionObservation.category code_set_version: '2021-12-16T18:04:24.376807+00:00' enum_CRDCH_HistologicalCompositionObservation_observation_type: name: enum_CRDCH_HistologicalCompositionObservation_observation_type description: Types of measurements that describe microscopic characteristics of a specimen - typically related to its cellular and tissue composition. notes: - Derived from [HistologicalCompositionObservation.observation_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: number_proliferating_cells: text: number_proliferating_cells description: Numeric value that represents the count of proliferating cells determined during pathologic review of the sample slide(s). percent_eosinophil_infiltration: text: percent_eosinophil_infiltration description: Numeric value to represent the percentage of infiltration by eosinophils in a tumor sample or specimen. percent_granulocyte_infiltration: text: percent_granulocyte_infiltration description: Numeric value to represent the percentage of infiltration by granulocytes in a tumor sample or specimen. percent_inflam_infiltration: text: percent_inflam_infiltration description: Numeric value to represent local response to cellular injury, marked by capillary dilatation, edema and leukocyte infiltration; clinically, inflammation is manifest by redness, heat, pain, swelling and loss of function, with the need to heal damaged tissue. percent_lymphocyte_infiltration: text: percent_lymphocyte_infiltration description: Numeric value to represent the percentage of infiltration by lymphocytes in a solid tissue normal sample or specimen. percent_monocyte_infiltration: text: percent_monocyte_infiltration description: Numeric value to represent the percentage of monocyte infiltration in a sample or specimen. percent_necrosis: text: percent_necrosis description: Numeric value to represent the percentage of cell death in a malignant tumor sample or specimen. percent_neutrophil_infiltration: text: percent_neutrophil_infiltration description: Numeric value to represent the percentage of infiltration by neutrophils in a tumor sample or specimen. percent_normal_cells: text: percent_normal_cells description: Numeric value to represent the percentage of normal cell content in a malignant tumor sample or specimen. percent_stromal_cells: text: percent_stromal_cells description: Numeric value to represent the percentage of reactive cells that are present in a malignant tumor sample or specimen but are not malignant such as fibroblasts, vascular structures, etc. percent_tumor_cells: text: percent_tumor_cells description: Numeric value that represents the percentage of infiltration by tumor cells in a sample. percent_tumor_nuclei: text: percent_tumor_nuclei description: Numeric value to represent the percentage of tumor nuclei in a malignant neoplasm sample or specimen. tumor_infiltrating_lymphocytes: text: tumor_infiltrating_lymphocytes description: Measure of Tumor-Infiltrating Lymphocytes non_tumor_tissue_area: text: non_tumor_tissue_area description: The area within a sample that is represented by non-tumor tissue. tumor_tissue_area: text: tumor_tissue_area description: The area within a sample that is comprised of tumor tissue. analysis_area: text: analysis_area description: The total area of a sample that is used for analysis. analysis_area_percentage_stroma: text: analysis_area_percentage_stroma description: The percentage of the analysis area that is represented by stromal tissue. analysis_area_percentage_tumor: text: analysis_area_percentage_tumor description: The percentage of the analysis area that is represented by tumor tissue. analysis_area_percentage_glass: text: analysis_area_percentage_glass description: The area of a sample on a slide that is represented by glass; the area of the sample that represents gaps in the sample. analysis_area_percentage_pigmented_tumor: text: analysis_area_percentage_pigmented_tumor description: The area of a sample on a slide that is represented by pigmented tumor tissue, which will be analyzed. enum_CRDCH_HistologicalCompositionObservation_method_type: name: enum_CRDCH_HistologicalCompositionObservation_method_type description: Autogenerated Enumeration for CRDC-H HistologicalCompositionObservation method_type comments: - 'Name according to TCCM: "CRDC-H.HistologicalCompositionObservation.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.HistologicalCompositionObservation.method_type code_set_version: '2021-12-16T18:04:24.668173+00:00' enum_CRDCH_HistologicalCompositionObservationSet_category: name: enum_CRDCH_HistologicalCompositionObservationSet_category description: Autogenerated Enumeration for CRDC-H HistologicalCompositionObservationSet category comments: - 'Name according to TCCM: "CRDC-H.HistologicalCompositionObservationSet.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.HistologicalCompositionObservationSet.category code_set_version: '2021-12-16T18:04:24.808640+00:00' enum_CRDCH_HistologicalCompositionObservationSet_method_type: name: enum_CRDCH_HistologicalCompositionObservationSet_method_type description: Autogenerated Enumeration for CRDC-H HistologicalCompositionObservationSet method_type comments: - 'Name according to TCCM: "CRDC-H.HistologicalCompositionObservationSet.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.HistologicalCompositionObservationSet.method_type code_set_version: '2021-12-16T18:04:24.958047+00:00' enum_CRDCH_Identifier_type: name: enum_CRDCH_Identifier_type description: Autogenerated Enumeration for CRDC-H Identifier type comments: - 'Name according to TCCM: "CRDC-H.Identifier.type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Identifier.type code_set_version: '2021-12-16T18:04:25.105760+00:00' enum_CRDCH_Observation_category: name: enum_CRDCH_Observation_category description: Autogenerated Enumeration for CRDC-H Observation category comments: - 'Name according to TCCM: "CRDC-H.Observation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Observation.category code_set_version: '2021-12-16T18:04:25.253691+00:00' enum_CRDCH_Observation_observation_type: name: enum_CRDCH_Observation_observation_type description: Autogenerated Enumeration for CRDC-H Observation observation_type comments: - 'Name according to TCCM: "CRDC-H.Observation.observation_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Observation.observation_type code_set_version: '2021-12-16T18:04:25.408145+00:00' enum_CRDCH_Observation_method_type: name: enum_CRDCH_Observation_method_type description: Autogenerated Enumeration for CRDC-H Observation method_type comments: - 'Name according to TCCM: "CRDC-H.Observation.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Observation.method_type code_set_version: '2021-12-16T18:04:25.552876+00:00' enum_CRDCH_Observation_value_codeable_concept: name: enum_CRDCH_Observation_value_codeable_concept description: Autogenerated Enumeration for CRDC-H Observation value_codeable_concept comments: - 'Name according to TCCM: "CRDC-H.Observation.value_codeable_concept"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Observation.value_codeable_concept code_set_version: '2021-12-16T18:04:25.700808+00:00' enum_CRDCH_ObservationSet_category: name: enum_CRDCH_ObservationSet_category description: Autogenerated Enumeration for CRDC-H ObservationSet category comments: - 'Name according to TCCM: "CRDC-H.ObservationSet.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.ObservationSet.category code_set_version: '2021-12-16T18:04:26.217142+00:00' enum_CRDCH_ObservationSet_method_type: name: enum_CRDCH_ObservationSet_method_type description: Autogenerated Enumeration for CRDC-H ObservationSet method_type comments: - 'Name according to TCCM: "CRDC-H.ObservationSet.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.ObservationSet.method_type code_set_version: '2021-12-16T18:04:26.363514+00:00' enum_CRDCH_Quantity_value_codeable_concept: name: enum_CRDCH_Quantity_value_codeable_concept description: Autogenerated Enumeration for CRDC-H Quantity value_codeable_concept comments: - 'Name according to TCCM: "CRDC-H.Quantity.value_codeable_concept"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Quantity.value_codeable_concept code_set_version: '2021-12-16T18:04:26.512767+00:00' permissible_values: Adjacent (< or = 2cm): text: Adjacent (< or = 2cm) description: Adjacent Not Reported: text: Not Reported description: Not Reported Unknown: text: Unknown description: Unknown Distal (>2cm): text: Distal (>2cm) description: Distal enum_CRDCH_Quantity_unit: name: enum_CRDCH_Quantity_unit description: The unit for a value notes: - Derived from [Quantity.unit in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: milligrams: text: milligrams description: '' days: text: days description: '' minutes: text: minutes description: '' enum_CRDCH_ResearchProject_research_project_type: name: enum_CRDCH_ResearchProject_research_project_type description: A high-level type of research activity notes: - Derived from [ResearchProject.research_project_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: Program: text: Program description: A broad framework of goals to be achieved. Project: text: Project description: Any specifically defined piece of work that is undertaken or attempted to meet a single requirement. Clinical Trial: text: Clinical Trial description: A research study that prospectively assigns participants to one or more health-related interventions to evaluate the effects on health outcomes. enum_CRDCH_ResearchSubject_primary_diagnosis_condition: name: enum_CRDCH_ResearchSubject_primary_diagnosis_condition description: Autogenerated Enumeration for CRDC-H ResearchSubject primary_diagnosis_condition comments: - 'Name according to TCCM: "CRDC-H.ResearchSubject.primary_diagnosis_condition"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.ResearchSubject.primary_diagnosis_condition code_set_version: '2021-12-16T18:04:26.993727+00:00' permissible_values: Uveal Melanoma: text: Uveal Melanoma Acute Myeloid Leukemia: text: Acute Myeloid Leukemia Myelodysplastic Syndromes: text: Myelodysplastic Syndromes description: Myelodysplastic Syndrome Sarcoma: text: Sarcoma Early Onset Gastric Cancer: text: Early Onset Gastric Cancer Nevi and Melanomas: text: Nevi and Melanomas description: Melanocytic Nevus and Melanoma Other Hematologic Disorders: text: Other Hematologic Disorders description: Other Hematologic and Lymphocytic Disorder Synovial-like Neoplasms: text: Synovial-like Neoplasms description: Synovial Neoplasm Testicular Germ Cell Tumors: text: Testicular Germ Cell Tumors Complex Epithelial Neoplasms: text: Complex Epithelial Neoplasms Clear Cell Renal Cell Carcinoma: text: Clear Cell Renal Cell Carcinoma Glioblastoma Multiforme: text: Glioblastoma Multiforme High-Risk Wilms Tumor: text: High-Risk Wilms Tumor Mast Cell Tumors: text: Mast Cell Tumors description: Mast Cell Neoplasm Transitional Cell Papillomas and Carcinomas: text: Transitional Cell Papillomas and Carcinomas description: Transitional Cell Papilloma and Transitional Cell Carcinoma Mature T- and NK-Cell Lymphomas: text: Mature T- and NK-Cell Lymphomas description: Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Plasma Cell Tumors: text: Plasma Cell Tumors description: Plasma Cell Neoplasm Miscellaneous Tumors: text: Miscellaneous Tumors description: Miscellaneous Neoplasm Myxomatous Neoplasms: text: Myxomatous Neoplasms description: Myxoma Soft Tissue Tumors and Sarcomas, NOS: text: Soft Tissue Tumors and Sarcomas, NOS description: Soft Tissue Neoplasm and Soft Tissue Sarcoma Glioblastoma: text: Glioblastoma Germ Cell Neoplasms: text: Germ Cell Neoplasms description: Germ Cell Tumor Hepatocellular Carcinoma: text: Hepatocellular Carcinoma Breast Invasive Carcinoma: text: Breast Invasive Carcinoma Adenomas and Adenocarcinomas: text: Adenomas and Adenocarcinomas description: Adenoma and Adenocarcinoma Uterine Carcinosarcoma: text: Uterine Carcinosarcoma Stomach Adenocarcinoma: text: Stomach Adenocarcinoma Neuroepitheliomatous Neoplasms: text: Neuroepitheliomatous Neoplasms description: Neuroepithelial Neoplasm Cystic, Mucinous and Serous Neoplasms: text: Cystic, Mucinous and Serous Neoplasms description: Cystic Neoplasm Mucinous Neoplasm and Serous Neoplasm Nerve Sheath Tumors: text: Nerve Sheath Tumors description: Nerve Sheath Neoplasm Lymphoid Neoplasm Diffuse Large B-cell Lymphoma: text: Lymphoid Neoplasm Diffuse Large B-cell Lymphoma Skin Cutaneous Melanoma: text: Skin Cutaneous Melanoma Colon Adenocarcinoma: text: Colon Adenocarcinoma Thymic Epithelial Neoplasms: text: Thymic Epithelial Neoplasms description: Combined Thymic Epithelial Neoplasm Esophageal Carcinoma: text: Esophageal Carcinoma Kidney Renal Clear Cell Carcinoma: text: Kidney Renal Clear Cell Carcinoma Not Applicable: text: Not Applicable Ductal and Lobular Neoplasms: text: Ductal and Lobular Neoplasms description: Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ Mesonephromas: text: Mesonephromas description: Mesonephric Neoplasm Papillary Renal Cell Carcinoma: text: Papillary Renal Cell Carcinoma HIV+ Tumor Molecular Characterization Project - Cervical Cancer: text: HIV+ Tumor Molecular Characterization Project - Cervical Cancer Meningiomas: text: Meningiomas description: Meningioma HIV+ Tumor Molecular Characterization Project - Lung Cancer: text: HIV+ Tumor Molecular Characterization Project - Lung Cancer Clear Cell Sarcoma of the Kidney: text: Clear Cell Sarcoma of the Kidney Complex Mixed and Stromal Neoplasms: text: Complex Mixed and Stromal Neoplasms description: Complex Mixed and Stromal Neoplasm Cholangiocarcinoma: text: Cholangiocarcinoma Precursor Cell Lymphoblastic Lymphoma: text: Precursor Cell Lymphoblastic Lymphoma description: Lymphoblastic Lymphoma Adnexal and Skin Appendage Neoplasms: text: Adnexal and Skin Appendage Neoplasms description: Adnexal Carcinoma and Skin Appendage Neoplasm Mucoepidermoid Neoplasms: text: Mucoepidermoid Neoplasms description: Mucoepidermoid Carcinoma Lung Adenocarcinoma: text: Lung Adenocarcinoma Leukemias, NOS: text: Leukemias, NOS description: Not Otherwise Specified Leukemia Hodgkin Lymphoma: text: Hodgkin Lymphoma description: Hodgkin Lymphoma Kidney Chromophobe: text: Kidney Chromophobe Chronic Myeloproliferative Disorders: text: Chronic Myeloproliferative Disorders description: Chronic Myeloproliferative Neoplasm Multiple Myeloma: text: Multiple Myeloma Lymphatic Vessel Tumors: text: Lymphatic Vessel Tumors description: Lymphatic Vessel Neoplasm Squamous Cell Neoplasms: text: Squamous Cell Neoplasms description: Squamous Cell Neoplasm Rectum Adenocarcinoma: text: Rectum Adenocarcinoma Chromophobe Renal Cell Carcinoma: text: Chromophobe Renal Cell Carcinoma Mesothelioma: text: Mesothelioma Uterine Corpus Endometrial Carcinoma: text: Uterine Corpus Endometrial Carcinoma Specialized Gonadal Neoplasms: text: Specialized Gonadal Neoplasms description: Specialized Gonadal Neoplasm Gliomas: text: Gliomas description: Glioma Myeloid Leukemias: text: Myeloid Leukemias description: Myeloid Leukemia Neuroblastoma: text: Neuroblastoma Pheochromocytoma and Paraganglioma: text: Pheochromocytoma and Paraganglioma Trophoblastic neoplasms: text: Trophoblastic neoplasms description: Trophoblastic Tumor Burkitt Lymphoma: text: Burkitt Lymphoma Thyroid Carcinoma: text: Thyroid Carcinoma Chronic Lymphocytic Leukemia: text: Chronic Lymphocytic Leukemia Adrenocortical Carcinoma: text: Adrenocortical Carcinoma Acinar Cell Neoplasms: text: Acinar Cell Neoplasms description: Acinar Cell Neoplasm Other: text: Other Lymphoid Leukemias: text: Lymphoid Leukemias description: Lymphoid Leukemia Paragangliomas and Glomus Tumors: text: Paragangliomas and Glomus Tumors description: Paraganglioma And Glomus Tumor Pediatric/AYA Brain Tumors: text: Pediatric/AYA Brain Tumors Malignant Lymphomas, NOS or Diffuse: text: Malignant Lymphomas, NOS or Diffuse description: Not Otherwise Specified or Diffuse Lymphoma Basal Cell Neoplasms: text: Basal Cell Neoplasms description: Basal Cell Neoplasm Rhabdoid Tumor: text: Rhabdoid Tumor Unknown: text: Unknown description: Unknown Myomatous Neoplasms: text: Myomatous Neoplasms description: Myomatous Neoplasm Kidney Renal Papillary Cell Carcinoma: text: Kidney Renal Papillary Cell Carcinoma Acute Lymphoblastic Leukemia: text: Acute Lymphoblastic Leukemia Bladder Urothelial Carcinoma: text: Bladder Urothelial Carcinoma Fibroepithelial Neoplasms: text: Fibroepithelial Neoplasms description: Fibroepithelial Neoplasm Granular Cell Tumors and Alveolar Soft Part Sarcomas: text: Granular Cell Tumors and Alveolar Soft Part Sarcomas description: Granular Cell Tumor and Alveolar Soft Part Sarcoma Brain Lower Grade Glioma: text: Brain Lower Grade Glioma Oral Squamous Cell Carcinoma: text: Oral Squamous Cell Carcinoma Thymoma: text: Thymoma Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: text: Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma Osseous and Chondromatous Neoplasms: text: Osseous and Chondromatous Neoplasms description: Osteogenic Neoplasm and Chondrogenic Neoplasm Neoplasms, NOS: text: Neoplasms, NOS description: Not Otherwise Specified Neoplasm Not Reported: text: Not Reported description: Not Reported Pancreatic Ductal Adenocarcinoma: text: Pancreatic Ductal Adenocarcinoma Pancreatic Adenocarcinoma: text: Pancreatic Adenocarcinoma Neoplasms of Histiocytes and Accessory Lymphoid Cells: text: Neoplasms of Histiocytes and Accessory Lymphoid Cells description: Neoplasms of Histiocytes and Accessory Lymphoid Cells Odontogenic Tumors: text: Odontogenic Tumors description: Odontogenic Neoplasm Ovarian Serous Cystadenocarcinoma: text: Ovarian Serous Cystadenocarcinoma Lung Squamous Cell Carcinoma: text: Lung Squamous Cell Carcinoma Prostate Adenocarcinoma: text: Prostate Adenocarcinoma Mature B-Cell Lymphomas: text: Mature B-Cell Lymphomas description: Mature B-Cell Non-Hodgkin Lymphoma Mesothelial Neoplasms: text: Mesothelial Neoplasms description: Mesothelial Neoplasm Fibromatous Neoplasms: text: Fibromatous Neoplasms description: Fibromatosis Head and Neck Squamous Cell Carcinoma: text: Head and Neck Squamous Cell Carcinoma Lipomatous Neoplasms: text: Lipomatous Neoplasms description: Lipomatous Neoplasm Other Leukemias: text: Other Leukemias description: Other Leukemia Osteosarcoma: text: Osteosarcoma Liver Hepatocellular Carcinoma: text: Liver Hepatocellular Carcinoma Miscellaneous Bone Tumors: text: Miscellaneous Bone Tumors description: Miscellaneous Bone Neoplasm Blood Vessel Tumors: text: Blood Vessel Tumors description: Blood Vessel Neoplasm Giant Cell Tumors: text: Giant Cell Tumors description: Giant Cell Tumor Epithelial Neoplasms, NOS: text: Epithelial Neoplasms, NOS description: Not Otherwise Specified Epithelial Neoplasm Immunoproliferative Diseases: text: Immunoproliferative Diseases description: Immunoproliferative Disease enum_CRDCH_ResearchSubject_index_timepoint: name: enum_CRDCH_ResearchSubject_index_timepoint description: Autogenerated Enumeration for CRDC-H ResearchSubject index_timepoint comments: - 'Name according to TCCM: "CRDC-H.ResearchSubject.index_timepoint"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.ResearchSubject.index_timepoint code_set_version: '2021-12-16T18:04:27.373345+00:00' permissible_values: First Treatment: text: First Treatment Initial Genomic Sequencing: text: Initial Genomic Sequencing Study Enrollment: text: Study Enrollment description: Clinical Study Enrollment Diagnosis: text: Diagnosis description: Diagnosis First Patient Visit: text: First Patient Visit description: First Patient Visit Sample Procurement: text: Sample Procurement description: Tissue Procurement Recurrence: text: Recurrence enum_CRDCH_Specimen_specimen_type: name: enum_CRDCH_Specimen_specimen_type description: A high-level type of specimen, based on its derivation provenance (i.e. how far removed it is from the original sample extracted from a source). notes: - Derived from [Specimen.specimen_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: Fresh Specimen: text: Fresh Specimen description: A specimen representing the material that was directly collected from a subject (i.e. not generated through portioning, aliquoting, or analyte extraction from an existing specimen). portion: text: portion description: A physical sub-part taken from an existing specimen. aliquot: text: aliquot description: A specimen that results from the division of some parent specimen into equal amounts for downstream analysis. analyte: text: analyte description: A specimen generated through the extraction of a specified class of substance/chemical (e.g. DNA, RNA, protein) from a parent specimen, which is stored in solution as an analyte. slide: text: slide description: A specimen that is mounted on a slide or coverslip for microscopic analysis. enum_CRDCH_Specimen_analyte_type: name: enum_CRDCH_Specimen_analyte_type description: Autogenerated Enumeration for CRDC-H Specimen analyte_type comments: - 'Name according to TCCM: "CRDC-H.Specimen.analyte_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Specimen.analyte_type code_set_version: '2021-12-16T18:04:27.663660+00:00' permissible_values: D: text: D description: DNA S: text: S X: text: X description: Repli-G X (Qiagen) DNA R: text: R description: Ribonucleic Acid T: text: T description: Total Ribonucleic Acid W: text: W description: Repli-G (Qiagen) DNA H: text: H description: Hybrid Extraction RNA G: text: G description: GenomePlex (Rubicon) Amplified DNA E: text: E Y: text: Y FFPE DNA: text: FFPE DNA description: Formalin-Fixed Paraffin-Embedded DNA Repli-G (Qiagen) DNA: text: Repli-G (Qiagen) DNA description: Repli-G (Qiagen) DNA GenomePlex (Rubicon) Amplified DNA: text: GenomePlex (Rubicon) Amplified DNA Total RNA: text: Total RNA description: Total Ribonucleic Acid Repli-G X (Qiagen) DNA: text: Repli-G X (Qiagen) DNA description: Repli-G X (Qiagen) DNA RNA: text: RNA description: Ribonucleic Acid Repli-G Pooled (Qiagen) DNA: text: Repli-G Pooled (Qiagen) DNA description: REPLI-g Pooled DNA DNA: text: DNA description: DNA EBV Immortalized Normal: text: EBV Immortalized Normal description: Normal Epstein-Barr Virus Immortalization FFPE RNA: text: FFPE RNA description: Formalin-Fixed Paraffin-Embedded RNA Protein: text: Protein description: Protein Nuclei RNA: text: Nuclei RNA cfDNA: text: cfDNA enum_CRDCH_Specimen_source_material_type: name: enum_CRDCH_Specimen_source_material_type description: Autogenerated Enumeration for CRDC-H Specimen source_material_type comments: - 'Name according to TCCM: "CRDC-H.Specimen.source_material_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Specimen.source_material_type code_set_version: '2021-12-16T18:04:27.866079+00:00' permissible_values: '20': text: '20' '10': text: '10' '13': text: '13' '14': text: '14' '02': text: '02' '61': text: '61' '11': text: '11' '15': text: '15' '41': text: '41' '17': text: '17' '86': text: '86' '99': text: '99' '06': text: '06' '30': text: '30' '42': text: '42' 09: text: 09 '16': text: '16' '18': text: '18' '31': text: '31' '60': text: '60' '40': text: '40' '12': text: '12' '50': text: '50' '85': text: '85' 08: text: 08 '03': text: '03' '05': text: '05' '07': text: '07' '04': text: '04' '01': text: '01' '32': text: '32' Expanded Next Generation Cancer Model: text: Expanded Next Generation Cancer Model Blood Derived Liquid Biopsy: text: Blood Derived Liquid Biopsy Xenograft Tissue: text: Xenograft Tissue RNA: text: RNA Not Allowed To Collect: text: Not Allowed To Collect Granulocytes: text: Granulocytes description: Granulocyte Lymphoid Normal: text: Lymphoid Normal Post neo-adjuvant therapy: text: Post neo-adjuvant therapy Blood Derived Normal: text: Blood Derived Normal Primary Blood Derived Cancer - Peripheral Blood: text: Primary Blood Derived Cancer - Peripheral Blood Primary Blood Derived Cancer - Bone Marrow: text: Primary Blood Derived Cancer - Bone Marrow Tumor: text: Tumor description: Neoplasm Additional Metastatic: text: Additional Metastatic Pleural Effusion: text: Pleural Effusion Next Generation Cancer Model: text: Next Generation Cancer Model Additional - New Primary: text: Additional - New Primary Mixed Adherent Suspension: text: Mixed Adherent Suspension Saliva: text: Saliva description: Saliva Slides: text: Slides Human Tumor Original Cells: text: Human Tumor Original Cells Metastatic: text: Metastatic Neoplasms of Uncertain and Unknown Behavior: text: Neoplasms of Uncertain and Unknown Behavior Bone Marrow Normal: text: Bone Marrow Normal Recurrent Blood Derived Cancer - Bone Marrow: text: Recurrent Blood Derived Cancer - Bone Marrow Mononuclear Cells from Bone Marrow Normal: text: Mononuclear Cells from Bone Marrow Normal Buccal Cell Normal: text: Buccal Cell Normal Solid Tissue Normal: text: Solid Tissue Normal Cell Lines: text: Cell Lines Repli-G X (Qiagen) DNA: text: Repli-G X (Qiagen) DNA Blood Derived Cancer - Peripheral Blood: text: Blood Derived Cancer - Peripheral Blood Benign Neoplasms: text: Benign Neoplasms Repli-G (Qiagen) DNA: text: Repli-G (Qiagen) DNA Recurrent Tumor: text: Recurrent Tumor Primary Xenograft Tissue: text: Primary Xenograft Tissue In Situ Neoplasms: text: In Situ Neoplasms Fibroblasts from Bone Marrow Normal: text: Fibroblasts from Bone Marrow Normal Tumor Adjacent Normal - Post Neo-adjuvant Therapy: text: Tumor Adjacent Normal - Post Neo-adjuvant Therapy Not Reported: text: Not Reported Blood Derived Cancer - Peripheral Blood, Post-treatment: text: Blood Derived Cancer - Peripheral Blood, Post-treatment Recurrent Blood Derived Cancer - Peripheral Blood: text: Recurrent Blood Derived Cancer - Peripheral Blood GenomePlex (Rubicon) Amplified DNA: text: GenomePlex (Rubicon) Amplified DNA Blood Derived Cancer - Bone Marrow: text: Blood Derived Cancer - Bone Marrow Unknown: text: Unknown Primary Tumor: text: Primary Tumor description: Primary Neoplasm Control Analyte: text: Control Analyte Total RNA: text: Total RNA FFPE Scrolls: text: FFPE Scrolls description: Formalin Fixed Paraffin Embedded Tissue Scroll Blood Derived Cancer - Bone Marrow, Post-treatment: text: Blood Derived Cancer - Bone Marrow, Post-treatment FFPE Recurrent: text: FFPE Recurrent EBV Immortalized Normal: text: EBV Immortalized Normal DNA: text: DNA Cell Line Derived Xenograft Tissue: text: Cell Line Derived Xenograft Tissue Normal Adjacent Tissue: text: Normal Adjacent Tissue enum_CRDCH_Specimen_tumor_status_at_collection: name: enum_CRDCH_Specimen_tumor_status_at_collection description: Autogenerated Enumeration for CRDC-H Specimen tumor_status_at_collection comments: - 'Name according to TCCM: "CRDC-H.Specimen.tumor_status_at_collection"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Specimen.tumor_status_at_collection code_set_version: '2021-12-16T18:04:28.204835+00:00' permissible_values: primary: text: primary Not Allowed To Collect: text: Not Allowed To Collect Progression: text: Progression recurrence: text: recurrence Unknown: text: Unknown metastasis: text: metastasis Premalignant: text: Premalignant description: Premalignant other: text: other not reported: text: not reported Not Applicable: text: Not Applicable Metastatic: text: Metastatic description: Metastatic Tumor Tissue NOS: text: NOS description: Not Otherwise Specified Not Reported: text: Not Reported Xenograft: text: Xenograft description: Xenograft Primary: text: Primary description: Primary Untreated Malignant Tumor Tissue Recurrence: text: Recurrence enum_CRDCH_Specimen_cellular_composition_type: name: enum_CRDCH_Specimen_cellular_composition_type description: Autogenerated Enumeration for CRDC-H Specimen cellular_composition_type comments: - 'Name according to TCCM: "CRDC-H.Specimen.cellular_composition_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Specimen.cellular_composition_type code_set_version: '2021-12-16T18:04:28.379034+00:00' permissible_values: Mixed Adherent Suspension: text: Mixed Adherent Suspension 3D Neurosphere: text: 3D Neurosphere Fibroblasts from Bone Marrow Normal: text: Fibroblasts from Bone Marrow Normal description: Normal Bone Marrow Fibroblast 2D Classical Conditionally Reprogrammed Cells: text: 2D Classical Conditionally Reprogrammed Cells Serum: text: Serum description: Serum 2D Modified Conditionally Reprogrammed Cells: text: 2D Modified Conditionally Reprogrammed Cells Granulocytes: text: Granulocytes description: Granulocyte Derived Cell Line: text: Derived Cell Line description: Derived Cell Line Bone Marrow Components NOS: text: Bone Marrow Components NOS description: Bone Marrow Component Not Otherwise Specified Buccal Cells: text: Buccal Cells description: Buccal Cell Mononuclear Cells from Bone Marrow Normal: text: Mononuclear Cells from Bone Marrow Normal description: Normal Bone Marrow Monocyte Human Original Cells: text: Human Original Cells Solid Tissue: text: Solid Tissue description: Solid Tissue Sorted Cells: text: Sorted Cells Not Reported: text: Not Reported 3D Organoid: text: 3D Organoid Peripheral Blood Components NOS: text: Peripheral Blood Components NOS description: Peripheral Blood Component Not Otherwise Specified Whole Bone Marrow: text: Whole Bone Marrow description: Whole Bone Marrow 3D Air-Liquid Interface Organoid: text: 3D Air-Liquid Interface Organoid Cell: text: Cell description: Cell Adherent Cell Line: text: Adherent Cell Line Pleural Effusion: text: Pleural Effusion description: Pleural Fluid Liquid Suspension Cell Line: text: Liquid Suspension Cell Line Control Analyte: text: Control Analyte description: Control Analyte Peripheral Whole Blood: text: Peripheral Whole Blood description: Peripheral Whole Blood Lymphocytes: text: Lymphocytes description: Lymphocyte Plasma: text: Plasma description: Plasma Bone Marrow Components: text: Bone Marrow Components description: Bone Marrow Component Sputum: text: Sputum description: Sputum Buffy Coat: text: Buffy Coat description: Buffy Coat Saliva: text: Saliva description: Saliva EBV Immortalized: text: EBV Immortalized description: Epstein-Barr Virus Immortalized Unknown: text: Unknown Not Allowed To Collect: text: Not Allowed To Collect enum_CRDCH_Specimen_general_tissue_pathology: name: enum_CRDCH_Specimen_general_tissue_pathology description: Autogenerated Enumeration for CRDC-H Specimen general_tissue_pathology comments: - 'Name according to TCCM: "CRDC-H.Specimen.general_tissue_pathology"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Specimen.general_tissue_pathology code_set_version: '2021-12-16T18:04:28.622991+00:00' permissible_values: Not Reported: text: Not Reported Normal: text: Normal description: Normal Tumor: text: Tumor description: Malignant Neoplasm Abnormal: text: Abnormal description: Abnormal Unknown: text: Unknown description: Unknown Peritumoral: text: Peritumoral description: Peritumoral Not Allowed To Collect: text: Not Allowed To Collect enum_CRDCH_Specimen_specific_tissue_pathology: name: enum_CRDCH_Specimen_specific_tissue_pathology description: Autogenerated Enumeration for CRDC-H Specimen specific_tissue_pathology comments: - 'Name according to TCCM: "CRDC-H.Specimen.specific_tissue_pathology"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Specimen.specific_tissue_pathology code_set_version: '2021-12-16T18:04:28.788333+00:00' permissible_values: '60': text: '60' '41': text: '41' '15': text: '15' '52': text: '52' '51': text: '51' '70': text: '70' '50': text: '50' '00': text: '00' '20': text: '20' '62': text: '62' '30': text: '30' '04': text: '04' '63': text: '63' '03': text: '03' '65': text: '65' '71': text: '71' '64': text: '64' '80': text: '80' '02': text: '02' '40': text: '40' '01': text: '01' '81': text: '81' '61': text: '61' '21': text: '21' '10': text: '10' NHL, anaplastic large cell lymphoma: text: NHL, anaplastic large cell lymphoma Acute lymphoblastic leukemia (ALL): text: Acute lymphoblastic leukemia (ALL) Clear cell sarcoma of the kidney (CCSK): text: Clear cell sarcoma of the kidney (CCSK) Wilms tumor (WT): text: Wilms tumor (WT) Cervical Cancer (all types): text: Cervical Cancer (all types) Anal Cancer (all types): text: Anal Cancer (all types) Ewing sarcoma: text: Ewing sarcoma CNS, rhabdoid tumor: text: CNS, rhabdoid tumor Non cancerous tissue: text: Non cancerous tissue CNS, other: text: CNS, other Acute Leukemia of Ambiguous Lineage (ALAL): text: Acute Leukemia of Ambiguous Lineage (ALAL) Lung Cancer (all types): text: Lung Cancer (all types) Induction Failure AML (AML-IF): text: Induction Failure AML (AML-IF) CNS, medulloblastoma: text: CNS, medulloblastoma CNS, ependymoma: text: CNS, ependymoma CNS, glioblastoma (GBM): text: CNS, glioblastoma (GBM) CNS, low grade glioma (LGG): text: CNS, low grade glioma (LGG) Diffuse Large B-Cell Lymphoma (DLBCL): text: Diffuse Large B-Cell Lymphoma (DLBCL) Rhabdoid tumor (kidney) (RT): text: Rhabdoid tumor (kidney) (RT) Osteosarcoma (OS): text: Osteosarcoma (OS) Soft tissue sarcoma, non-rhabdomyosarcoma: text: Soft tissue sarcoma, non-rhabdomyosarcoma NHL, Burkitt lymphoma (BL): text: NHL, Burkitt lymphoma (BL) Neuroblastoma (NBL): text: Neuroblastoma (NBL) Rhabdomyosarcoma: text: Rhabdomyosarcoma Acute myeloid leukemia (AML): text: Acute myeloid leukemia (AML) enum_CRDCH_Specimen_preinvasive_tissue_morphology: name: enum_CRDCH_Specimen_preinvasive_tissue_morphology description: Autogenerated Enumeration for CRDC-H Specimen preinvasive_tissue_morphology comments: - 'Name according to TCCM: "CRDC-H.Specimen.preinvasive_tissue_morphology"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Specimen.preinvasive_tissue_morphology code_set_version: '2021-12-16T18:04:29.034984+00:00' enum_CRDCH_Specimen_morphology_assessor_role: name: enum_CRDCH_Specimen_morphology_assessor_role description: Autogenerated Enumeration for CRDC-H Specimen morphology_assessor_role comments: - 'Name according to TCCM: "CRDC-H.Specimen.morphology_assessor_role"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Specimen.morphology_assessor_role code_set_version: '2021-12-16T18:04:29.184186+00:00' enum_CRDCH_Specimen_morphology_assessment_method: name: enum_CRDCH_Specimen_morphology_assessment_method description: Autogenerated Enumeration for CRDC-H Specimen morphology_assessment_method comments: - 'Name according to TCCM: "CRDC-H.Specimen.morphology_assessment_method"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Specimen.morphology_assessment_method code_set_version: '2021-12-16T18:04:29.331265+00:00' enum_CRDCH_Specimen_degree_of_dysplasia: name: enum_CRDCH_Specimen_degree_of_dysplasia description: Autogenerated Enumeration for CRDC-H Specimen degree_of_dysplasia comments: - 'Name according to TCCM: "CRDC-H.Specimen.degree_of_dysplasia"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Specimen.degree_of_dysplasia code_set_version: '2021-12-16T18:04:29.469027+00:00' enum_CRDCH_Specimen_section_location: name: enum_CRDCH_Specimen_section_location related_mappings: - GDC:Sample.section_location description: The location in a parent specimen from which a section/portion was excised. notes: - Derived from [Specimen.section_location in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: top: text: top description: The part of a specimen designated as its 'top' based on specified orientation criteria. unknown: text: unknown description: An unknown location on a specimen. bottom: text: bottom description: The part of a specimen designated as its 'bottom' based on specified orientation criteria. enum_CRDCH_SpecimenContainer_container_type: name: enum_CRDCH_SpecimenContainer_container_type description: Autogenerated Enumeration for CRDC-H SpecimenContainer container_type comments: - 'Name according to TCCM: "CRDC-H.SpecimenContainer.container_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.SpecimenContainer.container_type code_set_version: '2021-12-16T18:04:29.748768+00:00' enum_CRDCH_SpecimenCreationActivity_activity_type: name: enum_CRDCH_SpecimenCreationActivity_activity_type description: The high-level type of activity through which the specimen was generated (i.e. via collection from the original source, or via derivation from an existing specimen) notes: - Derived from [SpecimenCreationActivity.activity_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: collection from source: text: collection from source description: An activity that collects an initial sample directly from a subject / source. derivation from specimen: text: derivation from specimen description: An activity that derives a new specimen from an existing one. enum_CRDCH_SpecimenCreationActivity_collection_method_type: name: enum_CRDCH_SpecimenCreationActivity_collection_method_type description: Autogenerated Enumeration for CRDC-H SpecimenCreationActivity collection_method_type comments: - 'Name according to TCCM: "CRDC-H.SpecimenCreationActivity.collection_method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.SpecimenCreationActivity.collection_method_type code_set_version: '2021-12-16T18:04:30.023438+00:00' permissible_values: Orchiectomy: text: Orchiectomy Metastasectomy: text: Metastasectomy Autopsy: text: Autopsy Unknown: text: Unknown Aspirate: text: Aspirate Right Hemicolectomy: text: Right Hemicolectomy Incisional Biopsy: text: Incisional Biopsy Blood Draw: text: Blood Draw Peritoneal Lavage: text: Peritoneal Lavage Open Radical Prostatectomy: text: Open Radical Prostatectomy Abdomino-perineal Resection of Rectum: text: Abdomino-perineal Resection of Rectum Salpingectomy: text: Salpingectomy Endo Rectal Tumor Resection: text: Endo Rectal Tumor Resection Biopsy: text: Biopsy Salpingo-oophorectomy: text: Salpingo-oophorectomy Not Allowed To Collect: text: Not Allowed To Collect Whipple Procedure: text: Whipple Procedure Enucleation: text: Enucleation Modified Radical Mastectomy: text: Modified Radical Mastectomy Paracentesis: text: Paracentesis Open Craniotomy: text: Open Craniotomy Wedge Resection: text: Wedge Resection Laparoscopic Radical Nephrectomy: text: Laparoscopic Radical Nephrectomy Open Partial Nephrectomy: text: Open Partial Nephrectomy Transurethral resection (TURBT): text: Transurethral resection (TURBT) Sigmoid Colectomy: text: Sigmoid Colectomy Oophorectomy: text: Oophorectomy Total Hepatectomy: text: Total Hepatectomy Indeterminant: text: Indeterminant Subtotal Resection: text: Subtotal Resection Left Hemicolectomy: text: Left Hemicolectomy Needle Biopsy: text: Needle Biopsy Other: text: Other Pancreatectomy: text: Pancreatectomy Thoracoscopic Biopsy: text: Thoracoscopic Biopsy Total Mastectomy: text: Total Mastectomy Excisional Biopsy: text: Excisional Biopsy Bone Marrow Aspirate: text: Bone Marrow Aspirate Local Resection (Exoresection; wall resection): text: Local Resection (Exoresection; wall resection) Lobectomy: text: Lobectomy Fine Needle Aspiration: text: Fine Needle Aspiration Omentectomy: text: Omentectomy Tumor Resection: text: Tumor Resection Cystectomy: text: Cystectomy Gross Total Resection: text: Gross Total Resection Thoracentesis: text: Thoracentesis Anterior Resection of Rectum: text: Anterior Resection of Rectum Transplant: text: Transplant Laparoscopic Partial Nephrectomy: text: Laparoscopic Partial Nephrectomy Laparoscopic Radical Prostatectomy with Robotics: text: Laparoscopic Radical Prostatectomy with Robotics Pneumonectomy: text: Pneumonectomy Pan-Procto Colectomy: text: Pan-Procto Colectomy Hysterectomy NOS: text: Hysterectomy NOS Core Biopsy: text: Core Biopsy Simple Mastectomy: text: Simple Mastectomy Lumpectomy: text: Lumpectomy Endoscopic Biopsy: text: Endoscopic Biopsy Simple Hysterectomy: text: Simple Hysterectomy Lymphadenectomy: text: Lymphadenectomy Laparoscopic Biopsy: text: Laparoscopic Biopsy Tumor Debulking: text: Tumor Debulking Ascites Drainage: text: Ascites Drainage Endoscopic Mucosal Resection (EMR): text: Endoscopic Mucosal Resection (EMR) Laparoscopic Radical Prostatectomy without Robotics: text: Laparoscopic Radical Prostatectomy without Robotics Total Colectomy: text: Total Colectomy Liquid Biopsy: text: Liquid Biopsy Radical Hysterectomy: text: Radical Hysterectomy Surgical Resection: text: Surgical Resection Open Radical Nephrectomy: text: Open Radical Nephrectomy Transverse Colectomy: text: Transverse Colectomy Hand Assisted Laparoscopic Radical Nephrectomy: text: Hand Assisted Laparoscopic Radical Nephrectomy Punch Biopsy: text: Punch Biopsy Partial Hepatectomy: text: Partial Hepatectomy Supracervical Hysterectomy: text: Supracervical Hysterectomy Other Surgical Resection: text: Other Surgical Resection Not Reported: text: Not Reported Full Hysterectomy: text: Full Hysterectomy 'No': text: 'No' 'Yes': text: 'Yes' Tonsillectomy: text: Tonsillectomy Supraglottic Laryngectomy: text: Supraglottic Laryngectomy Superficial Parotidectomy: text: Superficial Parotidectomy Laryngopharyngectomy: text: Laryngopharyngectomy Transurethral Resection (TURP): text: Transurethral Resection (TURP) Maxillectomy: text: Maxillectomy Partial Nephrectomy: text: Partial Nephrectomy Mandibulectomy: text: Mandibulectomy Buccal Mucosal Resection: text: Buccal Mucosal Resection Vertical Hemilaryngectomy: text: Vertical Hemilaryngectomy Total Nephrectomy: text: Total Nephrectomy Total Laryngectomy: text: Total Laryngectomy Transoral Laser Excision: text: Transoral Laser Excision Parotidectomy, NOS: text: Parotidectomy, NOS Radical Maxillectomy: text: Radical Maxillectomy Endolaryngeal Excision: text: Endolaryngeal Excision Palatectomy: text: Palatectomy Glossectomy: text: Glossectomy Partial Laryngectomy: text: Partial Laryngectomy Lymph Node Dissection: text: Lymph Node Dissection Radical Prostatectomy: text: Radical Prostatectomy Deep Parotidectomy: text: Deep Parotidectomy Subtotal Prostatectomy: text: Subtotal Prostatectomy Radical Nephrectomy: text: Radical Nephrectomy Supracricoid Laryngectomy: text: Supracricoid Laryngectomy Partial Maxillectomy: text: Partial Maxillectomy enum_CRDCH_SpecimenCreationActivity_derivation_method_type: name: enum_CRDCH_SpecimenCreationActivity_derivation_method_type description: Autogenerated Enumeration for CRDC-H SpecimenCreationActivity derivation_method_type comments: - 'Name according to TCCM: "CRDC-H.SpecimenCreationActivity.derivation_method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.SpecimenCreationActivity.derivation_method_type code_set_version: '2021-12-16T18:04:30.373776+00:00' enum_CRDCH_SpecimenQualityObservation_category: name: enum_CRDCH_SpecimenQualityObservation_category description: Autogenerated Enumeration for CRDC-H SpecimenQualityObservation category comments: - 'Name according to TCCM: "CRDC-H.SpecimenQualityObservation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.SpecimenQualityObservation.category code_set_version: '2021-12-16T18:04:30.515200+00:00' enum_CRDCH_SpecimenQualityObservation_observation_type: name: enum_CRDCH_SpecimenQualityObservation_observation_type description: Types of measurements that reflect the quality of a specimen or its suitability for use. notes: - Derived from [SpecimenQualityObservation.observation_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: 'a260_a280_ratio ': text: 'a260_a280_ratio ' description: Ratio of absorbance measured at a wavelength of 260 over that at a wavelength of 280. ribosomal_rna_28s_16s_ratio: text: ribosomal_rna_28s_16s_ratio description: Ratio of quantity of 28s RNA over that of 16s RNA. enum_CRDCH_SpecimenQualityObservation_method_type: name: enum_CRDCH_SpecimenQualityObservation_method_type related_mappings: - GDC:Analyte.spectrophotometer_method - PDC:Analyte.spectrophotometer_method description: A type of method used in determining the quantity of a specimen. notes: - Derived from [SpecimenQualityObservation.method_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: UV Spec: text: UV Spec description: A technique used to measure light absorbance across the ultraviolet and visible ranges of the electromagnetic spectrum. Pico Green: text: Pico Green description: A technique applying the Pico488 fluorescent sensor dye that is used for quantifying the amount of double-stranded DNA (dsDNA) present in a given sample. enum_CRDCH_SpecimenQuantityObservation_category: name: enum_CRDCH_SpecimenQuantityObservation_category description: Autogenerated Enumeration for CRDC-H SpecimenQuantityObservation category comments: - 'Name according to TCCM: "CRDC-H.SpecimenQuantityObservation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.SpecimenQuantityObservation.category code_set_version: '2021-12-16T18:04:30.942437+00:00' enum_CRDCH_SpecimenQuantityObservation_observation_type: name: enum_CRDCH_SpecimenQuantityObservation_observation_type description: Measures related to the quantity of a specimen or analyte it currently contains - e.g. its weight, volume, or concentration. notes: - Derived from [SpecimenQuantityObservation.observation_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: weight: text: weight description: The current weight of the specimen, at the time of recording (as opposed to an initial weight before its processing or portioning). volume: text: volume description: The current total volume of the specimen, at the time of recording. concentration: text: concentration description: The concentration of an extracted analyte that is present in a specimen (specifically, in a specimen of type 'analyte', or an 'aliquot' derived from an analyte). For example, the concentration of DNA in a specimen created through extracting DNA from a blood sample. enum_CRDCH_SpecimenQuantityObservation_method_type: name: enum_CRDCH_SpecimenQuantityObservation_method_type description: Autogenerated Enumeration for CRDC-H SpecimenQuantityObservation method_type comments: - 'Name according to TCCM: "CRDC-H.SpecimenQuantityObservation.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.SpecimenQuantityObservation.method_type code_set_version: '2021-12-16T18:04:31.226101+00:00' enum_CRDCH_SpecimenProcessingActivity_activity_type: name: enum_CRDCH_SpecimenProcessingActivity_activity_type description: The high-level type of processing activity performed. notes: - Derived from [SpecimenProcessingActivity.activity_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: Fixation: text: Fixation description: A processing activity that applies chemicals to preserve biological tissues from decay due to autolysis or putrefaction Freezing: text: Freezing description: A processing activity that aims to freeze a specimen. Mounting: text: Mounting description: A processing activity that aims to secure a specimen or slide in place in preparation for further examination (usually via microscopy) Preservation: text: Preservation description: A processing activity that aims to preserve a specimen. enum_CRDCH_SpecimenProcessingActivity_method_type: name: enum_CRDCH_SpecimenProcessingActivity_method_type related_mappings: - GDC:Sample.freezing_method - GDC:Sample.preservation_method - GDC:Sample.is_ffpe - GDC:Portion.is_ffpe - GDC:Sample.oct_embedded - PDC:Sample.freezing_method - PDC:Sample.preservation_method - PDC:Sample.is_ffpe - GDC:Portion.is_ffpe - PDC:Sample.oct_embedded - HTAN:Biospecimen.PRESERVATION_METHOD description: A type of method used to process a specimen (e.g. freezing, fixing, treating, preserving, labeling, etc.). notes: - Derived from [SpecimenProcessingActivity.method_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: Minues 80 Degrees Celsius Freezer: text: Minues 80 Degrees Celsius Freezer description: Freezing at -80 degrees celcius '-20': text: '-20' description: Freezing at -20 degrees celcius LN2: text: LN2 description: Freezing in liquid nitrogen. isopentane: text: isopentane description: Freezing in isopentane. enum_CRDCH_SpecimenStorageActivity_method_type: name: enum_CRDCH_SpecimenStorageActivity_method_type description: Autogenerated Enumeration for CRDC-H SpecimenStorageActivity method_type comments: - 'Name according to TCCM: "CRDC-H.SpecimenStorageActivity.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.SpecimenStorageActivity.method_type code_set_version: '2021-12-16T18:04:31.675280+00:00' enum_CRDCH_Subject_species: name: enum_CRDCH_Subject_species description: The scientific binomial name for the species of the subject notes: - Derived from [Subject.species in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: Homo sapiens: text: Homo sapiens description: '' Canis familiaris: text: Canis familiaris description: '' Mus musculus: text: Mus musculus description: '' enum_CRDCH_Subject_breed: name: enum_CRDCH_Subject_breed description: A label given to a group of animals homogeneous in appearance and other characteristics that distinguish it from other animals of the same species. notes: - Derived from [Subject.breed in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: Akita: text: Akita description: '' American Staffordshire Terrier: text: American Staffordshire Terrier description: '' Australian Shepherd: text: Australian Shepherd description: '' Basset Hound: text: Basset Hound description: '' Beagle: text: Beagle description: '' Belgian Malinois: text: Belgian Malinois description: '' Bernese Mountain Dog: text: Bernese Mountain Dog description: '' Black and Tan Coonhound: text: Black and Tan Coonhound description: '' Border Collie: text: Border Collie description: '' Boston Terrier: text: Boston Terrier description: '' Bouvier des Flandres: text: Bouvier des Flandres description: '' Boxer: text: Boxer description: '' Bulldog: text: Bulldog description: '' Bullmastiff: text: Bullmastiff description: '' Cavalier King Charles Spaniel: text: Cavalier King Charles Spaniel description: '' Chesapeake Bay Retriever: text: Chesapeake Bay Retriever description: '' Chihuahua: text: Chihuahua description: '' Chinese Shar-Pei: text: Chinese Shar-Pei description: '' Cocker Spaniel: text: Cocker Spaniel description: '' Dalmatian: text: Dalmatian description: '' Doberman Pinscher: text: Doberman Pinscher description: '' English Setter: text: English Setter description: '' Flat-Coated Retriever: text: Flat-Coated Retriever description: '' French Bulldog: text: French Bulldog description: '' German Shepherd Dog: text: German Shepherd Dog description: '' German Shorthaired Pointer: text: German Shorthaired Pointer description: '' Giant Schnauzer: text: Giant Schnauzer description: '' Golden Retriever: text: Golden Retriever description: '' Gordon Setter: text: Gordon Setter description: '' Greyhound: text: Greyhound description: '' Irish Setter: text: Irish Setter description: '' Irish Wolfhound: text: Irish Wolfhound description: '' Labrador Retriever: text: Labrador Retriever description: '' Mastiff: text: Mastiff description: '' Miniature Schnauzer: text: Miniature Schnauzer description: '' Mixed Breed: text: Mixed Breed description: '' Parson Russell Terrier: text: Parson Russell Terrier description: '' Poodle: text: Poodle description: '' Rottweiler: text: Rottweiler description: '' Saint Bernard: text: Saint Bernard description: '' Samoyed: text: Samoyed description: '' Shih Tzu: text: Shih Tzu description: '' Staffordshire Bull Terrier: text: Staffordshire Bull Terrier description: '' Vizsla: text: Vizsla description: '' Weimaraner: text: Weimaraner description: '' West Highland White Terrier: text: West Highland White Terrier description: '' Yorkshire Terrier: text: Yorkshire Terrier description: '' enum_CRDCH_Subject_sex: name: enum_CRDCH_Subject_sex description: Autogenerated Enumeration for CRDC-H Subject sex comments: - 'Name according to TCCM: "CRDC-H.Subject.sex"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Subject.sex code_set_version: '2021-12-16T18:04:32.112679+00:00' permissible_values: unspecified: text: unspecified unknown: text: unknown female: text: female male: text: male not reported: text: not reported enum_CRDCH_Subject_ethnicity: name: enum_CRDCH_Subject_ethnicity description: Autogenerated Enumeration for CRDC-H Subject ethnicity comments: - 'Name according to TCCM: "CRDC-H.Subject.ethnicity"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Subject.ethnicity code_set_version: '2021-12-16T18:04:32.260053+00:00' permissible_values: hispanic or latino: text: hispanic or latino not reported: text: not reported Unknown: text: Unknown description: Unknown not allowed to collect: text: not allowed to collect not hispanic or latino: text: not hispanic or latino unknown: text: unknown enum_CRDCH_Subject_race: name: enum_CRDCH_Subject_race description: Autogenerated Enumeration for CRDC-H Subject race comments: - 'Name according to TCCM: "CRDC-H.Subject.race"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Subject.race code_set_version: '2021-12-16T18:04:32.417638+00:00' permissible_values: other: text: other american indian or alaska native: text: american indian or alaska native native hawaiian or other pacific islander: text: native hawaiian or other pacific islander asian: text: asian not reported: text: not reported not allowed to collect: text: not allowed to collect white: text: white Unknown: text: Unknown description: Unknown black or african american: text: black or african american unknown: text: unknown enum_CRDCH_Subject_vital_status: name: enum_CRDCH_Subject_vital_status description: Autogenerated Enumeration for CRDC-H Subject vital_status comments: - 'Name according to TCCM: "CRDC-H.Subject.vital_status"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Subject.vital_status code_set_version: '2021-12-16T18:04:32.571797+00:00' permissible_values: Unknown: text: Unknown description: Unknown Not Reported: text: Not Reported description: Not Reported Alive: text: Alive description: ALIVE Dead: text: Dead description: DEAD enum_CRDCH_Subject_cause_of_death: name: enum_CRDCH_Subject_cause_of_death description: Autogenerated Enumeration for CRDC-H Subject cause_of_death comments: - 'Name according to TCCM: "CRDC-H.Subject.cause_of_death"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Subject.cause_of_death code_set_version: '2021-12-16T18:04:32.719969+00:00' permissible_values: Spinal Muscular Atrophy: text: Spinal Muscular Atrophy description: Spinal Muscular Atrophy Not Cancer Related: text: Not Cancer Related Not Reported: text: Not Reported description: Not Reported Cardiovascular Disorder, NOS: text: Cardiovascular Disorder, NOS description: Cardiovascular Disorder, NOS Renal Disorder, NOS: text: Renal Disorder, NOS description: Renal Disorder, NOS Surgical Complications: text: Surgical Complications description: Surgical Procedure Complication Cancer Related: text: Cancer Related End-stage Renal Disease: text: End-stage Renal Disease description: Chronic Kidney Disease, Stage 5 Infection: text: Infection description: Infection Toxicity: text: Toxicity description: Toxicity Unknown: text: Unknown description: Unknown enum_CRDCH_Substance_substance_type: name: enum_CRDCH_Substance_substance_type description: Autogenerated Enumeration for CRDC-H Substance substance_type comments: - 'Name according to TCCM: "CRDC-H.Substance.substance_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Substance.substance_type code_set_version: '2021-12-16T18:04:32.883250+00:00' permissible_values: Autologous Anti-CD19 CAR-CD28 T-cells ET019002: text: Autologous Anti-CD19 CAR-CD28 T-cells ET019002 Enoblituzumab: text: Enoblituzumab PBN Derivative OKN-007: text: PBN Derivative OKN-007 Pan-mutation-selective EGFR Inhibitor CLN-081: text: Pan-mutation-selective EGFR Inhibitor CLN-081 Cyclosporine: text: Cyclosporine MEK 1/2 Inhibitor FCN-159: text: MEK 1/2 Inhibitor FCN-159 Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020: text: Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020 Phellodendron amurense Bark Extract: text: Phellodendron amurense Bark Extract Lupartumab Amadotin: text: Lupartumab Amadotin Goserelin: text: Goserelin Anti-CD39 Monoclonal Antibody TTX-030: text: Anti-CD39 Monoclonal Antibody TTX-030 Apomine: text: Apomine Sodium Dichloroacetate: text: Sodium Dichloroacetate Zinostatin: text: Zinostatin Tezacitabine Anhydrous: text: Tezacitabine Anhydrous Carbendazim: text: Carbendazim Conditionally Active Biologic Anti-AXL Antibody-drug Conjugate BA3011: text: Conditionally Active Biologic Anti-AXL Antibody-drug Conjugate BA3011 Anti-Denatured Collagen Monoclonal Antibody TRC093: text: Anti-Denatured Collagen Monoclonal Antibody TRC093 Endothelin Receptor Type A Antagonist YM598: text: Endothelin Receptor Type A Antagonist YM598 Abagovomab: text: Abagovomab Masoprocol: text: Masoprocol Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes: text: Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes Autologous BCMA-targeted CAR T Cells LCAR-B4822M: text: Autologous BCMA-targeted CAR T Cells LCAR-B4822M Tubulin Polymerization Inhibitor CKD-516: text: Tubulin Polymerization Inhibitor CKD-516 Anti-c-Met Monoclonal Antibody HLX55: text: Anti-c-Met Monoclonal Antibody HLX55 Anti-LAMP1 Antibody-drug Conjugate SAR428926: text: Anti-LAMP1 Antibody-drug Conjugate SAR428926 Immunomodulatory Agent CC-11006: text: Immunomodulatory Agent CC-11006 Tepotinib: text: Tepotinib Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022: text: Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022 Nortopixantrone: text: Nortopixantrone Troglitazone: text: Troglitazone Celecoxib: text: Celecoxib Ofatumumab: text: Ofatumumab Ruthenium Ru-106: text: Ruthenium Ru-106 Tubercidin: text: Tubercidin DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457: text: DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457 Copper Cu 67 Tyr3-octreotate: text: Copper Cu 67 Tyr3-octreotate MOv-gamma Chimeric Receptor Gene: text: MOv-gamma Chimeric Receptor Gene Recombinant Human 6Ckine: text: Recombinant Human 6Ckine Tafasitamab: text: Tafasitamab PD-1 Directed Probody CX-188: text: PD-1 Directed Probody CX-188 Immunoconjugate RO5479599: text: Immunoconjugate RO5479599 siRNA-transfected Peripheral Blood Mononuclear Cells APN401: text: siRNA-transfected Peripheral Blood Mononuclear Cells APN401 Oleclumab: text: Oleclumab Anti-PD-1 Monoclonal Antibody AMG 404: text: Anti-PD-1 Monoclonal Antibody AMG 404 Lenvatinib: text: Lenvatinib Toremifene: text: Toremifene Anti-CD73 Monoclonal Antibody CPI-006: text: Anti-CD73 Monoclonal Antibody CPI-006 Triazinate: text: Triazinate Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119: text: Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119 Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11: text: Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11 Colchicine-Site Binding Agent ABT-751: text: Colchicine-Site Binding Agent ABT-751 Autologous Anti-BCMA CAR-transduced T-cells KITE-585: text: Autologous Anti-BCMA CAR-transduced T-cells KITE-585 Beauvericin: text: Beauvericin Porfiromycin: text: Porfiromycin Nitric Oxide-Releasing Acetylsalicylic Acid Derivative: text: Nitric Oxide-Releasing Acetylsalicylic Acid Derivative IDO/TDO Inhibitor LY-01013: text: IDO/TDO Inhibitor LY-01013 Fedratinib Hydrochloride: text: Fedratinib Hydrochloride Sapitinib: text: Sapitinib Anti-ICOS Agonist Antibody GSK3359609: text: Anti-ICOS Agonist Antibody GSK3359609 CDK4/6 Inhibitor HS-10342: text: CDK4/6 Inhibitor HS-10342 Tiragolumab: text: Tiragolumab Tamoxifen Citrate: text: Tamoxifen Citrate Anti-PD-L1 Monoclonal Antibody MDX-1105: text: Anti-PD-L1 Monoclonal Antibody MDX-1105 Monomethyl Auristatin E: text: Monomethyl Auristatin E Anaxirone: text: Anaxirone Cisplatin-E Therapeutic Implant: text: Cisplatin-E Therapeutic Implant Favezelimab: text: Favezelimab 2-Hydroxyestrone: text: 2-Hydroxyestrone PARP/Tankyrase Inhibitor 2X-121: text: PARP/Tankyrase Inhibitor 2X-121 KSP Inhibitor AZD4877: text: KSP Inhibitor AZD4877 Sitimagene Ceradenovec: text: Sitimagene Ceradenovec Staurosporine: text: Staurosporine Anti-CD70 Antibody-drug Conjugate SGN-CD70A: text: Anti-CD70 Antibody-drug Conjugate SGN-CD70A SR-BP1/HSI Inhibitor SR31747A: text: SR-BP1/HSI Inhibitor SR31747A Puquitinib Mesylate: text: Puquitinib Mesylate Epothilone KOS-1584: text: Epothilone KOS-1584 Cantrixil: text: Cantrixil Olinvacimab: text: Olinvacimab Telomerase-specific Type 5 Adenovirus OBP-301: text: Telomerase-specific Type 5 Adenovirus OBP-301 Uroacitides: text: Uroacitides Urelumab: text: Urelumab Dacetuzumab: text: Dacetuzumab p53/HDM2 Interaction Inhibitor CGM097: text: p53/HDM2 Interaction Inhibitor CGM097 PEG-interleukin-2: text: PEG-interleukin-2 Saracatinib: text: Saracatinib Yttrium Y-90 Tacatuzumab Tetraxetan: text: Yttrium Y-90 Tacatuzumab Tetraxetan Grapiprant: text: Grapiprant Tavokinogene Telseplasmid: text: Tavokinogene Telseplasmid Pol I Inhibitor CX5461: text: Pol I Inhibitor CX5461 Immunotoxin CMD-193: text: Immunotoxin CMD-193 pan FGFR Inhibitor PRN1371: text: pan FGFR Inhibitor PRN1371 Enterococcus gallinarum Strain MRx0518: text: Enterococcus gallinarum Strain MRx0518 Mitindomide: text: Mitindomide Ganitumab: text: Ganitumab Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine: text: Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine Modotuximab: text: Modotuximab Trofosfamide: text: Trofosfamide Tipiracil: text: Tipiracil Lorukafusp alfa: text: Lorukafusp alfa PSMA/CD3 Tri-specific T-cell Activating Construct HPN424: text: PSMA/CD3 Tri-specific T-cell Activating Construct HPN424 GS/pan-Notch Inhibitor BMS-986115: text: GS/pan-Notch Inhibitor BMS-986115 Cantuzumab Ravtansine: text: Cantuzumab Ravtansine Navarixin: text: Navarixin Anti-mesothelin Antibody-drug Conjugate BMS-986148: text: Anti-mesothelin Antibody-drug Conjugate BMS-986148 Sunitinib Malate: text: Sunitinib Malate Olutasidenib: text: Olutasidenib Enasidenib: text: Enasidenib PEG-Proline-Interferon Alfa-2b: text: PEG-Proline-Interferon Alfa-2b Anti-CD32B Monoclonal Antibody BI-1206: text: Anti-CD32B Monoclonal Antibody BI-1206 Vedolizumab: text: Vedolizumab Sodium Iodide I-131: text: Sodium Iodide I-131 Pravastatin Sodium: text: Pravastatin Sodium CBP/beta-catenin Modulator E7386: text: CBP/beta-catenin Modulator E7386 Monoclonal Antibody A1G4 Anti-Idiotype Vaccine: text: Monoclonal Antibody A1G4 Anti-Idiotype Vaccine Itacitinib Adipate: text: Itacitinib Adipate Glesatinib: text: Glesatinib Vocimagene Amiretrorepvec: text: Vocimagene Amiretrorepvec Upamostat: text: Upamostat Anti-CD47 Monoclonal Antibody Hu5F9-G4: text: Anti-CD47 Monoclonal Antibody Hu5F9-G4 EP4 Antagonist ONO-4578: text: EP4 Antagonist ONO-4578 Anti-HER2 Monoclonal Antibody CT-P6: text: Anti-HER2 Monoclonal Antibody CT-P6 Vinorelbine: text: Vinorelbine Anti-CLEC12A/CD3 Bispecific Antibody MCLA117: text: Anti-CLEC12A/CD3 Bispecific Antibody MCLA117 IL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000: text: IL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000 Tritylcysteine: text: Tritylcysteine Octreotide Acetate: text: Octreotide Acetate Anti-RANKL Monoclonal Antibody GB-223: text: Anti-RANKL Monoclonal Antibody GB-223 Akt Inhibitor SR13668: text: Akt Inhibitor SR13668 IL-12-expressing HSV-1 NSC 733972: text: IL-12-expressing HSV-1 NSC 733972 Ivosidenib: text: Ivosidenib STING Agonist TAK-676: text: STING Agonist TAK-676 CYP17 Inhibitor CFG920: text: CYP17 Inhibitor CFG920 Monoclonal Antibody NEO-201: text: Monoclonal Antibody NEO-201 pan-PI3K Inhibitor CLR457: text: pan-PI3K Inhibitor CLR457 Anti-EGFR Monoclonal Antibody SYN004: text: Anti-EGFR Monoclonal Antibody SYN004 Sonidegib: text: Sonidegib Atamestane: text: Atamestane Adenoviral Cancer Vaccine PF-06936308: text: Adenoviral Cancer Vaccine PF-06936308 Beta-lapachone Prodrug ARQ 761: text: Beta-lapachone Prodrug ARQ 761 Recombinant Human TRAIL-Trimer Fusion Protein SCB-313: text: Recombinant Human TRAIL-Trimer Fusion Protein SCB-313 Vesencumab: text: Vesencumab Gemcitabine Hydrochloride Emulsion: text: Gemcitabine Hydrochloride Emulsion SDF-1 Receptor Antagonist PTX-9908: text: SDF-1 Receptor Antagonist PTX-9908 Gusperimus Trihydrochloride: text: Gusperimus Trihydrochloride Valrubicin: text: Valrubicin Lenalidomide: text: Lenalidomide Multi-AGC Kinase Inhibitor AT13148: text: Multi-AGC Kinase Inhibitor AT13148 Prednisolone Acetate: text: Prednisolone Acetate CSF1R Inhibitor PLX73086: text: CSF1R Inhibitor PLX73086 Anti-BTLA Monoclonal Antibody TAB004: text: Anti-BTLA Monoclonal Antibody TAB004 Belantamab Mafodotin: text: Belantamab Mafodotin Volociximab: text: Volociximab Paclitaxel Trevatide: text: Paclitaxel Trevatide LAIR-2 Fusion Protein NC410: text: LAIR-2 Fusion Protein NC410 Bevacizumab: text: Bevacizumab Radgocitabine Hydrochloride: text: Radgocitabine Hydrochloride Anti-TIM-3 Antibody BMS-986258: text: Anti-TIM-3 Antibody BMS-986258 BH3 Mimetic ABT-737: text: BH3 Mimetic ABT-737 G Protein-coupled Estrogen Receptor Agonist LNS8801: text: G Protein-coupled Estrogen Receptor Agonist LNS8801 Anti-FGFR3 Antibody-drug Conjugate LY3076226: text: Anti-FGFR3 Antibody-drug Conjugate LY3076226 Taxane Compound: text: Taxane Compound Anti-CD30 Monoclonal Antibody XmAb2513: text: Anti-CD30 Monoclonal Antibody XmAb2513 Imgatuzumab: text: Imgatuzumab Mitobronitol: text: Mitobronitol Uproleselan: text: Uproleselan IDH1(R132) Inhibitor IDH305: text: IDH1(R132) Inhibitor IDH305 Allogeneic Renal Cell Carcinoma Vaccine MGN1601: text: Allogeneic Renal Cell Carcinoma Vaccine MGN1601 HSP90alpha/beta Inhibitor TAS-116: text: HSP90alpha/beta Inhibitor TAS-116 Clomesone: text: Clomesone Squalamine Lactate: text: Squalamine Lactate cEt KRAS Antisense Oligonucleotide AZD4785: text: cEt KRAS Antisense Oligonucleotide AZD4785 Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310: text: Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310 Parvovirus H-1: text: Parvovirus H-1 Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101: text: Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101 Fimepinostat: text: Fimepinostat Chlorambucil: text: Chlorambucil Lapuleucel-T: text: Lapuleucel-T Trifluridine: text: Trifluridine Anti-GD3 Antibody-drug Conjugate PF-06688992: text: Anti-GD3 Antibody-drug Conjugate PF-06688992 Src Kinase Inhibitor M475271: text: Src Kinase Inhibitor M475271 Onatasertib: text: Onatasertib Iodine I 131 Monoclonal Antibody 81C6: text: Iodine I 131 Monoclonal Antibody 81C6 Nitroglycerin Transdermal Patch: text: Nitroglycerin Transdermal Patch Amuvatinib: text: Amuvatinib Diarylsulfonylurea Compound ILX-295501: text: Diarylsulfonylurea Compound ILX-295501 Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10: text: Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10 LMB-2 Immunotoxin: text: LMB-2 Immunotoxin Doxifluridine: text: Doxifluridine Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101: text: Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101 Nanoparticle Albumin-Bound Docetaxel: text: Nanoparticle Albumin-Bound Docetaxel Vorasidenib: text: Vorasidenib Deuteporfin: text: Deuteporfin Recombinant Interferon Alfa-2a: text: Recombinant Interferon Alfa-2a Anti-BCMA Antibody-drug Conjugate CC-99712: text: Anti-BCMA Antibody-drug Conjugate CC-99712 Class 1/4 Histone Deacetylase Inhibitor OKI-179: text: Class 1/4 Histone Deacetylase Inhibitor OKI-179 Natalizumab: text: Natalizumab VEGFR/FGFR Inhibitor ODM-203: text: VEGFR/FGFR Inhibitor ODM-203 Foslinanib Disodium: text: Foslinanib Disodium Flanvotumab: text: Flanvotumab Silibinin: text: Silibinin Porcupine Inhibitor ETC-1922159: text: Porcupine Inhibitor ETC-1922159 PARP Inhibitor E7016: text: PARP Inhibitor E7016 N-(5-tert-butyl-3-isoxazolyl)-N-(4-(4-pyridinyl)oxyphenyl) Urea: text: N-(5-tert-butyl-3-isoxazolyl)-N-(4-(4-pyridinyl)oxyphenyl) Urea Ilginatinib: text: Ilginatinib Dengue Virus Adjuvant PV-001-DV: text: Dengue Virus Adjuvant PV-001-DV BET Inhibitor CPI-0610: text: BET Inhibitor CPI-0610 Anti-Folate Receptor-alpha Antibody Drug Conjugate STRO-002: text: Anti-Folate Receptor-alpha Antibody Drug Conjugate STRO-002 Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201: text: Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201 Plinabulin: text: Plinabulin Olaratumab: text: Olaratumab Anti-CTGF Monoclonal Antibody FG-3019: text: Anti-CTGF Monoclonal Antibody FG-3019 Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015: text: Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015 Cintirorgon: text: Cintirorgon Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370: text: Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370 PARP Inhibitor CEP-9722: text: PARP Inhibitor CEP-9722 SLCT Inhibitor GNS561: text: SLCT Inhibitor GNS561 Decitabine and Cedazuridine: text: Decitabine and Cedazuridine Ceritinib: text: Ceritinib Aurora Kinase/VEGFR2 Inhibitor CYC116: text: Aurora Kinase/VEGFR2 Inhibitor CYC116 Anti-c-fms Monoclonal Antibody AMG 820: text: Anti-c-fms Monoclonal Antibody AMG 820 Leuprolide: text: Leuprolide Spherical Nucleic Acid Nanoparticle NU-0129: text: Spherical Nucleic Acid Nanoparticle NU-0129 NLRP3 Agonist BMS-986299: text: NLRP3 Agonist BMS-986299 Oxcarbazepine: text: Oxcarbazepine Bendamustine Hydrochloride: text: Bendamustine Hydrochloride Anti-DLL4/VEGF Bispecific Monoclonal Antibody OMP-305B83: text: Anti-DLL4/VEGF Bispecific Monoclonal Antibody OMP-305B83 BRAF Inhibitor ARQ 736: text: BRAF Inhibitor ARQ 736 Anti-SIRPa Monoclonal Antibody CC-95251: text: Anti-SIRPa Monoclonal Antibody CC-95251 Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343: text: Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343 EGFR/VEGFR/RET Inhibitor HA121-28: text: EGFR/VEGFR/RET Inhibitor HA121-28 Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522: text: Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522 EGFR T790M Antagonist BPI-15086: text: EGFR T790M Antagonist BPI-15086 Oncolytic Herpes Simplex Virus-1 ONCR-177: text: Oncolytic Herpes Simplex Virus-1 ONCR-177 Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC: text: Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC Antibody-drug Conjugate SC-002: text: Antibody-drug Conjugate SC-002 Therapeutic Cancer Vaccine ATP128: text: Therapeutic Cancer Vaccine ATP128 Chiauranib: text: Chiauranib Hsp90 Inhibitor BIIB028: text: Hsp90 Inhibitor BIIB028 Mirvetuximab Soravtansine: text: Mirvetuximab Soravtansine Autologous Tumor Infiltrating Lymphocytes LN-145: text: Autologous Tumor Infiltrating Lymphocytes LN-145 Anti-EGFR Monoclonal Antibody EMD 55900: text: Anti-EGFR Monoclonal Antibody EMD 55900 Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66: text: Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66 Anti-CTLA4 Monoclonal Antibody BMS-986218: text: Anti-CTLA4 Monoclonal Antibody BMS-986218 Troriluzole: text: Troriluzole PDK1 Inhibitor AR-12: text: PDK1 Inhibitor AR-12 Anti-A33 Monoclonal Antibody KRN330: text: Anti-A33 Monoclonal Antibody KRN330 PI3K-gamma Inhibitor IPI-549: text: PI3K-gamma Inhibitor IPI-549 Arcitumomab: text: Arcitumomab Topixantrone: text: Topixantrone Ingenol Mebutate: text: Ingenol Mebutate Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2: text: Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2 PRMT5 Inhibitor PRT811: text: PRMT5 Inhibitor PRT811 Anti-PD-L1 Monoclonal Antibody MSB2311: text: Anti-PD-L1 Monoclonal Antibody MSB2311 ALK Inhibitor: text: ALK Inhibitor Chemotherapy: text: Chemotherapy Oncolytic Virus ASP9801: text: Oncolytic Virus ASP9801 Anti-ICOS Monoclonal Antibody KY1044: text: Anti-ICOS Monoclonal Antibody KY1044 Autologous Clonal Neoantigen T Cells ATL001: text: Autologous Clonal Neoantigen T Cells ATL001 Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100: text: Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100 Toripalimab: text: Toripalimab 7-Cyanoquinocarcinol: text: 7-Cyanoquinocarcinol Guadecitabine: text: Guadecitabine Valemetostat: text: Valemetostat Sizofiran: text: Sizofiran Anti-FAP/Interleukin-2 Fusion Protein RO6874281: text: Anti-FAP/Interleukin-2 Fusion Protein RO6874281 PH20 Hyaluronidase-expressing Adenovirus VCN-01: text: PH20 Hyaluronidase-expressing Adenovirus VCN-01 Iodine I 131 Monoclonal Antibody G-250: text: Iodine I 131 Monoclonal Antibody G-250 Bispecific Antibody MDX-H210: text: Bispecific Antibody MDX-H210 Acetylcysteine: text: Acetylcysteine Aceglatone: text: Aceglatone Anti-CD33 Monoclonal Antibody-DM4 Conjugate AVE9633: text: Anti-CD33 Monoclonal Antibody-DM4 Conjugate AVE9633 Yttrium Y 90 Resin Microspheres: text: Yttrium Y 90 Resin Microspheres Anhydrous Enol-oxaloacetate: text: Anhydrous Enol-oxaloacetate V930 Vaccine: text: V930 Vaccine Amuvatinib Hydrochloride: text: Amuvatinib Hydrochloride MEK Inhibitor PD0325901: text: MEK Inhibitor PD0325901 Anti-CD70 Antibody-Drug Conjugate MDX-1203: text: Anti-CD70 Antibody-Drug Conjugate MDX-1203 Sialyl Tn Antigen: text: Sialyl Tn Antigen Cedazuridine/Azacitidine Combination Agent ASTX030: text: Cedazuridine/Azacitidine Combination Agent ASTX030 Cyclophosphamide Anhydrous: text: Cyclophosphamide Anhydrous Anti-HER2 Bi-specific Monoclonal Antibody ZW25: text: Anti-HER2 Bi-specific Monoclonal Antibody ZW25 CAIX Inhibitor SLC-0111: text: CAIX Inhibitor SLC-0111 Monoclonal Antibody 81C6: text: Monoclonal Antibody 81C6 Integrin Receptor Antagonist GLPG0187: text: Integrin Receptor Antagonist GLPG0187 Temsirolimus: text: Temsirolimus Anti-CD123 x Anti-CD3 Bispecific Antibody XmAb1404: text: Anti-CD123 x Anti-CD3 Bispecific Antibody XmAb1404 FLT3/KIT Kinase Inhibitor AKN-028: text: FLT3/KIT Kinase Inhibitor AKN-028 PIM Kinase Inhibitor TP-3654: text: PIM Kinase Inhibitor TP-3654 FLT3 Inhibitor FF-10101 Succinate: text: FLT3 Inhibitor FF-10101 Succinate Anti-CTLA-4 Probody BMS-986288: text: Anti-CTLA-4 Probody BMS-986288 Rebastinib Tosylate: text: Rebastinib Tosylate Rituximab Conjugate CON-4619: text: Rituximab Conjugate CON-4619 Anti-CD73 Monoclonal Antibody TJ4309: text: Anti-CD73 Monoclonal Antibody TJ4309 Polysialic Acid: text: Polysialic Acid Selective Estrogen Receptor Modulator CC-8490: text: Selective Estrogen Receptor Modulator CC-8490 BMI1 Inhibitor PTC596: text: BMI1 Inhibitor PTC596 S1P Receptor Agonist KRP203: text: S1P Receptor Agonist KRP203 G-Quadruplex Stabilizer BMVC: text: G-Quadruplex Stabilizer BMVC Src/tubulin Inhibitor KX02: text: Src/tubulin Inhibitor KX02 ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471: text: ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471 2-Hydroxyoleic Acid: text: 2-Hydroxyoleic Acid Brequinar: text: Brequinar Theliatinib: text: Theliatinib XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410: text: XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410 iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596: text: iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596 S-equol: text: S-equol Mcl-1 Inhibitor MIK665: text: Mcl-1 Inhibitor MIK665 Futibatinib: text: Futibatinib Betulinic Acid: text: Betulinic Acid Radgocitabine: text: Radgocitabine Tubulin Inhibitor ALB-109564: text: Tubulin Inhibitor ALB-109564 FGFR4 Inhibitor BLU 9931: text: FGFR4 Inhibitor BLU 9931 Chlorozotocin: text: Chlorozotocin Inactivated Oncolytic Virus Particle GEN0101: text: Inactivated Oncolytic Virus Particle GEN0101 PIM Kinase Inhibitor SGI-1776: text: PIM Kinase Inhibitor SGI-1776 Nedaplatin: text: Nedaplatin Nogalamycin: text: Nogalamycin Omipalisib: text: Omipalisib Idronoxil Suppository NOX66: text: Idronoxil Suppository NOX66 Anti-PD-1/CD47 Infusion Protein HX009: text: Anti-PD-1/CD47 Infusion Protein HX009 Recombinant Interferon Beta: text: Recombinant Interferon Beta Anti-HER2 Bispecific Antibody-drug Conjugate ZW49: text: Anti-HER2 Bispecific Antibody-drug Conjugate ZW49 Valspodar: text: Valspodar Apoptosis Inducer GCS-100: text: Apoptosis Inducer GCS-100 FGFR Inhibitor Debio 1347: text: FGFR Inhibitor Debio 1347 BCG Solution: text: BCG Solution Neoantigen-based Glioblastoma Vaccine: text: Neoantigen-based Glioblastoma Vaccine Pirarubicin Hydrochloride: text: Pirarubicin Hydrochloride Chk1 Inhibitor GDC-0425: text: Chk1 Inhibitor GDC-0425 Polyethylene Glycol Recombinant Endostatin: text: Polyethylene Glycol Recombinant Endostatin Anti-CD19 Monoclonal Antibody MDX-1342: text: Anti-CD19 Monoclonal Antibody MDX-1342 Nanoscale Coordination Polymer Nanoparticles CPI-100: text: Nanoscale Coordination Polymer Nanoparticles CPI-100 Triptorelin Pamoate: text: Triptorelin Pamoate Corticorelin Acetate: text: Corticorelin Acetate MEK 1/2 Inhibitor AS703988/MSC2015103B: text: MEK 1/2 Inhibitor AS703988/MSC2015103B Bcl-2 Inhibitor S65487: text: Bcl-2 Inhibitor S65487 JAK2 Inhibitor BMS-911543: text: JAK2 Inhibitor BMS-911543 Bisthianostat: text: Bisthianostat Naptumomab Estafenatox: text: Naptumomab Estafenatox Radium Ra 224-labeled Calcium Carbonate Microparticles: text: Radium Ra 224-labeled Calcium Carbonate Microparticles DR5-targeting Tetrameric Nanobody Agonist TAS266: text: DR5-targeting Tetrameric Nanobody Agonist TAS266 Ursolic Acid: text: Ursolic Acid Botanical Agent LEAC-102: text: Botanical Agent LEAC-102 Glasdegib: text: Glasdegib Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94: text: Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94 Geldanamycin: text: Geldanamycin PSA/PSMA DNA Plasmid INO-5150: text: PSA/PSMA DNA Plasmid INO-5150 Nanocell-encapsulated miR-16-based microRNA Mimic: text: Nanocell-encapsulated miR-16-based microRNA Mimic Peptichemio: text: Peptichemio Tovetumab: text: Tovetumab hTERT Vaccine V934/V935: text: hTERT Vaccine V934/V935 Survivin mRNA Antagonist EZN-3042: text: Survivin mRNA Antagonist EZN-3042 Apitolisib: text: Apitolisib Recombinant Interferon: text: Recombinant Interferon Hsp90 Inhibitor BIIB021: text: Hsp90 Inhibitor BIIB021 Aranose: text: Aranose Annamycin: text: Annamycin Penicillamine: text: Penicillamine Abituzumab: text: Abituzumab Dexanabinol: text: Dexanabinol Anti-c-Met Antibody-drug Conjugate TR1801: text: Anti-c-Met Antibody-drug Conjugate TR1801 PI3K Alpha/Beta Inhibitor BAY1082439: text: PI3K Alpha/Beta Inhibitor BAY1082439 Aurora B Serine/Threonine Kinase Inhibitor TAK-901: text: Aurora B Serine/Threonine Kinase Inhibitor TAK-901 Batabulin: text: Batabulin Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19: text: Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19 dUTPase/DPD Inhibitor TAS-114: text: dUTPase/DPD Inhibitor TAS-114 BET Inhibitor GSK2820151: text: BET Inhibitor GSK2820151 Mitomycin B: text: Mitomycin B Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B: text: Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B OX40L-expressing Oncolytic Adenovirus DNX-2440: text: OX40L-expressing Oncolytic Adenovirus DNX-2440 Prolgolimab: text: Prolgolimab Yttrium Y 90 Monoclonal Antibody B3: text: Yttrium Y 90 Monoclonal Antibody B3 Lutetium Lu-177 Rituximab: text: Lutetium Lu-177 Rituximab CDK9 Inhibitor AZD4573: text: CDK9 Inhibitor AZD4573 ALK Inhibitor TAE684: text: ALK Inhibitor TAE684 Crizotinib: text: Crizotinib Batimastat: text: Batimastat Ivuxolimab: text: Ivuxolimab Immediate-release Onapristone: text: Immediate-release Onapristone Daclizumab: text: Daclizumab Vincristine Sulfate: text: Vincristine Sulfate Octreotide: text: Octreotide Trilaciclib: text: Trilaciclib Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564: text: Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564 Clomiphene: text: Clomiphene Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022: text: Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022 Liposomal Irinotecan: text: Liposomal Irinotecan Tamibarotene: text: Tamibarotene Balstilimab: text: Balstilimab Anti-TGF-beta RII Monoclonal Antibody IMC-TR1: text: Anti-TGF-beta RII Monoclonal Antibody IMC-TR1 Pegylated Paclitaxel: text: Pegylated Paclitaxel Anti-CD137 Agonistic Monoclonal Antibody AGEN2373: text: Anti-CD137 Agonistic Monoclonal Antibody AGEN2373 Polo-like Kinase 4 Inhibitor CFI-400945 Fumarate: text: Polo-like Kinase 4 Inhibitor CFI-400945 Fumarate Anti-PD-1 Monoclonal Antibody LZM009: text: Anti-PD-1 Monoclonal Antibody LZM009 Nilotinib Hydrochloride Anhydrous: text: Nilotinib Hydrochloride Anhydrous Ropeginterferon Alfa-2B: text: Ropeginterferon Alfa-2B Radium Ra 223 Dichloride: text: Radium Ra 223 Dichloride Naxitamab: text: Naxitamab Anti-CD20 Monoclonal Antibody B001: text: Anti-CD20 Monoclonal Antibody B001 ALK Inhibitor ASP3026: text: ALK Inhibitor ASP3026 Anti-IL-8 Monoclonal Antibody HuMax-IL8: text: Anti-IL-8 Monoclonal Antibody HuMax-IL8 RAD51 Inhibitor CYT-0851: text: RAD51 Inhibitor CYT-0851 Sulofenur: text: Sulofenur Yttrium Y 90 Tabituximab Barzuxetan: text: Yttrium Y 90 Tabituximab Barzuxetan Hsp90 Antagonist KW-2478: text: Hsp90 Antagonist KW-2478 Spartalizumab: text: Spartalizumab Arabinoxylan Compound MGN3: text: Arabinoxylan Compound MGN3 Tasisulam: text: Tasisulam Dual-affinity B7-H3/CD3-targeted Protein MGD009: text: Dual-affinity B7-H3/CD3-targeted Protein MGD009 Cinobufotalin: text: Cinobufotalin Recombinant Super-compound Interferon: text: Recombinant Super-compound Interferon Vaccine-Sensitized Draining Lymph Node Cells: text: Vaccine-Sensitized Draining Lymph Node Cells Anti-HB-EGF Monoclonal Antibody KHK2866: text: Anti-HB-EGF Monoclonal Antibody KHK2866 Tagraxofusp-erzs: text: Tagraxofusp-erzs Intermediate-affinity Interleukin-2 Receptor Agonist ALKS 4230: text: Intermediate-affinity Interleukin-2 Receptor Agonist ALKS 4230 Anti-HER2 Immune Stimulator-antibody Conjugate NJH395: text: Anti-HER2 Immune Stimulator-antibody Conjugate NJH395 Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809: text: Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809 Anti-Neuropilin-1 Monoclonal Antibody MNRP1685A: text: Anti-Neuropilin-1 Monoclonal Antibody MNRP1685A Sonolisib: text: Sonolisib Alpha-tocopheryloxyacetic Acid: text: Alpha-tocopheryloxyacetic Acid Relacorilant: text: Relacorilant Atiprimod Dihydrochloride: text: Atiprimod Dihydrochloride Yttrium Y 90 Monoclonal Antibody Hu3S193: text: Yttrium Y 90 Monoclonal Antibody Hu3S193 Lifastuzumab Vedotin: text: Lifastuzumab Vedotin Personalized Neoantigen DNA Vaccine GNOS-PV01: text: Personalized Neoantigen DNA Vaccine GNOS-PV01 Palifosfamide Tromethamine: text: Palifosfamide Tromethamine Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules: text: Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules c-Met Inhibitor GST-HG161: text: c-Met Inhibitor GST-HG161 Anti-CDH6 Antibody-drug Conjugate HKT288: text: Anti-CDH6 Antibody-drug Conjugate HKT288 Yiqi-yangyin-jiedu Herbal Decoction: text: Yiqi-yangyin-jiedu Herbal Decoction AXL Inhibitor DS-1205c: text: AXL Inhibitor DS-1205c EP4 Antagonist INV-1120: text: EP4 Antagonist INV-1120 Cenisertib: text: Cenisertib Cevostamab: text: Cevostamab Liposomal Daunorubicin Citrate: text: Liposomal Daunorubicin Citrate Wee1 Kinase Inhibitor Debio 0123: text: Wee1 Kinase Inhibitor Debio 0123 Picoplatin: text: Picoplatin Iodine I 124 Monoclonal Antibody A33: text: Iodine I 124 Monoclonal Antibody A33 Camidanlumab Tesirine: text: Camidanlumab Tesirine Anti-CD19 Antibody-T-cell Receptor-expressing T-cells ET019003: text: Anti-CD19 Antibody-T-cell Receptor-expressing T-cells ET019003 Tergenpumatucel-L: text: Tergenpumatucel-L HIF-2alpha Inhibitor PT2977: text: HIF-2alpha Inhibitor PT2977 Anti-5T4 Antibody-Drug Conjugate PF-06263507: text: Anti-5T4 Antibody-Drug Conjugate PF-06263507 Talotrexin Ammonium: text: Talotrexin Ammonium Trastuzumab Duocarmazine: text: Trastuzumab Duocarmazine DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015: text: DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015 Anti-CTLA-4 Monoclonal Antibody BCD-145: text: Anti-CTLA-4 Monoclonal Antibody BCD-145 Pexastimogene Devacirepvec: text: Pexastimogene Devacirepvec Bortezomib: text: Bortezomib HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN: text: HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN Therapeutic Estradiol: text: Therapeutic Estradiol TRK Inhibitor AZD6918: text: TRK Inhibitor AZD6918 Oregovomab: text: Oregovomab Anti-CD40/Anti-4-1BB Bispecific Agonist Monoclonal Antibody GEN1042: text: Anti-CD40/Anti-4-1BB Bispecific Agonist Monoclonal Antibody GEN1042 Rilimogene Galvacirepvec/Rilimogene Glafolivec: text: Rilimogene Galvacirepvec/Rilimogene Glafolivec Atiprimod: text: Atiprimod TLR7/8/9 Antagonist IMO-8400: text: TLR7/8/9 Antagonist IMO-8400 Cetuximab: text: Cetuximab Ispinesib Mesylate: text: Ispinesib Mesylate Inalimarev: text: Inalimarev Fruquintinib: text: Fruquintinib Sam68 Modulator CWP232291: text: Sam68 Modulator CWP232291 Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466: text: Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466 iPSC-derived Natural Killer Cells FT500: text: iPSC-derived Natural Killer Cells FT500 Teglarinad: text: Teglarinad FLT3 Tyrosine Kinase Inhibitor TTT-3002: text: FLT3 Tyrosine Kinase Inhibitor TTT-3002 Telomerase Inhibitor FJ5002: text: Telomerase Inhibitor FJ5002 Racotumomab: text: Racotumomab MDM2 Antagonist ASTX295: text: MDM2 Antagonist ASTX295 c-Met Inhibitor MSC2156119J: text: c-Met Inhibitor MSC2156119J Androgen Receptor Antagonist TAS3681: text: Androgen Receptor Antagonist TAS3681 Cixutumumab: text: Cixutumumab Azimexon: text: Azimexon Aurora A Kinase Inhibitor LY3295668: text: Aurora A Kinase Inhibitor LY3295668 Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360: text: Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360 Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514: text: Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514 Lomustine: text: Lomustine Anti-HER2-DM1 Antibody-drug Conjugate GQ1001: text: Anti-HER2-DM1 Antibody-drug Conjugate GQ1001 PD-L1/PD-L2/VISTA Antagonist CA-170: text: PD-L1/PD-L2/VISTA Antagonist CA-170 PI3K-delta Inhibitor PWT143: text: PI3K-delta Inhibitor PWT143 LMP-2:419-427 Peptide Vaccine: text: LMP-2:419-427 Peptide Vaccine Anti-OX40 Agonist Monoclonal Antibody ABBV-368: text: Anti-OX40 Agonist Monoclonal Antibody ABBV-368 Anti-DKK1 Monoclonal Antibody BHQ880: text: Anti-DKK1 Monoclonal Antibody BHQ880 Palladium Pd-103: text: Palladium Pd-103 Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells: text: Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells pan-PIM Kinase Inhibitor NVP-LGB-321: text: pan-PIM Kinase Inhibitor NVP-LGB-321 Ibandronate Sodium: text: Ibandronate Sodium Amsilarotene: text: Amsilarotene Wobe-Mugos E: text: Wobe-Mugos E Ixazomib Citrate: text: Ixazomib Citrate Anti-CD137 Agonistic Monoclonal Antibody ADG106: text: Anti-CD137 Agonistic Monoclonal Antibody ADG106 Orelabrutinib: text: Orelabrutinib HDAC/EGFR/HER2 Inhibitor CUDC-101: text: HDAC/EGFR/HER2 Inhibitor CUDC-101 Pterostilbene: text: Pterostilbene Padoporfin: text: Padoporfin Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s: text: Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s HPPH: text: HPPH Flutamide: text: Flutamide Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01: text: Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01 Iobenguane I-131: text: Iobenguane I-131 Venetoclax: text: Venetoclax Adenosine A2A Receptor Antagonist CS3005: text: Adenosine A2A Receptor Antagonist CS3005 Interferon-gamma-expressing Adenovirus Vaccine ASN-002: text: Interferon-gamma-expressing Adenovirus Vaccine ASN-002 Oncolytic HSV-1 C134: text: Oncolytic HSV-1 C134 Interferon: text: Interferon Indoximod: text: Indoximod Macrocycle-bridged STING Agonist E7766: text: Macrocycle-bridged STING Agonist E7766 Flumatinib Mesylate: text: Flumatinib Mesylate Monoclonal Antibody HeFi-1: text: Monoclonal Antibody HeFi-1 Nocodazole: text: Nocodazole Epcoritamab: text: Epcoritamab SarCNU: text: SarCNU Antibody-drug Conjugate ABBV-155: text: Antibody-drug Conjugate ABBV-155 FASN Inhibitor TVB-2640: text: FASN Inhibitor TVB-2640 Anti-CLEVER-1 Monoclonal Antibody FP-1305: text: Anti-CLEVER-1 Monoclonal Antibody FP-1305 Etoprine: text: Etoprine Lapatinib Ditosylate: text: Lapatinib Ditosylate Aerosolized Liposomal Rubitecan: text: Aerosolized Liposomal Rubitecan Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858: text: Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858 Dihydroorotate Dehydrogenase Inhibitor AG-636: text: Dihydroorotate Dehydrogenase Inhibitor AG-636 ATR Kinase Inhibitor M6620: text: ATR Kinase Inhibitor M6620 Recombinant Interferon Alfa: text: Recombinant Interferon Alfa Bemcentinib: text: Bemcentinib Encelimab: text: Encelimab Amatuximab: text: Amatuximab Paclitaxel Liposome: text: Paclitaxel Liposome Plevitrexed: text: Plevitrexed PD-L1 Inhibitor GS-4224: text: PD-L1 Inhibitor GS-4224 Cergutuzumab Amunaleukin: text: Cergutuzumab Amunaleukin Synthetic hTERT DNA Vaccine INO-1400: text: Synthetic hTERT DNA Vaccine INO-1400 CAR T-Cells AMG 119: text: CAR T-Cells AMG 119 LRP5/6 Antagonist BI 905677: text: LRP5/6 Antagonist BI 905677 Birinapant: text: Birinapant Telaglenastat Hydrochloride: text: Telaglenastat Hydrochloride Cevipabulin Succinate: text: Cevipabulin Succinate Platinum: text: Platinum Anti-CD137 Agonistic Monoclonal Antibody CTX-471: text: Anti-CD137 Agonistic Monoclonal Antibody CTX-471 Survivin-expressing CVD908ssb-TXSVN Vaccine: text: Survivin-expressing CVD908ssb-TXSVN Vaccine Yttrium Y 90-DOTA-di-HSG Peptide IMP-288: text: Yttrium Y 90-DOTA-di-HSG Peptide IMP-288 Kanitinib: text: Kanitinib Molibresib Besylate: text: Molibresib Besylate OPCs/Green Tea/Spirullina/Curcumin/Antrodia Camphorate/Fermented Soymilk Extract Capsule: text: OPCs/Green Tea/Spirullina/Curcumin/Antrodia Camphorate/Fermented Soymilk Extract Capsule Deoxycytidine Analogue TAS-109 Hydrochloride: text: Deoxycytidine Analogue TAS-109 Hydrochloride Nogapendekin Alfa: text: Nogapendekin Alfa Anti-LIV-1 Monoclonal Antibody-MMAE Conjugate SGN-LIV1A: text: Anti-LIV-1 Monoclonal Antibody-MMAE Conjugate SGN-LIV1A Anti-B7-H3/DXd Antibody-drug Conjugate DS-7300a: text: Anti-B7-H3/DXd Antibody-drug Conjugate DS-7300a PI3K-beta Inhibitor SAR260301: text: PI3K-beta Inhibitor SAR260301 Anti-PD-1 Monoclonal Antibody HX008: text: Anti-PD-1 Monoclonal Antibody HX008 Pemlimogene Merolisbac: text: Pemlimogene Merolisbac ERK Inhibitor GDC-0994: text: ERK Inhibitor GDC-0994 Anti-alpha BCMA/Anti-alpha CD3 T-cell Engaging Bispecific Antibody TNB-383B: text: Anti-alpha BCMA/Anti-alpha CD3 T-cell Engaging Bispecific Antibody TNB-383B Anti-TIGIT Monoclonal Antibody SGN-TGT: text: Anti-TIGIT Monoclonal Antibody SGN-TGT Tyroserleutide: text: Tyroserleutide BMS-275183: text: BMS-275183 HER2-targeting Antibody Fc Fragment FS102: text: HER2-targeting Antibody Fc Fragment FS102 Opioid Growth Factor: text: Opioid Growth Factor Lutetium Lu 177 DOTA-N3-CTT1403: text: Lutetium Lu 177 DOTA-N3-CTT1403 p70S6K/Akt Inhibitor MSC2363318A: text: p70S6K/Akt Inhibitor MSC2363318A Thiarabine: text: Thiarabine Lucatumumab: text: Lucatumumab DI-Leu16-IL2 Immunocytokine: text: DI-Leu16-IL2 Immunocytokine Hsp90 Inhibitor XL888: text: Hsp90 Inhibitor XL888 Allovectin-7: text: Allovectin-7 Interferon Beta-1A: text: Interferon Beta-1A Pan-IDH Mutant Inhibitor AG-881: text: Pan-IDH Mutant Inhibitor AG-881 Vitespen: text: Vitespen Bleomycin Sulfate: text: Bleomycin Sulfate Bizalimogene Ralaplasmid: text: Bizalimogene Ralaplasmid Therapeutic Hydrocortisone: text: Therapeutic Hydrocortisone Antibody-drug Conjugate SC-004: text: Antibody-drug Conjugate SC-004 Camptothecin Sodium: text: Camptothecin Sodium SIRPa-IgG4-Fc Fusion Protein TTI-622: text: SIRPa-IgG4-Fc Fusion Protein TTI-622 Anti-TIGIT Monoclonal Antibody COM902: text: Anti-TIGIT Monoclonal Antibody COM902 Isatuximab: text: Isatuximab Anti-CD38-targeted IgG4-attenuated IFNa TAK-573: text: Anti-CD38-targeted IgG4-attenuated IFNa TAK-573 BRAF/EGFR Inhibitor BGB-283: text: BRAF/EGFR Inhibitor BGB-283 Ranolazine: text: Ranolazine LSD1 Inhibitor RO7051790: text: LSD1 Inhibitor RO7051790 Mitoxantrone: text: Mitoxantrone ATR Kinase Inhibitor VX-803: text: ATR Kinase Inhibitor VX-803 Iproplatin: text: Iproplatin Pegylated Recombinant Human Arginase I BCT-100: text: Pegylated Recombinant Human Arginase I BCT-100 Piperazinedione: text: Piperazinedione Miptenalimab: text: Miptenalimab Anti-CA19-9 Monoclonal Antibody 5B1: text: Anti-CA19-9 Monoclonal Antibody 5B1 Anti-TIM-3 Monoclonal Antibody MBG453: text: Anti-TIM-3 Monoclonal Antibody MBG453 Total Androgen Blockade: text: Total Androgen Blockade CD47 Antagonist ALX148: text: CD47 Antagonist ALX148 c-Met Inhibitor AL2846: text: c-Met Inhibitor AL2846 Arginase Inhibitor INCB001158: text: Arginase Inhibitor INCB001158 Daunorubicin: text: Daunorubicin Daunorubicin Hydrochloride: text: Daunorubicin Hydrochloride Anastrozole: text: Anastrozole GSK-3 Inhibitor LY2090314: text: GSK-3 Inhibitor LY2090314 Oxidopamine: text: Oxidopamine IDO1/TDO2 Inhibitor DN1406131: text: IDO1/TDO2 Inhibitor DN1406131 Rigosertib Sodium: text: Rigosertib Sodium P-p68 Inhibitor RX-5902: text: P-p68 Inhibitor RX-5902 LSD1 Inhibitor CC-90011: text: LSD1 Inhibitor CC-90011 Anti-Nucleolin Aptamer AS1411: text: Anti-Nucleolin Aptamer AS1411 Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307: text: Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307 Conatumumab: text: Conatumumab Ipilimumab: text: Ipilimumab CENP-E Inhibitor GSK-923295: text: CENP-E Inhibitor GSK-923295 Indusatumab Vedotin: text: Indusatumab Vedotin Trastuzumab Conjugate BI-CON-02: text: Trastuzumab Conjugate BI-CON-02 Phosphaplatin PT-112: text: Phosphaplatin PT-112 Retinol: text: Retinol Vonlerolizumab: text: Vonlerolizumab Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715: text: Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715 Picrasinoside H: text: Picrasinoside H At 211 Monoclonal Antibody 81C6: text: At 211 Monoclonal Antibody 81C6 Light-activated AU-011: text: Light-activated AU-011 ATM Kinase Inhibitor AZD1390: text: ATM Kinase Inhibitor AZD1390 Crystalline Genistein Formulation AXP107-11: text: Crystalline Genistein Formulation AXP107-11 Cyclodextrin-Based Polymer-Camptothecin CRLX101: text: Cyclodextrin-Based Polymer-Camptothecin CRLX101 cFMS Tyrosine Kinase Inhibitor ARRY-382: text: cFMS Tyrosine Kinase Inhibitor ARRY-382 Gold Sodium Thiomalate: text: Gold Sodium Thiomalate Anti-CSF1R Monoclonal Antibody SNDX-6352: text: Anti-CSF1R Monoclonal Antibody SNDX-6352 p53-HDM2 Protein-protein Interaction Inhibitor APG-115: text: p53-HDM2 Protein-protein Interaction Inhibitor APG-115 Gefitinib: text: Gefitinib Losoxantrone: text: Losoxantrone Cetuximab Sarotalocan: text: Cetuximab Sarotalocan SIRPa-4-1BBL Fusion Protein DSP107: text: SIRPa-4-1BBL Fusion Protein DSP107 Artemether Sublingual Spray: text: Artemether Sublingual Spray DNMT1 Inhibitor NTX-301: text: DNMT1 Inhibitor NTX-301 Lacutamab: text: Lacutamab Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901: text: Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901 I 131 Monoclonal Antibody CC49: text: I 131 Monoclonal Antibody CC49 Shared Anti-Idiotype-AB-S024A: text: Shared Anti-Idiotype-AB-S024A Docetaxel-loaded Nanopharmaceutical CRLX301: text: Docetaxel-loaded Nanopharmaceutical CRLX301 Gamma-Secretase Inhibitor RO4929097: text: Gamma-Secretase Inhibitor RO4929097 CAIX Inhibitor DTP348: text: CAIX Inhibitor DTP348 Antibody-drug Conjugate ABBV-176: text: Antibody-drug Conjugate ABBV-176 Anti-CD22 ADC TRPH-222: text: Anti-CD22 ADC TRPH-222 Glutaminase Inhibitor CB-839: text: Glutaminase Inhibitor CB-839 FAP/4-1BB-targeting Fusion Protein RO7122290: text: FAP/4-1BB-targeting Fusion Protein RO7122290 Anti-PKN3 siRNA Atu027: text: Anti-PKN3 siRNA Atu027 Tris-acryl Gelatin Microspheres: text: Tris-acryl Gelatin Microspheres Domatinostat: text: Domatinostat Lurtotecan: text: Lurtotecan Allogeneic Melanoma Vaccine AGI-101H: text: Allogeneic Melanoma Vaccine AGI-101H RAF Kinase Inhibitor XL281: text: RAF Kinase Inhibitor XL281 Lutetium Lu-177 Girentuximab: text: Lutetium Lu-177 Girentuximab Lontucirev: text: Lontucirev Lapatinib: text: Lapatinib Fascin Inhibitor NP-G2-044: text: Fascin Inhibitor NP-G2-044 Pyridyl Cyanoguanidine CHS 828: text: Pyridyl Cyanoguanidine CHS 828 Autologous Anti-BCMA CAR T-cells PHE885: text: Autologous Anti-BCMA CAR T-cells PHE885 Elsamitrucin: text: Elsamitrucin HDAC Inhibitor AR-42: text: HDAC Inhibitor AR-42 Macimorelin: text: Macimorelin Bicalutamide: text: Bicalutamide Lyophilized Black Raspberry Saliva Substitute: text: Lyophilized Black Raspberry Saliva Substitute Pentamethylmelamine: text: Pentamethylmelamine Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a: text: Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a Recombinant Interleukin-13: text: Recombinant Interleukin-13 Rilimogene Glafolivec: text: Rilimogene Glafolivec Pirfenidone: text: Pirfenidone Androgen Receptor Downregulator AZD3514: text: Androgen Receptor Downregulator AZD3514 Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241: text: Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241 Agonistic Anti-CD40 Monoclonal Antibody ADC-1013: text: Agonistic Anti-CD40 Monoclonal Antibody ADC-1013 Anti-EGFR/CD16A Bispecific Antibody AFM24: text: Anti-EGFR/CD16A Bispecific Antibody AFM24 Glutamine Antagonist DRP-104: text: Glutamine Antagonist DRP-104 Marizomib: text: Marizomib Fresolimumab: text: Fresolimumab Thioguanine: text: Thioguanine Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes: text: Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes Yttrium Y 90 Monoclonal Antibody BrE-3: text: Yttrium Y 90 Monoclonal Antibody BrE-3 PARP 1/2 Inhibitor IMP4297: text: PARP 1/2 Inhibitor IMP4297 Tyrosinase Peptide: text: Tyrosinase Peptide Trimethylcolchicinic Acid: text: Trimethylcolchicinic Acid Anti-CD33/CD3 Bispecific Antibody GEM 333: text: Anti-CD33/CD3 Bispecific Antibody GEM 333 SHP2 Inhibitor JAB-3068: text: SHP2 Inhibitor JAB-3068 PKA Regulatory Subunit RIalpha Mixed-Backbone Antisense Oligonucleotide GEM 231: text: PKA Regulatory Subunit RIalpha Mixed-Backbone Antisense Oligonucleotide GEM 231 Methionine Aminopeptidase 2 Inhibitor M8891: text: Methionine Aminopeptidase 2 Inhibitor M8891 Autologous CD19-targeted CAR T Cells JWCAR029: text: Autologous CD19-targeted CAR T Cells JWCAR029 Limonene, (+)-: text: Limonene, (+)- FGFR/CSF-1R Inhibitor 3D185: text: FGFR/CSF-1R Inhibitor 3D185 Archexin: text: Archexin Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017: text: Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017 Flt3/MerTK Inhibitor MRX-2843: text: Flt3/MerTK Inhibitor MRX-2843 Antineoplastic Agent Combination SM-88: text: Antineoplastic Agent Combination SM-88 Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1: text: Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1 KRAS-MAPK Signaling Pathway Inhibitor JAB-3312: text: KRAS-MAPK Signaling Pathway Inhibitor JAB-3312 Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110: text: Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110 Combretastatin A-1: text: Combretastatin A-1 Sorghum bicolor Supplement: text: Sorghum bicolor Supplement Raltitrexed: text: Raltitrexed Monoclonal Antibody E2.3: text: Monoclonal Antibody E2.3 Misonidazole: text: Misonidazole Vesigenurtucel-L: text: Vesigenurtucel-L Antitumor B Key Active Component-alpha: text: Antitumor B Key Active Component-alpha Prednimustine: text: Prednimustine Lutetium Lu 177 Dotatate: text: Lutetium Lu 177 Dotatate Pladienolide Derivative E7107: text: Pladienolide Derivative E7107 Tyrosine Kinase Inhibitor XL228: text: Tyrosine Kinase Inhibitor XL228 EP2/EP4 Antagonist TPST-1495: text: EP2/EP4 Antagonist TPST-1495 Mitoguazone: text: Mitoguazone Monoclonal Antibody m170: text: Monoclonal Antibody m170 p300/CBP Bromodomain Inhibitor CCS1477: text: p300/CBP Bromodomain Inhibitor CCS1477 Liposome-encapsulated TAAs mRNA Vaccine W_ova1: text: Liposome-encapsulated TAAs mRNA Vaccine W_ova1 MMP Inhibitor S-3304: text: MMP Inhibitor S-3304 Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076: text: Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076 Fluoxymesterone: text: Fluoxymesterone Rhenium Re-188 Ethiodized Oil: text: Rhenium Re-188 Ethiodized Oil Liposomal Docetaxel: text: Liposomal Docetaxel Bruceanol G: text: Bruceanol G Aryl Hydrocarbon Receptor Antagonist BAY2416964: text: Aryl Hydrocarbon Receptor Antagonist BAY2416964 Polyamine Analogue SBP-101: text: Polyamine Analogue SBP-101 Anti-Glypican 3/CD3 Bispecific Antibody ERY974: text: Anti-Glypican 3/CD3 Bispecific Antibody ERY974 Transferrin-CRM107: text: Transferrin-CRM107 Lutetium Lu 177 Monoclonal Antibody CC49: text: Lutetium Lu 177 Monoclonal Antibody CC49 Metformin: text: Metformin Docetaxel Emulsion ANX-514: text: Docetaxel Emulsion ANX-514 Imalumab: text: Imalumab huBC1-huIL12 Fusion Protein AS1409: text: huBC1-huIL12 Fusion Protein AS1409 Lutetium Lu 177 DOTA-biotin: text: Lutetium Lu 177 DOTA-biotin Elmustine: text: Elmustine Duvortuxizumab: text: Duvortuxizumab Anti-CD19/CD3 Tetravalent Antibody AFM11: text: Anti-CD19/CD3 Tetravalent Antibody AFM11 Aspacytarabine: text: Aspacytarabine Aprutumab: text: Aprutumab Globo H-DT Vaccine OBI-833: text: Globo H-DT Vaccine OBI-833 Anti-CD38 Monoclonal Antibody TAK-079: text: Anti-CD38 Monoclonal Antibody TAK-079 Anti-PD-1/CTLA-4 Bispecific Antibody MEDI5752: text: Anti-PD-1/CTLA-4 Bispecific Antibody MEDI5752 Talimogene Laherparepvec: text: Talimogene Laherparepvec Abemaciclib Mesylate: text: Abemaciclib Mesylate Hsp90 Inhibitor MPC-3100: text: Hsp90 Inhibitor MPC-3100 Lysine-specific Demethylase 1 Inhibitor INCB059872: text: Lysine-specific Demethylase 1 Inhibitor INCB059872 Autologous Anti-CD19 CAR T-cells IM19: text: Autologous Anti-CD19 CAR T-cells IM19 Anti-CTLA-4 Monoclonal Antibody HBM4003: text: Anti-CTLA-4 Monoclonal Antibody HBM4003 Retrovector Encoding Mutant Anti-Cyclin G1: text: Retrovector Encoding Mutant Anti-Cyclin G1 Aurora Kinase Inhibitor AMG 900: text: Aurora Kinase Inhibitor AMG 900 MDM2 Inhibitor AMGMDS3: text: MDM2 Inhibitor AMGMDS3 Sustained-release Mitomycin C Hydrogel Formulation UGN-102: text: Sustained-release Mitomycin C Hydrogel Formulation UGN-102 Ezabenlimab: text: Ezabenlimab c-Met Inhibitor AMG 337: text: c-Met Inhibitor AMG 337 BMS-184476: text: BMS-184476 Lyophilized Black Raspberry Lozenge: text: Lyophilized Black Raspberry Lozenge Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801: text: Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801 Tyrosinase-KLH: text: Tyrosinase-KLH Saracatinib Difumarate: text: Saracatinib Difumarate Iroplact: text: Iroplact Immunocytokine NHS-IL12: text: Immunocytokine NHS-IL12 Navicixizumab: text: Navicixizumab Vinfosiltine: text: Vinfosiltine Coenzyme Q10: text: Coenzyme Q10 O-Chloroacetylcarbamoylfumagillol: text: O-Chloroacetylcarbamoylfumagillol Phenesterin: text: Phenesterin Tinostamustine: text: Tinostamustine Zebularine: text: Zebularine Selonsertib: text: Selonsertib HPV6/11-targeted DNA Plasmid Vaccine INO-3107: text: HPV6/11-targeted DNA Plasmid Vaccine INO-3107 DACH Polymer Platinate AP5346: text: DACH Polymer Platinate AP5346 Antibody-drug Conjugate SC-005: text: Antibody-drug Conjugate SC-005 Autologous Anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T Lymphocytes GSK3377794: text: Autologous Anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T Lymphocytes GSK3377794 Anti-CD20 Monoclonal Antibody MIL62: text: Anti-CD20 Monoclonal Antibody MIL62 c-Met Inhibitor MK2461: text: c-Met Inhibitor MK2461 Methoxyamine Hydrochloride: text: Methoxyamine Hydrochloride Genetically Modified Interleukin-12 Transgene-encoding Bifidobacterium longum: text: Genetically Modified Interleukin-12 Transgene-encoding Bifidobacterium longum Erdafitinib: text: Erdafitinib SIRPa-Fc-CD40L Fusion Protein SL-172154: text: SIRPa-Fc-CD40L Fusion Protein SL-172154 Anti-PD-1/Anti-HER2 Bispecific Antibody IBI315: text: Anti-PD-1/Anti-HER2 Bispecific Antibody IBI315 Hsp90 Inhibitor SNX-5422 Mesylate: text: Hsp90 Inhibitor SNX-5422 Mesylate Monoclonal Antibody CEP-37250/KHK2804: text: Monoclonal Antibody CEP-37250/KHK2804 Mezagitamab: text: Mezagitamab Pexidartinib: text: Pexidartinib Histrelin Acetate: text: Histrelin Acetate Zorubicin Hydrochloride: text: Zorubicin Hydrochloride Orantinib: text: Orantinib Multi-kinase Inhibitor XL092: text: Multi-kinase Inhibitor XL092 Avitinib Maleate: text: Avitinib Maleate Anti-HER-2 Bispecific Antibody KN026: text: Anti-HER-2 Bispecific Antibody KN026 Deoxycytidine Analogue TAS-109: text: Deoxycytidine Analogue TAS-109 Ripretinib: text: Ripretinib Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T: text: Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T Soy Isoflavones: text: Soy Isoflavones Axatilimab: text: Axatilimab Imexon: text: Imexon Zalutumumab: text: Zalutumumab Dinaciclib: text: Dinaciclib Anti-ILT4 Monoclonal Antibody MK-4830: text: Anti-ILT4 Monoclonal Antibody MK-4830 Enloplatin: text: Enloplatin Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01: text: Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01 Alefacept: text: Alefacept Autologous CD19-targeted CAR-T Cells GC007F: text: Autologous CD19-targeted CAR-T Cells GC007F Tasquinimod: text: Tasquinimod Etoglucid: text: Etoglucid AKT 1/2 Inhibitor BAY1125976: text: AKT 1/2 Inhibitor BAY1125976 BCMA/CD3e Tri-specific T-cell Activating Construct HPN217: text: BCMA/CD3e Tri-specific T-cell Activating Construct HPN217 Monoclonal Antibody huJ591: text: Monoclonal Antibody huJ591 Topotecan Hydrochloride Liposomes: text: Topotecan Hydrochloride Liposomes HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131: text: HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131 Ribonuclease QBI-139: text: Ribonuclease QBI-139 Monoclonal Antibody 14G2A: text: Monoclonal Antibody 14G2A Tegavivint: text: Tegavivint Receptor Tyrosine Kinase Inhibitor R1530: text: Receptor Tyrosine Kinase Inhibitor R1530 HDM2 Inhibitor MK-8242: text: HDM2 Inhibitor MK-8242 Cinacalcet Hydrochloride: text: Cinacalcet Hydrochloride Numidargistat: text: Numidargistat PRMT1 Inhibitor GSK3368715: text: PRMT1 Inhibitor GSK3368715 Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404: text: Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404 Anti-AG7 Antibody Drug Conjugate AbGn-107: text: Anti-AG7 Antibody Drug Conjugate AbGn-107 Amrubicin: text: Amrubicin Yttrium-90 Polycarbonate Brachytherapy Plaque: text: Yttrium-90 Polycarbonate Brachytherapy Plaque Anti-c-MET Monoclonal Antibody LY2875358: text: Anti-c-MET Monoclonal Antibody LY2875358 Anti-CD123/CD3 Bispecific Antibody APVO436: text: Anti-CD123/CD3 Bispecific Antibody APVO436 Anti-HER2 Antibody-drug Conjugate DP303c: text: Anti-HER2 Antibody-drug Conjugate DP303c Aminoflavone Prodrug AFP464: text: Aminoflavone Prodrug AFP464 Nifurtimox: text: Nifurtimox Wnt Signaling Pathway Inhibitor SM08502: text: Wnt Signaling Pathway Inhibitor SM08502 CD73 Inhibitor AB680: text: CD73 Inhibitor AB680 Naratuximab Emtansine: text: Naratuximab Emtansine Allogeneic Anti-CD20-CAR T-cells PBCAR20A: text: Allogeneic Anti-CD20-CAR T-cells PBCAR20A Anti-EGFR Monoclonal Antibody GC1118: text: Anti-EGFR Monoclonal Antibody GC1118 Anti-CD98 Monoclonal Antibody IGN523: text: Anti-CD98 Monoclonal Antibody IGN523 Nadofaragene Firadenovec: text: Nadofaragene Firadenovec Anti-CD33 Monoclonal Antibody BI 836858: text: Anti-CD33 Monoclonal Antibody BI 836858 Bruceanol H: text: Bruceanol H Letrozole: text: Letrozole PGG Beta-Glucan: text: PGG Beta-Glucan Fumagillin-Derived Polymer Conjugate XMT-1107: text: Fumagillin-Derived Polymer Conjugate XMT-1107 Doxorubicin-Eluting Beads: text: Doxorubicin-Eluting Beads Anti-HER2 ADC DS-8201a: text: Anti-HER2 ADC DS-8201a STING Agonist MK-1454: text: STING Agonist MK-1454 Durvalumab: text: Durvalumab Rogletimide: text: Rogletimide Fimaporfin A: text: Fimaporfin A Pexmetinib: text: Pexmetinib Aurora Kinase Inhibitor MLN8054: text: Aurora Kinase Inhibitor MLN8054 Peplomycin Sulfate: text: Peplomycin Sulfate Shark Cartilage Extract AE-941: text: Shark Cartilage Extract AE-941 Denileukin Diftitox: text: Denileukin Diftitox CDC7 Inhibitor TAK-931: text: CDC7 Inhibitor TAK-931 Autologous Mesenchymal Stem Cells Apceth_101: text: Autologous Mesenchymal Stem Cells Apceth_101 Fenebrutinib: text: Fenebrutinib p97 Inhibitor CB-5339 Tosylate: text: p97 Inhibitor CB-5339 Tosylate Superagonist Interleukin-15:Interleukin-15 Receptor alphaSu/Fc Fusion Complex ALT-803: text: Superagonist Interleukin-15:Interleukin-15 Receptor alphaSu/Fc Fusion Complex ALT-803 HDAC Inhibitor MPT0E028: text: HDAC Inhibitor MPT0E028 Ixabepilone: text: Ixabepilone Yangzheng Xiaoji Extract: text: Yangzheng Xiaoji Extract Synthetic hTERT DNA Vaccine INO-1401: text: Synthetic hTERT DNA Vaccine INO-1401 Recombinant MIP1-alpha Variant ECI301: text: Recombinant MIP1-alpha Variant ECI301 mRNA-based Personalized Cancer Vaccine mRNA-4157: text: mRNA-based Personalized Cancer Vaccine mRNA-4157 Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo: text: Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo Mutant p53 Activator COTI-2: text: Mutant p53 Activator COTI-2 Transferrin Receptor-Targeted Liposomal p53 cDNA: text: Transferrin Receptor-Targeted Liposomal p53 cDNA Enpromate: text: Enpromate Barasertib: text: Barasertib Trastuzumab/Hyaluronidase-oysk: text: Trastuzumab/Hyaluronidase-oysk PLK1 Inhibitor TAK-960: text: PLK1 Inhibitor TAK-960 Anti-c-Met Antibody-drug Conjugate HTI-1066: text: Anti-c-Met Antibody-drug Conjugate HTI-1066 DHA-Paclitaxel: text: DHA-Paclitaxel Picropodophyllin: text: Picropodophyllin Tilogotamab: text: Tilogotamab Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A: text: Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A MDM2 Antagonist RO6839921: text: MDM2 Antagonist RO6839921 Vinorelbine Tartrate: text: Vinorelbine Tartrate Caffeic Acid Phenethyl Ester: text: Caffeic Acid Phenethyl Ester Degarelix: text: Degarelix MAGE-A3-specific Immunotherapeutic GSK 2132231A: text: MAGE-A3-specific Immunotherapeutic GSK 2132231A Topotecan Sustained-release Episcleral Plaque: text: Topotecan Sustained-release Episcleral Plaque Fosbretabulin: text: Fosbretabulin ChiNing Decoction: text: ChiNing Decoction TLR7 agonist BNT411: text: TLR7 agonist BNT411 Aminopterin: text: Aminopterin HCV DNA Vaccine INO-8000: text: HCV DNA Vaccine INO-8000 Allogeneic Anti-CD19-CAR T-cells PBCAR0191: text: Allogeneic Anti-CD19-CAR T-cells PBCAR0191 Methylprednisolone: text: Methylprednisolone EGFR Inhibitor AZD3759: text: EGFR Inhibitor AZD3759 Lucitanib: text: Lucitanib PI3K-delta Inhibitor AMG 319: text: PI3K-delta Inhibitor AMG 319 Prednisolone: text: Prednisolone Androgen Receptor Antisense Oligonucleotide AZD5312: text: Androgen Receptor Antisense Oligonucleotide AZD5312 pan-HER Kinase Inhibitor AC480: text: pan-HER Kinase Inhibitor AC480 Axitinib: text: Axitinib Mucoadhesive Paclitaxel Formulation: text: Mucoadhesive Paclitaxel Formulation Exatecan Mesylate Anhydrous: text: Exatecan Mesylate Anhydrous Nimodipine: text: Nimodipine Ingenol Mebutate Gel: text: Ingenol Mebutate Gel Tin Ethyl Etiopurpurin: text: Tin Ethyl Etiopurpurin Anti-B7H3 Antibody-drug Conjugate MGC018: text: Anti-B7H3 Antibody-drug Conjugate MGC018 Azintuxizumab Vedotin: text: Azintuxizumab Vedotin Oral Sodium Phenylbutyrate: text: Oral Sodium Phenylbutyrate MDM2 Antagonist RO5045337: text: MDM2 Antagonist RO5045337 Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine: text: Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine Autologous CD123-4SCAR-expressing T-cells 4SCAR123: text: Autologous CD123-4SCAR-expressing T-cells 4SCAR123 Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12: text: Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 Clomiphene Citrate: text: Clomiphene Citrate Lorvotuzumab Mertansine: text: Lorvotuzumab Mertansine Plozalizumab: text: Plozalizumab Nab-paclitaxel: text: Nab-paclitaxel Multifunctional/Multitargeted Anticancer Agent OMN54: text: Multifunctional/Multitargeted Anticancer Agent OMN54 Yttrium Y-90 Epratuzumab Tetraxetan: text: Yttrium Y-90 Epratuzumab Tetraxetan Maekmoondong-tang: text: Maekmoondong-tang Monoclonal Antibody L6: text: Monoclonal Antibody L6 Cereblon E3 Ubiquitin Ligase Modulating Agent CC-99282: text: Cereblon E3 Ubiquitin Ligase Modulating Agent CC-99282 Anti-PD-1/CTLA-4 Bispecific Antibody AK104: text: Anti-PD-1/CTLA-4 Bispecific Antibody AK104 LSD1 Inhibitor SYHA1807: text: LSD1 Inhibitor SYHA1807 Anti-gpA33/CD3 Monoclonal Antibody MGD007: text: Anti-gpA33/CD3 Monoclonal Antibody MGD007 Demcizumab: text: Demcizumab Anti-APRIL Monoclonal Antibody BION-1301: text: Anti-APRIL Monoclonal Antibody BION-1301 HAAH Lambda phage Vaccine SNS-301: text: HAAH Lambda phage Vaccine SNS-301 CCR2 Antagonist PF-04136309: text: CCR2 Antagonist PF-04136309 Carboquone: text: Carboquone Oral Milataxel: text: Oral Milataxel Anti-CD166 Probody-drug Conjugate CX-2009: text: Anti-CD166 Probody-drug Conjugate CX-2009 Buparlisib: text: Buparlisib IRAK4 Inhibitor CA-4948: text: IRAK4 Inhibitor CA-4948 Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter: text: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter Fedratinib: text: Fedratinib EGFR/HER2 Inhibitor AV-412: text: EGFR/HER2 Inhibitor AV-412 CDK7 Inhibitor SY-1365: text: CDK7 Inhibitor SY-1365 Oblimersen Sodium: text: Oblimersen Sodium Topoisomerase I/II Inhibitor NEV-801: text: Topoisomerase I/II Inhibitor NEV-801 Efizonerimod: text: Efizonerimod Ad-RTS-hIL-12: text: Ad-RTS-hIL-12 Galarubicin: text: Galarubicin Erlotinib: text: Erlotinib Dolastatin 15: text: Dolastatin 15 Phenytoin Sodium: text: Phenytoin Sodium Autologous Anti-CD19 T-cell Receptor T cells ET190L1: text: Autologous Anti-CD19 T-cell Receptor T cells ET190L1 Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC: text: Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine: text: Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine BET Inhibitor CC-90010: text: BET Inhibitor CC-90010 Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536: text: Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536 Polyunsaturated Fatty Acid: text: Polyunsaturated Fatty Acid Anti-PRAME Immunotherapeutic GSK2302032A: text: Anti-PRAME Immunotherapeutic GSK2302032A Combretastatin: text: Combretastatin Chaparrinone: text: Chaparrinone WT1 Peptide Vaccine OCV-501: text: WT1 Peptide Vaccine OCV-501 Valecobulin: text: Valecobulin EphA2-targeting Bicycle Toxin Conjugate BT5528: text: EphA2-targeting Bicycle Toxin Conjugate BT5528 Antisense Oligonucleotide GTI-2040: text: Antisense Oligonucleotide GTI-2040 Ketoconazole: text: Ketoconazole Renal Cell Carcinoma Peptides Vaccine IMA901: text: Renal Cell Carcinoma Peptides Vaccine IMA901 Pixantrone Dimaleate: text: Pixantrone Dimaleate Coriolus Versicolor Extract: text: Coriolus Versicolor Extract Roneparstat: text: Roneparstat p38 MAPK Inhibitor LY3007113: text: p38 MAPK Inhibitor LY3007113 Anti-CD46 Antibody-drug Conjugate FOR46: text: Anti-CD46 Antibody-drug Conjugate FOR46 CDK4/6 Inhibitor FCN-437: text: CDK4/6 Inhibitor FCN-437 Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907: text: Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907 Anti-GRP78 Monoclonal Antibody PAT-SM6: text: Anti-GRP78 Monoclonal Antibody PAT-SM6 Diazooxonorleucine: text: Diazooxonorleucine Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells: text: Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells Vapreotide: text: Vapreotide Tivantinib: text: Tivantinib Nucleolin Antagonist IPP-204106N: text: Nucleolin Antagonist IPP-204106N STING-expressing E. coli SYNB1891: text: STING-expressing E. coli SYNB1891 Factor VII-targeting Immunoconjugate Protein ICON-1: text: Factor VII-targeting Immunoconjugate Protein ICON-1 Nutraceutical TBL-12: text: Nutraceutical TBL-12 Anti-PD-L1/4-1BB Bispecific Antibody INBRX-105: text: Anti-PD-L1/4-1BB Bispecific Antibody INBRX-105 Vemurafenib: text: Vemurafenib Vanucizumab: text: Vanucizumab FGFR Inhibitor ASP5878: text: FGFR Inhibitor ASP5878 Colorectal Tumor-Associated Peptides Vaccine IMA910: text: Colorectal Tumor-Associated Peptides Vaccine IMA910 Magnesium Valproate: text: Magnesium Valproate PEP-3-KLH Conjugate Vaccine: text: PEP-3-KLH Conjugate Vaccine Tasisulam Sodium: text: Tasisulam Sodium Adenoviral MUC1 Vaccine ETBX-061: text: Adenoviral MUC1 Vaccine ETBX-061 Perifosine: text: Perifosine Denintuzumab Mafodotin: text: Denintuzumab Mafodotin Bruceantin: text: Bruceantin Epirubicin: text: Epirubicin Aurora Kinase Inhibitor BI 811283: text: Aurora Kinase Inhibitor BI 811283 PI3Kalpha Inhibitor AZD8835: text: PI3Kalpha Inhibitor AZD8835 LMB-1 Immunotoxin: text: LMB-1 Immunotoxin Oleandrin: text: Oleandrin Macitentan: text: Macitentan Strontium Chloride Sr-89: text: Strontium Chloride Sr-89 Mercaptopurine Anhydrous: text: Mercaptopurine Anhydrous Anti-PSCA Monoclonal Antibody AGS-1C4D4: text: Anti-PSCA Monoclonal Antibody AGS-1C4D4 Spirogermanium: text: Spirogermanium Cancell: text: Cancell Apaziquone: text: Apaziquone Pyruvate Kinase M2 Isoform Activator TP-1454: text: Pyruvate Kinase M2 Isoform Activator TP-1454 Sonepcizumab: text: Sonepcizumab CYP11A1 Inhibitor ODM-209: text: CYP11A1 Inhibitor ODM-209 HIF-1alpha Inhibitor PX-478: text: HIF-1alpha Inhibitor PX-478 Ombrabulin: text: Ombrabulin Cesalin: text: Cesalin Anti-CD20 Monoclonal Antibody BAT4306F: text: Anti-CD20 Monoclonal Antibody BAT4306F Personalized Neoantigen DNA Vaccine GNOS-PVO2: text: Personalized Neoantigen DNA Vaccine GNOS-PVO2 FLT3 Inhibitor HM43239: text: FLT3 Inhibitor HM43239 PI3Kdelta Inhibitor GS-9901: text: PI3Kdelta Inhibitor GS-9901 MAT2A Inhibitor AG-270: text: MAT2A Inhibitor AG-270 CDK4/6 Inhibitor BPI-16350: text: CDK4/6 Inhibitor BPI-16350 Oncolytic Newcastle Disease Virus Strain PV701: text: Oncolytic Newcastle Disease Virus Strain PV701 FLT3/FGFR Dual Kinase Inhibitor MAX-40279: text: FLT3/FGFR Dual Kinase Inhibitor MAX-40279 Wee1 Inhibitor ZN-c3: text: Wee1 Inhibitor ZN-c3 Anti-CD205 Antibody-drug Conjugate OBT076: text: Anti-CD205 Antibody-drug Conjugate OBT076 Imatinib: text: Imatinib Oltipraz: text: Oltipraz Unknown: text: Unknown Recombinant Transforming Growth Factor-Beta: text: Recombinant Transforming Growth Factor-Beta Caricotamide/Tretazicar: text: Caricotamide/Tretazicar Methylcantharidimide: text: Methylcantharidimide Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200: text: Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200 Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL: text: Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL Anti-CD47 ADC SGN-CD47M: text: Anti-CD47 ADC SGN-CD47M Hyaluronidase-zzxf/Pertuzumab/Trastuzumab: text: Hyaluronidase-zzxf/Pertuzumab/Trastuzumab Anti-GITR Agonistic Monoclonal Antibody INCAGN01876: text: Anti-GITR Agonistic Monoclonal Antibody INCAGN01876 FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999: text: FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999 Trabectedin: text: Trabectedin Scopoletin: text: Scopoletin Anti-PD-1 Monoclonal Antibody HLX10: text: Anti-PD-1 Monoclonal Antibody HLX10 Recombinant Interleukin-18: text: Recombinant Interleukin-18 HDAC Class I/IIb Inhibitor HG146: text: HDAC Class I/IIb Inhibitor HG146 Platinum Compound: text: Platinum Compound Ruthenium-based Small Molecule Therapeutic BOLD-100: text: Ruthenium-based Small Molecule Therapeutic BOLD-100 Aurora Kinase Inhibitor PF-03814735: text: Aurora Kinase Inhibitor PF-03814735 Anti-S15 Monoclonal Antibody NC318: text: Anti-S15 Monoclonal Antibody NC318 Lestaurtinib: text: Lestaurtinib Axl/Mer Inhibitor INCB081776: text: Axl/Mer Inhibitor INCB081776 Hydrocortisone Sodium Succinate: text: Hydrocortisone Sodium Succinate Trimetrexate Glucuronate: text: Trimetrexate Glucuronate Anti-CD37 Bispecific Monoclonal Antibody GEN3009: text: Anti-CD37 Bispecific Monoclonal Antibody GEN3009 Fosquidone: text: Fosquidone Ashwagandha Root Powder Extract: text: Ashwagandha Root Powder Extract Thymidylate Synthase Inhibitor CX1106: text: Thymidylate Synthase Inhibitor CX1106 Sodium Stibogluconate: text: Sodium Stibogluconate Thalicarpine: text: Thalicarpine Pan-FLT3/Pan-BTK Multi-kinase Inhibitor CG-806: text: Pan-FLT3/Pan-BTK Multi-kinase Inhibitor CG-806 Androgen Receptor Antagonist TRC253: text: Androgen Receptor Antagonist TRC253 Liposome-encapsulated miR-34 Mimic MRX34: text: Liposome-encapsulated miR-34 Mimic MRX34 Ubidecarenone Nanodispersion BPM31510n: text: Ubidecarenone Nanodispersion BPM31510n Autologous TCR-engineered T-cells IMA202: text: Autologous TCR-engineered T-cells IMA202 Yttrium Y 90 Colloid: text: Yttrium Y 90 Colloid MVA-FCU1 TG4023: text: MVA-FCU1 TG4023 Tocotrienol: text: Tocotrienol BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351: text: BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351 Ridaforolimus: text: Ridaforolimus DM-CHOC-PEN: text: DM-CHOC-PEN MET Kinase Inhibitor OMO-1: text: MET Kinase Inhibitor OMO-1 Interleukin Therapy: text: Interleukin Therapy Dasatinib: text: Dasatinib Eribulin Mesylate: text: Eribulin Mesylate Micro Needle Array-Doxorubicin: text: Micro Needle Array-Doxorubicin Anlotinib Hydrochloride: text: Anlotinib Hydrochloride Dezapelisib: text: Dezapelisib Suramin: text: Suramin FLT3 Inhibitor SKI-G-801: text: FLT3 Inhibitor SKI-G-801 Vibostolimab: text: Vibostolimab Ketotrexate: text: Ketotrexate IDO1/TDO2 Inhibitor M4112: text: IDO1/TDO2 Inhibitor M4112 Anti-PD-1 Monoclonal Antibody AK105: text: Anti-PD-1 Monoclonal Antibody AK105 Nimustine Hydrochloride: text: Nimustine Hydrochloride Procaspase Activating Compound-1 VO-100: text: Procaspase Activating Compound-1 VO-100 EZH1/2 Inhibitor HH2853: text: EZH1/2 Inhibitor HH2853 Pazopanib Hydrochloride: text: Pazopanib Hydrochloride Sabarubicin: text: Sabarubicin Ganglioside GM2: text: Ganglioside GM2 Rodorubicin: text: Rodorubicin Pegzilarginase: text: Pegzilarginase Everolimus: text: Everolimus Glutaminase Inhibitor IPN60090: text: Glutaminase Inhibitor IPN60090 Selumetinib Sulfate: text: Selumetinib Sulfate Autologous Pancreatic Adenocarcinoma Lysate and mRNA-loaded Dendritic Cell Vaccine: text: Autologous Pancreatic Adenocarcinoma Lysate and mRNA-loaded Dendritic Cell Vaccine Ranpirnase: text: Ranpirnase Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY): text: Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY) Repotrectinib: text: Repotrectinib Anti-PD-L1 Monoclonal Antibody GR1405: text: Anti-PD-L1 Monoclonal Antibody GR1405 Anti-MUC16/CD3 Bispecific Antibody REGN4018: text: Anti-MUC16/CD3 Bispecific Antibody REGN4018 Vulinacimab: text: Vulinacimab Anti-CD123/CD3 BiTE Antibody SAR440234: text: Anti-CD123/CD3 BiTE Antibody SAR440234 CEA-MUC-1-TRICOM Vaccine CV301: text: CEA-MUC-1-TRICOM Vaccine CV301 Arugula Seed Powder: text: Arugula Seed Powder Gemcitabine Prodrug LY2334737: text: Gemcitabine Prodrug LY2334737 Boanmycin Hydrochloride: text: Boanmycin Hydrochloride Mosunetuzumab: text: Mosunetuzumab Dalotuzumab: text: Dalotuzumab Enclomiphene: text: Enclomiphene Tubulin Binding Agent TTI-237: text: Tubulin Binding Agent TTI-237 Sargramostim: text: Sargramostim THL-P: text: THL-P Cidan Herbal Capsule: text: Cidan Herbal Capsule mTOR Kinase Inhibitor PP242: text: mTOR Kinase Inhibitor PP242 D-methionine Formulation MRX-1024: text: D-methionine Formulation MRX-1024 Anti-OFA Immunotherapeutic BB-MPI-03: text: Anti-OFA Immunotherapeutic BB-MPI-03 Talabostat: text: Talabostat Cediranib: text: Cediranib SNS01-T Nanoparticles: text: SNS01-T Nanoparticles Dibrospidium Chloride: text: Dibrospidium Chloride 3'-dA Phosphoramidate NUC-7738: text: 3'-dA Phosphoramidate NUC-7738 Paclitaxel PPE Microspheres: text: Paclitaxel PPE Microspheres Anti-Ep-CAM Monoclonal Antibody ING-1: text: Anti-Ep-CAM Monoclonal Antibody ING-1 Luminespib: text: Luminespib FGFR2 Inhibitor RLY-4008: text: FGFR2 Inhibitor RLY-4008 Lanreotide Acetate: text: Lanreotide Acetate TGF-beta Receptor 1 Kinase Inhibitor SH3051: text: TGF-beta Receptor 1 Kinase Inhibitor SH3051 Cosibelimab: text: Cosibelimab Capecitabine Rapidly Disintegrating Tablet: text: Capecitabine Rapidly Disintegrating Tablet Apoptosis Inducer MPC-2130: text: Apoptosis Inducer MPC-2130 Bazedoxifene: text: Bazedoxifene ATM Inhibitor M 3541: text: ATM Inhibitor M 3541 Sodium Phenylbutyrate: text: Sodium Phenylbutyrate PAK4/NAMPT Inhibitor KPT-9274: text: PAK4/NAMPT Inhibitor KPT-9274 BET inhibitor BI 894999: text: BET inhibitor BI 894999 Tubulin Polymerization Inhibitor VERU-111: text: Tubulin Polymerization Inhibitor VERU-111 PI3K-delta Inhibitor INCB050465: text: PI3K-delta Inhibitor INCB050465 Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101: text: Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101 Pan-PIM Inhibitor INCB053914: text: Pan-PIM Inhibitor INCB053914 Anti-B7-H3 Antibody DS-5573a: text: Anti-B7-H3 Antibody DS-5573a DNA Minor Groove Binding Agent SG2000: text: DNA Minor Groove Binding Agent SG2000 DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555: text: DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555 Triapine: text: Triapine Zuclomiphene Citrate: text: Zuclomiphene Citrate Dexamethasone Phosphate: text: Dexamethasone Phosphate TP40 Immunotoxin: text: TP40 Immunotoxin Marimastat: text: Marimastat Retaspimycin Hydrochloride: text: Retaspimycin Hydrochloride Pegylated Liposomal Doxorubicin Hydrochloride: text: Pegylated Liposomal Doxorubicin Hydrochloride Anti-PD-L1 Monoclonal Antibody CBT-502: text: Anti-PD-L1 Monoclonal Antibody CBT-502 Digitoxin: text: Digitoxin Autologous Anti-CD19/CD22 CAR T-cells AUTO3: text: Autologous Anti-CD19/CD22 CAR T-cells AUTO3 IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1: text: IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1 Cladribine: text: Cladribine Anti-TWEAK Monoclonal Antibody RG7212: text: Anti-TWEAK Monoclonal Antibody RG7212 Brivanib Alaninate: text: Brivanib Alaninate Axicabtagene Ciloleucel: text: Axicabtagene Ciloleucel Tegafur-Gimeracil-Oteracil Potassium-Leucovorin Calcium Oral Formulation: text: Tegafur-Gimeracil-Oteracil Potassium-Leucovorin Calcium Oral Formulation Vibecotamab: text: Vibecotamab EGFR T790M Inhibitor HS-10296: text: EGFR T790M Inhibitor HS-10296 Androgen Receptor Antagonist SHR3680: text: Androgen Receptor Antagonist SHR3680 Anti-Claudin18.2 Monoclonal Antibody TST001: text: Anti-Claudin18.2 Monoclonal Antibody TST001 Thalidomide: text: Thalidomide pan-PI3K/mTOR Inhibitor SF1126: text: pan-PI3K/mTOR Inhibitor SF1126 MDM2 Inhibitor BI 907828: text: MDM2 Inhibitor BI 907828 Hu14.18-IL2 Fusion Protein EMD 273063: text: Hu14.18-IL2 Fusion Protein EMD 273063 Roquinimex: text: Roquinimex Noscapine Hydrochloride: text: Noscapine Hydrochloride Ormaplatin: text: Ormaplatin Hsp90-targeted Photosensitizer HS-201: text: Hsp90-targeted Photosensitizer HS-201 Emitefur: text: Emitefur Edrecolomab: text: Edrecolomab Navoximod: text: Navoximod Monoclonal Antibody 3F8: text: Monoclonal Antibody 3F8 Telaglenastat: text: Telaglenastat SERD ZN-c5: text: SERD ZN-c5 Tetraphenyl Chlorin Disulfonate: text: Tetraphenyl Chlorin Disulfonate Floxuridine: text: Floxuridine pan-RAF Kinase Inhibitor CCT3833: text: pan-RAF Kinase Inhibitor CCT3833 Emepepimut-S: text: Emepepimut-S DKK1-Neutralizing Monoclonal Antibody DKN-01: text: DKK1-Neutralizing Monoclonal Antibody DKN-01 Maraba Oncolytic Virus Expressing Mutant HPV E6/E7: text: Maraba Oncolytic Virus Expressing Mutant HPV E6/E7 VLP-encapsulated TLR9 Agonist CMP-001: text: VLP-encapsulated TLR9 Agonist CMP-001 Jin Fu Kang: text: Jin Fu Kang Vinflunine: text: Vinflunine Colorectal Cancer Peptide Vaccine PolyPEPI1018: text: Colorectal Cancer Peptide Vaccine PolyPEPI1018 Oxeclosporin: text: Oxeclosporin Lenalidomide Analog KPG-121: text: Lenalidomide Analog KPG-121 Octreotide Pamoate: text: Octreotide Pamoate Sho-Saiko-To: text: Sho-Saiko-To Mitazalimab: text: Mitazalimab Ruthenium-based Transferrin Targeting Agent NKP-1339: text: Ruthenium-based Transferrin Targeting Agent NKP-1339 Gemcitabine Hydrochloride: text: Gemcitabine Hydrochloride Relugolix: text: Relugolix Combretastatin A1 Diphosphate: text: Combretastatin A1 Diphosphate AEE788: text: AEE788 IMT-1012 Immunotherapeutic Vaccine: text: IMT-1012 Immunotherapeutic Vaccine Immune Checkpoint Inhibitor ASP8374: text: Immune Checkpoint Inhibitor ASP8374 Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931: text: Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931 Lutetium Lu 177-PSMA-617: text: Lutetium Lu 177-PSMA-617 Compound Kushen Injection: text: Compound Kushen Injection Nelipepimut-S Plus GM-CSF Vaccine: text: Nelipepimut-S Plus GM-CSF Vaccine Polo-like Kinase 1 Inhibitor GSK461364: text: Polo-like Kinase 1 Inhibitor GSK461364 Linifanib: text: Linifanib Litronesib: text: Litronesib IL-2 Recombinant Fusion Protein ALT-801: text: IL-2 Recombinant Fusion Protein ALT-801 Chk1 Inhibitor CCT245737: text: Chk1 Inhibitor CCT245737 FGF Receptor Antagonist HGS1036: text: FGF Receptor Antagonist HGS1036 FLT3/ABL/Aurora Kinase Inhibitor KW-2449: text: FLT3/ABL/Aurora Kinase Inhibitor KW-2449 Triamcinolone Acetonide: text: Triamcinolone Acetonide A2A Receptor Antagonist EOS100850: text: A2A Receptor Antagonist EOS100850 Anti-HER2 Antibody-drug Conjugate BAT8001: text: Anti-HER2 Antibody-drug Conjugate BAT8001 CD80-Fc Fusion Protein ALPN-202: text: CD80-Fc Fusion Protein ALPN-202 Cortisone Acetate: text: Cortisone Acetate Medroxyprogesterone Acetate: text: Medroxyprogesterone Acetate Nilotinib: text: Nilotinib Trimetrexate: text: Trimetrexate Iadademstat: text: Iadademstat Aurora Kinase Inhibitor SNS-314: text: Aurora Kinase Inhibitor SNS-314 Bermekimab: text: Bermekimab Camptothecin Analogue TLC388: text: Camptothecin Analogue TLC388 Zanolimumab: text: Zanolimumab Losatuxizumab Vedotin: text: Losatuxizumab Vedotin Ovine Submaxillary Mucin: text: Ovine Submaxillary Mucin Smac Mimetic GDC-0917: text: Smac Mimetic GDC-0917 Bruceanol D: text: Bruceanol D Golnerminogene Pradenovec: text: Golnerminogene Pradenovec P-cadherin Antagonist PF-03732010: text: P-cadherin Antagonist PF-03732010 JAK Inhibitor: text: JAK Inhibitor Recombinant Leukocyte Interleukin: text: Recombinant Leukocyte Interleukin Proxalutamide: text: Proxalutamide Pegylated Deoxycytidine Analogue DFP-14927: text: Pegylated Deoxycytidine Analogue DFP-14927 MAGE-A3 Multipeptide Vaccine GL-0817: text: MAGE-A3 Multipeptide Vaccine GL-0817 Piritrexim Isethionate: text: Piritrexim Isethionate Testolactone: text: Testolactone Topoisomerase I Inhibitor LMP400: text: Topoisomerase I Inhibitor LMP400 Elpamotide: text: Elpamotide Mapatumumab: text: Mapatumumab L-Gossypol: text: L-Gossypol Tandutinib: text: Tandutinib Ripertamab: text: Ripertamab Lenzilumab: text: Lenzilumab Anti-gremlin-1 Monoclonal Antibody UCB6114: text: Anti-gremlin-1 Monoclonal Antibody UCB6114 Pegylated Recombinant Interleukin-2 THOR-707: text: Pegylated Recombinant Interleukin-2 THOR-707 Cordycepin Triphosphate: text: Cordycepin Triphosphate Amblyomin-X: text: Amblyomin-X Puquitinib: text: Puquitinib SERD SAR439859: text: SERD SAR439859 Ixazomib: text: Ixazomib Cabiralizumab: text: Cabiralizumab Iodine I 131 Tositumomab: text: Iodine I 131 Tositumomab Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240: text: Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240 Recombinant Interferon Alfa-2b: text: Recombinant Interferon Alfa-2b CXCR4 Peptide Antagonist LY2510924: text: CXCR4 Peptide Antagonist LY2510924 Iodine I 131 Tenatumomab: text: Iodine I 131 Tenatumomab Ocrelizumab: text: Ocrelizumab Viagenpumatucel-L: text: Viagenpumatucel-L Tozasertib Lactate: text: Tozasertib Lactate Antibody-drug Conjugate ABBV-838: text: Antibody-drug Conjugate ABBV-838 Antibody-drug Conjugate SC-007: text: Antibody-drug Conjugate SC-007 Anti-PVRIG Monoclonal Antibody COM701: text: Anti-PVRIG Monoclonal Antibody COM701 Alvespimycin Hydrochloride: text: Alvespimycin Hydrochloride Seribantumab: text: Seribantumab Clofarabine: text: Clofarabine mTOR Kinase Inhibitor CC-223: text: mTOR Kinase Inhibitor CC-223 Noscapine: text: Noscapine Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736: text: Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736 PARP-1/2 Inhibitor ABT-767: text: PARP-1/2 Inhibitor ABT-767 USP14/UCHL5 Inhibitor VLX1570: text: USP14/UCHL5 Inhibitor VLX1570 Monoclonal Antibody TRK-950: text: Monoclonal Antibody TRK-950 IGF-1R Inhibitor: text: IGF-1R Inhibitor Autologous CD38-4SCAR-expressing T-cells 4SCAR38: text: Autologous CD38-4SCAR-expressing T-cells 4SCAR38 Anti-HER2 Antibody-drug Conjugate A166: text: Anti-HER2 Antibody-drug Conjugate A166 Rivoceranib Mesylate: text: Rivoceranib Mesylate Oncolytic HSV1716: text: Oncolytic HSV1716 SIRPa-Fc Fusion Protein TTI-621: text: SIRPa-Fc Fusion Protein TTI-621 Menatetrenone: text: Menatetrenone Plk1 Inhibitor BI 2536: text: Plk1 Inhibitor BI 2536 Vantictumab: text: Vantictumab Dactolisib Tosylate: text: Dactolisib Tosylate Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19: text: Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19 Galectin Inhibitor GR-MD-02: text: Galectin Inhibitor GR-MD-02 Recombinant Humanized Anti-HER-2 Bispecific Monoclonal Antibody MBS301: text: Recombinant Humanized Anti-HER-2 Bispecific Monoclonal Antibody MBS301 Cevipabulin Fumarate: text: Cevipabulin Fumarate Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A: text: Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A Entinostat: text: Entinostat Algenpantucel-L: text: Algenpantucel-L HER2 Tri-specific Natural Killer Cell Engager DF1001: text: HER2 Tri-specific Natural Killer Cell Engager DF1001 Oral Topotecan Hydrochloride: text: Oral Topotecan Hydrochloride Taurultam: text: Taurultam Seclidemstat: text: Seclidemstat Antiangiogenic Drug Combination TL-118: text: Antiangiogenic Drug Combination TL-118 Hemiasterlin Analog E7974: text: Hemiasterlin Analog E7974 Glioma Lysate Vaccine GBM6-AD: text: Glioma Lysate Vaccine GBM6-AD Osilodrostat: text: Osilodrostat iNKT Cell Agonist ABX196: text: iNKT Cell Agonist ABX196 Phosphorodiamidate Morpholino Oligomer AVI-4126: text: Phosphorodiamidate Morpholino Oligomer AVI-4126 Checkpoint Kinase Inhibitor XL844: text: Checkpoint Kinase Inhibitor XL844 WT1 Protein-derived Peptide Vaccine DSP-7888: text: WT1 Protein-derived Peptide Vaccine DSP-7888 Sotrastaurin Acetate: text: Sotrastaurin Acetate Anti-CD38 Antibody-drug Conjugate STI-6129: text: Anti-CD38 Antibody-drug Conjugate STI-6129 Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342: text: Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342 Anti-PD-L1 Monoclonal Antibody BGB-A333: text: Anti-PD-L1 Monoclonal Antibody BGB-A333 Monoclonal Antibody Lym-1: text: Monoclonal Antibody Lym-1 TLR-Directed Cationic Lipid-DNA Complex JVRS-100: text: TLR-Directed Cationic Lipid-DNA Complex JVRS-100 Peptide 946 Melanoma Vaccine: text: Peptide 946 Melanoma Vaccine Anti-FLT3 Monoclonal Antibody 4G8-SDIEM: text: Anti-FLT3 Monoclonal Antibody 4G8-SDIEM Oral Microencapsulated Diindolylmethane: text: Oral Microencapsulated Diindolylmethane Enclomiphene Citrate: text: Enclomiphene Citrate Thymidylate Synthase Inhibitor DFP-11207: text: Thymidylate Synthase Inhibitor DFP-11207 IL-10 Immunomodulator MK-1966: text: IL-10 Immunomodulator MK-1966 CDC7 Kinase Inhibitor LY3143921 Hydrate: text: CDC7 Kinase Inhibitor LY3143921 Hydrate Pegaspargase: text: Pegaspargase CDK2 Inhibitor PF-07104091: text: CDK2 Inhibitor PF-07104091 Bacillus Calmette-Guerin Substrain Connaught Live Antigen: text: Bacillus Calmette-Guerin Substrain Connaught Live Antigen Tanomastat: text: Tanomastat Liposomal SN-38: text: Liposomal SN-38 ALK Inhibitor PLB 1003: text: ALK Inhibitor PLB 1003 Ropocamptide: text: Ropocamptide Diphencyprone: text: Diphencyprone Teroxirone: text: Teroxirone Olvimulogene Nanivacirepvec: text: Olvimulogene Nanivacirepvec Monoclonal Antibody A27.15: text: Monoclonal Antibody A27.15 Rezivertinib: text: Rezivertinib Mafosfamide: text: Mafosfamide Stallimycin: text: Stallimycin DNA Vaccine VB10.16: text: DNA Vaccine VB10.16 CD40 Agonistic Monoclonal Antibody APX005M: text: CD40 Agonistic Monoclonal Antibody APX005M Tazarotene: text: Tazarotene TRPM8 Agonist D-3263: text: TRPM8 Agonist D-3263 LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes: text: LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes Recombinant CD40-Ligand: text: Recombinant CD40-Ligand Anti-CEACAM1 Monoclonal Antibody CM-24: text: Anti-CEACAM1 Monoclonal Antibody CM-24 Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752: text: Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752 Qilisheng Immunoregulatory Oral Solution: text: Qilisheng Immunoregulatory Oral Solution Cytidine Analog RX-3117: text: Cytidine Analog RX-3117 Cyproterone: text: Cyproterone Sevacizumab: text: Sevacizumab P-cadherin-targeting Agent PF-06671008: text: P-cadherin-targeting Agent PF-06671008 mTORC1/2 Kinase Inhibitor BI 860585: text: mTORC1/2 Kinase Inhibitor BI 860585 Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine: text: Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine Rivoceranib: text: Rivoceranib Autologous CD19-targeted CAR T Cells CC-97540: text: Autologous CD19-targeted CAR T Cells CC-97540 Tolnidamine: text: Tolnidamine Adagloxad Simolenin: text: Adagloxad Simolenin Lifileucel: text: Lifileucel Anti-CTLA-4/LAG-3 Bispecific Antibody XmAb22841: text: Anti-CTLA-4/LAG-3 Bispecific Antibody XmAb22841 Anti-LAG-3 Monoclonal Antibody INCAGN02385: text: Anti-LAG-3 Monoclonal Antibody INCAGN02385 Thorium Th 227 Anetumab Corixetan: text: Thorium Th 227 Anetumab Corixetan Pegylated Recombinant L-asparaginase Erwinia chrysanthemi: text: Pegylated Recombinant L-asparaginase Erwinia chrysanthemi pan-RAF Inhibitor LXH254: text: pan-RAF Inhibitor LXH254 BET Bromodomain Inhibitor ZEN-3694: text: BET Bromodomain Inhibitor ZEN-3694 Poliglusam: text: Poliglusam PI3K-delta Inhibitor HMPL 689: text: PI3K-delta Inhibitor HMPL 689 Smoothened Antagonist TAK-441: text: Smoothened Antagonist TAK-441 p70S6K Inhibitor LY2584702: text: p70S6K Inhibitor LY2584702 Triptolide Analog: text: Triptolide Analog Anakinra: text: Anakinra Androstane Steroid HE3235: text: Androstane Steroid HE3235 Porcupine Inhibitor WNT974: text: Porcupine Inhibitor WNT974 mRNA-based TriMix Melanoma Vaccine ECI-006: text: mRNA-based TriMix Melanoma Vaccine ECI-006 Amustaline Dihydrochloride: text: Amustaline Dihydrochloride Cytarabine: text: Cytarabine Alpha-Thioguanine Deoxyriboside: text: Alpha-Thioguanine Deoxyriboside Anti-BCMA/PBD ADC MEDI2228: text: Anti-BCMA/PBD ADC MEDI2228 Zinc Finger Nuclease ZFN-758: text: Zinc Finger Nuclease ZFN-758 Motesanib Diphosphate: text: Motesanib Diphosphate Y 90 Monoclonal Antibody M195: text: Y 90 Monoclonal Antibody M195 Liposome-Encapsulated Doxorubicin Citrate: text: Liposome-Encapsulated Doxorubicin Citrate Multi-neo-epitope Vaccine OSE 2101: text: Multi-neo-epitope Vaccine OSE 2101 Alisertib: text: Alisertib Baltaleucel-T: text: Baltaleucel-T Sipuleucel-T: text: Sipuleucel-T Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101: text: Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101 Glembatumumab Vedotin: text: Glembatumumab Vedotin KRAS Mutant-targeting AMG 510: text: KRAS Mutant-targeting AMG 510 Anti-5T4 Antibody-drug Conjugate ASN004: text: Anti-5T4 Antibody-drug Conjugate ASN004 SSTR2-targeting Protein/DM1 Conjugate PEN-221: text: SSTR2-targeting Protein/DM1 Conjugate PEN-221 Alflutinib Mesylate: text: Alflutinib Mesylate Taxane Analogue TPI 287: text: Taxane Analogue TPI 287 Essiac: text: Essiac Phenethyl Isothiocyanate-containing Watercress Juice: text: Phenethyl Isothiocyanate-containing Watercress Juice Anti-CD40/Anti-TAA Bispecific Monoclonal Antibody ABBV-428: text: Anti-CD40/Anti-TAA Bispecific Monoclonal Antibody ABBV-428 Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306: text: Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306 Oncolytic Newcastle Disease Virus MEDI5395: text: Oncolytic Newcastle Disease Virus MEDI5395 Oxidative Phosphorylation Inhibitor IACS-010759: text: Oxidative Phosphorylation Inhibitor IACS-010759 ALK-FAK Inhibitor CEP-37440: text: ALK-FAK Inhibitor CEP-37440 Smac Mimetic LCL161: text: Smac Mimetic LCL161 IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051: text: IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051 Piritrexim: text: Piritrexim Glecaprevir/Pibrentasvir: text: Glecaprevir/Pibrentasvir Triplatin Tetranitrate: text: Triplatin Tetranitrate Interleukin-12-Fc Fusion Protein DF6002: text: Interleukin-12-Fc Fusion Protein DF6002 Pibrozelesin: text: Pibrozelesin PI3K Inhibitor GSK1059615: text: PI3K Inhibitor GSK1059615 Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A: text: Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A 2-O, 3-O Desulfated Heparin: text: 2-O, 3-O Desulfated Heparin Varlilumab: text: Varlilumab Emibetuzumab: text: Emibetuzumab PVA Microporous Hydrospheres/Doxorubicin Hydrochloride: text: PVA Microporous Hydrospheres/Doxorubicin Hydrochloride Anti-ANG2 Monoclonal Antibody MEDI-3617: text: Anti-ANG2 Monoclonal Antibody MEDI-3617 Anti-latent TGF-beta 1 Monoclonal Antibody SRK-181: text: Anti-latent TGF-beta 1 Monoclonal Antibody SRK-181 SHP2 Inhibitor RMC-4630: text: SHP2 Inhibitor RMC-4630 Lometrexol Sodium: text: Lometrexol Sodium Bromacrylide: text: Bromacrylide DNA-PK inhibitor AZD7648: text: DNA-PK inhibitor AZD7648 Metformin Hydrochloride: text: Metformin Hydrochloride Anti-PRL-3 Monoclonal Antibody PRL3-zumab: text: Anti-PRL-3 Monoclonal Antibody PRL3-zumab Trapoxin: text: Trapoxin Vitamin E Compound: text: Vitamin E Compound Anti-GITR Monoclonal Antibody MK-4166: text: Anti-GITR Monoclonal Antibody MK-4166 Dianhydrogalactitol: text: Dianhydrogalactitol Anti-PD-1 Monoclonal Antibody F520: text: Anti-PD-1 Monoclonal Antibody F520 N,N-Dibenzyl Daunomycin: text: N,N-Dibenzyl Daunomycin Bleomycin: text: Bleomycin I 131 Monoclonal Antibody A33: text: I 131 Monoclonal Antibody A33 Thioguanine Anhydrous: text: Thioguanine Anhydrous Alvocidib Prodrug TP-1287: text: Alvocidib Prodrug TP-1287 Engineered Toxin Body Targeting HER2 MT-5111: text: Engineered Toxin Body Targeting HER2 MT-5111 Sorafenib: text: Sorafenib Chlorotoxin: text: Chlorotoxin Lifirafenib: text: Lifirafenib Elagolix: text: Elagolix GITR Agonist MEDI1873: text: GITR Agonist MEDI1873 Darolutamide: text: Darolutamide DNA-dependent Protein Kinase Inhibitor VX-984: text: DNA-dependent Protein Kinase Inhibitor VX-984 MDM2/MDMX Inhibitor ALRN-6924: text: MDM2/MDMX Inhibitor ALRN-6924 Binimetinib: text: Binimetinib Bcl-Xs Adenovirus Vaccine: text: Bcl-Xs Adenovirus Vaccine Tocilizumab: text: Tocilizumab PI3K-beta Inhibitor GSK2636771: text: PI3K-beta Inhibitor GSK2636771 Black Cohosh: text: Black Cohosh Refametinib: text: Refametinib IDO Peptide Vaccine IO102: text: IDO Peptide Vaccine IO102 Vincristine Sulfate Liposome: text: Vincristine Sulfate Liposome Carbetimer: text: Carbetimer Lisocabtagene Maraleucel: text: Lisocabtagene Maraleucel Cinobufagin: text: Cinobufagin Personalized Cancer Vaccine RO7198457: text: Personalized Cancer Vaccine RO7198457 Idarubicin-Eluting Beads: text: Idarubicin-Eluting Beads Anti-HGF Monoclonal Antibody TAK-701: text: Anti-HGF Monoclonal Antibody TAK-701 CXCR4/E-selectin Antagonist GMI-1359: text: CXCR4/E-selectin Antagonist GMI-1359 Sibrotuzumab: text: Sibrotuzumab KSP Inhibitor SB-743921: text: KSP Inhibitor SB-743921 Etoposide Phosphate: text: Etoposide Phosphate Cytochlor: text: Cytochlor Polo-like Kinase 1 Inhibitor NMS-1286937: text: Polo-like Kinase 1 Inhibitor NMS-1286937 Lm-tLLO-neoantigens Vaccine ADXS-NEO: text: Lm-tLLO-neoantigens Vaccine ADXS-NEO Alobresib: text: Alobresib Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles: text: Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles Glufosfamide: text: Glufosfamide Anti-A5B1 Integrin Monoclonal Antibody PF-04605412: text: Anti-A5B1 Integrin Monoclonal Antibody PF-04605412 Valproic Acid: text: Valproic Acid Semuloparin: text: Semuloparin Maackia amurensis Seed Lectin: text: Maackia amurensis Seed Lectin DNMT1 Mixed-Backbone Antisense Oligonucleotide MG 98: text: DNMT1 Mixed-Backbone Antisense Oligonucleotide MG 98 Simalikalactone D: text: Simalikalactone D Milatuzumab: text: Milatuzumab Glutaminase Inhibitor CB-839 Hydrochloride: text: Glutaminase Inhibitor CB-839 Hydrochloride EZH2 inhibitor CPI-0209: text: EZH2 inhibitor CPI-0209 Anti-CD123 Monoclonal Antibody KHK2823: text: Anti-CD123 Monoclonal Antibody KHK2823 Methotrexate: text: Methotrexate Lutetium Lu 177-NeoB: text: Lutetium Lu 177-NeoB Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101: text: Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101 Tegafur: text: Tegafur Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130: text: Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130 TLR7 Agonist 852A: text: TLR7 Agonist 852A SN-38-Loaded Polymeric Micelles NK012: text: SN-38-Loaded Polymeric Micelles NK012 Prime Cancer Vaccine MVA-BN-CV301: text: Prime Cancer Vaccine MVA-BN-CV301 Olmutinib: text: Olmutinib DAB389 Epidermal Growth Factor: text: DAB389 Epidermal Growth Factor Pidilizumab: text: Pidilizumab Alpelisib: text: Alpelisib Syk Inhibitor HMPL-523: text: Syk Inhibitor HMPL-523 Efatutazone: text: Efatutazone Autologous CD22-4SCAR-expressing T-cells 4SCAR22: text: Autologous CD22-4SCAR-expressing T-cells 4SCAR22 Anti-CD52 Monoclonal Antibody ALLO-647: text: Anti-CD52 Monoclonal Antibody ALLO-647 Anti-BCMA/CD3 BiTE Antibody AMG 701: text: Anti-BCMA/CD3 BiTE Antibody AMG 701 Anti-Ly6E Antibody-Drug Conjugate RG 7841: text: Anti-Ly6E Antibody-Drug Conjugate RG 7841 Yttrium Y-90 Clivatuzumab Tetraxetan: text: Yttrium Y-90 Clivatuzumab Tetraxetan iNOS Dimerization Inhibitor ASP9853: text: iNOS Dimerization Inhibitor ASP9853 Briciclib Sodium: text: Briciclib Sodium LRP5 Antagonist BI 905681: text: LRP5 Antagonist BI 905681 Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135: text: Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135 Tubulin-Binding Agent SSR97225: text: Tubulin-Binding Agent SSR97225 Entrectinib: text: Entrectinib PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1: text: PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1 Indicine-N-Oxide: text: Indicine-N-Oxide Anhydrovinblastine: text: Anhydrovinblastine Triamcinolone Hexacetonide: text: Triamcinolone Hexacetonide Daromun: text: Daromun Radioactive Iodine: text: Radioactive Iodine Dopamine-Somatostatin Chimeric Molecule BIM-23A760: text: Dopamine-Somatostatin Chimeric Molecule BIM-23A760 Neratinib Maleate: text: Neratinib Maleate CK2-targeting Synthetic Peptide CIGB-300: text: CK2-targeting Synthetic Peptide CIGB-300 Fludarabine Phosphate: text: Fludarabine Phosphate Liposomal NDDP: text: Liposomal NDDP Hexamethylene Bisacetamide: text: Hexamethylene Bisacetamide Estradiol Valerate: text: Estradiol Valerate Paclitaxel Poliglumex: text: Paclitaxel Poliglumex Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001: text: Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001 Glasdegib Maleate: text: Glasdegib Maleate Nidanilimab: text: Nidanilimab MVA-BN Smallpox Vaccine: text: MVA-BN Smallpox Vaccine Remetinostat: text: Remetinostat Exatecan Mesylate: text: Exatecan Mesylate Clanfenur: text: Clanfenur Clostridium Novyi-NT Spores: text: Clostridium Novyi-NT Spores Recombinant Granulocyte-Macrophage Colony-Stimulating Factor: text: Recombinant Granulocyte-Macrophage Colony-Stimulating Factor Eribulin: text: Eribulin Simeprevir: text: Simeprevir Antroquinonol Capsule: text: Antroquinonol Capsule Pipobroman: text: Pipobroman Interferon Alfa-N3: text: Interferon Alfa-N3 Vorolanib: text: Vorolanib Infigratinib: text: Infigratinib Dezaguanine Mesylate: text: Dezaguanine Mesylate TRK Inhibitor TQB3558: text: TRK Inhibitor TQB3558 Nab-paclitaxel/Rituximab-coated Nanoparticle AR160: text: Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 Trientine Hydrochloride: text: Trientine Hydrochloride Pegylated Liposomal Belotecan: text: Pegylated Liposomal Belotecan Tirapazamine: text: Tirapazamine Polymeric Camptothecin Prodrug XMT-1001: text: Polymeric Camptothecin Prodrug XMT-1001 PCNU: text: PCNU PSA/IL-2/GM-CSF Vaccine: text: PSA/IL-2/GM-CSF Vaccine Roflumilast: text: Roflumilast Niraparib: text: Niraparib Camptothecin Glycoconjugate BAY 38-3441: text: Camptothecin Glycoconjugate BAY 38-3441 MTF-1 Inhibitor APTO-253 HCl: text: MTF-1 Inhibitor APTO-253 HCl Diindolylmethane: text: Diindolylmethane Mercaptopurine Oral Suspension: text: Mercaptopurine Oral Suspension Vascular Disrupting Agent BNC105P: text: Vascular Disrupting Agent BNC105P Neoantigen-based Therapeutic Cancer Vaccine GRT-R904: text: Neoantigen-based Therapeutic Cancer Vaccine GRT-R904 Ifabotuzumab: text: Ifabotuzumab O6-Benzylguanine: text: O6-Benzylguanine Amivantamab: text: Amivantamab BET Inhibitor GS-5829: text: BET Inhibitor GS-5829 Capmatinib: text: Capmatinib Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424: text: Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424 Acridine Carboxamide: text: Acridine Carboxamide Elotuzumab: text: Elotuzumab Anti-VISTA Monoclonal Antibody JNJ 61610588: text: Anti-VISTA Monoclonal Antibody JNJ 61610588 Prostate Health Cocktail Dietary Supplement: text: Prostate Health Cocktail Dietary Supplement Quinine: text: Quinine Lutetium Lu 177-Edotreotide: text: Lutetium Lu 177-Edotreotide Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101: text: Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101 Spongistatin: text: Spongistatin Relatlimab: text: Relatlimab Tapotoclax: text: Tapotoclax Rituximab: text: Rituximab JAK Inhibitor INCB047986: text: JAK Inhibitor INCB047986 Chloroquine: text: Chloroquine VEGFR2 Tyrosine Kinase Inhibitor PF-00337210: text: VEGFR2 Tyrosine Kinase Inhibitor PF-00337210 Denosumab: text: Denosumab Seneca Valley Virus-001: text: Seneca Valley Virus-001 Prostate Cancer Vaccine ONY-P1: text: Prostate Cancer Vaccine ONY-P1 Morpholinodoxorubicin: text: Morpholinodoxorubicin Anti-DLL4 Monoclonal Antibody MEDI0639: text: Anti-DLL4 Monoclonal Antibody MEDI0639 Anti-PD-L1/CD137 Bispecific Antibody MCLA-145: text: Anti-PD-L1/CD137 Bispecific Antibody MCLA-145 Camsirubicin: text: Camsirubicin Ametantrone: text: Ametantrone Sparfosic Acid: text: Sparfosic Acid HER2-directed TLR8 Agonist SBT6050: text: HER2-directed TLR8 Agonist SBT6050 2,6-Dimethoxyquinone: text: 2,6-Dimethoxyquinone Henatinib Maleate: text: Henatinib Maleate Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201: text: Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201 Gemtuzumab Ozogamicin: text: Gemtuzumab Ozogamicin Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE: text: Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE Bendamustine: text: Bendamustine Anti-PD-L1 Monoclonal Antibody BCD-135: text: Anti-PD-L1 Monoclonal Antibody BCD-135 H1299 Tumor Cell Lysate Vaccine: text: H1299 Tumor Cell Lysate Vaccine Filgrastim: text: Filgrastim Pegylated Recombinant Human Hyaluronidase PH20: text: Pegylated Recombinant Human Hyaluronidase PH20 Trametinib: text: Trametinib Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3006: text: Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3006 Z-Endoxifen Hydrochloride: text: Z-Endoxifen Hydrochloride EZH2 Inhibitor PF-06821497: text: EZH2 Inhibitor PF-06821497 Tidutamab: text: Tidutamab Trimeric GITRL-Fc OMP-336B11: text: Trimeric GITRL-Fc OMP-336B11 Verpasep Caltespen: text: Verpasep Caltespen Monoclonal Antibody IMMU-14: text: Monoclonal Antibody IMMU-14 FMS Inhibitor JNJ-40346527: text: FMS Inhibitor JNJ-40346527 Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201: text: Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201 Bispecific Antibody AMG 509: text: Bispecific Antibody AMG 509 Panobinostat Nanoparticle Formulation MTX110: text: Panobinostat Nanoparticle Formulation MTX110 Bempegaldesleukin: text: Bempegaldesleukin Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388: text: Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388 Selatinib Ditosilate: text: Selatinib Ditosilate Anti-LIF Monoclonal Antibody MSC-1: text: Anti-LIF Monoclonal Antibody MSC-1 Anti-claudin18.2 Monoclonal Antibody AB011: text: Anti-claudin18.2 Monoclonal Antibody AB011 Ethaselen: text: Ethaselen Blueberry Powder Supplement: text: Blueberry Powder Supplement Itraconazole: text: Itraconazole Gamboge Resin Extract TSB-9-W1: text: Gamboge Resin Extract TSB-9-W1 Anti-CD27L Antibody-Drug Conjugate AMG 172: text: Anti-CD27L Antibody-Drug Conjugate AMG 172 MKNK1 Inhibitor BAY 1143269: text: MKNK1 Inhibitor BAY 1143269 Doxercalciferol: text: Doxercalciferol CDK1 Inhibitor BEY1107: text: CDK1 Inhibitor BEY1107 Carboxyphenyl Retinamide: text: Carboxyphenyl Retinamide cis-Urocanic Acid: text: cis-Urocanic Acid Peldesine: text: Peldesine MEK inhibitor CS3006: text: MEK inhibitor CS3006 Nutlin-3a: text: Nutlin-3a Plasmid DNA Vaccine pING-hHER3FL: text: Plasmid DNA Vaccine pING-hHER3FL Asulacrine Isethionate: text: Asulacrine Isethionate Cemiplimab: text: Cemiplimab Monoclonal Antibody 1F5: text: Monoclonal Antibody 1F5 Pyrotinib Dimaleate: text: Pyrotinib Dimaleate Sodium Borocaptate: text: Sodium Borocaptate Samarium Sm 153-DOTMP: text: Samarium Sm 153-DOTMP Inodiftagene Vixteplasmid: text: Inodiftagene Vixteplasmid Xanthohumol: text: Xanthohumol Afuresertib: text: Afuresertib Akt/ERK Inhibitor ONC201: text: Akt/ERK Inhibitor ONC201 Recombinant Macrophage Colony-Stimulating Factor: text: Recombinant Macrophage Colony-Stimulating Factor Thymopentin: text: Thymopentin Pibenzimol: text: Pibenzimol LMP-2:340-349 Peptide Vaccine: text: LMP-2:340-349 Peptide Vaccine Anti-FLT3 Monoclonal Antibody IMC-EB10: text: Anti-FLT3 Monoclonal Antibody IMC-EB10 Rhenium Re 188 BMEDA-labeled Liposomes: text: Rhenium Re 188 BMEDA-labeled Liposomes Pimitespib: text: Pimitespib Quinacrine Hydrochloride: text: Quinacrine Hydrochloride Liposomal Vinorelbine: text: Liposomal Vinorelbine Tasadenoturev: text: Tasadenoturev Topical Betulinic Acid: text: Topical Betulinic Acid Anti-HER2 Antibody-drug Conjugate ARX788: text: Anti-HER2 Antibody-drug Conjugate ARX788 Telisotuzumab: text: Telisotuzumab Recombinant KSA Glycoprotein CO17-1A: text: Recombinant KSA Glycoprotein CO17-1A Triazene Derivative CB10-277: text: Triazene Derivative CB10-277 Anti-OX40 Antibody BMS 986178: text: Anti-OX40 Antibody BMS 986178 Niacinamide: text: Niacinamide Aurora A Kinase Inhibitor MK5108: text: Aurora A Kinase Inhibitor MK5108 Extended Release Flucytosine: text: Extended Release Flucytosine Anti-HLA-G Antibody TTX-080: text: Anti-HLA-G Antibody TTX-080 Dostarlimab: text: Dostarlimab Dexamethasone: text: Dexamethasone Imiquimod: text: Imiquimod Fursultiamine: text: Fursultiamine Thorium Th 227 Anti-HER2 Monoclonal Antibody BAY2701439: text: Thorium Th 227 Anti-HER2 Monoclonal Antibody BAY2701439 Lurbinectedin: text: Lurbinectedin Istiratumab: text: Istiratumab Anti-CD44 Monoclonal Antibody RO5429083: text: Anti-CD44 Monoclonal Antibody RO5429083 Hydroxychloroquine: text: Hydroxychloroquine Bispecific Antibody 2B1: text: Bispecific Antibody 2B1 Nagrestipen: text: Nagrestipen Daratumumab/rHuPH20: text: Daratumumab/rHuPH20 BXQ-350 Nanovesicle Formulation: text: BXQ-350 Nanovesicle Formulation BMS-188797: text: BMS-188797 Carbon C 14-pamiparib: text: Carbon C 14-pamiparib Ecromeximab: text: Ecromeximab CL 246738: text: CL 246738 MARCKS Protein Inhibitor BIO-11006: text: MARCKS Protein Inhibitor BIO-11006 Monoclonal Antibody R24: text: Monoclonal Antibody R24 Bardoxolone Methyl: text: Bardoxolone Methyl Porcupine Inhibitor CGX1321: text: Porcupine Inhibitor CGX1321 Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901: text: Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901 Dromostanolone Propionate: text: Dromostanolone Propionate RAF Kinase Inhibitor L-779450: text: RAF Kinase Inhibitor L-779450 Buthionine Sulfoximine: text: Buthionine Sulfoximine Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes: text: Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes Anti-CTLA-4 Monoclonal Antibody MK-1308: text: Anti-CTLA-4 Monoclonal Antibody MK-1308 Multikinase Inhibitor SAR103168: text: Multikinase Inhibitor SAR103168 Recombinant Leukoregulin: text: Recombinant Leukoregulin Photosensitizer LUZ 11: text: Photosensitizer LUZ 11 Camptothecin-20(S)-O-Propionate Hydrate: text: Camptothecin-20(S)-O-Propionate Hydrate Prostaglandin E2 EP4 Receptor Inhibitor E7046: text: Prostaglandin E2 EP4 Receptor Inhibitor E7046 Aniline Mustard: text: Aniline Mustard Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1: text: Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1 CHK1 Inhibitor MK-8776: text: CHK1 Inhibitor MK-8776 Pan-RAR Agonist/AP-1 Inhibitor LGD 1550: text: Pan-RAR Agonist/AP-1 Inhibitor LGD 1550 CD123-CD33 Compound CAR T Cells: text: CD123-CD33 Compound CAR T Cells Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1: text: Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1 Dupilumab: text: Dupilumab Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208: text: Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208 B-Raf/VEGFR-2 Inhibitor RAF265: text: B-Raf/VEGFR-2 Inhibitor RAF265 Narnatumab: text: Narnatumab Larotrectinib Sulfate: text: Larotrectinib Sulfate BR96-Doxorubicin Immunoconjugate: text: BR96-Doxorubicin Immunoconjugate Axalimogene Filolisbac: text: Axalimogene Filolisbac Antibody-drug Conjugate ABBV-085: text: Antibody-drug Conjugate ABBV-085 Anti-PD-1 Monoclonal Antibody BCD-100: text: Anti-PD-1 Monoclonal Antibody BCD-100 Interleukin-15 Fusion Protein BJ-001: text: Interleukin-15 Fusion Protein BJ-001 Genistein: text: Genistein Polyamine Analog SL11093: text: Polyamine Analog SL11093 Ofranergene Obadenovec: text: Ofranergene Obadenovec ALK/ROS1/Met Inhibitor TQ-B3101: text: ALK/ROS1/Met Inhibitor TQ-B3101 Belimumab: text: Belimumab Halichondrin Analogue E7130: text: Halichondrin Analogue E7130 DPT/BCG/Measles/Serratia/Pneumococcus Vaccine: text: DPT/BCG/Measles/Serratia/Pneumococcus Vaccine Larotaxel: text: Larotaxel Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22: text: Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22 Carbogen: text: Carbogen Ficlatuzumab: text: Ficlatuzumab Mavelertinib: text: Mavelertinib Antibody-drug Conjugate SC-006: text: Antibody-drug Conjugate SC-006 Fotemustine: text: Fotemustine Oncolytic HSV-1 NV1020: text: Oncolytic HSV-1 NV1020 Anti-CD20/CD3 Monoclonal Antibody XmAb13676: text: Anti-CD20/CD3 Monoclonal Antibody XmAb13676 Cannabidiol: text: Cannabidiol Annonaceous Acetogenins: text: Annonaceous Acetogenins Recombinant Interferon Alfa-1b: text: Recombinant Interferon Alfa-1b Aphidicoline Glycinate: text: Aphidicoline Glycinate Edicotinib: text: Edicotinib Canfosfamide Hydrochloride: text: Canfosfamide Hydrochloride p97 Inhibitor CB-5083: text: p97 Inhibitor CB-5083 Uncaria tomentosa Extract: text: Uncaria tomentosa Extract Recombinant Transforming Growth Factor-Beta-2: text: Recombinant Transforming Growth Factor-Beta-2 BL22 Immunotoxin: text: BL22 Immunotoxin Cusatuzumab: text: Cusatuzumab NY-ESO-1 Plasmid DNA Cancer Vaccine pPJV7611: text: NY-ESO-1 Plasmid DNA Cancer Vaccine pPJV7611 Rocakinogene Sifuplasmid: text: Rocakinogene Sifuplasmid Smac Mimetic GDC-0152: text: Smac Mimetic GDC-0152 Azurin:50-77 Cell Penetrating Peptide p28: text: Azurin:50-77 Cell Penetrating Peptide p28 ADH-1: text: ADH-1 Etalocib: text: Etalocib Oral Fludarabine Phosphate: text: Oral Fludarabine Phosphate Autologous ROR2-targeted CAR T-cells CCT301-59: text: Autologous ROR2-targeted CAR T-cells CCT301-59 PRAME-targeting T-cell Receptor/Inducible Caspase 9 BPX-701: text: PRAME-targeting T-cell Receptor/Inducible Caspase 9 BPX-701 17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521: text: 17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521 Adenoviral PSA Vaccine ETBX-071: text: Adenoviral PSA Vaccine ETBX-071 Margetuximab: text: Margetuximab Autologous Multi-lineage Potential Cells: text: Autologous Multi-lineage Potential Cells Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T-lymphocytes JCARH125: text: Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T-lymphocytes JCARH125 Oxidative Phosphorylation Inhibitor IM156: text: Oxidative Phosphorylation Inhibitor IM156 PIM/FLT3 Kinase Inhibitor SEL24: text: PIM/FLT3 Kinase Inhibitor SEL24 Obinutuzumab: text: Obinutuzumab Aurora B/C Kinase Inhibitor GSK1070916A: text: Aurora B/C Kinase Inhibitor GSK1070916A Vinepidine: text: Vinepidine Benaxibine: text: Benaxibine Daporinad: text: Daporinad Licorice: text: Licorice Mitozolomide: text: Mitozolomide Merbarone: text: Merbarone Phytochlorin Sodium-Polyvinylpyrrolidone Complex: text: Phytochlorin Sodium-Polyvinylpyrrolidone Complex Liposome-encapsulated OSI-7904: text: Liposome-encapsulated OSI-7904 Melanoma Monoclonal Antibody hIgG2A: text: Melanoma Monoclonal Antibody hIgG2A Ponatinib Hydrochloride: text: Ponatinib Hydrochloride Mavorixafor: text: Mavorixafor Raloxifene Hydrochloride: text: Raloxifene Hydrochloride Aziridinylbenzoquinone RH1: text: Aziridinylbenzoquinone RH1 HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201: text: HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201 S-Adenosylmethionine: text: S-Adenosylmethionine Anti-CTLA-4 Monoclonal Antibody ADG116: text: Anti-CTLA-4 Monoclonal Antibody ADG116 Seocalcitol: text: Seocalcitol Selective Estrogen Receptor Degrader LY3484356: text: Selective Estrogen Receptor Degrader LY3484356 Icrucumab: text: Icrucumab Ceralasertib: text: Ceralasertib Lucanthone: text: Lucanthone EGFR/FLT3/Abl Inhibitor SKLB1028: text: EGFR/FLT3/Abl Inhibitor SKLB1028 Fianlimab: text: Fianlimab Intoplicine: text: Intoplicine Bersanlimab: text: Bersanlimab ERa36 Modulator Icaritin: text: ERa36 Modulator Icaritin Wnt Signaling Inhibitor SM04755: text: Wnt Signaling Inhibitor SM04755 RIPK1 Inhibitor GSK3145095: text: RIPK1 Inhibitor GSK3145095 Anti-PD-1 Monoclonal Antibody GLS-010: text: Anti-PD-1 Monoclonal Antibody GLS-010 Tocotrienol-rich Fraction: text: Tocotrienol-rich Fraction Galiximab: text: Galiximab Merestinib: text: Merestinib Tomaralimab: text: Tomaralimab Verapamil: text: Verapamil Polyamine Analogue PG11047: text: Polyamine Analogue PG11047 Belapectin: text: Belapectin HuaChanSu: text: HuaChanSu Oral Aminolevulinic Acid Hydrochloride: text: Oral Aminolevulinic Acid Hydrochloride Bcl-2 Inhibitor APG 2575: text: Bcl-2 Inhibitor APG 2575 Conbercept: text: Conbercept Protease-activated Anti-PD-L1 Antibody Prodrug CX-072: text: Protease-activated Anti-PD-L1 Antibody Prodrug CX-072 Dihydro-5-Azacytidine: text: Dihydro-5-Azacytidine Iodine I 131 Monoclonal Antibody muJ591: text: Iodine I 131 Monoclonal Antibody muJ591 Gatipotuzumab: text: Gatipotuzumab Cisplatin: text: Cisplatin BRAF(V600E) Kinase Inhibitor ABM-1310: text: BRAF(V600E) Kinase Inhibitor ABM-1310 RET Inhibitor DS-5010: text: RET Inhibitor DS-5010 Satraplatin: text: Satraplatin Irinotecan-Eluting Beads: text: Irinotecan-Eluting Beads Anti-NaPi2b Antibody-drug Conjugate XMT-1592: text: Anti-NaPi2b Antibody-drug Conjugate XMT-1592 Dabrafenib Mesylate: text: Dabrafenib Mesylate PEOX-based Polymer Encapsulated Paclitaxel FID-007: text: PEOX-based Polymer Encapsulated Paclitaxel FID-007 Tyrosine Kinase Inhibitor: text: Tyrosine Kinase Inhibitor CYP17/Androgen Receptor Inhibitor ODM 204: text: CYP17/Androgen Receptor Inhibitor ODM 204 Foritinib Succinate: text: Foritinib Succinate Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014: text: Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014 Antibody-drug Conjugate PF-06664178: text: Antibody-drug Conjugate PF-06664178 Tegafur-Uracil: text: Tegafur-Uracil Miransertib: text: Miransertib DNA Interference Oligonucleotide PNT2258: text: DNA Interference Oligonucleotide PNT2258 Metamelfalan: text: Metamelfalan CK1alpha/CDK7/CDK9 Inhibitor BTX-A51: text: CK1alpha/CDK7/CDK9 Inhibitor BTX-A51 Goserelin Acetate: text: Goserelin Acetate Oral Docetaxel: text: Oral Docetaxel Anti-CD19 iCAR NK Cells: text: Anti-CD19 iCAR NK Cells Apomab: text: Apomab HIF-2alpha Inhibitor PT2385: text: HIF-2alpha Inhibitor PT2385 Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4: text: Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4 Ipafricept: text: Ipafricept Tucatinib: text: Tucatinib Lometrexol: text: Lometrexol Mitoflaxone: text: Mitoflaxone Febuxostat: text: Febuxostat Edatrexate: text: Edatrexate Ethylnitrosourea: text: Ethylnitrosourea Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8: text: Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 Laetrile: text: Laetrile PR1 Leukemia Peptide Vaccine: text: PR1 Leukemia Peptide Vaccine Pirotinib: text: Pirotinib Copper Gluconate: text: Copper Gluconate Linsitinib: text: Linsitinib Choline Kinase Alpha Inhibitor TCD-717: text: Choline Kinase Alpha Inhibitor TCD-717 Ifosfamide: text: Ifosfamide North American Ginseng Extract AFX-2: text: North American Ginseng Extract AFX-2 Futuximab: text: Futuximab HER2 Inhibitor DZD1516: text: HER2 Inhibitor DZD1516 Panulisib: text: Panulisib CYP17 Lyase Inhibitor ASN001: text: CYP17 Lyase Inhibitor ASN001 Milataxel: text: Milataxel Oncolytic Adenovirus Ad5-DNX-2401: text: Oncolytic Adenovirus Ad5-DNX-2401 Mitomycin C Analog KW-2149: text: Mitomycin C Analog KW-2149 Midostaurin: text: Midostaurin Autologous TCR-engineered T-cells IMA201: text: Autologous TCR-engineered T-cells IMA201 BRD4 Inhibitor PLX51107: text: BRD4 Inhibitor PLX51107 Anti-C4.4a Antibody-Drug Conjugate BAY1129980: text: Anti-C4.4a Antibody-Drug Conjugate BAY1129980 Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A: text: Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A Integrin alpha-2 Inhibitor E7820: text: Integrin alpha-2 Inhibitor E7820 TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells: text: TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells Nucleotide Analogue GS 9219: text: Nucleotide Analogue GS 9219 Bavituximab: text: Bavituximab Triciribine Phosphate: text: Triciribine Phosphate Cintredekin Besudotox: text: Cintredekin Besudotox Anti-FLT3/CD3 BiTE Antibody AMG 427: text: Anti-FLT3/CD3 BiTE Antibody AMG 427 IAP Inhibitor APG-1387: text: IAP Inhibitor APG-1387 Recombinant Anti-WT1 Immunotherapeutic GSK2302024A: text: Recombinant Anti-WT1 Immunotherapeutic GSK2302024A Dolastatin 10: text: Dolastatin 10 10-Deacetyltaxol: text: 10-Deacetyltaxol Citarinostat: text: Citarinostat Emapalumab: text: Emapalumab Canertinib Dihydrochloride: text: Canertinib Dihydrochloride Oportuzumab Monatox: text: Oportuzumab Monatox TGF-beta Receptor 1 Inhibitor PF-06952229: text: TGF-beta Receptor 1 Inhibitor PF-06952229 Anti-CD123/CD3 Bispecific Antibody JNJ-63709178: text: Anti-CD123/CD3 Bispecific Antibody JNJ-63709178 Anti-PD-L1 Monoclonal Antibody CS1001: text: Anti-PD-L1 Monoclonal Antibody CS1001 Anti-Tissue Factor Monoclonal Antibody MORAb-066: text: Anti-Tissue Factor Monoclonal Antibody MORAb-066 Anti-EGFRvIII Antibody Drug Conjugate AMG 595: text: Anti-EGFRvIII Antibody Drug Conjugate AMG 595 Coxsackievirus A21: text: Coxsackievirus A21 Taurolidine: text: Taurolidine Sialyl Tn-KLH Vaccine: text: Sialyl Tn-KLH Vaccine Anti-ErbB3 Monoclonal Antibody AV-203: text: Anti-ErbB3 Monoclonal Antibody AV-203 Epitinib Succinate: text: Epitinib Succinate Hsp90 Inhibitor SNX-5542 Mesylate: text: Hsp90 Inhibitor SNX-5542 Mesylate Dacplatinum: text: Dacplatinum Voxtalisib: text: Voxtalisib Sacubitril/Valsartan: text: Sacubitril/Valsartan Acai Berry Juice: text: Acai Berry Juice Ethinyl Estradiol: text: Ethinyl Estradiol 2-Hydroxyestradiol: text: 2-Hydroxyestradiol Vilaprisan: text: Vilaprisan IGF-1R/IR Inhibitor KW-2450: text: IGF-1R/IR Inhibitor KW-2450 Dactinomycin: text: Dactinomycin Anti-TGF-beta Monoclonal Antibody SAR-439459: text: Anti-TGF-beta Monoclonal Antibody SAR-439459 CDK4/6 Inhibitor CS3002: text: CDK4/6 Inhibitor CS3002 Boronophenylalanine-Fructose Complex: text: Boronophenylalanine-Fructose Complex BF-200 Gel Formulation: text: BF-200 Gel Formulation Exisulind: text: Exisulind Anti-MMP-9 Monoclonal Antibody GS-5745: text: Anti-MMP-9 Monoclonal Antibody GS-5745 Pixatimod: text: Pixatimod Green Tea Extract-based Antioxidant Supplement: text: Green Tea Extract-based Antioxidant Supplement Staphylococcal Enterotoxin A: text: Staphylococcal Enterotoxin A Tabalumab: text: Tabalumab Natural IFN-alpha OPC-18: text: Natural IFN-alpha OPC-18 Oral Cancer Vaccine V3-OVA: text: Oral Cancer Vaccine V3-OVA Incyclinide: text: Incyclinide Indatuximab Ravtansine: text: Indatuximab Ravtansine R-(-)-Gossypol Acetic Acid: text: R-(-)-Gossypol Acetic Acid NEDD8 Activating Enzyme E1 Inhibitor TAS4464: text: NEDD8 Activating Enzyme E1 Inhibitor TAS4464 Edodekin alfa: text: Edodekin alfa Anti-PSMA/CD3 Bispecific Antibody JNJ-63898081: text: Anti-PSMA/CD3 Bispecific Antibody JNJ-63898081 Olaptesed Pegol: text: Olaptesed Pegol Tebentafusp: text: Tebentafusp Ivaltinostat: text: Ivaltinostat Nucleotide Analog Prodrug NUC-3373: text: Nucleotide Analog Prodrug NUC-3373 Zelavespib: text: Zelavespib ERK1/2 Inhibitor HH2710: text: ERK1/2 Inhibitor HH2710 Porfimer Sodium: text: Porfimer Sodium Farletuzumab: text: Farletuzumab Brachyury-expressing Yeast Vaccine GI-6301: text: Brachyury-expressing Yeast Vaccine GI-6301 Pyrazinamide: text: Pyrazinamide Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024: text: Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024 Aurora kinase A/B inhibitor TT-00420: text: Aurora kinase A/B inhibitor TT-00420 Intetumumab: text: Intetumumab Aclarubicin: text: Aclarubicin PI3K Inhibitor GDC0077: text: PI3K Inhibitor GDC0077 HDAC6 Inhibitor KA2507: text: HDAC6 Inhibitor KA2507 Topotecan: text: Topotecan Empesertib: text: Empesertib Anti-C5aR Monoclonal Antibody IPH5401: text: Anti-C5aR Monoclonal Antibody IPH5401 Ranimustine: text: Ranimustine Brontictuzumab: text: Brontictuzumab Tomivosertib: text: Tomivosertib PI3Ka/mTOR Inhibitor PKI-179: text: PI3Ka/mTOR Inhibitor PKI-179 Nanoparticle Paclitaxel Ointment SOR007: text: Nanoparticle Paclitaxel Ointment SOR007 Anti-KSP/Anti-VEGF siRNAs ALN-VSP02: text: Anti-KSP/Anti-VEGF siRNAs ALN-VSP02 Anti-TIM3 Monoclonal Antibody SHR-1702: text: Anti-TIM3 Monoclonal Antibody SHR-1702 pbi-shRNA STMN1 Lipoplex: text: pbi-shRNA STMN1 Lipoplex Carmustine Implant: text: Carmustine Implant Protein Arginine Methyltransferase 5 Inhibitor GSK3326595: text: Protein Arginine Methyltransferase 5 Inhibitor GSK3326595 Anti-PD-L1/Anti-4-1BB Bispecific Monoclonal Antibody GEN1046: text: Anti-PD-L1/Anti-4-1BB Bispecific Monoclonal Antibody GEN1046 Bomedemstat: text: Bomedemstat Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01: text: Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01 Utomilumab: text: Utomilumab Tarenflurbil: text: Tarenflurbil Neratinib: text: Neratinib Pseudoisocytidine: text: Pseudoisocytidine Human Monoclonal Antibody 216: text: Human Monoclonal Antibody 216 Anti-GITR Agonistic Monoclonal Antibody ASP1951: text: Anti-GITR Agonistic Monoclonal Antibody ASP1951 2'-F-ara-deoxyuridine: text: 2'-F-ara-deoxyuridine Anti-DR5 Agonist Monoclonal Antibody TRA-8: text: Anti-DR5 Agonist Monoclonal Antibody TRA-8 Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11: text: Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11 PI3K Inhibitor WX-037: text: PI3K Inhibitor WX-037 Anti-CD73 Monoclonal Antibody NZV930: text: Anti-CD73 Monoclonal Antibody NZV930 Doxorubicin-Magnetic Targeted Carrier Complex: text: Doxorubicin-Magnetic Targeted Carrier Complex Vinzolidine Sulfate: text: Vinzolidine Sulfate Anti-ErbB3 Monoclonal Antibody CDX-3379: text: Anti-ErbB3 Monoclonal Antibody CDX-3379 Ozarelix: text: Ozarelix Sorafenib Tosylate: text: Sorafenib Tosylate mRNA-based Personalized Cancer Vaccine NCI-4650: text: mRNA-based Personalized Cancer Vaccine NCI-4650 HSP90-targeted SN-38 Conjugate PEN-866: text: HSP90-targeted SN-38 Conjugate PEN-866 TLR7 Agonist LHC165: text: TLR7 Agonist LHC165 Anti-ICAM-1 Monoclonal Antibody BI-505: text: Anti-ICAM-1 Monoclonal Antibody BI-505 Patidegib: text: Patidegib Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564: text: Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564 Patritumab: text: Patritumab Serine/Threonine Kinase Inhibitor XL418: text: Serine/Threonine Kinase Inhibitor XL418 Thorium Th 227 Anti-PSMA Monoclonal Antibody BAY 2315497: text: Thorium Th 227 Anti-PSMA Monoclonal Antibody BAY 2315497 Anti-GITR Monoclonal Antibody GWN 323: text: Anti-GITR Monoclonal Antibody GWN 323 Axl/Mer Inhibitor PF-07265807: text: Axl/Mer Inhibitor PF-07265807 Sugemalimab: text: Sugemalimab Pelitinib: text: Pelitinib Androgen Receptor Degrader ARV-110: text: Androgen Receptor Degrader ARV-110 MEK Inhibitor WX-554: text: MEK Inhibitor WX-554 Rocapuldencel-T: text: Rocapuldencel-T Lexatumumab: text: Lexatumumab Imidazole Mustard: text: Imidazole Mustard Liarozole Fumarate: text: Liarozole Fumarate Blinatumomab: text: Blinatumomab Ladirubicin: text: Ladirubicin Monoclonal Antibody HuHMFG1: text: Monoclonal Antibody HuHMFG1 Ras Peptide VAL: text: Ras Peptide VAL Personalized Peptide Cancer Vaccine NEO-PV-01: text: Personalized Peptide Cancer Vaccine NEO-PV-01 Anti-prolactin Receptor Antibody LFA102: text: Anti-prolactin Receptor Antibody LFA102 2-Methoxyestrone: text: 2-Methoxyestrone RNR Inhibitor COH29: text: RNR Inhibitor COH29 Oral Picoplatin: text: Oral Picoplatin Clinical Trial Agent: text: Clinical Trial Agent PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901: text: PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901 Bimiralisib: text: Bimiralisib Sardomozide: text: Sardomozide ALK/TRK Inhibitor TSR-011: text: ALK/TRK Inhibitor TSR-011 Multi-kinase Inhibitor TPX-0022: text: Multi-kinase Inhibitor TPX-0022 STAT3 Inhibitor WP1066: text: STAT3 Inhibitor WP1066 eIF4E Antisense Oligonucleotide ISIS 183750: text: eIF4E Antisense Oligonucleotide ISIS 183750 Carboxyamidotriazole: text: Carboxyamidotriazole Extended-release Onapristone: text: Extended-release Onapristone PI3K/BET Inhibitor LY294002: text: PI3K/BET Inhibitor LY294002 Liposomal Rhenium Re 186: text: Liposomal Rhenium Re 186 Thioinosine: text: Thioinosine Timonacic: text: Timonacic Ribosome-Inactivating Protein CY503: text: Ribosome-Inactivating Protein CY503 Fosgemcitabine Palabenamide: text: Fosgemcitabine Palabenamide Recombinant Human Plasminogen Kringle 5 Domain ABT 828: text: Recombinant Human Plasminogen Kringle 5 Domain ABT 828 Mcl-1 Inhibitor AZD5991: text: Mcl-1 Inhibitor AZD5991 Phospholipid Ether-drug Conjugate CLR 131: text: Phospholipid Ether-drug Conjugate CLR 131 Alemtuzumab: text: Alemtuzumab Anti-SLITRK6 Monoclonal Antibody-MMAE Conjugate AGS15E: text: Anti-SLITRK6 Monoclonal Antibody-MMAE Conjugate AGS15E Sodium Butyrate: text: Sodium Butyrate Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001: text: Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001 Dihydroorotate Dehydrogenase Inhibitor BAY2402234: text: Dihydroorotate Dehydrogenase Inhibitor BAY2402234 Lutetium Lu 177-DTPA-omburtamab: text: Lutetium Lu 177-DTPA-omburtamab Methylmercaptopurine Riboside: text: Methylmercaptopurine Riboside Anti-CD73 Monoclonal Antibody BMS-986179: text: Anti-CD73 Monoclonal Antibody BMS-986179 Aglatimagene Besadenovec: text: Aglatimagene Besadenovec Detorubicin: text: Detorubicin Anti-CEA BiTE Monoclonal Antibody AMG211: text: Anti-CEA BiTE Monoclonal Antibody AMG211 Alestramustine: text: Alestramustine JAK2 Inhibitor AZD1480: text: JAK2 Inhibitor AZD1480 Y 90 Monoclonal Antibody HMFG1: text: Y 90 Monoclonal Antibody HMFG1 HPV E6/E7-encoding Arenavirus Vaccine HB-201: text: HPV E6/E7-encoding Arenavirus Vaccine HB-201 Talaporfin Sodium: text: Talaporfin Sodium Anti-LAG3 Monoclonal Antibody MK-4280: text: Anti-LAG3 Monoclonal Antibody MK-4280 Leflunomide: text: Leflunomide VEGFR-2 DNA Vaccine VXM01: text: VEGFR-2 DNA Vaccine VXM01 Busulfan: text: Busulfan Anti-CD37 MMAE Antibody-drug Conjugate AGS67E: text: Anti-CD37 MMAE Antibody-drug Conjugate AGS67E pan-RAF Kinase Inhibitor TAK-580: text: pan-RAF Kinase Inhibitor TAK-580 Azacitidine: text: Azacitidine Clodronate Disodium: text: Clodronate Disodium Vincristine Liposomal: text: Vincristine Liposomal Neoantigen-based Melanoma-Poly-ICLC Vaccine: text: Neoantigen-based Melanoma-Poly-ICLC Vaccine Enobosarm: text: Enobosarm Inotuzumab Ozogamicin: text: Inotuzumab Ozogamicin BET-bromodomain Inhibitor ODM-207: text: BET-bromodomain Inhibitor ODM-207 Daunorubicin Citrate: text: Daunorubicin Citrate Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302: text: Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302 Fosaprepitant: text: Fosaprepitant Edotecarin: text: Edotecarin Fluorouracil Implant: text: Fluorouracil Implant Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa: text: Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa Zinc Finger Nuclease ZFN-603: text: Zinc Finger Nuclease ZFN-603 Idarubicin Hydrochloride: text: Idarubicin Hydrochloride Triazene Derivative TriN2755: text: Triazene Derivative TriN2755 Alpha V Beta 8 Antagonist PF-06940434: text: Alpha V Beta 8 Antagonist PF-06940434 Niraparib Tosylate Monohydrate: text: Niraparib Tosylate Monohydrate Procarbazine Hydrochloride: text: Procarbazine Hydrochloride MET Tyrosine Kinase Inhibitor EMD 1204831: text: MET Tyrosine Kinase Inhibitor EMD 1204831 CD123-specific Targeting Module TM123: text: CD123-specific Targeting Module TM123 Y 90 Monoclonal Antibody m170: text: Y 90 Monoclonal Antibody m170 Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701: text: Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701 Talmapimod: text: Talmapimod SMO Protein Inhibitor ZSP1602: text: SMO Protein Inhibitor ZSP1602 Taletrectinib: text: Taletrectinib Entolimod: text: Entolimod CD44v6-specific CAR T-cells: text: CD44v6-specific CAR T-cells Monoclonal Antibody ASP1948: text: Monoclonal Antibody ASP1948 Adenosine A2B Receptor Antagonist PBF-1129: text: Adenosine A2B Receptor Antagonist PBF-1129 Liposomal Mitoxantrone Hydrochloride: text: Liposomal Mitoxantrone Hydrochloride Phenyl Acetate: text: Phenyl Acetate Doxorubicin-loaded EGFR-targeting Nanocells: text: Doxorubicin-loaded EGFR-targeting Nanocells Mivavotinib: text: Mivavotinib Levothyroxine Sodium: text: Levothyroxine Sodium Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225: text: Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225 Ethyleneimine: text: Ethyleneimine Threonine Tyrosine Kinase Inhibitor CFI-402257: text: Threonine Tyrosine Kinase Inhibitor CFI-402257 ROBO1-targeted BiCAR-NKT Cells: text: ROBO1-targeted BiCAR-NKT Cells Micellar Nanoparticle-encapsulated Epirubicin: text: Micellar Nanoparticle-encapsulated Epirubicin Shared Anti-Idiotype-AB-S006: text: Shared Anti-Idiotype-AB-S006 Ribociclib/Letrozole: text: Ribociclib/Letrozole JAK1 Inhibitor INCB052793: text: JAK1 Inhibitor INCB052793 Artesunate: text: Artesunate Recombinant Interferon Alpha 2b-like Protein: text: Recombinant Interferon Alpha 2b-like Protein Ortataxel: text: Ortataxel Indisulam: text: Indisulam Mitomycin: text: Mitomycin Deferoxamine Mesylate: text: Deferoxamine Mesylate Cyclin-dependent Kinase Inhibitor PF-06873600: text: Cyclin-dependent Kinase Inhibitor PF-06873600 Bcl-2 Inhibitor BGB-11417: text: Bcl-2 Inhibitor BGB-11417 Miltefosine: text: Miltefosine Cationic Peptide Cream Cypep-1: text: Cationic Peptide Cream Cypep-1 Allodepleted T Cell Immunotherapeutic ATIR101: text: Allodepleted T Cell Immunotherapeutic ATIR101 ITK Inhibitor CPI-818: text: ITK Inhibitor CPI-818 C/EBP Beta Antagonist ST101: text: C/EBP Beta Antagonist ST101 Anti-DLL3/CD3 BiTE Antibody AMG 757: text: Anti-DLL3/CD3 BiTE Antibody AMG 757 Namodenoson: text: Namodenoson Long Peptide Vaccine 7: text: Long Peptide Vaccine 7 Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1: text: Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1 Olaparib: text: Olaparib Taselisib: text: Taselisib Polidocanol: text: Polidocanol Danusertib: text: Danusertib Polypodium leucotomos Extract: text: Polypodium leucotomos Extract Platinum Acetylacetonate-Titanium Dioxide Nanoparticles: text: Platinum Acetylacetonate-Titanium Dioxide Nanoparticles KRN5500: text: KRN5500 Efatutazone Dihydrochloride: text: Efatutazone Dihydrochloride Liothyronine Sodium: text: Liothyronine Sodium Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006: text: Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006 Sasanlimab: text: Sasanlimab Nirogacestat: text: Nirogacestat Ciltacabtagene Autoleucel: text: Ciltacabtagene Autoleucel Benzaldehyde Dimethane Sulfonate: text: Benzaldehyde Dimethane Sulfonate Pralsetinib: text: Pralsetinib Ibrutinib: text: Ibrutinib Polo-like Kinase 1 Inhibitor MK1496: text: Polo-like Kinase 1 Inhibitor MK1496 Cyclodisone: text: Cyclodisone Recombinant Modified Vaccinia Ankara-5T4 Vaccine: text: Recombinant Modified Vaccinia Ankara-5T4 Vaccine Doxorubicin Prodrug L-377,202: text: Doxorubicin Prodrug L-377,202 Oncolytic Newcastle Disease Virus MTH-68H: text: Oncolytic Newcastle Disease Virus MTH-68H Recombinant Thyroglobulin: text: Recombinant Thyroglobulin Oral Ixabepilone: text: Oral Ixabepilone Nitrogen Mustard Prodrug PR-104: text: Nitrogen Mustard Prodrug PR-104 CXCR4 Inhibitor Q-122: text: CXCR4 Inhibitor Q-122 CXCR4 Antagonist BL-8040: text: CXCR4 Antagonist BL-8040 Patupilone: text: Patupilone Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217: text: Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217 Anti-Melanin Monoclonal Antibody PTI-6D2: text: Anti-Melanin Monoclonal Antibody PTI-6D2 Leuprolide Mesylate Injectable Suspension: text: Leuprolide Mesylate Injectable Suspension Fibromun: text: Fibromun Verubulin Hydrochloride: text: Verubulin Hydrochloride Anti-CD30/DM1 Antibody-drug Conjugate F0002: text: Anti-CD30/DM1 Antibody-drug Conjugate F0002 Antibody-Drug Conjugate DFRF4539A: text: Antibody-Drug Conjugate DFRF4539A iPSC-derived CD16-expressing Natural Killer Cells FT516: text: iPSC-derived CD16-expressing Natural Killer Cells FT516 13-Deoxydoxorubicin: text: 13-Deoxydoxorubicin Lisavanbulin: text: Lisavanbulin TrkA Inhibitor VMD-928: text: TrkA Inhibitor VMD-928 MEK Inhibitor SHR 7390: text: MEK Inhibitor SHR 7390 Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207: text: Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207 Sodium Selenite: text: Sodium Selenite Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine: text: Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine Anti-CD47 Monoclonal Antibody IBI188: text: Anti-CD47 Monoclonal Antibody IBI188 Telisotuzumab Vedotin: text: Telisotuzumab Vedotin Antrodia cinnamomea Supplement: text: Antrodia cinnamomea Supplement TGFbeta Inhibitor LY3200882: text: TGFbeta Inhibitor LY3200882 Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480: text: Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480 Realgar-Indigo naturalis Formulation: text: Realgar-Indigo naturalis Formulation Anti-B7-H4 Monoclonal Antibody FPA150: text: Anti-B7-H4 Monoclonal Antibody FPA150 Mifamurtide: text: Mifamurtide Olivomycin: text: Olivomycin Anti-PD-1 Fusion Protein AMP-224: text: Anti-PD-1 Fusion Protein AMP-224 Mercaptopurine: text: Mercaptopurine Talotrexin: text: Talotrexin SERD GDC-9545: text: SERD GDC-9545 Gemcitabine-Phosphoramidate Hydrochloride NUC-1031: text: Gemcitabine-Phosphoramidate Hydrochloride NUC-1031 Trabedersen: text: Trabedersen Mitotane: text: Mitotane PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480: text: PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480 Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47: text: Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47 Guselkumab: text: Guselkumab Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014: text: Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014 Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1: text: Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1 Recombinant Platelet Factor 4: text: Recombinant Platelet Factor 4 HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001: text: HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001 Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111: text: Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111 Ningetinib Tosylate: text: Ningetinib Tosylate MCL-1 inhibitor AMG 397: text: MCL-1 inhibitor AMG 397 HDAC Inhibitor CXD101: text: HDAC Inhibitor CXD101 Samotolisib: text: Samotolisib Neoantigen-based Therapeutic Cancer Vaccine GRT-C903: text: Neoantigen-based Therapeutic Cancer Vaccine GRT-C903 Penclomedine: text: Penclomedine Altretamine: text: Altretamine Teniposide: text: Teniposide AKR1C3-activated Prodrug OBI-3424: text: AKR1C3-activated Prodrug OBI-3424 Anti-CD117 Monoclonal Antibody JSP191: text: Anti-CD117 Monoclonal Antibody JSP191 Hsp90 Inhibitor AB-010: text: Hsp90 Inhibitor AB-010 HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901: text: HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901 Ionomycin: text: Ionomycin Anti-PD-1/Anti-LAG-3 Bispecific Antibody RO7247669: text: Anti-PD-1/Anti-LAG-3 Bispecific Antibody RO7247669 Vopratelimab: text: Vopratelimab Human MOAB LICO 28a32: text: Human MOAB LICO 28a32 Rofecoxib: text: Rofecoxib Anti-CD47 Monoclonal Antibody CC-90002: text: Anti-CD47 Monoclonal Antibody CC-90002 Samrotamab Vedotin: text: Samrotamab Vedotin Selective Glucocorticoid Receptor Antagonist CORT125281: text: Selective Glucocorticoid Receptor Antagonist CORT125281 Liothyronine I-131: text: Liothyronine I-131 Asparaginase Erwinia chrysanthemi: text: Asparaginase Erwinia chrysanthemi Obatoclax Mesylate: text: Obatoclax Mesylate TLR8 Agonist DN1508052: text: TLR8 Agonist DN1508052 BTK Inhibitor ICP-022: text: BTK Inhibitor ICP-022 Arsenic Trioxide Capsule Formulation ORH 2014: text: Arsenic Trioxide Capsule Formulation ORH 2014 Streptozocin: text: Streptozocin ? Chrysanthemum morifolium/Ganoderma lucidum/Glycyrrhiza glabra/Isatis indigotica/Panax pseudoginseng/Rabdosia rubescens/Scutellaria baicalensis/Serona repens Supplement : text: Chrysanthemum morifolium/Ganoderma lucidum/Glycyrrhiza glabra/Isatis indigotica/Panax pseudoginseng/Rabdosia rubescens/Scutellaria baicalensis/Serona repens Supplement Epratuzumab-cys-tesirine: text: Epratuzumab-cys-tesirine Bisantrene: text: Bisantrene Antimetabolite FF-10502: text: Antimetabolite FF-10502 Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2: text: Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2 Cycloleucine: text: Cycloleucine Simurosertib: text: Simurosertib Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A: text: Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A Hypericin: text: Hypericin Monoclonal Antibody AK002: text: Monoclonal Antibody AK002 Antibody-drug Conjugate ABBV-011: text: Antibody-drug Conjugate ABBV-011 Anti-c-Met Monoclonal Antibody ABT-700: text: Anti-c-Met Monoclonal Antibody ABT-700 Anti-HER2 Antibody-drug Conjugate MEDI4276: text: Anti-HER2 Antibody-drug Conjugate MEDI4276 Alectinib: text: Alectinib Anti-PD-1/Anti-CTLA4 DART Protein MGD019: text: Anti-PD-1/Anti-CTLA4 DART Protein MGD019 Anti-EGFR/PBD Antibody-drug Conjugate ABBV-321: text: Anti-EGFR/PBD Antibody-drug Conjugate ABBV-321 Famitinib: text: Famitinib Bruceanol A: text: Bruceanol A Simtuzumab: text: Simtuzumab Iodine I 131 Monoclonal Antibody CC49-deltaCH2: text: Iodine I 131 Monoclonal Antibody CC49-deltaCH2 Loncastuximab Tesirine: text: Loncastuximab Tesirine GI-4000 Vaccine: text: GI-4000 Vaccine Duvelisib: text: Duvelisib Dihydrolenperone: text: Dihydrolenperone Exemestane: text: Exemestane Opucolimab: text: Opucolimab FGF/FGFR Pathway Inhibitor E7090: text: FGF/FGFR Pathway Inhibitor E7090 Lintuzumab: text: Lintuzumab HDAC Inhibitor OBP-801: text: HDAC Inhibitor OBP-801 Tetradecanoylphorbol Acetate: text: Tetradecanoylphorbol Acetate Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1): text: Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1) MNK1/2 Inhibitor ETC-1907206: text: MNK1/2 Inhibitor ETC-1907206 Necitumumab: text: Necitumumab Anti-MUC1 Monoclonal Antibody BTH1704: text: Anti-MUC1 Monoclonal Antibody BTH1704 Ganetespib: text: Ganetespib DNA Plasmid Encoding Interleukin-12 INO-9012: text: DNA Plasmid Encoding Interleukin-12 INO-9012 Fulvestrant: text: Fulvestrant Ambamustine: text: Ambamustine Liposomal MUC1/PET-lipid A Vaccine ONT-10: text: Liposomal MUC1/PET-lipid A Vaccine ONT-10 SHP2 Inhibitor TNO155: text: SHP2 Inhibitor TNO155 Polymer-encapsulated Luteolin Nanoparticle: text: Polymer-encapsulated Luteolin Nanoparticle Figitumumab: text: Figitumumab Vistusertib: text: Vistusertib Acalisib: text: Acalisib Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029: text: Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029 Naphthalimide Analogue UNBS5162: text: Naphthalimide Analogue UNBS5162 Hormone Therapy: text: Hormone Therapy ERK1/2 Inhibitor KO-947: text: ERK1/2 Inhibitor KO-947 Interferon Alfa-N1: text: Interferon Alfa-N1 Pralatrexate: text: Pralatrexate TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein AVID200: text: TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein AVID200 Mirzotamab Clezutoclax: text: Mirzotamab Clezutoclax Anti-OX40 Agonist Monoclonal Antibody PF-04518600: text: Anti-OX40 Agonist Monoclonal Antibody PF-04518600 Dinutuximab: text: Dinutuximab Mibefradil Dihydrochloride: text: Mibefradil Dihydrochloride Autologous NKG2D CAR T-cells CYAD-02: text: Autologous NKG2D CAR T-cells CYAD-02 MOF Compound RiMO-301: text: MOF Compound RiMO-301 Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055: text: Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055 Methotrexate-E Therapeutic Implant: text: Methotrexate-E Therapeutic Implant PI3K p110beta/delta Inhibitor KA2237: text: PI3K p110beta/delta Inhibitor KA2237 Interleukin-2 Liposome: text: Interleukin-2 Liposome EGFR Mutant-specific Inhibitor CK-101: text: EGFR Mutant-specific Inhibitor CK-101 Trastuzumab-TLR 7/8 Agonist BDC-1001: text: Trastuzumab-TLR 7/8 Agonist BDC-1001 Sepantronium Bromide: text: Sepantronium Bromide Not Otherwise Specified: text: Not Otherwise Specified Alpha V Beta 1 Inhibitor ATN-161: text: Alpha V Beta 1 Inhibitor ATN-161 Hsp90 Inhibitor PU-H71: text: Hsp90 Inhibitor PU-H71 Bisnafide Dimesylate: text: Bisnafide Dimesylate Muparfostat: text: Muparfostat BiTE Antibody AMG 910: text: BiTE Antibody AMG 910 Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo: text: Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo Personalized ALL-specific Multi-HLA-binding Peptide Vaccine: text: Personalized ALL-specific Multi-HLA-binding Peptide Vaccine PAK4 Inhibitor PF-03758309: text: PAK4 Inhibitor PF-03758309 Protein Arginine Methyltransferase 5 Inhibitor PRT543: text: Protein Arginine Methyltransferase 5 Inhibitor PRT543 Holmium Ho 166 Poly(L-Lactic Acid) Microspheres: text: Holmium Ho 166 Poly(L-Lactic Acid) Microspheres Brostacillin Hydrochloride: text: Brostacillin Hydrochloride Pevonedistat: text: Pevonedistat Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A: text: Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A Monoclonal Antibody Hu3S193: text: Monoclonal Antibody Hu3S193 Avdoralimab: text: Avdoralimab Pharmacological Ascorbate: text: Pharmacological Ascorbate Tositumomab: text: Tositumomab Dacomitinib: text: Dacomitinib Custirsen Sodium: text: Custirsen Sodium Nanosomal Docetaxel Lipid Suspension: text: Nanosomal Docetaxel Lipid Suspension Duborimycin: text: Duborimycin Anti-FGFR4 Monoclonal Antibody U3-1784: text: Anti-FGFR4 Monoclonal Antibody U3-1784 MDR Modulator CBT-1: text: MDR Modulator CBT-1 Agatolimod Sodium: text: Agatolimod Sodium PTEF-b/CDK9 Inhibitor BAY1251152: text: PTEF-b/CDK9 Inhibitor BAY1251152 p53 Peptide Vaccine MPS-128: text: p53 Peptide Vaccine MPS-128 Survivin Antigen Vaccine DPX-Survivac: text: Survivin Antigen Vaccine DPX-Survivac Warfarin Sodium: text: Warfarin Sodium ATR Inhibitor RP-3500: text: ATR Inhibitor RP-3500 Anti-PD-1/Anti-LAG-3 DART Protein MGD013: text: Anti-PD-1/Anti-LAG-3 DART Protein MGD013 Anti-LAG-3/PD-L1 Bispecific Antibody FS118: text: Anti-LAG-3/PD-L1 Bispecific Antibody FS118 Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride: text: Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride CD80-Fc Fusion Protein FPT155: text: CD80-Fc Fusion Protein FPT155 Epirubicin Hydrochloride: text: Epirubicin Hydrochloride Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012: text: Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012 Anti-CCR7 Antibody-drug Conjugate JBH492: text: Anti-CCR7 Antibody-drug Conjugate JBH492 Tilarginine: text: Tilarginine Immunotherapy Regimen MKC-1106-MT: text: Immunotherapy Regimen MKC-1106-MT IDH1 Mutant Inhibitor LY3410738: text: IDH1 Mutant Inhibitor LY3410738 Retinyl Acetate: text: Retinyl Acetate TGF-beta Receptor 1 Kinase Inhibitor YL-13027: text: TGF-beta Receptor 1 Kinase Inhibitor YL-13027 Iodine I 131 Derlotuximab Biotin: text: Iodine I 131 Derlotuximab Biotin Banoxantrone: text: Banoxantrone Patidegib Topical Gel: text: Patidegib Topical Gel Partially Engineered T-regulatory Cell Donor Graft TRGFT-201: text: Partially Engineered T-regulatory Cell Donor Graft TRGFT-201 Autologous Anti-CD123 CAR-T Cells: text: Autologous Anti-CD123 CAR-T Cells Zanubrutinib: text: Zanubrutinib Trastuzumab Deruxtecan: text: Trastuzumab Deruxtecan Pembrolizumab: text: Pembrolizumab Anti-HER3 Antibody-drug Conjugate U3 1402: text: Anti-HER3 Antibody-drug Conjugate U3 1402 Protein Stabilized Liposomal Docetaxel Nanoparticles: text: Protein Stabilized Liposomal Docetaxel Nanoparticles Irinotecan Sucrosofate: text: Irinotecan Sucrosofate Y 90 Monoclonal Antibody CC49: text: Y 90 Monoclonal Antibody CC49 BCG Tokyo-172 Strain Solution: text: BCG Tokyo-172 Strain Solution BC-819 Plasmid/Polyethylenimine Complex: text: BC-819 Plasmid/Polyethylenimine Complex Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10: text: Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10 CHP-NY-ESO-1 Peptide Vaccine IMF-001: text: CHP-NY-ESO-1 Peptide Vaccine IMF-001 Alkotinib: text: Alkotinib MALT1 Inhibitor JNJ-67856633: text: MALT1 Inhibitor JNJ-67856633 Retinoic Acid Agent Ro 16-9100: text: Retinoic Acid Agent Ro 16-9100 Fas Receptor Agonist APO010: text: Fas Receptor Agonist APO010 Spiromustine: text: Spiromustine Sergiolide: text: Sergiolide Umbralisib: text: Umbralisib Monoclonal Antibody SGN-14: text: Monoclonal Antibody SGN-14 CDK7 Inhibitor CT7001: text: CDK7 Inhibitor CT7001 Glucarpidase: text: Glucarpidase BTK Inhibitor ARQ 531: text: BTK Inhibitor ARQ 531 Anti-DKK-1 Monoclonal Antibody LY2812176: text: Anti-DKK-1 Monoclonal Antibody LY2812176 Anti-EGFR/DM1 Antibody-drug Conjugate AVID100: text: Anti-EGFR/DM1 Antibody-drug Conjugate AVID100 Tubulin Inhibitor ALB 109564 Dihydrochloride: text: Tubulin Inhibitor ALB 109564 Dihydrochloride Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001: text: Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001 Depatuxizumab Mafodotin: text: Depatuxizumab Mafodotin Anti-CD39 Monoclonal Antibody SRF617: text: Anti-CD39 Monoclonal Antibody SRF617 Cabozantinib: text: Cabozantinib Oral Azacitidine: text: Oral Azacitidine Cevipabulin: text: Cevipabulin Milciclib Maleate: text: Milciclib Maleate Anti-HER2/MMAE Antibody-drug Conjugate MRG002: text: Anti-HER2/MMAE Antibody-drug Conjugate MRG002 Ponatinib: text: Ponatinib Penberol: text: Penberol Recombinant Adenovirus-p53 SCH-58500: text: Recombinant Adenovirus-p53 SCH-58500 Monoclonal Antibody GD2 Anti-Idiotype Vaccine: text: Monoclonal Antibody GD2 Anti-Idiotype Vaccine Allogeneic Anti-CD19 Universal CAR-T Cells CTA101: text: Allogeneic Anti-CD19 Universal CAR-T Cells CTA101 Survivin Antigen: text: Survivin Antigen Etanercept: text: Etanercept CDK1/2/4 Inhibitor AG-024322: text: CDK1/2/4 Inhibitor AG-024322 Medorubicin: text: Medorubicin Bizelesin: text: Bizelesin Autologous TCRm-expressing T-cells ET140203: text: Autologous TCRm-expressing T-cells ET140203 Recombinant Interleukin-2: text: Recombinant Interleukin-2 Poly-alendronate Dextran-Guanidine Conjugate: text: Poly-alendronate Dextran-Guanidine Conjugate Androgen Receptor Antagonist BAY 1161116: text: Androgen Receptor Antagonist BAY 1161116 Taladegib: text: Taladegib Anti-CD3/CD7-Ricin Toxin A Immunotoxin: text: Anti-CD3/CD7-Ricin Toxin A Immunotoxin Apolizumab: text: Apolizumab STAT Inhibitor OPB-111077: text: STAT Inhibitor OPB-111077 Pictilisib Bismesylate: text: Pictilisib Bismesylate c-Met Inhibitor HS-10241: text: c-Met Inhibitor HS-10241 9H-Purine-6Thio-98D: text: 9H-Purine-6Thio-98D Plamotamab: text: Plamotamab Resistant Starch: text: Resistant Starch NAMPT Inhibitor OT-82: text: NAMPT Inhibitor OT-82 CD4-specific Telomerase Peptide Vaccine UCPVax: text: CD4-specific Telomerase Peptide Vaccine UCPVax Aviscumine: text: Aviscumine Fostriecin: text: Fostriecin Antineoplaston A10: text: Antineoplaston A10 c-Met Inhibitor AMG 208: text: c-Met Inhibitor AMG 208 Tavolimab: text: Tavolimab Bcl-2 Inhibitor LP-108: text: Bcl-2 Inhibitor LP-108 Trifluridine and Tipiracil Hydrochloride: text: Trifluridine and Tipiracil Hydrochloride Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006: text: Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006 Anti-CD33/CD3 BiTE Antibody AMG 330: text: Anti-CD33/CD3 BiTE Antibody AMG 330 Topoisomerase-II-beta Inhibitor Racemic XK469: text: Topoisomerase-II-beta Inhibitor Racemic XK469 Anti-ICOS Agonist Monoclonal Antibody BMS-986226: text: Anti-ICOS Agonist Monoclonal Antibody BMS-986226 Detirelix: text: Detirelix Motixafortide: text: Motixafortide Tyrosine Kinase Inhibitor SU5402: text: Tyrosine Kinase Inhibitor SU5402 Belagenpumatucel-L: text: Belagenpumatucel-L Anti-TF Monoclonal Antibody ALT-836: text: Anti-TF Monoclonal Antibody ALT-836 Tasidotin: text: Tasidotin Palbociclib Isethionate: text: Palbociclib Isethionate SERD G1T48: text: SERD G1T48 Brigatinib: text: Brigatinib Leurubicin: text: Leurubicin Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962: text: Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962 Glaucarubolone: text: Glaucarubolone Anti-CD45 Monoclonal Antibody AHN-12: text: Anti-CD45 Monoclonal Antibody AHN-12 Docetaxel: text: Docetaxel Piroxantrone: text: Piroxantrone Linrodostat: text: Linrodostat HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c: text: HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c BP-Cx1-Platinum Complex BP-C1: text: BP-Cx1-Platinum Complex BP-C1 Epipropidine: text: Epipropidine Multipeptide Vaccine S-588210: text: Multipeptide Vaccine S-588210 Prednisone: text: Prednisone HDM2 Inhibitor HDM201: text: HDM2 Inhibitor HDM201 Erbulozole: text: Erbulozole Trodusquemine: text: Trodusquemine Actinium Ac-225 Anti-PSMA Monoclonal Antibody J591: text: Actinium Ac-225 Anti-PSMA Monoclonal Antibody J591 Factor VIIa Inhibitor PCI-27483: text: Factor VIIa Inhibitor PCI-27483 2-Fluorofucose-containing SGN-2FF: text: 2-Fluorofucose-containing SGN-2FF Anti-CD20-engineered Toxin Body MT-3724: text: Anti-CD20-engineered Toxin Body MT-3724 EGFR Mutant-selective Inhibitor TQB3804: text: EGFR Mutant-selective Inhibitor TQB3804 Monoclonal Antibody CC49-delta CH2: text: Monoclonal Antibody CC49-delta CH2 Monoclonal Antibody CAL: text: Monoclonal Antibody CAL Liposomal Topotecan FF-10850: text: Liposomal Topotecan FF-10850 Anti-AXL Fusion Protein AVB-S6-500: text: Anti-AXL Fusion Protein AVB-S6-500 Anti-CD47 Monoclonal Antibody SHR-1603: text: Anti-CD47 Monoclonal Antibody SHR-1603 Ublituximab: text: Ublituximab Adenosine A2A/A2B Receptor Antagonist AB928: text: Adenosine A2A/A2B Receptor Antagonist AB928 Lorlatinib: text: Lorlatinib Emofolin Sodium: text: Emofolin Sodium Plitidepsin: text: Plitidepsin Methylselenocysteine: text: Methylselenocysteine Motexafin Gadolinium: text: Motexafin Gadolinium AR Antagonist BMS-641988: text: AR Antagonist BMS-641988 Retifanlimab: text: Retifanlimab Pertuzumab: text: Pertuzumab Pemetrexed: text: Pemetrexed MET Tyrosine Kinase Inhibitor PF-04217903: text: MET Tyrosine Kinase Inhibitor PF-04217903 MUC1-targeted Peptide GO-203-2C: text: MUC1-targeted Peptide GO-203-2C Cytokine-based Biologic Agent IRX-2: text: Cytokine-based Biologic Agent IRX-2 BCMA-CD19 Compound CAR T Cells: text: BCMA-CD19 Compound CAR T Cells PI3K/mTOR Kinase Inhibitor PF-04691502: text: PI3K/mTOR Kinase Inhibitor PF-04691502 Sacituzumab Govitecan: text: Sacituzumab Govitecan Anti-PD-1/VEGF Bispecific Antibody AK112: text: Anti-PD-1/VEGF Bispecific Antibody AK112 Pegylated Liposomal Mitoxantrone Hydrochloride: text: Pegylated Liposomal Mitoxantrone Hydrochloride Anti-PD-1 Monoclonal Antibody CS1003: text: Anti-PD-1 Monoclonal Antibody CS1003 Geranylgeranyltransferase I Inhibitor: text: Geranylgeranyltransferase I Inhibitor Imidazole-Pyrazole: text: Imidazole-Pyrazole Adenosine A2A Receptor Antagonist NIR178: text: Adenosine A2A Receptor Antagonist NIR178 Interferon Gamma-1b: text: Interferon Gamma-1b Sotorasib: text: Sotorasib Oligonucleotide SPC2996: text: Oligonucleotide SPC2996 TIGIT Inhibitor M6223: text: TIGIT Inhibitor M6223 Carubicin Hydrochloride: text: Carubicin Hydrochloride Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A: text: Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A Anti-CD40 Agonist Monoclonal Antibody CDX-1140: text: Anti-CD40 Agonist Monoclonal Antibody CDX-1140 p97 Inhibitor CB-5339: text: p97 Inhibitor CB-5339 Limonene, (+/-)-: text: Limonene, (+/-)- Recombinant Interferon Gamma: text: Recombinant Interferon Gamma CYL-02 Plasmid DNA: text: CYL-02 Plasmid DNA Anti-TIGIT Monoclonal Antibody BGB-A1217: text: Anti-TIGIT Monoclonal Antibody BGB-A1217 Rucaparib Phosphate: text: Rucaparib Phosphate Teglarinad Chloride: text: Teglarinad Chloride Anti-HA Epitope Monoclonal Antibody MEDI8852: text: Anti-HA Epitope Monoclonal Antibody MEDI8852 Annamycin Liposomal: text: Annamycin Liposomal Pomalidomide: text: Pomalidomide Burixafor Hydrobromide: text: Burixafor Hydrobromide Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011: text: Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011 Anti-PD-L1 Monoclonal Antibody ZKAB001: text: Anti-PD-L1 Monoclonal Antibody ZKAB001 Ziv-Aflibercept: text: Ziv-Aflibercept Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F: text: Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F Anti-CD30 Monoclonal Antibody MDX-1401: text: Anti-CD30 Monoclonal Antibody MDX-1401 Degarelix Acetate: text: Degarelix Acetate Placebo: text: Placebo Anti-Globo H Monoclonal Antibody OBI-888: text: Anti-Globo H Monoclonal Antibody OBI-888 ATM Kinase Inhibitor AZD0156: text: ATM Kinase Inhibitor AZD0156 Cenersen: text: Cenersen Liposomal Eribulin Mesylate: text: Liposomal Eribulin Mesylate PI3K/mTOR Kinase Inhibitor DS-7423: text: PI3K/mTOR Kinase Inhibitor DS-7423 Spanlecortemlocel: text: Spanlecortemlocel Src Kinase Inhibitor KX2-391: text: Src Kinase Inhibitor KX2-391 Anti-PD-L1 Monoclonal Antibody TG-1501: text: Anti-PD-L1 Monoclonal Antibody TG-1501 Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3005: text: Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3005 Beta-elemene: text: Beta-elemene Erythrocyte-encapsulated L-asparaginase Suspension: text: Erythrocyte-encapsulated L-asparaginase Suspension Lutetium Lu 177 Lilotomab-satetraxetan: text: Lutetium Lu 177 Lilotomab-satetraxetan Ladiratuzumab Vedotin: text: Ladiratuzumab Vedotin Anti-GARP Monoclonal Antibody ABBV-151: text: Anti-GARP Monoclonal Antibody ABBV-151 Maytansine: text: Maytansine Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244: text: Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244 Dynemicin: text: Dynemicin Mofarotene: text: Mofarotene Hydroxyurea: text: Hydroxyurea Hsp90 Inhibitor TQB3474: text: Hsp90 Inhibitor TQB3474 Canfosfamide: text: Canfosfamide H-ras Antisense Oligodeoxynucleotide ISIS 2503: text: H-ras Antisense Oligodeoxynucleotide ISIS 2503 Tilsotolimod Sodium: text: Tilsotolimod Sodium BET Inhibitor INCB057643: text: BET Inhibitor INCB057643 Tesevatinib: text: Tesevatinib Dicycloplatin: text: Dicycloplatin KRAS G12C Inhibitor LY3499446: text: KRAS G12C Inhibitor LY3499446 WT1 Peptide Vaccine WT2725: text: WT1 Peptide Vaccine WT2725 Lodapolimab: text: Lodapolimab Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191: text: Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191 Dynemicin A: text: Dynemicin A Pegylated Interferon Alfa: text: Pegylated Interferon Alfa Anti-IL-1 alpha Monoclonal Antibody MABp1: text: Anti-IL-1 alpha Monoclonal Antibody MABp1 Silmitasertib Sodium: text: Silmitasertib Sodium Cytarabine-asparagine Prodrug BST-236: text: Cytarabine-asparagine Prodrug BST-236 Seviteronel: text: Seviteronel Bisnafide: text: Bisnafide FGFR4 Inhibitor H3B-6527: text: FGFR4 Inhibitor H3B-6527 Anti-PD1/CTLA4 Bispecific Antibody XmAb20717: text: Anti-PD1/CTLA4 Bispecific Antibody XmAb20717 Monocarboxylate Transporter 1 Inhibitor AZD3965: text: Monocarboxylate Transporter 1 Inhibitor AZD3965 Anti-OX40 Monoclonal Antibody IBI101: text: Anti-OX40 Monoclonal Antibody IBI101 Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999: text: Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999 Benzoylphenylurea: text: Benzoylphenylurea Pioglitazone Hydrochloride: text: Pioglitazone Hydrochloride Bemarituzumab: text: Bemarituzumab MUC-1/WT1 Peptide-primed Autologous Dendritic Cells: text: MUC-1/WT1 Peptide-primed Autologous Dendritic Cells Ilorasertib: text: Ilorasertib 7-Ethyl-10-Hydroxycamptothecin: text: 7-Ethyl-10-Hydroxycamptothecin Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128: text: Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128 Autologous AXL-targeted CAR T-cells CCT301-38: text: Autologous AXL-targeted CAR T-cells CCT301-38 Anti-ErbB3 Antibody ISU104: text: Anti-ErbB3 Antibody ISU104 Other: text: Other PI3K Inhibitor GDC-0084: text: PI3K Inhibitor GDC-0084 Girentuximab: text: Girentuximab EGFR Antagonist Hemay022: text: EGFR Antagonist Hemay022 Halofuginone: text: Halofuginone Liarozole: text: Liarozole Actinomycin C3: text: Actinomycin C3 KRASG12C Inhibitor JNJ-74699157: text: KRASG12C Inhibitor JNJ-74699157 MET Tyrosine Kinase Inhibitor SAR125844: text: MET Tyrosine Kinase Inhibitor SAR125844 8-Azaguanine: text: 8-Azaguanine Photodynamic Compound TLD-1433: text: Photodynamic Compound TLD-1433 Idelalisib: text: Idelalisib CDK2/4/6/FLT3 Inhibitor FN-1501: text: CDK2/4/6/FLT3 Inhibitor FN-1501 Morinda Citrifolia Fruit Extract: text: Morinda Citrifolia Fruit Extract Ondansetron Hydrochloride: text: Ondansetron Hydrochloride CEBPA-targeting saRNA MTL-CEBPA Liposome: text: CEBPA-targeting saRNA MTL-CEBPA Liposome Tisotumab Vedotin: text: Tisotumab Vedotin Anti-CD123 Monoclonal Antibody CSL360: text: Anti-CD123 Monoclonal Antibody CSL360 Elacestrant: text: Elacestrant Methanol Extraction Residue of BCG: text: Methanol Extraction Residue of BCG Lavendustin A: text: Lavendustin A Demecolcine: text: Demecolcine Acridine: text: Acridine Picibanil: text: Picibanil Indocyanine Green-labeled Polymeric Micelles ONM-100: text: Indocyanine Green-labeled Polymeric Micelles ONM-100 Halichondrin B: text: Halichondrin B Avelumab: text: Avelumab Phosphoramide Mustard: text: Phosphoramide Mustard Carmustine: text: Carmustine Anti-CD38 Monoclonal Antibody MOR03087: text: Anti-CD38 Monoclonal Antibody MOR03087 Mipsagargin: text: Mipsagargin Pentostatin: text: Pentostatin EZH2 Inhibitor SHR2554: text: EZH2 Inhibitor SHR2554 Licartin: text: Licartin HDAC8 Inhibitor NBM-BMX: text: HDAC8 Inhibitor NBM-BMX CDK Inhibitor AT7519: text: CDK Inhibitor AT7519 CAB-ROR2-ADC BA3021: text: CAB-ROR2-ADC BA3021 Interleukin-15 Agonist Fusion Protein SHR1501: text: Interleukin-15 Agonist Fusion Protein SHR1501 Redaporfin: text: Redaporfin Recombinant Tyrosinase-Related Protein-2: text: Recombinant Tyrosinase-Related Protein-2 Zalifrelimab: text: Zalifrelimab Trastuzumab Monomethyl Auristatin F: text: Trastuzumab Monomethyl Auristatin F Zandelisib: text: Zandelisib Idecabtagene Vicleucel: text: Idecabtagene Vicleucel Anti-PD-1/TIM-3 Bispecific Antibody RO7121661: text: Anti-PD-1/TIM-3 Bispecific Antibody RO7121661 Demplatin Pegraglumer: text: Demplatin Pegraglumer hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301: text: hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301 Hsp90 Inhibitor DS-2248: text: Hsp90 Inhibitor DS-2248 CTLA-4-directed Probody BMS-986249: text: CTLA-4-directed Probody BMS-986249 Cimetidine: text: Cimetidine NY-ESO-1/GLA-SE Vaccine ID-G305: text: NY-ESO-1/GLA-SE Vaccine ID-G305 Pirarubicin: text: Pirarubicin Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949: text: Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949 Romidepsin: text: Romidepsin Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01: text: Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01 Anti-PD-1 Monoclonal Antibody JTX-4014: text: Anti-PD-1 Monoclonal Antibody JTX-4014 Ancitabine: text: Ancitabine KRAS G12C Inhibitor GDC-6036: text: KRAS G12C Inhibitor GDC-6036 Imipramine Blue: text: Imipramine Blue ATR Kinase Inhibitor M1774: text: ATR Kinase Inhibitor M1774 Pegylated Liposomal Irinotecan: text: Pegylated Liposomal Irinotecan Siplizumab: text: Siplizumab Liarozole Hydrochloride: text: Liarozole Hydrochloride Anti-CD19 Monoclonal Antibody XmAb5574: text: Anti-CD19 Monoclonal Antibody XmAb5574 Nazartinib: text: Nazartinib Laniquidar: text: Laniquidar Anti-LAG3 Monoclonal Antibody BI 754111: text: Anti-LAG3 Monoclonal Antibody BI 754111 Mitomycin A: text: Mitomycin A Crenolanib: text: Crenolanib Gemcitabine Elaidate: text: Gemcitabine Elaidate Ruxotemitide: text: Ruxotemitide F16-IL2 Fusion Protein: text: F16-IL2 Fusion Protein Anti-mesothelin/MMAE Antibody-drug Conjugate RC88: text: Anti-mesothelin/MMAE Antibody-drug Conjugate RC88 Mutant-selective EGFR Inhibitor PF-06459988: text: Mutant-selective EGFR Inhibitor PF-06459988 Pelabresib: text: Pelabresib Gallium-based Bone Resorption Inhibitor AP-002: text: Gallium-based Bone Resorption Inhibitor AP-002 Amolimogene Bepiplasmid: text: Amolimogene Bepiplasmid Eg5 Kinesin-Related Motor Protein Inhibitor ARQ 621: text: Eg5 Kinesin-Related Motor Protein Inhibitor ARQ 621 Etirinotecan Pegol: text: Etirinotecan Pegol Elbasvir/Grazoprevir: text: Elbasvir/Grazoprevir Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143: text: Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143 Laromustine: text: Laromustine C-VISA BikDD:Liposome: text: C-VISA BikDD:Liposome Clodronic Acid: text: Clodronic Acid Mivobulin: text: Mivobulin Anti-LGR5 Monoclonal Antibody BNC101: text: Anti-LGR5 Monoclonal Antibody BNC101 FAK Inhibitor VS-4718: text: FAK Inhibitor VS-4718 Autologous Anti-CD19 TAC-T cells TAC01-CD19: text: Autologous Anti-CD19 TAC-T cells TAC01-CD19 Cordycepin: text: Cordycepin Anti-CD20 Monoclonal Antibody PRO131921: text: Anti-CD20 Monoclonal Antibody PRO131921 HER2 Inhibitor TAS0728: text: HER2 Inhibitor TAS0728 Colloidal Gold-Bound Tumor Necrosis Factor: text: Colloidal Gold-Bound Tumor Necrosis Factor RhoC Peptide Vaccine RV001V: text: RhoC Peptide Vaccine RV001V VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593: text: VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593 Methylprednisolone Sodium Succinate: text: Methylprednisolone Sodium Succinate STAT3 Inhibitor TTI-101: text: STAT3 Inhibitor TTI-101 Infliximab: text: Infliximab NG-nitro-L-arginine: text: NG-nitro-L-arginine EGFR Mutant-specific Inhibitor D-0316: text: EGFR Mutant-specific Inhibitor D-0316 Iodine I 124 Monoclonal Antibody M5A: text: Iodine I 124 Monoclonal Antibody M5A Onvatilimab: text: Onvatilimab Anti-BTN3A Agonistic Monoclonal Antibody ICT01: text: Anti-BTN3A Agonistic Monoclonal Antibody ICT01 Human Papillomavirus 16 E7 Peptide/Padre 965.10: text: Human Papillomavirus 16 E7 Peptide/Padre 965.10 Cancer Peptide Vaccine S-588410: text: Cancer Peptide Vaccine S-588410 Y 90 Monoclonal Antibody Lym-1: text: Y 90 Monoclonal Antibody Lym-1 Antineoplastic Vaccine GV-1301: text: Antineoplastic Vaccine GV-1301 TAM/c-Met Inhibitor RXDX-106: text: TAM/c-Met Inhibitor RXDX-106 Fenretinide Lipid Matrix: text: Fenretinide Lipid Matrix Veltuzumab: text: Veltuzumab TGFa-PE38 Immunotoxin: text: TGFa-PE38 Immunotoxin pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0: text: pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0 Rucaparib Camsylate: text: Rucaparib Camsylate CSF1R Inhibitor ABSK021: text: CSF1R Inhibitor ABSK021 Ibritumomab Tiuxetan: text: Ibritumomab Tiuxetan Inproquone: text: Inproquone STAT3 Inhibitor OPB-51602: text: STAT3 Inhibitor OPB-51602 Icotinib Hydrochloride: text: Icotinib Hydrochloride Dexrazoxane: text: Dexrazoxane Enasidenib Mesylate: text: Enasidenib Mesylate AKT Inhibitor ARQ 092: text: AKT Inhibitor ARQ 092 Recombinant Oncolytic Poliovirus PVS-RIPO: text: Recombinant Oncolytic Poliovirus PVS-RIPO Anti-KIR Monoclonal Antibody IPH 2101: text: Anti-KIR Monoclonal Antibody IPH 2101 Lovastatin: text: Lovastatin Allogeneic Third-party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T-cells CTL 19: text: Allogeneic Third-party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T-cells CTL 19 Anti-AGS-8 Monoclonal Antibody AGS-8M4: text: Anti-AGS-8 Monoclonal Antibody AGS-8M4 Anti-ROR1 ADC VLS-101: text: Anti-ROR1 ADC VLS-101 Zibotentan: text: Zibotentan Tetanus Toxoid Vaccine: text: Tetanus Toxoid Vaccine Ulinastatin: text: Ulinastatin Anti-CD37 Antibody-Drug Conjugate IMGN529: text: Anti-CD37 Antibody-Drug Conjugate IMGN529 EGFR/HER2 Kinase Inhibitor TAK-285: text: EGFR/HER2 Kinase Inhibitor TAK-285 HPV E6/E7 DNA Vaccine GX-188E: text: HPV E6/E7 DNA Vaccine GX-188E 11D10 AluGel Anti-Idiotype Monoclonal Antibody: text: 11D10 AluGel Anti-Idiotype Monoclonal Antibody Synthetic Plumbagin PCUR-101: text: Synthetic Plumbagin PCUR-101 Apilimod Dimesylate Capsule: text: Apilimod Dimesylate Capsule FGFR4 Inhibitor FGF401: text: FGFR4 Inhibitor FGF401 Telapristone Acetate: text: Telapristone Acetate Src/Abl Kinase Inhibitor AZD0424: text: Src/Abl Kinase Inhibitor AZD0424 Monoclonal Antibody HuAFP31: text: Monoclonal Antibody HuAFP31 Ciforadenant: text: Ciforadenant BRAFV600/PI3K Inhibitor ASN003: text: BRAFV600/PI3K Inhibitor ASN003 Acitretin: text: Acitretin Nolatrexed Dihydrochloride: text: Nolatrexed Dihydrochloride Liver X Receptor beta Agonist RGX-104: text: Liver X Receptor beta Agonist RGX-104 Otlertuzumab: text: Otlertuzumab Eftozanermin Alfa: text: Eftozanermin Alfa Tazemetostat: text: Tazemetostat Ianalumab: text: Ianalumab ALK/c-Met Inhibitor TQ-B3139: text: ALK/c-Met Inhibitor TQ-B3139 Dalantercept: text: Dalantercept Dovitinib: text: Dovitinib MEK-1/MEKK-1 Inhibitor E6201: text: MEK-1/MEKK-1 Inhibitor E6201 Cobomarsen: text: Cobomarsen Immunotherapeutic GSK1572932A: text: Immunotherapeutic GSK1572932A Prexigebersen: text: Prexigebersen FGFR Inhibitor AZD4547: text: FGFR Inhibitor AZD4547 Kanglaite: text: Kanglaite Nintedanib: text: Nintedanib Anti-TAG-72 Monoclonal Antibody scFV CC-49/218: text: Anti-TAG-72 Monoclonal Antibody scFV CC-49/218 Cryptophycin: text: Cryptophycin Quarfloxin: text: Quarfloxin Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702: text: Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702 Anti-CD19/CD3 BiTE Antibody AMG 562: text: Anti-CD19/CD3 BiTE Antibody AMG 562 Alofanib: text: Alofanib siG12D LODER: text: siG12D LODER Anti-PGF Monoclonal Antibody RO5323441: text: Anti-PGF Monoclonal Antibody RO5323441 Anti-EGFR Monoclonal Antibody RO5083945: text: Anti-EGFR Monoclonal Antibody RO5083945 Ramucirumab: text: Ramucirumab RET/SRC Inhibitor TPX-0046: text: RET/SRC Inhibitor TPX-0046 Tesetaxel: text: Tesetaxel Thyroid Extract: text: Thyroid Extract P-cadherin Inhibitor PCA062: text: P-cadherin Inhibitor PCA062 MEK Inhibitor TAK-733: text: MEK Inhibitor TAK-733 CDK4/6 Inhibitor: text: CDK4/6 Inhibitor CDK Inhibitor R547: text: CDK Inhibitor R547 Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine: text: Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine Capivasertib: text: Capivasertib Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F: text: Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F Allogeneic Natural Killer Cell Line NK-92: text: Allogeneic Natural Killer Cell Line NK-92 Ovapuldencel-T: text: Ovapuldencel-T Rosopatamab: text: Rosopatamab Carmofur: text: Carmofur Telatinib Mesylate: text: Telatinib Mesylate Letolizumab: text: Letolizumab Puromycin Hydrochloride: text: Puromycin Hydrochloride Lutetium Lu-177 Capromab: text: Lutetium Lu-177 Capromab mTOR Inhibitor GDC-0349: text: mTOR Inhibitor GDC-0349 Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013: text: Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013 MetAP2 Inhibitor SDX-7320: text: MetAP2 Inhibitor SDX-7320 Autologous Dendritic Cell Vaccine ACT2001: text: Autologous Dendritic Cell Vaccine ACT2001 Larotinib Mesylate: text: Larotinib Mesylate Glioblastoma Multiforme Multipeptide Vaccine IMA950: text: Glioblastoma Multiforme Multipeptide Vaccine IMA950 Sustained-release Lipid Inhaled Cisplatin: text: Sustained-release Lipid Inhaled Cisplatin Mechlorethamine Hydrochloride: text: Mechlorethamine Hydrochloride Yttrium Y 90-DOTA-Biotin: text: Yttrium Y 90-DOTA-Biotin Anti-CEACAM6 Antibody BAY1834942: text: Anti-CEACAM6 Antibody BAY1834942 Vadacabtagene Leraleucel: text: Vadacabtagene Leraleucel Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918: text: Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918 PRMT5 Inhibitor JNJ-64619178: text: PRMT5 Inhibitor JNJ-64619178 Avadomide Hydrochloride: text: Avadomide Hydrochloride Galectin-1 Inhibitor OTX008: text: Galectin-1 Inhibitor OTX008 Pegfilgrastim: text: Pegfilgrastim BTK inhibitor TG-1701: text: BTK inhibitor TG-1701 Anti-sCLU Monoclonal Antibody AB-16B5: text: Anti-sCLU Monoclonal Antibody AB-16B5 Glumetinib: text: Glumetinib Oncolytic Adenovirus ORCA-010: text: Oncolytic Adenovirus ORCA-010 Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME: text: Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME Allogeneic Anti-BCMA/CS1 Bispecific CAR-T Cells: text: Allogeneic Anti-BCMA/CS1 Bispecific CAR-T Cells LSD1 Inhibitor GSK2879552: text: LSD1 Inhibitor GSK2879552 Medroxyprogesterone: text: Medroxyprogesterone STING Agonist IMSA101: text: STING Agonist IMSA101 Smoothened Antagonist LDE225 Topical: text: Smoothened Antagonist LDE225 Topical Dociparstat sodium: text: Dociparstat sodium Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR: text: Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR Hexylresorcinol: text: Hexylresorcinol mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902: text: mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902 Anti-TROP2 Antibody-drug Conjugate BAT8003: text: Anti-TROP2 Antibody-drug Conjugate BAT8003 Aerosol Gemcitabine: text: Aerosol Gemcitabine Lilotomab: text: Lilotomab Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10: text: Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10 HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C: text: HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C Cationic Liposome-Encapsulated Paclitaxel: text: Cationic Liposome-Encapsulated Paclitaxel EGFR/TGFb Fusion Monoclonal Antibody BCA101: text: EGFR/TGFb Fusion Monoclonal Antibody BCA101 Brostallicin: text: Brostallicin Copper Cu 64-ATSM: text: Copper Cu 64-ATSM 2-Fluoroadenine: text: 2-Fluoroadenine Anti-DR5 Agonistic Antibody DS-8273a: text: Anti-DR5 Agonistic Antibody DS-8273a Anti-MUC17/CD3 BiTE Antibody AMG 199: text: Anti-MUC17/CD3 BiTE Antibody AMG 199 Alpha-Gal AGI-134: text: Alpha-Gal AGI-134 Iodine I-131: text: Iodine I-131 Mps1 Inhibitor BAY 1217389: text: Mps1 Inhibitor BAY 1217389 Allogeneic Anti-CD19 CAR T-cells ALLO-501A: text: Allogeneic Anti-CD19 CAR T-cells ALLO-501A Paxalisib: text: Paxalisib Docetaxel-PNP: text: Docetaxel-PNP Tipifarnib: text: Tipifarnib IGF-1R Inhibitor PL225B: text: IGF-1R Inhibitor PL225B Vecabrutinib: text: Vecabrutinib Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3: text: Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3 CDC7 Kinase Inhibitor BMS-863233: text: CDC7 Kinase Inhibitor BMS-863233 Apoptosis Inducer BZL101: text: Apoptosis Inducer BZL101 Etoposide Toniribate: text: Etoposide Toniribate Fenretinide: text: Fenretinide MEK Inhibitor HL-085: text: MEK Inhibitor HL-085 Zoledronic Acid: text: Zoledronic Acid Isobrucein B: text: Isobrucein B Fotretamine: text: Fotretamine Tigatuzumab: text: Tigatuzumab Abarelix: text: Abarelix Anti-PD-1 Monoclonal Antibody BAT1306: text: Anti-PD-1 Monoclonal Antibody BAT1306 Sustained-release Mitomycin C Hydrogel Formulation UGN-101: text: Sustained-release Mitomycin C Hydrogel Formulation UGN-101 DEC-205/NY-ESO-1 Fusion Protein CDX-1401: text: DEC-205/NY-ESO-1 Fusion Protein CDX-1401 Volasertib: text: Volasertib Drozitumab: text: Drozitumab Leucovorin: text: Leucovorin Anti-PSMA Monoclonal Antibody MDX1201-A488: text: Anti-PSMA Monoclonal Antibody MDX1201-A488 Temozolomide: text: Temozolomide Pictilisib: text: Pictilisib Immediate-release Tablet Afuresertib: text: Immediate-release Tablet Afuresertib Polyandrol: text: Polyandrol 7-Hydroxystaurosporine: text: 7-Hydroxystaurosporine Cemadotin Hydrochloride: text: Cemadotin Hydrochloride Vorinostat: text: Vorinostat Elliptinium: text: Elliptinium Forodesine Hydrochloride: text: Forodesine Hydrochloride Recombinant Human Apolipoprotein(a) Kringle V MG1102: text: Recombinant Human Apolipoprotein(a) Kringle V MG1102 Oligo-fucoidan: text: Oligo-fucoidan Calcium Release-activated Channels Inhibitor RP4010: text: Calcium Release-activated Channels Inhibitor RP4010 Androgen Receptor Antisense Oligonucleotide EZN-4176: text: Androgen Receptor Antisense Oligonucleotide EZN-4176 Brilanestrant: text: Brilanestrant Monoclonal Antibody Me1-14 F(ab')2: text: Monoclonal Antibody Me1-14 F(ab')2 Anti-HLA-DR Monoclonal Antibody IMMU-114: text: Anti-HLA-DR Monoclonal Antibody IMMU-114 Anti-PD-L1 Monoclonal Antibody RC98: text: Anti-PD-L1 Monoclonal Antibody RC98 Hydroxyprogesterone Caproate: text: Hydroxyprogesterone Caproate Etoposide: text: Etoposide Evofosfamide: text: Evofosfamide Betaglucin Gel: text: Betaglucin Gel Radotinib Hydrochloride: text: Radotinib Hydrochloride Azathioprine: text: Azathioprine Anti-FLT3 Antibody-drug Conjugate AGS62P1: text: Anti-FLT3 Antibody-drug Conjugate AGS62P1 OxPhos Inhibitor VLX600: text: OxPhos Inhibitor VLX600 SHP2 Inhibitor RLY-1971: text: SHP2 Inhibitor RLY-1971 Tirabrutinib: text: Tirabrutinib Trametinib Dimethyl Sulfoxide: text: Trametinib Dimethyl Sulfoxide Irosustat: text: Irosustat Anti-NRP1 Antibody ASP1948: text: Anti-NRP1 Antibody ASP1948 Ropidoxuridine: text: Ropidoxuridine Fadrozole Hydrochloride: text: Fadrozole Hydrochloride Anti-GITR Agonistic Monoclonal Antibody BMS-986156: text: Anti-GITR Agonistic Monoclonal Antibody BMS-986156 Amustaline: text: Amustaline Bryostatin 1: text: Bryostatin 1 Lutetium Lu 177 Monoclonal Antibody J591: text: Lutetium Lu 177 Monoclonal Antibody J591 VEGF/HGF-targeting DARPin MP0250: text: VEGF/HGF-targeting DARPin MP0250 Xiliertinib: text: Xiliertinib Liposomal Vinorelbine Tartrate: text: Liposomal Vinorelbine Tartrate Bcl-2 Inhibitor BCL201: text: Bcl-2 Inhibitor BCL201 Mitolactol: text: Mitolactol Ispinesib: text: Ispinesib Transdermal 4-Hydroxytestosterone: text: Transdermal 4-Hydroxytestosterone Calcium Release-activated Channel Inhibitor CM4620: text: Calcium Release-activated Channel Inhibitor CM4620 MEK/Aurora Kinase Inhibitor BI 847325: text: MEK/Aurora Kinase Inhibitor BI 847325 Uzansertib: text: Uzansertib Cabozantinib S-malate: text: Cabozantinib S-malate Pemigatinib: text: Pemigatinib Yttrium Y 90-Edotreotide: text: Yttrium Y 90-Edotreotide Trans Sodium Crocetinate: text: Trans Sodium Crocetinate Norgestrel: text: Norgestrel Alpha Galactosylceramide: text: Alpha Galactosylceramide Tegafur-gimeracil-oteracil Potassium: text: Tegafur-gimeracil-oteracil Potassium Monoclonal Antibody HuPAM4: text: Monoclonal Antibody HuPAM4 Pyrotinib: text: Pyrotinib Cyclin-dependent Kinase 8/19 Inhibitor BCD 115: text: Cyclin-dependent Kinase 8/19 Inhibitor BCD 115 Cobimetinib: text: Cobimetinib Masitinib Mesylate: text: Masitinib Mesylate Pipendoxifene: text: Pipendoxifene Anti-CD19 Monoclonal Antibody DI-B4: text: Anti-CD19 Monoclonal Antibody DI-B4 Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217: text: Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217 VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820: text: VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820 Acodazole Hydrochloride: text: Acodazole Hydrochloride Oral Hsp90 Inhibitor IPI-493: text: Oral Hsp90 Inhibitor IPI-493 CDK4 Inhibitor P1446A-05: text: CDK4 Inhibitor P1446A-05 EGFR Mutant-specific Inhibitor BPI-7711: text: EGFR Mutant-specific Inhibitor BPI-7711 CD44 Targeted Agent SPL-108: text: CD44 Targeted Agent SPL-108 Riviciclib: text: Riviciclib Anti-CD33/CD3 Bispecific Antibody JNJ-67571244: text: Anti-CD33/CD3 Bispecific Antibody JNJ-67571244 Landogrozumab: text: Landogrozumab Anti-PD-1 Monoclonal Antibody SCT-I10A: text: Anti-PD-1 Monoclonal Antibody SCT-I10A Upifitamab: text: Upifitamab Docetaxel Nanoparticle CPC634: text: Docetaxel Nanoparticle CPC634 Citatuzumab Bogatox: text: Citatuzumab Bogatox Monoclonal Antibody 4B5 Anti-Idiotype Vaccine: text: Monoclonal Antibody 4B5 Anti-Idiotype Vaccine Proapoptotic Sulindac Analog CP-461: text: Proapoptotic Sulindac Analog CP-461 PD-L1 Inhibitor INCB086550: text: PD-L1 Inhibitor INCB086550 Camptothecin: text: Camptothecin Lutetium Lu 177 DOTA-Tetulomab: text: Lutetium Lu 177 DOTA-Tetulomab MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP: text: MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP Uracil Ointment: text: Uracil Ointment HER2-targeted DARPin MP0274: text: HER2-targeted DARPin MP0274 Brivudine: text: Brivudine Nanafrocin: text: Nanafrocin Foretinib: text: Foretinib Anti-PD-1 Checkpoint Inhibitor PF-06801591: text: Anti-PD-1 Checkpoint Inhibitor PF-06801591 Antibody-like CD95 Receptor/Fc-fusion Protein CAN-008: text: Antibody-like CD95 Receptor/Fc-fusion Protein CAN-008 Chlorodihydropyrimidine: text: Chlorodihydropyrimidine FPV-Brachyury-TRICOM Vaccine: text: FPV-Brachyury-TRICOM Vaccine Monoclonal Antibody muJ591: text: Monoclonal Antibody muJ591 MET x MET Bispecific Antibody REGN5093: text: MET x MET Bispecific Antibody REGN5093 SR-T100 Gel: text: SR-T100 Gel Pamrevlumab: text: Pamrevlumab Talabostat Mesylate: text: Talabostat Mesylate JAK2 Inhibitor XL019: text: JAK2 Inhibitor XL019 Navitoclax: text: Navitoclax Aurora A Kinase Inhibitor LY3295668 Erbumine: text: Aurora A Kinase Inhibitor LY3295668 Erbumine Docetaxel Anhydrous: text: Docetaxel Anhydrous Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1: text: Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1 Anti-IRF4 Antisense Oligonucleotide ION251: text: Anti-IRF4 Antisense Oligonucleotide ION251 Terameprocol: text: Terameprocol Synthetic Alkaloid PM00104: text: Synthetic Alkaloid PM00104 Cord Blood Derived CAR T-Cells: text: Cord Blood Derived CAR T-Cells Rebeccamycin: text: Rebeccamycin Tiazofurin: text: Tiazofurin Phosphatidylcholine-Bound Silybin: text: Phosphatidylcholine-Bound Silybin HLA-A*2402-Restricted Multipeptide Vaccine S-488410: text: HLA-A*2402-Restricted Multipeptide Vaccine S-488410 Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318: text: Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318 Etoricoxib: text: Etoricoxib Mannosulfan: text: Mannosulfan Topical Fluorouracil: text: Topical Fluorouracil Atrasentan Hydrochloride: text: Atrasentan Hydrochloride Bispecific Antibody MDX447: text: Bispecific Antibody MDX447 SLC6A8 Inhibitor RGX-202: text: SLC6A8 Inhibitor RGX-202 Botanical Agent BEL-X-HG: text: Botanical Agent BEL-X-HG Anti-CSF1R Monoclonal Antibody IMC-CS4: text: Anti-CSF1R Monoclonal Antibody IMC-CS4 SHP-1 Agonist SC-43: text: SHP-1 Agonist SC-43 alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801: text: alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801 Splicing Inhibitor H3B-8800: text: Splicing Inhibitor H3B-8800 PSMA-targeted Tubulysin B-containing Conjugate EC1169: text: PSMA-targeted Tubulysin B-containing Conjugate EC1169 Apricoxib: text: Apricoxib Polyvalent Melanoma Vaccine: text: Polyvalent Melanoma Vaccine EZH1/2 Inhibitor DS-3201: text: EZH1/2 Inhibitor DS-3201 Bi-functional Alkylating Agent VAL-083: text: Bi-functional Alkylating Agent VAL-083 Atorvastatin Sodium: text: Atorvastatin Sodium CDK4/6 Inhibitor G1T38: text: CDK4/6 Inhibitor G1T38 PI3K Inhibitor BGT226: text: PI3K Inhibitor BGT226 Cemadotin: text: Cemadotin Beta Alethine: text: Beta Alethine HER2 Inhibitor CP-724,714: text: HER2 Inhibitor CP-724,714 Anti-CD157 Monoclonal Antibody MEN1112: text: Anti-CD157 Monoclonal Antibody MEN1112 Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414: text: Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414 Ets-family Transcription Factor Inhibitor TK216: text: Ets-family Transcription Factor Inhibitor TK216 Anti-CTLA-4 Monoclonal Antibody ADU-1604: text: Anti-CTLA-4 Monoclonal Antibody ADU-1604 Methoxyamine: text: Methoxyamine Amsacrine Lactate: text: Amsacrine Lactate Arfolitixorin: text: Arfolitixorin FGFR4 Inhibitor ICP-105: text: FGFR4 Inhibitor ICP-105 Iboctadekin: text: Iboctadekin CT2584 HMS: text: CT2584 HMS Lentinan: text: Lentinan Calcium Saccharate: text: Calcium Saccharate Cactinomycin: text: Cactinomycin Simmitinib: text: Simmitinib Abiraterone: text: Abiraterone Anti-ICOS Monoclonal Antibody MEDI-570: text: Anti-ICOS Monoclonal Antibody MEDI-570 EBNA-1 inhibitor VK-2019: text: EBNA-1 inhibitor VK-2019 Beta-Glucan MM-10-001: text: Beta-Glucan MM-10-001 Robatumumab: text: Robatumumab Synthetic Long E6/E7 Peptides Vaccine HPV-01: text: Synthetic Long E6/E7 Peptides Vaccine HPV-01 Anti-EGFRvIII Immunotoxin MR1-1: text: Anti-EGFRvIII Immunotoxin MR1-1 Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine: text: Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine Antibody-drug Conjugate PF-06647263: text: Antibody-drug Conjugate PF-06647263 Piposulfan: text: Piposulfan Ulixertinib: text: Ulixertinib TORC1/2 Kinase Inhibitor DS-3078a: text: TORC1/2 Kinase Inhibitor DS-3078a Quisinostat: text: Quisinostat Sulforaphane: text: Sulforaphane Calaspargase Pegol-mknl: text: Calaspargase Pegol-mknl mTOR1/2 Kinase Inhibitor ME-344: text: mTOR1/2 Kinase Inhibitor ME-344 mRNA-derived Lung Cancer Vaccine BI 1361849: text: mRNA-derived Lung Cancer Vaccine BI 1361849 Yttrium Y 90 Monoclonal Antibody MN-14: text: Yttrium Y 90 Monoclonal Antibody MN-14 Mutant IDH1 Inhibitor DS-1001: text: Mutant IDH1 Inhibitor DS-1001 IDH1R132H-Specific Peptide Vaccine PEPIDH1M: text: IDH1R132H-Specific Peptide Vaccine PEPIDH1M Estramustine Phosphate Sodium: text: Estramustine Phosphate Sodium Ras Peptide ASP: text: Ras Peptide ASP Epothilone Analog UTD1: text: Epothilone Analog UTD1 ALK-2 Inhibitor TP-0184: text: ALK-2 Inhibitor TP-0184 Sapacitabine: text: Sapacitabine Tributyrin: text: Tributyrin Testosterone Enanthate: text: Testosterone Enanthate Fenretinide Phospholipid Suspension ST-001: text: Fenretinide Phospholipid Suspension ST-001 Roducitabine: text: Roducitabine Recombinant Human Papillomavirus Nonavalent Vaccine: text: Recombinant Human Papillomavirus Nonavalent Vaccine Monoclonal Antibody AbGn-7: text: Monoclonal Antibody AbGn-7 Vandortuzumab Vedotin: text: Vandortuzumab Vedotin Cinrebafusp Alfa: text: Cinrebafusp Alfa Alvocidib: text: Alvocidib Aprinocarsen: text: Aprinocarsen Pacmilimab: text: Pacmilimab Anti-human GITR Monoclonal Antibody AMG 228: text: Anti-human GITR Monoclonal Antibody AMG 228 Cryptophycin 52: text: Cryptophycin 52 Peginterferon Alfa-2b: text: Peginterferon Alfa-2b Anti-EGFR Monoclonal Antibody SCT200: text: Anti-EGFR Monoclonal Antibody SCT200 Rogaratinib: text: Rogaratinib Recombinant Bispecific Single-Chain Antibody rM28: text: Recombinant Bispecific Single-Chain Antibody rM28 Anti-EphA2 Monoclonal Antibody DS-8895a: text: Anti-EphA2 Monoclonal Antibody DS-8895a Indole-3-Carbinol: text: Indole-3-Carbinol Bushen-Jianpi Decoction: text: Bushen-Jianpi Decoction Selicrelumab: text: Selicrelumab Autologous CD19/PD-1 Bispecific CAR-T Cells: text: Autologous CD19/PD-1 Bispecific CAR-T Cells Urabrelimab: text: Urabrelimab Cobolimab: text: Cobolimab Anti-C-met Monoclonal Antibody SAIT301: text: Anti-C-met Monoclonal Antibody SAIT301 Parsaclisib Hydrochloride: text: Parsaclisib Hydrochloride Semaxanib: text: Semaxanib Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A: text: Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A Erlotinib Hydrochloride: text: Erlotinib Hydrochloride CD40 Agonist Monoclonal Antibody CP-870,893: text: CD40 Agonist Monoclonal Antibody CP-870,893 Selitrectinib: text: Selitrectinib Elliptinium Acetate: text: Elliptinium Acetate MELK Inhibitor OTS167: text: MELK Inhibitor OTS167 Bispecific Antibody GS-1423: text: Bispecific Antibody GS-1423 Cofetuzumab Pelidotin: text: Cofetuzumab Pelidotin Sabatolimab: text: Sabatolimab Pan-AKT Inhibitor ARQ751: text: Pan-AKT Inhibitor ARQ751 Sintilimab: text: Sintilimab Crenolanib Besylate: text: Crenolanib Besylate PSMA-targeted Docetaxel Nanoparticles BIND-014: text: PSMA-targeted Docetaxel Nanoparticles BIND-014 Inosine Monophosphate Dehydrogenase Inhibitor AVN944: text: Inosine Monophosphate Dehydrogenase Inhibitor AVN944 Simotaxel: text: Simotaxel Xevinapant: text: Xevinapant Pan-TRK Inhibitor ONO-7579: text: Pan-TRK Inhibitor ONO-7579 Attenuated Measles Virus Encoding SCD Transgene TMV-018: text: Attenuated Measles Virus Encoding SCD Transgene TMV-018 Orvacabtagene Autoleucel: text: Orvacabtagene Autoleucel Nilotinib Hydrochloride Monohydrate: text: Nilotinib Hydrochloride Monohydrate Calicheamicin Gamma 1I: text: Calicheamicin Gamma 1I Vintafolide: text: Vintafolide PI3K-delta Inhibitor YY-20394: text: PI3K-delta Inhibitor YY-20394 KRAS G12C Inhibitor MRTX849: text: KRAS G12C Inhibitor MRTX849 Recombinant Human Papillomavirus Bivalent Vaccine: text: Recombinant Human Papillomavirus Bivalent Vaccine Anti-OX40 Monoclonal Antibody GSK3174998: text: Anti-OX40 Monoclonal Antibody GSK3174998 PI3K Inhibitor ZSTK474: text: PI3K Inhibitor ZSTK474 Super Enhancer Inhibitor GZ17-6.02: text: Super Enhancer Inhibitor GZ17-6.02 Afimoxifene: text: Afimoxifene CBP/beta-catenin Antagonist PRI-724: text: CBP/beta-catenin Antagonist PRI-724 Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102: text: Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102 Bactobolin: text: Bactobolin Liposomal Bcl-2 Antisense Oligonucleotide BP1002: text: Liposomal Bcl-2 Antisense Oligonucleotide BP1002 Diazepinomicin: text: Diazepinomicin Bispecific Antibody AGEN1223: text: Bispecific Antibody AGEN1223 Varlitinib: text: Varlitinib Epacadostat: text: Epacadostat Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100: text: Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100 Pan-RAF Inhibitor LY3009120: text: Pan-RAF Inhibitor LY3009120 Clioquinol: text: Clioquinol Doxazosin: text: Doxazosin Checkpoint Kinase Inhibitor AZD7762: text: Checkpoint Kinase Inhibitor AZD7762 Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a: text: Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a EGFR Antisense DNA BB-401: text: EGFR Antisense DNA BB-401 Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody: text: Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody Mps1 Inhibitor BOS172722: text: Mps1 Inhibitor BOS172722 Vinzolidine: text: Vinzolidine Topoisomerase I Inhibitor LMP776: text: Topoisomerase I Inhibitor LMP776 Dendritic Cell-Autologous Lung Tumor Vaccine: text: Dendritic Cell-Autologous Lung Tumor Vaccine Mivobulin Isethionate: text: Mivobulin Isethionate Idasanutlin: text: Idasanutlin Enzastaurin Hydrochloride: text: Enzastaurin Hydrochloride Garlic: text: Garlic ncmtRNA Oligonucleotide Andes-1537: text: ncmtRNA Oligonucleotide Andes-1537 Cetuximab-IR700 Conjugate RM-1929: text: Cetuximab-IR700 Conjugate RM-1929 Hypoxia-activated Prodrug TH-4000: text: Hypoxia-activated Prodrug TH-4000 Taltobulin: text: Taltobulin Teclistamab: text: Teclistamab Glofitamab: text: Glofitamab Zirconium Zr 89 Panitumumab: text: Zirconium Zr 89 Panitumumab Denibulin: text: Denibulin Therapeutic Liver Cancer Peptide Vaccine IMA970A: text: Therapeutic Liver Cancer Peptide Vaccine IMA970A I 131 Antiferritin Immunoglobulin: text: I 131 Antiferritin Immunoglobulin Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19: text: Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19 Anti-ErbB3/Anti-IGF-1R Bispecific Monoclonal Antibody MM-141: text: Anti-ErbB3/Anti-IGF-1R Bispecific Monoclonal Antibody MM-141 Fisogatinib: text: Fisogatinib Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells: text: Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells Gutolactone: text: Gutolactone Vatalanib Succinate: text: Vatalanib Succinate Goserelin Acetate Extended-release Microspheres LY01005: text: Goserelin Acetate Extended-release Microspheres LY01005 Anti-PD-1 Monoclonal Antibody BI 754091: text: Anti-PD-1 Monoclonal Antibody BI 754091 MEK Inhibitor GDC-0623: text: MEK Inhibitor GDC-0623 Samuraciclib: text: Samuraciclib c-raf Antisense Oligonucleotide ISIS 5132: text: c-raf Antisense Oligonucleotide ISIS 5132 Vinorelbine Tartrate Oral: text: Vinorelbine Tartrate Oral Monalizumab: text: Monalizumab Angiogenesis/Heparanase Inhibitor PG545: text: Angiogenesis/Heparanase Inhibitor PG545 Synchrovax SEM Plasmid DNA Vaccine: text: Synchrovax SEM Plasmid DNA Vaccine Anti-CD19 Monoclonal Antibody MEDI-551: text: Anti-CD19 Monoclonal Antibody MEDI-551 Agerafenib: text: Agerafenib Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087: text: Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087 Anti-FGFR2 Antibody BAY1179470: text: Anti-FGFR2 Antibody BAY1179470 Mirabegron: text: Mirabegron Padeliporfin: text: Padeliporfin Bexarotene: text: Bexarotene Belzutifan: text: Belzutifan Tariquidar: text: Tariquidar Nanatinostat: text: Nanatinostat Antibody-drug Conjugate ADC XMT-1536: text: Antibody-drug Conjugate ADC XMT-1536 Anti-CD20/CD3 Monoclonal Antibody REGN1979: text: Anti-CD20/CD3 Monoclonal Antibody REGN1979 Pacritinib: text: Pacritinib Doxorubicin: text: Doxorubicin Ruxolitinib: text: Ruxolitinib Razoxane: text: Razoxane Poly-gamma Glutamic Acid: text: Poly-gamma Glutamic Acid Ceramide Nanoliposome: text: Ceramide Nanoliposome Elinafide: text: Elinafide Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells: text: Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells EGFR/HER1/HER2 Inhibitor PKI166: text: EGFR/HER1/HER2 Inhibitor PKI166 Extended Release Metformin Hydrochloride: text: Extended Release Metformin Hydrochloride Ontuxizumab: text: Ontuxizumab Pazopanib: text: Pazopanib Losoxantrone Hydrochloride: text: Losoxantrone Hydrochloride Anti-CD70 Monoclonal Antibody MDX-1411: text: Anti-CD70 Monoclonal Antibody MDX-1411 Anti-EGFR/c-Met Bispecific Antibody EMB-01: text: Anti-EGFR/c-Met Bispecific Antibody EMB-01 Mobocertinib: text: Mobocertinib Recombinant Interleukin-6: text: Recombinant Interleukin-6 Triethylenemelamine: text: Triethylenemelamine Individualized MVA-based Vaccine TG4050: text: Individualized MVA-based Vaccine TG4050 Ginsenoside Rg3 Capsule: text: Ginsenoside Rg3 Capsule Uprosertib: text: Uprosertib Ritrosulfan: text: Ritrosulfan Anti-PD1 Monoclonal Antibody AGEN2034: text: Anti-PD1 Monoclonal Antibody AGEN2034 TLR Agonist BDB001: text: TLR Agonist BDB001 Recombinant Human Papillomavirus 11-valent Vaccine: text: Recombinant Human Papillomavirus 11-valent Vaccine Anti-EGFR/c-Met Bispecific Antibody JNJ-61186372: text: Anti-EGFR/c-Met Bispecific Antibody JNJ-61186372 Taxol Analogue SID 530: text: Taxol Analogue SID 530 Capecitabine: text: Capecitabine Anti-LAG-3 Monoclonal Antibody LAG525: text: Anti-LAG-3 Monoclonal Antibody LAG525 Captopril: text: Captopril Anti-OX40 Agonist Monoclonal Antibody BGB-A445: text: Anti-OX40 Agonist Monoclonal Antibody BGB-A445 Anti-PD-1/Anti-PD-L1 Bispecific Antibody LY3434172: text: Anti-PD-1/Anti-PD-L1 Bispecific Antibody LY3434172 Dactolisib: text: Dactolisib Immunomodulatory Oligonucleotide HYB2055: text: Immunomodulatory Oligonucleotide HYB2055 Adavosertib: text: Adavosertib Tallimustine: text: Tallimustine FLT3/CDK4/6 Inhibitor FLX925: text: FLT3/CDK4/6 Inhibitor FLX925 Paricalcitol: text: Paricalcitol Ioflubenzamide I-131: text: Ioflubenzamide I-131 Isocoumarin NM-3: text: Isocoumarin NM-3 CCR2/CCR5 Antagonist BMS-813160: text: CCR2/CCR5 Antagonist BMS-813160 Huaier Extract Granule: text: Huaier Extract Granule Notch Signaling Inhibitor PF-06650808: text: Notch Signaling Inhibitor PF-06650808 PV-10: text: PV-10 Multikinase Inhibitor AT9283: text: Multikinase Inhibitor AT9283 Iodine I 131 TM-601: text: Iodine I 131 TM-601 Anti-CD25-PBD Antibody-drug Conjugate ADCT-301: text: Anti-CD25-PBD Antibody-drug Conjugate ADCT-301 Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101: text: Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101 Siltuximab: text: Siltuximab Glycooptimized Trastuzumab-GEX: text: Glycooptimized Trastuzumab-GEX Giredestrant: text: Giredestrant Reparixin: text: Reparixin Anti-LILRB4 Monoclonal Antibody IO-202: text: Anti-LILRB4 Monoclonal Antibody IO-202 Anti-PSMA Monoclonal Antibody MLN591-DM1 Immunoconjugate MLN2704: text: Anti-PSMA Monoclonal Antibody MLN591-DM1 Immunoconjugate MLN2704 Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP: text: Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP Iodine I 131 Anti-Fibronectin Antibody Fragment L19-SIP: text: Iodine I 131 Anti-Fibronectin Antibody Fragment L19-SIP Carmustine in Ethanol: text: Carmustine in Ethanol Anti-TIM-3 Monoclonal Antibody Sym023: text: Anti-TIM-3 Monoclonal Antibody Sym023 Therapeutic Angiotensin-(1-7): text: Therapeutic Angiotensin-(1-7) Angiogenesis Inhibitor GT-111: text: Angiogenesis Inhibitor GT-111 Hycanthone: text: Hycanthone Multikinase Inhibitor AEE788: text: Multikinase Inhibitor AEE788 Anti-EGP-2 Immunotoxin MOC31-PE: text: Anti-EGP-2 Immunotoxin MOC31-PE Melanoma TRP2 CTL Epitope Vaccine SCIB1: text: Melanoma TRP2 CTL Epitope Vaccine SCIB1 Autologous Anti-PSMA CAR-T Cells P-PSMA-101: text: Autologous Anti-PSMA CAR-T Cells P-PSMA-101 Dioscorea nipponica Makino Extract DNE3: text: Dioscorea nipponica Makino Extract DNE3 Eltanexor: text: Eltanexor Zanidatamab: text: Zanidatamab Tanespimycin: text: Tanespimycin Tosedostat: text: Tosedostat Tremelimumab: text: Tremelimumab Guanabenz Acetate: text: Guanabenz Acetate Hsp90 Inhibitor Debio 0932: text: Hsp90 Inhibitor Debio 0932 Deferoxamine: text: Deferoxamine Berubicin Hydrochloride: text: Berubicin Hydrochloride Labetuzumab Govitecan: text: Labetuzumab Govitecan PI3K-delta Inhibitor SHC014748M: text: PI3K-delta Inhibitor SHC014748M Tarextumab: text: Tarextumab Bardoxolone: text: Bardoxolone Tepoditamab: text: Tepoditamab L-methylfolate: text: L-methylfolate Anti-ErbB3 Monoclonal Antibody REGN1400: text: Anti-ErbB3 Monoclonal Antibody REGN1400 Docetaxel Formulation CKD-810: text: Docetaxel Formulation CKD-810 Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A: text: Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A Giloralimab: text: Giloralimab Sobuzoxane: text: Sobuzoxane Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX: text: Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX Menogaril: text: Menogaril Bruceanol C: text: Bruceanol C Enzalutamide: text: Enzalutamide Dual Variable Domain Immunoglobulin ABT-165: text: Dual Variable Domain Immunoglobulin ABT-165 Rilimogene Galvacirepvec: text: Rilimogene Galvacirepvec Cerdulatinib: text: Cerdulatinib Anti-TIM3 Monoclonal Antibody LY3321367: text: Anti-TIM3 Monoclonal Antibody LY3321367 Motolimod: text: Motolimod Anti-IGF-1R Monoclonal Antibody AVE1642: text: Anti-IGF-1R Monoclonal Antibody AVE1642 Onalespib Lactate: text: Onalespib Lactate Gossypol Acetic Acid: text: Gossypol Acetic Acid Bleomycin B2: text: Bleomycin B2 Anti-CD33/CD3 BiTE Antibody AMG 673: text: Anti-CD33/CD3 BiTE Antibody AMG 673 Tesidolumab: text: Tesidolumab Acolbifene Hydrochloride: text: Acolbifene Hydrochloride Ubenimex: text: Ubenimex Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110: text: Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110 Estrogen Receptor Agonist GTx-758: text: Estrogen Receptor Agonist GTx-758 Siremadlin: text: Siremadlin Gamma-delta Tocotrienol: text: Gamma-delta Tocotrienol Estrogens, Conjugated: text: Estrogens, Conjugated HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202: text: HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202 Halofuginone Hydrobromide: text: Halofuginone Hydrobromide ALK/FAK/Pyk2 Inhibitor CT-707: text: ALK/FAK/Pyk2 Inhibitor CT-707 Anti-CA6-DM4 Immunoconjugate SAR566658: text: Anti-CA6-DM4 Immunoconjugate SAR566658 Silatecan AR-67: text: Silatecan AR-67 Mitoguazone Dihydrochloride: text: Mitoguazone Dihydrochloride Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody JNJ-64007957: text: Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody JNJ-64007957 Perflenapent Emulsion: text: Perflenapent Emulsion STING Agonist GSK3745417: text: STING Agonist GSK3745417 BRD4 Inhibitor PLX2853: text: BRD4 Inhibitor PLX2853 Transdermal 17beta-Estradiol Gel BHR-200: text: Transdermal 17beta-Estradiol Gel BHR-200 Pan-AKT Kinase Inhibitor GSK690693: text: Pan-AKT Kinase Inhibitor GSK690693 DPX-E7 HPV Vaccine: text: DPX-E7 HPV Vaccine Ricolinostat: text: Ricolinostat Defactinib Hydrochloride: text: Defactinib Hydrochloride Isotretinoin: text: Isotretinoin Poziotinib: text: Poziotinib Nelarabine: text: Nelarabine Paclitaxel: text: Paclitaxel Triptorelin: text: Triptorelin Anti-HER2 Monoclonal Antibody HLX22: text: Anti-HER2 Monoclonal Antibody HLX22 Rhenium Re-188 Etidronate: text: Rhenium Re-188 Etidronate Prednisolone Sodium Phosphate: text: Prednisolone Sodium Phosphate Futuximab/Modotuximab Mixture: text: Futuximab/Modotuximab Mixture Aminopterin Sodium: text: Aminopterin Sodium Aprutumab Ixadotin: text: Aprutumab Ixadotin Bruceanol F: text: Bruceanol F BMS-214662: text: BMS-214662 Chk1 Inhibitor GDC-0575: text: Chk1 Inhibitor GDC-0575 STAT3 Inhibitor OPB-31121: text: STAT3 Inhibitor OPB-31121 Bintrafusp Alfa: text: Bintrafusp Alfa IDO1 Inhibitor PF-06840003: text: IDO1 Inhibitor PF-06840003 CXCR1/2 Inhibitor SX-682: text: CXCR1/2 Inhibitor SX-682 Topoisomerase-1 Inhibitor LMP744: text: Topoisomerase-1 Inhibitor LMP744 Tauromustine: text: Tauromustine Brentuximab: text: Brentuximab Bushen Culuan Decoction: text: Bushen Culuan Decoction Bromebric Acid: text: Bromebric Acid Coltuximab Ravtansine: text: Coltuximab Ravtansine ERK1/2 Inhibitor ASN007: text: ERK1/2 Inhibitor ASN007 3'-C-ethynylcytidine: text: 3'-C-ethynylcytidine Lerociclib: text: Lerociclib Bruceanol B: text: Bruceanol B Anti-TIM-3 Monoclonal Antibody TSR-022: text: Anti-TIM-3 Monoclonal Antibody TSR-022 Phenethyl Isothiocyanate: text: Phenethyl Isothiocyanate Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547: text: Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547 mRNA-derived Prostate Cancer Vaccine CV9104: text: mRNA-derived Prostate Cancer Vaccine CV9104 PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170: text: PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170 Galunisertib: text: Galunisertib Antisense Oligonucleotide QR-313: text: Antisense Oligonucleotide QR-313 Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318: text: Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318 Anti-PD-1 Monoclonal Antibody Sym021: text: Anti-PD-1 Monoclonal Antibody Sym021 Sivifene: text: Sivifene Anti-hepcidin Monoclonal Antibody LY2787106: text: Anti-hepcidin Monoclonal Antibody LY2787106 Anti-IL-15 Monoclonal Antibody AMG 714: text: Anti-IL-15 Monoclonal Antibody AMG 714 ATR Kinase Inhibitor BAY1895344: text: ATR Kinase Inhibitor BAY1895344 Theramide: text: Theramide Multi-epitope HER2 Peptide Vaccine H2NVAC: text: Multi-epitope HER2 Peptide Vaccine H2NVAC EGFR Inhibitor PD-168393: text: EGFR Inhibitor PD-168393 ERK Inhibitor LTT462: text: ERK Inhibitor LTT462 Lobaplatin: text: Lobaplatin Filanesib: text: Filanesib DACH-Platin Micelle NC-4016: text: DACH-Platin Micelle NC-4016 IDO1 Inhibitor KHK2455: text: IDO1 Inhibitor KHK2455 JAK2/Src Inhibitor NS-018: text: JAK2/Src Inhibitor NS-018 MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201: text: MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201 Esperamicin A1: text: Esperamicin A1 Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100: text: Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100 Anti-BCMA/CD3 BiTE Antibody AMG 420: text: Anti-BCMA/CD3 BiTE Antibody AMG 420 Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002: text: Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002 Carboxyamidotriazole Orotate: text: Carboxyamidotriazole Orotate Anti-CD40 Monoclonal Antibody Chi Lob 7/4: text: Anti-CD40 Monoclonal Antibody Chi Lob 7/4 Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet: text: Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet Paclitaxel Polymeric Micelle Formulation NANT-008: text: Paclitaxel Polymeric Micelle Formulation NANT-008 Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex: text: Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex Microbiome-derived Peptide Vaccine EO2401: text: Microbiome-derived Peptide Vaccine EO2401 Peretinoin: text: Peretinoin Docetaxel Lipid Microspheres: text: Docetaxel Lipid Microspheres Tertomotide: text: Tertomotide c-Kit Inhibitor PLX9486: text: c-Kit Inhibitor PLX9486 Acivicin: text: Acivicin Black Raspberry Nectar: text: Black Raspberry Nectar Trioxifene: text: Trioxifene SMAC Mimetic BI 891065: text: SMAC Mimetic BI 891065 Apatorsen: text: Apatorsen DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine: text: DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine Vandetanib-eluting Radiopaque Bead BTG-002814: text: Vandetanib-eluting Radiopaque Bead BTG-002814 MYC-targeting siRNA DCR-MYC: text: MYC-targeting siRNA DCR-MYC Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01: text: Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01 Anti-VEGF Monoclonal Antibody hPV19: text: Anti-VEGF Monoclonal Antibody hPV19 CDK4/6 Inhibitor TQB3616: text: CDK4/6 Inhibitor TQB3616 Albumin-binding Cisplatin Prodrug BTP-114: text: Albumin-binding Cisplatin Prodrug BTP-114 Firtecan Pegol: text: Firtecan Pegol Anti-TIM-3 Monoclonal Antibody BGB-A425: text: Anti-TIM-3 Monoclonal Antibody BGB-A425 Monoclonal Antibody 3H1 Anti-Idiotype Vaccine: text: Monoclonal Antibody 3H1 Anti-Idiotype Vaccine Resiquimod: text: Resiquimod Yang Yin Fu Zheng: text: Yang Yin Fu Zheng T900607: text: T900607 Retelliptine: text: Retelliptine Anti-MUC16/CD3 BiTE Antibody REGN4018: text: Anti-MUC16/CD3 BiTE Antibody REGN4018 Recombinant Human Adenovirus Type 5 H101: text: Recombinant Human Adenovirus Type 5 H101 Atorvastatin Calcium: text: Atorvastatin Calcium IDO1 Inhibitor MK-7162: text: IDO1 Inhibitor MK-7162 NA17-A Antigen: text: NA17-A Antigen Pamidronic Acid: text: Pamidronic Acid Abiraterone Acetate: text: Abiraterone Acetate Tefinostat: text: Tefinostat Anti-CD38 Monoclonal Antibody SAR442085: text: Anti-CD38 Monoclonal Antibody SAR442085 Bisantrene Hydrochloride: text: Bisantrene Hydrochloride Toremifene Citrate: text: Toremifene Citrate Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T: text: Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T Shenqi Fuzheng Injection SQ001: text: Shenqi Fuzheng Injection SQ001 12-Allyldeoxoartemisinin: text: 12-Allyldeoxoartemisinin Epratuzumab: text: Epratuzumab DNA-PK/TOR Kinase Inhibitor CC-115: text: DNA-PK/TOR Kinase Inhibitor CC-115 Pimurutamab: text: Pimurutamab WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401: text: WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401 Chloroquinoxaline Sulfonamide: text: Chloroquinoxaline Sulfonamide Anti-CD352 Antibody-drug Conjugate SGN-CD352A: text: Anti-CD352 Antibody-drug Conjugate SGN-CD352A Ipomeanol: text: Ipomeanol Amifostine: text: Amifostine Oraxol: text: Oraxol Lutetium Lu 177 Satoreotide Tetraxetan: text: Lutetium Lu 177 Satoreotide Tetraxetan Alvespimycin: text: Alvespimycin FGFR Inhibitor CPL304110: text: FGFR Inhibitor CPL304110 Codrituzumab: text: Codrituzumab IGF-methotrexate Conjugate: text: IGF-methotrexate Conjugate STING Agonist BMS-986301: text: STING Agonist BMS-986301 Aderbasib: text: Aderbasib Sapanisertib: text: Sapanisertib Peposertib: text: Peposertib Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088: text: Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088 Anti-HER2-DM1 ADC B003: text: Anti-HER2-DM1 ADC B003 EED Inhibitor MAK683: text: EED Inhibitor MAK683 Azaribine: text: Azaribine Tivozanib: text: Tivozanib Dual IGF-1R/InsR Inhibitor BMS-754807: text: Dual IGF-1R/InsR Inhibitor BMS-754807 FPV Vaccine CV301: text: FPV Vaccine CV301 Rice Bran: text: Rice Bran Lactoferrin-derived Lytic Peptide LTX-315: text: Lactoferrin-derived Lytic Peptide LTX-315 Anti-CD3/CD20 Bispecific Antibody GEN3013: text: Anti-CD3/CD20 Bispecific Antibody GEN3013 Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778,123: text: Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778,123 Rhenium Re-186 Hydroxyethylidene Diphosphonate: text: Rhenium Re-186 Hydroxyethylidene Diphosphonate Gandotinib: text: Gandotinib Anti-5T4 Antibody-drug Conjugate SYD1875: text: Anti-5T4 Antibody-drug Conjugate SYD1875 Multi-mode Kinase Inhibitor EOC317: text: Multi-mode Kinase Inhibitor EOC317 Raf Kinase Inhibitor HM95573: text: Raf Kinase Inhibitor HM95573 Auranofin: text: Auranofin Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV: text: Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV BTK Inhibitor DTRMWXHS-12: text: BTK Inhibitor DTRMWXHS-12 ICT-121 Dendritic Cell Vaccine: text: ICT-121 Dendritic Cell Vaccine BTK Inhibitor LOXO-305: text: BTK Inhibitor LOXO-305 Afatinib: text: Afatinib Microbiome GEN-001: text: Microbiome GEN-001 Anti-LAG-3 Monoclonal Antibody REGN3767: text: Anti-LAG-3 Monoclonal Antibody REGN3767 Girodazole: text: Girodazole Itraconazole Dispersion In Polymer Matrix: text: Itraconazole Dispersion In Polymer Matrix Ensituximab: text: Ensituximab CDK/JAK2/FLT3 Inhibitor TG02 Citrate: text: CDK/JAK2/FLT3 Inhibitor TG02 Citrate Lyso-Thermosensitive Liposome Doxorubicin: text: Lyso-Thermosensitive Liposome Doxorubicin Recombinant Human Angiotensin Converting Enzyme 2 APN01: text: Recombinant Human Angiotensin Converting Enzyme 2 APN01 Pegvisomant: text: Pegvisomant Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777: text: Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777 Emactuzumab: text: Emactuzumab Serine/Threonine Kinase Inhibitor CBP501: text: Serine/Threonine Kinase Inhibitor CBP501 Imatinib Mesylate: text: Imatinib Mesylate Lirilumab: text: Lirilumab AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M: text: AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M Ascrinvacumab: text: Ascrinvacumab Anti-PD-L1 Monoclonal Antibody HLX20: text: Anti-PD-L1 Monoclonal Antibody HLX20 Fosbretabulin Tromethamine: text: Fosbretabulin Tromethamine PARP Inhibitor AZD2461: text: PARP Inhibitor AZD2461 Anti c-KIT Antibody-drug Conjugate LOP628: text: Anti c-KIT Antibody-drug Conjugate LOP628 c-Met Inhibitor JNJ-38877605: text: c-Met Inhibitor JNJ-38877605 Ansamitomicin P-3: text: Ansamitomicin P-3 White Carrot: text: White Carrot Everolimus Tablets for Oral Suspension: text: Everolimus Tablets for Oral Suspension Pimasertib: text: Pimasertib Paclitaxel Ceribate: text: Paclitaxel Ceribate Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso: text: Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso CD28/ICOS Antagonist ALPN-101: text: CD28/ICOS Antagonist ALPN-101 BET Inhibitor RO6870810: text: BET Inhibitor RO6870810 Quizartinib: text: Quizartinib Sirolimus: text: Sirolimus Herba Scutellaria Barbata: text: Herba Scutellaria Barbata MK0731: text: MK0731 Bleomycin A2: text: Bleomycin A2 Teloxantrone: text: Teloxantrone Brivanib: text: Brivanib Oncolytic HSV-1 rQNestin34.5v.2: text: Oncolytic HSV-1 rQNestin34.5v.2 Docetaxel/Ritonavir: text: Docetaxel/Ritonavir Monoclonal Antibody A33: text: Monoclonal Antibody A33 Resminostat: text: Resminostat Palifosfamide: text: Palifosfamide Mifepristone: text: Mifepristone Tiomolibdate Choline: text: Tiomolibdate Choline Porcupine Inhibitor RXC004: text: Porcupine Inhibitor RXC004 N-Methylformamide: text: N-Methylformamide Dexamethason: text: Dexamethason Arginine Butyrate: text: Arginine Butyrate Ruxolitinib Phosphate: text: Ruxolitinib Phosphate St. John's Wort: text: St. John's Wort Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88: text: Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88 Dichloroallyl Lawsone: text: Dichloroallyl Lawsone Resveratrol: text: Resveratrol Alanosine: text: Alanosine Motesanib: text: Motesanib Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053: text: Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053 HM2/MMAE Antibody-Drug Conjugate ALT-P7: text: HM2/MMAE Antibody-Drug Conjugate ALT-P7 Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H: text: Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H Zinostatin Stimalamer: text: Zinostatin Stimalamer Anti-LAG-3 Monoclonal Antibody IBI-110: text: Anti-LAG-3 Monoclonal Antibody IBI-110 Lonafarnib: text: Lonafarnib Mannosylerythritol Lipid: text: Mannosylerythritol Lipid Pibrozelesin Hydrobromide: text: Pibrozelesin Hydrobromide Tenalisib: text: Tenalisib Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104: text: Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104 Sagopilone: text: Sagopilone Diaziquone: text: Diaziquone Anti-ILDR2 Monoclonal Antibody BAY 1905254: text: Anti-ILDR2 Monoclonal Antibody BAY 1905254 Tyrosinase:146-156 Peptide: text: Tyrosinase:146-156 Peptide CCR4 Inhibitor FLX475: text: CCR4 Inhibitor FLX475 Hsp90 Inhibitor HSP990: text: Hsp90 Inhibitor HSP990 Tankyrase Inhibitor STP1002: text: Tankyrase Inhibitor STP1002 Asunercept: text: Asunercept Anti-PSMA/CD3 Bispecific Antibody CCW702: text: Anti-PSMA/CD3 Bispecific Antibody CCW702 Epipodophyllotoxin Analog GL331: text: Epipodophyllotoxin Analog GL331 LSD1 Inhibitor IMG-7289: text: LSD1 Inhibitor IMG-7289 Berzosertib: text: Berzosertib LMB-9 Immunotoxin: text: LMB-9 Immunotoxin Exicorilant: text: Exicorilant Enfortumab Vedotin: text: Enfortumab Vedotin Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine: text: Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine Azaserine: text: Azaserine E2F1 Pathway Activator ARQ 171: text: E2F1 Pathway Activator ARQ 171 Niclosamide: text: Niclosamide mTORC1/mTORC2/DHFR Inhibitor ABTL0812: text: mTORC1/mTORC2/DHFR Inhibitor ABTL0812 Selective Estrogen Receptor Degrader SRN-927: text: Selective Estrogen Receptor Degrader SRN-927 Fludarabine: text: Fludarabine Chaparrin: text: Chaparrin Immunomodulator OHR/AVR118: text: Immunomodulator OHR/AVR118 Selective Cytokine Inhibitory Drug CC-1088: text: Selective Cytokine Inhibitory Drug CC-1088 Tirbanibulin: text: Tirbanibulin Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205: text: Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205 MCL-1 Inhibitor ABBV-467: text: MCL-1 Inhibitor ABBV-467 MEK Inhibitor RO4987655: text: MEK Inhibitor RO4987655 Iso-fludelone: text: Iso-fludelone Enadenotucirev: text: Enadenotucirev Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623: text: Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623 Zoptarelin Doxorubicin: text: Zoptarelin Doxorubicin Eflornithine Hydrochloride: text: Eflornithine Hydrochloride CEA-targeting Agent RG6123: text: CEA-targeting Agent RG6123 Selective Estrogen Receptor Degrader AZD9496: text: Selective Estrogen Receptor Degrader AZD9496 Feladilimab: text: Feladilimab Brivudine Phosphoramidate: text: Brivudine Phosphoramidate Polatuzumab Vedotin: text: Polatuzumab Vedotin Canerpaturev: text: Canerpaturev Anti-AGS-16 Monoclonal Antibody AGS-16M18: text: Anti-AGS-16 Monoclonal Antibody AGS-16M18 Procarbazine: text: Procarbazine Anti-CD33 Antibody-drug Conjugate IMGN779: text: Anti-CD33 Antibody-drug Conjugate IMGN779 Sodium Salicylate: text: Sodium Salicylate Oglufanide Disodium: text: Oglufanide Disodium Monoclonal Antibody 11D10: text: Monoclonal Antibody 11D10 PRIMA-1 Analog APR-246: text: PRIMA-1 Analog APR-246 Denenicokin: text: Denenicokin Anti-VEGFR3 Monoclonal Antibody IMC-3C5: text: Anti-VEGFR3 Monoclonal Antibody IMC-3C5 EGFR Inhibitor BIBX 1382: text: EGFR Inhibitor BIBX 1382 TLR Agonist CADI-05: text: TLR Agonist CADI-05 Adecatumumab: text: Adecatumumab Buserelin: text: Buserelin Paclitaxel Injection Concentrate for Nanodispersion: text: Paclitaxel Injection Concentrate for Nanodispersion Tyrosine Kinase Inhibitor OSI-930: text: Tyrosine Kinase Inhibitor OSI-930 Vinblastine Sulfate: text: Vinblastine Sulfate Infigratinib Mesylate: text: Infigratinib Mesylate HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101: text: HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101 Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b: text: Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b Tacedinaline: text: Tacedinaline Ralaniten Acetate: text: Ralaniten Acetate Carboplatin: text: Carboplatin Iberdomide: text: Iberdomide Anti-PD-L1 Monoclonal Antibody FAZ053: text: Anti-PD-L1 Monoclonal Antibody FAZ053 Carmustine Sustained-Release Implant Wafer: text: Carmustine Sustained-Release Implant Wafer Panitumumab: text: Panitumumab Tyrosine Kinase Inhibitor TL-895: text: Tyrosine Kinase Inhibitor TL-895 HPV-6-targeting Immunotherapeutic Vaccine INO-3106: text: HPV-6-targeting Immunotherapeutic Vaccine INO-3106 Anti-nf-P2X7 Antibody Ointment BIL-010t: text: Anti-nf-P2X7 Antibody Ointment BIL-010t Ranibizumab: text: Ranibizumab Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641: text: Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641 Iloprost: text: Iloprost Oncolytic HSV-1 rRp450: text: Oncolytic HSV-1 rRp450 LOXL2 Inhibitor PAT-1251: text: LOXL2 Inhibitor PAT-1251 Daniquidone: text: Daniquidone Dabrafenib: text: Dabrafenib DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151: text: DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151 Daratumumab and Hyaluronidase-fihj: text: Daratumumab and Hyaluronidase-fihj IDO/TDO Inhibitor HTI-1090: text: IDO/TDO Inhibitor HTI-1090 Pomegranate Liquid Extract: text: Pomegranate Liquid Extract Ex Vivo-expanded Autologous T Cells IMA101: text: Ex Vivo-expanded Autologous T Cells IMA101 Dexamethasone Sodium Phosphate: text: Dexamethasone Sodium Phosphate Pegylated SN-38 Conjugate PLX038: text: Pegylated SN-38 Conjugate PLX038 TSP-1 Mimetic Fusion Protein CVX-045: text: TSP-1 Mimetic Fusion Protein CVX-045 RET Mutation/Fusion Inhibitor BLU-667: text: RET Mutation/Fusion Inhibitor BLU-667 Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome: text: Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome NY-ESO-B: text: NY-ESO-B Pracinostat: text: Pracinostat Cytarabine Monophosphate Prodrug MB07133: text: Cytarabine Monophosphate Prodrug MB07133 Xentuzumab: text: Xentuzumab Nanoparticle-encapsulated Doxorubicin Hydrochloride: text: Nanoparticle-encapsulated Doxorubicin Hydrochloride Gataparsen Sodium: text: Gataparsen Sodium Flumatinib: text: Flumatinib EGb761: text: EGb761 Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001: text: Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001 Palonosetron Hydrochloride: text: Palonosetron Hydrochloride Abexinostat: text: Abexinostat Almurtide: text: Almurtide Topical Celecoxib: text: Topical Celecoxib Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein: text: Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein Beta-Carotene: text: Beta-Carotene Naquotinib: text: Naquotinib MCL-1 Inhibitor AMG 176: text: MCL-1 Inhibitor AMG 176 Fluorine F 18 Ara-G: text: Fluorine F 18 Ara-G SERD SHR9549: text: SERD SHR9549 DR5 HexaBody Agonist GEN1029: text: DR5 HexaBody Agonist GEN1029 Arsenic Trioxide: text: Arsenic Trioxide Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1: text: Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1 Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459: text: Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459 Foslinanib: text: Foslinanib APE1/Ref-1 Redox Inhibitor APX3330: text: APE1/Ref-1 Redox Inhibitor APX3330 VEGF Inhibitor PTC299: text: VEGF Inhibitor PTC299 Intiquinatine: text: Intiquinatine Anti-PD-1 Antibody-interleukin-21 Mutein Fusion Protein AMG 256: text: Anti-PD-1 Antibody-interleukin-21 Mutein Fusion Protein AMG 256 Acronine: text: Acronine Metarrestin: text: Metarrestin Tipiracil Hydrochloride: text: Tipiracil Hydrochloride PGLA/PEG Copolymer-Based Paclitaxel: text: PGLA/PEG Copolymer-Based Paclitaxel Methionine Aminopeptidase 2 Inhibitor PPI-2458: text: Methionine Aminopeptidase 2 Inhibitor PPI-2458 Bexmarilimab: text: Bexmarilimab Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx: text: Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx Revdofilimab: text: Revdofilimab Monoclonal Antibody 105AD7 Anti-idiotype Vaccine: text: Monoclonal Antibody 105AD7 Anti-idiotype Vaccine Duligotuzumab: text: Duligotuzumab EGFR Mutant-specific Inhibitor ZN-e4: text: EGFR Mutant-specific Inhibitor ZN-e4 Polyamine Transport Inhibitor AMXT-1501 Dicaprate: text: Polyamine Transport Inhibitor AMXT-1501 Dicaprate Estramustine: text: Estramustine Telapristone: text: Telapristone Artemisinin Dimer: text: Artemisinin Dimer Elacytarabine: text: Elacytarabine c-Met Inhibitor MK8033: text: c-Met Inhibitor MK8033 Delolimogene Mupadenorepvec: text: Delolimogene Mupadenorepvec p53-HDM2 Interaction Inhibitor MI-773: text: p53-HDM2 Interaction Inhibitor MI-773 Anti-CLDN6 Monoclonal Antibody ASP1650: text: Anti-CLDN6 Monoclonal Antibody ASP1650 TIGIT-targeting Agent MK-7684: text: TIGIT-targeting Agent MK-7684 Autologous Tumor Infiltrating Lymphocytes LN-144: text: Autologous Tumor Infiltrating Lymphocytes LN-144 Anti-TROP2 Antibody-drug Conjugate SKB264: text: Anti-TROP2 Antibody-drug Conjugate SKB264 Nurulimab: text: Nurulimab PI3K-alpha Inhibitor MEN1611: text: PI3K-alpha Inhibitor MEN1611 Tranylcypromine Sulfate: text: Tranylcypromine Sulfate Atuveciclib: text: Atuveciclib Pinatuzumab Vedotin: text: Pinatuzumab Vedotin Indibulin: text: Indibulin Dovitinib Lactate: text: Dovitinib Lactate Audencel: text: Audencel Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A: text: Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A Allogeneic CD56-positive CD3-negative Natural Killer Cells CYNK-001: text: Allogeneic CD56-positive CD3-negative Natural Killer Cells CYNK-001 Nucleoside Analog DFP-10917: text: Nucleoside Analog DFP-10917 pNGVL4a-CRT-E6E7L2 DNA Vaccine: text: pNGVL4a-CRT-E6E7L2 DNA Vaccine Leucovorin Calcium: text: Leucovorin Calcium Ontorpacept: text: Ontorpacept Esorubicin Hydrochloride: text: Esorubicin Hydrochloride NA17.A2 Peptide Vaccine: text: NA17.A2 Peptide Vaccine Pasireotide: text: Pasireotide Rovalpituzumab Tesirine: text: Rovalpituzumab Tesirine Autologous Bi-epitope BCMA-targeted CAR T-cells JNJ-68284528: text: Autologous Bi-epitope BCMA-targeted CAR T-cells JNJ-68284528 Rucaparib: text: Rucaparib Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100: text: Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100 PIM Kinase Inhibitor LGH447: text: PIM Kinase Inhibitor LGH447 Mitotenamine: text: Mitotenamine Clarithromycin: text: Clarithromycin ERK 1/2 Inhibitor ASTX029: text: ERK 1/2 Inhibitor ASTX029 GM-CSF-encoding Oncolytic Adenovirus CGTG-102: text: GM-CSF-encoding Oncolytic Adenovirus CGTG-102 Idronoxil: text: Idronoxil Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010: text: Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010 Alitretinoin: text: Alitretinoin Anti-PD-L1/IL-15 Fusion Protein KD033: text: Anti-PD-L1/IL-15 Fusion Protein KD033 Berberine Chloride: text: Berberine Chloride Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718: text: Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718 MEK Inhibitor AZD8330: text: MEK Inhibitor AZD8330 Recombinant Fas Ligand: text: Recombinant Fas Ligand Anetumab Ravtansine: text: Anetumab Ravtansine PI3K Inhibitor ACP-319: text: PI3K Inhibitor ACP-319 Anti-PD-L1 Monoclonal Antibody A167: text: Anti-PD-L1 Monoclonal Antibody A167 Multikinase Inhibitor 4SC-203: text: Multikinase Inhibitor 4SC-203 Folic Acid: text: Folic Acid Burosumab: text: Burosumab Fc-engineered Anti-CD40 Agonist Antibody 2141-V11: text: Fc-engineered Anti-CD40 Agonist Antibody 2141-V11 Semustine: text: Semustine Kunecatechins Ointment: text: Kunecatechins Ointment Serclutamab Talirine: text: Serclutamab Talirine FGFR1/2/3 Inhibitor HMPL-453: text: FGFR1/2/3 Inhibitor HMPL-453 Natural Killer Cells ZRx101: text: Natural Killer Cells ZRx101 Selective Androgen Receptor Modulator RAD140: text: Selective Androgen Receptor Modulator RAD140 Metatinib Tromethamine: text: Metatinib Tromethamine Muscadine Grape Extract: text: Muscadine Grape Extract Mibefradil: text: Mibefradil Rilotumumab: text: Rilotumumab Salmonella VNP20009: text: Salmonella VNP20009 Pemetrexed Disodium: text: Pemetrexed Disodium BCG Vaccine: text: BCG Vaccine Bozitinib: text: Bozitinib Bendamustine-containing Nanoparticle-based Formulation RXDX-107: text: Bendamustine-containing Nanoparticle-based Formulation RXDX-107 BTK Inhibitor CT-1530: text: BTK Inhibitor CT-1530 Inulin: text: Inulin Baricitinib: text: Baricitinib Indomethacin: text: Indomethacin PI3Kbeta Inhibitor AZD8186: text: PI3Kbeta Inhibitor AZD8186 Aurora Kinase Inhibitor TTP607: text: Aurora Kinase Inhibitor TTP607 Aldoxorubicin: text: Aldoxorubicin EZH2 Inhibitor CPI-1205: text: EZH2 Inhibitor CPI-1205 Anti-PD-1 Monoclonal Antibody 609A: text: Anti-PD-1 Monoclonal Antibody 609A Gelonin: text: Gelonin Ifetroban: text: Ifetroban CDC7 Kinase Inhibitor NMS-1116354: text: CDC7 Kinase Inhibitor NMS-1116354 Aminocamptothecin Colloidal Dispersion: text: Aminocamptothecin Colloidal Dispersion 2,6-Diaminopurine: text: 2,6-Diaminopurine Yttrium Y 90 Daclizumab: text: Yttrium Y 90 Daclizumab Anti-myostatin Monoclonal Antibody LY2495655: text: Anti-myostatin Monoclonal Antibody LY2495655 Herbimycin: text: Herbimycin Alacizumab Pegol: text: Alacizumab Pegol Synchrotope TA2M Plasmid DNA Vaccine: text: Synchrotope TA2M Plasmid DNA Vaccine Dendritic Cell-targeting Lentiviral Vector ID-LV305: text: Dendritic Cell-targeting Lentiviral Vector ID-LV305 Anti-CTLA-4 Monoclonal Antibody ONC-392: text: Anti-CTLA-4 Monoclonal Antibody ONC-392 Ambazone: text: Ambazone Autologous Nectin-4/FAP-targeted CAR-T Cells: text: Autologous Nectin-4/FAP-targeted CAR-T Cells Pelitrexol: text: Pelitrexol Talazoparib: text: Talazoparib STING Agonist SB 11285: text: STING Agonist SB 11285 Matuzumab: text: Matuzumab Bivalent BRD4 Inhibitor AZD5153: text: Bivalent BRD4 Inhibitor AZD5153 Iodine I 131 Monoclonal Antibody BC8: text: Iodine I 131 Monoclonal Antibody BC8 Mosedipimod: text: Mosedipimod Anti-BCMA/CD3 BiTE Antibody REGN5458: text: Anti-BCMA/CD3 BiTE Antibody REGN5458 Lumretuzumab: text: Lumretuzumab NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301: text: NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301 Acyclic Nucleoside Phosphonate Prodrug ABI-1968: text: Acyclic Nucleoside Phosphonate Prodrug ABI-1968 Eflornithine: text: Eflornithine P-TEFb Inhibitor BAY1143572: text: P-TEFb Inhibitor BAY1143572 Batabulin Sodium: text: Batabulin Sodium Protein Phosphatase 2A Inhibitor LB-100: text: Protein Phosphatase 2A Inhibitor LB-100 Anti-CEACAM5 Antibody-Drug Conjugate SAR408701: text: Anti-CEACAM5 Antibody-Drug Conjugate SAR408701 5-Fluoro-2-Deoxycytidine: text: 5-Fluoro-2-Deoxycytidine 2-Ethylhydrazide: text: 2-Ethylhydrazide TLR Agonist BSG-001: text: TLR Agonist BSG-001 Nimotuzumab: text: Nimotuzumab Iodine I 131 Ethiodized Oil: text: Iodine I 131 Ethiodized Oil Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707: text: Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707 Spebrutinib: text: Spebrutinib Idetrexed: text: Idetrexed Vinblastine: text: Vinblastine 11C Topotecan: text: 11C Topotecan Budigalimab: text: Budigalimab Concentrated Lingzhi Mushroom Extract: text: Concentrated Lingzhi Mushroom Extract pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2: text: pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2 Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A: text: Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A Zolbetuximab: text: Zolbetuximab Anti-FCRH5/CD3 BiTE Antibody BFCR4350A: text: Anti-FCRH5/CD3 BiTE Antibody BFCR4350A 4-Thio-2-deoxycytidine: text: 4-Thio-2-deoxycytidine Encapsulated Rapamycin: text: Encapsulated Rapamycin Radix Angelicae Sinensis/Radix Astragali Herbal Supplement: text: Radix Angelicae Sinensis/Radix Astragali Herbal Supplement ERK Inhibitor CC-90003: text: ERK Inhibitor CC-90003 Veliparib: text: Veliparib Tigapotide: text: Tigapotide Carzelesin: text: Carzelesin Altiratinib: text: Altiratinib Orteronel: text: Orteronel Esterified Estrogens: text: Esterified Estrogens WT1-A10/AS01B Immunotherapeutic GSK2130579A: text: WT1-A10/AS01B Immunotherapeutic GSK2130579A EGFR Inhibitor DBPR112: text: EGFR Inhibitor DBPR112 Cyclophosphamide: text: Cyclophosphamide Andecaliximab: text: Andecaliximab PKC-alpha Antisense Oligodeoxynucleotide ISIS 3521: text: PKC-alpha Antisense Oligodeoxynucleotide ISIS 3521 ARC Fusion Protein SL-279252: text: ARC Fusion Protein SL-279252 Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2: text: Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2 Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001: text: Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001 Sofituzumab Vedotin: text: Sofituzumab Vedotin Anti-CSF1 Monoclonal Antibody PD-0360324: text: Anti-CSF1 Monoclonal Antibody PD-0360324 Tamoxifen: text: Tamoxifen Pasotuxizumab: text: Pasotuxizumab Megestrol Acetate: text: Megestrol Acetate Rolinsatamab Talirine: text: Rolinsatamab Talirine LMP7 Inhibitor M3258: text: LMP7 Inhibitor M3258 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatases Isoform 3 Inhibitor ACT-PFK-158: text: 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatases Isoform 3 Inhibitor ACT-PFK-158 Melphalan Flufenamide: text: Melphalan Flufenamide STAT3 Inhibitor DSP-0337: text: STAT3 Inhibitor DSP-0337 Antineoplaston AS2-1: text: Antineoplaston AS2-1 Recombinant Tumor Necrosis Factor-Alpha: text: Recombinant Tumor Necrosis Factor-Alpha Delanzomib: text: Delanzomib Anti-c-Met Monoclonal Antibody ARGX-111: text: Anti-c-Met Monoclonal Antibody ARGX-111 Retaspimycin: text: Retaspimycin Roblitinib: text: Roblitinib Breflate: text: Breflate Paclitaxel-Loaded Polymeric Micelle: text: Paclitaxel-Loaded Polymeric Micelle ERK1/2 Inhibitor LY3214996: text: ERK1/2 Inhibitor LY3214996 Safingol: text: Safingol Anti-LAG3 Monoclonal Antibody TSR-033: text: Anti-LAG3 Monoclonal Antibody TSR-033 Camrelizumab: text: Camrelizumab Onartuzumab: text: Onartuzumab Rigosertib: text: Rigosertib Double-armed TMZ-CD40L/4-1BBL Oncolytic Ad5/35 Adenovirus LOAd703: text: Double-armed TMZ-CD40L/4-1BBL Oncolytic Ad5/35 Adenovirus LOAd703 LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine ADXS31-164: text: LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine ADXS31-164 BRAF(V600E) Kinase Inhibitor RO5212054: text: BRAF(V600E) Kinase Inhibitor RO5212054 Belinostat: text: Belinostat Balixafortide: text: Balixafortide Anti-TIGIT Monoclonal Antibody BMS-986207: text: Anti-TIGIT Monoclonal Antibody BMS-986207 Pamidronate Disodium: text: Pamidronate Disodium Amrubicin Hydrochloride: text: Amrubicin Hydrochloride Pan-Mutant-IDH1 Inhibitor Bay-1436032: text: Pan-Mutant-IDH1 Inhibitor Bay-1436032 c-Met Inhibitor ABN401: text: c-Met Inhibitor ABN401 Ulocuplumab: text: Ulocuplumab TRPV6 Calcium Channel Inhibitor SOR-C13: text: TRPV6 Calcium Channel Inhibitor SOR-C13 Anti-angiopoietin Monoclonal Antibody AMG 780: text: Anti-angiopoietin Monoclonal Antibody AMG 780 Etidronate-Cytarabine Conjugate MBC-11: text: Etidronate-Cytarabine Conjugate MBC-11 CD11b Agonist GB1275: text: CD11b Agonist GB1275 Methotrexate Sodium: text: Methotrexate Sodium Serplulimab: text: Serplulimab Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19: text: Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19 EGFR Inhibitor TY-9591: text: EGFR Inhibitor TY-9591 Prinomastat: text: Prinomastat Calcitriol: text: Calcitriol Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001: text: Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001 FAK Inhibitor GSK2256098: text: FAK Inhibitor GSK2256098 Anti-TIM-3 Monoclonal Antibody INCAGN02390: text: Anti-TIM-3 Monoclonal Antibody INCAGN02390 Taminadenant: text: Taminadenant Formestane: text: Formestane Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A: text: Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A Enoticumab: text: Enoticumab Dendritic Cell Vaccine: text: Dendritic Cell Vaccine Oral Myoma Vaccine V3-myoma: text: Oral Myoma Vaccine V3-myoma Aurora A Kinase Inhibitor TAS-119: text: Aurora A Kinase Inhibitor TAS-119 Lenvatinib Mesylate: text: Lenvatinib Mesylate Anti-CD20 Monoclonal Antibody TL011: text: Anti-CD20 Monoclonal Antibody TL011 Beta-Glucan: text: Beta-Glucan Anti-OX40 Hexavalent Agonist Antibody INBRX-106: text: Anti-OX40 Hexavalent Agonist Antibody INBRX-106 XIAP Antisense Oligonucleotide AEG35156: text: XIAP Antisense Oligonucleotide AEG35156 Xiaoai Jiedu Decoction: text: Xiaoai Jiedu Decoction Toll-like Receptor 7 Agonist DSP-0509: text: Toll-like Receptor 7 Agonist DSP-0509 Heterodimeric Interleukin-15: text: Heterodimeric Interleukin-15 hTERT-encoding DNA Vaccine INVAC-1: text: hTERT-encoding DNA Vaccine INVAC-1 I 131 Monoclonal Antibody F19: text: I 131 Monoclonal Antibody F19 Linoleyl Carbonate-Paclitaxel: text: Linoleyl Carbonate-Paclitaxel Superoxide Dismutase Mimetic GC4711: text: Superoxide Dismutase Mimetic GC4711 Carlumab: text: Carlumab Iodine I 131 Apamistamab: text: Iodine I 131 Apamistamab Namirotene: text: Namirotene Broccoli Sprout/Broccoli Seed Extract Supplement: text: Broccoli Sprout/Broccoli Seed Extract Supplement Anti-CD22 Monoclonal Antibody-MMAE Conjugate DCDT2980S: text: Anti-CD22 Monoclonal Antibody-MMAE Conjugate DCDT2980S Murizatoclax: text: Murizatoclax Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes: text: Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes Prostaglandin E2 EP4 Receptor Inhibitor AN0025: text: Prostaglandin E2 EP4 Receptor Inhibitor AN0025 Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968: text: Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968 Polymer-conjugated IL-15 Receptor Agonist NKTR-255: text: Polymer-conjugated IL-15 Receptor Agonist NKTR-255 Light-Emitting Oncolytic Vaccinia Virus GL-ONC1: text: Light-Emitting Oncolytic Vaccinia Virus GL-ONC1 Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01: text: Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01 Gimatecan: text: Gimatecan Rexinoid NRX 194204: text: Rexinoid NRX 194204 Dimethylmyleran: text: Dimethylmyleran Tetrathiomolybdate: text: Tetrathiomolybdate Anti-CTLA-4 Monoclonal Antibody REGN4659: text: Anti-CTLA-4 Monoclonal Antibody REGN4659 Dubermatinib: text: Dubermatinib Melapuldencel-T: text: Melapuldencel-T Iodine I 131 Rituximab: text: Iodine I 131 Rituximab Anti-CD123 ADC IMGN632: text: Anti-CD123 ADC IMGN632 Bruceanol E: text: Bruceanol E Anti-EGFR Monoclonal Antibody Mixture MM-151: text: Anti-EGFR Monoclonal Antibody Mixture MM-151 Folate Receptor-Targeted Tubulysin Conjugate EC1456: text: Folate Receptor-Targeted Tubulysin Conjugate EC1456 Ditiocarb: text: Ditiocarb TLC ELL-12: text: TLC ELL-12 Anti-PD-L1 Monoclonal Antibody SHR-1316: text: Anti-PD-L1 Monoclonal Antibody SHR-1316 Clinical Trial: text: Clinical Trial CD73 Inhibitor LY3475070: text: CD73 Inhibitor LY3475070 HDAC Inhibitor CKD-581: text: HDAC Inhibitor CKD-581 Phosphorus P-32: text: Phosphorus P-32 Folitixorin: text: Folitixorin Mechlorethamine: text: Mechlorethamine Recombinant Erwinia asparaginase JZP-458: text: Recombinant Erwinia asparaginase JZP-458 Magrolimab: text: Magrolimab Luminespib Mesylate: text: Luminespib Mesylate Rosmantuzumab: text: Rosmantuzumab Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307: text: Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307 Zorubicin: text: Zorubicin Sumoylation Inhibitor TAK-981: text: Sumoylation Inhibitor TAK-981 Smoothened Antagonist BMS-833923: text: Smoothened Antagonist BMS-833923 Oncolytic HSV-1 G207: text: Oncolytic HSV-1 G207 Anti-BCMA Antibody-drug Conjugate AMG 224: text: Anti-BCMA Antibody-drug Conjugate AMG 224 Sotrastaurin: text: Sotrastaurin Larotrectinib: text: Larotrectinib Matrix Metalloproteinase Inhibitor MMI270: text: Matrix Metalloproteinase Inhibitor MMI270 Azapicyl: text: Azapicyl Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044: text: Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044 Vismodegib: text: Vismodegib Praluzatamab Ravtansine: text: Praluzatamab Ravtansine Anti-CD40 Monoclonal Antibody SEA-CD40: text: Anti-CD40 Monoclonal Antibody SEA-CD40 IAP Inhibitor AT-406: text: IAP Inhibitor AT-406 Etaracizumab: text: Etaracizumab ssRNA-based Immunomodulator CV8102: text: ssRNA-based Immunomodulator CV8102 Thorium Th 227 Anetumab: text: Thorium Th 227 Anetumab Afatinib Dimaleate: text: Afatinib Dimaleate Shark Cartilage: text: Shark Cartilage Iridium Ir 192: text: Iridium Ir 192 Teloxantrone Hydrochloride: text: Teloxantrone Hydrochloride Innate Immunostimulator rBBX-01: text: Innate Immunostimulator rBBX-01 MET Tyrosine Kinase Inhibitor SGX523: text: MET Tyrosine Kinase Inhibitor SGX523 Asulacrine: text: Asulacrine Anti-CD137 Agonistic Monoclonal Antibody ATOR-1017: text: Anti-CD137 Agonistic Monoclonal Antibody ATOR-1017 Tislelizumab: text: Tislelizumab ALK Inhibitor WX-0593: text: ALK Inhibitor WX-0593 Docetaxel Polymeric Micelles: text: Docetaxel Polymeric Micelles Vinflunine Ditartrate: text: Vinflunine Ditartrate CDK2/5/9 Inhibitor CYC065: text: CDK2/5/9 Inhibitor CYC065 Sodium Metaarsenite: text: Sodium Metaarsenite PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate: text: PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate Decitabine: text: Decitabine Anti-EGFR Monoclonal Antibody HLX-07: text: Anti-EGFR Monoclonal Antibody HLX-07 FACT Complex-targeting Curaxin CBL0137: text: FACT Complex-targeting Curaxin CBL0137 Anti-CTLA4 Antibody Fc Fusion Protein KN044: text: Anti-CTLA4 Antibody Fc Fusion Protein KN044 Depatuxizumab: text: Depatuxizumab Samalizumab: text: Samalizumab Sitravatinib: text: Sitravatinib Resveratrol Formulation SRT501: text: Resveratrol Formulation SRT501 Anti-IL-13 Humanized Monoclonal Antibody TNX-650: text: Anti-IL-13 Humanized Monoclonal Antibody TNX-650 Cyproterone Acetate: text: Cyproterone Acetate Monoclonal Antibody 7C11: text: Monoclonal Antibody 7C11 Inositol: text: Inositol Rebimastat: text: Rebimastat Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6: text: Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6 Erastin Analogue PRLX 93936: text: Erastin Analogue PRLX 93936 Nicotinamide Riboside: text: Nicotinamide Riboside Clivatuzumab: text: Clivatuzumab Shu Yu Wan Formula: text: Shu Yu Wan Formula CDK8/19 Inhibitor SEL 120: text: CDK8/19 Inhibitor SEL 120 Piperine Extract (Standardized): text: Piperine Extract (Standardized) CYP11A1 inhibitor ODM-208: text: CYP11A1 inhibitor ODM-208 Autologous Anti-CD19 Chimeric Antigen Receptor T-cells AUTO1: text: Autologous Anti-CD19 Chimeric Antigen Receptor T-cells AUTO1 AXL Inhibitor SLC-391: text: AXL Inhibitor SLC-391 Troxacitabine: text: Troxacitabine Manelimab: text: Manelimab Idarubicin: text: Idarubicin Pingyangmycin: text: Pingyangmycin Telratolimod: text: Telratolimod Onalespib: text: Onalespib Talampanel: text: Talampanel Dulanermin: text: Dulanermin Itacitinib: text: Itacitinib Falimarev: text: Falimarev PARP7 Inhibitor RBN-2397: text: PARP7 Inhibitor RBN-2397 Recombinant MAGE-3.1 Antigen: text: Recombinant MAGE-3.1 Antigen ERK Inhibitor MK-8353: text: ERK Inhibitor MK-8353 Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A: text: Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A Yttrium Y 90 Glass Microspheres: text: Yttrium Y 90 Glass Microspheres Anti-CTLA-4 Monoclonal Antibody AGEN1181: text: Anti-CTLA-4 Monoclonal Antibody AGEN1181 Eniluracil/5-FU Combination Tablet: text: Eniluracil/5-FU Combination Tablet Imetelstat Sodium: text: Imetelstat Sodium mTOR Kinase Inhibitor AZD8055: text: mTOR Kinase Inhibitor AZD8055 Aclacinomycin B: text: Aclacinomycin B Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001: text: Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001 Piroxantrone Hydrochloride: text: Piroxantrone Hydrochloride Pegilodecakin: text: Pegilodecakin Talacotuzumab: text: Talacotuzumab Carzinophilin: text: Carzinophilin Antineoplastic Vaccine: text: Antineoplastic Vaccine Binetrakin: text: Binetrakin Iodine I 131 MIP-1095: text: Iodine I 131 MIP-1095 Agonistic Anti-OX40 Monoclonal Antibody MEDI6469: text: Agonistic Anti-OX40 Monoclonal Antibody MEDI6469 PLK1 Inhibitor CYC140: text: PLK1 Inhibitor CYC140 Gamma-Secretase Inhibitor LY3039478: text: Gamma-Secretase Inhibitor LY3039478 Astuprotimut-R: text: Astuprotimut-R Birabresib: text: Birabresib Cathelicidin LL-37: text: Cathelicidin LL-37 Irinotecan: text: Irinotecan Suramin Sodium: text: Suramin Sodium Perfosfamide: text: Perfosfamide Anti-AXL/PBD Antibody-drug Conjugate ADCT-601: text: Anti-AXL/PBD Antibody-drug Conjugate ADCT-601 XPO1 Inhibitor SL-801: text: XPO1 Inhibitor SL-801 Mesna: text: Mesna Recombinant Fractalkine: text: Recombinant Fractalkine Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM: text: Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM Allosteric ErbB Inhibitor BDTX-189: text: Allosteric ErbB Inhibitor BDTX-189 Gilteritinib Fumarate: text: Gilteritinib Fumarate CD20-CD19 Compound CAR T Cells: text: CD20-CD19 Compound CAR T Cells CDK4/6 Inhibitor SHR6390: text: CDK4/6 Inhibitor SHR6390 ALK Inhibitor RO5424802: text: ALK Inhibitor RO5424802 Anti-CD137 Agonistic Monoclonal Antibody LVGN6051: text: Anti-CD137 Agonistic Monoclonal Antibody LVGN6051 Anti-CD47 Monoclonal Antibody SRF231: text: Anti-CD47 Monoclonal Antibody SRF231 Oxaliplatin Eluting Beads: text: Oxaliplatin Eluting Beads Zotiraciclib Citrate: text: Zotiraciclib Citrate Gossypol: text: Gossypol Becatecarin: text: Becatecarin BET Inhibitor FT-1101: text: BET Inhibitor FT-1101 Sparfosate Sodium: text: Sparfosate Sodium Nivolumab: text: Nivolumab Neoantigen Vaccine GEN-009: text: Neoantigen Vaccine GEN-009 Anti-CD40L Fc-Fusion Protein BMS-986004: text: Anti-CD40L Fc-Fusion Protein BMS-986004 Vascular Disrupting Agent ZD6126: text: Vascular Disrupting Agent ZD6126 Temoporfin: text: Temoporfin Milademetan Tosylate: text: Milademetan Tosylate Elgemtumab: text: Elgemtumab Anti-HER2-vc0101 ADC PF-06804103: text: Anti-HER2-vc0101 ADC PF-06804103 Tisagenlecleucel: text: Tisagenlecleucel Autologous Anti-FLT3 CAR T Cells AMG 553: text: Autologous Anti-FLT3 CAR T Cells AMG 553 Hexaminolevulinate: text: Hexaminolevulinate Asaley: text: Asaley mTOR Kinase Inhibitor OSI-027: text: mTOR Kinase Inhibitor OSI-027 TLR9 Agonist AST-008: text: TLR9 Agonist AST-008 BET Inhibitor BAY1238097: text: BET Inhibitor BAY1238097 Echinomycin: text: Echinomycin Golvatinib: text: Golvatinib Tretazicar: text: Tretazicar Givinostat: text: Givinostat Adenoviral Brachyury Vaccine ETBX-051: text: Adenoviral Brachyury Vaccine ETBX-051 Rituximab and Hyaluronidase Human: text: Rituximab and Hyaluronidase Human Recombinant Interleukin-12: text: Recombinant Interleukin-12 MetAP2 Inhibitor APL-1202: text: MetAP2 Inhibitor APL-1202 Short Chain Fatty Acid HQK-1004: text: Short Chain Fatty Acid HQK-1004 FGFR Inhibitor TAS-120: text: FGFR Inhibitor TAS-120 Melphalan Hydrochloride: text: Melphalan Hydrochloride Bufalin: text: Bufalin Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202: text: Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202 Budotitane: text: Budotitane Glucocorticoid Receptor Antagonist ORIC-101: text: Glucocorticoid Receptor Antagonist ORIC-101 Mureletecan: text: Mureletecan Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01: text: Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01 Mycophenolic Acid: text: Mycophenolic Acid Src Kinase Inhibitor AP 23846: text: Src Kinase Inhibitor AP 23846 Fadraciclib: text: Fadraciclib ASP4132: text: ASP4132 Anti-GnRH Vaccine PEP223: text: Anti-GnRH Vaccine PEP223 Bosutinib: text: Bosutinib BET Inhibitor INCB054329: text: BET Inhibitor INCB054329 Darleukin: text: Darleukin Arnebia Indigo Jade Pearl Topical Cream: text: Arnebia Indigo Jade Pearl Topical Cream HPV-16 E6 Peptides Vaccine/Candida albicans Extract: text: HPV-16 E6 Peptides Vaccine/Candida albicans Extract Puromycin: text: Puromycin Tezacitabine: text: Tezacitabine Tipapkinogene Sovacivec: text: Tipapkinogene Sovacivec Ancitabine Hydrochloride: text: Ancitabine Hydrochloride Cabazitaxel: text: Cabazitaxel Tomato-Soy Juice: text: Tomato-Soy Juice MKC-1: text: MKC-1 Ilixadencel: text: Ilixadencel Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327: text: Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327 Entospletinib: text: Entospletinib Cereblon Modulator CC-90009: text: Cereblon Modulator CC-90009 Anthrapyrazole: text: Anthrapyrazole Filgotinib: text: Filgotinib Pegargiminase: text: Pegargiminase Vorsetzumab Mafodotin: text: Vorsetzumab Mafodotin Rubitecan: text: Rubitecan Anti-CD20 Monoclonal Antibody SCT400: text: Anti-CD20 Monoclonal Antibody SCT400 Selective Estrogen Receptor Degrader LSZ102: text: Selective Estrogen Receptor Degrader LSZ102 Hafnium Oxide-containing Nanoparticles NBTXR3: text: Hafnium Oxide-containing Nanoparticles NBTXR3 Monoclonal Antibody D6.12: text: Monoclonal Antibody D6.12 Pentamustine: text: Pentamustine Anti-NaPi2b Monoclonal Antibody XMT-1535: text: Anti-NaPi2b Monoclonal Antibody XMT-1535 Lipid Nanoparticle Encapsulated OX40L mRNA-2416: text: Lipid Nanoparticle Encapsulated OX40L mRNA-2416 Vandetanib: text: Vandetanib GSK-3 Inhibitor 9-ING-41: text: GSK-3 Inhibitor 9-ING-41 Akt Inhibitor MK2206: text: Akt Inhibitor MK2206 Bcr-Abl Kinase Inhibitor K0706: text: Bcr-Abl Kinase Inhibitor K0706 RORgamma Agonist LYC-55716: text: RORgamma Agonist LYC-55716 Anti-CD27 Agonistic Monoclonal Antibody MK-5890: text: Anti-CD27 Agonistic Monoclonal Antibody MK-5890 FAP/4-1BB-targeting DARPin MP0310: text: FAP/4-1BB-targeting DARPin MP0310 Tanibirumab: text: Tanibirumab MDM2 Inhibitor KRT-232: text: MDM2 Inhibitor KRT-232 Antibody-drug Conjugate SC-003: text: Antibody-drug Conjugate SC-003 Flotetuzumab: text: Flotetuzumab Soy Protein Isolate: text: Soy Protein Isolate Retinoid 9cUAB30: text: Retinoid 9cUAB30 Androgen Receptor Degrader CC-94676: text: Androgen Receptor Degrader CC-94676 Radiolabeled CC49: text: Radiolabeled CC49 Serdemetan: text: Serdemetan CYP17/CYP11B2 Inhibitor LAE001: text: CYP17/CYP11B2 Inhibitor LAE001 FAK Inhibitor PF-00562271: text: FAK Inhibitor PF-00562271 Tucotuzumab Celmoleukin: text: Tucotuzumab Celmoleukin IAP Inhibitor HGS1029: text: IAP Inhibitor HGS1029 Yttrium Y 90 Basiliximab: text: Yttrium Y 90 Basiliximab Carfilzomib: text: Carfilzomib Galamustine: text: Galamustine STING-activating Cyclic Dinucleotide Agonist MIW815: text: STING-activating Cyclic Dinucleotide Agonist MIW815 Donafenib: text: Donafenib Ribozyme RPI.4610: text: Ribozyme RPI.4610 Anti-PD-L1 Monoclonal Antibody IMC-001: text: Anti-PD-L1 Monoclonal Antibody IMC-001 Inebilizumab: text: Inebilizumab Ensartinib: text: Ensartinib Personalized Neoepitope Yeast Vaccine YE-NEO-001: text: Personalized Neoepitope Yeast Vaccine YE-NEO-001 Monoclonal Antibody 11D10 Anti-Idiotype Vaccine: text: Monoclonal Antibody 11D10 Anti-Idiotype Vaccine Etigilimab: text: Etigilimab Vofatamab: text: Vofatamab Long-acting Release Pasireotide: text: Long-acting Release Pasireotide PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1: text: PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1 Acodazole: text: Acodazole Brimonidine Tartrate Nanoemulsion OCU-300: text: Brimonidine Tartrate Nanoemulsion OCU-300 Metoprine: text: Metoprine Pegylated Liposomal Mitomycin C Lipid-based Prodrug: text: Pegylated Liposomal Mitomycin C Lipid-based Prodrug Dusigitumab: text: Dusigitumab mRNA-derived KRAS-targeted Vaccine V941: text: mRNA-derived KRAS-targeted Vaccine V941 Momelotinib: text: Momelotinib Cisplatin Liposomal: text: Cisplatin Liposomal Topotecan Hydrochloride: text: Topotecan Hydrochloride mTORC 1/2 Inhibitor LXI-15029: text: mTORC 1/2 Inhibitor LXI-15029 Gemcitabine-Releasing Intravesical System: text: Gemcitabine-Releasing Intravesical System Motexafin Lutetium: text: Motexafin Lutetium Doxorubicin-HPMA Conjugate: text: Doxorubicin-HPMA Conjugate Autologous Tumor Infiltrating Lymphocytes MDA-TIL: text: Autologous Tumor Infiltrating Lymphocytes MDA-TIL Gemcitabine: text: Gemcitabine Pan-FGFR Inhibitor LY2874455: text: Pan-FGFR Inhibitor LY2874455 Pioglitazone: text: Pioglitazone Protein Kinase C Inhibitor IDE196: text: Protein Kinase C Inhibitor IDE196 Tetrahydrouridine: text: Tetrahydrouridine Gedatolisib: text: Gedatolisib Xeloda: text: Xeloda Amcasertib: text: Amcasertib Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1: text: Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1 Actinium Ac 225 Lintuzumab: text: Actinium Ac 225 Lintuzumab TRAIL Receptor Agonist ABBV-621: text: TRAIL Receptor Agonist ABBV-621 Mivebresib: text: Mivebresib Diethylnorspermine: text: Diethylnorspermine DHEA Mustard: text: DHEA Mustard Copanlisib Hydrochloride: text: Copanlisib Hydrochloride Deuterated Enzalutamide: text: Deuterated Enzalutamide Ragifilimab: text: Ragifilimab Plocabulin: text: Plocabulin Allogeneic Anti-BCMA-CAR T-cells PBCAR269A: text: Allogeneic Anti-BCMA-CAR T-cells PBCAR269A Topical Gemcitabine Hydrochloride: text: Topical Gemcitabine Hydrochloride Devimistat: text: Devimistat Fluorouracil: text: Fluorouracil Anti-human GITR Monoclonal Antibody TRX518: text: Anti-human GITR Monoclonal Antibody TRX518 Zorifertinib: text: Zorifertinib pan-PIM Kinase Inhibitor AZD1208: text: pan-PIM Kinase Inhibitor AZD1208 Perillyl Alcohol: text: Perillyl Alcohol Atiprimod Dimaleate: text: Atiprimod Dimaleate Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142: text: Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142 Bcr-Abl Kinase Inhibitor PF-114: text: Bcr-Abl Kinase Inhibitor PF-114 Anti-BCMA Antibody SEA-BCMA: text: Anti-BCMA Antibody SEA-BCMA Tucidinostat: text: Tucidinostat Anti-c-KIT Monoclonal Antibody CDX 0158: text: Anti-c-KIT Monoclonal Antibody CDX 0158 Lapachone: text: Lapachone Carubicin: text: Carubicin Attenuated Listeria monocytogenes CRS-100: text: Attenuated Listeria monocytogenes CRS-100 Rosabulin: text: Rosabulin Activin Type 2B Receptor Fc Fusion Protein STM 434: text: Activin Type 2B Receptor Fc Fusion Protein STM 434 Chimeric Monoclonal Antibody 81C6: text: Chimeric Monoclonal Antibody 81C6 Anti-CD47 Monoclonal Antibody IMC-002: text: Anti-CD47 Monoclonal Antibody IMC-002 DNA-PK/PI3K-delta Inhibitor BR101801: text: DNA-PK/PI3K-delta Inhibitor BR101801 Anti-alpha5beta1 Integrin Antibody MINT1526A: text: Anti-alpha5beta1 Integrin Antibody MINT1526A Anti-PLGF Monoclonal Antibody TB-403: text: Anti-PLGF Monoclonal Antibody TB-403 Raloxifene: text: Raloxifene Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A: text: Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A Hedgehog Inhibitor IPI-609: text: Hedgehog Inhibitor IPI-609 Inecalcitol: text: Inecalcitol Vinorelbine Tartrate Emulsion: text: Vinorelbine Tartrate Emulsion Tamrintamab Pamozirine: text: Tamrintamab Pamozirine Virulizin: text: Virulizin Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002: text: Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002 Darinaparsin: text: Darinaparsin Pelareorep: text: Pelareorep Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C: text: Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C Salirasib: text: Salirasib Membrane-Disrupting Peptide EP-100: text: Membrane-Disrupting Peptide EP-100 Selective Estrogen Receptor Degrader AZD9833: text: Selective Estrogen Receptor Degrader AZD9833 Fluvastatin Sodium: text: Fluvastatin Sodium Anti-EGFR Monoclonal Antibody CPGJ 602: text: Anti-EGFR Monoclonal Antibody CPGJ 602 Cositecan: text: Cositecan Anti-CD47 Monoclonal Antibody AO-176: text: Anti-CD47 Monoclonal Antibody AO-176 Nimesulide-Hyaluronic Acid Conjugate CA102N: text: Nimesulide-Hyaluronic Acid Conjugate CA102N Digoxin: text: Digoxin Pegdinetanib: text: Pegdinetanib IL4-Pseudomonas Exotoxin Fusion Protein MDNA55: text: IL4-Pseudomonas Exotoxin Fusion Protein MDNA55 Epitiostanol: text: Epitiostanol Simlukafusp Alfa: text: Simlukafusp Alfa 14C BMS-275183: text: 14C BMS-275183 Anti-IL-8 Monoclonal Antibody BMS-986253: text: Anti-IL-8 Monoclonal Antibody BMS-986253 Ganoderma lucidum Spores Powder Capsule: text: Ganoderma lucidum Spores Powder Capsule Methylprednisolone Acetate: text: Methylprednisolone Acetate Autologous Tetravalent Dendritic Cell Vaccine MIDRIX4-LUNG: text: Autologous Tetravalent Dendritic Cell Vaccine MIDRIX4-LUNG Apalutamide: text: Apalutamide Porcupine Inhibitor XNW7201: text: Porcupine Inhibitor XNW7201 Androgen Antagonist APC-100: text: Androgen Antagonist APC-100 Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12: text: Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12 Anti-CD47 Monoclonal Antibody TJC4: text: Anti-CD47 Monoclonal Antibody TJC4 Aerosolized Aldesleukin: text: Aerosolized Aldesleukin CXCR4 Antagonist USL311: text: CXCR4 Antagonist USL311 Lung-targeted Immunomodulator QBKPN: text: Lung-targeted Immunomodulator QBKPN Oral Pancreatic Cancer Vaccine V3-P: text: Oral Pancreatic Cancer Vaccine V3-P Iodine I 131 IPA: text: Iodine I 131 IPA Anti-Met Monoclonal Antibody Mixture Sym015: text: Anti-Met Monoclonal Antibody Mixture Sym015 Angiogenesis Inhibitor JI-101: text: Angiogenesis Inhibitor JI-101 Angiopoietin-2-specific Fusion Protein PF-04856884: text: Angiopoietin-2-specific Fusion Protein PF-04856884 Prexasertib: text: Prexasertib Synthetic Hypericin: text: Synthetic Hypericin Hydroxytyrosol: text: Hydroxytyrosol Esorubicin: text: Esorubicin Pancratistatin: text: Pancratistatin C-myb Antisense Oligonucleotide G4460: text: C-myb Antisense Oligonucleotide G4460 Eicosapentaenoic Acid: text: Eicosapentaenoic Acid Laprituximab Emtansine: text: Laprituximab Emtansine Fazarabine: text: Fazarabine Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130: text: Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130 Felzartamab: text: Felzartamab Patritumab Deruxtecan: text: Patritumab Deruxtecan Liposomal Cytarabine: text: Liposomal Cytarabine Plicamycin: text: Plicamycin Monoclonal Microbial EDP1503: text: Monoclonal Microbial EDP1503 Topical Potassium Dobesilate: text: Topical Potassium Dobesilate Silicon Phthalocyanine 4: text: Silicon Phthalocyanine 4 Topsalysin: text: Topsalysin Submicron Particle Paclitaxel Sterile Suspension: text: Submicron Particle Paclitaxel Sterile Suspension Prohibitin-Targeting Peptide 1: text: Prohibitin-Targeting Peptide 1 Omacetaxine Mepesuccinate: text: Omacetaxine Mepesuccinate Ipatasertib: text: Ipatasertib Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201: text: Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201 mRNA-Derived Prostate Cancer Vaccine CV9103: text: mRNA-Derived Prostate Cancer Vaccine CV9103 CCR2 Antagonist CCX872-B: text: CCR2 Antagonist CCX872-B Dienogest: text: Dienogest MEK Inhibitor CI-1040: text: MEK Inhibitor CI-1040 Nimustine: text: Nimustine Treosulfan: text: Treosulfan Monoclonal Antibody 3622W94: text: Monoclonal Antibody 3622W94 BET Inhibitor BMS-986158: text: BET Inhibitor BMS-986158 Heparan Sulfate Glycosaminoglycan Mimetic M402: text: Heparan Sulfate Glycosaminoglycan Mimetic M402 Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126: text: Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126 Asciminib: text: Asciminib Tubulin Polymerization Inhibitor AEZS 112: text: Tubulin Polymerization Inhibitor AEZS 112 Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01: text: Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01 Dacarbazine: text: Dacarbazine Onvansertib: text: Onvansertib Didox: text: Didox Carotuximab: text: Carotuximab Varlitinib Tosylate: text: Varlitinib Tosylate Topical Trichloroacetic Acid: text: Topical Trichloroacetic Acid Edelfosine: text: Edelfosine Aryl Hydrocarbon Receptor Inhibitor IK-175: text: Aryl Hydrocarbon Receptor Inhibitor IK-175 Abemaciclib: text: Abemaciclib Pamiparib: text: Pamiparib Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate: text: Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate Folate-FITC: text: Folate-FITC BRAF Inhibitor BGB-3245: text: BRAF Inhibitor BGB-3245 Avadomide: text: Avadomide Bazlitoran: text: Bazlitoran 2-Deoxy-D-glucose: text: 2-Deoxy-D-glucose Anti-CD19/CD22 CAR NK Cells: text: Anti-CD19/CD22 CAR NK Cells Tolebrutinib: text: Tolebrutinib Autologous TCR-engineered T-cells IMA203: text: Autologous TCR-engineered T-cells IMA203 Resiquimod Topical Gel: text: Resiquimod Topical Gel Bromocriptine Mesylate: text: Bromocriptine Mesylate Belotecan Hydrochloride: text: Belotecan Hydrochloride Heparin Derivative SST0001: text: Heparin Derivative SST0001 Microtubule Inhibitor SCB01A: text: Microtubule Inhibitor SCB01A Letetresgene Autoleucel: text: Letetresgene Autoleucel Navy Bean Powder: text: Navy Bean Powder APC8015F: text: APC8015F Notch Signaling Pathway Inhibitor MK0752: text: Notch Signaling Pathway Inhibitor MK0752 Anti-DR5 Agonistic Monoclonal Antibody INBRX-109: text: Anti-DR5 Agonistic Monoclonal Antibody INBRX-109 LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1: text: LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1 Serabelisib: text: Serabelisib Thioureidobutyronitrile: text: Thioureidobutyronitrile Copanlisib: text: Copanlisib Derazantinib: text: Derazantinib Rhizoxin: text: Rhizoxin Methazolamide: text: Methazolamide Risperidone Formulation in Rumenic Acid: text: Risperidone Formulation in Rumenic Acid Anti-GD2 hu3F8/Anti-CD3 huOKT3 Bispecific Antibody: text: Anti-GD2 hu3F8/Anti-CD3 huOKT3 Bispecific Antibody Anti-CD40 Agonist Monoclonal Antibody ABBV-927: text: Anti-CD40 Agonist Monoclonal Antibody ABBV-927 Molibresib: text: Molibresib Tropomyosin Receptor Kinase Inhibitor AZD7451: text: Tropomyosin Receptor Kinase Inhibitor AZD7451 Dezaguanine: text: Dezaguanine Andrographolide: text: Andrographolide Odronextamab: text: Odronextamab Gonadotropin-releasing Hormone Analog: text: Gonadotropin-releasing Hormone Analog SRPK1/ABCG2 Inhibitor SCO-101: text: SRPK1/ABCG2 Inhibitor SCO-101 Staphylococcal Enterotoxin B: text: Staphylococcal Enterotoxin B Anti-EGFRvIII/CD3 BiTE Antibody AMG 596: text: Anti-EGFRvIII/CD3 BiTE Antibody AMG 596 Etanidazole: text: Etanidazole Atezolizumab: text: Atezolizumab Anti-Ribonucleoprotein Antibody ATRC-101: text: Anti-Ribonucleoprotein Antibody ATRC-101 Mogamulizumab: text: Mogamulizumab JNK Inhibitor CC-401: text: JNK Inhibitor CC-401 Denibulin Hydrochloride: text: Denibulin Hydrochloride Danvatirsen: text: Danvatirsen Anti-HBEGF Monoclonal Antibody U3-1565: text: Anti-HBEGF Monoclonal Antibody U3-1565 Anthramycin: text: Anthramycin Mechlorethamine Hydrochloride Gel: text: Mechlorethamine Hydrochloride Gel Amino Acid Injection: text: Amino Acid Injection Trastuzumab: text: Trastuzumab Melphalan: text: Melphalan FGFR4 Antagonist INCB062079: text: FGFR4 Antagonist INCB062079 BTK Inhibitor HZ-A-018: text: BTK Inhibitor HZ-A-018 Recombinant Bacterial Minicells VAX014: text: Recombinant Bacterial Minicells VAX014 Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA: text: Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA Napabucasin: text: Napabucasin XIAP/cIAP1 Antagonist ASTX660: text: XIAP/cIAP1 Antagonist ASTX660 Oprozomib: text: Oprozomib Nesvacumab: text: Nesvacumab Nemorubicin: text: Nemorubicin Actinomycin F1: text: Actinomycin F1 2-Methoxyestradiol: text: 2-Methoxyestradiol Anti-VEGF/ANG2 Nanobody BI 836880: text: Anti-VEGF/ANG2 Nanobody BI 836880 Encorafenib: text: Encorafenib Parsaclisib: text: Parsaclisib Wnt-5a Mimic Hexapeptide Foxy-5: text: Wnt-5a Mimic Hexapeptide Foxy-5 Anti-HER2 Monoclonal Antibody B002: text: Anti-HER2 Monoclonal Antibody B002 Pyruvate Kinase Inhibitor TLN-232: text: Pyruvate Kinase Inhibitor TLN-232 Methoxsalen: text: Methoxsalen Lurtotecan Liposome: text: Lurtotecan Liposome Chromomycin A3: text: Chromomycin A3 Topoisomerase-II Inhibitor Racemic XK469: text: Topoisomerase-II Inhibitor Racemic XK469 Pepinemab: text: Pepinemab FLT3/KIT/CSF1R Inhibitor NMS-03592088: text: FLT3/KIT/CSF1R Inhibitor NMS-03592088 Elisidepsin: text: Elisidepsin Lexibulin: text: Lexibulin Immunocytokine NHS-IL2-LT: text: Immunocytokine NHS-IL2-LT Anti-CD19 Antibody-drug Conjugate SGN-CD19B: text: Anti-CD19 Antibody-drug Conjugate SGN-CD19B Mixed Bacteria Vaccine: text: Mixed Bacteria Vaccine Vitamin D3 Analogue ILX23-7553: text: Vitamin D3 Analogue ILX23-7553 Imetelstat: text: Imetelstat 4'-Iodo-4'-Deoxydoxorubicin: text: 4'-Iodo-4'-Deoxydoxorubicin Commensal Bacterial Strain Formulation VE800: text: Commensal Bacterial Strain Formulation VE800 Engineered Human Umbilical Vein Endothelial Cells AB-205: text: Engineered Human Umbilical Vein Endothelial Cells AB-205 Rosiglitazone Maleate: text: Rosiglitazone Maleate Curcumin: text: Curcumin Mocetinostat: text: Mocetinostat Paclitaxel Vitamin E-Based Emulsion: text: Paclitaxel Vitamin E-Based Emulsion Envafolimab: text: Envafolimab Ras Peptide CYS: text: Ras Peptide CYS Ertumaxomab: text: Ertumaxomab Parsatuzumab: text: Parsatuzumab Aldesleukin: text: Aldesleukin Allogeneic CRISPR-Cas9 Engineered Anti-BCMA T Cells CTX120: text: Allogeneic CRISPR-Cas9 Engineered Anti-BCMA T Cells CTX120 VGEF Mixed-Backbone Antisense Oligonucleotide GEM 220: text: VGEF Mixed-Backbone Antisense Oligonucleotide GEM 220 Mitoxantrone Hydrochloride: text: Mitoxantrone Hydrochloride Anti-VEGFC Monoclonal Antibody VGX-100: text: Anti-VEGFC Monoclonal Antibody VGX-100 Glioblastoma Cancer Vaccine ERC1671: text: Glioblastoma Cancer Vaccine ERC1671 LMB-7 Immunotoxin: text: LMB-7 Immunotoxin Lead Pb 212 TCMC-trastuzumab: text: Lead Pb 212 TCMC-trastuzumab Akt Inhibitor LY2780301: text: Akt Inhibitor LY2780301 Fluorodopan: text: Fluorodopan Trebananib: text: Trebananib MAGE-A3 Peptide Vaccine: text: MAGE-A3 Peptide Vaccine SBIL-2: text: SBIL-2 Vascular Disrupting Agent BNC105: text: Vascular Disrupting Agent BNC105 Mirdametinib: text: Mirdametinib Anti-GCC Antibody-Drug Conjugate MLN0264: text: Anti-GCC Antibody-Drug Conjugate MLN0264 Galocitabine: text: Galocitabine Burixafor: text: Burixafor Actinomycin C2: text: Actinomycin C2 Opolimogene Capmilisbac: text: Opolimogene Capmilisbac Hydralazine Hydrochloride: text: Hydralazine Hydrochloride Fosbretabulin Disodium: text: Fosbretabulin Disodium 4-Nitroestrone 3-Methyl Ether: text: 4-Nitroestrone 3-Methyl Ether Anti-GD2 Monoclonal Antibody hu14.18K322A: text: Anti-GD2 Monoclonal Antibody hu14.18K322A Autologous BCMA-targeted CAR T Cells CC-98633: text: Autologous BCMA-targeted CAR T Cells CC-98633 Lutetium Lu-177 PSMA-R2: text: Lutetium Lu-177 PSMA-R2 Thiodiglycol: text: Thiodiglycol Adenosine A2A Receptor Antagonist AZD4635: text: Adenosine A2A Receptor Antagonist AZD4635 Modified Vitamin D Binding Protein Macrophage Activator EF-022: text: Modified Vitamin D Binding Protein Macrophage Activator EF-022 Anti-CD74 Antibody-drug Conjugate STRO-001: text: Anti-CD74 Antibody-drug Conjugate STRO-001 PI3K/mTOR Kinase Inhibitor VS-5584: text: PI3K/mTOR Kinase Inhibitor VS-5584 Methyl-5-Aminolevulinate Hydrochloride Cream: text: Methyl-5-Aminolevulinate Hydrochloride Cream Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300: text: Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300 CDK7 Inhibitor SY-5609: text: CDK7 Inhibitor SY-5609 Levothyroxine: text: Levothyroxine Bosutinib Monohydrate: text: Bosutinib Monohydrate Pan-TRK Inhibitor NOV1601: text: Pan-TRK Inhibitor NOV1601 Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107: text: Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107 VEGFR Inhibitor KRN951: text: VEGFR Inhibitor KRN951 Autologous Genetically-modified MAGE-A4 C1032 T Cells: text: Autologous Genetically-modified MAGE-A4 C1032 T Cells Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1: text: Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1 Tiomolibdate Diammonium: text: Tiomolibdate Diammonium Cediranib Maleate: text: Cediranib Maleate Recombinant Erythropoietin: text: Recombinant Erythropoietin Bafetinib: text: Bafetinib Monoclonal Antibody RAV12: text: Monoclonal Antibody RAV12 Gentuximab: text: Gentuximab Cirmtuzumab: text: Cirmtuzumab Immunomodulator LAM-003: text: Immunomodulator LAM-003 Azotomycin: text: Azotomycin PD-1 Inhibitor: text: PD-1 Inhibitor Bovine Cartilage: text: Bovine Cartilage Not Reported: text: Not Reported Roniciclib: text: Roniciclib Recombinant Human Endostatin: text: Recombinant Human Endostatin Hematoporphyrin Derivative: text: Hematoporphyrin Derivative Huang Lian: text: Huang Lian Mitoclomine: text: Mitoclomine Cyclopentenyl Cytosine: text: Cyclopentenyl Cytosine Ieramilimab: text: Ieramilimab BRAF Inhibitor: text: BRAF Inhibitor Selective Estrogen Receptor Modulator TAS-108: text: Selective Estrogen Receptor Modulator TAS-108 Ribociclib: text: Ribociclib Dilpacimab: text: Dilpacimab Gastrin Immunotoxin: text: Gastrin Immunotoxin Broad-Spectrum Human Papillomavirus Vaccine V505: text: Broad-Spectrum Human Papillomavirus Vaccine V505 Fosifloxuridine Nafalbenamide: text: Fosifloxuridine Nafalbenamide Golotimod: text: Golotimod Autologous Tumor Infiltrating Lymphocytes LN-145-S1: text: Autologous Tumor Infiltrating Lymphocytes LN-145-S1 HDAC inhibitor CG200745: text: HDAC inhibitor CG200745 N-dihydrogalactochitosan: text: N-dihydrogalactochitosan Selpercatinib: text: Selpercatinib 5-Aza-4'-thio-2'-deoxycytidine: text: 5-Aza-4'-thio-2'-deoxycytidine Protein Arginine Methyltransferase 5 Inhibitor PF-06939999: text: Protein Arginine Methyltransferase 5 Inhibitor PF-06939999 Selective Estrogen Receptor Degrader LX-039: text: Selective Estrogen Receptor Degrader LX-039 Ganglioside GD2: text: Ganglioside GD2 Triaziquone: text: Triaziquone Bis(choline)tetrathiomolybdate: text: Bis(choline)tetrathiomolybdate Trastuzumab Emtansine: text: Trastuzumab Emtansine Savolitinib: text: Savolitinib Enzastaurin: text: Enzastaurin Anti-CD26 Monoclonal Antibody YS110: text: Anti-CD26 Monoclonal Antibody YS110 Urokinase-Derived Peptide A6: text: Urokinase-Derived Peptide A6 Vosaroxin: text: Vosaroxin EGFR/HER2 Inhibitor DZD9008: text: EGFR/HER2 Inhibitor DZD9008 Teprotumumab: text: Teprotumumab Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062: text: Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062 PARP Inhibitor NMS-03305293: text: PARP Inhibitor NMS-03305293 IDO-1 Inhibitor LY3381916: text: IDO-1 Inhibitor LY3381916 Autologous Dendritic Cell-based Immunotherapeutic AV0113: text: Autologous Dendritic Cell-based Immunotherapeutic AV0113 Ras Inhibitor: text: Ras Inhibitor Anti-VEGFR2 Monoclonal Antibody HLX06: text: Anti-VEGFR2 Monoclonal Antibody HLX06 Enavatuzumab: text: Enavatuzumab RFT5-dgA Immunotoxin IMTOX25: text: RFT5-dgA Immunotoxin IMTOX25 9-Ethyl 6-Mercaptopurine: text: 9-Ethyl 6-Mercaptopurine Vadimezan: text: Vadimezan Defactinib: text: Defactinib Fluvastatin: text: Fluvastatin Anti-HER3 Monoclonal Antibody GSK2849330: text: Anti-HER3 Monoclonal Antibody GSK2849330 Pyroxamide: text: Pyroxamide Cord Blood-derived Expanded Natural Killer Cells PNK-007: text: Cord Blood-derived Expanded Natural Killer Cells PNK-007 Iodine I 131 Omburtamab: text: Iodine I 131 Omburtamab Caracemide: text: Caracemide Irofulven: text: Irofulven Broxuridine: text: Broxuridine Solitomab: text: Solitomab Selinexor: text: Selinexor Zalcitabine: text: Zalcitabine Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118: text: Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118 Crolibulin: text: Crolibulin Verubulin: text: Verubulin Selumetinib: text: Selumetinib Rosuvastatin: text: Rosuvastatin Acalabrutinib: text: Acalabrutinib Interferon Alfacon-1: text: Interferon Alfacon-1 Trigriluzole: text: Trigriluzole Pilaralisib: text: Pilaralisib Cedazuridine: text: Cedazuridine Tecogalan Sodium: text: Tecogalan Sodium Antibody-drug Conjugate MEDI7247: text: Antibody-drug Conjugate MEDI7247 Anti-GCC Antibody-Drug Conjugate TAK-164: text: Anti-GCC Antibody-Drug Conjugate TAK-164 Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108: text: Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108 Brentuximab Vedotin: text: Brentuximab Vedotin Anti-GD2 Monoclonal Antibody MORAb-028: text: Anti-GD2 Monoclonal Antibody MORAb-028 Progestational IUD: text: Progestational IUD Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502: text: Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502 MET Tyrosine Kinase Inhibitor BMS-777607: text: MET Tyrosine Kinase Inhibitor BMS-777607 BET Inhibitor ABBV-744: text: BET Inhibitor ABBV-744 Multi-epitope HER2 Peptide Vaccine TPIV100: text: Multi-epitope HER2 Peptide Vaccine TPIV100 Liposomal Curcumin: text: Liposomal Curcumin Panobinostat: text: Panobinostat Anti-PD-L1 Monoclonal Antibody LY3300054: text: Anti-PD-L1 Monoclonal Antibody LY3300054 AXL/ FLT3/VEGFR2 Inhibitor KC1036: text: AXL/ FLT3/VEGFR2 Inhibitor KC1036 Doxorubicin Hydrochloride: text: Doxorubicin Hydrochloride PARP 1/2 Inhibitor NOV1401: text: PARP 1/2 Inhibitor NOV1401 Anti-VEGFR2 Monoclonal Antibody MSB0254: text: Anti-VEGFR2 Monoclonal Antibody MSB0254 Tabelecleucel: text: Tabelecleucel Tocladesine: text: Tocladesine Alvocidib Hydrochloride: text: Alvocidib Hydrochloride Anti-CD70 CAR-expressing T Lymphocytes: text: Anti-CD70 CAR-expressing T Lymphocytes Thiotepa: text: Thiotepa Talactoferrin Alfa: text: Talactoferrin Alfa Imaradenant: text: Imaradenant PI3K/mTOR Kinase Inhibitor WXFL10030390: text: PI3K/mTOR Kinase Inhibitor WXFL10030390 Androgen Receptor Inhibitor EPI-7386: text: Androgen Receptor Inhibitor EPI-7386 Pomegranate Juice: text: Pomegranate Juice Peplomycin: text: Peplomycin ISS 1018 CpG Oligodeoxynucleotide: text: ISS 1018 CpG Oligodeoxynucleotide TSP-1 Mimetic ABT-510: text: TSP-1 Mimetic ABT-510 Actinium Ac 225-FPI-1434: text: Actinium Ac 225-FPI-1434 Anti-Met/EGFR Monoclonal Antibody LY3164530: text: Anti-Met/EGFR Monoclonal Antibody LY3164530 Catumaxomab: text: Catumaxomab Rose Bengal Solution PV-10: text: Rose Bengal Solution PV-10 Deslorelin Acetate: text: Deslorelin Acetate Pixantrone: text: Pixantrone Rabusertib: text: Rabusertib Anti-CD30/CD16A Monoclonal Antibody AFM13: text: Anti-CD30/CD16A Monoclonal Antibody AFM13 Dexrazoxane Hydrochloride: text: Dexrazoxane Hydrochloride Vadastuximab Talirine: text: Vadastuximab Talirine Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05: text: Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05 Cetrelimab: text: Cetrelimab Mycobacterium w: text: Mycobacterium w CXC Chemokine Receptor 2 Antagonist AZD5069: text: CXC Chemokine Receptor 2 Antagonist AZD5069 Marcellomycin: text: Marcellomycin NTRK/ROS1 Inhibitor DS-6051b: text: NTRK/ROS1 Inhibitor DS-6051b Interleukin-15/Interleukin-15 Receptor Alpha Sushi+ Domain Fusion Protein SO-C101: text: Interleukin-15/Interleukin-15 Receptor Alpha Sushi+ Domain Fusion Protein SO-C101 Alsevalimab: text: Alsevalimab Tinzaparin Sodium: text: Tinzaparin Sodium Liposome: text: Liposome Pan-KRAS Inhibitor BI 1701963: text: Pan-KRAS Inhibitor BI 1701963 Anti-PTK7/Auristatin-0101 Antibody-drug Conjugate PF-06647020: text: Anti-PTK7/Auristatin-0101 Antibody-drug Conjugate PF-06647020 VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813: text: VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813 Vindesine: text: Vindesine Nanoparticle-based Paclitaxel Suspension: text: Nanoparticle-based Paclitaxel Suspension Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202: text: Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202 Allogeneic Anti-CD20 CAR T-cells LUCAR-20S: text: Allogeneic Anti-CD20 CAR T-cells LUCAR-20S CDK Inhibitor SNS-032: text: CDK Inhibitor SNS-032 Seliciclib: text: Seliciclib Anti-CD37 Monoclonal Antibody BI 836826: text: Anti-CD37 Monoclonal Antibody BI 836826 Anti-PD-L1 Monoclonal Antibody CK-301: text: Anti-PD-L1 Monoclonal Antibody CK-301 Allogeneic Natural Killer Cell Line MG4101: text: Allogeneic Natural Killer Cell Line MG4101 CSF-1R Inhibitor BLZ945: text: CSF-1R Inhibitor BLZ945 Linperlisib: text: Linperlisib Lefitolimod: text: Lefitolimod Cilengitide: text: Cilengitide Calculus bovis/Moschus/Olibanum/Myrrha Capsule: text: Calculus bovis/Moschus/Olibanum/Myrrha Capsule MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells: text: MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells Galeterone: text: Galeterone Iniparib: text: Iniparib Moxetumomab Pasudotox: text: Moxetumomab Pasudotox Recombinant Thyrotropin Alfa: text: Recombinant Thyrotropin Alfa Methyltestosterone: text: Methyltestosterone Belvarafenib: text: Belvarafenib UAE Inhibitor TAK-243: text: UAE Inhibitor TAK-243 AE37 Peptide/GM-CSF Vaccine: text: AE37 Peptide/GM-CSF Vaccine Anti-TIGIT Monoclonal Antibody AB154: text: Anti-TIGIT Monoclonal Antibody AB154 Yttrium Y-90 Ibritumomab Tiuxetan: text: Yttrium Y-90 Ibritumomab Tiuxetan HDAC Inhibitor CHR-2845: text: HDAC Inhibitor CHR-2845 Temarotene: text: Temarotene Oncolytic Virus RP1: text: Oncolytic Virus RP1 Cibisatamab: text: Cibisatamab Anti-PD-1 Monoclonal Antibody MEDI0680: text: Anti-PD-1 Monoclonal Antibody MEDI0680 Nelipepimut-S: text: Nelipepimut-S Anti-PSMA/PBD ADC MEDI3726: text: Anti-PSMA/PBD ADC MEDI3726 Ocaratuzumab: text: Ocaratuzumab CpG Oligodeoxynucleotide GNKG168: text: CpG Oligodeoxynucleotide GNKG168 Coxsackievirus V937: text: Coxsackievirus V937 Troxacitabine Nucleotide Prodrug MIV-818: text: Troxacitabine Nucleotide Prodrug MIV-818 CHK1 Inhibitor PF-477736: text: CHK1 Inhibitor PF-477736 BTK Inhibitor M7583: text: BTK Inhibitor M7583 Anti-PD-1 Monoclonal Antibody TSR-042: text: Anti-PD-1 Monoclonal Antibody TSR-042 Lazertinib: text: Lazertinib Milk Thistle: text: Milk Thistle Fluorouracil-E Therapeutic Implant: text: Fluorouracil-E Therapeutic Implant Gilteritinib: text: Gilteritinib Palbociclib: text: Palbociclib CSF1R Inhibitor DCC-3014: text: CSF1R Inhibitor DCC-3014 Autologous CD20-4SCAR-expressing T-cells 4SCAR20: text: Autologous CD20-4SCAR-expressing T-cells 4SCAR20 I 131 Monoclonal Antibody Lym-1: text: I 131 Monoclonal Antibody Lym-1 EGFR/HER2 Inhibitor AP32788: text: EGFR/HER2 Inhibitor AP32788 Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439: text: Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439 Polysaccharide-K: text: Polysaccharide-K Avapritinib: text: Avapritinib Nemorubicin Hydrochloride: text: Nemorubicin Hydrochloride Immunotherapeutic Combination Product CMB305: text: Immunotherapeutic Combination Product CMB305 Anti-VEGF Anticalin PRS-050-PEG40: text: Anti-VEGF Anticalin PRS-050-PEG40 Monoclonal Antibody MX35 F(ab')2: text: Monoclonal Antibody MX35 F(ab')2 BRAF Inhibitor PLX8394: text: BRAF Inhibitor PLX8394 RSK1-4 Inhibitor PMD-026: text: RSK1-4 Inhibitor PMD-026 Amonafide L-Malate: text: Amonafide L-Malate Anti-CD19-DM4 Immunoconjugate SAR3419: text: Anti-CD19-DM4 Immunoconjugate SAR3419 Streptonigrin: text: Streptonigrin Phaleria macrocarpa Extract DLBS-1425: text: Phaleria macrocarpa Extract DLBS-1425 2-Hydroxyflutamide Depot: text: 2-Hydroxyflutamide Depot MDM2 Inhibitor AMG-232: text: MDM2 Inhibitor AMG-232 Anti-TGF-beta Monoclonal Antibody NIS793: text: Anti-TGF-beta Monoclonal Antibody NIS793 HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302: text: HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302 Osimertinib: text: Osimertinib MAGE-10.A2: text: MAGE-10.A2 HIF2a RNAi ARO-HIF2: text: HIF2a RNAi ARO-HIF2 Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981: text: Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981 Irinotecan Hydrochloride: text: Irinotecan Hydrochloride Rociletinib: text: Rociletinib HPV DNA Plasmids Therapeutic Vaccine VGX-3100: text: HPV DNA Plasmids Therapeutic Vaccine VGX-3100 Babaodan Capsule: text: Babaodan Capsule Elesclomol: text: Elesclomol Pumitepa: text: Pumitepa Trimelamol: text: Trimelamol Aminocamptothecin: text: Aminocamptothecin Nanoparticle Albumin-Bound Rapamycin: text: Nanoparticle Albumin-Bound Rapamycin Mitosis Inhibitor T 1101 Tosylate: text: Mitosis Inhibitor T 1101 Tosylate FAK/ALK/ROS1 Inhibitor APG-2449: text: FAK/ALK/ROS1 Inhibitor APG-2449 Taurultam Analogue GP-2250: text: Taurultam Analogue GP-2250 Anti-BCMA Antibody-drug Conjugate GSK2857916: text: Anti-BCMA Antibody-drug Conjugate GSK2857916 Recombinant Luteinizing Hormone: text: Recombinant Luteinizing Hormone Retinyl Palmitate: text: Retinyl Palmitate RARalpha Agonist IRX5183: text: RARalpha Agonist IRX5183 Iodine I 131 Monoclonal Antibody F16SIP: text: Iodine I 131 Monoclonal Antibody F16SIP MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1: text: MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1 Engineered Toxin Body Targeting CD38 TAK-169: text: Engineered Toxin Body Targeting CD38 TAK-169 Nedisertib: text: Nedisertib INO-1001: text: INO-1001 Liposomal c-raf Antisense Oligonucleotide: text: Liposomal c-raf Antisense Oligonucleotide Oxaliplatin: text: Oxaliplatin Regorafenib: text: Regorafenib Anti-PD-1 Monoclonal Antibody MGA012: text: Anti-PD-1 Monoclonal Antibody MGA012 CXCR2 Antagonist QBM076: text: CXCR2 Antagonist QBM076 Tretinoin: text: Tretinoin Sulfatinib: text: Sulfatinib Anti-CXCR4 Monoclonal Antibody PF-06747143: text: Anti-CXCR4 Monoclonal Antibody PF-06747143 Ciclopirox Prodrug CPX-POM: text: Ciclopirox Prodrug CPX-POM Pyrazoloacridine: text: Pyrazoloacridine Rindopepimut: text: Rindopepimut 2-Methoxyestradiol Nanocrystal Colloidal Dispersion: text: 2-Methoxyestradiol Nanocrystal Colloidal Dispersion Indoximod Prodrug NLG802: text: Indoximod Prodrug NLG802 GS/pan-Notch Inhibitor AL101: text: GS/pan-Notch Inhibitor AL101 Src Kinase Inhibitor KX2-391 Ointment: text: Src Kinase Inhibitor KX2-391 Ointment Terfluranol: text: Terfluranol Anti-TIGIT Monoclonal Antibody OMP-313M32: text: Anti-TIGIT Monoclonal Antibody OMP-313M32 Allogeneic Irradiated Melanoma Cell Vaccine CSF470: text: Allogeneic Irradiated Melanoma Cell Vaccine CSF470 Folate Receptor Targeted Epothilone BMS753493: text: Folate Receptor Targeted Epothilone BMS753493 Daratumumab: text: Daratumumab Lutetium Lu 177-DOTA-EB-TATE: text: Lutetium Lu 177-DOTA-EB-TATE Autologous Deep IL-15 Primed T-cells TRQ15-01: text: Autologous Deep IL-15 Primed T-cells TRQ15-01 Spiroplatin: text: Spiroplatin Iratumumab: text: Iratumumab Elesclomol Sodium: text: Elesclomol Sodium Pegvorhyaluronidase Alfa: text: Pegvorhyaluronidase Alfa Modakafusp Alfa: text: Modakafusp Alfa Sulindac: text: Sulindac Cedefingol: text: Cedefingol Sedoxantrone Trihydrochloride: text: Sedoxantrone Trihydrochloride Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352: text: Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352 Cedazuridine/Decitabine Combination Agent ASTX727: text: Cedazuridine/Decitabine Combination Agent ASTX727 Pentoxifylline: text: Pentoxifylline Iodine I 125-Anti-EGFR-425 Monoclonal Antibody: text: Iodine I 125-Anti-EGFR-425 Monoclonal Antibody Nilutamide: text: Nilutamide Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207: text: Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207 Levetiracetam: text: Levetiracetam Mevociclib: text: Mevociclib Gimeracil: text: Gimeracil Leuprolide Acetate: text: Leuprolide Acetate Vactosertib: text: Vactosertib Sotigalimab: text: Sotigalimab Pinometostat: text: Pinometostat Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F: text: Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F PKC-beta Inhibitor MS-553: text: PKC-beta Inhibitor MS-553 Fluzoparib: text: Fluzoparib PPAR Alpha Antagonist TPST-1120: text: PPAR Alpha Antagonist TPST-1120 Vector-peptide Conjugated Paclitaxel: text: Vector-peptide Conjugated Paclitaxel Lutetium Lu 177 PP-F11N: text: Lutetium Lu 177 PP-F11N Minretumomab: text: Minretumomab Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E: text: Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E JAK1 Inhibitor AZD4205: text: JAK1 Inhibitor AZD4205 Thioredoxin-1 Inhibitor PX-12: text: Thioredoxin-1 Inhibitor PX-12 Ralimetinib Mesylate: text: Ralimetinib Mesylate Monoclonal Antibody F19: text: Monoclonal Antibody F19 Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711: text: Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711 Peginterferon Alfa-2a: text: Peginterferon Alfa-2a ERK1/2 Inhibitor JSI-1187: text: ERK1/2 Inhibitor JSI-1187 Amsacrine: text: Amsacrine Menin-MLL Interaction Inhibitor SNDX-5613: text: Menin-MLL Interaction Inhibitor SNDX-5613 Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601: text: Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601 Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257: text: Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257 Tenifatecan: text: Tenifatecan Tretinoin Liposome: text: Tretinoin Liposome Cold Contaminant-free Iobenguane I-131: text: Cold Contaminant-free Iobenguane I-131 Anti-CD25 Monoclonal Antibody RO7296682: text: Anti-CD25 Monoclonal Antibody RO7296682 Anti-PSMA/CD28 Bispecific Antibody REGN5678: text: Anti-PSMA/CD28 Bispecific Antibody REGN5678 Vatalanib: text: Vatalanib Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C: text: Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C Deslorelin: text: Deslorelin Anti-RANKL Monoclonal Antibody JMT103: text: Anti-RANKL Monoclonal Antibody JMT103 BCMA x CD3 T-cell Engaging Antibody CC-93269: text: BCMA x CD3 T-cell Engaging Antibody CC-93269 Anti-PSMA Monoclonal Antibody-MMAE Conjugate: text: Anti-PSMA Monoclonal Antibody-MMAE Conjugate EGFR/EGFRvIII Inhibitor WSD0922-FU: text: EGFR/EGFRvIII Inhibitor WSD0922-FU Liposome-encapsulated Daunorubicin-Cytarabine: text: Liposome-encapsulated Daunorubicin-Cytarabine Asparaginase: text: Asparaginase Topoisomerase I Inhibitor Genz-644282: text: Topoisomerase I Inhibitor Genz-644282 Imifoplatin: text: Imifoplatin Vosilasarm: text: Vosilasarm Opaganib: text: Opaganib Xisomab 3G3: text: Xisomab 3G3 Beta-Thioguanine Deoxyriboside: text: Beta-Thioguanine Deoxyriboside Mycobacterium tuberculosis Arabinomannan Z-100: text: Mycobacterium tuberculosis Arabinomannan Z-100 Anti-HER2 Antibody-drug Conjugate RC48: text: Anti-HER2 Antibody-drug Conjugate RC48 Anti-EGFR TAP Antibody-drug Conjugate IMGN289: text: Anti-EGFR TAP Antibody-drug Conjugate IMGN289 Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999: text: Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999 Smoothened Antagonist LEQ506: text: Smoothened Antagonist LEQ506 Allogeneic Cellular Vaccine 1650-G: text: Allogeneic Cellular Vaccine 1650-G Protein Tyrosine Kinase 2 Inhibitor IN10018: text: Protein Tyrosine Kinase 2 Inhibitor IN10018 Cell Cycle Checkpoint/DNA Repair Antagonist IC83: text: Cell Cycle Checkpoint/DNA Repair Antagonist IC83 Folate Receptor-Targeted Vinca Alkaloid EC0489: text: Folate Receptor-Targeted Vinca Alkaloid EC0489 Abexinostat Tosylate: text: Abexinostat Tosylate GBM Antigens and Alloantigens Immunotherapeutic Vaccine: text: GBM Antigens and Alloantigens Immunotherapeutic Vaccine Zotatifin: text: Zotatifin Brequinar Sodium: text: Brequinar Sodium Eftilagimod Alpha: text: Eftilagimod Alpha Endothelin B Receptor Blocker ENB 003: text: Endothelin B Receptor Blocker ENB 003 Vincristine: text: Vincristine SERD D-0502: text: SERD D-0502 Etarotene: text: Etarotene Sunitinib: text: Sunitinib Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323: text: Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323 enum_CRDCH_Substance_role: name: enum_CRDCH_Substance_role description: Autogenerated Enumeration for CRDC-H Substance role comments: - 'Name according to TCCM: "CRDC-H.Substance.role"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Substance.role code_set_version: '2021-12-16T18:05:29.337171+00:00' enum_CRDCH_TimePoint_event_type: name: enum_CRDCH_TimePoint_event_type description: Autogenerated Enumeration for CRDC-H TimePoint event_type comments: - 'Name according to TCCM: "CRDC-H.TimePoint.event_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.TimePoint.event_type code_set_version: '2021-12-16T18:05:29.485922+00:00' enum_CRDCH_TobaccoExposureObservation_category: name: enum_CRDCH_TobaccoExposureObservation_category description: Autogenerated Enumeration for CRDC-H TobaccoExposureObservation category comments: - 'Name according to TCCM: "CRDC-H.TobaccoExposureObservation.category"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.TobaccoExposureObservation.category code_set_version: '2021-12-16T18:05:29.638391+00:00' enum_CRDCH_TobaccoExposureObservation_observation_type: name: enum_CRDCH_TobaccoExposureObservation_observation_type description: Types of observations about a Subject's exposure to or use of tobacco. notes: - Derived from [TobaccoExposureObservation.observation_type in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: cigarettes_per_day: text: cigarettes_per_day description: The average number of cigarettes smoked per day. pack_years_smoked: text: pack_years_smoked description: Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20. tobacco_smoking_onset_year: text: tobacco_smoking_onset_year description: The year in which the participant began smoking. tobacco_smoking_quit_year: text: tobacco_smoking_quit_year description: The year in which the participant quit smoking. years_smoked: text: years_smoked description: Numeric value (or unknown) to represent the number of years a person has been smoking. smoking_frequency: text: smoking_frequency description: The text term used to generally describe how often the patient smokes. time_between_waking_and_first_smoke: text: time_between_waking_and_first_smoke description: The text term used to describe the approximate amount of time elapsed between the time the patient wakes up in the morning to the time they smoke their first cigarette. environmental_tobacco_smoke_exposure: text: environmental_tobacco_smoke_exposure description: The yes/no/unknown indicator used to describe whether a patient was exposed to smoke that is emitted from burning tobacco, including cigarettes, pipes, and cigars. This includes tobacco smoke exhaled by smokers. tobacco_smoking_status: text: tobacco_smoking_status description: Category describing current smoking status and smoking history as self-reported by a patient. type_of_tobacco_used: text: type_of_tobacco_used description: The text term used to describe the specific type of tobacco used by the patient. enum_CRDCH_TobaccoExposureObservation_method_type: name: enum_CRDCH_TobaccoExposureObservation_method_type description: Autogenerated Enumeration for CRDC-H TobaccoExposureObservation method_type comments: - 'Name according to TCCM: "CRDC-H.TobaccoExposureObservation.method_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.TobaccoExposureObservation.method_type code_set_version: '2021-12-16T18:05:29.959770+00:00' enum_CRDCH_TobaccoExposureObservation_value_codeable_concept: name: enum_CRDCH_TobaccoExposureObservation_value_codeable_concept description: Autogenerated Enumeration for CRDC-H TobaccoExposureObservation value_codeable_concept comments: - 'Name according to TCCM: "CRDC-H.TobaccoExposureObservation.value_codeable_concept"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.TobaccoExposureObservation.value_codeable_concept code_set_version: '2021-12-16T18:05:30.103785+00:00' permissible_values: Cigar: text: Cigar Electronic Cigarette: text: Electronic Cigarette Smokeless Tobacco: text: Smokeless Tobacco Cigarette: text: Cigarette Pipe: text: Pipe Other: text: Other Within 5 Minutes: text: Within 5 Minutes 31-60 Minutes: text: 31-60 Minutes 6-30 Minutes: text: 6-30 Minutes Unknown: text: Unknown description: Unknown After 60 Minutes: text: After 60 Minutes '3': text: '3' description: Current Reformed Smoker for > 15 yrs '6': text: '6' description: Smoker at Diagnosis '5': text: '5' description: Current Reformed Smoker, Duration Not Specified '7': text: '7' description: Smoking history not documented '1': text: '1' description: Lifelong Non-Smoker '4': text: '4' description: Current Reformed Smoker for < or = 15 yrs '2': text: '2' description: Current Smoker Not Reported: text: Not Reported 'Yes': text: 'Yes' 'No': text: 'No' Every day: text: Every day Some days: text: Some days Cigarettes: text: Cigarettes enum_CRDCH_Treatment_treatment_type: name: enum_CRDCH_Treatment_treatment_type description: Autogenerated Enumeration for CRDC-H Treatment treatment_type comments: - 'Name according to TCCM: "CRDC-H.Treatment.treatment_type"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Treatment.treatment_type code_set_version: '2021-12-16T18:05:30.301377+00:00' permissible_values: Stem Cell Transplantation, Non-Myeloablative: text: Stem Cell Transplantation, Non-Myeloablative Radiation, Proton Beam: text: Radiation, Proton Beam Ablation, Cryo: text: Ablation, Cryo Stem Cell Transplantation, Allogeneic: text: Stem Cell Transplantation, Allogeneic External Beam Radiation: text: External Beam Radiation Steroid Therapy: text: Steroid Therapy Internal Radiation: text: Internal Radiation description: Internal Radiation Therapy Surgery: text: Surgery description: Surgical Procedure Stem Cell Transplantation, Syngenic: text: Stem Cell Transplantation, Syngenic Stem Cell Transplantation, Autologous: text: Stem Cell Transplantation, Autologous Organ Transplantation: text: Organ Transplantation Radiation, Photon Beam: text: Radiation, Photon Beam Other: text: Other description: Other Immunotherapy (Including Vaccines): text: Immunotherapy (Including Vaccines) Stem Cell Transplantation, Haploidentical: text: Stem Cell Transplantation, Haploidentical Radiation, Radioisotope: text: Radiation, Radioisotope Radiation, Combination: text: Radiation, Combination Not Reported: text: Not Reported Pleurodesis: text: Pleurodesis Radioactive Iodine Therapy: text: Radioactive Iodine Therapy Chemoembolization: text: Chemoembolization I-131 Radiation Therapy: text: I-131 Radiation Therapy Pharmaceutical Therapy, NOS: text: Pharmaceutical Therapy, NOS Stem Cell Transplantation, NOS: text: Stem Cell Transplantation, NOS Ablation, Ethanol Injection: text: Ablation, Ethanol Injection Radiosensitizing Agent: text: Radiosensitizing Agent Ablation, NOS: text: Ablation, NOS Radiation, Stereotactic/Gamma Knife/SRS: text: Radiation, Stereotactic/Gamma Knife/SRS Isolated Limb Perfusion (ILP): text: Isolated Limb Perfusion (ILP) Targeted Molecular Therapy: text: Targeted Molecular Therapy description: Targeted Molecular Therapy Radiation, Implants: text: Radiation, Implants Radiation Therapy, NOS: text: Radiation Therapy, NOS Brachytherapy, High Dose: text: Brachytherapy, High Dose description: High-Dose Rate Brachytherapy Stereotactic Radiosurgery: text: Stereotactic Radiosurgery Concurrent Chemoradiation: text: Concurrent Chemoradiation Radiation, Hypofractionated: text: Radiation, Hypofractionated Hormone Therapy: text: Hormone Therapy description: Endocrine Therapy Radiation, Internal: text: Radiation, Internal Ablation, Radiosurgical: text: Ablation, Radiosurgical Ethanol Injection Ablation: text: Ethanol Injection Ablation Chemoprotectant: text: Chemoprotectant Stem Cell Treatment: text: Stem Cell Treatment Radiation, External Beam: text: Radiation, External Beam Antiseizure Treatment: text: Antiseizure Treatment Radiation, Mixed Photon Beam: text: Radiation, Mixed Photon Beam Radioembolization: text: Radioembolization Ablation, Microwave: text: Ablation, Microwave Brachytherapy, Low Dose: text: Brachytherapy, Low Dose description: Low-Dose Rate Brachytherapy Chemotherapy: text: Chemotherapy description: Chemotherapy Embolization: text: Embolization Blinded Study, Treatment Unknown: text: Blinded Study, Treatment Unknown Ancillary Treatment: text: Ancillary Treatment Bisphosphonate Therapy: text: Bisphosphonate Therapy Unknown: text: Unknown description: Unknown Radiation, 2D Conventional: text: Radiation, 2D Conventional Radiation, Intensity-Modulated Radiotherapy: text: Radiation, Intensity-Modulated Radiotherapy Radiation, Systemic: text: Radiation, Systemic Ablation, Radiofrequency: text: Ablation, Radiofrequency Stem Cell Transplantation, Double Autologous: text: Stem Cell Transplantation, Double Autologous Radiation, Cyberknife: text: Radiation, Cyberknife Brachytherapy, NOS: text: Brachytherapy, NOS Radiation, 3D Conformal: text: Radiation, 3D Conformal Cryoablation: text: Cryoablation enum_CRDCH_Treatment_treatment_end_reason: name: enum_CRDCH_Treatment_treatment_end_reason description: Autogenerated Enumeration for CRDC-H Treatment treatment_end_reason comments: - 'Name according to TCCM: "CRDC-H.Treatment.treatment_end_reason"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Treatment.treatment_end_reason code_set_version: '2021-12-16T18:05:30.631571+00:00' permissible_values: Adverse Event: text: Adverse Event Death: text: Death Other: text: Other Course of Therapy Completed: text: Course of Therapy Completed Withdrawal by Subject: text: Withdrawal by Subject Disease Progression: text: Disease Progression enum_CRDCH_Treatment_regimen: name: enum_CRDCH_Treatment_regimen description: Autogenerated Enumeration for CRDC-H Treatment regimen comments: - 'Name according to TCCM: "CRDC-H.Treatment.regimen"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Treatment.regimen code_set_version: '2021-12-16T18:05:30.783791+00:00' enum_CRDCH_Treatment_treatment_frequency: name: enum_CRDCH_Treatment_treatment_frequency description: Autogenerated Enumeration for CRDC-H Treatment treatment_frequency comments: - 'Name according to TCCM: "CRDC-H.Treatment.treatment_frequency"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Treatment.treatment_frequency code_set_version: '2021-12-16T18:05:30.930012+00:00' permissible_values: Every Hour: text: Every Hour Twice Weekly: text: Twice Weekly Every 24 Hours: text: Every 24 Hours Five Times Daily: text: Five Times Daily Not Reported: text: Not Reported Three Times Daily: text: Three Times Daily Twice Daily: text: Twice Daily Unknown: text: Unknown Every Other Day: text: Every Other Day Once Weekly: text: Once Weekly Four Times Daily: text: Four Times Daily enum_CRDCH_Treatment_treatment_intent: name: enum_CRDCH_Treatment_treatment_intent description: Autogenerated Enumeration for CRDC-H Treatment treatment_intent comments: - 'Name according to TCCM: "CRDC-H.Treatment.treatment_intent"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Treatment.treatment_intent code_set_version: '2021-12-16T18:05:31.098062+00:00' permissible_values: Palliative: text: Palliative description: Palliative Prevention: text: Prevention description: Cancer Prevention Cure: text: Cure description: Cure Neoadjuvant: text: Neoadjuvant description: Neoadjuvant Therapy Unknown: text: Unknown Not Reported: text: Not Reported Cancer Control: text: Cancer Control Androgen Deprivation Therapy (ADT): text: Androgen Deprivation Therapy (ADT) Maintenance Therapy: text: Maintenance Therapy Adjuvant: text: Adjuvant description: Adjuvant Therapy enum_CRDCH_Treatment_treatment_effect: name: enum_CRDCH_Treatment_treatment_effect description: Autogenerated Enumeration for CRDC-H Treatment treatment_effect comments: - 'Name according to TCCM: "CRDC-H.Treatment.treatment_effect"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Treatment.treatment_effect code_set_version: '2021-12-16T18:05:31.264574+00:00' permissible_values: Not Reported: text: Not Reported description: Not Reported Incomplete Necrosis (Viable Tumor Present): text: Incomplete Necrosis (Viable Tumor Present) Complete Necrosis (No Viable Tumor): text: Complete Necrosis (No Viable Tumor) Unknown: text: Unknown description: Unknown No Necrosis: text: No Necrosis No Known Treatment Effect: text: No Known Treatment Effect 'No': text: 'No' 'Yes': text: 'Yes' enum_CRDCH_Treatment_treatment_outcome: name: enum_CRDCH_Treatment_treatment_outcome description: Autogenerated Enumeration for CRDC-H Treatment treatment_outcome comments: - 'Name according to TCCM: "CRDC-H.Treatment.treatment_outcome"' code_set: https://terminology.ccdh.io/enumerations/CRDC-H.Treatment.treatment_outcome code_set_version: '2021-12-16T18:05:31.426513+00:00' permissible_values: Persistent Disease: text: Persistent Disease description: Persistent disease (Hematologic persistence) Mixed Response: text: Mixed Response description: Mixed response Stable Disease: text: Stable Disease description: Stable Disease Complete Response: text: Complete Response description: Complete Response No Measurable Disease: text: No Measurable Disease Treatment Ongoing: text: Treatment Ongoing description: Treatment Still in Progress Unknown: text: Unknown description: Unknown Partial Response: text: Partial Response description: Partial Response Treatment Stopped Due to Toxicity: text: Treatment Stopped Due to Toxicity description: Treatment Terminated Due to Toxicity No Response: text: No Response description: No Response Progressive Disease: text: Progressive Disease description: Progressive Disease Not Reported: text: Not Reported Very Good Partial Response: text: Very Good Partial Response description: Very good Partial Response enum_CRDCH_ResearchProject_primary_anatomic_site: name: enum_CRDCH_ResearchProject_primary_anatomic_site description: The text term used to describe the general location of the malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O). notes: - Derived from [ResearchProject.primary_anatomic_site in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) enum_CRDCH_Substance__role: name: enum_CRDCH_Substance__role description: A role played by the substance in a particular application (e.g. the role of a lysis buffer when applied in a specimen creation activity, or the role of fixative when applied in specimen processing) notes: - Derived from [Substance. role in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: lysis buffer: text: lysis buffer description: A buffer applied to lyse and extract content from biological material. mounting medium: text: mounting medium description: A substance applied to secure a specimen or slide in place for further examination (typically through microscopy) fixative: text: fixative description: A substance applied preserve biological tissues from decay due to autolysis or putrefaction collection media: text: collection media description: A substance applied to stabilize or support the growth/metabolic activity of a specimen or derived product such as a cell line. enum_CRDCH_TimePoint_eventType: name: enum_CRDCH_TimePoint_eventType description: A specific type of event for which a timepoint is captured notes: - Derived from [TimePoint.eventType in sheet O_CCDH Enums](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=196972368) permissible_values: IACUC approval: text: IACUC approval description: The date that the Institutional Animal Care and Use Committee (IACUC) approved an animal study protocol. This date cannot be released to funding agencies until congruency between the animal use in the funding proposal and the IACUC approved protocol has been verified. IRB approval: text: IRB approval description: The date that the Institutional Review Board (IRB) approved a study protocol Histological confirmation of diagnosis: text: Histological confirmation of diagnosis description: The date that a histological diagnosis was confirmed. classes: AlcoholExposureObservation: name: AlcoholExposureObservation description: A structured object that describes a single data item about an individual's exposure to alcohol, as generated through a point-in-time observation, measurement, or interpretation. notes: - Derived from [AlcoholExposureObservation in sheet AlcoholExposureObservation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1894439514) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: AlcoholExposureObservation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..0' examples: - value: '' values_from: crdch:enum_CRDCH_AlcoholExposureObservation_category domain: AlcoholExposureObservation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The specific type of alcohol exposure observation made - i.e. the feature or characteristic that was observed, measured, estimated, etc.. notes: - 'Cardinality: 1..1' comments: - This field holds the 'key' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. examples: - value: alcohol_days_per_week - value: alcohol_drinks_per_day - value: alcohol_history - value: alcohol_intensity values_from: crdch:enum_CRDCH_AlcoholExposureObservation_observation_type domain: AlcoholExposureObservation multivalued: false range: CodeableConcept required: true method_type: name: method_type description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..0' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy',). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_AlcoholExposureObservation_method_type domain: AlcoholExposureObservation multivalued: false range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..0' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: AlcoholExposureObservation multivalued: false range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..0' examples: - value: '' domain: AlcoholExposureObservation multivalued: false range: Subject required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..0' examples: - value: '' domain: AlcoholExposureObservation multivalued: false range: Organization required: false value_integer: name: value_integer exact_mappings: - GDC:Exposure.alcohol_days_per_week - PDC:Exposure.alcohol_days_per_week - GDC:Exposure.alcohol_drinks_per_day - PDC:Exposure.alcohol_drinks_per_day description: The result of the observation, encoded as an integer. notes: - 'Cardinality: 0..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: AlcoholExposureObservation multivalued: false range: crdch_integer required: false value_codeable_concept: name: value_codeable_concept exact_mappings: - GDC:Exposure.alcohol_history - PDC:Exposure.alcohol_history - GDC:Exposure.alcohol_intensity - PDC:Exposure.alcohol_intensity description: The result of the observation, encoded as a CodeableConcept. notes: - 'Cardinality: 0..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' values_from: crdch:enum_CRDCH_AlcoholExposureObservation_value_codeable_concept domain: AlcoholExposureObservation multivalued: false range: CodeableConcept required: false BodySite: name: BodySite description: A site in the body of an organism, typically described in terms of an anatomical concept and optional qualifiers (e.g. left/right, upper/lower). But body sites as defined here may include non-canonical sites, such as an implanted medical device. notes: - Derived from [BodySite in sheet BodySite](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1097478901) is_a: Entity attributes: site: name: site exact_mappings: - GDC:Sample.biospecimen_anatomic_site - PDC:Sample.biospecimen_anatomic_site - ICDC:Sample.sample_site - HTAN:Biospecimen.SiteofResectionorBiopsy - GDC:Case.primary_site - PDC:Case.primary_site - GDC:Project.primary_site - GDC:Treatment.treatment_anatomic_site - PDC:Treatment.treatment_anatomic_site - GDC:Diagnosis.site_of_resection_or_biopsy - PDC:Diagnosis.site_of_resection_or_biopsy description: A term describing any site in the body. notes: - 'Cardinality: 1..1' examples: - value: Adenoid - value: Adipose - value: Adrenal values_from: crdch:enum_CRDCH_BodySite_site domain: BodySite multivalued: false range: CodeableConcept required: true qualifier: name: qualifier exact_mappings: - GDC:Sample.biospecimen_laterality - PDC:Sample.biospecimen_laterality description: A qualifier that further refines or specifies the location of the body site - e.g. to indicate laterality, upper v. lower, containment in some other anatomical structure (e.g. 'blood' contained in the 'hepatic vein') notes: - 'Cardinality: 0..m' examples: - value: left - value: right - value: bilateral values_from: crdch:enum_CRDCH_BodySite_qualifier domain: BodySite multivalued: true range: CodeableConcept required: false BiologicProduct: name: BiologicProduct description: A living organism, or a metabolically active biological system such as a cell culture, tissue culture, or organoid that is maintained or propagated in vitro. notes: - Derived from [BiologicProduct in sheet BiologicProduct](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1097989080) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: BiologicProduct multivalued: false range: crdch_string required: false identifier: name: identifier description: A 'business' identifier or accession number for the entity, typically as provided by an external system or authority, that are globally unique and persist across implementing systems. Also, since these identifiers are created outside the information system through a specific business process, the Identifier type has additional attributes to capture this additional metadata so the actual identifier values are qualified by the context that created those values. This additional context allows "identifier" instances to be transmitted as business data across systems while still being able to trace them back to the system of origin. notes: - 'Cardinality: 0..m' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' domain: BiologicProduct multivalued: true inlined_as_list: true range: Identifier required: false description: name: description description: A free text field to capture additional info/explanation about the model system notes: - 'Cardinality: 0..1' examples: - value: '' domain: BiologicProduct multivalued: false range: crdch_string required: false product_type: name: product_type description: The high level type of model system (e.g. cell line, cell culture, tissue culture, organoid) notes: - 'Cardinality: 0..1' examples: - value: cell line - value: cell culture - value: tissue culture - value: organoid values_from: crdch:enum_CRDCH_BiologicProduct_product_type domain: BiologicProduct multivalued: false range: CodeableConcept required: false passage_number: name: passage_number exact_mappings: - GDC:Sample.passage_count - PDC:Sample.passage_count description: When the specimen an actively growing model system, such as a cell or tissue culture, this property captures its passage number. examples: - value: '' domain: BiologicProduct multivalued: true inlined_as_list: true range: crdch_integer required: false growth_rate: name: growth_rate exact_mappings: - GDC:Sample.growth_rate - PDC:Sample.growth_rate description: When the specimen an actively growing model system, such as a cell or tissue culture, this property captures its rate of growth. examples: - value: '' domain: BiologicProduct multivalued: true inlined_as_list: true range: crdch_string required: false CancerGradeObservation: name: CancerGradeObservation description: A data structure with key (observation_type) and value (value_codeable_concept) attributes that represents a single cancer grade observation notes: - Derived from [CancerGradeObservation in sheet CancerGradeObservation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1099484640) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: CancerGradeObservation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..0' examples: - value: '' values_from: crdch:enum_CRDCH_CancerGradeObservation_category domain: CancerGradeObservation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The cancer grade classification system being used to classify the cancer (e.g. INPC, Gleason, etc.) notes: - 'Cardinality: 1..1' comments: - 'This field holds the ''key'' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. ' examples: - value: enneking_msts_grade - value: esophageal_columnar_dysplasia_degree - value: inpc_grade - value: gleason_grade_group - value: primary_gleason_grade - value: secondary_gleason_grade - value: tumor_grade values_from: crdch:enum_CRDCH_CancerGradeObservation_observation_type domain: CancerGradeObservation multivalued: false range: CodeableConcept required: true method_type: name: method_type description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..0' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy',). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_CancerGradeObservation_method_type domain: CancerGradeObservation multivalued: false range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..0' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: CancerGradeObservation multivalued: false range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..0' examples: - value: '' domain: CancerGradeObservation multivalued: false range: Subject required: false value_codeable_concept: name: value_codeable_concept exact_mappings: - GDC:Diagnosis.enneking_msts_grade - PDC:Diagnosis.enneking_msts_grade - GDC:Diagnosis.esophageal_columnar_dysplasia_degree - PDC:Diagnosis.esophageal_columnar_dysplasia_degree - GDC:Diagnosis.inpc_grade - PDC:Diagnosis.inpc_grade - GDC:Diagnosis.gleason_grade_group - PDC:Diagnosis.gleason_grade_group - HTAN:Diagnosis.GleasonGradeGroup - GDC:Diagnosis.primary_gleason_grade - PDC:Diagnosis.primary_gleason_grade - HTAN:Diagnosis.PrimaryGleasonGrade - GDC:Diagnosis.secondary_gleason_grade - PDC:Diagnosis.secondary_gleason_grade - HTAN:Diagnosis.SecondaryGleasonGrade - GDC:Diagnosis.tumor_grade - PDC:Diagnosis.tumor_grade - HTAN:Diagnosis.TumorGrade - ICDC:Diagnosis.histological_grade description: The value from the grade classification system that classifies the cancer (e.g. Poorly differentiated, differentiated, etc.) notes: - 'Cardinality: 1..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' values_from: crdch:enum_CRDCH_CancerGradeObservation_value_codeable_concept domain: CancerGradeObservation multivalued: false range: CodeableConcept required: true CancerGradeObservationSet: name: CancerGradeObservationSet description: A structured object to hold related data items about the grade of cancer (e.g. overall, primary gleason, secondary gleason, etc.). notes: - Derived from [CancerGradeObservationSet in sheet CancerGradeObservationSet](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1025765903) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: CancerGradeObservationSet multivalued: false range: crdch_string required: false category: name: category description: The general category of observation set described notes: - 'Cardinality: 0..0' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' values_from: crdch:enum_CRDCH_CancerGradeObservationSet_category domain: CancerGradeObservationSet multivalued: false range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..m' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: CancerGradeObservationSet multivalued: true inlined_as_list: true range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: CancerGradeObservationSet multivalued: false range: Subject required: false method_type: name: method_type description: The cancer grade classification system being used to classify the cancer (e.g. INPC, Gleason, etc.) notes: - 'Cardinality: 0..m' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy'). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: Gleason - value: INPC - value: Unspecified grading system values_from: crdch:enum_CRDCH_CancerGradeObservationSet_method_type domain: CancerGradeObservationSet multivalued: true range: CodeableConcept required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: CancerGradeObservationSet multivalued: false range: Organization required: false observations: name: observations description: A set of one or more more atomic observations about the cancer grade that classifies the cancer (e.g. Poorly differentiated, differentiated, etc.) notes: - 'Cardinality: 0..m' examples: - value: '' domain: CancerGradeObservationSet multivalued: true inlined_as_list: true range: CancerGradeObservation required: false CancerStageObservation: name: CancerStageObservation description: A data structure with key (observation_type) and value (value_codeable_concept) attributes that represents a single cancer staging observation, such as the Clinical Metastasis (M) component of a clinical TNM staging. notes: - Derived from [CancerStageObservation in sheet CancerStageObservation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1189722404) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: CancerStageObservation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..0' examples: - value: '' values_from: crdch:enum_CRDCH_CancerStageObservation_category domain: CancerStageObservation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The type of cancer staging component being represented (e.g. 'Clinical Metastasis (M)') notes: - 'Cardinality: 1..1' comments: - 'This field holds the ''key'' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. ''Overall'' should be used when: the source staging value is not definitively ''Clinical'' or ''Pathological'' (e.g. a TNM staged cancer without a clear indication of clinical vs pathological), or the source staging system does not use T, N, or M components and only has a single overall staging value (e.g. FIGO staging)' examples: - value: Overall - value: Tumor (T) - value: Node (N) - value: Metastasis (M) - value: Clinical Overall - value: Clinical Tumor (T) - value: Clinical Node (N) - value: Clinical Metastasis (M) - value: Pathological Overall - value: Pathological Tumor (T) - value: Pathological Node (N) - value: Pathological Metastasis (M) - value: Ann Arbor Modifier values_from: crdch:enum_CRDCH_CancerStageObservation_observation_type domain: CancerStageObservation multivalued: false range: CodeableConcept required: true method_type: name: method_type description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..0' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy',). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_CancerStageObservation_method_type domain: CancerStageObservation multivalued: false range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..0' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: CancerStageObservation multivalued: false range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..0' examples: - value: '' domain: CancerStageObservation multivalued: false range: Subject required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..0' examples: - value: '' domain: CancerStageObservation multivalued: false range: Organization required: false value_codeable_concept: name: value_codeable_concept exact_mappings: - GDC:Diagnosis.ajcc_clinical_m - PDC:Diagnosis.ajcc_clinical_m - GDC:Diagnosis.ajcc_clinical_n - PDC:Diagnosis.ajcc_clinical_n - GDC:Diagnosis.ajcc_clinical_t - PDC:Diagnosis.ajcc_clinical_t - GDC:Diagnosis.ajcc_clinical_stage - PDC:Diagnosis.ajcc_clinical_stage - HTAN:Diagnosis.AJCCClinicalM - HTAN:Diagnosis.AJCCClinicalN - HTAN:Diagnosis.AJCCClinicalT - HTAN:Diagnosis.AJCCClinicalStage - HTAN:Diagnosis.AJCCPathologicM - HTAN:Diagnosis.AJCCPathologicN - HTAN:Diagnosis.AJCCPathologicT - HTAN:Diagnosis.AJCCPathologicStage - GDC:Diagnosis.tumor_stage - PDC:Diagnosis.tumor_stage - ICDC:Diagnosis.stage_of_disease - GDC:Diagnosis.ajcc_pathologic_m - PDC:Diagnosis.ajcc_pathologic_m - GDC:Diagnosis.ajcc_pathologic_n - PDC:Diagnosis.ajcc_pathologic_n - GDC:Diagnosis.ajcc_pathologic_t - PDC:Diagnosis.ajcc_pathologic_t - GDC:Diagnosis.ajcc_pathologic_stage - PDC:Diagnosis.ajcc_pathologic_stage - GDC:Diagnosis.ajcc_staging_system_edition - PDC:Diagnosis.ajcc_staging_system_edition - GDC:Diagnosis.ann_arbor_clinical_stage - PDC:Diagnosis.ann_arbor_clinical_stage - GDC:Diagnosis.ann_arbor_pathologic_stage - PDC:Diagnosis.ann_arbor_pathologic_stage - GDC:Diagnosis.figo_stage - PDC:Diagnosis.figo_stage - GDC:Diagnosis.igcccg_stage - PDC:Diagnosis.igcccg_stage - GDC:Diagnosis.inss_stage - PDC:Diagnosis.inss_stage - GDC:Diagnosis.iss_stage - PDC:Diagnosis.iss_stage - GDC:Diagnosis.masaoka_stage - PDC:Diagnosis.masaoka_stage - GDC:Diagnosis.cog_liver_stage - PDC:Diagnosis.cog_liver_stage - GDC:Diagnosis.cog_renal_stage - PDC:Diagnosis.cog_renal_stage - GDC:Diagnosis.enneking_msts_metastasis - PDC:Diagnosis.enneking_msts_metastasis - GDC:Diagnosis.enneking_msts_stage - PDC:Diagnosis.enneking_msts_stage - GDC:Diagnosis.enneking_msts_tumor_site - PDC:Diagnosis.enneking_msts_tumor_site - GDC:Diagnosis.inrg_stage - PDC:Diagnosis.inrg_stage - GDC:Diagnosis.irs_stage - PDC:Diagnosis.irs_stage - GDC:Diagnosis.ann_arbor_b_symptoms - PDC:Diagnosis.ann_arbor_b_symptoms - GDC:Diagnosis.ann_arbor_extranodal_involvement - PDC:Diagnosis.ann_arbor_extranodal_involvement description: The value for a cancer staging component being represented (e.g. 'M1'), encoded as a CodeableConcept. notes: - 'Cardinality: 1..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: M0 - value: M1 - value: M1a - value: N0 - value: N0 (i+) - value: N0 (i-) values_from: crdch:enum_CRDCH_CancerStageObservation_value_codeable_concept domain: CancerStageObservation multivalued: false range: CodeableConcept required: true CancerStageObservationSet: name: CancerStageObservationSet description: A structured object to hold related data items about the staging of cancer (e.g. overall, T, N, and M components of a Cancer Staging observation). notes: - Derived from [CancerStageObservationSet in sheet CancerStageObservationSet](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1668576212) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: CancerStageObservationSet multivalued: false range: crdch_string required: false category: name: category description: The general category of observation set described notes: - 'Cardinality: 0..0' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' values_from: crdch:enum_CRDCH_CancerStageObservationSet_category domain: CancerStageObservationSet multivalued: false range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..m' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: CancerStageObservationSet multivalued: true inlined_as_list: true range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: CancerStageObservationSet multivalued: false range: Subject required: false method_type: name: method_type close_mappings: - GDC:Diagnosis.ajcc_staging_system_edition - PDC:Diagnosis.ajcc_staging_system_edition - HTAN:Diagnosis.AJCCStagingSystemEdition description: A type of method used in generating each of the Observations bundled in the set, in this case, the particular staging system being used to classify the cancer. notes: - 'Cardinality: 0..m' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy'). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: AJCC staging system 1st edition - value: AJCC staging system 2nd edition - value: AJCC staging system 3rd edition - value: AJCC staging system 4th edition - value: AJCC staging system 5th edition - value: AJCC staging system 6th edition - value: AJCC staging system 7th edition - value: AJCC staging system 8th edition - value: Ann Arbor staging system - value: COG Liver staging system - value: COG Renal staging system - value: Enneking MSTS staging system - value: FIGO staging system - value: IGCCCG staging system - value: INRG staging system - value: INSS staging system - value: IRS staging system - value: ISS staging system - value: Masaoka staging system - value: Unspecified staging system values_from: crdch:enum_CRDCH_CancerStageObservationSet_method_type domain: CancerStageObservationSet multivalued: true range: CodeableConcept required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: CancerStageObservationSet multivalued: false range: Organization required: false observations: name: observations description: A set of one or more more atomic observations about the cancer stage notes: - 'Cardinality: 0..m' examples: - value: '' domain: CancerStageObservationSet multivalued: true inlined_as_list: true range: CancerStageObservation required: false CodeableConcept: name: CodeableConcept description: A representation of a concept that may be defined by or mapped to one or more codes in code systems (terminologies, ontologies, dictionaries, code sets, etc) - but may also be defined by the provision of text. notes: - Derived from [CodeableConcept in sheet CodeableConcept](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1820375300) comments: - 'More than one code may be used in CodeableConcept. The concept may be coded multiple times in different code systems (or even multiple times in the same code systems, where multiple forms are possible). Each Coding is a representation of the concept as described above and may have slightly different granularity due to the differences in the definitions of the underlying codes. There is no meaning associated with the ordering of Coding within a CodeableConcept. A typical use of CodeableConcept is to send the local code that the concept was coded with, and also one or more translations to publicly defined code systems such as LOINC or SNOMED CT. ' is_a: Entity attributes: coding: name: coding description: A reference to a code defined by a terminology system notes: - 'Cardinality: 0..m' examples: - value: '' domain: CodeableConcept multivalued: true inlined_as_list: true range: Coding required: false text: name: text description: A human language representation of the concept represented by the Coding. notes: - 'Cardinality: 0..1' comments: - 'The text attribute represents the concept as entered or chosen by the user; often the value of text is the same as a display of one of the codings. A concept that does not have an appropriate or known coding can be represented using free-text in the text attribute. ' examples: - value: '' domain: CodeableConcept multivalued: false range: crdch_string required: false Coding: name: Coding description: A structured representation of a coded/enumerated data value, that includes additional metadata about the code and code system. notes: - Derived from [Coding in sheet Coding](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1218588936) is_a: Entity attributes: code: name: code description: The symbol/value of the code, as defined by the code system. notes: - 'Cardinality: 1..1' examples: - value: '' domain: Coding multivalued: false range: crdch_string required: true label: name: label description: A human-readable name for the code, as defined by the code system. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Coding multivalued: false range: crdch_string required: false system: name: system description: The URL of the code system where the code is defined. notes: - 'Cardinality: 1..1' examples: - value: '' domain: Coding multivalued: false range: crdch_string required: true system_version: name: system_version description: The version of the code system. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Coding multivalued: false range: crdch_string required: false value_set: name: value_set description: The identifier of the enumeration / value set that the code is a part of in the context of this element notes: - 'Cardinality: 0..1' examples: - value: '' domain: Coding multivalued: false range: crdch_string required: false value_set_version: name: value_set_version description: The version of the enuemration / value set the code is pulled from notes: - 'Cardinality: 0..1' examples: - value: '' domain: Coding multivalued: false range: crdch_string required: false tag: name: tag description: original value | harmonized value | notes: - 'Cardinality: 0..m' examples: - value: '' domain: Coding multivalued: true inlined_as_list: true range: crdch_string required: false Diagnosis: name: Diagnosis description: A collection of characteristics that describe an abnormal condition of the body as assessed at a point in time. May be used to capture information about neoplastic and non-neoplastic conditions. notes: - Derived from [Diagnosis in sheet Diagnosis](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1015759209) is_a: Entity attributes: id: name: id exact_mappings: - GDC:Diagnosis.id - PDC:Diagnosis.diagnosis_id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: Diagnosis multivalued: false range: crdch_string required: false identifier: name: identifier exact_mappings: - GDC:Diagnosis.submitter_id - PDC:Diagnosis.diagnosis_submitter_id description: A 'business' identifier or accession number for the entity, typically as provided by an external system or authority, that are globally unique and persist across implementing systems. Also, since these identifiers are created outside the information system through a specific business process, the Identifier type has additional attributes to capture this additional metadata so the actual identifier values are qualified by the context that created those values. This additional context allows "identifier" instances to be transmitted as business data across systems while still being able to trace them back to the system of origin. notes: - 'Cardinality: 0..m' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' domain: Diagnosis multivalued: true inlined_as_list: true range: Identifier required: false subject: name: subject description: The subject of this diagnosis. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Diagnosis multivalued: false range: Subject required: false age_at_diagnosis: name: age_at_diagnosis close_mappings: - GDC:Diagnosis.age_at_diagnosis - PDC:Diagnosis.age_at_diagnosis - HTAN:Diagnosis.AgeatDiagnosis description: The age in days of the individual at the time of diagnosis notes: - 'Cardinality: 0..1' examples: - value: '' domain: Diagnosis multivalued: false range: Quantity required: false diagnosis_date: name: diagnosis_date close_mappings: - GDC:Diagnosis.year_of_diagnosis - GDC:Diagnosis.days_to_diagnosis - PDC:Diagnosis.year_of_diagnosis - PDC:Diagnosis.days_to_diagnosis - HTAN:Diagnosis.YearofDiagnosis - ICDC:Diagnosis.date_of_diagnosis description: When the diagnosis was made. notes: - 'Cardinality: 0..1' comments: - 'A TimePoint object supports three ways to specify a point in time, each of which might be used in the context of capturing a diagnosis date - as source node data can report this date as an explicit year or date (e.g. 2021-05-05), or an offset from an indexed point in time. See description of the TimePoint entity for more information here. ' examples: - value: '' domain: Diagnosis multivalued: false range: TimePoint required: false condition: name: condition exact_mappings: - GDC:Diagnosis.primary_diagnosis - PDC:Diagnosis.primary_diagnosis - HTAN:Diagnosis.PrimaryDiagnosis - ICDC:Diagnosis.disease_term - ICDC:Diagnosis.concurrent_disease_type - GDC:Diagnosis.icd_10_code - PDC:Diagnosis.icd_10_code description: Code that captures the condition being diagnosed (e.g. ICD-O, ICD-10, SNOMED, etc.) notes: - 'Cardinality: 0..1' comments: - This attribute will subsume source attributes that are bound to ICD-O and ICD-10 classification systems. examples: - value: '' values_from: crdch:enum_CRDCH_Diagnosis_condition domain: Diagnosis multivalued: false range: CodeableConcept required: false primary_site: name: primary_site close_mappings: - GDC:Diagnosis.tissue_or_organ_of_origin - PDC:Diagnosis.tissue_or_organ_of_origin - HTAN:Diagnosis.TissueorOrganofOrigin - ICDC:Diagnosis.primary_disease_site - GDC:Diagnosis.laterality - PDC:Diagnosis.laterality - GDC:Diagnosis.site_of_resection_or_biopsy - PDC:Diagnosis.site_of_resection_or_biopsy - HTAN:Diagnosis.SiteofResectionorBiopsy description: The anatomical location of the primary condition notes: - 'Cardinality: 0..m' examples: - value: '' domain: Diagnosis multivalued: true inlined_as_list: true range: BodySite required: false metastatic_site: name: metastatic_site description: The anatomical location(s) of metastatic disease notes: - 'Cardinality: 0..m' examples: - value: '' domain: Diagnosis multivalued: true inlined_as_list: true range: BodySite required: false stage: name: stage close_mappings: - GDC:Diagnosis.ajcc_clinical_m - PDC:Diagnosis.ajcc_clinical_m - GDC:Diagnosis.ajcc_clinical_n - PDC:Diagnosis.ajcc_clinical_n - GDC:Diagnosis.ajcc_clinical_t - PDC:Diagnosis.ajcc_clinical_t - GDC:Diagnosis.ajcc_clinical_stage - PDC:Diagnosis.ajcc_clinical_stage - GDC:Diagnosis.tumor_stage - PDC:Diagnosis.tumor_stage - ICDC:Diagnosis.stage_of_disease - GDC:Diagnosis.ajcc_pathologic_m - PDC:Diagnosis.ajcc_pathologic_m - GDC:Diagnosis.ajcc_pathologic_n - PDC:Diagnosis.ajcc_pathologic_n - GDC:Diagnosis.ajcc_pathologic_t - PDC:Diagnosis.ajcc_pathologic_t - GDC:Diagnosis.ajcc_pathologic_stage - PDC:Diagnosis.ajcc_pathologic_stage - GDC:Diagnosis.ajcc_staging_system_edition - PDC:Diagnosis.ajcc_staging_system_edition - GDC:Diagnosis.ann_arbor_clinical_stage - PDC:Diagnosis.ann_arbor_clinical_stage - GDC:Diagnosis.ann_arbor_pathologic_stage - PDC:Diagnosis.ann_arbor_pathologic_stage - GDC:Diagnosis.figo_stage - PDC:Diagnosis.figo_stage - GDC:Diagnosis.igcccg_stage - PDC:Diagnosis.igcccg_stage - GDC:Diagnosis.inss_stage - PDC:Diagnosis.inss_stage - GDC:Diagnosis.iss_stage - PDC:Diagnosis.iss_stage - GDC:Diagnosis.masaoka_stage - PDC:Diagnosis.masaoka_stage - GDC:Diagnosis.cog_liver_stage - PDC:Diagnosis.cog_liver_stage - GDC:Diagnosis.cog_renal_stage - PDC:Diagnosis.cog_renal_stage - GDC:Diagnosis.enneking_msts_metastasis - PDC:Diagnosis.enneking_msts_metastasis - GDC:Diagnosis.enneking_msts_stage - PDC:Diagnosis.enneking_msts_stage - GDC:Diagnosis.enneking_msts_tumor_site - PDC:Diagnosis.enneking_msts_tumor_site - GDC:Diagnosis.inrg_stage - PDC:Diagnosis.inrg_stage - GDC:Diagnosis.irs_stage - PDC:Diagnosis.irs_stage description: The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body. notes: - 'Cardinality: 0..m' examples: - value: '' domain: Diagnosis multivalued: true inlined_as_list: true range: CancerStageObservationSet required: false grade: name: grade close_mappings: - GDC:Diagnosis.enneking_msts_grade - PDC:Diagnosis.enneking_msts_grade - GDC:Diagnosis.esophageal_columnar_dysplasia_degree - PDC:Diagnosis.esophageal_columnar_dysplasia_degree - GDC:Diagnosis.inpc_grade - PDC:Diagnosis.inpc_grade - GDC:Diagnosis.gleason_grade_group - PDC:Diagnosis.gleason_grade_group - GDC:Diagnosis.primary_gleason_grade - PDC:Diagnosis.primary_gleason_grade - GDC:Diagnosis.secondary_gleason_grade - PDC:Diagnosis.secondary_gleason_grade - GDC:Diagnosis.tumor_grade - PDC:Diagnosis.tumor_grade - HTAN:Diagnosis.TumorGrade - ICDC:Diagnosis.histological_grade - GDC:Diagnosis.tumor_regression_grade - PDC:Diagnosis.tumor_regression_grade description: The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems. notes: - 'Cardinality: 0..m' examples: - value: '' domain: Diagnosis multivalued: true inlined_as_list: true range: CancerGradeObservationSet required: false morphology: name: morphology exact_mappings: - GDC:Diagnosis.morphology - PDC:Diagnosis.morphology - HTAN:Diagnosis.Morphology description: Code that represents the histology of the disease using the third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms. notes: - 'Cardinality: 0..1' examples: - value: 8001/3 - value: 8002/3 - value: 8003/3 - value: 8004/3 - value: 8005/3 values_from: crdch:enum_CRDCH_Diagnosis_morphology domain: Diagnosis multivalued: false range: CodeableConcept required: false disease_status: name: disease_status exact_mappings: - GDC:Treatment.initial_disease_status - PDC:Treatment.initial_disease_status description: A term that refers to the nature and/or clinical outcome of a disease (e.g., primary disease, metastatic disease, recurrent disease, etc.) notes: - 'Cardinality: 0..1' examples: - value: Initial Diagnosis - value: Progressive Disease - value: Recurrent Disease - value: Residual Disease - value: Unknown - value: Not Reported values_from: crdch:enum_CRDCH_Diagnosis_disease_status domain: Diagnosis multivalued: false range: CodeableConcept required: false prior_diagnosis: name: prior_diagnosis description: A reference to a prior cancer diagnosis. In the case of relapse/recurrent disease, this attribute may be populated with a reference to the initial diagnosis. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Diagnosis multivalued: false range: Diagnosis required: false method_of_diagnosis: name: method_of_diagnosis exact_mappings: - GDC:Diagnosis.method_of_diagnosis - PDC:Diagnosis.method_of_diagnosis description: The method used to confirm the patients malignant diagnosis notes: - 'Cardinality: 0..1' examples: - value: Autopsy - value: Biopsy - value: Blood Draw - value: Bone Marrow Aspirate - value: Core Biopsy - value: .. values_from: crdch:enum_CRDCH_Diagnosis_method_of_diagnosis domain: Diagnosis multivalued: false range: CodeableConcept required: false related_specimen: name: related_specimen description: The specimen from which this diagnosis is made notes: - 'Cardinality: 0..m' examples: - value: '' domain: Diagnosis multivalued: true inlined_as_list: true range: Specimen required: false primary_tumor_dimensional_measures: name: primary_tumor_dimensional_measures close_mappings: - GDC:Diagnosis.tumor_largest_dimension_diameter - PDC:Diagnosis.tumor_largest_dimension_diameter description: Observations about the current physical dimensions of the primary tumor. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Diagnosis multivalued: false range: DimensionalObservationSet required: false supporting_observation: name: supporting_observation exact_mappings: - GDC:Diagnosis.international_prognostic_index - PDC:Diagnosis.international_prognostic_index - GDC:Diagnosis.lymph_nodes_positive - PDC:Diagnosis.lymph_nodes_positive - GDC:Diagnosis.lymphatic_invasion_present - PDC:Diagnosis.lymphatic_invasion_present - GDC:Diagnosis.metastasis_at_diagnosis - PDC:Diagnosis.metastasis_at_diagnosis description: One or more observations that capture information relevant to this condition or diagnosis. notes: - 'Cardinality: 0..m' examples: - value: '' domain: Diagnosis multivalued: true inlined_as_list: true range: Observation required: false DimensionalObservation: name: DimensionalObservation description: A structured object that describes a single data item about the physical dimensions of an entity (e.g. length width, area), as generated through a point-in-time observation or measurement. notes: - Derived from [DimensionalObservation in sheet DimensionalObservation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1045447308) comments: - At the core of an Observation is a flexible key-value pair (or a structured collection of key-value pairs), where a 'key' field defines the type of observation made, and the 'value' field describes the value or outcome of the observation. The fact that the type of observation captured is defined in the data allow Observation to convey a broad range of observation data. is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: DimensionalObservation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..0' comments: - Use only if we don't define named subtypes of Observation for specific categories. examples: - value: '' values_from: crdch:enum_CRDCH_DimensionalObservation_category domain: DimensionalObservation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The specific type of observation made - i.e. the feature or characteristic that was observed, measured, estimated, etc. notes: - 'Cardinality: 1..1' comments: - This field holds the 'key' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. examples: - value: '' values_from: crdch:enum_CRDCH_DimensionalObservation_observation_type domain: DimensionalObservation multivalued: false range: CodeableConcept required: true method_type: name: method_type description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..m' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy',). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_DimensionalObservation_method_type domain: DimensionalObservation multivalued: true range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..m' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: DimensionalObservation multivalued: true inlined_as_list: true range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: DimensionalObservation multivalued: false range: Subject required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: DimensionalObservation multivalued: false range: Organization required: false value_quantity: name: value_quantity description: The result of the observation, encoded as a free-text Quantity. notes: - 'Cardinality: 1..1' examples: - value: '' domain: DimensionalObservation multivalued: false range: Quantity required: true DimensionalObservationSet: name: DimensionalObservationSet description: A set of one or more discrete observations about the physical dimensions of an object (e.g. length, width, area). notes: - Derived from [DimensionalObservationSet in sheet DimensionalObservationSet](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1118507095) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: DimensionalObservationSet multivalued: false range: crdch_string required: false category: name: category description: The general category of observation set described notes: - 'Cardinality: 0..0' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' values_from: crdch:enum_CRDCH_DimensionalObservationSet_category domain: DimensionalObservationSet multivalued: false range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..m' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: DimensionalObservationSet multivalued: true inlined_as_list: true range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: DimensionalObservationSet multivalued: false range: Subject required: false method_type: name: method_type exact_mappings: - GDC:Analyte.spectrophotometer_method - PDC:Analyte.spectrophotometer_method - HTAN:Biospecimen.HistologyAssessmentMedium description: A type of method used in generating each of the Observations bundled in the set. notes: - 'Cardinality: 0..m' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy'). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_DimensionalObservationSet_method_type domain: DimensionalObservationSet multivalued: true range: CodeableConcept required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: DimensionalObservationSet multivalued: false range: Organization required: false observations: name: observations description: A set of one or more more atomic observations that are conceptually or logically related - e.g. two components of some compound measurement (e.g. the systolic and diastolic components of a blood pressure measurement), or a panel of related measurements run and interpreted together on the same subject/specimen (e.g. a blood panel, or separate dimensional measurements of a specimen). notes: - 'Cardinality: 0..m' examples: - value: '' domain: DimensionalObservationSet multivalued: true inlined_as_list: true range: DimensionalObservation required: false Document: name: Document description: A collection of information intented to be understood together as a whole, and codified in human-readable form. notes: - Derived from [Document in sheet Document](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=809861603) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: Document multivalued: false range: crdch_string required: false identifier: name: identifier description: A 'business' identifier or accession number for the entity, typically as provided by an external system or authority, that are globally unique and persist across implementing systems. Also, since these identifiers are created outside the information system through a specific business process, the Identifier type has additional attributes to capture this additional metadata so the actual identifier values are qualified by the context that created those values. This additional context allows "identifier" instances to be transmitted as business data across systems while still being able to trace them back to the system of origin. notes: - 'Cardinality: 0..m' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' domain: Document multivalued: true inlined_as_list: true range: Identifier required: false document_type: name: document_type description: The high-level type of the document (e.g. 'publication', 'pathology report') notes: - 'Cardinality: 0..1' examples: - value: '' values_from: crdch:enum_CRDCH_Document_document_type domain: Document multivalued: false range: CodeableConcept required: false description: name: description description: A free text description or summary of the report. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Document multivalued: false range: crdch_string required: false focus: name: focus description: The entity that the report is primarily about notes: - 'Cardinality: 0..1' examples: - value: '' domain: Document multivalued: false range: Entity required: false url: name: url description: A URL/web address where the document can be accessed. notes: - 'Cardinality: 0..m' examples: - value: '' domain: Document multivalued: true inlined_as_list: true range: crdch_string required: false Entity: name: Entity description: Any resource that has its own identifier notes: - Derived from [Entity in sheet Entity](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=65213867) EnvironmentalExposureObservation: name: EnvironmentalExposureObservation description: A structured object that describes a single data item about an individual's exposure to an environmental factor, as generated through a point-in-time observation, measurement, or interpretation. notes: - Derived from [EnvironmentalExposureObservation in sheet EnvironmentalExposureObservation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=274611680) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: EnvironmentalExposureObservation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..0' examples: - value: '' values_from: crdch:enum_CRDCH_EnvironmentalExposureObservation_category domain: EnvironmentalExposureObservation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The specific type of environmental exposure observation made - i.e. the feature or characteristic that was observed, measured, estimated, etc.. notes: - 'Cardinality: 1..1' comments: - This field holds the 'key' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. examples: - value: asbestos_exposure - value: coal_dust_exposure - value: radon_exposure - value: respirable_crystalline_silica_exposure - value: type_of_smoke_exposure values_from: crdch:enum_CRDCH_EnvironmentalExposureObservation_observation_type domain: EnvironmentalExposureObservation multivalued: false range: CodeableConcept required: true method_type: name: method_type description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..0' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy',). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_EnvironmentalExposureObservation_method_type domain: EnvironmentalExposureObservation multivalued: false range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..0' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: EnvironmentalExposureObservation multivalued: false range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: EnvironmentalExposureObservation multivalued: false range: Subject required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..0' examples: - value: '' domain: EnvironmentalExposureObservation multivalued: false range: Organization required: false value_codeable_concept: name: value_codeable_concept exact_mappings: - GDC:Exposure.asbestos_exposure - PDC:Exposure.asbestos_exposure - GDC:Exposure.coal_dust_exposure - PDC:Exposure.coal_dust_exposure - GDC:Exposure.radon_exposure - PDC:Exposure.radon_exposure - GDC:Exposure.respirable_crystalline_silica_exposure - PDC:Exposure.respirable_crystalline_silica_exposure - GDC:Exposure.type_of_smoke_exposure - PDC:Exposure.type_of_smoke_exposure description: The result of the observation, encoded as a CodeableConcept. notes: - 'Cardinality: 1..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' values_from: crdch:enum_CRDCH_EnvironmentalExposureObservation_value_codeable_concept domain: EnvironmentalExposureObservation multivalued: false range: CodeableConcept required: true ExecutionConditionObservation: name: ExecutionConditionObservation description: 'A structured object that describes how long certain parts on an activity took to complete, as determined through a point-in-time observation or measurement. Information describing the environmental conditions in which an activity, or a specific part of an activity, was performed.' notes: - Derived from [ExecutionConditionObservation in sheet ExecutionConditionObservation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1598634433) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: ExecutionConditionObservation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..0' examples: - value: '' values_from: crdch:enum_CRDCH_ExecutionConditionObservation_category domain: ExecutionConditionObservation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The specific type of environmental exposure observation made - i.e. the feature or characteristic that was observed, measured, estimated, etc.. notes: - 'Cardinality: 1..1' comments: - This field holds the 'key' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. examples: - value: '' values_from: crdch:enum_CRDCH_ExecutionConditionObservation_observation_type domain: ExecutionConditionObservation multivalued: false range: CodeableConcept required: true method_type: name: method_type description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..0' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy',). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_ExecutionConditionObservation_method_type domain: ExecutionConditionObservation multivalued: false range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..0' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: ExecutionConditionObservation multivalued: false range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ExecutionConditionObservation multivalued: false range: Subject required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..0' examples: - value: '' domain: ExecutionConditionObservation multivalued: false range: Organization required: false value_codeable_concept: name: value_codeable_concept exact_mappings: - HTAN:Biospecimen.ISCHEMIC_TEMPERATURE - HTAN:Biospecimen.SHIPPING_CONDITIONS description: The result of the observation, encoded as a CodeableConcept. notes: - 'Cardinality: 1..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' values_from: crdch:enum_CRDCH_ExecutionConditionObservation_value_codeable_concept domain: ExecutionConditionObservation multivalued: false range: CodeableConcept required: true ExecutionTimeObservation: name: ExecutionTimeObservation description: 'A structured object that describes how long certain parts on an activity took to complete, as determined through a point-in-time observation or measurement. Information describing the environmental conditions in which an activity, or a specific part of an activity, was performed.' notes: - Derived from [ExecutionTimeObservation in sheet ExecutionTimeObservation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=638866265) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: ExecutionTimeObservation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..0' examples: - value: '' values_from: crdch:enum_CRDCH_ExecutionTimeObservation_category domain: ExecutionTimeObservation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The specific type of environmental exposure observation made - i.e. the feature or characteristic that was observed, measured, estimated, etc.. notes: - 'Cardinality: 1..1' comments: - This field holds the 'key' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. examples: - value: '' values_from: crdch:enum_CRDCH_ExecutionTimeObservation_observation_type domain: ExecutionTimeObservation multivalued: false range: CodeableConcept required: true method_type: name: method_type description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..0' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy',). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_ExecutionTimeObservation_method_type domain: ExecutionTimeObservation multivalued: false range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..0' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: ExecutionTimeObservation multivalued: false range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ExecutionTimeObservation multivalued: false range: Subject required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..0' examples: - value: '' domain: ExecutionTimeObservation multivalued: false range: Organization required: false value_quantity: name: value_quantity description: The result of the observation, encoded as a free-text Quantity. notes: - 'Cardinality: 1..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: ExecutionTimeObservation multivalued: false range: Quantity required: true Exposure: name: Exposure description: Contact between an agent and a target. A state of contact or close proximity to a medicinal product, chemical, pathogen, radioisotope or other substance. notes: - Derived from [Exposure in sheet Exposure](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1402410931) is_a: Entity attributes: id: name: id exact_mappings: - GDC:Exposure.id - PDC:Exposure.id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 1..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: Exposure multivalued: false range: crdch_string required: true identifier: name: identifier close_mappings: - GDC:Exposure.submitter_id - PDC:Exposure.submitter_id description: A 'business' identifier or accession number for the entity, typically as provided by an external system or authority, that are globally unique and persist across implementing systems. Also, since these identifiers are created outside the information system through a specific business process, the Identifier type has additional attributes to capture this additional metadata so the actual identifier values are qualified by the context that created those values. This additional context allows "identifier" instances to be transmitted as business data across systems while still being able to trace them back to the system of origin. notes: - 'Cardinality: 0..m' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' domain: Exposure multivalued: true inlined_as_list: true range: Identifier required: false tobacco_exposure: name: tobacco_exposure close_mappings: - GDC:Exposure.cigarettes_per_day - PDC:Exposure.cigarettes_per_day - GDC:Exposure.environmental_tobacco_smoke_exposure - PDC:Exposure.environmental_tobacco_smoke_exposure - GDC:Exposure.pack_years_smoked - PDC:Exposure.pack_years_smoked - GDC:Exposure.smoking_frequency - PDC:Exposure.smoking_frequency - GDC:Exposure.time_between_waking_and_first_smoke - PDC:Exposure.time_between_waking_and_first_smoke - GDC:Exposure.tobacco_smoking_onset_year - PDC:Exposure.tobacco_smoking_onset_year - GDC:Exposure.tobacco_smoking_quit_year - PDC:Exposure.tobacco_smoking_quit_year - GDC:Exposure.tobacco_smoking_status - PDC:Exposure.tobacco_smoking_status - GDC:Exposure.type_of_tobacco_used - PDC:Exposure.type_of_tobacco_used - GDC:Exposure.years_smoked - PDC:Exposure.years_smoked description: Observations about an individual's exposure to tobacco. notes: - 'Cardinality: 0..m' examples: - value: '' domain: Exposure multivalued: true inlined_as_list: true range: TobaccoExposureObservation required: false alcohol_exposure: name: alcohol_exposure close_mappings: - GDC:Exposure.alcohol_days_per_week - PDC:Exposure.alcohol_days_per_week - GDC:Exposure.alcohol_drinks_per_day - PDC:Exposure.alcohol_drinks_per_day - GDC:Exposure.alcohol_history - PDC:Exposure.alcohol_history - GDC:Exposure.alcohol_intensity - PDC:Exposure.alcohol_intensity description: Observations about an individual's exposure to alcohol. notes: - 'Cardinality: 0..m' examples: - value: '' domain: Exposure multivalued: true inlined_as_list: true range: AlcoholExposureObservation required: false environmental_exposure: name: environmental_exposure close_mappings: - GDC:Exposure.asbestos_exposure - PDC:Exposure.asbestos_exposure - GDC:Exposure.coal_dust_exposure - PDC:Exposure.coal_dust_exposure - GDC:Exposure.radon_exposure - PDC:Exposure.radon_exposure - GDC:Exposure.respirable_crystalline_silica_exposure - PDC:Exposure.respirable_crystalline_silica_exposure - GDC:Exposure.type_of_smoke_exposure - PDC:Exposure.type_of_smoke_exposure description: Observations about an individual's exposure to environmental substances that may impact clinical outcomes. notes: - 'Cardinality: 0..m' examples: - value: '' domain: Exposure multivalued: true inlined_as_list: true range: EnvironmentalExposureObservation required: false subject: name: subject description: A reference to the Subject that is the subject of this Exposure notes: - 'Cardinality: 0..1' examples: - value: '' domain: Exposure multivalued: false range: Subject required: false HistologicalCompositionObservation: name: HistologicalCompositionObservation description: An observation about characteristics of a specimen at a microscopic level - typically related to its cellular or tissue composition. (e.g. how many cells in the specimen are of a given type, or exhibit a particular cellular phenotype). notes: - Derived from [HistologicalCompositionObservation in sheet HistologicalCompositionObservation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1411171873) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: HistologicalCompositionObservation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..0' comments: - Use only if we don't define named subtypes of Observation for specific categories. examples: - value: '' values_from: crdch:enum_CRDCH_HistologicalCompositionObservation_category domain: HistologicalCompositionObservation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The specific type of observation made - i.e. the feature or characteristic that was observed, measured, estimated, etc.. notes: - 'Cardinality: 1..1' comments: - This field holds the 'key' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. examples: - value: '' values_from: crdch:enum_CRDCH_HistologicalCompositionObservation_observation_type domain: HistologicalCompositionObservation multivalued: false range: CodeableConcept required: true method_type: name: method_type description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..m' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy,). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_HistologicalCompositionObservation_method_type domain: HistologicalCompositionObservation multivalued: true range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..m' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: HistologicalCompositionObservation multivalued: true inlined_as_list: true range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: HistologicalCompositionObservation multivalued: false range: Subject required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: HistologicalCompositionObservation multivalued: false range: Organization required: false value_quantity: name: value_quantity description: The result of the observation, encoded as a free-text Quantity. notes: - 'Cardinality: 1..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: HistologicalCompositionObservation multivalued: false range: Quantity required: true HistologicalCompositionObservationSet: name: HistologicalCompositionObservationSet description: A set of one or more discrete observations that quantify the relative or absolute composition of a specimen at cellular level - e.g. how many cells in the specimen are of a given type, or exhibit a particular cellular phenotype. notes: - Derived from [HistologicalCompositionObservationSet in sheet HistologicalCompositionObservationSet](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=815777747) comments: - An Observation Set is comprised of one or more logically related Observations made about the same entity. The Observations in a set may be grouped because they were generated on a single occasion using a common methodology (e.g. a blood panel), and/or or because describe aspects of the same underlying feature of an entity and as such are considered together as a logical unit of information (e.g. diastolic and systolic measures that comprise a blood pressure observation, or T, N, and M components of a Cancer Staging observation). is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 1..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: HistologicalCompositionObservationSet multivalued: false range: crdch_string required: true category: name: category description: The general category of observation set described notes: - 'Cardinality: 1..1' examples: - value: '' values_from: crdch:enum_CRDCH_HistologicalCompositionObservationSet_category domain: HistologicalCompositionObservationSet multivalued: false range: CodeableConcept required: true focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..m' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: HistologicalCompositionObservationSet multivalued: true inlined_as_list: true range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: HistologicalCompositionObservationSet multivalued: false range: Subject required: false method_type: name: method_type description: A type of method used in generating each of the Observations bundled in the set. notes: - 'Cardinality: 0..m' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy'). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_HistologicalCompositionObservationSet_method_type domain: HistologicalCompositionObservationSet multivalued: true range: CodeableConcept required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: HistologicalCompositionObservationSet multivalued: false range: Organization required: false observations: name: observations description: A set of one or more more atomic observations that are conceptually or logically related - e.g. two components of some compound measurement (e.g. the systolic and diastolic components of a blood pressure measurement), or a panel of related measurements run and interpreted together on the same subject/specimen (e.g. a blood panel, or separate dimensional measurements of a specimen). notes: - 'Cardinality: 0..m' examples: - value: '' domain: HistologicalCompositionObservationSet multivalued: true inlined_as_list: true range: HistologicalCompositionObservation required: false Identifier: name: Identifier description: An Identifier is associated with a unique object or entity within a given system. notes: - Derived from [Identifier in sheet Identifier](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1307792462) comments: - This data type is intended to be used to represent business identifiers that are shared between systems. is_a: Entity attributes: value: name: value exact_mappings: - GDC:Sample.submitter_id - GDC:Analyte.submitter_id - GDC:Slide.submitter_id - PDC:Sample.sample_submitter_id - PDC:Analyte.analyte_submitter_id - GDC:Sample.pathology_report_uuid - PDC:Sample.pathology_report_uuid - HTAN:Biospecimen.ProtocolLink - GDC:Sample.distributor_reference - PDC:Sample.distributor_reference - GDC:Sample.catalog_reference - PDC:Sample.catalog_reference - GDC:Program.dbgap_accession_number - GDC:Project.dbgap_accession_number - PDC:Program.program_submitter_id - PDC:Project.project_submitter_id - ICDC:Study.clinical_study_designation - GDC:Case.submitter_id - PDC:Case.case_submitter_id description: The value of the identifier, as defined by the system. notes: - 'Cardinality: 1..1' examples: - value: '' domain: Identifier multivalued: false range: crdch_string required: true system: name: system description: The system or namespace that defines the identifier. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Identifier multivalued: false range: crdch_string required: false type: name: type description: A code that defines the type of the identifier. notes: - 'Cardinality: 0..1' examples: - value: '' values_from: crdch:enum_CRDCH_Identifier_type domain: Identifier multivalued: false range: CodeableConcept required: false Observation: name: Observation description: A structured object that describes a single data item about an entity, as generated through a point-in-time observation, measurement, or interpretation. notes: - Derived from [Observation in sheet Observation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=550424063) comments: - At the core of an Observation is a flexible key-value pair (or a structured collection of key-value pairs), where a 'key' field defines the type of observation made, and the 'value' field describes the value or outcome of the observation. The fact that the type of observation captured is defined in the data allow Observation to convey a broad range of observation data. is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: Observation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..1' comments: - Use only if we don't define named subtypes of Observation for specific categories. examples: - value: DimensionalMeasure - value: TissueCompositionMeasure - value: SpecimenQualityMeasure - value: CellularCompositionMeasure - value: TobbaccoExposureMeasure values_from: crdch:enum_CRDCH_Observation_category domain: Observation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The specific type of observation made - i.e. the feature or characteristic that was observed, measured, estimated, etc.. notes: - 'Cardinality: 1..1' comments: - This field holds the 'key' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. examples: - value: tumor_tissue_area - value: percentage_stroma - value: a260_a280_ratio - value: width_of_tumor - value: time_between_excision_and_freezing values_from: crdch:enum_CRDCH_Observation_observation_type domain: Observation multivalued: false range: CodeableConcept required: true method_type: name: method_type exact_mappings: - GDC:Analyte.spectrophotometer_method - PDC:Analyte.spectrophotometer_method - HTAN:Biospecimen.HistologyAssessmentMedium description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..m' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy'). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_Observation_method_type domain: Observation multivalued: true range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..m' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: Observation multivalued: true inlined_as_list: true range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Observation multivalued: false range: Subject required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Observation multivalued: false range: Organization required: false value_entity: name: value_entity description: The value of an observation notes: - 'Cardinality: 0..1' examples: - value: '' domain: Observation multivalued: false range: Entity required: false value_string: name: value_string description: The result of the observation, encoded as a free-text string. notes: - 'Cardinality: 0..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: Observation multivalued: false range: crdch_string required: false value_integer: name: value_integer description: The result of the observation, encoded as a decimal. notes: - 'Cardinality: 0..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: Observation multivalued: false range: crdch_decimal required: false value_decimal: name: value_decimal description: The result of the observation, encoded as a decimal. notes: - 'Cardinality: 0..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: Observation multivalued: false range: crdch_decimal required: false value_boolean: name: value_boolean description: The result of the observation, encoded as a boolean. notes: - 'Cardinality: 0..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: Observation multivalued: false range: crdch_boolean required: false value_date_time: name: value_date_time description: The result of the observation, encoded as a dateTime. notes: - 'Cardinality: 0..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: Observation multivalued: false range: crdch_dateTime required: false value_quantity: name: value_quantity description: The result of the observation, encoded as a free-text Quantity. notes: - 'Cardinality: 0..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: Observation multivalued: false range: Quantity required: false value_codeable_concept: name: value_codeable_concept description: The result of the observation, encoded as a CodeableConcept. notes: - 'Cardinality: 0..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' values_from: crdch:enum_CRDCH_Observation_value_codeable_concept domain: Observation multivalued: false range: CodeableConcept required: false ObservationSet: name: ObservationSet description: A structured object to hold related data items about an entity, as generated through a point-in-time observation, measurement, or interpretation. notes: - Derived from [ObservationSet in sheet ObservationSet](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1243450201) comments: - An Observation Set is comprised of one or more logically related Observations made about the same entity. The Observations in a set may be grouped because they were generated on a single occasion using a common methodology (e.g. a blood panel), and/or or because describe aspects of the same underlying feature of an entity and as such are considered together as a logical unit of information (e.g. diastolic and systolic measures that comprise a blood pressure observation, or T, N, and M components of a Cancer Staging observation). is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 1..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: ObservationSet multivalued: false range: crdch_string required: true category: name: category description: The general category of observation set described notes: - 'Cardinality: 1..1' examples: - value: DimensionalMeasureSet - value: TissueCompositionMeasureSet - value: CellularCompositionMeasureSet values_from: crdch:enum_CRDCH_ObservationSet_category domain: ObservationSet multivalued: false range: CodeableConcept required: true focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..m' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: ObservationSet multivalued: true inlined_as_list: true range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ObservationSet multivalued: false range: Subject required: false method_type: name: method_type exact_mappings: - GDC:Analyte.spectrophotometer_method - PDC:Analyte.spectrophotometer_method - HTAN:Biospecimen.HistologyAssessmentMedium description: A type of method used in generating each of the Observations bundled in the set. notes: - 'Cardinality: 0..m' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy'). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_ObservationSet_method_type domain: ObservationSet multivalued: true range: CodeableConcept required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ObservationSet multivalued: false range: Organization required: false observations: name: observations description: A set of one or more more atomic observations that are conceptually or logically related - e.g. two components of some compound measurement (e.g. the systolic and diastolic components of a blood pressure measurement), or a panel of related measurements run and interpreted together on the same subject/specimen (e.g. a blood panel, or separate dimensional measurements of a specimen). notes: - 'Cardinality: 0..m' examples: - value: '' domain: ObservationSet multivalued: true inlined_as_list: true range: Observation required: false Organization: name: Organization description: A grouping of people or organizations with a common purpose such as a data coordinating center, an university, or an institute within a university notes: - Derived from [Organization in sheet Organization](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1477577710) is_a: Entity attributes: id: name: id exact_mappings: - GDC:Center.id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 1..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: Organization multivalued: false range: crdch_string required: true identifier: name: identifier exact_mappings: - GDC:Center.code - HTAN:Biospecimen.SiteDataSource description: A 'business' identifier or accession number for the entity, typically as provided by an external system or authority, that are globally unique and persist across implementing systems. Also, since these identifiers are created outside the information system through a specific business process, the Identifier type has additional attributes to capture this additional metadata so the actual identifier values are qualified by the context that created those values. This additional context allows "identifier" instances to be transmitted as business data across systems while still being able to trace them back to the system of origin. notes: - 'Cardinality: 0..m' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' domain: Organization multivalued: true inlined_as_list: true range: Identifier required: false name: name: name exact_mappings: - GDC:Center.name - GDC:Aliquot.source_center - HTAN:Biospecimen.SiteDataSource description: The full legal name by which the organization is known (e.g. 'National Cancer Institute') notes: - 'Cardinality: 0..1' examples: - value: '' domain: Organization multivalued: false range: crdch_string required: false alias: name: alias exact_mappings: - GDC:Center.short_name description: A secondary name for the organization such as a short name or abbreviation (e.g. 'NCI') notes: - 'Cardinality: 0..1' examples: - value: '' domain: Organization multivalued: false range: crdch_string required: false organization_type: name: organization_type exact_mappings: - GDC:Center.center_type description: The type of the organization (e.g. 'Cancer Genome Characterization Center') notes: - 'Cardinality: 0..1' comments: - See dev issues column examples: - value: '' domain: Organization multivalued: false range: crdch_string required: false Quantity: name: Quantity description: A structured object to represent an amount of something (e.g., weight, mass, length, duration of time) - including a value and unit. notes: - Derived from [Quantity in sheet Quantity](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1941950611) comments: - QuantityMeasure' may be implemented as an Observation-like object that will let us capture any type of measure of the amount of some substance (e.g. weight, volume, maybe even concentration?), with distinct timestamps and methods associated. It could be implemented as a "simple" observation (one measurement per instance, where the 'code' fields is bound to a value set describing the different types of quantity measures allowed - e.g. 'weight', 'volume', 'concentration'), or as "composite" observation (multiple measurements possible in a single instance, each captured as a component defined to hold a specific type of quantity measure - e.g. 'weight', 'volume', 'concentration'). The number of different quantity measures we anticipate needed to support, and the potential for data sparseness, are factors that determine whether a simple or composite Observation would be most appropriate. is_a: Entity attributes: value_decimal: name: value_decimal exact_mappings: - GDC:Sample.initial_weight - PDC:Sample.initial_weight - GDC:Sample.current_weight - GDC:Aliquot.amount - GDC:Portion.weight - GDC:Aliquot.aliquot_quantity - GDC:Analyte.amount - GDC:Analyte.analyte_quantity - PDC:Sample.current_weight - PDC:Aliquot.amount - PDC:Portion.weight - PDC:Aliquot.aliquot_quantity - PDC:Analyte.amount - PDC:Analyte.analyte_quantity - GDC:Aliquot.aliquot_volume - GDC:Aliquot.amount - GDC:Analyte.amount - GDC:Analyte.analyte_volume - PDC:Aliquot.aliquot_volume - PDC:Aliquot.amount - PDC:Analyte.amount - PDC:Analyte.analyte_volume - GDC:Aliquot.concentration - GDC:Analyte.concentration - PDC:Aliquot.concentration - PDC:Analyte.concentration - GDC:Sample.longest_dimension - GDC:Sample.shortest_dimension - GDC:Sample.intermediate_dimension - PDC:Sample.longest_dimension - PDC:Sample.shortest_dimension - PDC:Sample.intermediate_dimension - ICDC:Sample.length_of_tumor - ICDC:Sample.width_of_tumor - ICDC:Sample.total_tissue_area - GDC:Slide.number_proliferating_cells - GDC:Slide.percent_eosinophil_infiltration - GDC:Slide.percent_granulocyte_infiltration - GDC:Slide.percent_inflam_infiltration - GDC:Slide.percent_lymphocyte_infiltration - GDC:Slide.percent_monocyte_infiltration - GDC:Slide.percent_necrosis - GDC:Slide.percent_neutrophil_infiltration - GDC:Slide.percent_normal_cells - GDC:Slide.percent_stromal_cells - GDC:Slide.percent_tumor_cells - GDC:Slide.percent_tumor_nuclei - GDC:Slide.percent_rhabdoid_features - GDC:Slide.percent_sarcomatoid_features - HTAN:Biospecimen.NumberProliferatingCells - HTAN:Biospecimen.PercentEosinophilInfiltration - HTAN:Biospecimen.PercentGranulocyteInfiltration - HTAN:Biospecimen.PercentInflamInfiltration - HTAN:Biospecimen.PercentLymphocyteInfiltration - HTAN:Biospecimen.PercentMonocyteInfiltration - HTAN:Biospecimen.PercentNecrosis - HTAN:Biospecimen.PercentNeutrophilInfiltration - HTAN:Biospecimen.PercentNormalCells - HTAN:Biospecimen.PercentStromalCells - HTAN:Biospecimen.PercentTumorCells - HTAN:Biospecimen.PercentTumorNuclei - HTAN:Biospecimen.TumorInfiltratingLymphocytes - ICDC:Sample.non_tumor_tissue_area - ICDC:Sample.tumor_tissue_area - ICDC:Sample.percentage_tumor - ICDC:Sample.percentage_stroma - ICDC:Sample.analysis_area - ICDC:Sample.analysis_area_percentage_stroma - ICDC:Sample.analysis_area_percentage_tumor - ICDC:Sample.analysis_area_percentage_glass - ICDC:Sample.analysis_area_percentage_pigmented_tumor - HTAN:Biospecimen.CollectionDaysfromIndex - HTAN:Biospecimen.ProcessingDaysfromIndex - HTAN:Biospecimen.SectioningDaysfromIndex - PDC:Sample.days_to_collection - GDC:Sample.time_between_excision_and_freezing - GDC:Sample.time_between_clamping_and_freezing - PDC:Sample.time_between_excision_and_freezing - PDC:Sample.time_between_clamping_and_freezing - HTAN:Biospecimen.ISCHEMIC_TIME - HTAN:Biospecimen.FIXATION_DURATION - GDC:Treatment.treatment_dose - GDC:Treatment.days_to_treatment_end - PDC:Treatment.days_to_treatment_end - GDC:Treatment.days_to_treatment_start - PDC:Treatment.days_to_treatment_start - GDC:Diagnosis.tumor_largest_dimension_diameter - PDC:Diagnosis.tumor_largest_dimension_diameter - GDC:Diagnosis.age_at_diagnosis - PDC:Diagnosis.age_at_diagnosis - HTAN:Diagnosis.AgeatDiagnosis - GDC:Diagnosis.days_to_diagnosis - PDC:Diagnosis.days_to_diagnosis description: An amount, in the given units (if specified) notes: - 'Cardinality: 0..1' examples: - value: '' domain: Quantity multivalued: false range: crdch_decimal required: false value_codeable_concept: name: value_codeable_concept exact_mappings: - GDC:Sample.distance_normal_to_tumor - PDC:Sample.distance_normal_to_tumor description: A coded value representing a quantity (e.g. "Adjacent (< or = 2cm)") notes: - 'Cardinality: 0..1' examples: - value: '' values_from: crdch:enum_CRDCH_Quantity_value_codeable_concept domain: Quantity multivalued: false range: CodeableConcept required: false unit: name: unit exact_mappings: - GDC:Treatment.treatment_dose_unit description: A coded or free text (in the .text field) representation of the unit. notes: - 'Cardinality: 0..1' examples: - value: '' values_from: crdch:enum_CRDCH_Quantity_unit domain: Quantity multivalued: false range: CodeableConcept required: false ResearchProject: name: ResearchProject description: "A process where a researcher or organization plans and then executes\ \ a series of steps intended to increase the field of healthcare-related knowledge.\ \ \nThis includes studies of safety, efficacy, comparative effectiveness and\ \ other information about medications, devices, therapies and other interventional\ \ \nand investigative techniques. A ResearchProject involves the gathering of\ \ information about human or animal subjects." notes: - Derived from [ResearchProject in sheet ResearchProject](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1123416579) is_a: Entity attributes: id: name: id exact_mappings: - GDC:Program.id - PDC:Program.program_id - PDC:Project.project_id - GDC:Project.id - ICDC:Study.clinical_study_id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: ResearchProject multivalued: false range: crdch_string required: false identifier: name: identifier close_mappings: - GDC:Program.program_id - GDC:Project.project_id - GDC:Program.dbgap_accession_number - GDC:Project.dbgap_accession_number - PDC:Program.program_submitter_id - PDC:Project.project_submitter_id - ICDC:Study.clinical_study_designation description: A 'business' identifier or accession number for the entity, typically as provided by an external system or authority, that are globally unique and persist across implementing systems. Also, since these identifiers are created outside the information system through a specific business process, the Identifier type has additional attributes to capture this additional metadata so the actual identifier values are qualified by the context that created those values. This additional context allows "identifier" instances to be transmitted as business data across systems while still being able to trace them back to the system of origin. notes: - 'Cardinality: 0..m' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' domain: ResearchProject multivalued: true inlined_as_list: true range: Identifier required: false name: name: name exact_mappings: - GDC:Program.name - PDC:Program.name - ICDC:Program.program_name - GDC:Project.name - PDC:Project.name - ICDC:Study.clinical_study_name description: An unabridged name of a research program, project, or study. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ResearchProject multivalued: false range: crdch_string required: false name_shortened: name: name_shortened exact_mappings: - ICDC:Program.program_acronym - PDC:Program.program_shortname description: An abbreviated name of a research program, project, or study. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ResearchProject multivalued: false range: crdch_string required: false description: name: description exact_mappings: - ICDC:Program.program_full_description description: An unabridged description of a research program, project, or study. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ResearchProject multivalued: false range: crdch_string required: false description_shortened: name: description_shortened exact_mappings: - ICDC:Program.program_short_description description: An abbreviated description of a research program, project, or study. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ResearchProject multivalued: false range: crdch_string required: false sponsor: name: sponsor exact_mappings: - PDC:Program.sponsor description: An entity that is responsible for the initiation, management, and/or financing of a research project. notes: - 'Cardinality: 0..m' examples: - value: '' domain: ResearchProject multivalued: true inlined_as_list: true range: crdch_string required: false date_started: name: date_started close_mappings: - ICDC:Study.dates_of_conduct description: The date when the research project began. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ResearchProject multivalued: false range: TimePoint required: false date_ended: name: date_ended close_mappings: - ICDC:Study.dates_of_conduct description: The date when the research project ended. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ResearchProject multivalued: false range: TimePoint required: false primary_anatomic_site: name: primary_anatomic_site close_mappings: - GDC:Project.primary_site description: The text term used to describe the general location of the malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O). In the context of ResearchProject, this attribute captures the anatomic sites of research interest. notes: - 'Cardinality: 0..m' examples: - value: '' domain: ResearchProject multivalued: true inlined_as_list: true range: BodySite required: false url: name: url exact_mappings: - ICDC:Program.program_external_url description: A URL address for a resource that provides information about a research program, project, or study. notes: - 'Cardinality: 0..m' examples: - value: '' domain: ResearchProject multivalued: true inlined_as_list: true range: crdch_string required: false part_of: name: part_of description: A reference to a parent ResearchProject (e.g. a link to the overarching CPTAC ResearchProject from a substudy of CPTAC) notes: - 'Cardinality: 0..m' examples: - value: '' domain: ResearchProject multivalued: true inlined_as_list: true range: ResearchProject required: false research_project_type: name: research_project_type exact_mappings: - ICDC:Study.clinical_study_type close_mappings: - GDC:Program - GDC:Project - PDC:Program - PDC:Project - ICDC:Program - ICDC:Study description: The 'type' of ResearchProject represented (e.g. a broad-based Program like 'CPTAC' or a more focused Project like 'CPTAC PDAC Discovery Study') notes: - 'Cardinality: 1..1' examples: - value: Program - value: Project - value: Clinical Trial values_from: crdch:enum_CRDCH_ResearchProject_research_project_type domain: ResearchProject multivalued: false range: CodeableConcept required: true associated_timepoint: name: associated_timepoint close_mappings: - ICDC:Study.date_of_iacuc_approval description: A collection of timepoint observations that are relevant to research projects (e.g. date of IACUC approval, date of IRB approval, date of embargo end, etc.) notes: - 'Cardinality: 0..m' examples: - value: '' domain: ResearchProject multivalued: true inlined_as_list: true range: TimePoint required: false ResearchSubject: name: ResearchSubject description: "A research subject is the entity of interest in a research study,\ \ typically a human being or an animal, but can also be a device, group of humans\ \ or animals, \nor a tissue sample. Human research subjects are usually not\ \ traceable to a particular person to protect the subject\u2019s privacy." notes: - Derived from [ResearchSubject in sheet ResearchSubject](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=665511119) is_a: Entity attributes: id: name: id exact_mappings: - GDC:Case.id - ICDC:Case.case_id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 1..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: ResearchSubject multivalued: false range: crdch_string required: true identifier: name: identifier close_mappings: - GDC:Case.submitter_id - PDC:Case.case_submitter_id description: A 'business' identifier or accession number for the entity, typically as provided by an external system or authority, that are globally unique and persist across implementing systems. Also, since these identifiers are created outside the information system through a specific business process, the Identifier type has additional attributes to capture this additional metadata so the actual identifier values are qualified by the context that created those values. This additional context allows "identifier" instances to be transmitted as business data across systems while still being able to trace them back to the system of origin. notes: - 'Cardinality: 0..m' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' domain: ResearchSubject multivalued: true inlined_as_list: true range: Identifier required: false description: name: description description: A free text field to capture additional info/explanation about the research subject. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ResearchSubject multivalued: false range: crdch_string required: false member_of_research_project: name: member_of_research_project exact_mappings: - GDC:Case.member_of - GDC:Case.project_id - PDC:Case.Project - ICDC:Case.member_of description: A reference to the Study(s) of which this ResearchSubject is a member notes: - 'Cardinality: 0..1' examples: - value: '' domain: ResearchSubject multivalued: false range: ResearchProject required: false age_at_enrollment: name: age_at_enrollment close_mappings: - ICDC:Demographic.patient_age_at_enrollment description: The age in days when the Subject enrolled on the ResearchProject notes: - 'Cardinality: 0..1' examples: - value: '' domain: ResearchSubject multivalued: false range: Quantity required: false primary_diagnosis_condition: name: primary_diagnosis_condition exact_mappings: - GDC:Case.disease_type - PDC:Case.disease_type description: The text term used to describe the type of malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O). This attribute represents the disease that qualified the subject for inclusion on the ResearchProject notes: - 'Cardinality: 0..1' comments: - In cases where a data source does not have sufficiently detailed information on the diagnosis that qualified a subject for inclusion on a ResearchProject in order to instantiate a Diagnosis entity, the primary_diagnosis_condition attribute should be populated when available. examples: - value: Acinar Cell Neoplasms - value: Adenomas and Adenocarcinomas - value: Adnexal and Skin Appendage Neoplasms - value: '' values_from: crdch:enum_CRDCH_ResearchSubject_primary_diagnosis_condition domain: ResearchSubject multivalued: false range: CodeableConcept required: false primary_diagnosis_site: name: primary_diagnosis_site close_mappings: - GDC:Case.primary_site - PDC:Case.primary_site description: The text term used to describe the primary site of disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O). This categorization groups cases into general categories. This attribute represents the primary site of disease that qualified the subject for inclusion on the ResearchProject. notes: - 'Cardinality: 0..1' comments: - In cases where a data source does not have sufficiently detailed information on the diagnosis that qualified a subject for inclusion on a ResearchProject in order to instantiate a Diagnosis entity, the primary_diagnosis_site attribute should be populated when available. examples: - value: Accessory sinuses - value: Adrenal gland - value: Anus and anal canal - value: '' domain: ResearchSubject multivalued: false range: BodySite required: false primary_diagnosis: name: primary_diagnosis description: The diagnosis instance that qualified a subject for inclusion on a ResearchProject notes: - 'Cardinality: 0..m' comments: - In cases where a data source has sufficiently detailed information on the diagnosis that qualifies a subject for inclusion on a ResearchProject, a Diagnosis entity should be instantiated and included here. examples: - value: '' domain: ResearchSubject multivalued: true inlined_as_list: true range: Diagnosis required: false comorbid_diagnosis: name: comorbid_diagnosis close_mappings: - ICDC:Diagnosis.concurrent_disease - ICDC:Diagnosis.concurrent_disease_type - GDC:Diagnosis.synchronous_malignancy - PDC:Diagnosis.synchronous_malignancy description: One or more diagnosis instance that are comorbid with the primary_diagnosis that qualified a subject for inclusion on a ResearchProject notes: - 'Cardinality: 0..m' comments: - In cases where a data source has sufficiently detailed information on comorbid diagnoses related to the diagnosis that qualified a subject for inclusion on a ResearchProject, a Diagnosis entity should be instantiated and included here. examples: - value: '' domain: ResearchSubject multivalued: true inlined_as_list: true range: Diagnosis required: false index_timepoint: name: index_timepoint exact_mappings: - GDC:Case.index_date - PDC:Case.index_date description: The text term used to describe the reference or anchor date used for date obfuscation, where a single date is obscured by creating one or more date ranges in relation to this date. notes: - 'Cardinality: 0..1' examples: - value: Diagnosis - value: First Patient Visit - value: First Treatment - value: '' values_from: crdch:enum_CRDCH_ResearchSubject_index_timepoint domain: ResearchSubject multivalued: false range: CodeableConcept required: false originating_site: name: originating_site exact_mappings: - PDC:Case.tissue_source_site_code description: The Organization at which a subject was enrolled on a ResearchProject. notes: - 'Cardinality: 0..1' examples: - value: '' domain: ResearchSubject multivalued: false range: Organization required: false associated_subject: name: associated_subject description: A reference to the Subject that is this ResearchSubject notes: - 'Cardinality: 1..1' examples: - value: '' domain: ResearchSubject multivalued: false range: Subject required: true Specimen: name: Specimen description: Any material taken as a sample from a biological entity (living or dead), or from a physical object or the environment. Specimens are usually collected as an example of their kind, often for use in some investigation. notes: - Derived from [Specimen in sheet Specimen](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1439310281) comments: - Definition adapted from FHIR Specimen. is_a: Entity attributes: id: name: id exact_mappings: - GDC:Aliquot.id - GDC:Analyte.id - GDC:Portion.id - GDC:Sample.id - GDC:Slide.id - PDC:Aliquot.aliquot_id - PDC:Analyte.analyte_id - PDC:Portion.portion_id - PDC:Sample.sample_id - ICDC:Sample.sample_id - HTAN:Biospecimen.HTANBiospecimenID description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: Specimen multivalued: false range: crdch_string required: false identifier: name: identifier close_mappings: - GDC:Sample.submitter_id - GDC:Analyte.submitter_id - GDC:Slide.submitter_id - PDC:Sample.sample_submitter_id - PDC:Analyte.analyte_submitter_id description: A 'business' identifier or accession number for the entity, typically as provided by an external system or authority, that are globally unique and persist across implementing systems. Also, since these identifiers are created outside the information system through a specific business process, the Identifier type has additional attributes to capture this additional metadata so the actual identifier values are qualified by the context that created those values. This additional context allows "identifier" instances to be transmitted as business data across systems while still being able to trace them back to the system of origin. notes: - 'Cardinality: 0..m' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' domain: Specimen multivalued: true inlined_as_list: true range: Identifier required: false description: name: description exact_mappings: - ICDC:Sample.comment description: A free text field to capture additional information or explanation about the specimen. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Specimen multivalued: false range: crdch_string required: false specimen_type: name: specimen_type exact_mappings: - HTAN:Biospecimen.BiospecimenType close_mappings: - GDC:Sample - GDC:Portion - GDC:Analyte - GDC:Aliquot - GDC:Slide - PDC:Sample - PDC:Portion - PDC:Analyte - PDC:Aliquot - PDC:Slide - ICDC:Sample description: The high-level type of the specimen, based on its derivation provenance (i.e. how far removed it is from the original sample extracted from a source). notes: - 'Cardinality: 0..1' comments: - Our model defines a single 'Specimen' type to cover speific subtypes of specimens delineated in some CRDC node models (e.g. GDC 'Sample', 'Portion', 'Aliquot', 'Analyte', and 'Slide'). The 'specimen_type' field is used to indicate which subtype a given Specimen instance represents. The enumerated values are meant to be mutually exclusive, such that only one can be applied to a given specimen. examples: - value: Fresh Specimen - value: Portion - value: Aliquot - value: Analyte - value: Slide values_from: crdch:enum_CRDCH_Specimen_specimen_type domain: Specimen multivalued: false range: CodeableConcept required: false analyte_type: name: analyte_type exact_mappings: - GDC:Aliquot.analyte_type - GDC:Aliquot.analyte_type_id - GDC:Analyte.analyte_type - GDC:Analyte.analyte_type_id - PDC:Aliquot.analyte_type - PDC:Aliquot.analyte_type_id - PDC:Analyte.analyte_type - PDC:Analyte.analyte_type_id - HTAN:Biospecimen.AnalyteBiospecimenType description: For specimens of type 'analyte' (or an 'aliquot' derived from an analyte), this is the category of chemcial the analyte of interest represents (e.g. DNA, RNA) notes: - 'Cardinality: 0..1' examples: - value: DNA - value: FFPE DNA - value: GenomePlex (Rubicon) Amplified DNA - value: Repli-G (Qiagen) DNA - value: RNA - value: FFPE RNA values_from: crdch:enum_CRDCH_Specimen_analyte_type domain: Specimen multivalued: false range: CodeableConcept required: false associated_project: name: associated_project exact_mappings: - GDC:Sample.project_id - GDC:Portion.project_id - GDC:Aliquot.project_id - GDC:Analyte.project_id - PDC:Sample.gdc_project_id description: The Project associated with the specimen. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Specimen multivalued: false range: ResearchProject required: false data_provider: name: data_provider close_mappings: - GDC:Aliquot.source_center - HTAN:Biospecimen.SiteDataSource description: The organization (e.g.a laboratory, processing center, or research site) that provided data associated with a specimen. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Specimen multivalued: false range: Organization required: false source_material_type: name: source_material_type exact_mappings: - GDC:Sample.sample_type - GDC:Sample.sample_type_id - PDC:Sample.sample_type - PDC:Sample.sample_type_id - ICDC:Sample.physical_sample_type - HTAN:Biospecimen.BiospecimenType description: The general kind of material from which the specimen was derived. notes: - 'Cardinality: 0..1' comments: - Values captured here may describe the type of molecular mixture, cell, tissue, organ, body fluid, embryo, excretory substance, or experimental system from which a specimen was derived. examples: - value: Tissue - value: Blood - value: Tumor Aspirate - value: Cell Line - value: Expanded Next Generation Cancer Model - value: Pleural Effusion - value: Xenograft Tissue values_from: crdch:enum_CRDCH_Specimen_source_material_type domain: Specimen multivalued: false range: CodeableConcept required: false parent_specimen: name: parent_specimen exact_mappings: - GDC:Sample.derived_from - GDC:Aliquot.derived_from - GDC:Aliquot.derived_from - GDC:Analyte.derived_from - GDC:Analyte.derived_from - GDC:Portion.derived_from - GDC:Slide.derived_from - PDC:Aliquot.Sample - PDC:Analyte.Portion - PDC:Analyte.Sample - PDC:Portion.Sample - HTAN:Biospecimen.HTANParentID description: An existing specimen from which the specimen of interest was directly derived (i.e its immediate parent specimen). notes: - 'Cardinality: 0..m' comments: - This property indicates only the direct parent specimen(s). Cardinality is 0..m to account for specimens derived from pooling of multiple specimens. examples: - value: '' domain: Specimen multivalued: true inlined_as_list: true range: Specimen required: false source_subject: name: source_subject exact_mappings: - PDC:Sample.Case - GDC:Sample.derived_from - ICDC:Sample.of_case - HTAN:Biospecimen.HTANParentID description: A specific Subject from which the specimen was directly or indirectly derived. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Specimen multivalued: false range: Subject required: false tumor_status_at_collection: name: tumor_status_at_collection exact_mappings: - GDC:Sample.tumor_descriptor - PDC:Sample.tumor_descriptor - HTAN:Biospecimen.TUMOR_TISSUE_TYPE - ICDC:Sample.tumor_sample_origin - GDC:Diagnosis.classification_of_tumor - PDC:Diagnosis.classification_of_tumor description: The status of the tumor at the time the specimen was collected (e.g. if it was primary, recurrent, metastatic, etc). notes: - 'Cardinality: 0..1' examples: - value: Additional Primary - value: Local recurrence - value: Metastatic - value: NOS - value: Premalignant - value: Primary - value: Recurrent - value: Xenograft values_from: crdch:enum_CRDCH_Specimen_tumor_status_at_collection domain: Specimen multivalued: false range: CodeableConcept required: false creation_activity: name: creation_activity close_mappings: - GDC:Portion.creation_datetime - PDC:Portion.creation_datetime - PDC:Sample.days_to_collection - ICDC:Sample.date_of_sample_collection - HTAN:Biospecimen.CollectionDaysfromIndex - GDC:Sample.method_of_sample_procurement - PDC:Sample.method_of_sample_procurement - PDC:Sample.pool - PDC:Aliquot.pool - HTAN:Biospecimen.AcquisitionMethodType - HTAN:Biospecimen.SlicingMethod - HTAN:Biospecimen.MethodofNucleicAcidIsolation - HTAN:Biospecimen.LysisBuffer - GDC:Sample.biospecimen_anatomic_site - GDC:Sample.biospecimen_laterality - PDC:Sample.biospecimen_anatomic_site - PDC:Sample.biospecimen_laterality - ICDC:Sample.sample_site - HTAN:Biospecimen.SiteofResectionorBiopsy - GDC:Sample.initial_weight - PDC:Sample.initial_weight - GDC:Sample.time_between_excision_and_freezing - GDC:Sample.time_between_clamping_and_freezing - PDC:Sample.time_between_excision_and_freezing - PDC:Sample.time_between_clamping_and_freezing - HTAN:Biospecimen.ISCHEMIC_TEMPERATURE - HTAN:Biospecimen.ISCHEMIC_TIME - GDC:Portion.portion_number - PDC:Portion.portion_number - ICDC:Sample.on_visit - ICDC:Sample.necropsy_sample - HTAN:Biospecimen.TimepointLabel description: The activity through which a specimen was created, by removing material from an biological subject, or deriving material from an existing specimen. notes: - 'Cardinality: 0..1' comments: - Note that a given specimen is the result of only one and only one SpecimenCreationActivity, but may be subject to many processing events that subsequently modify or derive new specimens from it. examples: - value: '' domain: Specimen multivalued: false range: SpecimenCreationActivity required: false processing_activity: name: processing_activity close_mappings: - HTAN:Biospecimen.ProcessingDaysfromIndex - HTAN:Biospecimen.FIXATION_DURATION - GDC:Sample.processed_at - HTAN:Biospecimen.ProcessingLocation - GDC:Sample.freezing_method - GDC:Sample.preservation_method - GDC:Sample.is_ffpe - GDC:Portion.is_ffpe - GDC:Sample.oct_embedded - PDC:Sample.freezing_method - PDC:Sample.preservation_method - PDC:Sample.is_ffpe - GDC:Portion.is_ffpe - PDC:Sample.oct_embedded - HTAN:Biospecimen.PRESERVATION_METHOD - HTAN:Biospecimen.FixativeType - HTAN:Biospecimen.MountingMedium description: An activity that modifies the physical structure, composition, or state of a specimen. notes: - 'Cardinality: 0..m' comments: - Note that a given specimen may undergo more than one distinct processing activity, through application of different methodologies that modify its physical state. However, if an activity generates a new specimen (e.g. via portioning, slicing) it is considered a SpeciemnCreationActivity. examples: - value: '' domain: Specimen multivalued: true inlined_as_list: true range: SpecimenProcessingActivity required: false storage_activity: name: storage_activity close_mappings: - HTAN:Biospecimen.StorageMethod description: An activity that results in the storage or maintenance of a specimen in a particular location, container, or state. notes: - 'Cardinality: 0..m' comments: - 'The 0..m cardinality of this attribute reflects the fact that a given specimen may undergo many separate periods of storage, in different locations and/or under different conditions ' examples: - value: '' domain: Specimen multivalued: true inlined_as_list: true range: SpecimenStorageActivity required: false transport_activity: name: transport_activity close_mappings: - GDC:Portion.shipped_to - GDC:Aliquot.shipped_to description: An activity through which the specimen is transported between locations. notes: - 'Cardinality: 0..m' comments: - The 0..m cardinality of this attribute reflects the fact that a given specimen may undergo many separate transport processes at different periods of time. examples: - value: '' domain: Specimen multivalued: true inlined_as_list: true range: SpecimenTransportActivity required: false contained_in: name: contained_in close_mappings: - GDC:Analyte.well_number - PDC:Analyte.well_number - HTAN:Biospecimen.CollectionMedia - GDC:Slide.charge_type description: A physical container in which a specimen is presently held or attached - as storage for future use, a substrate for growth (e.g. a cell culture dish), or a vessel to enable analysis (e.g. a microscope slide or 96-well plate) notes: - 'Cardinality: 0..1' comments: - 'The 0..1 cardinality on this attribute means that you cannot directly references multiple nested containers holding a sample. To capture this scenario, use the ''parent_container'' attribute of the Container entity. ' examples: - value: '' domain: Specimen multivalued: false range: SpecimenContainer required: false dimensional_measures: name: dimensional_measures close_mappings: - GDC:Sample.longest_dimension - GDC:Sample.shortest_dimension - GDC:Sample.intermediate_dimension - PDC:Sample.longest_dimension - PDC:Sample.shortest_dimension - PDC:Sample.intermediate_dimension - ICDC:Sample.length_of_tumor - ICDC:Sample.width_of_tumor - ICDC:Sample.total_tissue_area description: Observations about the current physical dimensions of an object (e.g. length, width, area). notes: - 'Cardinality: 0..1' comments: - Observations are flexible containers for capturing a specific type of observation/measurement data about an object, along with metadata about how it was generated. The specific type of observation made is captured as data in the Observation object. examples: - value: '' domain: Specimen multivalued: false range: DimensionalObservationSet required: false quantity_measure: name: quantity_measure close_mappings: - GDC:Sample.current_weight - GDC:Aliquot.amount - GDC:Portion.weight - GDC:Aliquot.aliquot_quantity - GDC:Analyte.amount - GDC:Analyte.analyte_quantity - PDC:Sample.current_weight - PDC:Aliquot.amount - PDC:Portion.weight - PDC:Aliquot.aliquot_quantity - PDC:Analyte.amount - PDC:Analyte.analyte_quantity - GDC:Aliquot.aliquot_volume - GDC:Aliquot.amount - GDC:Analyte.amount - GDC:Analyte.analyte_volume - PDC:Aliquot.aliquot_volume - PDC:Aliquot.amount - PDC:Analyte.amount - PDC:Analyte.analyte_volume - GDC:Aliquot.concentration - GDC:Analyte.concentration - PDC:Aliquot.concentration - PDC:Analyte.concentration - GDC:Analyte.spectrophotometer_method - PDC:Analyte.spectrophotometer_method description: An observation related to the present quantity of a specimen - e.g. its weight, volume, or analyte concentration. notes: - 'Cardinality: 0..m' comments: - Observations are flexible containers for capturing a specific type of observation/measurement data about an object, along with metadata about how it was generated. The specific type of observation made is captured as data in the Observation object. examples: - value: '' domain: Specimen multivalued: true inlined_as_list: true range: SpecimenQuantityObservation required: false quality_measure: name: quality_measure close_mappings: - GDC:Analyte.a260_a280_ratio - GDC:Analyte.ribosomal_rna_28s_16s_ratio - PDC:Analyte.a260_a280_ratio - PDC:Analyte.ribosomal_rna_28s_16s_ratio description: An observation about characteristics of a specimen that are indicative of its quality or suitability for use. notes: - 'Cardinality: 0..m' comments: - Observations are flexible containers for capturing a specific type of observation/measurement data about an object, along with metadata about how it was generated. The specific type of observation made is captured as data in the Observation object. examples: - value: '' domain: Specimen multivalued: true inlined_as_list: true range: SpecimenQualityObservation required: false cellular_composition_type: name: cellular_composition_type exact_mappings: - GDC:Sample.composition - PDC:Sample.composition description: A term describing the type of cell or cellular material comprising a specimen. notes: - 'Cardinality: 0..1' examples: - value: 2D Classical Conditionally Reprogrammed Cells - value: Adherent Cell Line - value: Bone Marrow Components - value: Buccal Cells - value: Buffy Coat - value: Derived Cell Line - value: Granulocytes - value: Pleural Effusion - value: Human Original Cells - value: Liquid Suspension Cell Line values_from: crdch:enum_CRDCH_Specimen_cellular_composition_type domain: Specimen multivalued: false range: CodeableConcept required: false histological_composition_measures: name: histological_composition_measures close_mappings: - GDC:Slide.number_proliferating_cells - GDC:Slide.percent_eosinophil_infiltration - GDC:Slide.percent_granulocyte_infiltration - GDC:Slide.percent_inflam_infiltration - GDC:Slide.percent_lymphocyte_infiltration - GDC:Slide.percent_monocyte_infiltration - GDC:Slide.percent_necrosis - GDC:Slide.percent_neutrophil_infiltration - GDC:Slide.percent_normal_cells - GDC:Slide.percent_stromal_cells - GDC:Slide.percent_tumor_cells - GDC:Slide.percent_tumor_nuclei - GDC:Slide.percent_rhabdoid_features - GDC:Slide.percent_sarcomatoid_features - HTAN:Biospecimen.NumberProliferatingCells - HTAN:Biospecimen.PercentEosinophilInfiltration - HTAN:Biospecimen.PercentGranulocyteInfiltration - HTAN:Biospecimen.PercentInflamInfiltration - HTAN:Biospecimen.PercentLymphocyteInfiltration - HTAN:Biospecimen.PercentMonocyteInfiltration - HTAN:Biospecimen.PercentNecrosis - HTAN:Biospecimen.PercentNeutrophilInfiltration - HTAN:Biospecimen.PercentNormalCells - HTAN:Biospecimen.PercentStromalCells - HTAN:Biospecimen.PercentTumorCells - HTAN:Biospecimen.PercentTumorNuclei - HTAN:Biospecimen.TumorInfiltratingLymphocytes - ICDC:Sample.non_tumor_tissue_area - ICDC:Sample.tumor_tissue_area - ICDC:Sample.percentage_tumor - ICDC:Sample.percentage_stroma - ICDC:Sample.analysis_area - ICDC:Sample.analysis_area_percentage_stroma - ICDC:Sample.analysis_area_percentage_tumor - ICDC:Sample.analysis_area_percentage_glass - ICDC:Sample.analysis_area_percentage_pigmented_tumor description: A set of one or more observations that quantify the relative or absolute composition of a specimen at cellular level - e.g. how many cells in the specimen are of a given type, or exhibit a particular cellular phenotype. notes: - 'Cardinality: 0..m' comments: - Observations are flexible containers for capturing a specific type of observation/measurement data about an object, along with metadata about how it was generated. The specific type of observation made is captured as data in the Observation object. examples: - value: '' domain: Specimen multivalued: true inlined_as_list: true range: HistologicalCompositionObservationSet required: false general_tissue_pathology: name: general_tissue_pathology exact_mappings: - GDC:Sample.tissue_type - PDC:Sample.tissue_type - ICDC:Sample.general_sample_pathology description: The high-level kind of tissue collected when generating a specimen, based on its disease status or proximity to tumor tissue (e.g. is it normal, abnormal, tumor, tumor-adjacent). notes: - 'Cardinality: 0..1' examples: - value: Tumor - value: Normal - value: Abnormal - value: Peritumoral - value: not applicable values_from: crdch:enum_CRDCH_Specimen_general_tissue_pathology domain: Specimen multivalued: false range: CodeableConcept required: false specific_tissue_pathology: name: specific_tissue_pathology exact_mappings: - GDC:Sample.tumor_code - GDC:Sample.tumor_code_id - PDC:Sample.tumor_code - PDC:Sample.tumor_code_id - ICDC:Sample.specific_sample_pathology - HTAN:Biospecimen.HistologicMorphologyCode description: A term describing the specific pathology exhibited by the tissue comprising a specimen. notes: - 'Cardinality: 0..1' examples: - value: Non cancerous tissue - value: Lung Cancer (all types) - value: CNS, medulloblastoma - value: '00' - value: '01' - value: '02' - value: Melanocytic hyperplasia - value: Atypical melanocytic proliferation - value: Melanoma in situ, superficial spreading values_from: crdch:enum_CRDCH_Specimen_specific_tissue_pathology domain: Specimen multivalued: false range: CodeableConcept required: false preinvasive_tissue_morphology: name: preinvasive_tissue_morphology exact_mappings: - HTAN:Biospecimen.PreinvasiveMorphology description: A term describing the specific pathology exhibited by pre-invasive tissue comprising a specimen. notes: - 'Cardinality: 0..1' examples: - value: '' values_from: crdch:enum_CRDCH_Specimen_preinvasive_tissue_morphology domain: Specimen multivalued: false range: CodeableConcept required: false morphology_pathologically_confirmed: name: morphology_pathologically_confirmed exact_mappings: - GDC:Sample.diagnosis_pathologically_confirmed - PDC:Sample.diagnosis_pathologically_confirmed description: A flag indicating whether the histologic assessment of specific morphology was confirmed by pathologist review. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Specimen multivalued: false range: crdch_boolean required: false morphology_assessor_role: name: morphology_assessor_role exact_mappings: - HTAN:Biospecimen.HistologyAssessmentBy description: A term describing the role of the person who histologically assessed the specific tissue morphology of a specimen notes: - 'Cardinality: 0..1' examples: - value: Pathologist - value: Research Scientist - value: Other - value: Unknown values_from: crdch:enum_CRDCH_Specimen_morphology_assessor_role domain: Specimen multivalued: false range: CodeableConcept required: false morphology_assessment_method: name: morphology_assessment_method exact_mappings: - HTAN:Biospecimen.HistologyAssessmentMedium description: The general method used to assess a specimens specific tissue morphology notes: - 'Cardinality: 0..1' examples: - value: Digital - value: Microscopy - value: Other - value: Unknown values_from: crdch:enum_CRDCH_Specimen_morphology_assessment_method domain: Specimen multivalued: false range: CodeableConcept required: false degree_of_dysplasia: name: degree_of_dysplasia exact_mappings: - HTAN:Biospecimen.DegreeofDysplasia description: A term describing the nature/extent of abnormal cells that are not cancer, as observed upon microscopic assessment of a specimen. Records the degree of dysplasia for the cyst or lesion under consideration. notes: - 'Cardinality: 0..1' examples: - value: Normal or basal cell hyperplasia or metaplasia - value: Mild dysplasia - value: Moderate dysplasia - value: Severe dysplasia - value: Carcinoma in Situ - value: Unknown values_from: crdch:enum_CRDCH_Specimen_degree_of_dysplasia domain: Specimen multivalued: false range: CodeableConcept required: false dysplasia_fraction: name: dysplasia_fraction exact_mappings: - HTAN:Biospecimen.DysplasiaFraction description: Resulting value to represent the number of pieces of dysplasia divided by the total number of pieces. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Specimen multivalued: false range: crdch_string required: false related_document: name: related_document close_mappings: - GDC:Sample.pathology_report_uuid - PDC:Sample.pathology_report_uuid - HTAN:Biospecimen.ProtocolLink description: A reference to an external document that is about or related to the specimen (e.g. a publication related to the study it is a part of, pathology report containing additional details about it, protocol describing how it was collected) notes: - 'Cardinality: 0..m' examples: - value: '' domain: Specimen multivalued: true inlined_as_list: true range: Document required: false section_location: name: section_location exact_mappings: - GDC:Slide.section_location description: The location in a parent specimen from which a section/portion was excised (e.g. top, middle, bottom) notes: - 'Cardinality: 0..1' comments: - This attribute applies only to Specimens that are of type 'portion' or 'slide'. examples: - value: Top - value: Bottom - value: Unknown values_from: crdch:enum_CRDCH_Specimen_section_location domain: Specimen multivalued: false range: CodeableConcept required: false derived_product: name: derived_product close_mappings: - GDC:Sample.passage_count - GDC:Sample.growth_rate - PDC:Sample.passage_count - PDC:Sample.growth_rate description: A 'living' biologically active product that was derived from the specimen (e.g. a cell culture, tissue culture, or organoid) notes: - 'Cardinality: 0..m' examples: - value: '' domain: Specimen multivalued: true inlined_as_list: true range: BiologicProduct required: false distance_from_paired_specimen: name: distance_from_paired_specimen close_mappings: - GDC:Sample.distance_normal_to_tumor - PDC:Sample.distance_normal_to_tumor description: The observed distance in the body of the specimen from a 'paired specimen' at the time of collection. (e.g. the distance between the in vivo location of a tumor tissue specimen and its paired normal specimen) notes: - 'Cardinality: 0..1' examples: - value: '' domain: Specimen multivalued: false range: Quantity required: false SpecimenContainer: name: SpecimenContainer description: A vessel in which a specimen is held or to which it is attached - for storage or as a substrate for growth (e.g. a cell culture dish) or analysis (e.g. a microscope slide or 96-well plate) notes: - Derived from [SpecimenContainer in sheet SpecimenContainer](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=729222697) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: SpecimenContainer multivalued: false range: crdch_string required: false identifier: name: identifier description: A 'business' identifier or accession number for the entity, typically as provided by an external system or authority, that are globally unique and persist across implementing systems. Also, since these identifiers are created outside the information system through a specific business process, the Identifier type has additional attributes to capture this additional metadata so the actual identifier values are qualified by the context that created those values. This additional context allows "identifier" instances to be transmitted as business data across systems while still being able to trace them back to the system of origin. notes: - 'Cardinality: 0..m' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' domain: SpecimenContainer multivalued: true inlined_as_list: true range: Identifier required: false container_type: name: container_type description: The kind of the container. notes: - 'Cardinality: 0..1' examples: - value: Capillary blood collection tube - value: Sputum specimen container - value: Cell culture flask - value: Glass slide values_from: crdch:enum_CRDCH_SpecimenContainer_container_type domain: SpecimenContainer multivalued: false range: CodeableConcept required: false container_number: name: container_number exact_mappings: - GDC:Analyte.well_number - PDC:Analyte.well_number description: Informal number by which the container is referenced or identified (e.g. a slide number, or a well number in a plate) notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenContainer multivalued: false range: crdch_string required: false additive: name: additive exact_mappings: - HTAN:Biospecimen.CollectionMedia description: A material substance added to the container (typically to support the primary contained object - e.g. culture media to support cell growth) notes: - 'Cardinality: 0..m' examples: - value: DMEM - value: DMEM+Serum - value: RPMI - value: RPMI+Serum domain: SpecimenContainer multivalued: true inlined_as_list: true range: Substance required: false parent_container: name: parent_container description: A larger container of which this container is a part (e.g. the complete 96-well plate of which a single well is a part) notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenContainer multivalued: false range: SpecimenContainer required: false SpecimenCreationActivity: name: SpecimenCreationActivity description: The process of creating a specimen. This may occur through observing and/or collecting material from an biological source or natural setting, or through derivation from an existing specimen (e.g. via portioning or aliquoting). notes: - Derived from [SpecimenCreationActivity in sheet SpecimenCreationActivity](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=693792130) comments: - A creation' activity represents the entire process up to the point where the specimen is physically modified, stored, or transported. is_a: Entity attributes: activity_type: name: activity_type description: The high-level type of creation activity. notes: - 'Cardinality: 0..1' comments: - At present our model collapses two types of processes through which specimens are created (initial collection from source, and derivation from an existing specimen). The 'category' is a flag to indicate which applies to a given instance, so that more specific recommendations about data entry in certain fields can be specified. examples: - value: Collection from Source - value: Derivation from Specimen values_from: crdch:enum_CRDCH_SpecimenCreationActivity_activity_type domain: SpecimenCreationActivity multivalued: false range: CodeableConcept required: false date_started: name: date_started close_mappings: - GDC:Sample.days_to_collection - GDC:Portion.creation_datetime - PDC:Portion.creation_datetime - PDC:Sample.days_to_collection - ICDC:Sample.date_of_sample_collection - HTAN:Biospecimen.CollectionDaysfromIndex description: The date when the activity began (in this case, a specimen creation event). notes: - 'Cardinality: 0..1' comments: - To allow for more precise specification of dates when an activity was performed, we provide date_started and date_ended attributes. If source data only provides a single date, it SHOULD be entered as both the date_started and date_ended. examples: - value: '' domain: SpecimenCreationActivity multivalued: false range: TimePoint required: false date_ended: name: date_ended close_mappings: - GDC:Sample.days_to_collection - GDC:Portion.creation_datetime - PDC:Portion.creation_datetime - PDC:Sample.days_to_collection - ICDC:Sample.date_of_sample_collection - HTAN:Biospecimen.CollectionDaysfromIndex description: The date when the activity ended (in this case, a specimen creation event). notes: - 'Cardinality: 0..1' comments: - To allow for more precise specification of dates when an activity was performed, we provide date_started and date_ended attributes. If source data only provides a single date, it SHOULD be entered as both the date_started and date_ended. examples: - value: '' domain: SpecimenCreationActivity multivalued: false range: TimePoint required: false performed_by: name: performed_by description: The organization or group that performed the activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenCreationActivity multivalued: false range: Organization required: false collection_method_type: name: collection_method_type exact_mappings: - GDC:Sample.method_of_sample_procurement - PDC:Sample.method_of_sample_procurement - PDC:Sample.pool - PDC:Aliquot.pool - HTAN:Biospecimen.AcquisitionMethodType description: The type of method applied in collecting a sample from its original source. notes: - 'Cardinality: 0..1' comments: - This attribute applies only when the Specimen.category = 'original'. examples: - value: Anterior Resection of Rectum - value: Ascites Drainage - value: Excisional Biopsy - value: Specimen Pooling values_from: crdch:enum_CRDCH_SpecimenCreationActivity_collection_method_type domain: SpecimenCreationActivity multivalued: false range: CodeableConcept required: false derivation_method_type: name: derivation_method_type exact_mappings: - HTAN:Biospecimen.SlicingMethod - HTAN:Biospecimen.MethodofNucleicAcidIsolation description: The type of method applied to derive a new specimen from an existing one. notes: - 'Cardinality: 0..1' comments: - This attribute applies only when Specimen.category = 'portion', 'aliquot', 'analyte', or 'slide'. examples: - value: Vibratome - value: Cryosectioning - value: Tissuemolds - value: Slidingmicrotome - value: Sectioning - value: Other - value: Unknown - value: NotReported values_from: crdch:enum_CRDCH_SpecimenCreationActivity_derivation_method_type domain: SpecimenCreationActivity multivalued: false range: CodeableConcept required: false additive: name: additive close_mappings: - HTAN:Biospecimen.LysisBuffer description: A type of material or reagent used applied as input when creating a specimen. notes: - 'Cardinality: 0..m' examples: - value: '' domain: SpecimenCreationActivity multivalued: true inlined_as_list: true range: Substance required: false collection_site: name: collection_site close_mappings: - GDC:Sample.biospecimen_anatomic_site - GDC:Sample.biospecimen_laterality - PDC:Sample.biospecimen_anatomic_site - PDC:Sample.biospecimen_laterality - ICDC:Sample.sample_site - HTAN:Biospecimen.SiteofResectionorBiopsy description: The anatomic site from which a specimen was collected. notes: - 'Cardinality: 0..1' comments: - This attribute is used when SpecimenCreationActivity.activity_type = 'Collection from Source'. examples: - value: Abdomen - value: Abdominal Wall - value: Acetabulum domain: SpecimenCreationActivity multivalued: false range: BodySite required: false quantity_collected: name: quantity_collected close_mappings: - GDC:Sample.initial_weight - PDC:Sample.initial_weight description: The quantity of material in the specimen as originally collected from its original source material (prior to downstream portioning or processing) notes: - 'Cardinality: 0..1' comments: - This attribute applies only when Specimen.category='initial sample'. examples: - value: '' domain: SpecimenCreationActivity multivalued: false range: Quantity required: false execution_time_observation: name: execution_time_observation close_mappings: - GDC:Sample.time_between_excision_and_freezing - GDC:Sample.time_between_clamping_and_freezing - PDC:Sample.time_between_excision_and_freezing - PDC:Sample.time_between_clamping_and_freezing description: Information describing how long certain parts on an activity took to complete. notes: - 'Cardinality: 0..m' examples: - value: '' domain: SpecimenCreationActivity multivalued: true inlined_as_list: true range: ExecutionTimeObservation required: false execution_condition_observation: name: execution_condition_observation close_mappings: - HTAN:Biospecimen.ISCHEMIC_TEMPERATURE - HTAN:Biospecimen.ISCHEMIC_TIME description: Information describing the environmental conditions in which an activity, or a specific part of an activity, was performed. notes: - 'Cardinality: 0..m' examples: - value: '' domain: SpecimenCreationActivity multivalued: true inlined_as_list: true range: ExecutionConditionObservation required: false specimen_order: name: specimen_order exact_mappings: - GDC:Portion.portion_number - PDC:Portion.portion_number description: A numeric value that represents the sequential order of this creation activity relative to those producing other specimens from the same source material or parent specimen. notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenCreationActivity multivalued: false range: crdch_integer required: false SpecimenQualityObservation: name: SpecimenQualityObservation description: A structured object that describes a characteristic of a specimen indicative of its quality or suitability for use, as generated through a point-in-time observation or measurement. notes: - Derived from [SpecimenQualityObservation in sheet SpecimenQualityObservation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=97281875) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: SpecimenQualityObservation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..0' comments: - Use only if we don't define named subtypes of Observation for specific categories. examples: - value: '' values_from: crdch:enum_CRDCH_SpecimenQualityObservation_category domain: SpecimenQualityObservation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The specific type of observation made - i.e. the feature or characteristic that was observed, measured, estimated, etc.. notes: - 'Cardinality: 1..1' comments: - This field holds the 'key' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. examples: - value: '' values_from: crdch:enum_CRDCH_SpecimenQualityObservation_observation_type domain: SpecimenQualityObservation multivalued: false range: CodeableConcept required: true method_type: name: method_type description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..m' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy',). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_SpecimenQualityObservation_method_type domain: SpecimenQualityObservation multivalued: true range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..m' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: SpecimenQualityObservation multivalued: true inlined_as_list: true range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenQualityObservation multivalued: false range: Subject required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenQualityObservation multivalued: false range: Organization required: false value_quantity: name: value_quantity description: The result of the observation, encoded as a free-text Quantity. notes: - 'Cardinality: 1..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: SpecimenQualityObservation multivalued: false range: Quantity required: true SpecimenQuantityObservation: name: SpecimenQuantityObservation description: A structured object that describes a single data item about the quantity of an entity, as generated through a point-in-time observation or measurement. notes: - Derived from [SpecimenQuantityObservation in sheet SpecimenQuantityObservation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=9917708) comments: - At the core of an Observation is a flexible key-value pair (or a structured collection of key-value pairs), where a 'key' field defines the type of observation made, and the 'value' field describes the value or outcome of the observation. The fact that the type of observation captured is defined in the data allow Observation to convey a broad range of observation data. is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: SpecimenQuantityObservation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..0' comments: - Use only if we don't define named subtypes of Observation for specific categories. examples: - value: '' values_from: crdch:enum_CRDCH_SpecimenQuantityObservation_category domain: SpecimenQuantityObservation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The specific type of observation made - i.e. the feature or characteristic that was observed, measured, estimated, etc.. notes: - 'Cardinality: 1..1' comments: - This field holds the 'key' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. examples: - value: '' values_from: crdch:enum_CRDCH_SpecimenQuantityObservation_observation_type domain: SpecimenQuantityObservation multivalued: false range: CodeableConcept required: true method_type: name: method_type exact_mappings: - GDC:Analyte.spectrophotometer_method - PDC:Analyte.spectrophotometer_method description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..m' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy',). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_SpecimenQuantityObservation_method_type domain: SpecimenQuantityObservation multivalued: true range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..m' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: SpecimenQuantityObservation multivalued: true inlined_as_list: true range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenQuantityObservation multivalued: false range: Subject required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenQuantityObservation multivalued: false range: Organization required: false value_quantity: name: value_quantity description: The result of the observation, encoded as a free-text Quantity. notes: - 'Cardinality: 1..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: SpecimenQuantityObservation multivalued: false range: Quantity required: true SpecimenProcessingActivity: name: SpecimenProcessingActivity description: An activity that modifies the physical structure, composition, or state of a specimen. Unlike SpecimenCreation, SpecimenProcessing activities do not result in the generation of new entities - they take a single specimen as input, and output that same specimen. notes: - Derived from [SpecimenProcessingActivity in sheet SpecimenProcessingActivity](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1726416617) comments: - '"Processing" as defined here alters the physical nature of a specimen, such that storage or transport activities do not qualify as processing activities. When instantiating this class, create a separate instances for each type/method of processing performed (e.g. each method of fixation, freezing, labeling, etc. that is applied).' is_a: Entity attributes: activity_type: name: activity_type description: The high-level type of processing activity notes: - 'Cardinality: 0..1' examples: - value: Fixation - value: Freezing - value: Mounting - value: Preservation values_from: crdch:enum_CRDCH_SpecimenProcessingActivity_activity_type domain: SpecimenProcessingActivity multivalued: false range: CodeableConcept required: false date_started: name: date_started close_mappings: - HTAN:Biospecimen.ProcessingDaysfromIndex - HTAN:Biospecimen.SectioningDaysfromIndex description: The date when the activity began (in this case, a specimen processing event). notes: - 'Cardinality: 0..1' comments: - To allow for more precise specification of dates when an activity was performed, we provide date_started and date_ended attributes. If source data only provides a single date, it SHOULD be entered as both the date_started and date_ended. examples: - value: '' domain: SpecimenProcessingActivity multivalued: false range: TimePoint required: false date_ended: name: date_ended close_mappings: - HTAN:Biospecimen.ProcessingDaysfromIndex description: The date when the activity began (in this case, a specimen processing event). notes: - 'Cardinality: 0..1' comments: - To allow for more precise specification of dates when an activity was performed, we provide date_started and date_ended attributes. If source data only provides a single date, it SHOULD be entered as both the date_started and date_ended. examples: - value: '' domain: SpecimenProcessingActivity multivalued: false range: TimePoint required: false duration: name: duration close_mappings: - HTAN:Biospecimen.FIXATION_DURATION description: The length of time over which the activity was performed. examples: - value: '' domain: SpecimenProcessingActivity multivalued: true inlined_as_list: true range: Quantity required: false performed_by: name: performed_by exact_mappings: - GDC:Sample.processed_at - HTAN:Biospecimen.ProcessingLocation description: The organization or group that performed the activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenProcessingActivity multivalued: false range: Organization required: false method_type: name: method_type exact_mappings: - GDC:Sample.freezing_method - GDC:Sample.preservation_method - GDC:Sample.is_ffpe - GDC:Portion.is_ffpe - GDC:Sample.oct_embedded - PDC:Sample.freezing_method - PDC:Sample.preservation_method - PDC:Sample.is_ffpe - GDC:Portion.is_ffpe - PDC:Sample.oct_embedded - HTAN:Biospecimen.PRESERVATION_METHOD - ICDC:Sample.sample_preservation description: A specific type of method or procedure performed to process the specimen notes: - 'Cardinality: 0..1' examples: - value: Snap Freezing - value: Cryopreservation in liquid nitrogen (dead tissue) - value: Cryopreservation in dry ice (dead tissue) - value: Formalin fixed paraffin embedded (FFPE) - value: Formalin fixed-unbuffered - value: Formalin fixed-buffered - value: OCT values_from: crdch:enum_CRDCH_SpecimenProcessingActivity_method_type domain: SpecimenProcessingActivity multivalued: false range: CodeableConcept required: false additive: name: additive close_mappings: - HTAN:Biospecimen.FixativeType - HTAN:Biospecimen.MountingMedium description: A type of material or reagent used as input when processing the specimen notes: - 'Cardinality: 0..m' examples: - value: Formalin domain: SpecimenProcessingActivity multivalued: true inlined_as_list: true range: Substance required: false execution_time_observation: name: execution_time_observation description: Information describing how long certain parts on an activity took to complete. notes: - 'Cardinality: 0..m' examples: - value: '' domain: SpecimenProcessingActivity multivalued: true inlined_as_list: true range: ExecutionTimeObservation required: false execution_condition_observation: name: execution_condition_observation description: Information describing the environmental conditions in which an activity, or a specific part of an activity, was performed. notes: - 'Cardinality: 0..m' examples: - value: '' domain: SpecimenProcessingActivity multivalued: true inlined_as_list: true range: ExecutionConditionObservation required: false SpecimenStorageActivity: name: SpecimenStorageActivity description: "An activity in which a specimen is stored or maintained in a particular\ \ location, container, or state. Unlike 'processing' activities, storage does\ \ not alter the \nintrinsic physical nature of a specimen." notes: - Derived from [SpecimenStorageActivity in sheet SpecimenStorageActivity](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1583133214) comments: - Think of the StorageActivity as being one of many possible periods when the specimen was stored at some location and in some state or condition. We may want to capture storage dates and conditions for each. is_a: Entity attributes: date_started: name: date_started description: The date when the activity began (in this case, a storage event). notes: - 'Cardinality: 0..1' comments: - To allow for more precise specification of dates when an activity was performed, we provide date_started and date_ended attributes. If source data only provides a single date, it SHOULD be entered as both the date_started and date_ended. examples: - value: '' domain: SpecimenStorageActivity multivalued: false range: TimePoint required: false date_ended: name: date_ended description: The date when the activity ended (in this case, a storage event). notes: - 'Cardinality: 0..1' comments: - To allow for more precise specification of dates when an activity was performed, we provide date_started and date_ended attributes. If source data only provides a single date, it SHOULD be entered as both the date_started and date_ended. examples: - value: '' domain: SpecimenStorageActivity multivalued: false range: TimePoint required: false duration: name: duration description: The length of time over which the activity was performed. notes: - 'Cardinality: 0..1' comments: - 'Quantity.unit MUST be a unit of time. ' examples: - value: '' domain: SpecimenStorageActivity multivalued: false range: Quantity required: false performed_by: name: performed_by description: The organization or group that performed the activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenStorageActivity multivalued: false range: Organization required: false method_type: name: method_type exact_mappings: - HTAN:Biospecimen.StorageMethod description: A specific type of method or procedure performed to store the specimen notes: - 'Cardinality: 0..1' examples: - value: ambient temperature - value: cut slide - value: fresh - value: frozen at -70C - value: frozen at -150C - value: frozen in liquid nitrogen - value: frozen in vapor phase - value: paraffin block - value: RNAlater at 4C values_from: crdch:enum_CRDCH_SpecimenStorageActivity_method_type domain: SpecimenStorageActivity multivalued: false range: CodeableConcept required: false container: name: container description: A container in which the specimen is held or affixed during its storage. notes: - 'Cardinality: 0..m' examples: - value: '' domain: SpecimenStorageActivity multivalued: true inlined_as_list: true range: SpecimenContainer required: false SpecimenTransportActivity: name: SpecimenTransportActivity description: An activity through which a specimen is transported between locations or organizations. notes: - Derived from [SpecimenTransportActivity in sheet SpecimenTransportActivity](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=359352096) comments: - Think of the TransportActivity as being one of many possible occasions when the specimen was moved from one location to another, in some state or condition. We may want to capture dates and conditions for each. is_a: Entity attributes: date_started: name: date_started description: The date when the activity began (in this case, a transport event). notes: - 'Cardinality: 0..1' comments: - To allow for more precise specification of dates when an activity was performed, we provide date_started and date_ended attributes. If source data only provides a single date, it SHOULD be entered as both the date_started and date_ended. examples: - value: '' domain: SpecimenTransportActivity multivalued: false range: TimePoint required: false date_ended: name: date_ended description: The date when the activity ended (in this case, a transport event). notes: - 'Cardinality: 0..1' comments: - To allow for more precise specification of dates when an activity was performed, we provide date_started and date_ended attributes. If source data only provides a single date, it SHOULD be entered as both the date_started and date_ended. examples: - value: '' domain: SpecimenTransportActivity multivalued: false range: TimePoint required: false duration: name: duration description: The length of time over which the activity was performed. examples: - value: '' domain: SpecimenTransportActivity multivalued: true inlined_as_list: true range: crdch_string required: false performed_by: name: performed_by description: The organization or group that performed the activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenTransportActivity multivalued: false range: Organization required: false transport_origin: name: transport_origin description: An organization (facility, site, lab, etc) from which the specimen was transported as a result of the activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenTransportActivity multivalued: false range: Organization required: false transport_destination: name: transport_destination exact_mappings: - GDC:Portion.shipped_to - GDC:Aliquot.shipped_to description: An organization (facility, site, lab, etc) to which the specimen is delivered as a result of the activity. notes: - 'Cardinality: 0..1' examples: - value: '' domain: SpecimenTransportActivity multivalued: false range: Organization required: false execution_condition_observation: name: execution_condition_observation close_mappings: - HTAN:Biospecimen.SHIPPING_CONDITIONS description: Information describing the environmental conditions in which an activity, or a specific part of an activity, was performed. notes: - 'Cardinality: 0..m' comments: - 'e.g. that a specimen was shipped with an ice pack, or at a specific temperature. ' examples: - value: '' domain: SpecimenTransportActivity multivalued: true inlined_as_list: true range: ExecutionConditionObservation required: false Subject: name: Subject description: Demographics and other administrative information about an individual or animal receiving care or other health-related services. notes: - Derived from [Subject in sheet Subject](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1651956379) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 1..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: Subject multivalued: false range: crdch_string required: true identifier: name: identifier exact_mappings: - ICDC:Case.patient_id description: A 'business' identifier or accession number for the entity, typically as provided by an external system or authority, that are globally unique and persist across implementing systems. Also, since these identifiers are created outside the information system through a specific business process, the Identifier type has additional attributes to capture this additional metadata so the actual identifier values are qualified by the context that created those values. This additional context allows "identifier" instances to be transmitted as business data across systems while still being able to trace them back to the system of origin. notes: - 'Cardinality: 0..m' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' domain: Subject multivalued: true inlined_as_list: true range: Identifier required: false species: name: species description: The scientific binomial name for the species of the subject (e.g. Homo sapiens, Mus musculus, etc.) notes: - 'Cardinality: 0..1' examples: - value: Homo sapiens - value: Canis familiaris - value: Mus musculus values_from: crdch:enum_CRDCH_Subject_species domain: Subject multivalued: false range: CodeableConcept required: false breed: name: breed exact_mappings: - ICDC:Demographic.breed description: A label given to a group of animals homogeneous in appearance and other characteristics that distinguish it from other animals of the same species. notes: - 'Cardinality: 0..1' examples: - value: Affenpinscher - value: Afghan Hound - value: Airedale Terrier - value: Akita values_from: crdch:enum_CRDCH_Subject_breed domain: Subject multivalued: false range: CodeableConcept required: false sex: name: sex exact_mappings: - ICDC:Demographic.sex - GDC:Demographic.gender - PDC:Demographic.gender - HTAN:Demographics.Gender description: The biologic character or quality that distinguishes male and female from one another as expressed by analysis of the person's gonadal, morphologic (internal and external), chromosomal, and hormonal characteristics. notes: - 'Cardinality: 0..1' examples: - value: Female - value: Intersex - value: Male - value: Not Reported - value: Unknown - value: Unspecified values_from: crdch:enum_CRDCH_Subject_sex domain: Subject multivalued: false range: CodeableConcept required: false ethnicity: name: ethnicity exact_mappings: - GDC:Clinical.ethnicity - GDC:Demographic.ethnicity - PDC:Demographic.ethnicity - HTAN:Demographics.Ethnicity description: An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau notes: - 'Cardinality: 0..1' comments: - Applicable only when Subject.species is Homo Sapiens examples: - value: Hispanic or Latino - value: Not Allowed To Collect - value: Not Hispanic or Latino - value: Not Reported - value: Unknown values_from: crdch:enum_CRDCH_Subject_ethnicity domain: Subject multivalued: false range: CodeableConcept required: false race: name: race exact_mappings: - GDC:Clinical.race - GDC:Demographic.race - PDC:Demographic.race - HTAN:Demographics.Race description: An arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation within a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau. notes: - 'Cardinality: 0..m' examples: - value: American Indian or Alaska Native - value: Asian - value: Black or African American - value: Native Hawaiian or other Pacific Islander - value: Not Allowed To Collect - value: Not Reported - value: Unknown - value: White values_from: crdch:enum_CRDCH_Subject_race domain: Subject multivalued: true range: CodeableConcept required: false year_of_birth: name: year_of_birth exact_mappings: - GDC:Demographic.year_of_birth - PDC:Demographic.year_of_birth - ICDC:Demographic.date_of_birth - HTAN:Demographics.YearOfBirth description: Numeric value to represent the calendar year in which an individual was born. notes: - 'Cardinality: 0..1' comments: - Applicable only when Subject.species is Homo Sapiens examples: - value: '' domain: Subject multivalued: false range: crdch_integer required: false vital_status: name: vital_status exact_mappings: - GDC:Demographic.vital_status - PDC:Demographic.vital_status - HTAN:Demographics.VitalStatus description: Coded value indicating the state or condition of being living or deceased; also includes the case where the vital status is unknown. notes: - 'Cardinality: 0..1' examples: - value: Alive - value: Dead - value: Unknown - value: Not Reported values_from: crdch:enum_CRDCH_Subject_vital_status domain: Subject multivalued: false range: CodeableConcept required: false age_at_death: name: age_at_death close_mappings: - GDC:Demographic.days_to_death - PDC:Demographic.days_to_death description: The age of an individual at the time of death, expressed in days since birth notes: - 'Cardinality: 0..1' examples: - value: '' domain: Subject multivalued: false range: Quantity required: false year_of_death: name: year_of_death exact_mappings: - GDC:Demographic.year_of_death - PDC:Demographic.year_of_death description: Numeric value to represent the calendar year in which an individual died. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Subject multivalued: false range: crdch_integer required: false cause_of_death: name: cause_of_death exact_mappings: - GDC:Demographic.cause_of_death - PDC:Demographic.cause_of_death description: Coded value indicating the circumstance or condition that results in the death of the subject. notes: - 'Cardinality: 0..1' examples: - value: Cancer Related - value: Cardiovascular Disorder, NOS - value: End-stage Renal Disease - value: '' values_from: crdch:enum_CRDCH_Subject_cause_of_death domain: Subject multivalued: false range: CodeableConcept required: false Substance: name: Substance description: A type of material substance, or instance thereof, as used in a particular application. May include information about the role the substance played in a particular application. notes: - Derived from [Substance in sheet Substance](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=385534272) is_a: Entity attributes: substance_type: name: substance_type exact_mappings: - HTAN:Biospecimen.LysisBuffer - HTAN:Biospecimen.FixativeType - HTAN:Biospecimen.MountingMedium - HTAN:Biospecimen.CollectionMedia - GDC:Treatment.therapeutic_agents - PDC:Treatment.therapeutic_agents description: The specific type of the substance - at as granular a level as possible. May be a specific chemical compound, or the name of a formulation/preparation made up of many compounds. notes: - 'Cardinality: 0..1' examples: - value: toluene - value: formalin - value: DMEM values_from: crdch:enum_CRDCH_Substance_substance_type domain: Substance multivalued: false range: CodeableConcept required: false role: name: role description: A role played by the substance in a particular application (e.g. the role of a lysis buffer when applied in a specimen creation activity, or the role of fixative when applied in specimen processing) notes: - 'Cardinality: 0..m' examples: - value: lysis buffer - value: fixative - value: mounting medium - value: collection media values_from: crdch:enum_CRDCH_Substance_role domain: Substance multivalued: true range: CodeableConcept required: false substance_quantity: name: substance_quantity exact_mappings: - GDC:Treatment.treatment_dose - GDC:Treatment.treatment_dose_unit description: The quantity of substance this instance stands for. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Substance multivalued: false range: Quantity required: false TimePoint: name: TimePoint description: A structured representation of a single point in time that allows direct/explicit declaration as a dateTime, specification in terms of offset from a defined index, or description of an event type as a proxy for the time point when it occurred. notes: - Derived from [TimePoint in sheet TimePoint](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=300932847) comments: - 'The TimePoint object supports three ways to specify a point in time. The date_time field is the most direct - capturing an explicit date (e.g. 2021-05-05). The paired fields index_time_point and offset_from_index allows specification of a point in time as an offset from a related fixed time point. Finally, the event_type field uses type of event as a proxy for the time point when the event occurred. ' is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: TimePoint multivalued: false range: crdch_string required: false date_time: name: date_time exact_mappings: - GDC:Portion.creation_datetime - PDC:Portion.creation_datetime - ICDC:Sample.date_of_sample_collection - ICDC:Study.date_of_iacuc_approval - GDC:Diagnosis.year_of_diagnosis - PDC:Diagnosis.year_of_diagnosis description: An explicitly specified timepoint described in terms of a date and optionally a time on that date. notes: - 'Cardinality: 0..1' comments: - 'Use when the TimePeriod is just a single instant / point in time. ' examples: - value: '' domain: TimePoint multivalued: false range: crdch_dateTime required: false index_time_point: name: index_time_point description: Another TimePoint from which this point is offset. notes: - 'Cardinality: 0..1' examples: - value: '' domain: TimePoint multivalued: false range: TimePoint required: false offset_from_index: name: offset_from_index close_mappings: - HTAN:Biospecimen.CollectionDaysfromIndex - HTAN:Biospecimen.ProcessingDaysfromIndex - HTAN:Biospecimen.SectioningDaysfromIndex - PDC:Sample.days_to_collection - GDC:Treatment.days_to_treatment_end - PDC:Treatment.days_to_treatment_end - GDC:Treatment.days_to_treatment_start - PDC:Treatment.days_to_treatment_start - GDC:Diagnosis.days_to_diagnosis - PDC:Diagnosis.days_to_diagnosis description: A quantity of time that, together with the index date or event, can be used to derive a specific timepoint. notes: - 'Cardinality: 0..1' comments: - Quantity.unit MUST be a unit of time, and SHOULD be set to 'days'. examples: - value: '' domain: TimePoint multivalued: false range: Quantity required: false event_type: name: event_type description: An event that occurred at the point in time specified by this TimePoint. notes: - 'Cardinality: 0..m' comments: - eventType can be used to associate a label for a particular event (e.g. IACUC approval, embargo lifted, etc.) to a dateTime. examples: - value: '' values_from: crdch:enum_CRDCH_TimePoint_event_type domain: TimePoint multivalued: true range: CodeableConcept required: false TimePeriod: name: TimePeriod description: A period of time between a start and end time point. notes: - Derived from [TimePeriod in sheet TimePeriod](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1590126992) is_a: Entity attributes: ? 'period_start start' : name: 'period_start start' description: When a period of time started. notes: - 'Cardinality: 0..1' examples: - value: '' domain: TimePeriod multivalued: false range: TimePoint required: false ? 'period_end end' : name: 'period_end end' description: When a period of time ended. notes: - 'Cardinality: 0..1' examples: - value: '' domain: TimePeriod multivalued: false range: TimePoint required: false TobaccoExposureObservation: name: TobaccoExposureObservation description: A structured object that describes a single data item about an individual's exposure to tobacco, as generated through a point-in-time observation, measurement, or interpretation. notes: - Derived from [TobaccoExposureObservation in sheet TobaccoExposureObservation](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=1464668175) is_a: Entity attributes: id: name: id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..0' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: TobaccoExposureObservation multivalued: false range: crdch_string required: false category: name: category description: The general category of observation described notes: - 'Cardinality: 0..0' examples: - value: '' values_from: crdch:enum_CRDCH_TobaccoExposureObservation_category domain: TobaccoExposureObservation multivalued: false range: CodeableConcept required: false observation_type: name: observation_type description: The specific type of tobacco exposure observation made - i.e. the feature or characteristic that was observed, measured, estimated, etc.. notes: - 'Cardinality: 1..1' comments: - This field holds the 'key' in the core key-value pair comprised of the observation_type field and the relevant value(s) field. examples: - value: cigarettes_per_day - value: environmental_tobacco_smoke_exposure - value: pack_years_smoked - value: smoking_frequency - value: time_between_waking_and_first_smoke - value: tobacco_smoking_onset_year - value: tobacco_smoking_quit_year - value: tobacco_smoking_status - value: type_of_tobacco_used - value: years_smoked values_from: crdch:enum_CRDCH_TobaccoExposureObservation_observation_type domain: TobaccoExposureObservation multivalued: false range: CodeableConcept required: true method_type: name: method_type description: A type of method used in generating the Observation result. notes: - 'Cardinality: 0..0' comments: - This may be a type of observational, measurement, experimental, or computational method specifying how to generate data (e.g. 'manual counting', 'bright field microscopy',). Or a Guideline or SOP specifying how to interpret data and/or encode the result of an Observation (e.g. a Cancer Staging system such as that defined by the AJCC, or variant interpretation guideline such as that provided by the ACMG). examples: - value: '' values_from: crdch:enum_CRDCH_TobaccoExposureObservation_method_type domain: TobaccoExposureObservation multivalued: false range: CodeableConcept required: false focus: name: focus description: The entity or entities directly observed/measured in generating an observation result. notes: - 'Cardinality: 0..0' comments: - 'The ''focus'', ''subject'', and ''specimen'' fields are useful when data creators want an Observation object to stand on its own, so it can point back to the entities it is about. These fields are not needed when an Observation is embedded in a Specimen or other entity, where focus, subject, and specimen can be determined from context. ' examples: - value: '' domain: TobaccoExposureObservation multivalued: false range: Entity required: false subject: name: subject description: The patient that the observation is about (if not the direct focus). e.g. observations are often made on specimens derived from a patient, or other entities related to a patient, that ultimately tell us something about the patient of interest. notes: - 'Cardinality: 0..0' examples: - value: '' domain: TobaccoExposureObservation multivalued: false range: Subject required: false performed_by: name: performed_by description: The organization or group that performed the observation activity. notes: - 'Cardinality: 0..0' examples: - value: '' domain: TobaccoExposureObservation multivalued: false range: Organization required: false value_integer: name: value_integer exact_mappings: - GDC:Exposure.cigarettes_per_day - PDC:Exposure.cigarettes_per_day - GDC:Exposure.pack_years_smoked - PDC:Exposure.pack_years_smoked - GDC:Exposure.tobacco_smoking_onset_year - PDC:Exposure.tobacco_smoking_onset_year - GDC:Exposure.tobacco_smoking_quit_year - PDC:Exposure.tobacco_smoking_quit_year - GDC:Exposure.years_smoked - PDC:Exposure.years_smoked description: The result of the observation, encoded as an integer. notes: - 'Cardinality: 0..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' domain: TobaccoExposureObservation multivalued: false range: crdch_integer required: false value_codeable_concept: name: value_codeable_concept exact_mappings: - GDC:Exposure.environmental_tobacco_smoke_exposure - PDC:Exposure.environmental_tobacco_smoke_exposure - GDC:Exposure.smoking_frequency - PDC:Exposure.smoking_frequency - GDC:Exposure.time_between_waking_and_first_smoke - PDC:Exposure.time_between_waking_and_first_smoke - GDC:Exposure.tobacco_smoking_status - PDC:Exposure.tobacco_smoking_status - GDC:Exposure.type_of_tobacco_used - PDC:Exposure.type_of_tobacco_used description: The result of the observation, encoded as a CodeableConcept. notes: - 'Cardinality: 0..1' comments: - One and only one of the value(x) fields must be populated. examples: - value: '' values_from: crdch:enum_CRDCH_TobaccoExposureObservation_value_codeable_concept domain: TobaccoExposureObservation multivalued: false range: CodeableConcept required: false Treatment: name: Treatment description: Represent medication administration or other treatment types. notes: - Derived from [Treatment in sheet Treatment](https://docs.google.com/spreadsheets/d/1oWS7cao-fgz2MKWtyr8h2dEL9unX__0bJrWKv6mQmM4/edit#gid=2111784779) comments: - This entity is overloaded with the idea of medication/substance based treatments, and other more procedure-like interventions that are also considered to be a treatment. We should probably separate these concerns and it will be useful to have a "Procedure" entity long term. If that is done, this entity will be renamed to "MedicationTreatment" or something like that and the other concerns refactored out to other entities. Also, if we can consider a medication/substance based treatment as a procedure as well (which is commonly the case in other models), we can make this entity more about the individual doses for such treatments if that level of granularity is needed. is_a: Entity attributes: id: name: id exact_mappings: - GDC:Treatment.id - PDC:Treatment.id description: The 'logical' identifier of the entity within the system of record. The simple value of this attribute stands for an identifier of this data object within the system, it can be used as a reference from other objects within the same system (i.e. primary and foreign keys), and it should be unique per type of object. The same data object copied to a different system will likely have a different "id" in the new system since "id" values are system specific and do not represent persistent business identifiers. Business identifiers are assigned outside the information system and are captured in the "identifier" field. The "id" field is more likely to be a serially or randomly generated value that is assigned to the data object as it is created in a system. notes: - 'Cardinality: 0..1' comments: - 'FHIR naming conventions are followed here, where ''id'' is used for logical identifiers, and ''identifier'' for business identifiers. The identified entity may have a different ''id'' in a different system, and have many external business ''identifiers'' associated with it. If an "id" value can also be considered to be a business identifier, and should be transmissible to other systems, it should be duplicated in the "identifier" attribute along with the additional metadata needed to give context to the value of "id". An entity in this model that does not have an "id" field is considered to be an embeddable entity that can not stand on its own. ' examples: - value: '' domain: Treatment multivalued: false range: crdch_string required: false identifier: name: identifier description: A 'business' identifier or accession number for the entity, typically as provided by an external system or authority, that are globally unique and persist across implementing systems. Also, since these identifiers are created outside the information system through a specific business process, the Identifier type has additional attributes to capture this additional metadata so the actual identifier values are qualified by the context that created those values. This additional context allows "identifier" instances to be transmitted as business data across systems while still being able to trace them back to the system of origin. notes: - 'Cardinality: 0..m' comments: - FHIR naming conventions are followed here, where 'id' is used for logical identifiers which are unique only within a given system, and 'identifier' for business identifiers, which are used to connect entities or share content across systems. The complex 'Identifier' data type is used to capture the identifier itself, along with metadata about its source. examples: - value: '' domain: Treatment multivalued: true inlined_as_list: true range: Identifier required: false treatment_for_diagnosis: name: treatment_for_diagnosis close_mappings: - GDC:Treatment.diagnosis - PDC:Treatment.Diagnosis - GDC:Treatment.initial_disease_status - PDC:Treatment.initial_disease_status description: The diagnosis for which this treatment is intended. notes: - 'Cardinality: 0..m' examples: - value: '' domain: Treatment multivalued: true inlined_as_list: true range: Diagnosis required: false concurrent_treatment: name: concurrent_treatment close_mappings: - GDC:Treatment.chemo_concurrent_to_radiation description: Treatment instance(s) that are concurrent with this treatment. notes: - 'Cardinality: 0..m' examples: - value: '' domain: Treatment multivalued: true inlined_as_list: true range: Treatment required: false treatment_type: name: treatment_type exact_mappings: - GDC:Treatment.treatment_type - PDC:Treatment.treatment_type description: The type of treatment administered, which may include medication/therapeutics or other procedures. notes: - 'Cardinality: 0..1' examples: - value: Ablation - value: Radiofrequency - value: Stem Cell Transplantation - value: Ablation, Cryo Ablation - value: Ethanol Injection Ablation - value: Microwave Ablation values_from: crdch:enum_CRDCH_Treatment_treatment_type domain: Treatment multivalued: false range: CodeableConcept required: false subject: name: subject description: The subject (person, animal, model system) to which the treatment was administered. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Treatment multivalued: false range: Subject required: false date_started: name: date_started close_mappings: - GDC:Treatment.days_to_treatment_start - PDC:Treatment.days_to_treatment_start description: The timepoint at which the treatment started. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Treatment multivalued: false range: TimePoint required: false date_ended: name: date_ended close_mappings: - GDC:Treatment.days_to_treatment_end - PDC:Treatment.days_to_treatment_end description: The timepoint at which the treatment ended. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Treatment multivalued: false range: TimePoint required: false treatment_end_reason: name: treatment_end_reason exact_mappings: - GDC:Treatment.reason_treatment_ended description: The reason the treatment ended. notes: - 'Cardinality: 0..m' examples: - value: Adverse Event Course of Therapy Completed - value: Death - value: Disease Progression - value: Other values_from: crdch:enum_CRDCH_Treatment_treatment_end_reason domain: Treatment multivalued: true range: CodeableConcept required: false regimen: name: regimen exact_mappings: - GDC:Treatment.regimen_or_line_of_therapy - PDC:Treatment.regimen_or_line_of_therapy description: The regimen or line of therapy notes: - 'Cardinality: 0..1' examples: - value: '' values_from: crdch:enum_CRDCH_Treatment_regimen domain: Treatment multivalued: false range: CodeableConcept required: false therapeutic_agent: name: therapeutic_agent close_mappings: - GDC:Treatment.therapeutic_agents - PDC:Treatment.therapeutic_agents - GDC:Treatment.treatment_dose - GDC:Treatment.treatment_dose_unit description: One or more therapeutic agents that are administered as part of this treatment. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Treatment multivalued: false range: Substance required: false number_of_cycles: name: number_of_cycles exact_mappings: - GDC:Treatment.number_of_cycles description: The number of treatment cycles the subject received. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Treatment multivalued: false range: crdch_integer required: false treatment_frequency: name: treatment_frequency exact_mappings: - GDC:Treatment.treatment_frequency description: The frequency of using the substance described by this instance. notes: - 'Cardinality: 0..1' examples: - value: Every Hour - value: Five Times Daily - value: Four Times Daily - value: Three Times Daily values_from: crdch:enum_CRDCH_Treatment_treatment_frequency domain: Treatment multivalued: false range: CodeableConcept required: false treatment_anatomic_site: name: treatment_anatomic_site close_mappings: - GDC:Treatment.treatment_anatomic_site - PDC:Treatment.treatment_anatomic_site description: The anatomical site that the treatment targets. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Treatment multivalued: false range: BodySite required: false treatment_intent: name: treatment_intent exact_mappings: - GDC:Treatment.treatment_intent_type - PDC:Treatment.treatment_intent_type description: The medical intent of the treatment. notes: - 'Cardinality: 0..1' examples: - value: Adjuvant - value: Cure - value: Palliative values_from: crdch:enum_CRDCH_Treatment_treatment_intent domain: Treatment multivalued: false range: CodeableConcept required: false treatment_effect: name: treatment_effect exact_mappings: - GDC:Treatment.treatment_effect - PDC:Treatment.treatment_effect - GDC:Treatment.treatment_effect_indicator description: The effect of a treatment on the diagnosis or tumor. notes: - 'Cardinality: 0..1' examples: - value: Complete Necrosis (No Viable Tumor) - value: No Necrosis values_from: crdch:enum_CRDCH_Treatment_treatment_effect domain: Treatment multivalued: false range: CodeableConcept required: false treatment_outcome: name: treatment_outcome exact_mappings: - GDC:Treatment.treatment_outcome - PDC:Treatment.treatment_outcome description: The final outcome of the treatment. notes: - 'Cardinality: 0..1' examples: - value: Complete Response - value: Mixed Response - value: No Measurable Disease - value: No Response - value: Partial Response - value: Persistent Disease values_from: crdch:enum_CRDCH_Treatment_treatment_outcome domain: Treatment multivalued: false range: CodeableConcept required: false treatment_dose: name: treatment_dose exact_mappings: - GDC:Treatment.treatment_dose - ICDC:AgentAdministration.medication_actual_dose description: The amount of the treatment given. notes: - 'Cardinality: 0..1' examples: - value: '' domain: Treatment multivalued: false range: Quantity required: false generation_date: '2021-12-16T17:59:41.886169+00:00'